Citrus Sinensis ID: 020946
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 319 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFV3 | 436 | Probable leucine-rich rep | no | no | 0.984 | 0.720 | 0.514 | 7e-84 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.645 | 0.221 | 0.535 | 3e-60 | |
| Q9FX99 | 663 | Probable receptor-like pr | no | no | 0.699 | 0.336 | 0.504 | 7e-57 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.918 | 0.341 | 0.398 | 1e-56 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.843 | 0.649 | 0.437 | 1e-55 | |
| Q9SR05 | 850 | Receptor-like protein kin | no | no | 0.902 | 0.338 | 0.401 | 2e-55 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.858 | 0.330 | 0.412 | 5e-55 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.695 | 0.232 | 0.491 | 6e-55 | |
| C0LGV0 | 895 | Probable LRR receptor-lik | no | no | 0.639 | 0.227 | 0.497 | 1e-54 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.655 | 0.410 | 0.488 | 1e-54 |
| >sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 310 bits (795), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 165/321 (51%), Positives = 219/321 (68%), Gaps = 7/321 (2%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGN-SSSRRAATLPIRANGVDS 59
M S ++IGIS+G+ +G+LLA+ F +++ RS + ++ + + TLP+
Sbjct: 1 MVNRSDLVVIGISVGLALGLLLALLLFFAIKWYYGRSHLRRCANEQNSPTLPVHT--AKR 58
Query: 60 CSILSDSTVGPES--PVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFT 117
++ D ES P ++G + W + VSASGIP Y+YKD+QKAT NFT
Sbjct: 59 GVVIPDDRANTESSQPPENGAPTQHQPWW-NNHTKDLTVSASGIPRYNYKDIQKATQNFT 117
Query: 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
T++GQG+FGPVYKA M GE A KV ++S QG++EFQTEV LLGRLHHRNLVNL GYC
Sbjct: 118 TVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLLGRLHHRNLVNLTGYC 177
Query: 178 AEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+K ML+Y FMS GSL + LY E L W R+ IALD++ G+EYLH+GAVPPVIH
Sbjct: 178 VDKSHRMLIYEFMSNGSLENLLYGGEGMQVLNWEERLQIALDISHGIEYLHEGAVPPVIH 237
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
RD+KS+NILLD SMRA+VADFGLS+E ++D+ + ++GT GY+DP YIST +T KSD+Y
Sbjct: 238 RDLKSANILLDHSMRAKVADFGLSKEMVLDRMTSGLKGTHGYMDPTYISTNKYTMKSDIY 297
Query: 297 SFGVLLFELIAGRSPLQGLME 317
SFGV++ ELI P Q LME
Sbjct: 298 SFGVIILELITAIHPQQNLME 318
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 112/209 (53%), Positives = 151/209 (72%), Gaps = 3/209 (1%)
Query: 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR 168
L++AT NF+ +G+G+FG VY +M G+ VAVK+ A S ++F TEV LL R+HHR
Sbjct: 601 LEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHR 660
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLH 227
NLV L+GYC E + +LVY +M GSL HL+ +Y PL W R+ IA D A+GLEYLH
Sbjct: 661 NLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLH 720
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANI-RGTFGYLDPEYIS 285
G P +IHRD+KSSNILLD +MRA+V+DFGLSR+ D H +++ +GT GYLDPEY +
Sbjct: 721 TGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYA 780
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
++ T+KSDVYSFGV+LFEL++G+ P+
Sbjct: 781 SQQLTEKSDVYSFGVVLFELLSGKKPVSA 809
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 7e-57, Method: Compositional matrix adjust.
Identities = 115/228 (50%), Positives = 150/228 (65%), Gaps = 5/228 (2%)
Query: 87 LEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLAT 146
L FK S+S ++SYK++ AT +F T+IGQG FG VYKA+ + G AVK +
Sbjct: 300 LPVFKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNK 359
Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP 206
S+Q E++F E+ LL +LHHRNLV L G+C K + LVY +M GSL HL+ P
Sbjct: 360 VSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHAIGKPP 419
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL---SREE 263
+W R+ IA+DVA LEYLH PP+ HRDIKSSNILLD++ A+++DFGL SR+
Sbjct: 420 PSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDG 479
Query: 264 MVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
V N IRGT GY+DPEY+ T+ T+KSDVYS+GV+L ELI GR
Sbjct: 480 SVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLLELITGR 527
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (560), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 126/316 (39%), Positives = 184/316 (58%), Gaps = 23/316 (7%)
Query: 9 IIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTV 68
I IG GV + CF ++++ + S S ++ LPI N S + ST+
Sbjct: 432 ITAFVIGSAGGVAAVLFCALCFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSAT---KSTI 488
Query: 69 GPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNF--TTLIGQGAFG 126
SG++ NG + SN+ +A +S +++ T NF + +IG G FG
Sbjct: 489 -------SGKSNNGSHL-------SNL-AAGLCRRFSLSEIKHGTHNFDESNVIGVGGFG 533
Query: 127 PVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186
VYK + G VA+K +S+QG EF+TE+ LL RL H++LV+L+GYC E G+ L+
Sbjct: 534 KVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLI 593
Query: 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL 246
Y +MS G+L HLY+ LTW R+ IA+ ARGL YLH GA +IHRD+K++NILL
Sbjct: 594 YDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILL 653
Query: 247 DQSMRARVADFGLSR--EEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLF 303
D++ A+V+DFGLS+ M H ++G+FGYLDPEY + T+KSDVYSFGV+LF
Sbjct: 654 DENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 713
Query: 304 ELIAGRSPLQGLMEQQ 319
E++ R L + ++
Sbjct: 714 EVLCARPALNPSLSKE 729
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (552), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 130/297 (43%), Positives = 180/297 (60%), Gaps = 28/297 (9%)
Query: 24 ISALFCFRYHRKRS--QIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESP-VKSGRNG 80
++ CF +H K+ + ++S RR + R N + PE+P + +N
Sbjct: 1 MNCFSCFYFHEKKKVPRDSDNSYRRNGEVTGRDN----------NKTHPENPKTVNEQNK 50
Query: 81 NGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNF--TTLIGQGAFGPVYKAQMS-TGE 137
N E + +N ++A +S+++L AT NF LIG+G FG VYK ++ TG
Sbjct: 51 NND----EDKEVTNNIAAQT---FSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGM 103
Query: 138 TVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS 197
VAVK L + QG KEF EV++L LHH++LVNL+GYCA+ Q +LVY +MS+GSL
Sbjct: 104 IVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLED 163
Query: 198 HLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA 255
HL D + PL W+ R+ IAL A GLEYLHD A PPVI+RD+K++NILLD A+++
Sbjct: 164 HLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLS 223
Query: 256 DFGLSREEMV-DKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
DFGL++ V DK ++ + GT+GY PEY T T KSDVYSFGV+L ELI GR
Sbjct: 224 DFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGR 280
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 125/311 (40%), Positives = 182/311 (58%), Gaps = 23/311 (7%)
Query: 14 IGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESP 73
IG GVL + CF ++K+ S ++ LPI N +T G +S
Sbjct: 433 IGSAGGVLAVLIGALCFTAYKKKQGYQGGDSHTSSWLPIYGNS---------TTSGTKST 483
Query: 74 VKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNF--TTLIGQGAFGPVYKA 131
+ SG++ NG + SN+ +A +S +++ T NF + +IG G FG VYK
Sbjct: 484 I-SGKSNNGSHL-------SNL-AAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKG 534
Query: 132 QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191
+ VAVK +S+QG EF+TE+ LL RL H++LV+L+GYC E G+ LVY +M+
Sbjct: 535 VIDGTTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMA 594
Query: 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
G+L HLY+ LTW R+ IA+ ARGL YLH GA +IHRD+K++NIL+D++
Sbjct: 595 FGTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWV 654
Query: 252 ARVADFGLSR--EEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG 308
A+V+DFGLS+ M H ++G+FGYLDPEY + T+KSDVYSFGV+LFE++
Sbjct: 655 AKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCA 714
Query: 309 RSPLQGLMEQQ 319
R L + ++
Sbjct: 715 RPALNPSLPKE 725
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (546), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 127/308 (41%), Positives = 176/308 (57%), Gaps = 34/308 (11%)
Query: 7 GLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDS 66
GLI+G +IG ++ V+ + + F RKR Q G+S + +P NG S S+
Sbjct: 405 GLIVGSAIGSLLAVVF-LGSCFVLYKKRKRGQDGHSKTW----MPFSINGTSMGSKYSNG 459
Query: 67 TVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNF--TTLIGQGA 124
T + N N + IP + KD AT NF + IG G
Sbjct: 460 T----TLTSITTNANYR-----------------IPFAAVKD---ATNNFDESRNIGVGG 495
Query: 125 FGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184
FG VYK +++ G VAVK S+QG EF+TE+ +L + HR+LV+L+GYC E + +
Sbjct: 496 FGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMI 555
Query: 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI 244
L+Y +M G++ SHLY LTW R+ I + ARGL YLH G PVIHRD+KS+NI
Sbjct: 556 LIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANI 615
Query: 245 LLDQSMRARVADFGLSR--EEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVL 301
LLD++ A+VADFGLS+ E+ H + ++G+FGYLDPEY + T KSDVYSFGV+
Sbjct: 616 LLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVV 675
Query: 302 LFELIAGR 309
LFE++ R
Sbjct: 676 LFEVLCAR 683
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 6e-55, Method: Compositional matrix adjust.
Identities = 115/234 (49%), Positives = 151/234 (64%), Gaps = 12/234 (5%)
Query: 91 KRSNVVS--ASGIPEYSYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLAT 146
KRS+ S G+ ++Y +L AT NF +T IGQG +G VYK + +G VA+K
Sbjct: 598 KRSSKASLKIEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQE 657
Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP 206
S QGEKEF TE+ LL RLHHRNLV+L+G+C E+G+ MLVY +M G+L ++ + P
Sbjct: 658 GSLQGEKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEP 717
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR----- 261
L + +R+ IAL A+G+ YLH A PP+ HRDIK+SNILLD A+VADFGLSR
Sbjct: 718 LDFAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVP 777
Query: 262 --EEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
E + +H + ++GT GYLDPEY T T KSDVYS GV+L EL G P+
Sbjct: 778 DMEGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPI 831
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (543), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 109/219 (49%), Positives = 151/219 (68%), Gaps = 15/219 (6%)
Query: 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLG 163
+S+K+++ AT NF +IG+G+FG VY+ ++ G+ VAVKV ++ G F EV LL
Sbjct: 596 FSHKEIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHLLS 655
Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP------LTWNLRVHIAL 217
++ H+NLV+ G+C E + +LVY ++S GSLA HL YGP L W R+ +A+
Sbjct: 656 QIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHL----YGPRSKRHSLNWVSRLKVAV 711
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI----R 273
D A+GL+YLH+G+ P +IHRD+KSSNILLD+ M A+V+DFGLS+ + A++I +
Sbjct: 712 DAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSK-QFTKADASHITTVVK 770
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
GT GYLDPEY ST T+KSDVYSFGV+L ELI GR PL
Sbjct: 771 GTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPL 809
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 104/213 (48%), Positives = 145/213 (68%), Gaps = 4/213 (1%)
Query: 104 YSYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVML 161
++Y+DL KAT NF T L+GQG FG V++ + G VA+K L + S QGE+EFQ E+
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
+ R+HHR+LV+L+GYC Q +LVY F+ +L HL+++ + W+ R+ IAL A+
Sbjct: 191 ISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALGAAK 250
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAAN-IRGTFGYL 279
GL YLH+ P IHRD+K++NIL+D S A++ADFGL+R + D H + I GTFGYL
Sbjct: 251 GLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTFGYL 310
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
PEY S+ T+KSDV+S GV+L ELI GR P+
Sbjct: 311 APEYASSGKLTEKSDVFSIGVVLLELITGRRPV 343
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 319 | ||||||
| 225461166 | 430 | PREDICTED: probable leucine-rich repeat | 0.987 | 0.732 | 0.902 | 1e-167 | |
| 30696480 | 440 | protein kinase family protein [Arabidops | 0.987 | 0.715 | 0.867 | 1e-163 | |
| 297792925 | 437 | kinase family protein [Arabidopsis lyrat | 0.987 | 0.720 | 0.867 | 1e-163 | |
| 255563627 | 431 | serine/threonine-specific protein kinase | 0.987 | 0.730 | 0.892 | 1e-157 | |
| 359806757 | 431 | probable leucine-rich repeat receptor-li | 0.984 | 0.728 | 0.893 | 1e-154 | |
| 356549811 | 431 | PREDICTED: probable leucine-rich repeat | 0.984 | 0.728 | 0.893 | 1e-154 | |
| 449463168 | 430 | PREDICTED: probable leucine-rich repeat | 0.987 | 0.732 | 0.826 | 1e-153 | |
| 449531988 | 430 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.987 | 0.732 | 0.826 | 1e-153 | |
| 255644914 | 397 | unknown [Glycine max] | 0.984 | 0.790 | 0.886 | 1e-153 | |
| 357452639 | 445 | Receptor-like protein kinase [Medicago t | 0.987 | 0.707 | 0.871 | 1e-152 |
| >gi|225461166|ref|XP_002282916.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 [Vitis vinifera] gi|302143190|emb|CBI20485.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1533), Expect = e-167, Method: Compositional matrix adjust.
Identities = 286/317 (90%), Positives = 301/317 (94%), Gaps = 2/317 (0%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
MKGESSGLIIGISIG+VIGVLLAI ALFCFRYHRKRSQIGNSSSRRAAT+PIR+NG DSC
Sbjct: 1 MKGESSGLIIGISIGLVIGVLLAILALFCFRYHRKRSQIGNSSSRRAATIPIRSNGADSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
+ILSDST+GP+SP SGRNG S WLEGFKRSNVVS SGIPEYSYKDLQKAT NFTTLI
Sbjct: 61 TILSDSTIGPDSPKASGRNG--MSFWLEGFKRSNVVSVSGIPEYSYKDLQKATYNFTTLI 118
Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEV LLGRLHHRNLVNLVGYCAEK
Sbjct: 119 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVHLLGRLHHRNLVNLVGYCAEK 178
Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
GQHML+YV+MSKGSLASHLYDE Y PL+W+LR++IALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GQHMLIYVYMSKGSLASHLYDEKYEPLSWDLRIYIALDVARGLEYLHDGAVPPVIHRDIK 238
Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
SSNILLDQSMRARVADFGLSREEMV KHA+NIRGTFGYLDPEY+STR FTKKSDVYSFGV
Sbjct: 239 SSNILLDQSMRARVADFGLSREEMVSKHASNIRGTFGYLDPEYVSTRAFTKKSDVYSFGV 298
Query: 301 LLFELIAGRSPLQGLME 317
LLFELIAGR+P QGLME
Sbjct: 299 LLFELIAGRNPQQGLME 315
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30696480|ref|NP_568809.2| protein kinase family protein [Arabidopsis thaliana] gi|9758951|dbj|BAB09338.1| serine/threonine-specific protein kinase-like protein [Arabidopsis thaliana] gi|332009132|gb|AED96515.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1495), Expect = e-163, Method: Compositional matrix adjust.
Identities = 276/318 (86%), Positives = 301/318 (94%), Gaps = 3/318 (0%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
M+GES GLI+GIS+G+VIGV+LAISALFCFRYHRK+SQI NS SRR+AT+PIR NG DSC
Sbjct: 1 MEGESKGLIVGISLGLVIGVVLAISALFCFRYHRKKSQIVNSGSRRSATIPIRENGADSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGF-KRSNVVSASGIPEYSYKDLQKATCNFTTL 119
+I+SDST+GP+SPVKS +NG +S+WLEGF KRSNV+SASGI EYSY+DLQKATCNFTTL
Sbjct: 61 NIMSDSTIGPDSPVKSSKNG--RSVWLEGFSKRSNVISASGILEYSYRDLQKATCNFTTL 118
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
IGQGAFGPVYKAQMSTGE VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL+GYCAE
Sbjct: 119 IGQGAFGPVYKAQMSTGEIVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLIGYCAE 178
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
KGQHML+YV+MSKGSLASHLY E + PL+W+LRV+IALDVARGLEYLHDGAVPPVIHRDI
Sbjct: 179 KGQHMLIYVYMSKGSLASHLYSEKHEPLSWDLRVYIALDVARGLEYLHDGAVPPVIHRDI 238
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR FTKKSDVY FG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRTFTKKSDVYGFG 298
Query: 300 VLLFELIAGRSPLQGLME 317
VLLFELIAGR+P QGLME
Sbjct: 299 VLLFELIAGRNPQQGLME 316
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297792925|ref|XP_002864347.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310182|gb|EFH40606.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1492), Expect = e-163, Method: Compositional matrix adjust.
Identities = 276/318 (86%), Positives = 300/318 (94%), Gaps = 3/318 (0%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
M+GES GLI+GIS+G+VIGV LAISALFCFRYHRKRSQI NS SRR+AT+PIR NG DSC
Sbjct: 1 MEGESFGLIVGISLGLVIGVALAISALFCFRYHRKRSQIVNSGSRRSATIPIRENGADSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGF-KRSNVVSASGIPEYSYKDLQKATCNFTTL 119
+++SDST+GP+SPVKS +NG +S+WLEGF KRSNV+SASGI EYSY+DLQKATCNFTTL
Sbjct: 61 NVMSDSTIGPDSPVKSSKNG--RSVWLEGFNKRSNVISASGILEYSYRDLQKATCNFTTL 118
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
IGQGAFGPVYKAQMSTGE VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL+GYCAE
Sbjct: 119 IGQGAFGPVYKAQMSTGEIVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLIGYCAE 178
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
KGQHML+YV+MSKGSLASHLY E + PL+W+LRV+IALDVARGLEYLHDGAVPPVIHRDI
Sbjct: 179 KGQHMLIYVYMSKGSLASHLYSEKHEPLSWDLRVYIALDVARGLEYLHDGAVPPVIHRDI 238
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR FTKKSDVY FG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRTFTKKSDVYGFG 298
Query: 300 VLLFELIAGRSPLQGLME 317
VLLFELIAGR+P QGLME
Sbjct: 299 VLLFELIAGRNPQQGLME 316
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255563627|ref|XP_002522815.1| serine/threonine-specific protein kinase, putative [Ricinus communis] gi|223537899|gb|EEF39513.1| serine/threonine-specific protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 559 bits (1441), Expect = e-157, Method: Compositional matrix adjust.
Identities = 283/317 (89%), Positives = 298/317 (94%), Gaps = 2/317 (0%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
MKGESSGLIIGISIGVVIGVLLAI LFCFRYHRKRSQIGNSSSRRAAT+PIRANG DSC
Sbjct: 1 MKGESSGLIIGISIGVVIGVLLAILGLFCFRYHRKRSQIGNSSSRRAATIPIRANGADSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
+ILSDST+GPESPVKSGRNG S WL+GFK+SNVV+ SGIPEYSYKDLQKAT NFTTLI
Sbjct: 61 TILSDSTLGPESPVKSGRNGT--SFWLDGFKKSNVVAVSGIPEYSYKDLQKATYNFTTLI 118
Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEF TEVMLLGRLHHRNLVNLVGYCAEK
Sbjct: 119 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFHTEVMLLGRLHHRNLVNLVGYCAEK 178
Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
GQHML+YVFMSKGSLASHLY EN+ L+W+ RV+IALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GQHMLIYVFMSKGSLASHLYSENHETLSWDWRVYIALDVARGLEYLHDGAVPPVIHRDIK 238
Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
SSNILLD SMRARVADFGLSREEMVD+ A NIRGTFGYLDPEYIS+R FTKKSDVYS+GV
Sbjct: 239 SSNILLDHSMRARVADFGLSREEMVDRRADNIRGTFGYLDPEYISSRTFTKKSDVYSYGV 298
Query: 301 LLFELIAGRSPLQGLME 317
LLFELIAGR+P QGLME
Sbjct: 299 LLFELIAGRNPQQGLME 315
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359806757|ref|NP_001241300.1| probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Glycine max] gi|223452504|gb|ACM89579.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1415), Expect = e-154, Method: Compositional matrix adjust.
Identities = 284/318 (89%), Positives = 299/318 (94%), Gaps = 4/318 (1%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
MK ES+GLIIGISIGVVIGV LAISALFC RYHRKRSQIGNSSSRRA T+PIR NGVDSC
Sbjct: 1 MKEESTGLIIGISIGVVIGVGLAISALFCLRYHRKRSQIGNSSSRRAHTIPIRENGVDSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRS-NVVSASGIPEYSYKDLQKATCNFTTL 119
+ILSDST+GPESPV+SGRNG S+WL+GFK+S N+VSASGIPEYSYKDLQKAT NFTTL
Sbjct: 61 NILSDSTLGPESPVRSGRNG--MSLWLDGFKKSSNMVSASGIPEYSYKDLQKATYNFTTL 118
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
IGQGAFGPVYKAQMSTGETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE
Sbjct: 119 IGQGAFGPVYKAQMSTGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 178
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
KGQHMLVYV+MSKGSLASHLY E G L W+LRVHIALDVARG+EYLHDGAVPPVIHRDI
Sbjct: 179 KGQHMLVYVYMSKGSLASHLYSEENGALGWDLRVHIALDVARGIEYLHDGAVPPVIHRDI 238
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
KSSNILLDQSMRARVADFGLSREEMVDKHAA IRGTFGYLDPEYIS+ FTKKSDVYSFG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAA-IRGTFGYLDPEYISSGTFTKKSDVYSFG 297
Query: 300 VLLFELIAGRSPLQGLME 317
VLLFELIAGR+P QGLME
Sbjct: 298 VLLFELIAGRNPQQGLME 315
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549811|ref|XP_003543284.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1414), Expect = e-154, Method: Compositional matrix adjust.
Identities = 284/318 (89%), Positives = 298/318 (93%), Gaps = 4/318 (1%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
MK ES+GLIIGISIGVVIGV LAISALFC RYHRKRSQIGNSSSRRA T+PIR NGVDSC
Sbjct: 1 MKEESTGLIIGISIGVVIGVGLAISALFCLRYHRKRSQIGNSSSRRAHTIPIRENGVDSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRS-NVVSASGIPEYSYKDLQKATCNFTTL 119
+ILSDST+GPESPV+SGRNG S WL+GFK+S N+VSASGIPEYSYKDLQKAT NFTTL
Sbjct: 61 NILSDSTLGPESPVRSGRNG--MSFWLDGFKKSSNMVSASGIPEYSYKDLQKATYNFTTL 118
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
IGQGAFGPVYKAQMSTGETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE
Sbjct: 119 IGQGAFGPVYKAQMSTGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 178
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
KGQHMLVYV+MSKGSLASHLY E G L W+LRVHIALDVARG+EYLHDGAVPPVIHRDI
Sbjct: 179 KGQHMLVYVYMSKGSLASHLYSEENGALGWDLRVHIALDVARGIEYLHDGAVPPVIHRDI 238
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
KSSNILLDQSMRARVADFGLSREEMVDKHAA IRGTFGYLDPEYIS+ FTKKSDVYSFG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAA-IRGTFGYLDPEYISSGTFTKKSDVYSFG 297
Query: 300 VLLFELIAGRSPLQGLME 317
VLLFELIAGR+P QGLME
Sbjct: 298 VLLFELIAGRNPQQGLME 315
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463168|ref|XP_004149306.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1413), Expect = e-153, Method: Compositional matrix adjust.
Identities = 262/317 (82%), Positives = 288/317 (90%), Gaps = 2/317 (0%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
MK ES+GL IGISIGVVIGVLLAI ALFCFRYHRKR QIGNSSSRRAA LPIR NG DSC
Sbjct: 1 MKEESTGLAIGISIGVVIGVLLAILALFCFRYHRKRLQIGNSSSRRAANLPIRTNGADSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
+ILSDSTVGPESP+K+ RN S W +GFKRS+V+SASG+PEYS KDLQKAT NFT++I
Sbjct: 61 TILSDSTVGPESPMKTSRNS--MSSWFDGFKRSSVISASGMPEYSIKDLQKATGNFTSVI 118
Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
GQGAFGPVYKA + +GETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE+
Sbjct: 119 GQGAFGPVYKATLPSGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAER 178
Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
G+HMLVYV+MSKGSLASHLY + G L WN+RV +ALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GEHMLVYVYMSKGSLASHLYSDKNGLLGWNMRVRVALDVARGLEYLHDGAVPPVIHRDIK 238
Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
S+NILLD+SMRARVADFGLSREEMVD AANIRGTFGYLDPEY+S+R F KKSDVYSFGV
Sbjct: 239 SANILLDESMRARVADFGLSREEMVDSRAANIRGTFGYLDPEYMSSRAFNKKSDVYSFGV 298
Query: 301 LLFELIAGRSPLQGLME 317
LLFE++AGR+P QGLME
Sbjct: 299 LLFEIVAGRNPQQGLME 315
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531988|ref|XP_004172967.1| PREDICTED: LOW QUALITY PROTEIN: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 262/317 (82%), Positives = 288/317 (90%), Gaps = 2/317 (0%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
MK ES+GL IGISIGVVIGVLLAI ALFCFRYHRKR QIGNSSSRRAA LPIR NG DSC
Sbjct: 1 MKEESTGLAIGISIGVVIGVLLAILALFCFRYHRKRLQIGNSSSRRAANLPIRTNGADSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
+ILSDSTVGPESP+K+ RN S W +GFKRS+V+SASG+PEYS KDLQKAT NFT++I
Sbjct: 61 TILSDSTVGPESPMKTSRNS--MSSWFDGFKRSSVISASGMPEYSIKDLQKATGNFTSVI 118
Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
GQGAFGPVYKA + +GETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE+
Sbjct: 119 GQGAFGPVYKATLPSGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAER 178
Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
G+HMLVYV+MSKGSLASHLY + G L WN+RV +ALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GEHMLVYVYMSKGSLASHLYSDKNGLLGWNMRVRVALDVARGLEYLHDGAVPPVIHRDIK 238
Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
S+NILLD+SMRARVADFGLSREEMVD AANIRGTFGYLDPEY+S+R F KKSDVYSFGV
Sbjct: 239 SANILLDESMRARVADFGLSREEMVDSQAANIRGTFGYLDPEYMSSRAFNKKSDVYSFGV 298
Query: 301 LLFELIAGRSPLQGLME 317
LLFE++AGR+P QGLME
Sbjct: 299 LLFEIVAGRNPQQGLME 315
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255644914|gb|ACU22957.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1405), Expect = e-153, Method: Compositional matrix adjust.
Identities = 282/318 (88%), Positives = 298/318 (93%), Gaps = 4/318 (1%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
MK ES+GLIIGISIGVVIGV LAISALFC RYHR+RSQIGNSSSRRA T+PIR NGVDSC
Sbjct: 1 MKEESTGLIIGISIGVVIGVGLAISALFCLRYHRRRSQIGNSSSRRAHTIPIRENGVDSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRS-NVVSASGIPEYSYKDLQKATCNFTTL 119
+ILSDST+GPESPV+SGRNG S+WL+GFK+S N+VSASGIPEYSYKDLQKAT NFTTL
Sbjct: 61 NILSDSTLGPESPVRSGRNG--MSLWLDGFKKSSNMVSASGIPEYSYKDLQKATYNFTTL 118
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
IGQGAFGPVYKAQMSTGETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYC E
Sbjct: 119 IGQGAFGPVYKAQMSTGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCTE 178
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
KGQHMLVYV+MSKGSLASHLY E G L W+LRVHIALDVARG+EYLHDGAVPPVIHRDI
Sbjct: 179 KGQHMLVYVYMSKGSLASHLYSEENGALGWDLRVHIALDVARGIEYLHDGAVPPVIHRDI 238
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
KSSNILLDQSMRARVADFGLSREEMVDKHAA IRGTFGYLDPEYIS+ FTKKSDVYSFG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAA-IRGTFGYLDPEYISSGTFTKKSDVYSFG 297
Query: 300 VLLFELIAGRSPLQGLME 317
VLLFELIAGR+P QGLME
Sbjct: 298 VLLFELIAGRNPQQGLME 315
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357452639|ref|XP_003596596.1| Receptor-like protein kinase [Medicago truncatula] gi|355485644|gb|AES66847.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1397), Expect = e-152, Method: Compositional matrix adjust.
Identities = 277/318 (87%), Positives = 296/318 (93%), Gaps = 3/318 (0%)
Query: 1 MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
MK ES+GLIIGISIGVVIGV+LAISAL CFRYHRKRSQIGNSSSRRAA +PIR NG DSC
Sbjct: 1 MKEESTGLIIGISIGVVIGVVLAISALICFRYHRKRSQIGNSSSRRAAAIPIRTNGADSC 60
Query: 61 SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
+ILSDST+GPESPV+SGRNG + W++GFK+SN++SASGI EYSYKDLQKAT NFTTLI
Sbjct: 61 TILSDSTLGPESPVRSGRNG--MNFWIDGFKKSNMISASGILEYSYKDLQKATYNFTTLI 118
Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
GQGAFGPVYKAQMSTGETVAVKVLAT+SKQGEKEF TEVMLLGRLHHRNLVNLVGYCAEK
Sbjct: 119 GQGAFGPVYKAQMSTGETVAVKVLATNSKQGEKEFHTEVMLLGRLHHRNLVNLVGYCAEK 178
Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
GQHMLVYV+MSKG+LASHLY E G L W+LRVHIALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GQHMLVYVYMSKGNLASHLYSEENGNLGWDLRVHIALDVARGLEYLHDGAVPPVIHRDIK 238
Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
S+NILLDQSMRARVADFGLSREEMVDKHAA IRGTFGYLDPEYIS+ FTKKSDVYSFGV
Sbjct: 239 SNNILLDQSMRARVADFGLSREEMVDKHAA-IRGTFGYLDPEYISSGTFTKKSDVYSFGV 297
Query: 301 LLFELIAGRSPLQGLMEQ 318
LLFELIAGR+P QGLME
Sbjct: 298 LLFELIAGRNPQQGLMEH 315
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 319 | ||||||
| TAIR|locus:2172149 | 440 | CRLK1 "calcium/calmodulin-regu | 0.909 | 0.659 | 0.877 | 5.8e-137 | |
| TAIR|locus:2143166 | 436 | CRLK2 "calcium/calmodulin-regu | 0.893 | 0.653 | 0.527 | 2.1e-77 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.639 | 0.219 | 0.541 | 6.6e-56 | |
| TAIR|locus:2090634 | 663 | AT3G19300 [Arabidopsis thalian | 0.658 | 0.316 | 0.516 | 3e-53 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.652 | 0.222 | 0.523 | 3.7e-53 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.655 | 0.478 | 0.483 | 8.7e-53 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.836 | 0.644 | 0.449 | 1.7e-52 | |
| TAIR|locus:2148830 | 858 | ANX2 "ANXUR2" [Arabidopsis tha | 0.852 | 0.317 | 0.416 | 1.7e-52 | |
| TAIR|locus:2012191 | 693 | AT1G49730 [Arabidopsis thalian | 0.689 | 0.317 | 0.506 | 3.5e-52 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.714 | 0.234 | 0.470 | 4.3e-52 |
| TAIR|locus:2172149 CRLK1 "calcium/calmodulin-regulated receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1341 (477.1 bits), Expect = 5.8e-137, P = 5.8e-137
Identities = 257/293 (87%), Positives = 277/293 (94%)
Query: 26 ALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSM 85
ALFCFRYHRK+SQI NS SRR+AT+PIR NG DSC+I+SDST+GP+SPVKS +NG +S+
Sbjct: 26 ALFCFRYHRKKSQIVNSGSRRSATIPIRENGADSCNIMSDSTIGPDSPVKSSKNG--RSV 83
Query: 86 WLEGF-KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVL 144
WLEGF KRSNV+SASGI EYSY+DLQKATCNFTTLIGQGAFGPVYKAQMSTGE VAVKVL
Sbjct: 84 WLEGFSKRSNVISASGILEYSYRDLQKATCNFTTLIGQGAFGPVYKAQMSTGEIVAVKVL 143
Query: 145 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY 204
ATDSKQGEKEFQTEVMLLGRLHHRNLVNL+GYCAEKGQHML+YV+MSKGSLASHLY E +
Sbjct: 144 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLIGYCAEKGQHMLIYVYMSKGSLASHLYSEKH 203
Query: 205 GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264
PL+W+LRV+IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM
Sbjct: 204 EPLSWDLRVYIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 263
Query: 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
VDKHAANIRGTFGYLDPEYISTR FTKKSDVY FGVLLFELIAGR+P QGLME
Sbjct: 264 VDKHAANIRGTFGYLDPEYISTRTFTKKSDVYGFGVLLFELIAGRNPQQGLME 316
|
|
| TAIR|locus:2143166 CRLK2 "calcium/calmodulin-regulated receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
Identities = 156/296 (52%), Positives = 203/296 (68%)
Query: 28 FCFRYHRKRSQIGN-SSSRRAATLPIRA--NGVDSCSILSDSTVGPES--PVKSGRNGNG 82
F +++ RS + ++ + + TLP+ GV ++ D ES P ++G
Sbjct: 28 FAIKWYYGRSHLRRCANEQNSPTLPVHTAKRGV----VIPDDRANTESSQPPENGAPTQH 83
Query: 83 KSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVK 142
+ W + VSASGIP Y+YKD+QKAT NFTT++GQG+FGPVYKA M GE A K
Sbjct: 84 QPWW-NNHTKDLTVSASGIPRYNYKDIQKATQNFTTVLGQGSFGPVYKAVMPNGELAAAK 142
Query: 143 VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD- 201
V ++S QG++EFQTEV LLGRLHHRNLVNL GYC +K ML+Y FMS GSL + LY
Sbjct: 143 VHGSNSSQGDREFQTEVSLLGRLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLLYGG 202
Query: 202 ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
E L W R+ IALD++ G+EYLH+GAVPPVIHRD+KS+NILLD SMRA+VADFGLS+
Sbjct: 203 EGMQVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHSMRAKVADFGLSK 262
Query: 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
E ++D+ + ++GT GY+DP YIST +T KSD+YSFGV++ ELI P Q LME
Sbjct: 263 EMVLDRMTSGLKGTHGYMDPTYISTNKYTMKSDIYSFGVIILELITAIHPQQNLME 318
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 582 (209.9 bits), Expect = 6.6e-56, P = 6.6e-56
Identities = 112/207 (54%), Positives = 151/207 (72%)
Query: 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR 168
L++AT NF+ +G+G+FG VY +M G+ VAVK+ A S ++F TEV LL R+HHR
Sbjct: 601 LEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHR 660
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLH 227
NLV L+GYC E + +LVY +M GSL HL+ +Y PL W R+ IA D A+GLEYLH
Sbjct: 661 NLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLH 720
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANI-RGTFGYLDPEYIS 285
G P +IHRD+KSSNILLD +MRA+V+DFGLSR+ D H +++ +GT GYLDPEY +
Sbjct: 721 TGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYA 780
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPL 312
++ T+KSDVYSFGV+LFEL++G+ P+
Sbjct: 781 SQQLTEKSDVYSFGVVLFELLSGKKPV 807
|
|
| TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 551 (199.0 bits), Expect = 3.0e-53, P = 3.0e-53
Identities = 111/215 (51%), Positives = 145/215 (67%)
Query: 100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEV 159
G ++SYK+++KAT +F +IG+G FG VYKA+ S G AVK + S+Q E EF E+
Sbjct: 312 GFRKFSYKEIRKATEDFNAVIGRGGFGTVYKAEFSNGLVAAVKKMNKSSEQAEDEFCREI 371
Query: 160 MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
LL RLHHR+LV L G+C +K + LVY +M GSL HL+ PL+W R+ IA+DV
Sbjct: 372 ELLARLHHRHLVALKGFCNKKNERFLVYEYMENGSLKDHLHSTEKSPLSWESRMKIAIDV 431
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL---SREEMVDKHAAN--IRG 274
A LEYLH PP+ HRDIKSSNILLD+ A++ADFGL SR+ + N IRG
Sbjct: 432 ANALEYLHFYCDPPLCHRDIKSSNILLDEHFVAKLADFGLAHASRDGSICFEPVNTDIRG 491
Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
T GY+DPEY+ T T+KSDVYS+GV+L E+I G+
Sbjct: 492 TPGYVDPEYVVTHELTEKSDVYSYGVVLLEIITGK 526
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 557 (201.1 bits), Expect = 3.7e-53, P = 3.7e-53
Identities = 112/214 (52%), Positives = 151/214 (70%)
Query: 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLG 163
++ ++++AT F IG G FG VY + G+ +AVKVLA +S QG++EF EV LL
Sbjct: 594 FTLYEIEEATKKFEKRIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLS 653
Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVAR 221
R+HHRNLV +GYC E+G++MLVY FM G+L HLY ++W R+ IA D AR
Sbjct: 654 RIHHRNLVQFLGYCQEEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAAR 713
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANI-RGTFGY 278
G+EYLH G VP +IHRD+K+SNILLD+ MRA+V+DFGLS+ VD H ++I RGT GY
Sbjct: 714 GIEYLHTGCVPAIIHRDLKTSNILLDKHMRAKVSDFGLSKFA-VDGTSHVSSIVRGTVGY 772
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
LDPEY ++ T+KSDVYSFGV+L EL++G+ +
Sbjct: 773 LDPEYYISQQLTEKSDVYSFGVILLELMSGQEAI 806
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 8.7e-53, Sum P(2) = 8.7e-53
Identities = 105/217 (48%), Positives = 143/217 (65%)
Query: 104 YSYKDLQKATCNFT--TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVML 161
YS KDL+ AT F+ +IG+G +G VY+A S G AVK L + Q EKEF+ EV
Sbjct: 133 YSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEA 192
Query: 162 LGRLHHRNLVNLVGYCAE--KGQHMLVYVFMSKGSLASHLYDE--NYGPLTWNLRVHIAL 217
+G++ H+NLV L+GYCA+ + Q MLVY ++ G+L L+ + PLTW++R+ IA+
Sbjct: 193 IGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAI 252
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGT 275
A+GL YLH+G P V+HRD+KSSNILLD+ A+V+DFGL++ + GT
Sbjct: 253 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGT 312
Query: 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
FGY+ PEY ST + SDVYSFGVLL E+I GRSP+
Sbjct: 313 FGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPV 349
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 544 (196.6 bits), Expect = 1.7e-52, P = 1.7e-52
Identities = 130/289 (44%), Positives = 178/289 (61%)
Query: 29 CFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLE 88
CF +H K+ +S + R NG + ++ PE+P K+ N + E
Sbjct: 6 CFYFHEKKKVPRDSDNS------YRRNG--EVTGRDNNKTHPENP-KTVNEQNKNND--E 54
Query: 89 GFKRSNVVSASGIPEYSYKDLQKATCNFTT--LIGQGAFGPVYKAQMS-TGETVAVKVLA 145
+ +N ++A +S+++L AT NF LIG+G FG VYK ++ TG VAVK L
Sbjct: 55 DKEVTNNIAAQ---TFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLD 111
Query: 146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--EN 203
+ QG KEF EV++L LHH++LVNL+GYCA+ Q +LVY +MS+GSL HL D +
Sbjct: 112 RNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPD 171
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
PL W+ R+ IAL A GLEYLHD A PPVI+RD+K++NILLD A+++DFGL++
Sbjct: 172 QIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLG 231
Query: 264 MV-DK-HAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
V DK H ++ + GT+GY PEY T T KSDVYSFGV+L ELI GR
Sbjct: 232 PVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGR 280
|
|
| TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 1.7e-52, P = 1.7e-52
Identities = 124/298 (41%), Positives = 181/298 (60%)
Query: 29 CFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLE 88
CF ++++ + S S ++ LPI N S + ST+ SG++ NG +
Sbjct: 452 CFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSAT---KSTI-------SGKSNNGSHL--- 498
Query: 89 GFKRSNVVSASGI-PEYSYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLA 145
SN+ A+G+ +S +++ T NF + +IG G FG VYK + G VA+K
Sbjct: 499 ----SNL--AAGLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSN 552
Query: 146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG 205
+S+QG EF+TE+ LL RL H++LV+L+GYC E G+ L+Y +MS G+L HLY+
Sbjct: 553 PNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRP 612
Query: 206 PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--E 263
LTW R+ IA+ ARGL YLH GA +IHRD+K++NILLD++ A+V+DFGLS+
Sbjct: 613 QLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 672
Query: 264 MVDKHAANI-RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ-GLMEQQ 319
M H + +G+FGYLDPEY + T+KSDVYSFGV+LFE++ R L L ++Q
Sbjct: 673 MNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQ 730
|
|
| TAIR|locus:2012191 AT1G49730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 3.5e-52, P = 3.5e-52
Identities = 114/225 (50%), Positives = 149/225 (66%)
Query: 90 FKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK 149
FK S+S ++SYK++ AT +F T+IGQG FG VYKA+ + G AVK + S+
Sbjct: 333 FKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSE 392
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTW 209
Q E++F E+ LL +LHHRNLV L G+C K + LVY +M GSL HL+ P +W
Sbjct: 393 QAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHAIGKPPPSW 452
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL---SREEMVD 266
R+ IA+DVA LEYLH PP+ HRDIKSSNILLD++ A+++DFGL SR+ V
Sbjct: 453 GTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDGSVC 512
Query: 267 KHAAN--IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
N IRGT GY+DPEY+ T+ T+KSDVYS+GV+L ELI GR
Sbjct: 513 FEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLLELITGR 557
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 4.3e-52, P = 4.3e-52
Identities = 110/234 (47%), Positives = 152/234 (64%)
Query: 86 WLEGFKRSN-VVSASGIPEYSYKDLQKATCNFTTL--IGQGAFGPVYKAQMSTGETVAVK 142
W K S G +SY++L+K T NF+ +G G +G VYK + G VA+K
Sbjct: 607 WASSGKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIK 666
Query: 143 VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE 202
S QG EF+TE+ LL R+HH+NLV LVG+C E+G+ +LVY +MS GSL L
Sbjct: 667 RAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGR 726
Query: 203 NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR- 261
+ L W R+ +AL ARGL YLH+ A PP+IHRD+KS+NILLD+++ A+VADFGLS+
Sbjct: 727 SGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKL 786
Query: 262 -EEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
+ H + ++GT GYLDPEY +T+ T+KSDVYSFGV++ ELI + P++
Sbjct: 787 VSDCTKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIE 840
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00027443001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (430 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 319 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-56 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-42 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-31 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-31 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-31 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-29 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-29 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-29 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-27 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-26 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-26 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-25 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-24 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-23 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-22 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-22 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-19 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-14 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-56
Identities = 71/205 (34%), Positives = 107/205 (52%), Gaps = 12/205 (5%)
Query: 116 FTTLIGQGAFGPVYKAQ-----MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRN 169
+G+GAFG VYK VAVK L D S+Q +EF E ++ +L H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
+V L+G C E+ M+V +M G L +L L+ + + AL +ARG+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYISTR 287
IHRD+ + N L+ +++ +++DFGLSR+ + + ++ PE +
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 288 NFTKKSDVYSFGVLLFELIA-GRSP 311
FT KSDV+SFGVLL+E+ G P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 6e-56
Identities = 73/205 (35%), Positives = 109/205 (53%), Gaps = 13/205 (6%)
Query: 116 FTTLIGQGAFGPVYKAQ-----MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRN 169
+G+GAFG VYK + VAVK L D S+Q +EF E ++ +L H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
+V L+G C E+ +V +M G L S+L N L+ + + AL +ARG+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGYLDPEYISTR 287
IHRD+ + N L+ +++ +++DFGLSR+ D + ++ PE +
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 288 NFTKKSDVYSFGVLLFELIA-GRSP 311
FT KSDV+SFGVLL+E+ G P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-55
Identities = 71/216 (32%), Positives = 111/216 (51%), Gaps = 27/216 (12%)
Query: 120 IGQGAFGPVYKAQMSTGET----VAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G+GAFG VYK ++ + VAVK L S++ K+F E ++ +L H N+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHL-------YDENYGPLTWNLRVHIALDVARGLEYLH 227
G C E+ LV +M G L +L L+ + A+ +A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-------IRGTFGYLD 280
+HRD+ + N L+ + + +++DFGLSR+ D + IR ++
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WMA 175
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
PE + FT KSDV+SFGVLL+E+ G +P GL
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-53
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 9/204 (4%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
+G+G+FG VY A+ TG+ VA+KV+ K+ + E+ +L +L H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVI 235
++ + LV + G L L + G L+ + + LEYLH G ++
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKG----IV 119
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
HRD+K NILLD+ ++ADFGL+R+ + GT Y+ PE + + + K D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 296 YSFGVLLFELIAGRSPLQGLMEQQ 319
+S GV+L+EL+ G+ P G +
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLL 203
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 8e-53
Identities = 70/210 (33%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 120 IGQGAFGPVYKAQM-----STGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+GAFG VYK + T VAVK L S++ +EF E ++ +L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+G C + +V +M G L L LT + +AL +A+G+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLESK---N 122
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG---YLDPEYISTRNFT 290
+HRD+ + N L+ +++ +++DFGLSR+ D + G ++ PE + FT
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
KSDV+SFGVLL+E+ G P G+ ++
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 76/200 (38%), Positives = 114/200 (57%), Gaps = 10/200 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
+G G+FG VYKA+ TG+ VAVK+L S + ++ + E+ +L RL H N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+K LV + G L +L GPL+ + IAL + RGLEYLH + IH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGI---IH 121
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN-FTKKSD 294
RD+K NILLD++ ++ADFGL+++ + + GT Y+ PE + N + K D
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181
Query: 295 VYSFGVLLFELIAGRSPLQG 314
V+S GV+L+EL+ G+ P G
Sbjct: 182 VWSLGVILYELLTGKPPFSG 201
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 6e-49
Identities = 72/191 (37%), Positives = 109/191 (57%), Gaps = 9/191 (4%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G+G FG VY A+ TG+ VA+K++ DS +E E+ +L +L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
++ LV + GSL L EN G L+ + + I L + GLEYLH +IHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 238 DIKSSNILLDQ-SMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYISTR-NFTKKSD 294
D+K NILLD + + ++ADFGLS+ I GT Y+ PE + + +++KSD
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 295 VYSFGVLLFEL 305
++S GV+L+EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-42
Identities = 66/204 (32%), Positives = 109/204 (53%), Gaps = 19/204 (9%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
L+G+G+FG VY A TGE +AVK L+ DS++ + + E+ +L L H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 176 YCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
++ ++ L +F+ S GSL+S L + +G L + + GL YLH G
Sbjct: 67 SERDEEKNTL-NIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN----IRGTFGYLDPEYISTR 287
++HRDIK +NIL+D ++ADFG ++ + D +RGT ++ PE I
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
+ + +D++S G + E+ G+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-36
Identities = 70/208 (33%), Positives = 111/208 (53%), Gaps = 17/208 (8%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH 166
K+L+ IG+G FG V G+ VAVK L DS + F E ++ L
Sbjct: 6 KELKLGAT-----IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLR 58
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
H NLV L+G + +V +M+KGSL +L +T ++ ALDV G+EYL
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYI 284
+ +HRD+ + N+L+ + + A+V+DFGL++E + + ++ T PE +
Sbjct: 119 EEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEAL 171
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSP 311
+ F+ KSDV+SFG+LL+E+ + GR P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 70/203 (34%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVK--VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
LIG+GAFG VYK + TG+ VA+K L ++ K E+ LL L H N+V +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 176 YCAEKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNL-RVHIALDVARGLEYLHDGAVPP 233
E + + + + GSL + + +GP +L V++ V +GL YLH+ V
Sbjct: 67 -SIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVY-QVLQGLAYLHEQGV-- 120
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
IHRDIK++NIL + ++ADFG++ + V K A++ GT ++ PE I +
Sbjct: 121 -IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 293 SDVYSFGVLLFELIAGRSPLQGL 315
SD++S G + EL+ G P L
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDL 202
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 70/202 (34%), Positives = 107/202 (52%), Gaps = 21/202 (10%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
IG+G FG VYKA TG+ VA+KV+ +SK+ +++ E+ +L + H N+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+K + +V F S GSL L LT + ++ ++ +GLEYLH + IHRD
Sbjct: 68 KKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI---IHRD 123
Query: 239 IKSSNILLDQSMRARVADFGLS--------REEMVDKHAANIRGTFGYLDPEYISTRNFT 290
IK++NILL ++ DFGLS R MV GT ++ PE I+ + +
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--------GTPYWMAPEVINGKPYD 175
Query: 291 KKSDVYSFGVLLFELIAGRSPL 312
K+D++S G+ EL G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 9/204 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+G G FG V++ VA+K+L +D +++FQ EV L RL H++L++L C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
++ M KGSL + L L + +A VA G+ YL + IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDL 130
Query: 240 KSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
+ NIL+ + + +VADFGL+R E++ I + + PE S F+ KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVW 188
Query: 297 SFGVLLFELIA-GRSPLQGLMEQQ 319
SFG+LL+E+ G+ P G+ +
Sbjct: 189 SFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ------TEVMLLGRLHHRNLVN 172
+G+G+FG V + TG+ A+KVL K+ + + TE +L R++H +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL---KKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-G 229
L + A + + L V + G L SHL E R + A ++ LEYLH G
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAA-EIVLALEYLHSLG 113
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN 288
+I+RD+K NILLD ++ DFGL++E + N GT YL PE + +
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG 169
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
+ K D +S GVLL+E++ G+ P
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 73/238 (30%), Positives = 113/238 (47%), Gaps = 40/238 (16%)
Query: 88 EGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLAT 146
++VS G P YK+L+K IG+GA G VYKA +TG+ VA+K +
Sbjct: 4 LKAALKDIVSE-GDPRELYKNLEK--------IGEGASGEVYKATDRATGKEVAIKKMRL 54
Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYG 205
+ E E++++ H N+V+ G + +V +M GSL + +N+
Sbjct: 55 RKQNKELIIN-EILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTD-IITQNFV 111
Query: 206 PLTWNLRVHIA---LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS-- 260
+ IA +V +GLEYLH VIHRDIKS NILL + ++ADFG +
Sbjct: 112 RMN---EPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165
Query: 261 -------REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
R +V GT ++ PE I +++ K D++S G++ E+ G P
Sbjct: 166 LTKEKSKRNSVV--------GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 76/234 (32%), Positives = 111/234 (47%), Gaps = 34/234 (14%)
Query: 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGET------VAVKVLA-TDSKQGEKEFQTEVML 161
+Q+ T +G+GAFG V+ + E VAVK L T S K+F+ E L
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------------YDENYGPLTW 209
L H N+V G C E ++V+ +M G L L D G LT
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE------E 263
+ + IA+ +A G+ YL A +HRD+ + N L+ + ++ DFG+SR+
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 264 MVDKHAA-NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
V H IR ++ PE I R FT +SDV+SFGV+L+E+ G+ P GL
Sbjct: 179 RVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-32
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLVGY 176
+G G FG V+ + VAVK L K G + F E ++ +L H LV L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
C+E+ +V +MSKGSL L L V +A +A G+ YL IH
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY---IH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSD 294
RD+ + NIL+ +++ ++ADFGL+R D++ A F + PE + FT KSD
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 295 VYSFGVLLFELIA-GRSPLQGL 315
V+SFG+LL E++ GR P G+
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-32
Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGYC 177
IG+G FG VYK + VAVK + K F E +L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+K +V + GSL + L + LT + ++LD A G+EYL IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHR 117
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-------IRGTFGYLDPEYISTRNFT 290
D+ + N L+ ++ +++DFG+SREE + + I+ T PE ++ +T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYGRYT 173
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+SDV+S+G+LL+E + G +P G+ QQ
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 8e-32
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 117 TTLIGQGAFGPVYKAQMSTG----ETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
+IG G FG V + ++ VA+K L S ++ +F TE ++G+ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
L G + M++ +M GSL L EN G T V + +A G++YL +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG---TFGYLDPEYISTR 287
V HRD+ + NIL++ ++ +V+DFGLSR + +G + PE I+ R
Sbjct: 128 V----HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 288 NFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
FT SDV+SFG++++E+++ G P + Q
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G FG V +TGE VAVK L +Q +F+ E+ +L L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 174 VGYCAEKGQ--HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G C + G L+ ++ GSL +L + + + + + +G++YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLGSQRY 130
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRG---TFGYLDPEYIST 286
IHRD+ + NIL++ +++DFGL++ E D + G F Y PE + T
Sbjct: 131 ---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186
Query: 287 RNFTKKSDVYSFGVLLFEL 305
F+ SDV+SFGV L+EL
Sbjct: 187 SKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-31
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNL 170
+G+G+FG VY A+ + VA+KVLA + + F E+ +L L H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDG 229
V L + ++G LV ++ GSL L GPL+ + + I + LEYLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 230 AVPPVIHRDIKSSNILLDQ-SMRARVADFGLSRE-------EMVDKHAANIRGTFGYLDP 281
+IHRDIK NILLD+ ++ DFGL++ + + GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 282 EYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
E + S + SD++S G+ L+EL+ G P +G
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL-ATDSKQGEKEF-QTEVMLLGRLHHRNLVNLVG 175
IG+G+FG VY + S G+ +K + ++ + E+E EV +L +L+H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 176 YCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLT----WNLRVHIALDVARGLEYL 226
EKG + + M G L+ + + P + V + L L+YL
Sbjct: 67 SFEEKG---KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYL 119
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYI 284
H + +HRDIK NI L + ++ DFG+S+ VD A + GT YL PE
Sbjct: 120 HSRKI---LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTVVGTPYYLSPELC 175
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ + KSD++S G +L+EL + P +G
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 73/205 (35%), Positives = 115/205 (56%), Gaps = 12/205 (5%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
+LQK T +IG+G FG V + + TG+ VAVK + D + F E ++ +LHH
Sbjct: 4 NLQKLT--LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHH 58
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
+NLV L+G G + +V MSKG+L + L ++ + +LDVA G+EYL
Sbjct: 59 KNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
++HRD+ + NIL+ + A+V+DFGL+R N + + PE + +
Sbjct: 118 S---KKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPVKWTAPEALKHK 172
Query: 288 NFTKKSDVYSFGVLLFELIA-GRSP 311
F+ KSDV+S+GVLL+E+ + GR+P
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-31
Identities = 73/235 (31%), Positives = 117/235 (49%), Gaps = 42/235 (17%)
Query: 120 IGQGAFGPVYKAQ---MSTGE---TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172
IGQGAFG V++A+ + E VAVK+L + S + +FQ E L+ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--------------------YDENYGPLTWNLR 212
L+G CA L++ +M+ G L L N PL+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAAN 271
+ IA VA G+ YL + +HRD+ + N L+ ++M ++ADFGLSR D + A+
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 272 ------IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
IR ++ PE I +T +SDV+++GV+L+E+ + G P G+ ++
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 119 LIGQGAFGPVYKAQMST--GET--VAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNL 173
+G G+FG V + + ST G+ VAVK L +D +F E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
G M+V GSL L + G + A+ +A G+ YL
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF-- 118
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEYISTRN 288
IHRD+ + NILL + ++ DFGL R E+ +++ F + PE + TR
Sbjct: 119 -IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY-VMEEHLKVPFAWCAPESLRTRT 176
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGL 315
F+ SDV+ FGV L+E+ G P GL
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGL 204
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+G G FG V++ + VAVK L + K+F E ++ +L H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ +V M GSL +L L + +A VA G+ YL IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
+ N+L+ ++ +VADFGL+R D + A F + PE F+ KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 298 FGVLLFELIA-GRSPLQGLMEQQ 319
FG+LL E++ GR P G+ +
Sbjct: 190 FGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLA-TDSKQGEKEFQTEVMLLGRL 165
DL++ +GQG+ G VYK + TG+ A+K + ++ K+ E+ L
Sbjct: 2 DLERVKV-----LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC 56
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
+V G ++G+ +V +M GSLA L G + + +IA + +GL+Y
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDY 114
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEY 283
LH +IHRDIK SN+L++ ++ADFG+S+ E +D+ + GT Y+ PE
Sbjct: 115 LH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPER 171
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
I +++ +D++S G+ L E G+ P
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFL 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 73/207 (35%), Positives = 114/207 (55%), Gaps = 20/207 (9%)
Query: 119 LIGQGAFGPVYKAQMSTGET----VAVKVLA--TDSKQGEKEFQTEVMLLGRLHHRNLVN 172
+IG+G FG VY + + AVK L TD ++ E+ F E +++ H N+++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVLS 60
Query: 173 LVGYC-AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
L+G C +G ++V +M G L + + E + P +L + L VA+G+EYL A
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-IGFGLQVAKGMEYL---AS 116
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP------EYIS 285
+HRD+ + N +LD+S +VADFGL+R+ + DK ++ G P E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARD-IYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSP 311
T+ FT KSDV+SFGVLL+EL+ G P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPP 202
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 8/199 (4%)
Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG G FG V+ VA+K + + E++F E ++ +L H LV L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
C E+ LV+ FM G L+ +L + G + + + LDV G+ YL VI
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKS 293
HRD+ + N L+ ++ +V+DFG++R + D++ ++ F + PE S ++ KS
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 294 DVYSFGVLLFELIA-GRSP 311
DV+SFGVL++E+ + G++P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 10/194 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
IG+G FG V G VAVK + D+ + F E ++ +L H NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 180 -KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
KG +V +M+KGSL +L L + + +LDV +EYL +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
+ + N+L+ + A+V+DFGL++E + + + PE + + F+ KSDV+SF
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSF 185
Query: 299 GVLLFELIA-GRSP 311
G+LL+E+ + GR P
Sbjct: 186 GILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-29
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G G +G VY+ TVAVK L D+ + E EF E ++ + H NLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ ++ FM+ G+L +L + N + + +++A ++ +EYL IHRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 129
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVY 296
+ + N L+ ++ +VADFGLSR D + A+ F + PE ++ F+ KSDV+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 189
Query: 297 SFGVLLFELIA-GRSPLQGL 315
+FGVLL+E+ G SP G+
Sbjct: 190 AFGVLLWEIATYGMSPYPGI 209
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLVG 175
I +GA+G V+ A+ STG+ A+KV+ + + TE +L + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58
Query: 176 YCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
Y + +G+ L V ++ G LAS L EN G L ++ ++ LEYLH +
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSNGI-- 114
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVD---------KHAANIRGTFGYLDPEYI 284
IHRD+K NIL+D + ++ DFGLS+ +V K I GT Y+ PE I
Sbjct: 115 -IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ +K D +S G +L+E + G P G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 75/227 (33%), Positives = 120/227 (52%), Gaps = 37/227 (16%)
Query: 119 LIGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEKEF-----QTEVM-LLGRLH 166
+G+GAFG V KA+ + TVAVK+L D+ EK+ + E+M ++G+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGK-- 74
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------YDENY-------GPLTWNLR 212
H+N++NL+G C ++G +V + + G+L L + LT
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD--KHA 269
V A VARG+E+L A IHRD+ + N+L+ + ++ADFGL+R+ +D +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
N R ++ PE + R +T +SDV+SFGVLL+E+ G SP G+
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 66/238 (27%), Positives = 118/238 (49%), Gaps = 36/238 (15%)
Query: 111 KATCNFTTLIGQGAFGPVYKAQ------MSTGETVAVKVLATD-SKQGEKEFQTEVMLLG 163
+ F +G+GAFG VYK + + +VA+K L + + ++EF+ E L+
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL--------------ASHLYDENYGPLTW 209
L H N+V L+G C ++ +++ +++ G L A + L
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE------- 262
+ +HIA+ +A G+EYL + +HRD+ + N L+ + + +++DFGLSR+
Sbjct: 124 SDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+ K +R ++ PE I FT +SD++SFGV+L+E+ + G P G Q+
Sbjct: 181 RVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 25/211 (11%)
Query: 120 IGQGAFGPVYKAQ-MSTGET----VAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
+G GAFG VYK + GE VA+KVL ++ + KE E ++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGP---LTWNLRVHIALDVARGLEYLHD 228
+G C Q L+ M G L ++ + +N G L W + +A+G+ YL +
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEE 127
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYIS 285
+ +HRD+ + N+L+ ++ DFGL++ VD+ HA + ++ E I
Sbjct: 128 KRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
R +T KSDV+S+GV ++EL+ G P +G+
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 43/231 (18%)
Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQ------GEKEFQTEVMLLGRL-HH 167
F +IG+G+F V A+ T + A+K+L K+ K + E +L RL H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKIL---DKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 168 RNLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
++ L Y + + L +V + G L ++ YG L A ++ LEY
Sbjct: 62 PGIIKL--YYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEY 117
Query: 226 LHD-GAVPPVIHRDIKSSNILLDQSMRARVADFG----LSREEMVD-------------- 266
LH G +IHRD+K NILLD+ M ++ DFG L +
Sbjct: 118 LHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 267 ---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ A+ GT Y+ PE ++ + K SD+++ G ++++++ G+ P +G
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-28
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
F +G+G FG V Q +TGE VAVK L + + ++F+ E+ +L L H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
V G C G+ LV ++ GSL +L ++ L + A + +G+EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYL-- 124
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG-----TFGYLDPEY 283
+HRD+ + NIL++ R ++ DFGL++ DK +R F Y PE
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PES 182
Query: 284 ISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEQ 318
++ F+ SDV+SFGV+L+EL SP M
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ---GEKEF---QTEVMLLGRLHHRNLVN 172
++G+GA+G VY + G+ +AVK + D+ EKE+ Q EV LL L H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
+G C + + F+ GS++S L +GPL + + G+ YLH+ V
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNCV- 123
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA------NIRGTFGYLDPEYIS 285
+HRDIK +N++L + ++ DFG +R V H ++ GT ++ PE I+
Sbjct: 124 --VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPL 312
+ +KSD++S G +FE+ G+ PL
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY-- 176
+G G G V K TG+ +AVK + + E + + L LH N +VG+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 177 -CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
G + +M GSL + E G + + IA+ V +GL YLH+ +I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKII 123
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
HRD+K SNIL++ + ++ DFG+S + +V+ A GT Y+ PE I +++ KSD+
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182
Query: 296 YSFGVLLFELIAGRSPL 312
+S G+ L EL GR P
Sbjct: 183 WSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 72/219 (32%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 120 IGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172
+G GAFG VY+ VAVK L S+Q E +F E +++ + +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYD-----ENYGPLTWNLRVHIALDVARGLEYLH 227
L+G E+ ++ M+ G L S L + E LT + A DVA+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSRE-EMVDKHAANIRGTF--GYLDP 281
+ IHRDI + N LL RVA DFG++R+ + R ++ P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
E FT K+DV+SFGVLL+E+ + G P G Q+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGE--KEFQTEVMLLGRLHHRNLV 171
+G GAF Y+A+ + TG +AVK + T S+Q E + + E+ L+ RL+H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
++G E L +M+ GS++ L YG + ++ + RGL YLH+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGLSYLHENQ- 123
Query: 232 PPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVDKHAAN-----IRGTFGYLDPEYIS 285
+IHRD+K +N+L+D + R R+ADFG + A + GT ++ PE +
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
+ + DV+S G ++ E+ + P
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 24/219 (10%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKE-------FQTEVMLLGRLHHR 168
LIG G+FG VY S+GE +AVK + S + E+ LL L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 169 NLVNLVGYCAEKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
N+V +G + H+ +++ ++ GS+A+ L NYG L + + +GL YLH
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-------KHAANIRGTFGYLD 280
+ + IHRDIK +NIL+D +++DFG+S++ + +++G+ ++
Sbjct: 124 NRGI---IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
PE + ++T+K+D++S G L+ E++ G+ P + Q
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-27
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQT---EVMLLGRLHHRNLVN 172
L+GQGAFG VY + TG +AVK + DS + +KE E+ LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G C + + +++ +M GS+ L + YG LT + + G+EYLH +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLS-REEMVDKHAANIR---GTFGYLDPEYISTR 287
+HRDIK +NIL D + ++ DFG S R + + ++ GT ++ PE IS
Sbjct: 126 ---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
+ +K+DV+S G + E++ + P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 18/203 (8%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKV--LATDSKQGE---KEFQTEVMLLGRLHHRNLVN 172
L+G G+FG VY+ + G+ AVK LA D + G+ K+ + E+ LL +L H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 173 LVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
+G E+ +Y+F+ GSLA L + YG + + GLEYLHD
Sbjct: 67 YLGTEREEDN---LYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRN 288
+HRDIK +NIL+D + ++ADFG++++ + A + +G+ ++ PE I
Sbjct: 122 NT---VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
+ +D++S G + E+ G+ P
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 73/226 (32%), Positives = 119/226 (52%), Gaps = 35/226 (15%)
Query: 120 IGQGAFGPVYKAQM--------STGETVAVKVL---ATDSKQGEKEFQTEVM-LLGRLHH 167
+G+G FG V +A+ TVAVK+L ATD + + E+M L+G+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-------DENY-------GPLTWNLRV 213
+N++NL+G C ++G ++ + +KG+L L D + L++ V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD--KHAA 270
A VARG+EYL IHRD+ + N+L+ + ++ADFGL+R +D K +
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
N R ++ PE + R +T +SDV+SFG+L++E+ G SP G+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
IG+G+FG V K + S G+ + K + EKE Q +EV +L L H N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDY-GNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 176 YCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
++ +Y+ M G LA + + + I + L H+ +
Sbjct: 67 RIIDRSNQ-TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 231 VPP--VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYIS 285
P V+HRD+K +NI LD + ++ DFGL++ ++ A GT Y+ PE ++
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
++ +KSD++S G L++EL A P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 20/219 (9%)
Query: 118 TLIGQGAFGPVYKAQM-----STGET-VAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNL 170
T +G+G FG V+ A+ GET V VK L T + + EF+ E+ + +L H+N+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYG--PLTWNLRVHIALDVARGL 223
V L+G C E H ++ + G L A+ DE PL+ +V + +A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLDP 281
++L + +HRD+ + N L+ +V+ LS++ + N +L P
Sbjct: 131 DHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
E + +F+ KSDV+SFGVL++E+ G P GL +++
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 120 IGQGAFGPVYKAQMST------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+GAFG V+ A+ VAVK L S+ ++FQ E LL L H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 174 VGYCAEKGQHMLVYVFMSKGSLA---------SHLYDENY----GPLTWNLRVHIALDVA 220
G C E ++V+ +M G L + + G LT + IA +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG-- 277
G+ YL A +HRD+ + N L+ Q + ++ DFG+SR+ D + R
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSP 311
++ PE I R FT +SD++SFGV+L+E+ G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEF-QTEVMLLGRLHHRNLVNLVGY 176
IG+G+FG VYKA T + VA+KV+ + + E E Q E+ L + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66
Query: 177 CAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
KG + ++ + GS L G L I +V GLEYLH+ I
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGK---I 120
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YLDPEYISTRNFTK 291
HRDIK++NILL + ++ADFG+S + + R TF G ++ PE I + +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 292 KSDVYSFGVLLFELIAGRSPLQGL 315
K+D++S G+ EL G PL L
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 31/217 (14%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-F-QT---EVMLLGRLHHRNLVNL 173
IG+G +G VYKA+ TGE VA+K + ++ EKE F T E+ LL +L H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 174 VGYCAEK--GQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
K G +V+ +M G L S T + + GL+YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-----KFTESQIKCYMKQLLEGLQYLHS 118
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-----IRGTFGYLDPEY 283
+ +HRDIK SNIL++ ++ADFGL+R +++A+ I T Y PE
Sbjct: 119 NGI---LHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVI--TLWYRPPEL 172
Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ + + D++S G +L EL G+ QG E +
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-26
Identities = 76/228 (33%), Positives = 121/228 (53%), Gaps = 39/228 (17%)
Query: 120 IGQGAFGPVYKAQM--------STGETVAVKVLATDSKQGEKEF-----QTEVM-LLGRL 165
+G+G FG V A+ TVAVK+L D+ EK+ + E+M ++G+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGK- 79
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-----------YDENYGP---LTWNL 211
H+N++NL+G C + G ++ + SKG+L +L YD P +T+
Sbjct: 80 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 212 RVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD--KH 268
V VARG+EYL A IHRD+ + N+L+ ++ ++ADFGL+R+ +D K
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
N R ++ PE + R +T +SDV+SFGVL++E+ G SP G+
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 80/252 (31%), Positives = 130/252 (51%), Gaps = 39/252 (15%)
Query: 96 VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
VS +PE ++ + +G+G FG V A+ + VAVK+L +D
Sbjct: 2 VSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD 61
Query: 148 SKQGEKEF-----QTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-- 199
+ EK+ + E+M ++G+ H+N++NL+G C + G ++ + SKG+L +L
Sbjct: 62 AT--EKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 117
Query: 200 ---------YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD 247
Y+ P L++ V A VARG+EYL A IHRD+ + N+L+
Sbjct: 118 RRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVT 174
Query: 248 QSMRARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFE 304
+ ++ADFGL+R+ +D K N R ++ PE + R +T +SDV+SFGVLL+E
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234
Query: 305 LIA-GRSPLQGL 315
+ G SP G+
Sbjct: 235 IFTLGGSPYPGV 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
+G+G FG V Q+ +TG+ A K L ++GE+ E +L ++ R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
Y E + LV M+ G L H+Y+ + A + GLE+LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI--- 116
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
++RD+K N+LLD R++D GL+ E K GT GY+ PE + + D
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 295 VYSFGVLLFELIAGRSPLQ 313
++ G L+E+IAGRSP +
Sbjct: 177 WFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 64/211 (30%), Positives = 115/211 (54%), Gaps = 25/211 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVK---VLATDSKQGE-------KEFQTEVMLLGRLHH 167
LIG+G +G VY A ++TGE +AVK + AT + + + K ++E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 168 RNLVNLVGYCAEKGQHML-VYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
N+V +G+ E + L +++ ++ GS+ S L YG L V GL Y
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAA-NIRGTFGYLDPE 282
LH + +HRD+K+ N+L+D +++DFG+S+ +++ D +++G+ ++ PE
Sbjct: 124 LHSKGI---LHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 283 YIST--RNFTKKSDVYSFGVLLFELIAGRSP 311
I + + ++ K D++S G ++ E+ AGR P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 15/212 (7%)
Query: 116 FTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-HH 167
F +G GAFG V +A + VAVK+L + E+E +E+ ++ L +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
N+VNL+G C G +++ + G L + L + LT + + VA+G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYI 284
A IHRD+ + N+LL ++ DFGL+R+ M D + N R ++ PE I
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
+T +SDV+S+G+LL+E+ + G +P G+
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
IG G +G VYKA+ +TGE VA+KV+ + + Q E+ +L H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ + +V + GSL +Y GPL+ ++ + +GL YLH+ IHRD
Sbjct: 71 RRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK---IHRD 126
Query: 239 IKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYISTRN---FTKKS 293
IK +NILL + ++ADFG+S + + K + I GT ++ PE + + K
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGKC 185
Query: 294 DVYSFGVLLFELIAGRSPLQGL 315
D+++ G+ EL + P+ L
Sbjct: 186 DIWALGITAIELAELQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G G G V K + + TG +A KV+ +K K+ E+ ++ +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+ + FM GSL +Y + GP+ + IA+ V GL YL++ V ++HR
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHR 128
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
DIK SNIL++ + ++ DFG+S E+++ A GT Y+ PE I +T KSDV+S
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWS 187
Query: 298 FGVLLFELIAGRSP 311
G+ + EL G+ P
Sbjct: 188 LGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 78/226 (34%), Positives = 121/226 (53%), Gaps = 35/226 (15%)
Query: 120 IGQGAFGPVYKAQM--------STGETVAVKVL---ATDSKQGEKEFQTEVM-LLGRLHH 167
+G+G FG V A+ + TVAVK+L ATD + + E+M ++G+ H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-----------YDENYGP---LTWNLRV 213
+N++NL+G C + G ++ + SKG+L +L +D P LT+ V
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD--KHAA 270
A VARG+EYL A IHRD+ + N+L+ + ++ADFGL+R+ +D K
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
N R ++ PE + R +T +SDV+SFGVLL+E+ G SP G+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 34/212 (16%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE--FQT---EVMLLGRLHHRNLVNL 173
+G+G +G VYKA+ TGE VA+K + D+ E+E T E+ LL L H N+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKL 63
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ + + LV+ + L +L D+ GPL+ NL I + RGL Y H +
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI-- 119
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE----------EMVDKHAANIRGTFGYLDPEY 283
+HRD+K NIL+++ ++ADFGL+R E+V T Y PE
Sbjct: 120 -LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---------TLWYRAPEI 169
Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ +++++ D++S G + E+I G+ G
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 22/221 (9%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE---FQT 157
+P + K ++K +G G FG V+ + VA+K L KQG F
Sbjct: 3 VPRETLKLVKK--------LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLA 50
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
E L+ +L H LV L ++ + ++ +M GSL L LT N + +A
Sbjct: 51 EANLMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF- 276
+A G+ ++ IHRD++++NIL+ +++ ++ADFGL+R +++ A F
Sbjct: 110 QIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 277 -GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
+ PE I+ FT KSDV+SFG+LL E++ GR P G+
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLVGY 176
+G G FG V+ + VA+K++ ++G E +F E ++ +L H NLV L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
C ++ +V +M+ G L ++L E G L + + DV +EYL IH
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSD 294
RD+ + N L+ + +V+DFGL+R + D++ ++ F + PE F+ KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 295 VYSFGVLLFELIA-GRSPLQGL 315
V+SFGVL++E+ + G+ P +
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
IG GA VY A + E VA+K + + Q E + EV + + +H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 178 AEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+ LV ++S GSL + G L + + +V +GLEYLH IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IH 125
Query: 237 RDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAA--NIRGTFGYLDPEYISTRN-FT 290
RDIK+ NILL + ++ADFG+S + GT ++ PE + + +
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 291 KKSDVYSFGVLLFELIAGRSPL 312
K+D++SFG+ EL G +P
Sbjct: 186 FKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-25
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLAT---DSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG+GAFG V Q T + A+K + K + E +L L+H LVNL
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW- 66
Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
Y + ++M LV + G L HL + ++ LEYLH +
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLALEYLHSKGI--- 121
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
IHRDIK NILLD+ + DF ++ + D + GT GY+ PE + + ++ D
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181
Query: 295 VYSFGVLLFELIAGRSPLQG 314
+S GV +E + G+ P +G
Sbjct: 182 WWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-24
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 8/203 (3%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+G G FG V + VA+K++ S E EF E ++ +L H LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ +V +MS G L ++L + L + + DV G+ YL IHRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLESKQF---IHRDL 126
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
+ N L+D +V+DFGLSR + D++ +++ F + PE + F+ KSDV++
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 298 FGVLLFELIA-GRSPLQGLMEQQ 319
FGVL++E+ + G+ P + +
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 74/218 (33%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVM 160
IP S + ++K +G G FG V+ + VAVK L + E F E
Sbjct: 3 IPRESLQLIKK--------LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQ 53
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
++ +L H LV L +E+ + +V +MSKGSL L D L V +A VA
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
G+ Y+ IHRD++S+NIL+ + ++ADFGL+R +++ A F +
Sbjct: 113 AGMAYIERMNY---IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
PE FT KSDV+SFG+LL EL+ GR P G+
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-24
Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 8/201 (3%)
Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
F +G G FG V+ + VA+K + + E++F E ++ +L H LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
C ++ +V FM G L ++L + G L+ ++ + + DV G+EYL + I
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERNSF---I 122
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKS 293
HRD+ + N L+ + +V+DFG++R + D++ ++ F + PE + ++ KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 294 DVYSFGVLLFELIA-GRSPLQ 313
DV+SFGVL++E+ G+ P +
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-24
Identities = 66/218 (30%), Positives = 111/218 (50%), Gaps = 15/218 (6%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVM 160
IP S K ++K +G G FG V+ + VAVK L + + F E
Sbjct: 3 IPRESIKLVKK--------LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEAN 53
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
L+ L H LV L ++ ++ +M+KGSL L + G + + + +A
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
G+ Y+ IHRD++++N+L+ +S+ ++ADFGL+R +++ A F +
Sbjct: 114 EGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
PE I+ +FT KSDV+SFG+LL+E++ G+ P G+
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 69/220 (31%), Positives = 117/220 (53%), Gaps = 23/220 (10%)
Query: 116 FTTLIGQGAFGPVYKAQMSTG---ETVAVKVLAT-DSKQGEKEFQTEVMLLGRL-HHRNL 170
F +IG+G FG V +A + A+K+L S+ ++F E+ +L +L HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----------YDENYGP---LTWNLRVHIA 216
+NL+G C +G + + G+L L + + +G LT + A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
DVA G++YL + IHRD+ + N+L+ +++ +++ADFGLSR E V R
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV 182
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
++ E ++ +T KSDV+SFGVLL+E+++ G +P G+
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-24
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+GAFG V+ A+ VAVK L S K+F E LL L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-------------LTWNLRVHIALDVA 220
G C E ++V+ +M G L L +GP LT + +HIA +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFG 277
G+ YL A +HRD+ + N L+ +++ ++ DFG+SR+ + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSP 311
++ PE I R FT +SDV+S GV+L+E+ G+ P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G GAFG VYKAQ TG A K++ +S++ ++F E+ +L H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ + ++ F G+L S + E LT ++ + L +LH V IHRD
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSHKV---IHRD 128
Query: 239 IKSSNILLDQSMRARVADFGLS---REEMVDKHAANIRGTFGYLDPEYISTRNFTK---- 291
+K+ NILL ++ADFG+S + + K I GT ++ PE ++ F
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 292 -KSDVYSFGVLLFELIAGRSP 311
K+D++S G+ L EL P
Sbjct: 187 YKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-24
Identities = 72/230 (31%), Positives = 118/230 (51%), Gaps = 23/230 (10%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTG---ETVAVKVLAT-DSKQGEKEFQTEVML 161
Y L+ F +IG+G FG V KA++ A+K + SK ++F E+ +
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 162 LGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL--------------ASHLYDENYGP 206
L +L HH N++NL+G C +G L + G+L A + +
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
L+ +H A DVARG++YL + IHRD+ + NIL+ ++ A++ADFGLSR + V
Sbjct: 121 LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177
Query: 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
R ++ E ++ +T SDV+S+GVLL+E+++ G +P G+
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-24
Identities = 74/226 (32%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 119 LIGQGAFGPVYKAQM------STGET-VAVKVL---ATDSKQGEKEFQTEVMLLGRLHHR 168
+G GAFG VY+ +G VAVK L ATD ++ KEF E L+ +H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHP 59
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD----ENYGP-LTWNLRVHIALDVARGL 223
N+V L+G C ++ M G L S+L D P LT + I LDVA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 224 EYLHDGAVPPVIHRDIKSSNILL-----DQSMRARVADFGLSREEMVDKHAANIRG---- 274
YL IHRD+ + N L+ D ++ DFGL+R ++ G
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLL 175
Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
++ PE + FT +SDV+SFGVL++E++ G+ P L Q+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-24
Identities = 71/242 (29%), Positives = 121/242 (50%), Gaps = 38/242 (15%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQ-----MSTGETVAVKVLAT-DSKQGEKEFQTEVML 161
+L + F +G+ AFG +YK M + VA+K L ++ Q EFQ E L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY------------DENYGPLTW 209
+ LHH N+V L+G ++ +++ ++++G L L DE+ G +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED-GTVKS 119
Query: 210 NLR----VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--- 262
+L +HIA+ +A G+EYL + +H+D+ + NIL+ + + +++D GLSRE
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 263 ----EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317
+ K IR ++ PE I F+ SD++SFGV+L+E+ + G P G
Sbjct: 177 ADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232
Query: 318 QQ 319
Q+
Sbjct: 233 QE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-24
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 119 LIGQGAFGPVYKAQMSTGET----VAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
++G+G FG V + Q+S + VAVK + D + +EF +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 173 LVGYCAEKGQH------MLVYVFMSKGSLASHLYDENYGPLTWNLRVH----IALDVARG 222
L+G C E M++ FM G L S L G L L + +D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYL 279
+EYL + IHRD+ + N +L + M VADFGLS++ + R ++
Sbjct: 126 MEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
E ++ R +T KSDV++FGV ++E+ G++P G+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-24
Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLHHRNLVNLVGY 176
IG+G +G VY+A+ ++GE VA+K + D+++ + E+ LL L H N+V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 177 CAEKGQHMLVYVFMSKG----SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
G+H L +F+ LAS L D P + + + L + RGL+YLH+ +
Sbjct: 75 VV--GKH-LDSIFLVMEYCEQDLAS-LLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI- 129
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYI-STRNFT 290
IHRD+K SN+LL ++ADFGL+R + K T Y PE + +T
Sbjct: 130 --IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLME 317
D+++ G +L EL+A + L G E
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 8e-24
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRN 169
F +G G+FG V + +G+ A+K+L+ KQ + E +L + H
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPF 62
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLE 224
LVNL G + LV ++ G L SHL + E R + A V LE
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA------RFYAA-QVVLALE 115
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
YLH + ++RD+K N+LLD ++ DFG ++ V + GT YL PE I
Sbjct: 116 YLHSLDI---VYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYTLCGTPEYLAPEII 170
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSP 311
++ + K D ++ G+L++E++AG P
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-23
Identities = 68/203 (33%), Positives = 106/203 (52%), Gaps = 8/203 (3%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+GQG FG V+ + VA+K L + E F E ++ +L H LV L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ + +V +MSKGSL L E L V +A +A G+ Y+ +HRD+
Sbjct: 73 EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 128
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
+++NIL+ +++ +VADFGL+R +++ A F + PE FT KSDV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 298 FGVLLFELIA-GRSPLQGLMEQQ 319
FG+LL EL GR P G++ ++
Sbjct: 189 FGILLTELTTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-23
Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYC 177
L+G+G FG V+K + VAVK D Q K +F +E +L + H N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
++ +V + G S L + T L V ALD A G+ YL IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-VKFALDAAAGMAYLES---KNCIHR 117
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG----TFGYLDPEYISTRNFTKKS 293
D+ + N L+ ++ +++DFG+SR+E D + G + PE ++ ++ +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 294 DVYSFGVLLFELIA-GRSPLQGLMEQQ 319
DV+S+G+LL+E + G P G+ QQ
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-23
Identities = 60/212 (28%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+IG G FG V++ + VA+K L +++ ++F +E ++G+ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
G + M++ +M G+L +L D + G + V + +A G++YL D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNY-- 128
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-----YLDPEYISTRN 288
+HRD+ + NIL++ ++ +V+DFGLSR + D + G + PE I+ R
Sbjct: 129 -VHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
FT SDV+SFG++++E+++ G P + +
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 119 LIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQ-----TEVMLLGRLHHR 168
L+ +G FG ++ + E V VK + K E Q E LL L H+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 169 NLVNLVGYCAEKGQH-MLVYVFMSKGSLASHLYDENYGP------LTWNLRVHIALDVAR 221
N++ ++ C E G+ ++Y +M+ G+L L G L+ VH+A+ +A
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKH--AANIRGTFGY 278
G+ YLH V IH+DI + N ++D+ ++ ++ D LSR+ +D H N +
Sbjct: 129 GMSYLHKRGV---IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSP 311
+ E + + ++ SDV+SFGVLL+EL+ G++P
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 35/220 (15%)
Query: 120 IGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+GAFG V+ A+ VAVK L + K+FQ E LL L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 174 VGYCAEKGQHMLVYVFMSKGSL----------ASHLYD----ENYGPLTWNLRVHIALDV 219
G C + ++V+ +M G L A L D + G L + +HIA +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-- 277
A G+ YL A +HRD+ + N L+ ++ ++ DFG+SR D ++ + G
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHT 185
Query: 278 -----YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSP 311
++ PE I R FT +SDV+SFGV+L+E+ G+ P
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-23
Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 8/203 (3%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+GQG FG V+ + VA+K L + E F E ++ +L H LV L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ + +V FM KGSL L + + L V +A +A G+ Y+ IHRD+
Sbjct: 73 EPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDL 128
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
+++NIL+ ++ ++ADFGL+R +++ A F + PE FT KSDV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 298 FGVLLFELIA-GRSPLQGLMEQQ 319
FG+LL EL+ GR P G++ ++
Sbjct: 189 FGILLTELVTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 67/235 (28%), Positives = 118/235 (50%), Gaps = 36/235 (15%)
Query: 118 TLIGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNL 170
+G+G FG V KA + TVAVK+L ++ E ++ +E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL--------------------YDENYG--PLT 208
+ L G C++ G +L+ + GSL S L Y +N LT
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 209 WNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMV 265
+ A ++RG++YL A ++HRD+ + N+L+ + + +++DFGLSR EE
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+ R ++ E + +T +SDV+SFGVLL+E++ G +P G+ ++
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-23
Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 22/207 (10%)
Query: 120 IGQGAFGPVY--KAQMSTGETVAVKVLATDSKQGEKEF-QTEVMLLGRLHHRNLVNLVGY 176
IG+G+FG +Y KA+ + V ++ T EKE + EV+LL ++ H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 177 CAEKGQHMLVYVFMSKGSLASH-------LYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
E G+ +V + G L L+ E+ L+W V I+L GL+++HD
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSW--FVQISL----GLKHIHDR 120
Query: 230 AVPPVIHRDIKSSNILLDQS-MRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYISTR 287
+ +HRDIKS NI L ++ M A++ DFG++R+ + A GT YL PE R
Sbjct: 121 KI---LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ K+D++S G +L+EL + P +G
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-23
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
++G+G +G VY A+ +ST +A+K + + + E+ L L HRN+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI--ALDVARGLEYLHDGAVPPVI 235
+E G +++ G S L +GPL N + I + GL+YLHD ++
Sbjct: 75 SENG-FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IV 130
Query: 236 HRDIKSSNILLDQ-SMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYIS--TRNFTK 291
HRDIK N+L++ S +++DFG S R ++ GT Y+ PE I R +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+D++S G + E+ G+ P L E Q
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-23
Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG+G+FG V+K + + A+K L+ +++ +E E +L +L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+KG+ +V + G L L + PL + + + GL +LH + +H
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI---LH 124
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDV 295
RDIKS N+ LD ++ D G+++ + + AN I GT YL PE + + +KSDV
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDV 184
Query: 296 YSFGVLLFELIAGRSP 311
++ GV+L+E G+ P
Sbjct: 185 WALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 5e-23
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G+G++G VYKA TG+ VA+KV+ + +E E+ +L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+ +V + GS+ S + LT I +GLEYLH IHR
Sbjct: 68 FKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK---IHR 123
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHA-AN-IRGTFGYLDPEYISTRNFTKKSDV 295
DIK+ NILL++ +A++ADFG+S ++ D A N + GT ++ PE I + K+D+
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADI 182
Query: 296 YSFGVLLFELIAGRSPLQGL 315
+S G+ E+ G+ P +
Sbjct: 183 WSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-23
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 119 LIGQGAFGPVYKA--QMSTGE--TVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL 173
IG+G FG VY+ E VAVK + +E F E ++ + H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 174 VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
+G E V++ M G L S+L Y L + + ++ L YL
Sbjct: 73 IGVITE----NPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLES-- 125
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRN 288
+HRDI + N+L+ ++ DFGLSR E+ A+ + ++ PE I+ R
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 289 FTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
FT SDV+ FGV ++E L+ G P QG+
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGV 212
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-23
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLA---------TDSKQGEKE-FQTEVMLLG 163
++G+G FG V A+ TGE A+K L +S EK F+T
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----AN 57
Query: 164 RLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVAR 221
H LVNL C + H+ V + + G L H++ + + P V A V
Sbjct: 58 SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA----VFYAACVVL 112
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLD 280
GL+YLH+ + ++RD+K N+LLD ++ADFGL +E M + GT +L
Sbjct: 113 GLQYLHENKI---VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
PE ++ ++T+ D + GVL++E++ G SP G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-23
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGE--TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G G FG V K M +G+ VAVK L G+KEF E ++ +L H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G C + MLV G L +L P++ +L+ +A VA G+ YL
Sbjct: 63 GVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVS-DLKE-LAHQVAMGMAYLESKHF--- 116
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVD----KHAANIRGTFGYLDPEYISTRNFT 290
+HRD+ + N+LL +A+++DFG+SR + R + PE I+ F+
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGL 315
KSDV+S+GV L+E + G P +
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-23
Identities = 61/205 (29%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+IG G FG V + ++ VA+K L + +++ ++F +E ++G+ H N+++L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
G + M++ FM G+L S L +N G T V + +A G++YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY-- 127
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPEYISTR 287
+HRD+ + NIL++ ++ +V+DFGLSR D + G + PE I+ R
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 288 NFTKKSDVYSFGVLLFELIA-GRSP 311
FT SDV+S+G++++E+++ G P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-23
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G+GA G V K ++ + A+K + TD +K+ E+ + +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 178 AEKGQHMLVYV--FMSKGSLASHLYDE---NYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
++ + + GSL S +Y + G + + IA V +GL YLH +
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI- 126
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
IHRDIK SNILL + + ++ DFG+S E+V+ A GT Y+ PE I + ++
Sbjct: 127 --IHRDIKPSNILLTRKGQVKLCDFGVS-GELVNSLAGTFTGTSFYMAPERIQGKPYSIT 183
Query: 293 SDVYSFGVLLFELIAGRSP 311
SDV+S G+ L E+ R P
Sbjct: 184 SDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTE-VMLLGRLHHRNLVNLV 174
I +GAFG VY A+ STG+ A+KVL +K + E +++ + + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
K LV +++ G AS + P W + +IA +V G+E LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQRGI--- 118
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
IHRDIK N+L+DQ+ ++ DFGLSR + +K GT YL PE I K SD
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK---KFVGTPDYLAPETILGVGDDKMSD 175
Query: 295 VYSFGVLLFELIAGRSP 311
+S G ++FE + G P
Sbjct: 176 WWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 7/199 (3%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLV 174
++G+G FG V Q+ +TG+ A K L ++GE E +L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
K LV M+ G L H+Y V A ++ GLE LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERI 123
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
++RD+K NILLD R++D GL+ + GT GY+ PE + +T D
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 295 VYSFGVLLFELIAGRSPLQ 313
++ G LL+E+IAG+SP Q
Sbjct: 184 WWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
++ + + +G G FG V+ A + VAVK + S E F E ++ L H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 60
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
LV L ++ +++ FM+KGSL L + + + +A G+ ++
Sbjct: 61 DKLVKLHAVVTKEPIYIITE-FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
IHRD++++NIL+ S+ ++ADFGL+R +++ A F + PE I+
Sbjct: 120 QRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
+FT KSDV+SFG+LL E++ GR P G+
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 23/217 (10%)
Query: 119 LIGQGAFGPVYKAQM----STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
++G+G FG V +AQ+ + + VAVK+L D S +EF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 173 LVGYCAE---KGQ---HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----ALDVARG 222
L+G KG+ M++ FM G L + L G + L + +D+A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYL 279
+EYL IHRD+ + N +L+++M VADFGLS++ + + +L
Sbjct: 126 MEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
E ++ +T SDV++FGV ++E++ G++P G+
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-22
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKE---FQTEVMLLGRLHHRNLVN 172
L+GQGAFG VY TG +AVK + D S + KE + E+ LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 173 LVGYCAEKGQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
G C + +FM GS+ L ++YG LT N+ + G+ YLH
Sbjct: 69 YYG-CLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREE----MVDKHAANIRGTFGYLDPEYIS 285
+ +HRDIK +NIL D ++ DFG S+ + ++ GT ++ PE IS
Sbjct: 126 MI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
+ +K+D++S G + E++ + P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-22
Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 14/210 (6%)
Query: 119 LIGQGAFGPVYKAQMSTGE----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+IG G FG V ++ VA+K L A +++ ++F +E ++G+ H N+++L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
G + M+V +M GSL + L ++ G T V + +A G++YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIASGMKYLSDMGY-- 127
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFGYLDPEYISTRNF 289
+HRD+ + NIL++ ++ +V+DFGLSR D AA RG + PE I+ R F
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 290 TKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318
T SDV+S+G++++E+++ G P + Q
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-22
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKE---FQTEVMLLGRLHHRNLVN 172
L+GQGAFG VY + TG +A K + D S + KE + E+ LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
G ++ + L +M GS+ L + YG LT ++ + G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLS-REEMVDKHAANIR---GTFGYLDPEYIST 286
+ +HRDIK +NIL D + ++ DFG S R + + IR GT ++ PE IS
Sbjct: 127 I---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSP 311
+ +K+DV+S G + E++ + P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-22
Identities = 69/217 (31%), Positives = 112/217 (51%), Gaps = 23/217 (10%)
Query: 119 LIGQGAFGPVYKAQMSTG---ETVAVKVLAT-DSKQGEKEFQTEVMLLGRL-HHRNLVNL 173
+IG+G FG V KA++ A+K + SK ++F E+ +L +L HH N++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHL-----------YDENYGP---LTWNLRVHIALDV 219
+G C +G L + G+L L + L+ +H A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL 279
ARG++YL IHRD+ + NIL+ ++ A++ADFGLSR + V R ++
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
E ++ +T SDV+S+GVLL+E+++ G +P G+
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
+IG+G +G VYKA+ TG+ VA+K++ + E+E + E +L + +H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 177 CAEKG------QHMLVYVFMSKGS---LASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
+K Q LV GS L L + L +I + RGL YLH
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRETLRGLAYLH 130
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YLDPEY 283
+ V IHRDIK NILL ++ ++ DFG+S + R TF G ++ PE
Sbjct: 131 ENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTPYWMAPEV 184
Query: 284 IS-----TRNFTKKSDVYSFGVLLFELIAGRSPL 312
I+ ++ +SDV+S G+ EL G+ PL
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 8e-22
Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 28/222 (12%)
Query: 120 IGQGAFGPVYK---AQMSTGE---TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
+GQG+FG VY+ + GE VA+K + ++ E+ EF E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL--------YDENYGPLTWNLRVHIALDVARGL 223
L+G + GQ LV + M+KG L S+L + GP T + +A ++A G+
Sbjct: 74 LLGVVS-TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL---- 279
YL +HRD+ + N ++ + + ++ DFG++R+ + + +G G L
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRW 187
Query: 280 -DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
PE + FT KSDV+SFGV+L+E+ P QGL ++
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 8e-22
Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETV----AVKVL-ATDSKQGEKEFQTEVMLL 162
L++ ++G GAFG VYK + GETV A+K+L T + EF E +++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVA 220
+ H +LV L+G C LV M G L ++++ +N G L ++ + +A
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGS---QLLLNWCVQIA 119
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG---TFG 277
+G+ YL + + +HRD+ + N+L+ ++ DFGL+R D+ N G
Sbjct: 120 KGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
++ E I R FT +SDV+S+GV ++EL+ G P G+
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-22
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATD---------SKQGEKEFQTEVMLLGRLHHR 168
++G+G+FG V A++ T E AVKVL D EK V+ L H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR----VLALAG-KHP 56
Query: 169 NLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
L L + + + L +V +++ G L H+ + G A ++ GL++L
Sbjct: 57 FLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIS 285
H+ + I+RD+K N+LLD ++ADFG+ +E ++ + GT Y+ PE +S
Sbjct: 113 HERGI---IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ + D ++ GVLL+E++AG+SP +G E +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLVNLVGY 176
IG G FG VY A + TGE +AVK + + KE E+ +L L H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 177 CAEKGQHMLVYVFM---SKGSLASHLY-----DENYGPLTWNLRVHIALDVARGLEYLHD 228
+ + VY+FM S G+L L DE+ +RV+ L + GL YLH
Sbjct: 68 EVHREK---VYIFMEYCSGGTLEELLEHGRILDEHV------IRVY-TLQLLEGLAYLHS 117
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLS-----REEMVDKHAANIRGTFGYLDPEY 283
+ +HRDIK +NI LD + ++ DFG + + + ++ GT Y+ PE
Sbjct: 118 HGI---VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 284 ISTRNFTKK---SDVYSFGVLLFELIAGRSPLQGL 315
I+ +D++S G ++ E+ G+ P L
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-21
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKE---FQTEVMLLGRLHHRNLVN 172
L+G+GAFG VY TG +AVK + D S++ KE + E+ LL L H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 173 LVGYCAEKGQHML-VYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
G + + L ++V +M GS+ L + YG LT N+ + +G+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE----EMVDKHAANIRGTFGYLDPEYIST 286
+ +HRDIK +NIL D + ++ DFG S+ M ++ GT ++ PE IS
Sbjct: 127 I---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSP 311
+ +K+DV+S + E++ + P
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD---------SKQGEKEFQTEVMLLGR 164
NF ++G+G+FG V A + T E A+K+L D EK + L G+
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV---LALPGK 59
Query: 165 LHHRNLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
L L + + L +V +++ G L H+ + G V A ++A G
Sbjct: 60 PPF--LTQL--HSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIG 113
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDP 281
L +LH + I+RD+K N++LD ++ADFG+ +E + K GT Y+ P
Sbjct: 114 LFFLHSKGI---IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAP 170
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
E I+ + + K D ++FGVLL+E++AG+ P G E +
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
+G+G FG V QM +TG+ A K L + K ++ E +L ++H R +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLY--DENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
K LV M+ G L H+Y DE + GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI-- 118
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTK 291
I+RD+K N+LLD R++D GL+ E+ D + GT G++ PE + +
Sbjct: 119 -IYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 292 KSDVYSFGVLLFELIAGRSPLQ 313
D ++ GV L+E+IA R P +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRL-----HHRNLVN 172
++G+G+FG V+ A++ T + A+K L D + + + M+ R+ H L +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFLTH 60
Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
L YC + + L +V +++ G L H+ ++ A ++ GL++LH
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNF 289
+ ++RD+K NILLD ++ADFG+ +E M+ D GT Y+ PE + + +
Sbjct: 117 I---VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
D +SFGVLL+E++ G+SP G E++
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
NF ++G+G+FG V A+ T E A+K+L D + + + E +L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
+ + C + + V +++ G L H+ + G V A +++ GL +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRN 288
+ I+RD+K N++LD ++ADFG+ +E MVD GT Y+ PE I+ +
Sbjct: 121 GI---IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ K D +++GVLL+E++AG+ P G E +
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-21
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA--TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG+G +G VYKA+ TGE VA+K + +S+ K E+ LL L+H N++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
KG LV+ FM L L + L +L + +GL + H + +H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI---LH 121
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR--------- 287
RD+K N+L++ ++ADFGL+R Y+ TR
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARS---------FGSPVRPYT-HYVVTRWYRAPELLL 171
Query: 288 ---NFTKKSDVYSFGVLLFELIAGRSPL 312
++ D++S G + EL++ R PL
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR-PL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-21
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLV 174
++G+G FG V Q+ +TG+ A K L ++GE E +L +++ + +VNL
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
K LV M+ G L H+Y+ + A ++ GLE LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT--- 123
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
++RD+K NILLD R++D GL+ + + GT GY+ PE ++ + +T D
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183
Query: 295 VYSFGVLLFELIAGRSPLQGLMEQ 318
+ G L++E+I G+SP +G E+
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-21
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
+G+G FG V Q+ +TG+ A K L K GEK E +L +++ +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
Y E H+ LV M+ G L H+Y+ L +H + + G+ +LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI--- 116
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
++RD+K N+LLD R++D GL+ E K GT GY+ PE + ++ D
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVD 176
Query: 295 VYSFGVLLFELIAGRSPLQGLMEQ 318
++ G ++E++AGR+P + E+
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-21
Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 117 TTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLV 174
LIG+GA+G VY+ + TG VA+K++ D+ + + Q EV LL +L N+
Sbjct: 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 175 GY--CAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL---DVARGLEYLHD 228
Y KG + ++ + GS+ + + GP+ +I++ +V L+Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIA---EKYISVIIREVLVALKYIHK 119
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYIST- 286
VIHRDIK++NIL+ + ++ DFG++ + GT ++ PE I+
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
+ + K+D++S G+ ++E+ G P +
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-21
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 120 IGQGAFGPV--YK---AQMSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G FG V Y A TGE VAVK L + +Q ++ E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G C+E+G L+ ++ GSL +L L A + G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL---FAQQICEGMAYLHSQHY 128
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSRE----EMVDKHAANIRGTFGYLDPEYISTR 287
IHRD+ + N+LLD ++ DFGL++ + + + E +
Sbjct: 129 ---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQ 313
F+ SDV+SFGV L+EL+ Q
Sbjct: 186 KFSYASDVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 22/215 (10%)
Query: 120 IGQGAFGPVYKAQMSTGET---VAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G+G FG V + Q++ ++ VAVK + A ++ ++F +E + + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 175 GYCAEKGQH------MLVYVFMSKGSLASHLYDENYGP----LTWNLRVHIALDVARGLE 224
G C + + +++ FM G L S L G L + V D+A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDP 281
YL + IHRD+ + N +L+++M VADFGLS++ + R ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
E ++ R +T KSDV+SFGV ++E+ G++P G+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVK----VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
IG+G FG V+ ++ T VAVK L D K +F E +L + H N+V L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 59
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-LTWNLRVHIALDVARGLEYLHDGAVPP 233
G C +K +V + G + L E GP L + + + A G+EYL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKHC-- 115
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN---IRGTFGYLDPEYISTRNFT 290
IHRD+ + N L+ + +++DFG+SREE +A+ + + PE ++ ++
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+SDV+SFG+LL+E + G P L QQ
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 17/205 (8%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGR---LHHRN--LVN 172
++G+G+FG V A++ GE AVK L D + + + M+ R L N L +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC-TMVEKRVLALAWENPFLTH 60
Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
L YC + + L +V F++ G L H+ D+ G A ++ GL++LH
Sbjct: 61 L--YCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNF 289
+ I+RD+K N++LD+ ++ADFG+ +E + D A+ GT Y+ PE + +
Sbjct: 117 I---IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
T D +SFGVLL+E++ G+SP G
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-20
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
L+G G +G VYK + + TG+ A+KV+ + E+E + E+ +L + HHRN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 177 CAEKG------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
+K Q LV F GS+ + + L +I ++ RGL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYI---- 284
V IHRDIK N+LL ++ ++ DFG+S + V + I GT ++ PE I
Sbjct: 132 V---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 187
Query: 285 ---STRNFTKKSDVYSFGVLLFELIAGRSPL 312
+T +F KSD++S G+ E+ G PL
Sbjct: 188 NPDATYDF--KSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
++G+G FG V Q+ +TG+ A K L ++GE E +L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
K LV M+ G L H+Y+ V A ++ GLE LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERI 123
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG---TFGYLDPEYISTRNFTK 291
++RD+K NILLD R++D GL+ E IRG T GY+ PE + +T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEI---PEGETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEQ 318
D + G L++E+I G+SP + E+
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 14/204 (6%)
Query: 119 LIGQGAFGPVYKAQMSTGETV----AVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
++GQG+FG V+ + TG A+KVL AT + + E +L ++H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTW-NLRVHIALDVARGLEYLHDGAV 231
L +G+ L+ F+ G L + L E T +++ ++A ++A L++LH +
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLA-ELALALDHLHSLGI 119
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFT 290
I+RD+K NILLD+ ++ DFGLS+E + +K A + GT Y+ PE ++ R T
Sbjct: 120 ---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
+ +D +SFGVL+FE++ G P QG
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKE-----FQTEVMLLGRLHHRNLVN 172
++G+G+FG V A++ T E A+K L D + + + V+ L H L +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTH 60
Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
L +C + + L +V +++ G L H+ G A ++ GL++LH
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG 116
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNF 289
+ I+RD+K N+LLD+ ++ADFG+ +E M + A+ GT Y+ PE + + +
Sbjct: 117 I---IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ D +SFGVLL+E++ G+SP G E +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 46/217 (21%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
++G+GA+G V K + +TGE VA+K + D + +K EV +L +L H N+VNL
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPL--------TWNLRVHIALDVARGLEYLH 227
KG+ LV+ ++ + L L + + G L W L + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIWQL--------LQAIAYCH 117
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
+ IHRDIK NIL+ +S ++ DFG +R A R D Y++TR
Sbjct: 118 SHNI---IHRDIKPENILVSESGVLKLCDFGFAR-------ALRARPASPLTD--YVATR 165
Query: 288 ------------NFTKKSDVYSFGVLLFELIAGRSPL 312
N+ K DV++ G ++ EL+ G PL
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE-PL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---T 157
PE + DL++ IG G+FG VY A+ T E VA+K ++ KQ +++Q
Sbjct: 13 PEKLFTDLRE--------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
EV L +L H N + G C + + + GS AS + + + PL I
Sbjct: 65 EVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCLGS-ASDILEVHKKPLQEVEIAAICH 122
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
+GL YLH IHRDIK+ NILL + ++ADFG + +V A + GT
Sbjct: 123 GALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA--SLVSP-ANSFVGTPY 176
Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
++ PE I + + K DV+S G+ EL + PL
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 37/238 (15%)
Query: 115 NFTTLIGQGAFGPVYKAQM----------------STGET-VAVKVLATD-SKQGEKEFQ 156
NF +G+G FG V+ + + VAVKVL D S ++F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 157 TEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD---------ENYGPL 207
EV +L RL N+ L+G C ++ +M G L L N L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
+++ +++A +A G+ YL +HRD+ + N L+ ++ ++ADFG+SR +
Sbjct: 128 SFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRN-LYSS 183
Query: 268 HAANIRGT----FGYLDPEYISTRNFTKKSDVYSFGVLLFEL--IAGRSPLQGLMEQQ 319
++G ++ E + FT KSDV++FGV L+E+ + P + L +QQ
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-20
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
++G G +G VYK + + TG+ A+KV+ + E+E + E+ +L + HHRN+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 177 CAEKG------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
+K Q LV F GS+ + + L + +I ++ RGL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--- 138
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYIST-- 286
VIHRDIK N+LL ++ ++ DFG+S + V + I GT ++ PE I+
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 197
Query: 287 ---RNFTKKSDVYSFGVLLFELIAGRSPL 312
+ +SD++S G+ E+ G PL
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-20
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
IG GA G VYK TG A+KV+ + + ++ E+ +L ++H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 178 AEKGQHMLVYVFMSKGSL-ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
G+ ++ FM GSL +H+ DE + +A + G+ YLH + +H
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADEQF-------LADVARQILSGIAYLHRRHI---VH 191
Query: 237 RDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTR-NFTK-- 291
RDIK SN+L++ + ++ADFG+SR + +D +++ GT Y+ PE I+T N
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYD 250
Query: 292 --KSDVYSFGVLLFELIAGRSPL 312
D++S GV + E GR P
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-20
Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 7/193 (3%)
Query: 117 TTLIGQGAFGPVYKAQMSTGET-VAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNL 173
++G+GAFG V+ + + V +K + + +K Q E +L L H N++
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
E M+V + G+LA ++ L + +H + + L ++H +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI-- 122
Query: 234 VIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
+HRD+K+ NILLD+ M ++ DFG+S+ A + GT Y+ PE + + +K
Sbjct: 123 -LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 293 SDVYSFGVLLFEL 305
SD+++ G +L+EL
Sbjct: 182 SDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-20
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 120 IGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNL 173
+G+G FG V + +TGE VAVK L +S + + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G C E G + L+ F+ GSL +L N + ++ A+ + +G++YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL---GS 127
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG-----TFGYLDPEYIST 286
+HRD+ + N+L++ + ++ DFGL++ DK ++ F Y PE +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-PECLIQ 186
Query: 287 RNFTKKSDVYSFGVLLFELI 306
F SDV+SFGV L+EL+
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 75/232 (32%), Positives = 107/232 (46%), Gaps = 47/232 (20%)
Query: 116 FTTL--IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQT----EVMLLGRLHH 167
F + IG+G +G VYKA+ TGE VA+K + D+ EKE F E+ +L +L+H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN---EKEGFPITAIREIKILRQLNH 65
Query: 168 RNLVNL----------VGYCAEKGQHMLVYVFMSK---GSLASHLYDENYGPLTWNLRVH 214
RN+VNL + + +KG LV+ +M G L S L + H
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS--------EDH 117
Query: 215 IA------LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
I L+ GL Y H +HRDIK SNILL+ + ++ADFGL+R ++
Sbjct: 118 IKSFMKQLLE---GLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 269 A--ANIRGTFGYLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
N T Y PE + + DV+S G +L EL + Q E
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 119 LIGQGAFGPVYKAQMSTGET-VAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G G FG V+ + E A+KV+A KQ E+ E +L + H ++ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSHPFIIRL 66
Query: 174 VGYCAEKGQHML--VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
+ E Q L + ++ G L S+L N G + + + A ++ LEYLH +
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
++RD+K NILLD+ ++ DFG +++ + D+ + GT YL PE I ++ K
Sbjct: 123 ---VYRDLKPENILLDKEGHIKLTDFGFAKK-LRDR-TWTLCGTPEYLAPEVIQSKGHNK 177
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
D ++ G+L++E++ G P
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
++G+G FG V Q+ +TG+ A K L ++GE E +L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 175 GYCAE-KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
Y E K LV M+ G L H+Y+ + A ++ GLE L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ER 122
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
+++RD+K NILLD R++D GL+ + + GT GY+ PE I+ +T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 294 DVYSFGVLLFELIAGRSPLQGLMEQ 318
D + G L++E+I G+SP + E+
Sbjct: 183 DWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 77/281 (27%), Positives = 122/281 (43%), Gaps = 83/281 (29%)
Query: 116 FTTLIGQGAFGPVYKAQ-MSTGE-----TVAVKVLATDSKQGEKE-FQTEVMLLGRL-HH 167
F +G GAFG V +A G+ VAVK+L + E+E +E+ +L L H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 168 RNLVNLVG-------------YCA---------EKGQHMLVYV----------------- 188
+N+VNL+G YC +K + L +V
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161
Query: 189 -----------FMSKG--------------SLASHLYDENYGPLTWNLRV----HIALDV 219
F S+G S +S DE +W L + + V
Sbjct: 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQV 221
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTF 276
A+G+++L A IHRD+ + N+LL A++ DFGL+R+ M D + N R
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316
++ PE I +T +SDV+S+G+LL+E+ + G+SP G++
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 78/270 (28%), Positives = 118/270 (43%), Gaps = 79/270 (29%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
+G+GAFG V +A + ++ TVAVK+L + E K TE+ +L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 172 NL--------------VGYC----------------------AEKGQHMLVYVFM----- 190
NL V YC + + + M
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 191 ---SKGSLASHLYDENYG----------------PLTWNLRVHIALDVARGLEYLHDGAV 231
S S AS + E+ PLT + + VARG+E+L A
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPEYIST 286
IHRD+ + NILL ++ ++ DFGL+R+ + V K A R ++ PE I
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA--RLPLKWMAPESIFD 249
Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
+ +T +SDV+SFGVLL+E+ + G SP G+
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 115 NFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKEFQ-TEVMLLGRLHHRN 169
+F L +G+G++G VYK + +S + A+K + S Q E+E E+ +L ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 170 LV---------NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
++ N + E + +SK L E W I + +
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ---EIWR----IFIQLL 113
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYL 279
RGL+ LH+ + +HRD+KS+NILL + ++ D G+S+ ++ K+ A + GT Y+
Sbjct: 114 RGLQALHEQKI---LHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQIGTPHYM 168
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
PE R ++ KSD++S G LL+E+ P +
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 63/227 (27%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL------ATDSKQGEKEFQTEVMLLGRL-HHRNLV 171
+G+GA+G V+KA T E VA+K + ATD+ ++ F+ E+M L L H N+V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA---QRTFR-EIMFLQELGDHPNIV 70
Query: 172 NLVG-YCAEKGQHM-LVYVFMS--------KGSLASHLYDENYGPLTWNLRVH---IALD 218
L+ AE + + LV+ +M L VH I
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL---------------EDVHKRYIMYQ 115
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY 278
+ + L+Y+H G V IHRD+K SNILL+ R ++ADFGL+R + +
Sbjct: 116 LLKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARS------LSELEENPEN 166
Query: 279 LD-PEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
+Y++TR +TK D++S G +L E++ G+ PL
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
NF ++G+G+FG V A+ T E A+K+L D + + + E +L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
+ + C + + V +++ G L + + G V A ++A GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRN 288
+ I+RD+K N++LD ++ADFG+ +E M D GT Y+ PE I+ +
Sbjct: 121 GI---IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ K D ++FGVLL+E++AG++P +G E +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-19
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
IG+G F VYKA + G VA+K + D+K + + E+ LL +L H N++ +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYL 68
Query: 175 GYCAEKGQHMLVYVFMSKGSLA---------SHLYDENYGPLTWNLRVHIALDVARGLEY 225
E + +V G L+ L E W V + LE+
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE---RTIWKYFVQLC----SALEH 121
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
+H + +HRDIK +N+ + + ++ D GL R + H+ + GT Y+ PE
Sbjct: 122 MHSKRI---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
I + KSD++S G LL+E+ A +SP G
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-19
Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 12/194 (6%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G G G VYKA + T +AVKV+ D + + +K+ +E+ +L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+ + + FM GSL + Y + ++ IA+ V +GL YL ++HR
Sbjct: 69 FVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLWS---LKILHR 119
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
D+K SN+L++ + ++ DFG+S + +V+ A GT Y+ PE IS + SDV+S
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQ-LVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWS 178
Query: 298 FGVLLFELIAGRSP 311
G+ EL GR P
Sbjct: 179 LGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
++G+G+FG V A++ +G AVKVL D + + + TE +L + + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 175 GYCAEKGQHML-VYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHD 228
C + + V F++ G L H+ +DE A ++ L +LHD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEITSALMFLHD 114
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTR 287
+ I+RD+K N+LLD ++ADFG+ +E + + K + GT Y+ PE +
Sbjct: 115 KGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
+ D ++ GVLL+E++ G +P + E
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 47/216 (21%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--------EVMLLGRL-HHRN 169
+G G FG VY A+ TGE VA+K + +K+F + EV L +L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD- 228
+V L E + V+ +M +G+L + D P + ++ I + +GL ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR- 287
G HRD+K N+L+ ++ADFGL+RE IR Y D Y+STR
Sbjct: 119 G----FFHRDLKPENLLVSGPEVVKIADFGLARE---------IRSRPPYTD--YVSTRW 163
Query: 288 -----------NFTKKSDVYSFGVLLFELIAGRSPL 312
+++ D+++ G ++ EL R PL
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR-PL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVK-VLATDSKQGEKEF----QTEVMLLGRLHHR 168
+G+G FG VYKA Q+ TG VA+K +L + K G F E+ +L +L H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHP 67
Query: 169 NLVNLVGYCAEKG---QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH--------IAL 217
N+V L+ E+ + V+M + D + L N V L
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYM-----VTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
+ G+ YLH+ + +HRDIK++NIL+D ++ADFGL+R G G
Sbjct: 123 QLLEGINYLHENHI---LHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 278 ------------YLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
Y PE + R +T D++ G + E+ R LQG
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 68/234 (29%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 91 KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK 149
K +VS G P+ Y +K IGQGA G VY A ++TG+ VA+K + +
Sbjct: 7 KLRTIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAIDVATGQEVAIKQMNL-QQ 56
Query: 150 QGEKEFQ-TEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGP 206
Q +KE E++++ H N+VN + + +V +++ GSL + + + G
Sbjct: 57 QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 116
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL------- 259
+ R + + LE+LH V IHRDIKS NILL ++ DFG
Sbjct: 117 IAAVCR-----ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168
Query: 260 --SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
R MV GT ++ PE ++ + + K D++S G++ E++ G P
Sbjct: 169 QSKRSTMV--------GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM-----LLGRLHHRNLV 171
+IG+G+FG V A+ + G+ AVKVL + +KE Q +M LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLV 59
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
L + V +++ G L HL E P R + A ++A L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-RARFYAA-EIASALGYLHS--- 114
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFT 290
+I+RD+K NILLD + DFGL +E + K + GT YL PE + + +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 291 KKSDVYSFGVLLFELIAGRSP 311
+ D + G +L+E++ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLV 171
FT L IG+G+FG VYK T E VA+K++ + + E E Q E+ +L + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G + + ++ ++ GS L GPL I ++ +GL+YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHS--- 119
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFT 290
IHRDIK++N+LL + ++ADFG++ + + N GT ++ PE I +
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGL 315
K+D++S G+ EL G P L
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLHHRNLVNLVGY 176
IG+GA G V+KA+ TGETVA+K +A +G Q E+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 177 CAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
G LV +M L+ L DE PL + +G+ Y+H + +
Sbjct: 68 FPH-GSGFVLVMEYMP-SDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHANGI---M 121
Query: 236 HRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEYI-STRNF 289
HRD+K +N+L+ ++ADFGL+R E + H T Y PE + R +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV---ATRWYRAPELLYGARKY 178
Query: 290 TKKSDVYSFGVLLFELIAGRSPL 312
D+++ G + EL+ G SPL
Sbjct: 179 DPGVDLWAVGCIFAELLNG-SPL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 119 LIGQGAFGPVYKA-QMSTGET----VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172
++G GAFG VYK + GE VA+KVL + S + KE E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L+G C LV M G L ++ EN + ++ + +A+G+ YL +
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLEE---V 128
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNF 289
++HRD+ + N+L+ ++ DFGL+R +D+ HA + ++ E I R F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 290 TKKSDVYSFGVLLFELIA-GRSPLQGL 315
T +SDV+S+GV ++EL+ G P G+
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 120 IGQGAFGPVYKAQMSTGETVA---VKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG G FG V + G + A VK L A+ + + F EV L+H N++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVP 232
C E ++LV F G L ++L ++ +A +VA GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-------EMVDKHAANIRGTFGYLDPEYIS 285
IH D+ N L + ++ D+GL+ E D HA +R +L PE +
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELVE 175
Query: 286 TR-------NFTKKSDVYSFGVLLFELI-AGRSPLQGLMEQQ 319
R + TKKS+++S GV ++EL A P L ++Q
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 56/194 (28%), Positives = 103/194 (53%), Gaps = 13/194 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G GAFG VYKA+ TG A KV+ T S++ +++ E+ +L +H +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
G+ ++ F G++ + + + + G ++V I + L+YLH +IHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIHRD 135
Query: 239 IKSSNILLDQSMRARVADFGLSREEM--VDKHAANIRGTFGYLDPEYISTRN-----FTK 291
+K+ N+LL ++ADFG+S + + + + + I GT ++ PE + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPYDY 194
Query: 292 KSDVYSFGVLLFEL 305
K+D++S G+ L E+
Sbjct: 195 KADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT-EVMLL 162
++K L+K +G+G + VYK + +TGE VA+K + D+++G E+ L+
Sbjct: 1 NFKQLEK--------LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLM 52
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDV 219
L H N+V L + + MLV+ +M K + +H G L N +
Sbjct: 53 KELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTH---GVRGALDPNTVKSFTYQL 109
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGY 278
+G+ + H+ V +HRD+K N+L+++ ++ADFGL+R + + +N T Y
Sbjct: 110 LKGIAFCHENRV---LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWY 166
Query: 279 LDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
P+ + +R ++ D++S G ++ E+I GR PL
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 73/237 (30%), Positives = 113/237 (47%), Gaps = 42/237 (17%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT----EV 159
Y+ L K IGQG FG V+KA+ T + VA+K VL + K+G F E+
Sbjct: 14 YEKLAK--------IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREI 62
Query: 160 MLLGRLHHRNLVNLVGYCAE--------KGQHMLVYVFMSKGSLASHLYDENYGPLTWNL 211
+L L H N+VNL+ C KG LV+ F LA L + + + L
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL---SNKNVKFTL 118
Query: 212 RV--HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269
+ + GL Y+H + +HRD+K++NIL+ + ++ADFGL+R + K++
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKI---LHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
Query: 270 ANIR-----GTFGYLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPL-QGLMEQQ 319
R T Y PE + R++ D++ G ++ E+ RSP+ QG EQ
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQH 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 67/236 (28%), Positives = 95/236 (40%), Gaps = 70/236 (29%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGR 164
IG GA+G V A TG VA+K + F E+ LL
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRH 55
Query: 165 LHHRNLVNLVGYCAEKGQHML----------VYV---FMSKGSLASHLYDENYGPLTWNL 211
L H N++ L+ +L VY+ M L + PLT
Sbjct: 56 LRHENIIGLL--------DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLT--- 101
Query: 212 RVHIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
HI + RGL+YLH V IHRD+K SNIL++ + ++ DFGL+R D+
Sbjct: 102 DDHIQYFLYQILRGLKYLHSANV---IHRDLKPSNILVNSNCDLKICDFGLARGVDPDE- 157
Query: 269 AANIRGTFGYLDPEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
G+L EY+ TR +TK D++S G + EL+ + PL
Sbjct: 158 -----DEKGFLT-EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 41/237 (17%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGET-----------------VAVKVLATD-SK 149
+ F +G+G FG V+ ++ + VAVK+L D +K
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL----ASHLYDENYG 205
+F EV +L RL N++ L+G C ++ ++ +M G L +SH D+
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 206 P-------------LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252
++++ +H+AL +A G++YL + +HRD+ + N L+ +++
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTI 177
Query: 253 RVADFGLSREEMV-DKHAANIRGTFG--YLDPEYISTRNFTKKSDVYSFGVLLFELI 306
++ADFG+SR D + R ++ E I FT SDV++FGV L+E++
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
L+G+G++G V K + TG+ VA+K + D K +K E+ +L +L H NLVNL+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
K + LV+ F+ L E Y L + + RG+E+ H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHNI--- 121
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR------EEMVDKHAANIRGTFGYLDPEY-ISTR 287
IHRDIK NIL+ QS ++ DFG +R E D A T Y PE +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-----TRWYRAPELLVGDT 176
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
+ + D+++ G L+ E++ G PL
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG-EPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 7e-18
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 42/224 (18%)
Query: 120 IGQGAFGPVYKAQMSTGET---VAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNL 173
IG+G +G VYKA+ G+ A+K D +Q Q+ E+ LL L H N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 174 VGYCAEKGQHMLVYVF------------MSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
V E + +F + + + L W + L+
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI-----LN--- 119
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILL--DQSMRARV--ADFGLSREEMVD---KHAANIRG 274
G+ YLH V +HRD+K +NIL+ + R V D GL+R + + K A++
Sbjct: 120 GVHYLHSNWV---LHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDP 174
Query: 275 ---TFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
T Y PE + R++TK D+++ G + EL+ +G
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-18
Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 27/217 (12%)
Query: 119 LIGQGAFGPVYKA-QMSTGET----VAVKVLATDSKQGEKEFQ--TEVML-LGRLHHRNL 170
L+G G FG V+K + G++ VA+K + + G + FQ T+ ML +G L H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
V L+G C LV GSL H+ ++ L ++ + +A+G+ YL +
Sbjct: 72 VRLLGICP-GASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPEY 283
+ +HR++ + NILL ++ADFG++ ++ +H I+ ++ E
Sbjct: 130 M---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMALES 182
Query: 284 ISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
I +T +SDV+S+GV ++E+++ G P G+ +
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-18
Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 38/241 (15%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQM---STGE---TVAVKVLATDSKQG--EKEFQTEV 159
++ +T F +G+ FG VYK + + GE VA+K L D +G +EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEA 59
Query: 160 MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-----------DENY---G 205
M+ RL H N+V L+G ++ +++ + S L L D++
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 206 PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265
L VHI +A G+E+L V+H+D+ + N+L+ + +++D GL RE
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE--- 173
Query: 266 DKHAANIRGTFG-------YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317
+AA+ G ++ PE I F+ SD++S+GV+L+E+ + G P G
Sbjct: 174 -VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232
Query: 318 Q 318
Q
Sbjct: 233 Q 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-18
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 120 IGQGAFGPVYKA--QMSTGE-TVAVKVLATDSKQG--EKEFQTEVMLLGRLHHRNLVNLV 174
+G G FG V K +M E TVAVK+L D+ + E E ++ +L + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 175 GYCAEKGQHMLVYVFMSKGSLAS------HLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
G C E MLV G L H+ ++N L VH V+ G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL-----VH---QVSMGMKYLEE 113
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYI 284
+HRD+ + N+LL A+++DFGLS+ D++ + + PE +
Sbjct: 114 TNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
+ F+ KSDV+SFGVL++E + G+ P +G+
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-18
Identities = 58/220 (26%), Positives = 111/220 (50%), Gaps = 24/220 (10%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
+GQG+FG VY+ ++ G ET VA+K + + E+ EF E ++ + ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLY--------DENYGPLTWNLRVHIALDVARGL 223
L+G ++ +++ M++G L S+L + P + + +A ++A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG--YLD 280
YL+ +HRD+ + N ++ + ++ DFG++R+ D + +G ++
Sbjct: 133 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
PE + FT SDV+SFGV+L+E+ P QG+ +Q
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-17
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLV 174
+IG+G FG VY + + TG+ A+K L KQGE E ++L + + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH----------IALDVARGLE 224
C + Y F + L+ L N G L ++L H A ++ GLE
Sbjct: 61 --C-------MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE 111
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
++H+ V ++RD+K +NILLD+ R++D GL+ + K A++ GT GY+ PE +
Sbjct: 112 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVL 167
Query: 285 ST-RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
+ +D +S G +LF+L+ G SP +
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE-KEFQTEV 159
PE + L+K IG+G+FG V+K T + VA+K++ + + E ++ Q E+
Sbjct: 2 PEELFTKLEK--------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI 53
Query: 160 MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
+L + + G + + ++ ++ GS L GPL I ++
Sbjct: 54 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREI 110
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGY 278
+GL+YLH IHRDIK++N+LL + ++ADFG++ + + N GT +
Sbjct: 111 LKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
+ PE I + K+D++S G+ EL G P
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 69/200 (34%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
IG G+FG VY A S T E VAVK ++ KQ +++Q EV L +L H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
C K + + GS AS L + + PL I +GL YLH + I
Sbjct: 89 -CYLKEHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---I 143
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN---FTKK 292
HRDIK+ NILL + + ++ADFG + A + GT ++ PE I + + K
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSAS---KSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 293 SDVYSFGVLLFELIAGRSPL 312
DV+S G+ EL + PL
Sbjct: 201 VDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-17
Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---T 157
PE + DL++ IG G+FG VY A+ + T E VA+K ++ KQ +++Q
Sbjct: 23 PEKLFTDLRE--------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 74
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
EV L R+ H N + G C + + + GS AS L + + PL I
Sbjct: 75 EVKFLQRIKHPNSIEYKG-CYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAITH 132
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
+GL YLH + IHRDIK+ NILL + + ++ADFG + + A + GT
Sbjct: 133 GALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSAS---IASPANSFVGTPY 186
Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
++ PE I + + K DV+S G+ EL + PL
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 75/272 (27%), Positives = 113/272 (41%), Gaps = 80/272 (29%)
Query: 119 LIGQGAFGPVYKAQM------STGETVAVKVL---ATDSKQGEKEFQTEVMLLGRL-HHR 168
++G GAFG V +A S+ TVAVK+L AT S+ K +E+ +L + +H
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH--KALMSELKILIHIGNHL 71
Query: 169 NLVNL--------------VGYC-------------------AEKGQHMLVYVF------ 189
N+VNL V +C EK
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 190 ----MSKGSLASHLYDENY------------------GPLTWNLRVHIALDVARGLEYLH 227
+ AS L+ PLT + + VARG+E+L
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL- 190
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYI 284
A IHRD+ + NILL ++ ++ DFGL+R+ D + R ++ PE I
Sbjct: 191 --ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
+ +T +SDV+SFGVLL+E+ + G SP G+
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
+G G+FG V A+ TGE A+K L K+ Q E +L L H +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
++ + + F+ G L +HL G ++ ++ EYLH + I
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLAFEYLHSKDI---I 140
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
+RD+K N+LLD +V DFG +++ V + GT YL PE I ++ K D
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGHGKAVDW 198
Query: 296 YSFGVLLFELIAGRSP 311
++ GVLL+E IAG P
Sbjct: 199 WTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVN 172
+G+G + VYKA TG VA+K + ++ K+ F E+ LL L H N++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI---ALDVARGLEYLHDG 229
L+ K LV+ FM L + + LT I L RGLEYLH
Sbjct: 67 LLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLT---PADIKSYMLMTLRGLEYLHSN 121
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR------EEMVDKHAANIRGTFGYLDPEY 283
+ +HRD+K +N+L+ ++ADFGL+R +M + T Y PE
Sbjct: 122 WI---LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-----TRWYRAPEL 173
Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ R++ D++S G + EL+ L G
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
IG+G+ G V A + TG+ VAVK + +Q + EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ +V F+ G+L + + + + L V R L YLH+ V IHRD
Sbjct: 90 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGV---IHRD 143
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHA---ANIRGTFGYLDPEYISTRNFTKKSDV 295
IKS +ILL R +++DFG + V K ++ GT ++ PE IS + + D+
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 296 YSFGVLLFELIAGRSP 311
+S G+++ E+I G P
Sbjct: 202 WSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 4e-17
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 37/233 (15%)
Query: 91 KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK 149
K ++VS G P+ Y +K IGQGA G VY A ++TG+ VA++ + +
Sbjct: 8 KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGPL 207
++ E++++ + N+VN + + +V +++ GSL + + + G +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL-------- 259
R + + LE+LH V IHRDIKS NILL ++ DFG
Sbjct: 119 AAVCR-----ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 260 -SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
R MV GT ++ PE ++ + + K D++S G++ E+I G P
Sbjct: 171 SKRSTMV--------GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 69/209 (33%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
IG+G FG VY+ + T A+KVL+ +KE E +L R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 176 --YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
+ + + LV +MS G L HL E + +IA ++ LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-RAKFYIA-ELVLALEHLHKY--- 115
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPE-YISTRNFT 290
+++RD+K NILLD + + DFGLS+ + D N GT YL PE + + +T
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
K D +S GVL+FE+ G SP QQ
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-17
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 120 IGQGAFGPVYKAQ---------MSTGE------TVAVKVLATD-SKQGEKEFQTEVMLLG 163
+G+G FG V+ + E VAVK+L D +K +F E+ ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL----------YDENYGPLTWNLRV 213
RL + N++ L+G C ++ +M G L L + N ++ +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR 273
++A+ +A G++YL A +HRD+ + N L+ ++ADFG+SR + I+
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NLYSGDYYRIQ 188
Query: 274 G----TFGYLDPEYISTRNFTKKSDVYSFGVLLFEL--IAGRSPLQGLMEQQ 319
G ++ E I FT SDV++FGV L+E+ + P L ++Q
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
IG G +G VYKA+ ++TGE A+KV+ + + Q E++++ H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ + + F GSL +Y GPL+ + +++ + +GL YLH +HRD
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVT-GPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131
Query: 239 IKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYISTR---NFTKKS 293
IK +NILL + ++ADFG+S + + K + I GT ++ PE + + +
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLC 190
Query: 294 DVYSFGVLLFELIAGRSPL 312
D+++ G+ EL + P+
Sbjct: 191 DIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G GAFG VYKAQ TG A KV+ T S++ +++ E+ +L H N+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ ++ F + G++ + + E PLT + L YLH+ + IHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLHENKI---IHRD 128
Query: 239 IKSSNILLDQSMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYI-----STRNFTKK 292
+K+ NIL ++ADFG+S + + + GT ++ PE + R + K
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188
Query: 293 SDVYSFGVLLFELIAGRSP 311
+DV+S G+ L E+ P
Sbjct: 189 ADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-17
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 29/234 (12%)
Query: 88 EGFKRS-NVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLA 145
E F+ + +V G P + K IG+G+ G V A STG VAVK +
Sbjct: 2 EQFRAALQLVVDPGDPRSYLDNFVK--------IGEGSTGIVCIATDKSTGRQVAVKKMD 53
Query: 146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG 205
+Q + EV+++ H N+V + + +V F+ G+L
Sbjct: 54 LRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-------- 105
Query: 206 PLTWNLRVH------IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259
+ + R++ + L V + L +LH V IHRDIKS +ILL R +++DFG
Sbjct: 106 -IVTHTRMNEEQIATVCLAVLKALSFLHAQGV---IHRDIKSDSILLTSDGRVKLSDFGF 161
Query: 260 SREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
+ + ++ GT ++ PE IS + + D++S G+++ E++ G P
Sbjct: 162 CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 9e-17
Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 91 KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK 149
K ++VS G P+ Y +K IGQGA G VY A ++TG+ VA+K + +
Sbjct: 7 KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGPL 207
++ E++++ + N+VN + + +V +++ GSL + + + G +
Sbjct: 58 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
R + + L++LH V IHRDIKS NILL ++ DFG + ++
Sbjct: 118 AAVCR-----ECLQALDFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169
Query: 268 HA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
+ + GT ++ PE ++ + + K D++S G++ E++ G P
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 69/213 (32%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 115 NFTTL--IGQGAFGPVYKAQM----STGETVAVKVL-----ATDSKQGEKEFQTEVMLLG 163
NF L +G GA+G V+ + G+ A+KVL +K E +TE +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLE 59
Query: 164 RLHHRN-LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
+ LV L + L+ +++ G L +HLY + + +RV+IA ++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLA 117
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLD 280
L++LH + I+RDIK NILLD + DFGLS+E + ++ A + GT Y+
Sbjct: 118 LDHLHQLGI---IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 281 PEYIST--RNFTKKSDVYSFGVLLFELIAGRSP 311
PE I K D +S GVL FEL+ G SP
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 42/229 (18%)
Query: 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQT---- 157
Y+ L + I +G +G VY+A+ TGE VA+K L + EKE F
Sbjct: 5 DEYEKLNR--------IEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLR 53
Query: 158 EVMLLGRLHHRNLVNL----VGYCAEKGQHMLVYVFMS------KGSLASHLYDENYGPL 207
E+ +L +L H N+V + VG +K +Y+ M K L + P
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKS-----LMETMKQPF 103
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD 266
+ + L + G+ +LHD + +HRD+K+SN+LL+ ++ DFGL+RE
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWI---LHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160
Query: 267 KHAANIRGTFGYLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
K + T Y PE + + ++ D++S G + EL+ + G
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+IG+G FG VY + + TG+ A+K L K+ K Q E + L+ R +++LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETL---ALNERIMLSLVSTG 54
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH----------IALDVARGLEYLH 227
+ Y F + L L N G L ++L H A ++ GLE++H
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
+ V ++RD+K +NILLD+ R++D GL+ + K A++ GT GY+ PE +
Sbjct: 115 NRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKG 170
Query: 288 N-FTKKSDVYSFGVLLFELIAGRSPLQ 313
+ +D +S G +LF+L+ G SP +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 119 LIGQGAFGPVYKA-QMSTGET----VAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
++G GAFG VYK + GE VA+K L AT S + KE E ++ + + ++
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVC 72
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYL 226
L+G C L+ M G L ++ + +N G L W + +A+G+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEY 283
+ + +HRD+ + N+L+ ++ DFGL++ D+ HA + ++ E
Sbjct: 126 EERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 284 ISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
I R +T +SDV+S+GV ++EL+ G P G+
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G G FG V ++ S T A+K + ++ Q ++ +E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 175 GYCAEKGQHMLVYVFMSK---GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
+K ++ +Y+ M G L + L D + R +IA V EYLH+ +
Sbjct: 60 RTFKDK-KY--IYMLMEYCLGGELWTILRDRGLFD-EYTARFYIAC-VVLAFEYLHNRGI 114
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
I+RD+K N+LLD + ++ DFG +++ + GT Y+ PE I + +
Sbjct: 115 ---IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDF 171
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
D +S G+LL+EL+ GR P
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
L+G+G FG V + ++G+ A+K+L + + E TE +L H L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
K + V +++ G L HL E + + ++ L+YLH G +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKI--- 116
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRNFTK 291
++RD+K N++LD+ ++ DFGL +E + D AA ++ GT YL PE + ++ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 292 KSDVYSFGVLLFELIAGRSPL 312
D + GV+++E++ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG GA+G V A +G+ VA+K + A D K E+ +L H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 177 CAEKGQHML-VYVFMS-KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G VYV M S H+ + PLT + + RGL+Y+H V
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANV--- 128
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR------- 287
IHRD+K SN+L+++ R+ DFG++R ++ Y EY++TR
Sbjct: 129 IHRDLKPSNLLVNEDCELRIGDFGMARG------LSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 288 -----NFTKKSDVYSFGVLLFELIAGRSPL 312
+T D++S G + E++ GR L
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 59/229 (25%), Positives = 111/229 (48%), Gaps = 22/229 (9%)
Query: 88 EGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLAT 146
E ++ + + G P+ Y +K IGQGA G V+ A ++TG+ VA+K +
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEK--------IGQGASGTVFTAIDVATGQEVAIKQINL 54
Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP 206
+ ++ E++++ L + N+VN + + +V +++ GSL + +
Sbjct: 55 QKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----- 109
Query: 207 LTWNLRVHIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
T IA + + LE+LH V IHRDIKS N+LL ++ DFG +
Sbjct: 110 -TCMDEAQIAAVCRECLQALEFLHANQV---IHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165
Query: 264 MVDKHA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
++ + + GT ++ PE ++ + + K D++S G++ E++ G P
Sbjct: 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 116 FTTLIGQGAFGPVYKAQMST-GETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
F ++G+G++G V + T G+ +K L S++ K + E LL +L H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 173 LV-GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
+ E G +V F G L L ++ L N V + +A L+YLH+
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--- 120
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNF 289
++HRD+K+ N+ L ++ +V D G++R E D A+ + GT Y+ PE S + +
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-ASTLIGTPYYMSPELFSNKPY 179
Query: 290 TKKSDVYSFGVLLFEL 305
KSDV++ G ++E+
Sbjct: 180 NYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT------- 157
Y DLQ +G GAFG V A+ TG+ VA+K + K F T
Sbjct: 12 YVDLQP--------VGMGAFGLVCSARDQLTGQNVAIKKIM-------KPFSTPVLAKRT 56
Query: 158 --EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI 215
E+ LL L H N+++L + + + L L PL +
Sbjct: 57 YRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL---TSRPLEKQFIQYF 113
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275
+ RGL+Y+H V +HRD+K SNIL++++ ++ DFGL+R + D T
Sbjct: 114 LYQILRGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQ--DPQMTGYVST 168
Query: 276 FGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPL 312
Y PE + T + + + D++S G + E++ G+ PL
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-PL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 64/233 (27%), Positives = 97/233 (41%), Gaps = 47/233 (20%)
Query: 118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRNLVN 172
+IG+GAFG V+ + TG+ A+KVL Q + E +L +V
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVK 65
Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-G 229
L Y + + + L V +M G L + L ++ P R +IA V L+ +H G
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL-ALDSVHKLG 121
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS----------------------------- 260
IHRDIK NIL+D ++ADFGL
Sbjct: 122 ----FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 261 REEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
R+ + AN GT Y+ PE + + + D +S GV+L+E++ G P
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---T 157
PE + DL++ IG G+FG VY A+ + E VA+K ++ KQ +++Q
Sbjct: 13 PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
EV L +L H N + G C + + + GS AS L + + PL +
Sbjct: 65 EVRFLQKLRHPNTIQYRG-CYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTH 122
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
+GL YLH + IHRD+K+ NILL + ++ DFG + + A GT
Sbjct: 123 GALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANXFVGTPY 176
Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
++ PE I + + K DV+S G+ EL + PL
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLV 171
FT L IG+G+FG V+K T + VA+K++ + + E E Q E+ +L + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G + + ++ ++ GS L GP + ++ +GL+YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHS--- 119
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA--NIRGTFGYLDPEYISTRNF 289
IHRDIK++N+LL + ++ADFG++ ++ D GT ++ PE I +
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 290 TKKSDVYSFGVLLFELIAGRSP 311
K+D++S G+ EL G P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 135 TGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLV--GYCAEKGQHMLVYVF 189
TG VA+K+L TD+ + E + F+ E L RL+H N+V L+ G G V+ +
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
+ +L L G L + L V L H+ + +HRD+K NI++ Q+
Sbjct: 61 VPGRTLREVL--AADGALPAGETGRLMLQVLDALACAHNQGI---VHRDLKPQNIMVSQT 115
Query: 250 ---MRARVADFGLS------REEMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
A+V DFG+ R+ V + GT Y PE + T SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 299 GVLLFELIAGRSPLQG 314
G++ E + G+ +QG
Sbjct: 176 GLIFLECLTGQRVVQG 191
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 24/220 (10%)
Query: 120 IGQGAFGPVYKA---QMSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
+GQG+FG VY+ + GE VAVK + + E+ EF E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHLY------DENYGPLTWNLR--VHIALDVARGL 223
L+G + KGQ LV + M+ G L S+L + N G L+ + +A ++A G+
Sbjct: 74 LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTF--GYLD 280
YL+ +HRD+ + N ++ ++ DFG++R+ D + +G ++
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
PE + FT SD++SFGV+L+E+ + P QGL +Q
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
IG+G+ G V A + S+G+ VAVK + +Q + EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ +V F+ G+L + + + + L V + L LH V IHRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQGV---IHRD 141
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHA---ANIRGTFGYLDPEYISTRNFTKKSDV 295
IKS +ILL R +++DFG + V K ++ GT ++ PE IS + + D+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 296 YSFGVLLFELIAGRSP 311
+S G+++ E++ G P
Sbjct: 200 WSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-16
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVG 175
+G G FG V K +M + VA+KVL ++++ + E E ++ +L + +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
C E MLV S G L L + N+ V + V+ G++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-VELMHQVSMGMKYLEGKNF---V 117
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-----YLDPEYISTRNFT 290
HRD+ + N+LL A+++DFGLS+ D R + G + PE I+ R F+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR-SAGKWPLKWYAPECINFRKFS 176
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGL 315
+SDV+S+G+ ++E + G+ P + +
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
L+G+G FG V + +TG+ A+K+L + + E TE +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ V + + G L HL E + + ++ L YLH V
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDV--- 116
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKS 293
++RD+K N++LD+ ++ DFGL +E + D GT YL PE + ++ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 294 DVYSFGVLLFELIAGRSP 311
D + GV+++E++ GR P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG+G+FG V + + T A+K + S+ E +L +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
+ LV F++ G L HL E L+ R + A ++ LE LH V I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFYTA-ELLCALENLHKFNV---I 115
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTRNFTKKSD 294
+RD+K NILLD + DFGL + M D N GT YL PE + +TK D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 295 VYSFGVLLFELIAGRSP 311
++ GVLL+E++ G P
Sbjct: 176 WWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGR-LHHRNLVNLVGY 176
+G+GA+G V K + + TG +AVK + AT + Q +K ++ + R + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 177 CAEKGQHMLVYVFMS--KGSLASHLYDENYGPLTWNLRV------HIALDVARGLEYLHD 228
+G V++ M SL Y + Y L + IA+ + + LEYLH
Sbjct: 69 LFREGD---VWICMEVMDTSL-DKFYKKVYDK---GLTIPEDILGKIAVSIVKALEYLHS 121
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYI--- 284
VIHRD+K SN+L++++ + ++ DFG+S +VD A I G Y+ PE I
Sbjct: 122 KL--SVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 285 -STRNFTKKSDVYSFGVLLFELIAGRSP 311
+ + + KSDV+S G+ + EL GR P
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHH-RNLVNLVG 175
IG G G VYK + TG +AVK + T +K+ K ++ ++ + H +V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 176 YCAEKGQHMLVYVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
Y V++ M + L GP+ ++ + + + + L YL + V
Sbjct: 82 YFITDSD---VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GV 136
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR--GTFGYLDPEYISTRNFTKK 292
IHRD+K SNILLD S ++ DFG+S +VD A R G Y+ PE I + K
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGIS-GRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPK 194
Query: 293 ----SDVYSFGVLLFELIAGRSPLQG 314
+DV+S G+ L EL G+ P +
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 49/220 (22%)
Query: 115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQT---------EVMLLGR 164
+ +G GA+G V A + TG VA+K L+ + FQ+ E+ LL
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKH 70
Query: 165 LHHRNLVNLV-----GYCAEKGQHMLVYVFMSKGSLASHLYDENYG------PLTWNLRV 213
+ H N++ L+ E Q VY+ HL + L+ +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQD--VYLVT-------HLMGADLNNIVKCQKLSDDHIQ 121
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAA 270
+ + RGL+Y+H + IHRD+K SNI +++ ++ DFGL+R +EM A
Sbjct: 122 FLVYQILRGLKYIHSAGI---IHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVA- 177
Query: 271 NIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGR 309
T Y PE + + ++ + D++S G ++ EL+ G+
Sbjct: 178 ----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-15
Identities = 48/197 (24%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 120 IGQGAFGP--VYKAQMSTGETVAVKV-LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
+G+GAFG +Y+ V +V L S++ ++ E+++L L H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 177 CAEKGQHMLVYVFMSKGSLA-------SHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
+ ++ + + G+L L++E + W L + + Y+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM--VLWYL-----FQIVSAVSYIHKA 120
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRN 288
+ +HRDIK+ NI L ++ ++ DFG+S+ + A + GT Y+ PE
Sbjct: 121 GI---LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 289 FTKKSDVYSFGVLLFEL 305
+ KSD+++ G +L+EL
Sbjct: 178 YNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---TE--VMLLGRLHHRNLVN 172
++G+G+FG V A++ T E A+KVL D + + TE ++ L H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLA-----SHLYDENYGPLTWNLRVHIALDVARGLEY 225
L +C + + L +V +++ G L S +DE A +V L +
Sbjct: 61 L--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-------YAAEVTLALMF 111
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYI 284
LH V I+RD+K NILLD ++ADFG+ +E ++ GT Y+ PE +
Sbjct: 112 LHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
+ D ++ GVL++E++AG+ P +
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG+G +G VYKA+ TGE VA+K L T+++ E+ LL L+H N+V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+ + LV+ F+ + L + + L + +GL + H V +H
Sbjct: 68 IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 123
Query: 237 RDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIRGTFGYLDPE-YIS 285
RD+K N+L++ ++ADFGL+R E+V T Y PE +
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLG 174
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ ++ D++S G + E++ R+ G
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G G G V K Q +G +A K++ + K + E+ +L + +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
G+ + M GSL L + P +V IA V RGL YL + ++HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKH--QIMHR 128
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
D+K SNIL++ ++ DFG+S +++D A + GT Y+ PE + +++ +SD++S
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 298 FGVLLFELIAGRSPL 312
G+ L EL GR P+
Sbjct: 188 MGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
P++ Y+ +Q+ +G G +G VYKA+ + TGE AVK++ + Q E+
Sbjct: 7 PQHDYELIQR--------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF 58
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
++ H N+V G + + + + GSL +Y GPL+ ++ +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVT-GPLSELQIAYVCRETL 116
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGY 278
+GL YLH +HRDIK +NILL + ++ADFG++ + + K + I GT +
Sbjct: 117 QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYW 172
Query: 279 LDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
+ PE + + + D+++ G+ EL + P+
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 9e-15
Identities = 36/98 (36%), Positives = 61/98 (62%), Gaps = 3/98 (3%)
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG 274
I++ V RGL YL + ++HRD+K SNIL++ ++ DFG+S +++D A + G
Sbjct: 104 ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDSMANSFVG 160
Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
T Y+ PE + ++T +SD++S G+ L E+ GR P+
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK---VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG+G F VY+A + + VA+K + + ++ E+ LL +L+H N++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-YDENYGPL-----TWNLRVHIALDVARGLEYLHDG 229
E + +V G L+ + Y + L W V + +E++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMHSR 125
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRN 288
V +HRDIK +N+ + + ++ D GL R AA ++ GT Y+ PE I
Sbjct: 126 RV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
+ KSD++S G LL+E+ A +SP G
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 115 NFTTL--IGQGAFGPVYKAQMSTG----ETVAVKVL---ATDSKQGEKEF-QTEVMLLGR 164
NF L +G GA+G V+ + TG + A+KVL A K E +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
+ + + Y + + L+ ++S G + +HLY + +R + ++ L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-EVRFYSG-EIILAL 118
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR--GTFGYLDP 281
E+LH + ++RDIK NILLD + DFGLS+E + ++ GT Y+ P
Sbjct: 119 EHLHKLGI---VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 282 EYISTRN-FTKKSDVYSFGVLLFELIAGRSPL 312
E I + K D +S G+L+FEL+ G SP
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 12/193 (6%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+I +G G YK + ++ + + +E+ +G+L H N+V L+G C
Sbjct: 697 VISRGKKGASYKGKSIKNG---MQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR 753
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ L++ ++ +L+ L + L+W R IA+ +A+ L +LH P V+ +
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
+ I++D + LS ++ + Y+ PE T++ T+KSD+Y F
Sbjct: 809 LSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISS-AYVAPETRETKDITEKSDIYGF 864
Query: 299 GVLLFELIAGRSP 311
G++L EL+ G+SP
Sbjct: 865 GLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
L+G+G FG V + +TG A+K+L + + E TE +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ V + + G L HL E T ++ LEYLH V
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS---RDV 116
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRNFTK 291
++RDIK N++LD+ ++ DFGL +E + D A ++ GT YL PE + ++ +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 292 KSDVYSFGVLLFELIAGRSPL 312
D + GV+++E++ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 69/203 (33%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 119 LIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVM-----LLGRLHHRNLVN 172
+IG+G+FG V A+ + G AVKVL + +KE Q +M LL L H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60
Query: 173 L--VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
L AEK +L YV + G L HL E L R + A +VA + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYV--NGGELFFHLQRERCF-LEPRARFYAA-EVASAIGYLHS-- 114
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNF 289
+I+RD+K NILLD + DFGL +E + ++ + GT YL PE + +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 290 TKKSDVYSFGVLLFELIAGRSPL 312
+ D + G +L+E++ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKAQM--STGETVAVK-------VLATDSKQGEKEFQ---TEVMLLG-RL 165
+G GAFG VYK + + +A+K D ++ +K +EV ++ +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGPLT----WNLRVHIALDV 219
H N+V E + +V + L H E T WN+ V + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL 279
L YLH ++HRD+ +NI+L + + + DFGL++++ + ++ GT Y
Sbjct: 125 --ALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
PE + + +K+DV++FG +L+++ + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVM-----LLGRLHHRNLVN 172
+IG+G+FG V A+ G+ AVKVL KE Q +M LL + H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVG 60
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L + V F++ G L HL E P R + A ++A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-RARFYAA-EIASALGYLHS---I 115
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTK 291
+++RD+K NILLD + DFGL +E + GT YL PE I + +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 292 KSDVYSFGVLLFELIAGRSPL 312
D + G +L+E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 42/114 (36%), Positives = 65/114 (57%), Gaps = 7/114 (6%)
Query: 206 PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265
LT + + VA+G+E+L A IHRD+ + NILL ++ ++ DFGL+R+
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 266 DK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
D + R ++ PE I R +T +SDV+SFGVLL+E+ + G SP G+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 6/198 (3%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
++G+G+FG Q +++ + A+K + S ++ + E +LL ++ H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
G +V + G L + + + + + + G++++H+ V +H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV---LH 123
Query: 237 RDIKSSNILLDQSMRARVADFGLSR-EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
RDIKS NI L Q+ + ++ DFG +R +A GT Y+ PE + KSD+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183
Query: 296 YSFGVLLFELIAGRSPLQ 313
+S G +L+EL + P Q
Sbjct: 184 WSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G G G V+K + +G +A K++ + K + E+ +L + +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
G+ + M GSL L + G + + +++ V +GL YL + ++HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 128
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
D+K SNIL++ ++ DFG+S +++D A + GT Y+ PE + +++ +SD++S
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 298 FGVLLFELIAGRSPL 312
G+ L E+ GR P+
Sbjct: 188 MGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G+G +G VYK TG T+A+K + + E +F +M L LH +V +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 179 EKGQHMLVYV---FMSKGSLASHLYDENY--GPLTWNLRVHIALDVARGLEYLHDGAVPP 233
VY+ +M GSL LY + ++ I V +GL++L +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--N 123
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN----- 288
+IHRD+K +N+L++ + + ++ DFG+S + NI G Y+ PE I +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQNP 182
Query: 289 -FTKKSDVYSFGVLLFELIAGRSP 311
+T +SDV+S G+ + E+ GR P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 29/222 (13%)
Query: 120 IGQGAFGPVYKAQMSTGET---VAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG G FG V ++++G T V VK L + S Q + +F E L H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGP-LTWNLRV--HIALDVARGLEYLHDGAVP 232
C E ++LV F G L +L +T + +A ++A GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLS----REE---MVDKHAANIRGTFGYLDPEYIS 285
IH D+ N LL + ++ D+GLS +E+ D+ +R ++ PE +
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPELVD 175
Query: 286 -------TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+ TK+S+V+S GV ++EL G P + L ++Q
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 119 LIGQGAFGPVYKAQMSTGETV-AVKVL---ATDSKQGEKEFQTEV-MLLGRLHHRNLVNL 173
+IG+G+FG V A+ E AVKVL A K+ EK +E +LL + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ V +++ G L HL E L R + A ++A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCF-LEPRARFYAA-EIASALGYLHS---LN 116
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNFTKK 292
+++RD+K NILLD + DFGL +E + + + GT YL PE + + + +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 293 SDVYSFGVLLFELIAGRSPL 312
D + G +L+E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
IG+G+ G V A + +G VAVK++ +Q + EV+++ H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK-SY 87
Query: 179 EKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
G+ + V + F+ G+L + L + V + L YLH V IHR
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGV---IHR 141
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
DIKS +ILL R +++DFG + D ++ GT ++ PE IS + + D++
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 297 SFGVLLFELIAGRSP 311
S G+++ E++ G P
Sbjct: 202 SLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-14
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL--ATDSKQGEKEFQT--EVMLLGRLHHRNL 170
++G+G +G V++ + TG + A+KVL AT + + T E +L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
V+L+ G+ L+ ++S G L HL E G + +++ LE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTRNF 289
+ I+RD+K NILLD ++ DFGL +E + + + GT Y+ PE +
Sbjct: 121 I---IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
K D +S G L+++++ G P
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 118 TLIG----QGAFGPVYKAQMSTGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLV 171
TLIG + K + T VAVK + DS E K Q E++ +L H N++
Sbjct: 4 TLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNL-RVHIAL---DVARGLEYLH 227
V + +V M+ GS L ++ L + IA DV L+Y+H
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGS-CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIH 118
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--------- 278
IHR +K+S+ILL + ++ S + KH R +
Sbjct: 119 SKGF---IHRSVKASHILLSGDGKVVLSGLRYSVS--MIKHGKRQRVVHDFPKSSVKNLP 173
Query: 279 -LDPE--YISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
L PE + + + +KSD+YS G+ EL G P +
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 43/134 (32%), Positives = 72/134 (53%), Gaps = 7/134 (5%)
Query: 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL 246
Y + + + L D+ LT + VARG+E+L A +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 247 DQSMRARVADFGLSREEMVDKHAANIRGTF---GYLDPEYISTRNFTKKSDVYSFGVLLF 303
Q ++ DFGL+R+ M D + + TF ++ PE I +T SDV+S+G+LL+
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 304 ELIA-GRSPLQGLM 316
E+ + G +P G++
Sbjct: 331 EIFSLGGTPYPGMI 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 38/158 (24%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLV--------YVFMSKGSLASHLYDENYGPLTW 209
E MLL ++H +++ + +V Y +++K PL
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK----------RSRPLPI 156
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269
+ + I + GL YLH + IHRD+K+ NI ++ + + D G ++ +V
Sbjct: 157 DQALIIEKQILEGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
+ GT PE ++ + K+D++S G++LFE++A
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-14
Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQT--EVML 161
SY+ L+K +G+G++ VYK + G+ VA+KV+ ++G F E L
Sbjct: 6 SYEKLEK--------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASL 56
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
L L H N+V L K LV+ ++ L ++ G N+++ + + R
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFL-FQLLR 114
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLD 280
GL Y+H + +HRD+K N+L+ + ++ADFGL+R + V H +N T Y
Sbjct: 115 GLSYIHQRYI---LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 281 PE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
P+ + + ++ D++ G + E+I G + G+ + Q
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
IG+G F VY+A + G VA+K + D+K + E+ LL +L+H N++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKYY 68
Query: 175 GYCAEKGQHMLVYVFMSKGSLAS---HLYDENY---GPLTWNLRVHIALDVARGLEYLHD 228
E + +V G L+ H + W V + LE++H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMHS 124
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTR 287
V +HRDIK +N+ + + ++ D GL R AA ++ GT Y+ PE I
Sbjct: 125 RRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ KSD++S G LL+E+ A +SP G
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 12/212 (5%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQM---STGE-TVAVKVL-ATDSKQGEKEFQTEVMLL 162
+L + ++G G FG + + + S E VA+ L A S + + F E + L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
G+ H N+V L G M+V +MS G+L S L ++ G L + + +A G
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASG 119
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL--D 280
++YL + +H+ + + +L++ + +++ F +E+ + + G L
Sbjct: 120 MKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAA 176
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSP 311
PE I +F+ SDV+SFG++++E+++ G P
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 39/234 (16%)
Query: 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQM---STGETVAVK-VLATDSKQGEKEFQTEV 159
++ +DL+ IG+GAFG V K M +G +AVK + +T ++ +K ++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 160 MLLGRLHHRNLVNLVGY------------CAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
++ R + +V + C E L+ + + K ++Y+ +
Sbjct: 54 DVVMR--SSDCPYIVKFYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVI 104
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
+ IA+ + L YL + +IHRD+K SNILLD++ ++ DFG+S ++VD
Sbjct: 105 PEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDS 161
Query: 268 HAANIR-GTFGYLDPEYI--STRN-FTKKSDVYSFGVLLFELIAGRSPLQGLME 317
A G Y+ PE I S R+ + +SDV+S G+ L+E+ G+ P
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 30/218 (13%)
Query: 115 NFTTL--IGQGAFGPVYKAQM----STGETVAVKVL--ATDSKQGE--KEFQTEVMLLGR 164
NF L +G GA+G V+ + +G+ A+KVL AT ++ + + +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALD 218
+ + + Y + + L+ +++ G L +HL + E ++++ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ------EVQIYSG-E 113
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTF 276
+ LE+LH + I+RDIK NILLD + + DFGLS+E D + A + GT
Sbjct: 114 IVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 277 GYLDPEYIS--TRNFTKKSDVYSFGVLLFELIAGRSPL 312
Y+ P+ + K D +S GVL++EL+ G SP
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNL- 173
+G GA+G V A TGE VA+K L+ S+ K E+ LL + H N++ L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 174 -VGYCAEKGQHM----LVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
V A G LV +M + + L ++ L + + GL+Y
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKY 132
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRG---TFGYLDP 281
+H + IHRD+K N+ +++ ++ DFGL+R HA A + G T Y P
Sbjct: 133 IHSAGI---IHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAP 183
Query: 282 EYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
E I + ++ + D++S G ++ E++ G++ +G
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVNL 173
IG GA+G VYKA+ +G VA+K + + + T EV LL RL H N+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 174 VGYCA-----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
+ CA + + LV+ + + L ++L L + RGL++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
+ +HRD+K NIL+ + ++ADFGL+R + T Y PE +
Sbjct: 127 NCI---VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
+ D++S G + E+ R PL
Sbjct: 184 YATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPV-YKAQMSTGETVAVKVLAT--DSKQGEKEFQTEVMLL 162
Y+DL++ +G GA+G V TG VA+K L S+ K E+ LL
Sbjct: 17 YRDLKQ--------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 163 GRLHHRNLVNLVG-YCAEKG-----QHMLVYVFMSK--GSLASH--LYDENYGPLTWNLR 212
+ H N++ L+ + + LV FM G L H L ++ L + +
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM- 127
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272
+GL+Y+H + IHRD+K N+ +++ ++ DFGL+R+ D
Sbjct: 128 -------LKGLKYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQ--TDSEMTGY 175
Query: 273 RGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
T Y PE I + ++T+ D++S G ++ E++ G+ +G
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 38/218 (17%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETV-AVKVLATDS--KQGEKEF---QTEVMLLGRLHHR 168
+ +IG+GAFG V + + + V A+K+L+ K+ + F + ++M H
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA-----HA 100
Query: 169 N---LVNLVGYCA---EKGQHMLVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVAR 221
N +V L + A +K +M V +M G L + + NY P W R + A +V
Sbjct: 101 NSEWIVQL--HYAFQDDKYLYM-VMEYMPGGDLVNLM--SNYDIPEKWA-RFYTA-EVVL 153
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFG 277
L+ +H IHRD+K N+LLD+S ++ADFG + MV GT
Sbjct: 154 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV--RCDTAVGTPD 208
Query: 278 YLDPEYISTRN----FTKKSDVYSFGVLLFELIAGRSP 311
Y+ PE + ++ + ++ D +S GV L+E++ G +P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNL 170
+ +L+G+G FG V + +TG+ A+KV+ +++ F+ E +L + +
Sbjct: 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI 63
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNL-RVHIALDVARGLEYLHD 228
L Y + ++ LV + G L S L + ++ + ++A ++ + +H
Sbjct: 64 PQLQ-YAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQ 120
Query: 229 -GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR--GTFGYLDPEYIS 285
G V HRDIK N+L+D++ ++ADFG + +K + GT Y+ PE ++
Sbjct: 121 MGYV----HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 286 TRNFTKKS------DVYSFGVLLFELIAGRSP 311
T N K D +S GV+ +E+I GRSP
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEF---QTEVMLLGRL-HHRNLVNL 173
+IG+G++ V ++ T A+KV+ + +++ QTE + + +H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ + V +++ G L H+ + P + R + A +++ L YLH+ +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYSA-EISLALNYLHERGI-- 117
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTKK 292
I+RD+K N+LLD ++ D+G+ +E + + GT Y+ PE + ++
Sbjct: 118 -IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 293 SDVYSFGVLLFELIAGRSPL 312
D ++ GVL+FE++AGRSP
Sbjct: 177 VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 9/191 (4%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG+G+FG + G+ +K + S + +E + EV +L + H N+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
E G +V + G L + + + + + + L+++HD + +H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI---LH 124
Query: 237 RDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
RDIKS NI L + ++ DFG++R V+ I GT YL PE R + KSD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSD 183
Query: 295 VYSFGVLLFEL 305
+++ G +L+E+
Sbjct: 184 IWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 116 FTTLIGQGAFGPVYKAQMSTGET-----------------VAVKVLATDS-KQGEKEFQT 157
F +G+G FG V+ + E VAVK+L D+ K +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL---------YDENYGPLT 208
E+ ++ RL N++ L+ C ++ +M G L L + ++
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 209 WNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
++ + +A +A G++YL + +HRD+ + N L+ ++ ++ADFG+SR +
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSGD 184
Query: 269 AANIRG----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELI 306
I+G ++ E I FT SDV++FGV L+E++
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 40/227 (17%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G G+ G V+ A + VAVK + Q K E+ ++ RL H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 179 EKGQHM-----------LVYVFMS--KGSLASHLYDENYGPLTWNLRVHIAL---DVARG 222
G + VY+ + LA+ L GPL+ H L + RG
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL---EQGPLSEE---HARLFMYQLLRG 126
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDKHAANIRG------- 274
L+Y+H V +HRD+K +N+ ++ + ++ DFGL+R +VD H ++ +G
Sbjct: 127 LKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLAR--IVDPHYSH-KGYLSEGLV 180
Query: 275 TFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGL--MEQ 318
T Y P + S N+TK D+++ G + E++ G+ G +EQ
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 67/212 (31%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVG-- 175
IG+G +G VYK G AVK+L S E E + E +L L +H N+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 176 YCAEK---GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV------HIALDVARGLEYL 226
Y A+K GQ LV + GS+ + G L R+ +I GL++L
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVK----GLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIS 285
H+ + IHRD+K +NILL ++ DFG+S + + N GT ++ PE I+
Sbjct: 145 HNNRI---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 286 TR-----NFTKKSDVYSFGVLLFELIAGRSPL 312
++ + DV+S G+ EL G PL
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYC 177
+G+G + V+K + T VA+K + + ++G EV LL L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
LV+ ++ K L ++ D N+++ + + RGL Y H V +HR
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHRRKV---LHR 128
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPE-YISTRNFTKKSDV 295
D+K N+L+++ ++ADFGL+R + V K +N T Y P+ + + ++ + D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 296 YSFGVLLFELIAGRSPLQG 314
+ G + FE+ +GR G
Sbjct: 189 WGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
L+G+G FG V + +TG A+K+L + + E TE +L H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ V + + G L HL E + + ++ L+YLH + V
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLH--SEKNV 117
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRNFTK 291
++RD+K N++LD+ ++ DFGL +E + D A ++ GT YL PE + ++ +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 292 KSDVYSFGVLLFELIAGRSPL 312
D + GV+++E++ GR P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 120 IGQGAFGPVYKAQ---MSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLH-HRNLVNL 173
+GQGA+G V A+ S ETVA+K + K K E+ LL H+N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 174 VGY-CAEKGQHMLVYVFMS--KGSLASHLYDENYGPLTWNLRVHIA---LDVARGLEYLH 227
G +Y++ + L + PLT H + GL+Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ--PLT---DAHFQSFIYQILCGLKYIH 122
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPE 282
V +HRD+K N+L++ ++ DFGL+R T Y PE
Sbjct: 123 SANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 283 -YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+S +++TK DV+S G +L EL+ + +G
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 21/158 (13%)
Query: 118 TLIGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT-EVMLLGRL---HHRNLV 171
IG+GA+G VYKA+ ++TG VA+K V S++G E+ LL +L H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 172 NLVGYCA----EKGQHM-LVYVFMSKGSLASHLYDENY---GPLTWNLRVHIALDVARGL 223
L+ C ++ + LV+ + + LA++L G ++ + + RG+
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIK-DLMRQLLRGV 120
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
++LH ++HRD+K NIL+ + ++ADFGL+R
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYC 177
+G+G + VYK + T VA+K + + ++G EV LL L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+ LV+ ++ K L +L D N+++ + + RGL Y H V+HR
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHR---RKVLHR 128
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPE-YISTRNFTKKSDV 295
D+K N+L+++ ++ADFGL+R + + K +N T Y P+ + + +++ + D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 296 YSFGVLLFELIAGRSPLQG 314
+ G + +E+ GR G
Sbjct: 189 WGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 54/223 (24%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT-------EVMLLGRLHHRNL 170
IG+GA+G V A TG VA+K K E QT E+ +L R H N+
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIK------KISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 171 VNLVG-YCAEKGQHM----LVYVFMS----KGSLASHLYDENYGPLTWNLRVHIALDVAR 221
+ ++ + +V M K HL +++ + + R
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ--------ILR 117
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
GL+Y+H V +HRD+K SN+LL+ + ++ DFGL+R T G+L
Sbjct: 118 GLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLAR-----IADPEHDHT-GFL-T 167
Query: 282 EYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
EY++TR +TK D++S G +L E+++ R PL
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 119 LIGQGAFGPVYKAQMSTGETV-AVKVLATDSKQGEKEF---QTEVMLLGRLHHRN-LVNL 173
+IG+G++ V ++ + + A+KV+ + +++ QTE + + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ LV +++ G L H+ + P + R + A ++ L +LH+ +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP-EEHARFYAA-EICIALNFLHERGI-- 117
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTKK 292
I+RD+K N+LLD ++ D+G+ +E + + GT Y+ PE + +
Sbjct: 118 -IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 293 SDVYSFGVLLFELIAGRSPL 312
D ++ GVL+FE++AGRSP
Sbjct: 177 VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEF---QTEVMLLGRL-HHRNLVN 172
+IG+G++ V ++ T A+KV+ + +++ QTE + +H LV
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L + + V F+S G L H+ + P + R + A +++ L +LH+ +
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP-EEHARFYSA-EISLALNFLHERGI- 117
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTK 291
I+RD+K N+LLD ++ D+G+ +E + + GT Y+ PE + ++
Sbjct: 118 --IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 292 KSDVYSFGVLLFELIAGRSP 311
D ++ GVL+FE++AGRSP
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
IG+G +G VYKA+ T ET+A+K + + ++ E T E+ LL + H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV--HIALDVARGLEYLHDGAVPP 233
+ + LV+ ++ L H+ ++ N R+ + RG+ Y H V
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV-- 123
Query: 234 VIHRDIKSSNILLDQSMRA-RVADFGLSR----------EEMVDKHAANIRGTFGYLDPE 282
+HRD+K N+L+D+ A ++ADFGL+R E+V T Y PE
Sbjct: 124 -LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---------TLWYRAPE 173
Query: 283 -YISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
+ +R+++ D++S G + E++ + PL
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK-PL 203
|
Length = 294 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 37/101 (36%), Positives = 58/101 (57%), Gaps = 7/101 (6%)
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGT 275
VA+G+ +L A IHRD+ + NILL ++ DFGL+R+ D + N R
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
++ PE I +T +SDV+S+G+LL+E+ + G SP G+
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
IG+G +G V+KA+ T E VA+K V D +G E+ LL L H+N+V L Y
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--Y 65
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
L VF +D G + + + +GL + H V +H
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV---LH 122
Query: 237 RDIKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-STRNFTKKS 293
RD+K N+L++++ ++ADFGL+R V ++A + T Y P+ + + ++
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 181
Query: 294 DVYSFGVLLFELIAGRSPL 312
D++S G + EL PL
Sbjct: 182 DMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 32/225 (14%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEK-EFQTEVMLLGRLHHRNLVNLVGY 176
IG G FG V+ + T E K ++ K+ EK + EV ++ L H+N+V +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 177 CAEKGQHMLVYVFMS---KGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
K L Y+ M G L+ ++ + +G + + V I + L Y H+
Sbjct: 81 FLNKANQKL-YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 232 PP----VIHRDIKSSNILLDQSMR-----------------ARVADFGLSREEMVDKHAA 270
P V+HRD+K NI L +R A++ DFGLS+ ++ A
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH 199
Query: 271 NIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
+ GT Y PE + T+++ KSD+++ G +++EL +G++P
Sbjct: 200 SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 64/269 (23%), Positives = 121/269 (44%), Gaps = 29/269 (10%)
Query: 62 ILSDSTVGPESPVKSGRNG------NGKSMWLEGFKRSNVVSASGIPEYSYK-DLQKA-- 112
I D + E K+ + G N K + E +N E D+ ++
Sbjct: 6 IDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPN 65
Query: 113 -TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
+ +IG G+FG VY+A + T E VA+K + D + +E ++++ L+H N+
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHINI 121
Query: 171 VNLVGY----CAEKGQ-HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----ALDVAR 221
+ L Y C +K + ++ + V M H Y ++Y L + + + + R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLD 280
L Y+H + HRD+K N+L+D + ++ DFG ++ + + + + + Y
Sbjct: 182 ALAYIHSKFI---CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238
Query: 281 PE-YISTRNFTKKSDVYSFGVLLFELIAG 308
PE + N+T D++S G ++ E+I G
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 116 FTTL--IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRN 169
F L +GQG +G V+ A+ TGE VA+K + + TE +L
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 170 LVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWN-LRVHIALDVARGLEYLH 227
LV L+ Y + +++ L ++ G + L N G L+ + R ++A ++ LH
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH 118
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
+ IHRD+K N L+D S ++ DFGLS+ + +A ++ G+ Y+ PE + +
Sbjct: 119 ELGY---IHRDLKPENFLIDASGHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEVLRGK 173
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ D +S G +L+E + G P G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 45/217 (20%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNL--V 174
IG+GA+G V A+ S T E VA+K + A D++ K E+ LL L H N++ + +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENY-------GPLTWNLRVHIALDVARGLEYLH 227
+ VY + L D + L+ + + + RGL+Y+H
Sbjct: 73 MPPPHREAFNDVY-------IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
V +HRD+K SN+LL+ + ++ DFGL+R + +G F EY+ TR
Sbjct: 126 SANV---LHRDLKPSNLLLNANCDLKICDFGLAR-------TTSEKGDFM---TEYVVTR 172
Query: 288 ------------NFTKKSDVYSFGVLLFELIAGRSPL 312
+T DV+S G + EL+ GR PL
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYC 177
+G+G + V+K + T VA+K + + ++G EV LL L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL-DVARGLEYLHDGAVPPVIH 236
+ LV+ ++ L +L +N G L V I + + RGL Y H + +H
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPE-YISTRNFTKKSD 294
RD+K N+L+++ ++ADFGL+R + V K +N T Y P+ + + ++ D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
++ G +L+E+ GR G
Sbjct: 187 MWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 33/233 (14%)
Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVK--VLATDSKQGEKEFQTEVML 161
+Y+ L+K IG+G +G VYKA+ +TG+ VA+K L D + E+ L
Sbjct: 2 AYEKLEK--------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISL 53
Query: 162 LGRLHHRN----LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG----PLTWNLRV 213
L L L+++ + G+ L VF S D N PL
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEM--VDKHAA 270
+ +G+ + H V +HRD+K N+L+D+ ++AD GL R V +
Sbjct: 114 SFMYQLLKGVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 271 NIRGTFGYLDPE-YISTRNFTKKSDVYSFGVLLFELI------AGRSPLQGLM 316
I T Y PE + + +++ D++S G + E+ G S LQ L+
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 65/222 (29%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 113 TCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNL 170
T IG+G +G V+K G AVK+L E E + E +L L H N+
Sbjct: 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNV 77
Query: 171 VNLVGYCAEKG-----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRV------HIALDV 219
V G +K Q LV + GS+ D G L R+ +I +
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAYILHEA 133
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGY 278
GL++LH IHRD+K +NILL ++ DFG+S + + N GT +
Sbjct: 134 LMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 279 LDPEYISTR-----NFTKKSDVYSFGVLLFELIAGRSPLQGL 315
+ PE I+ + + DV+S G+ EL G PL L
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLV 174
++G+GA+G V K + T E VA+K DS++ E+ +T E+ +L L N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+G+ LV+ ++ K L L + G +R +I + + + + H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKNDI--- 121
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
+HRDIK N+L+ + ++ DFG +R E + + T Y PE + + K
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 293 SDVYSFGVLLFELIAGRSPLQGLME 317
D++S G +L EL G+ G E
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 44/218 (20%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
IG+G +G VYK + TG+ VA+K + +S++ E T E+ LL L H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH---DGAV- 231
++ + L++ F+S L +L +L +D YL+ G +
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLD---------SLPKGQYMDAELVKSYLYQILQGILF 116
Query: 232 ---PPVIHRDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIRGTFGY 278
V+HRD+K N+L+D ++ADFGL+R E+V T Y
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV---------TLWY 167
Query: 279 LDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
PE + S R ++ D++S G + E+ + G
Sbjct: 168 RAPEVLLGSPR-YSTPVDIWSIGTIFAEMATKKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 35/234 (14%)
Query: 103 EYSYKDLQKATCNFTTL--------IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQG 151
+ + +Q A FT L IG GA G V A G VAVK L+ ++
Sbjct: 4 DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVG-YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWN 210
K E++LL ++H+N+++L+ + +K V+ L L D N +
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY-----LVMELMDANLCQV--- 115
Query: 211 LRVHIALDVAR----------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260
+H+ LD R G+++LH + IHRD+K SNI++ ++ DFGL+
Sbjct: 116 --IHMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLA 170
Query: 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
R + T Y PE I + + D++S G ++ EL+ G QG
Sbjct: 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-12
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVN 172
IG+GA+G V+KA+ + G VA+K + + + T EV +L L H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 173 LVGYCA-----EKGQHMLVYVFMSKGSLASHLY---DENYGPLTWNLRVHIALDVARGLE 224
L C + + LV+ + + L ++L + T + + RGL+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK---DMMFQLLRGLD 124
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
+LH V +HRD+K NIL+ S + ++ADFGL+R ++ T Y PE +
Sbjct: 125 FLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPL 312
++ D++S G + E+ R PL
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 120 IGQGAFGPVYKAQMSTGETVA-VKVLATDSKQGEKEFQTEVMLLGR----LHHRNLVNLV 174
IG G FG V +++ T VA V V + KE Q E + G L H N++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE-QNEFLQQGDPYRILQHPNILQCL 61
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
G C E ++LV+ + G L S+L + L +A ++A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLS----REEMV---DKHAANIRGTFGYLDPEYIS 285
+H D+ N L + +V D+G+ +E+ + D +R +L PE +
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPELVG 174
Query: 286 TRN-------FTKKSDVYSFGVLLFEL 305
+ TK S+V++ GV L+EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 33/84 (39%), Positives = 50/84 (59%), Gaps = 3/84 (3%)
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNFT 290
+IHRDIKS+NILL + ++ DFG S+ + D GT Y+ PE + ++
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
KK+D++S GVLL+EL+ + P G
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 43/145 (29%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK--VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG+G++G V+K + TG+ VA+K V + D +K E+ +L +L H NLVNL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
K + LV+ + L + ++N + +L I + + + H IH
Sbjct: 69 FRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC---IH 123
Query: 237 RDIKSSNILLDQSMRARVADFGLSR 261
RD+K NIL+ + + ++ DFG +R
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGE--TVAVKVLAT----DSKQGEKEFQTEVMLLGRLHHR 168
NF +G G+FG V A + VA+K KQ + F +E +L ++H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHP 91
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
VNL G ++ LV F+ G + L P ++ A + EYL
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN--DVGCFYAAQIVLIFEYLQS 149
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
+++RD+K N+LLD+ ++ DFG ++ +VD + GT Y+ PE +
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVG 204
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
K +D ++ G+ ++E++ G P
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQT--EVML 161
+YK L K +G+G++ VYK + TG+ VA+K + + ++G F E L
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASL 56
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
L L H N+V L K LV+ ++ L ++ D G N+R+ + + R
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFL-FQLLR 114
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLD 280
GL Y H V +HRD+K N+L+ + ++ADFGL+R + V +N T Y
Sbjct: 115 GLAYCHQRRV---LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRP 171
Query: 281 PE-YISTRNFTKKSDVYSFGVLLFELIAGR 309
P+ + + ++ D++ G + +E+ GR
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 57/217 (26%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT--EVML 161
SY +L+K +G+G++ VYK G+ VA+KV++ +++G F E L
Sbjct: 6 SYLNLEK--------LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASL 56
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
L L H N+V L K V+ +M LA ++ G +N+R+ + + R
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFM-FQLLR 114
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV--DKHAANIRGTFGYL 279
GL Y+H + +HRD+K N+L+ ++ADFGL+R + + +++ + T Y
Sbjct: 115 GLAYIHGQHI---LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYR 170
Query: 280 DPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
P+ + +++ D++ G + E++ G+ G+
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
+G GA+G V A TG VAVK L+ S K E+ LL + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYG------PLTWNLRVHIALDVARGLEYLHDG 229
+ + V+ L +HL + LT + + + RGL+Y+H
Sbjct: 85 FTPARSLEEFNDVY-----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRN 288
+ IHRD+K SN+ +++ ++ DFGL+R D T Y PE ++ +
Sbjct: 140 DI---IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
+ + D++S G ++ EL+ GR+ G
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 14/179 (7%)
Query: 139 VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASH 198
V VK + G K E+ +L + HR ++NL+ K V + M K
Sbjct: 122 VIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRWKS---TVCMVMPKYKCDLF 173
Query: 199 LYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG 258
Y + GPL + I + L YLH + IHRD+K+ NI LD+ A + DFG
Sbjct: 174 TYVDRSGPLPLEQAITIQRRLLEALAYLHGRGI---IHRDVKTENIFLDEPENAVLGDFG 230
Query: 259 LSREEMVDKHAANIRGTFGYLD---PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ + G G L+ PE ++ + K+D++S G++LFE+ L G
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 47/235 (20%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
L+G+G G V+ ++ TG+ A+KVL +K K TE +L L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKV--KRVLTEQEILATLDHPFLPT 65
Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH-DG 229
L Y + + + L V + G L L + L+ + A +V LEYLH G
Sbjct: 66 L--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-----REEMVDKHAANIR----------- 273
+++RD+K NILL +S ++DF LS V K
Sbjct: 124 ----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 274 --------------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
GT Y+ PE IS D ++ G+LL+E++ G +P +G
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVG 175
+IG+GAFG V + ST + A+K+L+ K+ + F E + + V +
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAVPP 233
Y + +++ +V +M G L + + NY P W R + A +V L+ +H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHSMGF-- 163
Query: 234 VIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFGYLDPEYISTRN- 288
IHRD+K N+LLD+S ++ADFG +++E MV A GT Y+ PE + ++
Sbjct: 164 -IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGG 220
Query: 289 ---FTKKSDVYSFGVLLFELIAGRSPL 312
+ ++ D +S GV L+E++ G +P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 13/195 (6%)
Query: 120 IGQGAFGPVY-----KAQMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNL 173
+G+G+FG VY KA V ++ + E + E LL +L H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
E+ ++ + L L L+ N + + G+ Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---Q 124
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFT 290
++HRD+K+ NI L ++ ++ DFG+SR M A GT Y+ PE + + +
Sbjct: 125 RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYD 183
Query: 291 KKSDVYSFGVLLFEL 305
KSD++S G +L+E+
Sbjct: 184 SKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHH 167
T +G GA+G V A + VAVK L+ + FQ+ E+ LL + H
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLS-------RPFQSLIHARRTYRELRLLKHMKH 73
Query: 168 RNLVNL--VGYCAEKGQHM----LVYVFMSKG----SLASHLYDENYGPLTWNLRVHIAL 217
N++ L V A ++ LV M L DE+ L + L
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL------ 127
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
RGL+Y+H + IHRD+K SN+ +++ R+ DFGL+R+ D T
Sbjct: 128 --LRGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVATRW 180
Query: 278 YLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
Y PE ++ ++ + D++S G ++ EL+ G++ G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 50/213 (23%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ-TEVMLLGRL-HHRNLVNLVGY 176
IG+G F V KAQ TG+ A+K + K E+ E+ L RL H N++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWN-------LRV-HIALDVARGLEYLHD 228
++ L VF L D N L RV + + L+++H
Sbjct: 67 LFDRKTGRLALVF--------ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP--EYIST 286
+ HRDIK NIL+ ++ADFG + RG + P EYIST
Sbjct: 119 NGI---FHRDIKPENILIKDD-ILKLADFG------------SCRGIYSKP-PYTEYIST 161
Query: 287 R------------NFTKKSDVYSFGVLLFELIA 307
R + K D+++ G + FE+++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 12/104 (11%)
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGY 278
RGL+YLH + +HRDIK N+L++ + ++ DFGL+R E D KH T Y
Sbjct: 114 RGLKYLHSAGI---LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 279 LDPEYI-STRNFTKKSDVYSFGVLLFELIAGR------SPLQGL 315
PE + +R++T D++S G + EL+ R SP+Q L
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQMSTGETV-AVKVLAT---DSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+IG+GAFG V + + + V A+K+L+ + F E ++ + +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 108
Query: 175 GYCAEKGQHMLVYV--FMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAV 231
+CA + L V +M G L + + NY P W + + A +V L+ +H +
Sbjct: 109 -FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHSMGL 163
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFG--LSREEMVDKHAANIRGTFGYLDPEYISTRN- 288
IHRD+K N+LLD+ ++ADFG + +E GT Y+ PE + ++
Sbjct: 164 ---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 289 ---FTKKSDVYSFGVLLFELIAGRSPL 312
+ ++ D +S GV LFE++ G +P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 40/118 (33%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
L++ V + VA G+E+L A +HRD+ + N+L+ + ++ DFGL+R+ M D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 267 KHAANIRGTF---GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL-MEQQ 319
+ + TF ++ PE I +T SDV+SFG+LL+E+ G +P L M +Q
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 31/161 (19%)
Query: 176 YCA-EKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNL-RVHIALDVARGLEYLHDGAVP 232
+C+ E +H+ +V ++ G A+ L +N G L ++ R++ A V LEYLH+ +
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVL-ALEYLHNYGI- 122
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSR-------------------EEMVDKHAANIR 273
+HRD+K N+L+ ++ DFGLS+ E +DK +
Sbjct: 123 --VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ---VC 177
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
GT Y+ PE I + + K D ++ G++L+E + G P G
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 33/229 (14%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGE--KEFQTEVMLLGR 164
++ + CN T+ VY A+ + TG V V++ ++ E K Q EV+L
Sbjct: 5 EIGRGFCNLTS---------VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHF 55
Query: 165 LHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP--LTWNLRVHIALDVARG 222
H N++ ++ FM+ GS A+ L + Y P ++ L +I RG
Sbjct: 56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGS-ANSLL-KTYFPEGMSEALIGNILFGALRG 113
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY---- 278
L YLH IHR+IK+S+IL+ S V+ GLS + ++ + + +
Sbjct: 114 LNYLHQNGY---IHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 279 ------LDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
L PE + + KSD+YS G+ EL GR P Q ++ Q
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEF--QT---EVMLLGRLHHRNLVNL 173
IG+G +G VYKA+ TGE VA+K + ++ E E T E+ LL L+H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ + + LV+ F+ L ++ L L + +G+ Y H V
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV-- 120
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIRGTFGYLDPE- 282
+HRD+K N+L+D+ ++ADFGL+R E+V T Y PE
Sbjct: 121 -LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEI 170
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
+ +R ++ D++S G + E++ R PL
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 120 IGQGAFGPVYKA----QMSTGET----VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV 171
+GQG F ++K GE V +KVL + + F ++ +L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
G C + ++V ++ GSL ++L ++N ++W L V A +A L +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV--AKQLAWALHFLEDKG 120
Query: 231 VPPVIHRDIKSSNILLDQSMRA--------RVADFG-----LSREEMVDKHAANIRGTFG 277
+ H ++ + N+LL + +++D G L +E ++++
Sbjct: 121 LT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER--------IP 169
Query: 278 YLDPEYIS-TRNFTKKSDVYSFGVLLFELIAG-RSPLQGLMEQQ 319
++ PE I +N + +D +SFG L+E+ +G PL L Q+
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 37/189 (19%), Positives = 86/189 (45%), Gaps = 15/189 (7%)
Query: 136 GETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM----LVYV 188
+ V ++ K + + E+ L R+ N++ + G+ + + L+
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ 248
+ ++G L L E L++ ++ +A+D +GL L+ P ++++ S + L+ +
Sbjct: 103 YCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTE 158
Query: 249 SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELI 306
+ + ++ GL E+++ Y + ++ +T K D+YS GV+L+E+
Sbjct: 159 NYKLKIICHGL--EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
Query: 307 AGRSPLQGL 315
G+ P + L
Sbjct: 217 TGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKE-----------FQT--EVMLLGR 164
+G+G +G V KA TG+ VA+K V + + F T E+ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 165 LHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
+ H N++ LV E LV M+ L + + LT + I L + GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV--DRKIRLTESQVKCILLQILNGLN 133
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---------EEMVDKHAANIRG- 274
LH +HRD+ +NI ++ ++ADFGL+R D+
Sbjct: 134 VLHKWYF---MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 275 -----TFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
T Y PE + + + + D++S G + EL+ G+ G
Sbjct: 191 TSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 9e-10
Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 21/153 (13%)
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGL 223
+ N + L H+L+ ++ G L +D + G L+ I + L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSR----EEMVDKHAANIRGTFGY 278
LH + IH DIK N+L D++ R + D+GL + D GT Y
Sbjct: 123 NDLHKHNI---IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------GTLDY 172
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
PE I N+ D ++ GVL +EL+ G+ P
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 30/84 (35%), Positives = 52/84 (61%), Gaps = 3/84 (3%)
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE---EMVDKHAANIRGTFGYLDPEYISTRNFT 290
++HRD+KS+NI L + ++ DFG S++ + A++ GT YL PE + ++
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
KK+D++S GV+L+EL+ P +G
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 43/212 (20%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLA------TDSKQGEKEFQTEVMLLGRLHHRNLVN 172
IG GA G V A TG+ VA+K L+ T +K+ +E +L+ ++H+N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIG 79
Query: 173 LVGYCAEKGQHML-----VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR------ 221
L+ Q L VY+ M L D N + + + LD R
Sbjct: 80 LLN--VFTPQKSLEEFQDVYLVM-------ELMDANLCQV-----IQMDLDHERMSYLLY 125
Query: 222 ----GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
G+++LH + IHRD+K SNI++ ++ DFGL+R T
Sbjct: 126 QMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
Y PE I + + D++S G ++ E+I G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 68/247 (27%)
Query: 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQT-----EVMLLGRLHHRNLV 171
+IG+GAFG V Q TG A+K L S+ EKE Q E +L + +V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKE-QVAHVRAERDILAEADNPWVV 64
Query: 172 NLVGYCA--EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNL-RVHI-----ALDVARGL 223
L Y + ++ L+ ++ G + + L ++ T R +I A+D L
Sbjct: 65 KL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIR 273
Y IHRDIK N+LLD +++DFGL ++ +
Sbjct: 121 GY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 274 -----------------------------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFE 304
GT Y+ PE + K+ D +S GV+++E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 305 LIAGRSP 311
++ G P
Sbjct: 232 MLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
+IG+GAFG V +M +TG+ A+K+L K+ E F+ E +L R + NL
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL- 66
Query: 175 GYCAEKGQHM-LVYVFMSKGSLASHL--YDENYGPLTWNLRVH---IALDVARGLEYLHD 228
Y + ++ LV + G L + L +++ + +A+D L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFGYLDPEYI 284
+HRDIK N+LLD++ R+ADFG L + V + A GT Y+ PE +
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISPEIL 175
Query: 285 -----STRNFTKKSDVYSFGVLLFELIAGRSP 311
+ + D +S GV ++E++ G +P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 31/206 (15%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
IG GA G V A + E VA+K L+ ++ K E++L+ ++H+N++ L+
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 176 YCAEKG--QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR----------GL 223
+ +K + VY+ M L D N + + + LD R G+
Sbjct: 92 FTPQKSLEEFQDVYIVM-------ELMDANLCQV-----IQMELDHERMSYLLYQMLCGI 139
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY 283
++LH + IHRD+K SNI++ ++ DFGL+R T Y PE
Sbjct: 140 KHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGR 309
I + + D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 17/163 (10%)
Query: 154 EFQTEVMLLGRLHHRNLVNLVGYC-AEKGQHMLV--YVFMSKGSLASHLYDENY----GP 206
+ + E++ LGRL+H N++ + +E +M+ Y F L S +YDE + P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG--LSREEM 264
L R I + +EY+HD + IHRDIK NI L+ + + DFG + E+
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
+ GT PE ++ + + +D++S G++L ++++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 16/105 (15%)
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANI 272
IA+D L Y +HRDIK NIL+D + R+ADFG + M D ++
Sbjct: 113 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163
Query: 273 RGTFGYLDPEYISTRN-----FTKKSDVYSFGVLLFELIAGRSPL 312
GT Y+ PE + + + D +S GV ++E++ G +P
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 9e-08
Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
IG GA G V A + VA+K L+ ++ K E++L+ ++H+N+++L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
+ +K V++ + ++L L ++ + G+++LH + I
Sbjct: 85 FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 141
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
HRD+K SNI++ ++ DFGL+R T Y PE I + + D+
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201
Query: 296 YSFGVLLFELI 306
+S G ++ E++
Sbjct: 202 WSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 48/144 (33%)
Query: 212 RVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL------------ 259
R +IA ++ +E +H IHRDIK NIL+D+ ++ DFGL
Sbjct: 104 RFYIA-ELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 260 ------SREEMVD----------------------KH----AANIRGTFGYLDPEYISTR 287
R++ ++ +H A ++ GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
+T+ D +S GV+L+E++ G+ P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 10/159 (6%)
Query: 157 TEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIA 216
TE +L ++H +++ L G L+ + K L +L + + L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI-LPRYKTDLYCYLAAKRNIAICDILA--IE 188
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
V R ++YLH+ + IHRDIK+ NI ++ + DFG + VD +A G
Sbjct: 189 RSVLRAIQYLHENRI---IHRDIKAENIFINHPGDVCLGDFGAACFP-VDINANKYYGWA 244
Query: 277 GYL---DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
G + PE ++ + D++S G++LFE+ L
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 40/226 (17%)
Query: 120 IGQGAFGPVYKA---QMSTGETVA----VKVLATDSKQGEK---EFQTEVMLLGRLHHRN 169
+GQG F +YK S + V V V+ + F L+ +L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-LTWNLRVHIALDVARGLEYLHD 228
LV L G C +++V ++ G L L+ E L W L V A +A L YL D
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 229 GAVPPVIHRDIKSSNILLDQ-------SMRARVADFG-----LSREEMVDKHAANIRGTF 276
++H ++ NIL+ + +++D G LSREE V++
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169
Query: 277 GYLDPEYI--STRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
++ PE I + T +D +SFG L E+ + G PL L +
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 47/221 (21%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
+IG+G++G V A TGE VA+K + + E+ LL L H ++V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI-- 64
Query: 176 YCAEKGQHML----------VYVFMSKGSLASH--------LYDENYGPLTWNLRVHIAL 217
+H++ +YV H L E++ + L
Sbjct: 65 ------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQL------ 112
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA----NIR 273
R L+Y+H V HRD+K NIL + + ++ DFGL+R D A +
Sbjct: 113 --LRALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 274 GTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPL 312
T Y PE + +T D++S G + E++ G+ PL
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNL----- 173
+G+G +G VYKA+ G+ L G E+ LL L H N+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 174 ------VGYCAEKGQHMLVYVF-MSKGSLASHLYDENYGP--LTWNLRVHIALDVARGLE 224
V + +H L ++ + S A N P L + + + G+
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPVQLPRGMVKSLLYQILDGIH 122
Query: 225 YLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSR------EEMVDKHAANIRG 274
YLH V +HRD+K +NIL+ + R ++AD G +R + + D +
Sbjct: 123 YLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 275 TFGYLDPE-YISTRNFTKKSDVYSFGVLLFELI 306
TF Y PE + R++TK D+++ G + EL+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 26/189 (13%)
Query: 139 VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASH 198
V +KVL + F ++ ++ H+++V L G C ++++V F+ G L
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF 94
Query: 199 LYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-------DQSMR 251
++ ++ LT + +A +A L YL D ++H ++ + NILL +
Sbjct: 95 MHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPF 150
Query: 252 ARVADFG-----LSREEMVDKHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFEL 305
+++D G LSR+E V++ ++ PE + ++N + +D +SFG L+E+
Sbjct: 151 IKLSDPGIPITVLSRQECVER--------IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 306 -IAGRSPLQ 313
G PL+
Sbjct: 203 CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNL----- 173
+G+G +G VYKA+ G+ L G E+ LL L H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 174 ------VGYCAEKGQHMLVYVF-MSKGSLASHLYDENYGP--LTWNLRVHIALDVARGLE 224
V + +H L ++ + S A N P L ++ + + G+
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPMQLPRSMVKSLLYQILDGIH 122
Query: 225 YLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSR------EEMVDKHAANIRG 274
YLH V +HRD+K +NIL+ + R ++AD G +R + + D +
Sbjct: 123 YLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 275 TFGYLDPE-YISTRNFTKKSDVYSFGVLLFELI 306
TF Y PE + R++TK D+++ G + EL+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 9/89 (10%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
+G+GAFG V +A + +T TVAVK+L + E + +E+ +L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHL 199
NL+G C + G ++V V F G+L+++L
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 7/85 (8%)
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLDPEYISTR----- 287
+HRDIK N+LLD + R+ADFG + D ++ GT Y+ PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
+ + D +S GV ++E++ G +P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 45/234 (19%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVL-ATDSKQGEK--EFQTEVMLLGRLHHRNLVNLV 174
+IG+GAFG V Q TG A+K+L D + E+ + E +L +V +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+K L+ F+ G + + L ++ LT + ++ +H
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGF--- 122
Query: 235 IHRDIKSSNILLDQSMRARVADFGL------------------------SREEMVDKHAA 270
IHRDIK N+LLD +++DFGL + + M K A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 271 -----NIR-------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
N R GT Y+ PE + K D +S GV+++E++ G P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 47/235 (20%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKE----FQTEVMLLGRLHHRNLVNL 173
+IG+GAFG V Q TG A+K+L + EKE + E +L +V +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+K L+ F+ G + + L ++ L+ + ++ +H
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGF-- 122
Query: 234 VIHRDIKSSNILLDQSMRARVADFGL------------------------SREEMVDKHA 269
IHRDIK N+LLD +++DFGL S + M K
Sbjct: 123 -IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 270 A-----NIR-------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
A N R GT Y+ PE + K D +S GV+++E++ G P
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 51/233 (21%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
LIG+G G VY A VA+K + D + K F E + L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 175 GYCAEKGQHMLVYVFM----------------SKGSLASHLYD-ENYGPLTWNLRVHIAL 217
C++ VY M K SL+ L + + G + I
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-----LSIFH 120
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS------REEMVDKHA-- 269
+ +EY+H V +HRD+K NILL + D+G + E+++D
Sbjct: 121 KICATIEYVHSKGV---LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 270 -----------ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
I GT Y+ PE + ++ +D+Y+ GV+L++++ P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
I +GAFG VY + + + AVKV+ +K + Q E L +V+L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
LV ++ G + S L+ YG + V +VA L+YLH + I
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH--IYGYFDEEMAVKYISEVALALDYLHRHGI---I 126
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEM 264
HRD+K N+L+ ++ DFGLS+ +
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 28/191 (14%)
Query: 139 VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASH 198
V +KVL + F L+ ++ H +L + G C ++++V F+ G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 199 LYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA----- 252
L E P+ W + V A +A L YL D ++H ++ + NILL + A
Sbjct: 107 LRKEKGRVPVAWKITV--AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSP 161
Query: 253 --RVADFG-----LSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFE 304
+++D G LSREE V++ ++ PE + + + +D +SFG L E
Sbjct: 162 FIKLSDPGVSFTALSREERVER--------IPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 305 L-IAGRSPLQG 314
+ G PL+
Sbjct: 214 ICFDGEVPLKE 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 58/245 (23%), Positives = 94/245 (38%), Gaps = 57/245 (23%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
+G GAFG V A ++ T A+K L ++ + E +L + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
+K V ++ G + S L P R +IA ++ +E +H I
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL-ARFYIA-ELTLAIESVHKMGF---I 123
Query: 236 HRDIKSSNILLDQSMRARVADFGL------------------------------------ 259
HRDIK NIL+D ++ DFGL
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183
Query: 260 -------SREEMVDKH-----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
+ E+ K A ++ GT Y+ PE + + +T+ D +S GV+LFE++
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243
Query: 308 GRSPL 312
G+ P
Sbjct: 244 GQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 63/263 (23%), Positives = 104/263 (39%), Gaps = 83/263 (31%)
Query: 115 NFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH---- 167
+F T+ IG+GAFG V Q TG+ A+K L ++E+ +L H
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAHVKAE 51
Query: 168 RNL---------VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNL-RVHIA 216
R++ V+L Y + Q++ L+ F+ G L + L Y + ++ R ++A
Sbjct: 52 RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMA 108
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------------- 260
+ +E +H IHRDIK NIL+D+ +++DFGLS
Sbjct: 109 -ECVLAIEAVHKLGF---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164
Query: 261 ------------REEMVD--------------------KHAANIRGTFGYLDPEYISTRN 288
VD A + GT Y+ PE +
Sbjct: 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224
Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
+ ++ D +S G ++FE + G P
Sbjct: 225 YGQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 35/135 (25%), Positives = 56/135 (41%), Gaps = 50/135 (37%)
Query: 235 IHRDIKSSNILLDQSMRARVADFGLS------------------REEMVD---------- 266
IHRDIK NIL+D+ ++ DFGL R++ +D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 267 ----------------KH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELI 306
+H A ++ GT Y+ PE + +T+ D +S GV+L+E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 307 AGRSPL--QGLMEQQ 319
G+ P Q +E Q
Sbjct: 243 VGQPPFLAQTPLETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 116 FTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-HH 167
F +G GAFG V +A + TVAVK+L + E+E +E+ +L L +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL 199
N+VNL+G C G +++ + G L + L
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 33/206 (16%)
Query: 135 TGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192
TGE V V+ + ++ E Q E+ + +H N+V + +V FM+
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83
Query: 193 GS----LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ 248
GS + +H D L +I V + L+Y+H +HR +K+S+IL+
Sbjct: 84 GSAKDLICTHFMD-GMSELAI---AYILQGVLKALDYIHHMGY---VHRSVKASHILI-- 134
Query: 249 SMRARVADFGL----------SREEMVD---KHAANIRGTFGYLDPEYI--STRNFTKKS 293
S+ +V GL R +V K++ + +L PE + + + + KS
Sbjct: 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV---LPWLSPEVLQQNLQGYDAKS 191
Query: 294 DVYSFGVLLFELIAGRSPLQGLMEQQ 319
D+YS G+ EL G P + + Q
Sbjct: 192 DIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 30/227 (13%)
Query: 107 KDLQKATCNFT--TLIGQGAFGPVYKA-QMSTGETVAVKVLA-----TDSKQGEKEFQTE 158
+D+ +T F +L+G+G FG V +A E AVK++ T + E +F +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218
V L+ + Y + HM + M K + +GP + I
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCI--VMPKYGPCLLDWIMKHGPFSHRHLAQIIFQ 239
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQS----------------MRARVADFGLSRE 262
L+Y H ++H D+K NIL++ S R R+ D G +
Sbjct: 240 TGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297
Query: 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
E + A I T Y PE + + +D++S G +++EL G+
Sbjct: 298 ERHSRTA--IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEKE-FQTEVMLLGRLH-HRNLV 171
+G GAFG V +A +S ++ VAVK+L + ++ EK+ +E+ ++ L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
NL+G C + G ++ + G L +L+ + L + LD R L G
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYY------LDKNRDDGSLISGGS 158
Query: 232 PPVIHR 237
P+ R
Sbjct: 159 TPLSQR 164
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 40/151 (26%), Positives = 60/151 (39%), Gaps = 19/151 (12%)
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP----LTWNLRVHIALDVARGLE 224
N+V L Y + LV G L SH+ P W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPE 282
LH + + RD+ +NILLD ++ F E + D A Y PE
Sbjct: 101 -LHREGI---VCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
T+ D +S G +LFEL+ G++ ++
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 46/226 (20%), Positives = 91/226 (40%), Gaps = 37/226 (16%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL----- 173
LIG G FG VY+ Q ++ + + +A + E ++ ++ + + L
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 174 ----VGY-----CAEKGQHMLVYVFM-------SKGSLASHLYDENYGPLTWNLRVHIAL 217
+G C + + Y F+ + + + +N L N I
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN-KKLIKN----IMK 133
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-------KHAA 270
D+ LEY+H+ + H DIK NI++D + R + D+G++ ++ K
Sbjct: 134 DMLTTLEYIHEHGIS---HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 271 NI-RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
++ RGT Y + + T++ D+ S G + + + P +G
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 10/93 (10%)
Query: 219 VARGL----EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG---LSREEMVDKHAAN 271
VAR L +Y+H + IHRDIK+ N+L++ + DFG +R
Sbjct: 265 VARQLLSAIDYIHGEGI---IHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFE 304
I GT PE ++ +T D++S G+++FE
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 26/97 (26%), Positives = 41/97 (42%), Gaps = 15/97 (15%)
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG 274
+ L L LH A KS NILL + + G + K R
Sbjct: 22 VCLQCLGALRELHRQA---------KSGNILL--TWDGLLKLDG----SVAFKTPEQSRP 66
Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
++ PE I +++T+K+D+YS G+ L+E + P
Sbjct: 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 29/145 (20%), Positives = 55/145 (37%), Gaps = 14/145 (9%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV--NLVGY 176
L+ G VY + E +K+ + K + + EV +L L + L ++
Sbjct: 5 LLKGGLTNRVYLLG-TKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLAS 61
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
G L+ ++ +G + +E + IA +A L LH + + H
Sbjct: 62 GESDGWSYLLMEWI-EGETLDEVSEEE--------KEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 237 RDIKSSNILLDQSMRARVADFGLSR 261
D+ NIL+D + D+ +
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 119 LIGQGAFGPVYKAQ---MSTGE---TVAVKVLATDSKQGEKE-FQTEVMLLGRL-HHRNL 170
++G GAFG V + +S + VAVK+L ++ EK+ +E+ ++ L H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLY 200
VNL+G C + G ++ + G L ++L+
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 319 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.43 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.35 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.17 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.17 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.11 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.1 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.05 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.81 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.54 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.45 | |
| PLN02236 | 344 | choline kinase | 97.37 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.35 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.21 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 97.13 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 96.99 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.98 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.76 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.7 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.63 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.57 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.57 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 96.27 | |
| PF01034 | 64 | Syndecan: Syndecan domain; InterPro: IPR001050 The | 96.25 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 96.24 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.21 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 96.09 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.03 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-52 Score=352.76 Aligned_cols=201 Identities=29% Similarity=0.521 Sum_probs=182.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.|.+.+.||+|+|++||+|+. .++..||||.+... .+...+.+..|+.+|+.++|||||++++++.+++..|+||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 455667799999999999954 47799999998765 555567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC------CceEEeecCCCccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS------MRARVADFGLSREE 263 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~------~~~kl~Dfg~~~~~ 263 (319)
|.+|+|..+++.. +.+++..++.++.||+.||++||+++ |+||||||+|||++.. -.+||+|||+|+..
T Consensus 91 C~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 91 CNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999654 46999999999999999999999999 9999999999999764 46899999999988
Q ss_pred cccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 264 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
.......+.+|+|-|||||++....|+.|+|+||+|+|+|+|++|+.||+..+.+
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 8888888999999999999999999999999999999999999999999966543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=363.23 Aligned_cols=216 Identities=54% Similarity=0.927 Sum_probs=193.7
Q ss_pred CCCCcCHHHHHHHhcccc--cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEE
Q 020946 100 GIPEYSYKDLQKATCNFT--TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177 (319)
Q Consensus 100 ~~~~~~~~~l~~~~~~~~--~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 177 (319)
....|++.++..+|.+|. +.||+|+||.||+|.+.+|..||||++........++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 466799999999999998 799999999999999988999999988765433145699999999999999999999999
Q ss_pred eeCC-eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEee
Q 020946 178 AEKG-QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD 256 (319)
Q Consensus 178 ~~~~-~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 256 (319)
.+.+ +.++|||||++|+|.++|+.....+++|.++++||.++|+||+|||+...++|+||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999875543899999999999999999999998888999999999999999999999999
Q ss_pred cCCCccccc-ccccccc-ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 257 FGLSREEMV-DKHAANI-RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 257 fg~~~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
||+|+.... ....... .||.+|+|||+...+..+.|+|||||||+|+||+||+.|.+..
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 999976544 3333333 7999999999999899999999999999999999999888754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=333.05 Aligned_cols=200 Identities=29% Similarity=0.526 Sum_probs=180.5
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..+++.+.||+|+||+||.++ .++++.+|+|++++. .....+....|..+|.+++||+||++...|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 355778999999999999994 467899999999765 2334567889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD- 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 266 (319)
||+.||.|..+|. +.+.+++..+..++.+|+.||.|||+++ |+||||||+|||+|++|+++|+|||+|+.....
T Consensus 105 d~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred eccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999999994 3456999999999999999999999999 999999999999999999999999999855444
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++||+.|||||++.+..|+..+|+||+|+++|||++|.+||.+.+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 45567899999999999999999999999999999999999999998865
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=339.03 Aligned_cols=200 Identities=40% Similarity=0.733 Sum_probs=176.7
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEeccCCccc--HHHHHHHHHHHhccCCCCcceeeeEEeeCC-eEEEEEEEccC
Q 020946 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG--EKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-QHMLVYVFMSK 192 (319)
Q Consensus 116 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 192 (319)
+.+.+|+|+||+||+|.+.....||+|++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999999655559999997653222 568999999999999999999999999887 79999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCcccccc-cccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVD-KHAA 270 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~-~~~~ 270 (319)
|+|..+++......+++..++.++.||++||.|||+++ + ||||||||+|||++.++ ++||+|||+++..... ....
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~ 202 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMT 202 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccceeecccccccc
Confidence 99999998755678999999999999999999999987 3 89999999999999997 9999999999865543 3344
Q ss_pred ccccccCccCccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 271 NIRGTFGYLDPEYIS--TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~--~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...||+.|||||++. ...|+.|+||||||++||||+||+.||.++..
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 478999999999999 67999999999999999999999999998864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=342.59 Aligned_cols=199 Identities=28% Similarity=0.522 Sum_probs=183.9
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
.+|...++||+|||+.+|.++. .+|+.||+|++... .....+.+.+|+++-++++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5678889999999999999965 89999999998653 3344677899999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD- 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 266 (319)
|+|.+++|..++. .++++++.+++.++.||+.||.|||+++ |+|||||..|++++++.++||+|||+|.....+
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999995 4568999999999999999999999999 999999999999999999999999999876644
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
....+.+|||.|.|||++.....+..+||||+||+||.||.|++||+..
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 6778899999999999999999999999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=338.21 Aligned_cols=210 Identities=31% Similarity=0.536 Sum_probs=185.7
Q ss_pred CHHHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 105 ~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
...++.....++.+.||+|.||+||.|.++....||+|.++.. ....+.|.+|+++|++++|+|||+++|+|...+..+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 3345556666778899999999999999987789999999765 333578899999999999999999999999988999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+|+|||+.|+|.++|.......+...+.+.++.|||+||+||++++ +|||||..+|||++++..+||+|||+|+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence 9999999999999998766778999999999999999999999999 9999999999999999999999999999443
Q ss_pred cccc--ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 265 VDKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 265 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
.+.. .....-+..|+|||.+....++.|||||||||+||||+| |+.||++.+..
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 3322 223345778999999999999999999999999999999 99999998765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=328.00 Aligned_cols=206 Identities=26% Similarity=0.466 Sum_probs=180.7
Q ss_pred HHHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCC-------cccHHHHHHHHHHHhccCCCCcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS-------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 179 (319)
......|-+.+.||+|+||.|-+| ...+|+.||||++.... ........+|+++|++++|||||++.+++..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 345677888999999999999999 56789999999996531 1123346799999999999999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC---CceEEee
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVAD 256 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~D 256 (319)
.+..|+|+||+++|+|.+.+..+ +.+.+...+.+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999999655 35788888999999999999999999 9999999999999866 7899999
Q ss_pred cCCCccccccccccccccccCccCccccCCCC--CC-cchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 257 FGLSREEMVDKHAANIRGTFGYLDPEYISTRN--FT-KKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 257 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~-~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
||+|+.........+.+|||.|.|||++.++. ++ .+.|+||+||+||-+++|.+||.+...+
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 99999887788889999999999999996554 33 4889999999999999999999876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=317.28 Aligned_cols=194 Identities=33% Similarity=0.498 Sum_probs=175.2
Q ss_pred cccccccCCCceEEEEEe-CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-eEEEEEEEccC
Q 020946 116 FTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-QHMLVYVFMSK 192 (319)
Q Consensus 116 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 192 (319)
..+.||+|..|+||++.. .+++.+|+|++... +....+++.+|++++++.+||+||.++|.|...+ ...++||||.+
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 346799999999999954 57889999999544 4455778999999999999999999999999988 59999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 271 (319)
|+|+..+... +.+++...-+++.++++||.|||+ ++ |+||||||+|+|++..|.+||||||.+...... ...+
T Consensus 163 GSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~t 236 (364)
T KOG0581|consen 163 GSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANT 236 (364)
T ss_pred CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-hccc
Confidence 9999999654 569999999999999999999996 55 999999999999999999999999999765443 6678
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
+.||..|||||-+.+..|+.++||||||+.++|+.+|+.||...
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 99999999999999999999999999999999999999999764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=347.34 Aligned_cols=209 Identities=34% Similarity=0.610 Sum_probs=181.6
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
++......+.+.||+|.||+||+|+.. +...||||.++..... ...+|++|++++..++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 444445567789999999999999542 3457999999887554 678999999999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDEN------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ 248 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~ 248 (319)
+..++|+|||..|||.+||.... ..+++..+.+.||.|||.||+||-++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999996421 223888999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCCcccccccccc---ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccccC
Q 020946 249 SMRARVADFGLSREEMVDKHAA---NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319 (319)
Q Consensus 249 ~~~~kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~~ 319 (319)
+..+||+|||+++.....+... ...-+.+|||||.+..++||++||||||||+|||+++ |+-||.+++++|
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 9999999999998654332211 2335789999999999999999999999999999999 999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=309.16 Aligned_cols=205 Identities=29% Similarity=0.431 Sum_probs=177.4
Q ss_pred HhcccccccccCCCceEEEE-EeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeee-EEeeCCe-EEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVG-YCAEKGQ-HMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 186 (319)
+.|.+.+.||+|.||+||++ ...+|..+|.|.+.-+ +....+.+..|+.+|++++|||||++++ -+.+.++ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45677889999999999999 5679999999988644 4445678899999999999999999998 4555555 8999
Q ss_pred EEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 187 YVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAV-PPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|||+..|+|...+.. +..+.+++..++++..|++.||.++|++-. ..+.||||||.||+++.+|.+||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998843 445679999999999999999999998320 23999999999999999999999999999866
Q ss_pred cccc-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... ...+.+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.|..
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 5443 3456789999999999999999999999999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=325.76 Aligned_cols=201 Identities=27% Similarity=0.487 Sum_probs=177.0
Q ss_pred HhcccccccccCCCceEEEE-EeCCCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 186 (319)
..+.|.+.||+|+|++|++| ...+++.+|||++.+. .....+.+..|-+.|.+| +||.|++|+..|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 45678899999999999999 4568999999998654 223345677888899999 899999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+++|+|.+++.. .+.|++...+.++.+|+.||+|||++| ||||||||+|||+|.|++++|+|||.|+.....
T Consensus 153 Le~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999954 467999999999999999999999999 999999999999999999999999988632211
Q ss_pred --------------ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 --------------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 --------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....++||..|.+||++.....++.+|+|+||||||+|+.|.+||.+..|
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 112458899999999999999999999999999999999999999998765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=301.35 Aligned_cols=197 Identities=29% Similarity=0.453 Sum_probs=176.9
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+++.+.||.|+||.|.+++. .+|..+|+|++....- ...+...+|..+|+.+.||+++++.+.|.+.+..++||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 34567899999999999965 4688999999976532 2245577899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
.++|.|..+++. .+.+++..++.++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+.... .+
T Consensus 126 v~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--rT 198 (355)
T KOG0616|consen 126 VPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--RT 198 (355)
T ss_pred cCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC--cE
Confidence 999999999954 456999999999999999999999999 99999999999999999999999999986533 36
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.+.+|||.|+|||.+..+.|..++|+|||||++|||+.|.+||.+..+
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 688999999999999999999999999999999999999999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=321.26 Aligned_cols=213 Identities=29% Similarity=0.493 Sum_probs=186.9
Q ss_pred cCHHHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCccc-HHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 104 ~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
....|+.+....|.+.||+|-||+|.++....+..||||.++.+.... ..+|.+|+++|.+++||||++++|+|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 456677788888999999999999999998788999999998875444 4899999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+++++|||++|+|.+++.......+.-.....|+.||+.||+||.+.+ ++|||+.++|||++.++++||+|||+++.
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 999999999999999997664333455667889999999999999999 99999999999999999999999999985
Q ss_pred ccccccc---cccccccCccCccccCCCCCCcchhhHHHHHHHHHHH--hCCCCCCCccccC
Q 020946 263 EMVDKHA---ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELI--AGRSPLQGLMEQQ 319 (319)
Q Consensus 263 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ell--tg~~pf~~~~~~~ 319 (319)
....... ....-+.+|||||.+..++++.++|+|+||+++||++ +...||..+++||
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 4433221 2345688999999999999999999999999999976 4899999998774
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=317.35 Aligned_cols=204 Identities=32% Similarity=0.448 Sum_probs=176.7
Q ss_pred HHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQH 183 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 183 (319)
.....|...++||+|.||.||+| +..+|+.||+|.+..+. .....-..+|+.+|++++||||+++.+...+. +..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34455666788999999999999 56789999999987664 33345568999999999999999999988776 789
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|+|+|||++ +|.-++.. ..-.|++.++..++.|++.||+|+|+++ ++|||||.+|||||++|.+||+|||||+..
T Consensus 194 YlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999999977 77777743 3456999999999999999999999999 999999999999999999999999999854
Q ss_pred ccc--ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVD--KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... ...+..+.|.+|.|||++.+ ..|+...|+||.||||.||++|++.|+|.+|
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 333 24566778999999999866 6799999999999999999999999999886
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=327.01 Aligned_cols=203 Identities=30% Similarity=0.528 Sum_probs=181.2
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 185 (319)
-..+++.++||+|+||+|+++.. .+++.+|||+++++. ..+.+....|..++... +||.+++++..|+..++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 34567789999999999999955 478899999998763 34456677888887776 59999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM- 264 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~- 264 (319)
||||..+|++..+. ....+++..+..++..++.||+|||+++ ||+||||.+|||+|.+|++||+|||+++...
T Consensus 447 vmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999944444 4456999999999999999999999999 9999999999999999999999999999776
Q ss_pred ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccC
Q 020946 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~~ 319 (319)
....+.+++|||.|+|||++.+..|+...|+|||||+||||+.|..||+|.+|+|
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee 575 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE 575 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 5567789999999999999999999999999999999999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=298.47 Aligned_cols=199 Identities=26% Similarity=0.396 Sum_probs=173.2
Q ss_pred cccccccccCCCceEEEEE-eCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|+....+|+|+||.||+++ ..+|+.||||.+.... +.-.+-..+|+++|++++|+|+|.++.+|......++|+||+
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 4445679999999999995 4589999999986542 233445689999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-ccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-~~~~~ 269 (319)
+..-|.+.-+ ....++...+.++++|++.|+.|+|+++ ++||||||+|||++.++.+||||||+|+... .....
T Consensus 84 dhTvL~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 84 DHTVLHELER--YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred chHHHHHHHh--ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 8755554432 3345899999999999999999999999 9999999999999999999999999999765 45556
Q ss_pred cccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+..+.|.+|.|||.+.+ ..|....||||+||++.||++|.+.|+|.++
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 67889999999999977 7899999999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=315.28 Aligned_cols=202 Identities=29% Similarity=0.484 Sum_probs=180.6
Q ss_pred HHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccC----Cc-ccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCe
Q 020946 110 QKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD----SK-QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 182 (319)
....|.+.+.||+|+||.|+.| ...+++.||+|++... .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3457888899999999999999 4557899999977553 11 23456778999999998 9999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-CceEEeecCCCc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSR 261 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~ 261 (319)
.++||||+.+|+|.+++.. .+.+++..+..++.|++.|++|||+++ |+||||||+|+|++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999966 467999999999999999999999999 9999999999999999 999999999998
Q ss_pred cc-cccccccccccccCccCccccCCCC-CC-cchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EE-MVDKHAANIRGTFGYLDPEYISTRN-FT-KKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 76 4566778899999999999999877 86 78999999999999999999999754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=314.10 Aligned_cols=200 Identities=28% Similarity=0.425 Sum_probs=174.1
Q ss_pred cccccccccCCCceEEEE-EeCCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+.+.+.||+|+||+||+| +..+|..+|+|++++. .....+.++.|-.+|....+|+||+++..|++.+.+||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 445578999999999999 4568999999999765 234456678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc----
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV---- 265 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~---- 265 (319)
++||++..+|.. ...|++..++.++.+++.|++-||+.| +|||||||+|+|||..|++||+|||||.-...
T Consensus 223 lPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 223 LPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred cCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999999954 467999999999999999999999999 99999999999999999999999999741000
Q ss_pred -----------------c-c-c-------------------------ccccccccCccCccccCCCCCCcchhhHHHHHH
Q 020946 266 -----------------D-K-H-------------------------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVL 301 (319)
Q Consensus 266 -----------------~-~-~-------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvi 301 (319)
. . . ....+|||.|+|||++.+..|+..+|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0 0 0 001349999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCcccc
Q 020946 302 LFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 302 l~elltg~~pf~~~~~~ 318 (319)
|||||.|-+||.+.+.+
T Consensus 378 myEmLvGyPPF~s~tp~ 394 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQ 394 (550)
T ss_pred HHHHHhCCCCCCCCCHH
Confidence 99999999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=316.47 Aligned_cols=197 Identities=30% Similarity=0.521 Sum_probs=175.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.|.+.+.||+|+||.||+|+. .+.+.||+|.+.+.. ..+.+.+.+|++++++++||||+.++++|+...+.++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 355667899999999999944 478899999987653 33456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+.+ +|..++.. .+.++++++..++.+++.||.|||+++ |+|||+||.|||++.++.+|++|||+|+....+. .
T Consensus 83 a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 83 AVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 976 99999954 356999999999999999999999999 9999999999999999999999999998655443 3
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.....|||-|||||+..+..|+..+|+||+|||+|||++|++||...
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 44578999999999999999999999999999999999999999754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=312.01 Aligned_cols=202 Identities=27% Similarity=0.390 Sum_probs=181.5
Q ss_pred HHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHH-HHHHHHHHHhccC-CCCcceeeeEEeeCC-eEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRLH-HRNLVNLVGYCAEKG-QHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv 186 (319)
-.+|.+.+.||.|.||.||+| ...+|+.||||.++..-...++ .-.+|++.|++++ ||||+++..++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 467888899999999999999 4568999999998765332222 2368999999999 999999999998877 99999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
||||+ .+|.+.+..+ ...|++..+..|+.||+.||+|+|.+| +.|||+||+|||+.....+||+|||+||.....
T Consensus 89 fE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred HHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC
Confidence 99995 5999999776 678999999999999999999999999 999999999999998889999999999988888
Q ss_pred ccccccccccCccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...+..+.|.+|+|||++ +...|+.+.||||+|||++|+++=++.|+|.+|
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 888889999999999987 567899999999999999999999999999876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=281.56 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=174.4
Q ss_pred hcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCccc--HHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQG--EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|...+.||+|.||.||+| +.++|+.||||.++.....+ .....+|++.|+.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4555678999999999999 56789999999997664332 34568999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
|+. +|...++++. ..++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++...... .
T Consensus 83 m~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 964 8888886644 57889999999999999999999999 9999999999999999999999999998654433 3
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+-|..|.|||.+.+ +.|+...||||.|||+.||+-|.+-|+|.++
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD 207 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD 207 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence 333468999999999865 6799999999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=300.66 Aligned_cols=198 Identities=30% Similarity=0.516 Sum_probs=169.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC--eEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--QHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 189 (319)
.|...+.||+|+||.||++.. ++|+..|||.....+....+.+.+|+.+|.+++|||||+++|.....+ .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 345568899999999999955 458999999886653333667899999999999999999999755544 68999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCCCccccc---
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMV--- 265 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~--- 265 (319)
+++|+|.+++..... .+++..++.+..|+++||+|||+++ ++||||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999976554 7999999999999999999999999 999999999999999 79999999999875442
Q ss_pred -cccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 266 -DKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 266 -~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
........||+.|||||++... ...+++|||||||++.||+||+.||..
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 2223457899999999999853 334699999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=309.71 Aligned_cols=196 Identities=29% Similarity=0.494 Sum_probs=177.2
Q ss_pred cccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 114 CNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
|.--..||+|+.|.||.| +..+++.||||.+........+-+.+|+.+|+..+|+|||++++.|...+.+|+|||||++
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 333467999999999999 5668899999999887777677789999999999999999999998888999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 271 (319)
|+|.+.... ..+++.++..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||+|....... ...+
T Consensus 355 gsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 355 GSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred Cchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 999998843 34899999999999999999999999 9999999999999999999999999997655443 5667
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
..|||.|||||+...+.|.+|.||||||++.+||+-|.+||-..
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE 472 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE 472 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC
Confidence 78999999999999999999999999999999999999999653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=298.77 Aligned_cols=201 Identities=30% Similarity=0.482 Sum_probs=174.8
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++..++|+||+++.+++.+.+..++++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 55678899999999999954 578999999886432 22234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
+++|+|..++.......+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++.........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99999998886554456899999999999999999999998 999999999999999999999999998754333333
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 455789999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=298.20 Aligned_cols=203 Identities=29% Similarity=0.474 Sum_probs=186.5
Q ss_pred HHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
-.+.+|.+.+.||+|.||.|-+| ....|+.||||.++.+. +++.-.+++|+++|..++||||+.++.+|++.+...
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34678899999999999999999 44689999999997663 344556889999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+||||..+|.|.+++. ..+.+++.++..++.||..|+.|+|.++ ++|||||.+|||+|+++++||+|||++....
T Consensus 130 ivMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 130 IVMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999994 4567999999999999999999999999 9999999999999999999999999998877
Q ss_pred ccccccccccccCccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDKHAANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......+++|+|-|.+||.+.+..|. +..|-|||||+||.|+.|..||+|.+
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 77888999999999999999999985 89999999999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=310.44 Aligned_cols=198 Identities=31% Similarity=0.547 Sum_probs=175.7
Q ss_pred CCCcCHHHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 101 ~~~~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
..+.+++++..- +-||.|+.|.||+|++ .++.||||.++. .-..+++-|++|+||||+.+.|+|...
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCC
Confidence 344455555433 4599999999999998 689999998632 224678899999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
..++++||||+.|.|.+.|+.. ..++......|..+||.||.|||.+. |||||||+-||||..+..+||+|||-+
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred ceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999999644 56888889999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+......+...+.||..|||||++.+...+.|.|||||||+|||||||..||.+..
T Consensus 260 ~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 260 KELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred HhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 87766677778999999999999999999999999999999999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=311.45 Aligned_cols=199 Identities=29% Similarity=0.484 Sum_probs=181.9
Q ss_pred hcccccccccCCCceEEEE-EeCCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|+.|.|-.| ...+|+.+|||++.... ......+.+|+.+|+.+.|||++++++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4667788999999999999 56799999999987652 2234568899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++|.|.+++.. .+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|.....+..
T Consensus 93 yv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 93 YVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred ecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 9999999999964 467999999999999999999999998 99999999999999999999999999988888888
Q ss_pred ccccccccCccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..+-||+|-|.|||++.+.+|+ .++||||.|||||.||||++||++-.
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 8999999999999999999996 79999999999999999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=322.61 Aligned_cols=208 Identities=30% Similarity=0.555 Sum_probs=181.9
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC----CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
|+......+.++||.|.||+||+|+++ ....||||.++... .....+|..|..+|.+++||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 344455667789999999999999664 23479999998763 4456789999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++.|||++|+|+.||+.+. +.|++.+...+.++|+.||.||.+.+ +|||||..+|||++.+..+|++|||+++.
T Consensus 705 vMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999998765 56999999999999999999999998 99999999999999999999999999986
Q ss_pred cccccc-c---cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccccC
Q 020946 263 EMVDKH-A---ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319 (319)
Q Consensus 263 ~~~~~~-~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~~ 319 (319)
...+.. . ....-+.+|.|||.+..++++.++||||||++|||.++ |..||.++++++
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 544431 1 12234689999999999999999999999999999888 999999998864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=308.47 Aligned_cols=200 Identities=27% Similarity=0.395 Sum_probs=172.5
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|+||+||++.. .+++.+|+|++.... ......+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 356778999999999999954 468899999986432 2234567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 82 FLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999998643 46899999999999999999999998 9999999999999999999999999986421110
Q ss_pred -----------------------------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 020946 268 -----------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312 (319)
Q Consensus 268 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf 312 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 012346999999999999999999999999999999999999999
Q ss_pred CCccc
Q 020946 313 QGLME 317 (319)
Q Consensus 313 ~~~~~ 317 (319)
.+.+.
T Consensus 237 ~~~~~ 241 (363)
T cd05628 237 CSETP 241 (363)
T ss_pred CCCCH
Confidence 87653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=305.58 Aligned_cols=206 Identities=30% Similarity=0.562 Sum_probs=176.2
Q ss_pred CHHHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 105 ~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
..+|+......+...||+|.||+||+|.|. ..||||++..+ ..+..+.|++|+..+++-+|.||+-++|+|..++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 445555555667889999999999999984 37899999765 33456789999999999999999999999998877
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+|..++++-+|+.+++... ..|...+.+.|+.||+.||.|||.++ |||||||..||++.+++.|||+|||++..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999998755 46889999999999999999999999 99999999999999999999999999752
Q ss_pred c---cccccccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 E---MVDKHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~---~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
. ..........|...|||||+++ ..+|++.+||||||+++|||+||..||..-..
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 2 2222334456788999999985 45789999999999999999999999985443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=292.60 Aligned_cols=202 Identities=28% Similarity=0.422 Sum_probs=178.8
Q ss_pred HhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||.|..++||+| ..+.++.||||++..+.. .+.+.+++|+..++.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 46788899999999999999 456889999999987643 3358899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc---
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--- 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~--- 266 (319)
|.+|++.+.+...-...+++..+..|.+++++||.|||++| .||||||+.||||+.+|.+||+|||.+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 99999999998776677999999999999999999999999 999999999999999999999999976432211
Q ss_pred -ccc-cccccccCccCccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 -KHA-ANIRGTFGYLDPEYIS--TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 -~~~-~~~~~t~~y~aPE~~~--~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... .++.||+.|||||++. ...|+.|+||||||++..||.+|+.||..+.
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 111 5668999999999963 4679999999999999999999999998775
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=285.78 Aligned_cols=201 Identities=28% Similarity=0.409 Sum_probs=173.3
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCC-cceeeeEEeeCC------e
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRN-LVNLVGYCAEKG------Q 182 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~ 182 (319)
.|...+.||+|+||+||+|+ ..+|+.||+|.+..... .......+|+.+++.++|+| |+++.+++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 34445679999999999994 55889999999876533 23455689999999999999 999999998877 8
Q ss_pred EEEEEEEccCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 183 HMLVYVFMSKGSLASHLYDENY--GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
.++|+||+. -+|..++..... ..++...++.++.||+.||+|||+++ |+||||||.|+|++++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 899999995 489999866443 35777889999999999999999999 999999999999999999999999999
Q ss_pred cccc-ccccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 REEM-VDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+... .........+|..|.|||++.+. .|+...||||+|||+.||++++..|+|.++
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 8544 33345667899999999999775 799999999999999999999999999876
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=276.81 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=183.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+++.+.||+|.||.||.|+. .++..||+|++.+. ......++.+|+++-..++||||++++++|.+....|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 457889999999999999954 46778999998654 23446789999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|...|.+...|.......+++.....++.|++.|+.|+|..+ ++||||||+|+|++.++.+||+|||.+-... ...
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~k 178 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNK 178 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-CCC
Confidence 999999999998777788999999999999999999999988 9999999999999999999999999986543 556
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
..+.+||..|.+||...+..++...|+|++|++.||++.|.+||...+++
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~ 228 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS 228 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH
Confidence 67889999999999999999999999999999999999999999887643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.81 Aligned_cols=213 Identities=30% Similarity=0.502 Sum_probs=169.5
Q ss_pred cCCCCCCcCHHHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHh--ccCCCCcceee
Q 020946 97 SASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLG--RLHHRNLVNLV 174 (319)
Q Consensus 97 ~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~ 174 (319)
+.++.|.+-...+ ..+..+.+.||+|.||+||+|++ .|+.||||++...+ ++...+|.++.+ .++|+||+.++
T Consensus 197 SGSGlplLVQRTi-arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 197 SGSGLPLLVQRTI-ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCCCchhHhHHhh-hheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhh
Confidence 4455555544444 34667889999999999999999 68999999996543 334455555555 56999999999
Q ss_pred eEEeeC----CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeEEcCCCCCCEE
Q 020946 175 GYCAEK----GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-----GAVPPVIHRDIKSSNIL 245 (319)
Q Consensus 175 ~~~~~~----~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~i~H~dlk~~Nil 245 (319)
+.-..+ .++|||.+|.++|+|.++|.. ..++.+..++++..++.||++||. ++.|.|.|||||+.|||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 875443 378999999999999999954 569999999999999999999995 67788999999999999
Q ss_pred EcCCCceEEeecCCCcccccc-----ccccccccccCccCccccCCCC----C--CcchhhHHHHHHHHHHHhC------
Q 020946 246 LDQSMRARVADFGLSREEMVD-----KHAANIRGTFGYLDPEYISTRN----F--TKKSDVYSFGVLLFELIAG------ 308 (319)
Q Consensus 246 l~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~----~--~~~~Dv~slGvil~elltg------ 308 (319)
+.+++.+.|+|+|+|-..... ......+||.+|||||+++..- + -..+||||||.++||+..+
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 999999999999998543222 2345568999999999996532 2 2569999999999998743
Q ss_pred ----CCCCCCccc
Q 020946 309 ----RSPLQGLME 317 (319)
Q Consensus 309 ----~~pf~~~~~ 317 (319)
++||.+..+
T Consensus 429 ~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 429 VEEYQLPYYDVVP 441 (513)
T ss_pred ehhhcCCcccCCC
Confidence 567777654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.42 Aligned_cols=194 Identities=27% Similarity=0.452 Sum_probs=169.4
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
+.||+|+||.||++.. .+|+.+|+|++.... ......+.+|+.+++.++||||+++.+++.+.+..+++|||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999954 578999999986532 223356778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-ccccccc
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANI 272 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 272 (319)
+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.... .......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 999888543 46899999999999999999999998 99999999999999999999999999874322 2233456
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 79999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=281.67 Aligned_cols=199 Identities=28% Similarity=0.410 Sum_probs=169.7
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCccc--HHHHHHHHHHHhccCCCCcceeeeEEe--eCCeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQG--EKEFQTEVMLLGRLHHRNLVNLVGYCA--EKGQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e 188 (319)
|...+.|++|.||.||+|+. .+++.||+|+++.+.... .-.-.+|+++|.+.+|||||.+-.+.. +-+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 44557899999999999954 578899999997653221 223578999999999999999988765 3457999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-c
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-K 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~ 267 (319)
|++. +|...+.. ..++|...++.-++.|+++|++|||.+. |+|||||++|+|++..|.+||+|||+|+..... .
T Consensus 158 ~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 158 YVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9976 88888854 3467999999999999999999999999 999999999999999999999999999865443 3
Q ss_pred cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..+..+-|.+|.|||++.+ ..|++..|+||+|||+.||+++++.|+|.+|
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 3455678999999999865 6799999999999999999999999999876
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=297.69 Aligned_cols=194 Identities=29% Similarity=0.473 Sum_probs=168.7
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
+.||+|+||.||++.. .+|..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999954 57899999998653 2223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccccc
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANI 272 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 272 (319)
+|..++... ..+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 998888543 46899999999999999999999998 999999999999999999999999998743222 223346
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 68999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.74 Aligned_cols=207 Identities=34% Similarity=0.532 Sum_probs=176.9
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeCC--C---cEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEe
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMST--G---ETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 178 (319)
+++......+.++||+|+||.||+|.+.. + ..||+|..... ......+|.+|.++++.++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44444555566899999999999996532 2 23899988752 3555678999999999999999999999999
Q ss_pred eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecC
Q 020946 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG 258 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 258 (319)
.....++|||++.+|+|.++|.... ..++..+...++.+.+.||+|||+++ ++||||..+|||++.++.+||+|||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999996544 36999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccccc-ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 259 LSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 259 ~~~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
+++......... .-.-+.+|+|||.+....|++++|||||||++||+++ |..||++...
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 998654222222 2246789999999999999999999999999999999 8999999764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.97 Aligned_cols=198 Identities=29% Similarity=0.477 Sum_probs=174.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4577889999999999999965 468899999986432 223456889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999998643 46889999999999999999999998 99999999999999999999999999875422
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 2234578999999999999999999999999999999999999998754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.52 Aligned_cols=198 Identities=25% Similarity=0.415 Sum_probs=173.3
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 467788999999999999965 478999999986432 2234568899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~ 154 (291)
T cd05612 82 YVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--R 154 (291)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC--C
Confidence 99999999998543 46899999999999999999999998 99999999999999999999999999875422 2
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2345689999999999998999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.88 Aligned_cols=205 Identities=29% Similarity=0.427 Sum_probs=180.4
Q ss_pred HHHHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-C-----CCcceeeeEEee
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-H-----RNLVNLVGYCAE 179 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~ 179 (319)
.|....+|.+.+.||+|.||.|.+| +..+++.||||+++..... ..+-..|+.+|..++ | -|+|+++++|..
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 4455557888999999999999999 6678999999999765333 455678999999997 4 389999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC--CceEEeec
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS--MRARVADF 257 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Df 257 (319)
.++.|+|+|++ ..+|.++++.++..+++...++.++.||+.||.+||+.+ |||+||||+|||+.+- ..+||+||
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 99999999999 459999999999999999999999999999999999998 9999999999999743 47999999
Q ss_pred CCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 258 GLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 258 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
|.++..... ..+...+..|+|||++.+..|+.+.||||||||+.||++|.+.|+|.+|-
T Consensus 336 GSSc~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 336 GSSCFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred ccccccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 999865333 23677899999999999999999999999999999999999999998874
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=304.96 Aligned_cols=199 Identities=27% Similarity=0.375 Sum_probs=170.8
Q ss_pred cccccccccCCCceEEEEE-eCCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
|.+.+.||+|+||+||+|. ..+++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 5667889999999999995 4578899999986532 23345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc---
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--- 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~--- 266 (319)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 83 IPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999998543 45889999999999999999999998 999999999999999999999999987421100
Q ss_pred ---------------------------------------------ccccccccccCccCccccCCCCCCcchhhHHHHHH
Q 020946 267 ---------------------------------------------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVL 301 (319)
Q Consensus 267 ---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvi 301 (319)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123468999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCccc
Q 020946 302 LFELIAGRSPLQGLME 317 (319)
Q Consensus 302 l~elltg~~pf~~~~~ 317 (319)
+|||++|+.||.+.+.
T Consensus 238 l~elltG~~Pf~~~~~ 253 (381)
T cd05626 238 LFEMLVGQPPFLAPTP 253 (381)
T ss_pred HHHHHhCCCCCcCCCH
Confidence 9999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=298.72 Aligned_cols=205 Identities=35% Similarity=0.612 Sum_probs=170.3
Q ss_pred HHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK 180 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 180 (319)
+...+|.+.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++..+ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4456788999999999999999953 235689999987542 23345788999999999 899999999988764
Q ss_pred -CeEEEEEEEccCCChhhhhhhcC--------------------------------------------------------
Q 020946 181 -GQHMLVYVFMSKGSLASHLYDEN-------------------------------------------------------- 203 (319)
Q Consensus 181 -~~~~lv~e~~~~g~l~~~l~~~~-------------------------------------------------------- 203 (319)
+..+++|||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46889999999999999886421
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc---ccccccccc
Q 020946 204 ----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTF 276 (319)
Q Consensus 204 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~ 276 (319)
...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 124788889999999999999999988 9999999999999999999999999987532221 112234567
Q ss_pred CccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 277 ~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8999999998899999999999999999997 999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=281.94 Aligned_cols=206 Identities=27% Similarity=0.383 Sum_probs=179.5
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
-..+++.+.||+|.-|+||++++. ++..+|+|++.... .....+.+.|.++|+.++||.++.+++.++.+...+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 344456688999999999999765 45899999997653 23345677899999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc--
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-- 264 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-- 264 (319)
||||++|+|...++.+..+.+++..++.++.+++-||+|||..| ||.|||||+||||.++|++.|+||.++....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999999999899999999999999999999999999 9999999999999999999999999853100
Q ss_pred --------------------------------c-c----------------------ccccccccccCccCccccCCCCC
Q 020946 265 --------------------------------V-D----------------------KHAANIRGTFGYLDPEYISTRNF 289 (319)
Q Consensus 265 --------------------------------~-~----------------------~~~~~~~~t~~y~aPE~~~~~~~ 289 (319)
. . .....++||..|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 01123568999999999999999
Q ss_pred CcchhhHHHHHHHHHHHhCCCCCCCccccC
Q 020946 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319 (319)
Q Consensus 290 ~~~~Dv~slGvil~elltg~~pf~~~~~~~ 319 (319)
+.+.|+|+|||++|||+.|..||.|.+.+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~ 342 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE 342 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh
Confidence 999999999999999999999999988764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.11 Aligned_cols=199 Identities=27% Similarity=0.389 Sum_probs=170.7
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 366778999999999999954 578999999985432 2234567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 82 FLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999998543 46899999999999999999999998 9999999999999999999999999985211000
Q ss_pred -----------------------------------------------cccccccccCccCccccCCCCCCcchhhHHHHH
Q 020946 268 -----------------------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300 (319)
Q Consensus 268 -----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGv 300 (319)
......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 001246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCcc
Q 020946 301 LLFELIAGRSPLQGLM 316 (319)
Q Consensus 301 il~elltg~~pf~~~~ 316 (319)
++|||++|+.||.+..
T Consensus 237 il~elltG~~Pf~~~~ 252 (377)
T cd05629 237 IMFECLIGWPPFCSEN 252 (377)
T ss_pred hhhhhhcCCCCCCCCC
Confidence 9999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=297.40 Aligned_cols=195 Identities=27% Similarity=0.484 Sum_probs=169.5
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999954 57899999998653 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-ccccccc
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANI 272 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 272 (319)
+|..++... ..+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.... .......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 998888543 46899999999999999999999998 99999999999999999999999999875322 2223346
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 789999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=299.08 Aligned_cols=200 Identities=24% Similarity=0.390 Sum_probs=174.1
Q ss_pred HHhcccccccccCCCceEEEEEeC-C-CcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-T-GETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
...|.+.+.||+|+||.||+|... + +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 346788899999999999999643 3 368999988543 22334567889999999999999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
+|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~- 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD- 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC-
Confidence 99999999999998543 46899999999999999999999998 9999999999999999999999999987532
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 183 -TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred -CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 223456789999999999988899999999999999999999999987653
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=305.04 Aligned_cols=198 Identities=27% Similarity=0.394 Sum_probs=170.4
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
|.+.+.||+|+||+||+|.. .+++.+|+|++.... ......+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 56778999999999999954 578899999986432 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc---
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--- 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~--- 266 (319)
+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 83 IPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999988543 45889999999999999999999998 999999999999999999999999997421000
Q ss_pred ---------------------------------------------ccccccccccCccCccccCCCCCCcchhhHHHHHH
Q 020946 267 ---------------------------------------------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVL 301 (319)
Q Consensus 267 ---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvi 301 (319)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00123468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCcc
Q 020946 302 LFELIAGRSPLQGLM 316 (319)
Q Consensus 302 l~elltg~~pf~~~~ 316 (319)
+|||++|+.||.+.+
T Consensus 238 l~elltG~~Pf~~~~ 252 (382)
T cd05625 238 LYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=299.44 Aligned_cols=198 Identities=27% Similarity=0.437 Sum_probs=174.3
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..+++||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 4677899999999999999654 68899999986532 2234567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--c
Confidence 99999999998543 46899999999999999999999998 99999999999999999999999999875432 3
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 3456789999999999988999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=288.96 Aligned_cols=195 Identities=28% Similarity=0.431 Sum_probs=166.3
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-----eEEEEEE
Q 020946 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHMLVYV 188 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e 188 (319)
.-.+++|.|+||.||+|.. .+++.||||..-.+.+ .-.+|+.+|+.+.|||||+++.+|.... ...+|+|
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 3457899999999999965 4578999998754433 2357899999999999999998886432 3468999
Q ss_pred EccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-CceEEeecCCCccccc
Q 020946 189 FMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMV 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~ 265 (319)
||+. +|.+.++. ..+..++...++-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+....
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9976 78887753 23456788888889999999999999988 9999999999999976 8999999999998888
Q ss_pred cccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+........|..|+|||.+.+ .+|+.+.||||.||++.||+-|++.|+|.+.
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~ 231 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS 231 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence 888888889999999999865 6899999999999999999999999999653
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=304.10 Aligned_cols=199 Identities=26% Similarity=0.391 Sum_probs=171.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..+++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 366788999999999999965 478999999986431 2234567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 82 YLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999998643 46899999999999999999999998 9999999999999999999999999986321110
Q ss_pred --------------------------------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCC
Q 020946 268 --------------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309 (319)
Q Consensus 268 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~ 309 (319)
......||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 011245899999999999999999999999999999999999
Q ss_pred CCCCCcc
Q 020946 310 SPLQGLM 316 (319)
Q Consensus 310 ~pf~~~~ 316 (319)
.||.+.+
T Consensus 237 ~Pf~~~~ 243 (364)
T cd05599 237 PPFCSDN 243 (364)
T ss_pred CCCCCCC
Confidence 9998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=294.82 Aligned_cols=192 Identities=31% Similarity=0.452 Sum_probs=168.0
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 120 lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
||+|+||.||+|.. .+++.||+|++... .......+.+|+.++..++||||+++++++.+.+..+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999955 46889999998643 223345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRG 274 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 274 (319)
.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++..... .......|
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 9998543 46899999999999999999999998 999999999999999999999999998753222 22334578
Q ss_pred ccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=303.57 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=171.4
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+..+++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 467789999999999999954 578999999986431 2234567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc---
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV--- 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~--- 265 (319)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999998543 45889999999999999999999998 99999999999999999999999998742100
Q ss_pred -----------------------------------------cccccccccccCccCccccCCCCCCcchhhHHHHHHHHH
Q 020946 266 -----------------------------------------DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFE 304 (319)
Q Consensus 266 -----------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~e 304 (319)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000113468999999999999999999999999999999
Q ss_pred HHhCCCCCCCccc
Q 020946 305 LIAGRSPLQGLME 317 (319)
Q Consensus 305 lltg~~pf~~~~~ 317 (319)
|++|+.||.+...
T Consensus 237 ll~G~~Pf~~~~~ 249 (376)
T cd05598 237 MLVGQPPFLADTP 249 (376)
T ss_pred hhhCCCCCCCCCH
Confidence 9999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=287.57 Aligned_cols=202 Identities=31% Similarity=0.495 Sum_probs=175.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
+|++.+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++.+.+.+.+..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 356778999999999999965 478899999986432 1223456789999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999998886655556999999999999999999999998 99999999999999999999999999875433333
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 3445789999999999988999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.05 Aligned_cols=190 Identities=34% Similarity=0.573 Sum_probs=158.0
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHh--ccCCCCcceeeeEEeeCC----eEEEEEEE
Q 020946 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLG--RLHHRNLVNLVGYCAEKG----QHMLVYVF 189 (319)
Q Consensus 116 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~----~~~lv~e~ 189 (319)
+.+++|+|.||.||+|.+ +++.||||++.. +..+.+.+|-++.+ .++|+||++++++-.... ++++|++|
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 446799999999999998 569999999954 44556777777666 458999999999876555 89999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG------AVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
.++|+|.++|..+ .++|....+++..+++||+|||+. ..|+|+|||||++|||+.+|++..|+|||+|...
T Consensus 290 h~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred ccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999554 599999999999999999999974 2368999999999999999999999999999754
Q ss_pred ccc---ccccccccccCccCccccCCCC-CC-----cchhhHHHHHHHHHHHhCCCCC
Q 020946 264 MVD---KHAANIRGTFGYLDPEYISTRN-FT-----KKSDVYSFGVLLFELIAGRSPL 312 (319)
Q Consensus 264 ~~~---~~~~~~~~t~~y~aPE~~~~~~-~~-----~~~Dv~slGvil~elltg~~pf 312 (319)
... ......+||.+|||||++.+.. +. .+.||||+|.+||||+++-.-+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 322 2334578999999999997642 22 4689999999999999875544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=321.20 Aligned_cols=205 Identities=34% Similarity=0.601 Sum_probs=177.0
Q ss_pred HHhcccccccccCCCceEEEEEeC--CCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS--TGE----TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
.....+.+.||+|.||.||.|... +|. .||+|.+... +.+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 444567788999999999999543 343 4899998765 556677899999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecC
Q 020946 184 MLVYVFMSKGSLASHLYDEN-----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG 258 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 258 (319)
++++|||++|+|..++.+.+ ...++..+.+.++.|||+|+.||++++ +|||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997642 346889999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccc-c--cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 259 LSREEMVDKH-A--ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 259 ~~~~~~~~~~-~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
+|+....... . ....-+.+|||||.+....|+.|+|||||||+|||++| |..||.+.++.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~ 911 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF 911 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence 9984433221 1 11245679999999999999999999999999999999 99999998764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=283.00 Aligned_cols=195 Identities=31% Similarity=0.489 Sum_probs=171.0
Q ss_pred ccccccCCCceEEEE-EeCCCcEEEEEEec--cCCcccHHHHHHHHHHHhccCCCCcceeeeEEee-----CCeEEEEEE
Q 020946 117 TTLIGQGAFGPVYKA-QMSTGETVAVKVLA--TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-----KGQHMLVYV 188 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~-~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e 188 (319)
.+.||+|+||.|+.+ ...+|+.||+|.+. -......++..+|+++|+.++|+||+.+.+++.. .+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 477999999999999 45688999999987 3455567788899999999999999999998865 457899999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc---
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV--- 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~--- 265 (319)
+| ..+|...+..+ ..++...+..+++|+++||.|+|+.+ ++||||||.|+|++.+..+||+|||+|+....
T Consensus 107 lM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred HH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 99 56888888543 35999999999999999999999999 99999999999999999999999999986643
Q ss_pred cccccccccccCccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+....|.+|.|||++ ....|+...||||.||||.||++|++.|+|.+.
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 3445667789999999987 567899999999999999999999999999764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=300.73 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=171.9
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
...|++.+.||+|+||.||++.. .+++.+|+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46788889999999999999965 46889999998542 222345678899999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999988432 4889999999999999999999998 999999999999999999999999998754322
Q ss_pred c--cccccccccCccCccccCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 K--HAANIRGTFGYLDPEYISTR----NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~--~~~~~~~t~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
. ......||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 1 22356799999999998654 37899999999999999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.08 Aligned_cols=200 Identities=32% Similarity=0.463 Sum_probs=166.7
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCc--------------ccHHHHHHHHHHHhccCCCCcceeeeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--------------QGEKEFQTEVMLLGRLHHRNLVNLVGY 176 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 176 (319)
..|.+.+.||+|.||.|-+|+ ..+++.||+|++..... ...+...+|+.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 467788899999999999994 45889999999854211 123578899999999999999999999
Q ss_pred EeeC--CeEEEEEEEccCCChhhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceE
Q 020946 177 CAEK--GQHMLVYVFMSKGSLASHLYDENYGP-LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253 (319)
Q Consensus 177 ~~~~--~~~~lv~e~~~~g~l~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 253 (319)
..+. +..|+|+||+..|.+...- ...+ +++.++++++.++..||+|||.++ |+||||||+|+|++++|++|
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEE
Confidence 8764 5899999999988776543 2334 899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccc------cccccccccccccCccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 254 VADFGLSREE------MVDKHAANIRGTFGYLDPEYISTRN----FTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 254 l~Dfg~~~~~------~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|+|||.+... ..+.......|||.|+|||.+.+.. .+.+.||||+||+||.|+.|+.||-+..+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999998643 1222233467999999999987632 35789999999999999999999987654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=295.58 Aligned_cols=195 Identities=27% Similarity=0.457 Sum_probs=168.2
Q ss_pred cccccCCCceEEEEE-eCCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
+.||+|+||.||++. ..++..||+|++... .......+.+|+.++..++||||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999995 457899999998653 2223456678999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
+|..++... ..+++..+..++.|++.||.|||+ .+ ++||||||+|||+++++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 999888543 468999999999999999999997 67 99999999999999999999999999864322 222334
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 5699999999999999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=291.90 Aligned_cols=198 Identities=30% Similarity=0.507 Sum_probs=168.4
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHH---hccCCCCcceeeeEEeeCCeEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLL---GRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|..++ ..++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45678899999999999954 478999999986432 22234566666554 567899999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV- 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~- 265 (319)
|||+++++|...+.. ..+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999888743 45899999999999999999999998 99999999999999999999999999864322
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
........|++.|+|||.+.+..++.++|+|||||++|||++|+.||.+.+.
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 2233456789999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=292.04 Aligned_cols=194 Identities=28% Similarity=0.510 Sum_probs=167.8
Q ss_pred cccccCCCceEEEEEe----CCCcEEEEEEeccC----CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQM----STGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5699999999999954 36789999998643 122234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence 9999999988543 45888899999999999999999998 999999999999999999999999998643222 22
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 334568999999999998889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=299.66 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=172.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|+||.||++.. .+++.+|+|++... .......+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 356778999999999999955 47889999998643 22334567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 82 FLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999998543 46899999999999999999999998 9999999999999999999999999976321100
Q ss_pred -----------------------------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 020946 268 -----------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312 (319)
Q Consensus 268 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf 312 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 011346899999999999999999999999999999999999999
Q ss_pred CCccc
Q 020946 313 QGLME 317 (319)
Q Consensus 313 ~~~~~ 317 (319)
.+.+.
T Consensus 237 ~~~~~ 241 (360)
T cd05627 237 CSETP 241 (360)
T ss_pred CCCCH
Confidence 87653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=291.16 Aligned_cols=199 Identities=31% Similarity=0.511 Sum_probs=169.8
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCC-CcceeeeEEeeCCeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHR-NLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e 188 (319)
|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+..|..++..++|+ +|+++.+++.+.+..+++||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 56788999999999999965 46789999998653 223345677889999988765 57888899999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~ 267 (319)
|+++|+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++..... ..
T Consensus 82 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 82 YVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999999888543 45899999999999999999999998 99999999999999999999999999864322 22
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 33345689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=303.60 Aligned_cols=202 Identities=25% Similarity=0.380 Sum_probs=174.8
Q ss_pred hcccccccccCCCceEEEEEe-CC-CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-ST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.|.+.+.||+|++|.||+|.. .+ ++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 378889999999999999943 34 6788999876555554567788999999999999999999999999999999999
Q ss_pred cCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 191 SKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 191 ~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
++|+|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999988754 23456889999999999999999999988 9999999999999999999999999987543221
Q ss_pred --cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 --HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 --~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 23345689999999999999999999999999999999999999987543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=291.72 Aligned_cols=199 Identities=31% Similarity=0.495 Sum_probs=169.5
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 188 (319)
|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|..++..+ +|++|+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 56778999999999999955 467899999986532 22234456677777776 58999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~ 267 (319)
|+++|+|..++... ..+++.++..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.... ..
T Consensus 82 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 82 YVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999999888543 45899999999999999999999998 99999999999999999999999999874322 22
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 33456789999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=291.40 Aligned_cols=192 Identities=27% Similarity=0.478 Sum_probs=167.1
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|..++..+ +||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999955 478899999987532 22345678899999888 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-ccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-~~~~~~~ 271 (319)
|+|..++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++... .......
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 9998888543 46999999999999999999999998 9999999999999999999999999986422 2223345
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
..||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 6789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=296.37 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=172.7
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
+....|.+.+.||+|+||.||++.. .+++.+|+|++... .......+.+|+.+++.++||||+++++.+.+.+..+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3456788899999999999999955 47889999998542 2223445788999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++|||+++|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999998854 34888999999999999999999998 9999999999999999999999999987543
Q ss_pred ccc--cccccccccCccCccccCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDK--HAANIRGTFGYLDPEYISTR----NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~--~~~~~~~t~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......||+.|+|||++... .++.++|||||||++|||++|+.||.+.+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 221 22356799999999998654 37899999999999999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=289.93 Aligned_cols=195 Identities=31% Similarity=0.538 Sum_probs=165.2
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhc-cCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGR-LHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999965 467899999986532 2223445556666654 4899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 9999888543 46899999999999999999999988 99999999999999999999999999874322 223344
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 5789999999999998999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=291.47 Aligned_cols=195 Identities=29% Similarity=0.466 Sum_probs=167.4
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999965 467899999986532 22334567788888765 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
++|...+... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++..... ......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 9999888543 46899999999999999999999998 99999999999999999999999999874322 222334
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 5689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=290.00 Aligned_cols=201 Identities=26% Similarity=0.416 Sum_probs=174.0
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
...|++.+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 45677889999999999999965 478899999987542 2334678999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +++||||||+|||+++++.+||+|||++..... ..
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SM 158 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc-cc
Confidence 99999999998543 45899999999999999999999853 299999999999999999999999999864422 22
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 334568999999999999899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=297.97 Aligned_cols=199 Identities=28% Similarity=0.424 Sum_probs=174.8
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4678899999999999999654 78999999986532 2334578899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999999654 56899999999999999999999988 9999999999999999999999999987543222
Q ss_pred -----------------------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 -----------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 -----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2234568999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.54 Aligned_cols=195 Identities=29% Similarity=0.494 Sum_probs=167.5
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||+||+|.. .+++.||+|++... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999965 46889999998643 122345567788888766 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
|+|..++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9999888543 46899999999999999999999998 99999999999999999999999999874322 223344
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 6789999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=284.72 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=167.8
Q ss_pred hcccccccccCCCceEEEEEe--CCCcEEEEEEeccCC--cccHHHHHHHHHHHhcc---CCCCcceeeeEEee-----C
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM--STGETVAVKVLATDS--KQGEKEFQTEVMLLGRL---HHRNLVNLVGYCAE-----K 180 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~ 180 (319)
+|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 477888999999999999965 346789999886542 22234556677666655 69999999998852 4
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
...++++||+. ++|.+++.......+++.++..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999996 68998886655566899999999999999999999998 999999999999999999999999998
Q ss_pred ccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+............+++.|+|||++.+..++.++|||||||++|||++|++||.+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 754443344456789999999999888999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=295.92 Aligned_cols=202 Identities=24% Similarity=0.401 Sum_probs=172.3
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
+....|.+.+.||+|+||.||++.. .+++.+|+|++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3446788889999999999999955 47889999998642 2223445778999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998854 34888899999999999999999998 9999999999999999999999999987543
Q ss_pred ccc--cccccccccCccCccccCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDK--HAANIRGTFGYLDPEYISTR----NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~--~~~~~~~t~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......||+.|+|||++... .++.++|||||||++|||++|+.||.+.+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 221 22345799999999998643 47899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=289.71 Aligned_cols=192 Identities=27% Similarity=0.484 Sum_probs=165.8
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||++.. .+++.+|+|++... .....+.+.+|+.++.++ +||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999965 46789999998753 222345577888888776 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
++|..++... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 9998887543 46899999999999999999999998 99999999999999999999999999874322 222345
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 6789999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=284.07 Aligned_cols=199 Identities=26% Similarity=0.419 Sum_probs=169.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 467788999999999999954 478899999986542 223456789999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
.+ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 86 ~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 86 DS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred Cc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 74 888887543 345789999999999999999999998 999999999999999999999999998643322 222
Q ss_pred cccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 34567999999998865 568999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=289.59 Aligned_cols=193 Identities=26% Similarity=0.467 Sum_probs=167.1
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||+||++.. .+++.+|+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999965 467899999987542 22345678899988888 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-ccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-~~~~~~~ 271 (319)
++|..++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++... .......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9999887543 46999999999999999999999998 9999999999999999999999999987432 2223345
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 67999999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.23 Aligned_cols=200 Identities=26% Similarity=0.428 Sum_probs=169.4
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 45778899999999999999654 788999999865432 2234677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
+. ++|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++...... ..
T Consensus 85 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 85 VH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred CC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 95 6788777543 356889999999999999999999998 999999999999999999999999998643221 22
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 234568999999999865 568899999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.82 Aligned_cols=194 Identities=30% Similarity=0.494 Sum_probs=168.1
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 120 IGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 120 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
||+|+||.||++.. .+|+.+|+|.+.... ......+..|+++++.++||||+++.+++.+....+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999954 468999999986431 12234456799999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t 275 (319)
.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 98887655566899999999999999999999988 999999999999999999999999998754333333345689
Q ss_pred cCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..|+|||++.+..++.++|+|||||++|||++|+.||.+..
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=289.96 Aligned_cols=194 Identities=31% Similarity=0.478 Sum_probs=164.9
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHH-HHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||+||+|.. .+|+.||+|++.... ......+.+|.. +++.++||||+++++.+.+.+..+++|||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3689999999999965 478999999986431 122334445544 56789999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
++|..++... ..+++..+..++.||+.||.|||+++ ++||||||+|||+++++.+||+|||+++.... ......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 9999988543 46899999999999999999999998 99999999999999999999999999874322 223344
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 578999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.07 Aligned_cols=203 Identities=30% Similarity=0.480 Sum_probs=182.9
Q ss_pred HHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 184 (319)
....|.+.+.||+|.||.||++... +|+.+|+|++..... ...+.+.+|+.+|+.+. ||||+.+.+++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457888899999999999999554 699999999976532 23468899999999998 999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC----CceEEeecCCC
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS----MRARVADFGLS 260 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~ 260 (319)
+|||++.+|.|.+.+... .+++..+..++.|++.++.|||+.+ ++||||||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999765 3999999999999999999999998 9999999999999643 47999999999
Q ss_pred ccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
............+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+++
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred eEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 8776666777899999999999999999999999999999999999999999998864
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=289.21 Aligned_cols=199 Identities=31% Similarity=0.513 Sum_probs=169.5
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 188 (319)
+++.+.||+|+||+||+|.. .+++.||+|++.... ....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56778999999999999954 478899999986531 223345677888888875 5778889999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-c
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-K 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~ 267 (319)
|+++|+|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++..... .
T Consensus 82 y~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999988543 46899999999999999999999998 999999999999999999999999998743222 2
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+..+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 23345689999999999998999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=290.10 Aligned_cols=194 Identities=31% Similarity=0.452 Sum_probs=164.2
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHH-HHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||+|.. .+++.+|+|++.... ......+.+|.. +++.++||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999965 468899999986432 122334445544 67889999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
++|...+.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 999888754 345889999999999999999999988 99999999999999999999999999874322 222344
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 568999999999998899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=291.07 Aligned_cols=194 Identities=30% Similarity=0.456 Sum_probs=165.1
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHH-HHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||+||+|.. .+|+.+|+|++... .......+..|.. +++.++||||+++++++...+..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999954 57899999998643 1222334555554 56778999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++.... ......
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 999888853 346899999999999999999999998 99999999999999999999999999874322 223345
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 678999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=284.89 Aligned_cols=205 Identities=29% Similarity=0.540 Sum_probs=170.9
Q ss_pred HHHhcccccccccCCCceEEEEEeC-----------------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcc
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS-----------------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLV 171 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv 171 (319)
...+|.+.+.||+|+||.||+|.+. ++..||+|.+.... .....++.+|+.++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 3467888899999999999999643 23479999987643 33355789999999999999999
Q ss_pred eeeeEEeeCCeEEEEEEEccCCChhhhhhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 020946 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDEN-----------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234 (319)
Q Consensus 172 ~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 234 (319)
++++++.+.+..+++|||+++++|.+++.... ...+++.++..++.|++.||.|||+.+ +
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 99999999999999999999999999885421 124688889999999999999999998 9
Q ss_pred EEcCCCCCCEEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh--CC
Q 020946 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GR 309 (319)
Q Consensus 235 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~ 309 (319)
+||||||+|||+++++.+||+|||+++...... ......++..|+|||++....++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999987432221 1122345788999999988889999999999999999986 67
Q ss_pred CCCCCccc
Q 020946 310 SPLQGLME 317 (319)
Q Consensus 310 ~pf~~~~~ 317 (319)
.||.+.+.
T Consensus 240 ~p~~~~~~ 247 (304)
T cd05096 240 QPYGELTD 247 (304)
T ss_pred CCCCcCCH
Confidence 88887653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=283.52 Aligned_cols=199 Identities=24% Similarity=0.367 Sum_probs=170.5
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 4678899999999999999664 67899999986542 23345678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-- 267 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-- 267 (319)
++++.+..+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99876654442 2346899999999999999999999988 9999999999999999999999999987543221
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......+++.|+|||++.+..++.++|+|||||++|||++|+.||.+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 2234568999999999988889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=287.45 Aligned_cols=202 Identities=26% Similarity=0.435 Sum_probs=174.6
Q ss_pred HHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
+....|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34567888999999999999999654 68889999886542 23345788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. + ++|+||||+|||+++++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999998543 4588999999999999999999974 5 99999999999999999999999999864322
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......++..|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 22234568999999999998899999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.70 Aligned_cols=195 Identities=30% Similarity=0.534 Sum_probs=165.9
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhc-cCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGR-LHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||+||+|.. .+++.||+|++.... ......+..|..++.. .+||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3589999999999965 467899999986531 2223445667777765 4899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
|+|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++..... ......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 9999988543 45889999999999999999999998 99999999999999999999999999864322 223345
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence 5689999999999998999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=271.96 Aligned_cols=202 Identities=27% Similarity=0.464 Sum_probs=177.4
Q ss_pred HHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
...|++.+.||+|.|+.|+++ ...+|+.+|+|++... ...+.+++.+|+.+-+.++||||+++...+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 455677788999999999999 6778999999988643 3446788999999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc---CCCceEEeecCCCcccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEM 264 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~~ 264 (319)
|+|.+++|..-+-.. --+++..+...+.||+++|.|+|.++ |+|||+||+|+|+. ...-+||+|||++....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999998766443 23778889999999999999999999 99999999999995 34579999999998766
Q ss_pred ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....-.+.|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+.++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~ 217 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 217 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH
Confidence 54555567899999999999999999999999999999999999999999654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.10 Aligned_cols=204 Identities=23% Similarity=0.468 Sum_probs=173.0
Q ss_pred HHHhcccccccccCCCceEEEEEeC----CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
....|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+..+..++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3457788999999999999999542 45689999987653 233457889999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++|||+++++|.+++... ...+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||.+....
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999998653 346899999999999999999999998 9999999999999999999999999876432
Q ss_pred cccc--ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 265 VDKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 265 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 2211 112335678999999998999999999999999999875 9999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=287.44 Aligned_cols=195 Identities=32% Similarity=0.549 Sum_probs=166.4
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhc-cCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGR-LHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||+|.. .+|..||+|++.... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3689999999999965 468899999986531 2233455667777765 4899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
++|..++... ..+++.++..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||+++.... ......
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 9999888543 45899999999999999999999998 99999999999999999999999999864322 223345
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 6789999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=280.11 Aligned_cols=200 Identities=32% Similarity=0.485 Sum_probs=173.1
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
|...+.||+|+||.||++.. .+++.+|+|.+..... .....+..|+.+++.++|+|++++.+.+.+.+..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 45668899999999999954 4788999998864322 2234567899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
+++++|.+++.......+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999886655556999999999999999999999988 999999999999999999999999998654333333
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....|+..|+|||++.+..++.++|+||||+++|+|++|+.||.+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 34568999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=289.03 Aligned_cols=195 Identities=30% Similarity=0.463 Sum_probs=164.2
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHH-HHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEV-MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||+||+|.. .+++.+|+|++.... ......+..|. .+++.++||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3689999999999965 467889999986431 12223344444 456788999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 9999988543 45888889999999999999999998 99999999999999999999999999874322 223345
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 6799999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.05 Aligned_cols=200 Identities=27% Similarity=0.402 Sum_probs=170.3
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|..++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 467789999999999999964 46889999998642 22234567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 82 YYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred cCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999998542 346899999999999999999999998 99999999999999999999999999864332221
Q ss_pred --ccccccccCccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 --AANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 --~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 223468999999999863 457889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=280.27 Aligned_cols=201 Identities=30% Similarity=0.491 Sum_probs=173.8
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
|...+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|+.+++.++|+|++++.+.+.+.+..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 45567899999999999955 578899999986432 12234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99999998887655557999999999999999999999988 999999999999999999999999998654333333
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....++..|+|||++.+..++.++|+||||+++|||++|+.||.+..+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 445689999999999988999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.16 Aligned_cols=201 Identities=25% Similarity=0.419 Sum_probs=181.3
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe-EEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ-HMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e 188 (319)
.|...+++|+|+||.++.++. .++..+++|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .+++|+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 466778999999999999943 467789999886543 3334467899999999999999999999999888 999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++|++.+.+..++...++++.+..++.|++.|+.|||+++ |+|||||+.||+++.++.+||+|||+|+......
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999999998888778999999999999999999999888 9999999999999999999999999999776665
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...+..||+.|+.||.+.+.+|..|+|||||||++|||++=+++|.+.+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 6678899999999999999999999999999999999999999998754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=281.21 Aligned_cols=192 Identities=20% Similarity=0.374 Sum_probs=165.8
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCccc---HHHHHHHHHHHhccCCCCcceeeeEEee----CCeEEEEEEEc
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLVYVFM 190 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 190 (319)
..|++|+++.||+|.. +|+.||+|.+....... .+.+.+|+.++.+++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5699999999999988 78999999987543332 4567899999999999999999999877 35789999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++.... ..
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~--~~ 177 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS--PP 177 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc--cc
Confidence 999999999643 4689999999999999999999984 5 78999999999999999999999999874322 12
Q ss_pred cccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 23457899999999966 6899999999999999999999999988754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=279.04 Aligned_cols=194 Identities=31% Similarity=0.493 Sum_probs=166.7
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 120 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
||+|+||+||++.. .+++.+|+|.+..... ...+.+..|+.+++.++||||+++.+++...+..+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999954 4788999999864322 2234677899999999999999999999999999999999999999
Q ss_pred hhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccccc
Q 020946 196 ASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANI 272 (319)
Q Consensus 196 ~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 272 (319)
..++.. .....+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 887743 23346899999999999999999999998 999999999999999999999999998643222 223345
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.||+.|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 68999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.71 Aligned_cols=197 Identities=30% Similarity=0.466 Sum_probs=168.4
Q ss_pred cccccccccCCCceEEEEEe----CCCcEEEEEEeccC----CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATD----SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 184 (319)
|.+.+.||+|+||.||+++. .+++.+|+|++... .....+.+..|+.++..+ +||||+++.+++.+.+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 56788999999999999854 36789999998643 122245678899999999 5999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 82 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999998643 45899999999999999999999998 9999999999999999999999999987432
Q ss_pred cc--ccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 265 VD--KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 265 ~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 22 222345789999999999765 4789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=302.08 Aligned_cols=203 Identities=26% Similarity=0.412 Sum_probs=173.4
Q ss_pred HhcccccccccCCCceEEEEEeCCC-cEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeE-Eee------CCe
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTG-ETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGY-CAE------KGQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~------~~~ 182 (319)
.+..+.+.|.+|||+.||.|....+ ..+|+|++...++...+.+.+|+++|++|+ |+|||.+++. ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3556778999999999999976655 999999988777777889999999999996 9999999993 221 136
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+|.||||++|+|.+++.......|++.++++|+.|+++|+.+||... +||||||||-+||||+.++..||||||.+..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 789999999999999997655556999999999999999999999976 8899999999999999999999999998864
Q ss_pred cccccccc----------ccccccCccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 263 EMVDKHAA----------NIRGTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 263 ~~~~~~~~----------~~~~t~~y~aPE~~---~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
........ ....|+.|+|||++ ++..+++|+|||+|||+||-|+....||.+.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 32222111 12369999999987 5778999999999999999999999999865
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=290.53 Aligned_cols=194 Identities=33% Similarity=0.519 Sum_probs=168.8
Q ss_pred cccccCCCceEEEEEe----CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 118 TLIGQGAFGPVYKAQM----STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
+.||+|+||.||++.. .+|+.+|+|++.... ......+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999853 367899999986532 2233456789999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 270 (319)
+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++...... ....
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 99999988543 45899999999999999999999998 999999999999999999999999998754333 2233
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||.+.+
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 4678999999999998889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=291.29 Aligned_cols=207 Identities=32% Similarity=0.592 Sum_probs=172.4
Q ss_pred HHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 179 (319)
.+....|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 45566788899999999999999853 233579999987543 23345688999999999 89999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcC--------------------------------------------------------
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDEN-------------------------------------------------------- 203 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~-------------------------------------------------------- 203 (319)
.+..+++|||+++|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999885321
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc---
Q 020946 204 ------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--- 268 (319)
Q Consensus 204 ------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 268 (319)
...+++.++.+++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 124788899999999999999999988 99999999999999999999999999875432221
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.....++..|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 112234567999999988899999999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=289.67 Aligned_cols=200 Identities=25% Similarity=0.356 Sum_probs=170.7
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||++.. .+++.+|+|++... .......+.+|..++..++|+||+++.+++.+.+..+++||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 467789999999999999965 46789999998642 12223457889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 y~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 82 YYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999653 246899999999999999999999998 99999999999999999999999999865432221
Q ss_pred --ccccccccCccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 --AANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 --~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 223568999999999865 467899999999999999999999997653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.72 Aligned_cols=198 Identities=26% Similarity=0.435 Sum_probs=166.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC-----CeEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHM 184 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 184 (319)
+|.+.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 367789999999999999954 57899999998643 223345688999999999999999999987543 3579
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++|||+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6888887543 45899999999999999999999998 9999999999999999999999999987432
Q ss_pred ccc----cccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDK----HAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 221 1123568999999999865 678999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=285.75 Aligned_cols=194 Identities=31% Similarity=0.524 Sum_probs=167.0
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||++... +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999654 67899999986532 22345567788888877 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
++|..++... ..+++.++..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++.... ......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 9999888543 46999999999999999999999998 99999999999999999999999999864322 222334
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..+++.|+|||++.+..++.++|+|||||++|||++|+.||.+.+
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 568999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=286.82 Aligned_cols=199 Identities=30% Similarity=0.472 Sum_probs=175.5
Q ss_pred cccccccccCCCceEEEE-EeCCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
|+-.+.||+|.||.||+| ...+++.||+|++..+. +...+++++|+.+|..++++||.++++.+..+..++++|||+.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 344477999999999999 45688999999998764 3445789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 270 (319)
+|++.+.+... ..+.+..+.-++.+++.|+.|||.++ .+|||||+.|||+..+|.+|++|||++-..... ....
T Consensus 95 gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 95 GGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred CcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999999433 34477788889999999999999999 999999999999999999999999998654333 3347
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
++.|||.|||||++....|+.|+||||||++.+||.+|.+||..+.+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 88999999999999988999999999999999999999999988764
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.05 Aligned_cols=203 Identities=32% Similarity=0.479 Sum_probs=180.5
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
++..-++||+|+||.||-++ ..+|+-+|.|.+... ......-..+|-.+|.+++.+.||.+-..|++.+.+++|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 33445789999999999994 458999999988543 12223445788999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
.|.+|+|.-+++......+++..++.++.+|+.||++||+.+ ||.||+||+|||+|+.|+++|+|+|+|........
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 999999999998777678999999999999999999999999 99999999999999999999999999987766666
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
.....||.+|||||++.+..|+...|+|||||++|||+.|+.||....++
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 67778999999999999999999999999999999999999999987654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=290.12 Aligned_cols=206 Identities=32% Similarity=0.541 Sum_probs=172.5
Q ss_pred HHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 179 (319)
++....|.+.+.||+|+||.||+|.. .++..||+|+++... ....+.+.+|+.++..+ +||||++++++|.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 44456788899999999999999953 345689999986542 23345788999999999 89999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcC--------------------------------------------------------
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDEN-------------------------------------------------------- 203 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~-------------------------------------------------------- 203 (319)
.+..+++|||+++|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999885422
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 204 -----------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 204 -----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
...+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788899999999999999999988 999999999999999999999999998754322
Q ss_pred cc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 267 KH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 267 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.. .....++..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 21 112334667999999999999999999999999999998 999998764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.97 Aligned_cols=200 Identities=25% Similarity=0.373 Sum_probs=169.9
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||++... +++.+|+|++... .......+.+|+.++..++|+||+++.+++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 4677889999999999999654 5778999998542 12223457889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 y~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999653 246899999999999999999999998 9999999999999999999999999986432222
Q ss_pred -cccccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 -HAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 122356899999999985 3468899999999999999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=281.91 Aligned_cols=192 Identities=30% Similarity=0.471 Sum_probs=161.6
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
+++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++|+||+++++++.+.+..++++||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 34567899999999999964 478999999986542 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 270 (319)
+++|.... ..++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++..... ....
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence 99886532 3567778899999999999999998 999999999999999999999999998754322 1223
Q ss_pred ccccccCccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 271 NIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
...||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 4568999999998743 2345689999999999999999999974
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=273.73 Aligned_cols=204 Identities=29% Similarity=0.529 Sum_probs=176.8
Q ss_pred HHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
....|.+.+.||+|++|.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+.+.+..++++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4567788899999999999999887888999998765332 356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc-
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH- 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 268 (319)
+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999999997665567899999999999999999999988 99999999999999999999999999875432211
Q ss_pred -ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.....++..|+|||++....++.++|+||||+++|+|++ |+.||.+.+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 122335678999999988889999999999999999998 9999987543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.21 Aligned_cols=200 Identities=26% Similarity=0.399 Sum_probs=171.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||+||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++.+++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 467788999999999999954 478899999987532 2234568889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999998653 246999999999999999999999998 9999999999999999999999999987543222
Q ss_pred -cccccccccCccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 -HAANIRGTFGYLDPEYIS------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......+|+.|+|||++. ...++.++|||||||++|||++|+.||.+.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 122346899999999986 4567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=288.42 Aligned_cols=193 Identities=24% Similarity=0.324 Sum_probs=167.0
Q ss_pred HHHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
....|.+.+.||+|+||.||++. ..+++.||+|... ...+.+|+.+++.++||||+++++++......++++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 34568889999999999999994 4578999999643 2356789999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc--c
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV--D 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~--~ 266 (319)
++. ++|..++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 164 ~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 985 6888887543 45899999999999999999999998 99999999999999999999999999864322 1
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 223345799999999999999999999999999999999999988754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.71 Aligned_cols=198 Identities=27% Similarity=0.368 Sum_probs=168.4
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC------
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------ 181 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 181 (319)
..+|.+.+.||+|+||.||++.. .+|..||+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 35688889999999999999954 57899999998643 2233556789999999999999999999886543
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..+++|||+.+ ++...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999965 5665552 24788999999999999999999998 9999999999999999999999999987
Q ss_pred cccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
............+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 5444434445678999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=271.39 Aligned_cols=205 Identities=30% Similarity=0.497 Sum_probs=176.7
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
+...++++.+.||+|++|.||+|...++..||+|.+.... ...+++.+|+.++++++||||+++.+++...+..++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4456788899999999999999987777899999986543 235678899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++.......+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999996655456899999999999999999999988 99999999999999999999999999875432211
Q ss_pred c--cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 A--ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 ~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
. .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 1 11223457999999998899999999999999999999 9999987654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=281.41 Aligned_cols=204 Identities=25% Similarity=0.409 Sum_probs=181.3
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.-|++.+.||+|.|..|-+|+ .-+|..||||++.+.. ......+..|+..|+.++|||||+++.+......+|+++|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346777889999999999993 4589999999996542 2234567899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEeecCCCccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~ 267 (319)
+-.+|+|.+|+.... ..+.++.+.+++.||+.|+.|+|+.. ++||||||+||.+. +-|-+||+|||++.......
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999996544 56999999999999999999999988 99999999999875 56899999999998877888
Q ss_pred cccccccccCccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCccccC
Q 020946 268 HAANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~pf~~~~~~~ 319 (319)
...+.+|+..|-|||.+.+..|+ ++.||||||||||.|++|++||+...+.|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 88899999999999999999997 78999999999999999999998776543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=286.94 Aligned_cols=208 Identities=29% Similarity=0.512 Sum_probs=172.8
Q ss_pred HHHHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccC-CCCcceeeeEE
Q 020946 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLH-HRNLVNLVGYC 177 (319)
Q Consensus 106 ~~~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 177 (319)
..+.....|.+.+.||+|+||.||+|... .+..||+|++..... ...+.+.+|+.+++.+. ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34444667788899999999999999642 234799999865432 33457899999999996 99999999999
Q ss_pred eeCCeEEEEEEEccCCChhhhhhhcC------------------------------------------------------
Q 020946 178 AEKGQHMLVYVFMSKGSLASHLYDEN------------------------------------------------------ 203 (319)
Q Consensus 178 ~~~~~~~lv~e~~~~g~l~~~l~~~~------------------------------------------------------ 203 (319)
.+.+..+++|||+++|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999998875421
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 204 ----------------------------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 204 ----------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
...+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 124788888999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
||+++++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 9999999999999999874332211 122346778999999988899999999999999999997 999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.00 Aligned_cols=197 Identities=26% Similarity=0.447 Sum_probs=163.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC--------Ce
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--------GQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~ 182 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+|+.+++.++||||+++.+++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 4688889999999999999955 578899999875432 2345799999999999999999876432 24
Q ss_pred EEEEEEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCC
Q 020946 183 HMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGL 259 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~ 259 (319)
.+++|||+++ ++.+++.. .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 6789999975 67666532 23456899999999999999999999998 99999999999999664 799999999
Q ss_pred CccccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
++............+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 986544444445678999999999865 468999999999999999999999998764
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.77 Aligned_cols=201 Identities=24% Similarity=0.373 Sum_probs=171.0
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
+|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+++.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 577889999999999999965 468999999986542 2234578899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCC
Q 020946 189 FMSKGSLASHLYDEN---------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 259 (319)
|+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999885311 123566778899999999999999998 99999999999999999999999999
Q ss_pred Ccccccc-------------------ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 260 SREEMVD-------------------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 260 ~~~~~~~-------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 8643110 01112468999999999999999999999999999999999999997644
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=275.83 Aligned_cols=200 Identities=39% Similarity=0.690 Sum_probs=168.7
Q ss_pred ccccccccCCCceEEEEEeC-----CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 115 NFTTLIGQGAFGPVYKAQMS-----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
++.+.||.|.||.||+|.+. .+..|+||.+... .....+.+.+|++.+++++||||++++|++.+.+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999765 3568999999654 33346789999999999999999999999998888999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc--
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-- 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-- 266 (319)
|+++|+|.+++.......+++.++..++.|++.||.|||+++ ++|+||+++||++++++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999998775667999999999999999999999998 999999999999999999999999998754211
Q ss_pred -ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
...........|+|||.+....++.++||||||+++|||++ |+.||.+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 12233456788999999988889999999999999999999 7899987654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=295.17 Aligned_cols=202 Identities=30% Similarity=0.414 Sum_probs=171.7
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-------
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------- 181 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 181 (319)
.+|.+.+.||+|+||+||+|. ..+++.||+|++... .......+.+|+..+..++|+|++++...+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 478889999999999999995 457899999998654 2333456788999999999999999887664332
Q ss_pred -eEEEEEEEccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecC
Q 020946 182 -QHMLVYVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG 258 (319)
Q Consensus 182 -~~~lv~e~~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 258 (319)
..+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecc
Confidence 368999999999999988643 2346899999999999999999999988 9999999999999999999999999
Q ss_pred CCccccc---cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 259 LSREEMV---DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 259 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9874322 122335679999999999999999999999999999999999999998754
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=263.97 Aligned_cols=199 Identities=28% Similarity=0.482 Sum_probs=174.0
Q ss_pred HhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCC----cc----cHHHHHHHHHHHhcc-CCCCcceeeeEEeeCC
Q 020946 112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS----KQ----GEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKG 181 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~----~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 181 (319)
+.|.-.+.||.|..+.|-++ ...+|..+|+|++.... .+ ..+.-.+|+.+|+++ .||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 44555678999999999998 45688899999885321 11 123456789999988 6999999999999999
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..++|+|.|+.|.|.++|.. .-.++++....|+.|+.+|++|||.++ |+||||||+|||++++.++||+|||+++
T Consensus 97 F~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999954 456999999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccCccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYIS------TRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
...........+|||+|.|||.+. ...|+...|+|++|||||.|+.|.+||...
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 888888888999999999999873 246889999999999999999999999754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.48 Aligned_cols=199 Identities=29% Similarity=0.429 Sum_probs=165.4
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc--ccHHHHHHHHHHHhcc---CCCCcceeeeEEee-----CCe
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRL---HHRNLVNLVGYCAE-----KGQ 182 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~~ 182 (319)
|.+.+.||+|+||+||+|.. .+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 67788999999999999954 4788999998865322 2233455677666655 79999999998764 245
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++++||+. ++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++..
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 789999997 48888886555556899999999999999999999998 99999999999999999999999999875
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...........++..|+|||++.+..++.++|||||||++|||++|++||.+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 443333344568899999999988899999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=269.08 Aligned_cols=201 Identities=29% Similarity=0.538 Sum_probs=172.8
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
..+.+.+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3567788999999999999988788899999876432 335678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc--
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-- 269 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 269 (319)
+|+|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.+||+|||.++........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999886433 35899999999999999999999998 999999999999999999999999998754322211
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 12234568999999988899999999999999999999 9999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=267.13 Aligned_cols=200 Identities=26% Similarity=0.449 Sum_probs=176.7
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHH---HHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+++.++||+|.||.|-+++ ..+++.+|+|+++++.....+ .-..|-++|+..+||.+..+...|+..+.+++|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 34567899999999999994 458999999999876433333 34578889999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~ 267 (319)
|..+|.|.-+|. ....++++....+...|+.||.|||+++ |+.||||.+|.|+|.+|++||+|||+|+.... ..
T Consensus 249 yanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 249 YANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 999999998884 3456999999999999999999999998 99999999999999999999999999986543 45
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...+++|||.|+|||++....|....|+|.+||+||||++|+.||...+-
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 67789999999999999999999999999999999999999999987543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=271.57 Aligned_cols=204 Identities=32% Similarity=0.559 Sum_probs=179.1
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
...|.+.+.||+|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45677889999999999999988779999999987665555678899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc-c
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-A 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 269 (319)
++++|.+++.......+++.++..++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||.+........ .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 9999999997766667899999999999999999999988 99999999999999999999999999865432211 1
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
....++..|+|||.+....++.++|+||||+++|+|++ |+.||.+...
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 23345678999999988889999999999999999998 8999987653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=279.58 Aligned_cols=202 Identities=26% Similarity=0.515 Sum_probs=169.2
Q ss_pred HHHhcccccccccCCCceEEEEEeC-CCc----EEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS-TGE----TVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
....|+..+.||+|+||.||+|.+. ++. .||+|.+.... ....+++.+|+.+++.++||||++++++|... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3456778899999999999999653 333 48999986542 33456788999999999999999999998765 56
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
+++++|+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++..
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 78999999999999986543 45889999999999999999999998 999999999999999999999999999754
Q ss_pred cccccc---cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 264 MVDKHA---ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 264 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
...... .....+..|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 332221 12234678999999999999999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=273.60 Aligned_cols=204 Identities=33% Similarity=0.606 Sum_probs=173.6
Q ss_pred HHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
..+|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 456778899999999999999653 3478999998765433 456889999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc
Q 020946 184 MLVYVFMSKGSLASHLYDEN------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~ 251 (319)
+++|||+++++|.+++.... ...+++.++..++.|++.|+.|||+++ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 234788999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 252 ARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 252 ~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999986432211 1123345778999999999999999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=282.91 Aligned_cols=200 Identities=26% Similarity=0.384 Sum_probs=170.6
Q ss_pred HHHHHHHhcccccccccCCCceEEEEEe---CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 106 YKDLQKATCNFTTLIGQGAFGPVYKAQM---STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 106 ~~~l~~~~~~~~~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
...+...+|.+.+.||+|+||.||++.. ..+..|++|.+... ....+|+.+++.++||||+++++++...+.
T Consensus 86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 3445566789999999999999999954 24578999987542 234689999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++|+++. ++|.+++. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 161 ~~lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEEehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999999985 68888883 3456999999999999999999999998 99999999999999999999999999864
Q ss_pred ccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||.+..
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 33221 1224568999999999999999999999999999999999999997754
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=269.87 Aligned_cols=203 Identities=32% Similarity=0.529 Sum_probs=174.0
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
....+.+.+.||+|++|.||+|.. ..+..+|+|.+.... ....++.+|+..++.++||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345577889999999999999954 468899999986542 335678899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++.......+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999987655566899999999999999999999988 99999999999999999999999999875433221
Q ss_pred c--cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 269 A--ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 269 ~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
. .....+..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1 11224568999999998999999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=290.81 Aligned_cols=199 Identities=31% Similarity=0.473 Sum_probs=174.4
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC------eEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------QHM 184 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~ 184 (319)
.|...+.||+|+||.||+|+ ..+|+.||||.+... .....+.-.+|+++|++++|+|||++.++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34456789999999999996 678999999998764 3444566789999999999999999999765543 678
Q ss_pred EEEEEccCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC--C--ceEEeecCC
Q 020946 185 LVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS--M--RARVADFGL 259 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~--~~kl~Dfg~ 259 (319)
++||||.+|||...+.+. +...|++.+.+.+..++..||.|||+++ |+||||||.||++-.+ | .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999999663 3457999999999999999999999999 9999999999999533 3 469999999
Q ss_pred CccccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
|+....++......||..|.+||+... +.|+...|.|||||++|+..||..||..
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 998888888889999999999999984 8899999999999999999999999964
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=283.77 Aligned_cols=197 Identities=25% Similarity=0.347 Sum_probs=168.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------Ce
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 182 (319)
.+|.+.+.||+|+||.||++.. ..++.||+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 5678889999999999999954 47889999998653 223345678899999999999999999987543 35
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+++ +|...+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred EEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 7999999965 6766663 24788999999999999999999998 99999999999999999999999999976
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...........+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 544333445678999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=272.77 Aligned_cols=203 Identities=31% Similarity=0.609 Sum_probs=171.0
Q ss_pred HhcccccccccCCCceEEEEEeCC------CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMST------GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
..+.+.+.||+|+||.||+|.... ...+|+|.+.... ......+.+|+..+..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 356778899999999999996532 2579999886543 233457889999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC
Q 020946 185 LVYVFMSKGSLASHLYDENY--------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM 250 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 250 (319)
+++||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 45788999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 251 RARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 251 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.++|+|||+++...... ......+++.|+|||.+....++.++|||||||++|||++ |..||.+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999986432221 1223346788999999988899999999999999999998 9999987554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=279.50 Aligned_cols=205 Identities=35% Similarity=0.604 Sum_probs=169.6
Q ss_pred HHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEee-
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE- 179 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~- 179 (319)
+..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3456788999999999999999943 234789999986542 22245677899999999 89999999998865
Q ss_pred CCeEEEEEEEccCCChhhhhhhcC--------------------------------------------------------
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDEN-------------------------------------------------------- 203 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~-------------------------------------------------------- 203 (319)
....++++||+++++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 457889999999999998885422
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc---cccccccccC
Q 020946 204 ---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFG 277 (319)
Q Consensus 204 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~ 277 (319)
...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.++|+|||+++...... ......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 125889999999999999999999988 9999999999999999999999999987543221 1122345678
Q ss_pred ccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 278 y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999999999999998 999998744
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=275.61 Aligned_cols=200 Identities=27% Similarity=0.427 Sum_probs=168.7
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++...+..+++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 3567788999999999999965 467899999986543 22344677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
+++ +|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++...... ..
T Consensus 86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 975 788877543 345889999999999999999999998 999999999999999999999999998643222 22
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 234467899999998854 568999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=284.54 Aligned_cols=192 Identities=32% Similarity=0.457 Sum_probs=160.5
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhcc---CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRL---HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 120 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
||+|+||+||+|.. .+++.||+|++..... .....+..|..++... +||||+++.+.+.+.+..+++|||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999954 4689999999854321 1223344566666554 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++..... ......
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 999988854 346899999999999999999999998 99999999999999999999999999864322 223345
Q ss_pred cccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 272 IRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 6799999999998654 58999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=268.21 Aligned_cols=201 Identities=30% Similarity=0.506 Sum_probs=172.4
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
..|.+.+.||+|+||.||+|+..++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999988777789999886443 235678999999999999999999999999889999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc--
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-- 269 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 269 (319)
+++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999886533 36899999999999999999999998 999999999999999999999999998643322211
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 12234567999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=272.14 Aligned_cols=204 Identities=32% Similarity=0.564 Sum_probs=173.4
Q ss_pred HHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
.+..+.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 345677889999999999999963 23456899988765555566789999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 184 MLVYVFMSKGSLASHLYDEN-----------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
++++||+++++|.+++.... ...+++.++..++.|++.||+|||+++ ++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999999986432 234899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 253 RVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
+|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999987432221 1122335678999999998899999999999999999998 999997754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=285.41 Aligned_cols=211 Identities=31% Similarity=0.519 Sum_probs=187.5
Q ss_pred CCcCHHHHHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 102 ~~~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
|..+.+|+.+..+.+.++||-|.||.||.|.|+ -...||||.++.+. ...++|..|..+|+.++|||+|+++|+|...
T Consensus 257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 345778888888888899999999999999885 35689999997653 3478999999999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
..+|+|.|||.+|+|.++|+.-++..++--..++++.||..||+||..++ +|||||..+|+|+.++..+|++|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999998877777888889999999999999999988 999999999999999999999999999
Q ss_pred ccccccccccc--cccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 261 REEMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 261 ~~~~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
+....+..... ..-+..|.|||.+-...++.|+|||+|||+|||+.| |..||+|.+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 87654433222 234678999999999999999999999999999998 999999975
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=267.73 Aligned_cols=204 Identities=30% Similarity=0.511 Sum_probs=175.8
Q ss_pred HHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
++...+|++.+.||+|+||.||+|...+++.+|+|.+..... ....+.+|+.+++.++|+||+++.+++. .+..++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 345678899999999999999999888889999999865433 3567889999999999999999999874 45789999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999987666667899999999999999999999988 9999999999999999999999999986443221
Q ss_pred c--ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 268 H--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 268 ~--~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
. .....++..|+|||++....++.++|+||||+++|||++ |+.||.+.+
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 1 122345678999999988889999999999999999999 999998654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=281.21 Aligned_cols=198 Identities=24% Similarity=0.336 Sum_probs=168.1
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------C
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------G 181 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 181 (319)
..+|.+.+.||+|+||.||++.. ..++.+|+|.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 35788889999999999999954 47889999998653 223345677899999999999999999988643 3
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..+++|||+++ ++.+.+. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 57999999965 6666653 24888999999999999999999998 9999999999999999999999999997
Q ss_pred cccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
............+|+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6544434445678999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=266.20 Aligned_cols=200 Identities=27% Similarity=0.444 Sum_probs=174.7
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|++|.||+|.. .++..+++|.+... .....+.+.+|+.+++.++|||++++++++.+.+..++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 45678899999999999965 47889999988643 3344567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999997655567899999999999999999999988 9999999999999999999999999987443222 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 33467889999999999899999999999999999999999998665
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=271.40 Aligned_cols=202 Identities=31% Similarity=0.562 Sum_probs=170.6
Q ss_pred HhcccccccccCCCceEEEEEe-----CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
..+++.+.||+|+||.||+|.. .++..+++|.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567889999999999999963 34578999998643 23334678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC
Q 020946 186 VYVFMSKGSLASHLYDEN---------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM 250 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 250 (319)
+|||+++++|.+++.... ...+++.+...++.|++.||.|||+++ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999885321 234788899999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 251 RARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 251 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.+||+|||++....... ......++..|+|||++.+..++.++|+||||+++|||++ |..||.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999986532221 1223345678999999988889999999999999999998 999997754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=267.68 Aligned_cols=202 Identities=32% Similarity=0.506 Sum_probs=171.7
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..+|.+.+.||+|+||.||+|...+...||+|.+..... ..+.+.+|+.+++.++||||+++++++.+ +..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 456889999999999999999876667899999875332 34678899999999999999999998754 5679999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc-
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA- 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 269 (319)
++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 9999999997654456899999999999999999999988 999999999999999999999999998643322211
Q ss_pred -cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 270 -ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 270 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
....++..|+|||+..+..++.++|+||||+++|||++ |+.||.+...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 12345678999999988899999999999999999999 8999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=270.56 Aligned_cols=206 Identities=25% Similarity=0.490 Sum_probs=171.7
Q ss_pred HHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG 181 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 181 (319)
+....|++.+.||+|+||.||+|... ++..||+|.+.... .....++.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 44567888999999999999998542 34679999886432 233456889999999999999999999999999
Q ss_pred eEEEEEEEccCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceE
Q 020946 182 QHMLVYVFMSKGSLASHLYDEN--------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 253 (319)
..++++||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999985422 124678889999999999999999988 99999999999999999999
Q ss_pred EeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 254 VADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 254 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999864322111 112345778999999998889999999999999999999 7999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=282.77 Aligned_cols=197 Identities=28% Similarity=0.420 Sum_probs=166.0
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-----eEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHML 185 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 185 (319)
+++.+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+ ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 35668899999999999964 57899999988643 2233457889999999999999999999998776 7899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++||+. ++|.+.+.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred Eeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 999996 578777743 346899999999999999999999998 99999999999999999999999999875332
Q ss_pred cc--cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 DK--HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 21 2223457899999999876 457899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=267.25 Aligned_cols=201 Identities=26% Similarity=0.444 Sum_probs=172.7
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
...|.+.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++..++||||+++++++...+..++++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45678889999999999999964 57889999998765444456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 9999999988543 46899999999999999999999988 9999999999999999999999999987543221 2
Q ss_pred ccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||.+. ...++.++|+||||+++|||++|+.||....
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 23456888999999884 3457889999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=287.51 Aligned_cols=194 Identities=27% Similarity=0.492 Sum_probs=167.4
Q ss_pred ccccccccCCCceEEEE-EeCCCcEEEEEEeccC----CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC--eEEEEE
Q 020946 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--QHMLVY 187 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 187 (319)
++..+||+|+|-+||+| +..+|..||.--++.. .....++|..|+.+|+.|+||||++++..+.+.. ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999 4457888887655432 3344578999999999999999999999988755 478999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCCCcccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVD 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~ 266 (319)
|++..|+|..|+... +.++...++.|+.||++||.|||++. |||+|||||.+||+|+. .|.+||+|+|||... ..
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~-r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL-RK 198 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh-hc
Confidence 999999999999654 45788899999999999999999976 89999999999999984 589999999999754 33
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
.......|||.|||||+.. ..|+...||||||++|+||+|+..||.
T Consensus 199 s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 4455688999999999997 889999999999999999999999985
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.84 Aligned_cols=202 Identities=33% Similarity=0.510 Sum_probs=172.9
Q ss_pred HHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
....|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3456788899999999999999887888999999875433 3567899999999999999999999875 4568899999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc-
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH- 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 268 (319)
+++++|.+++.......+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999997655556899999999999999999999988 99999999999999999999999999864322211
Q ss_pred -ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 269 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 112234567999999988889999999999999999999 999997754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=267.90 Aligned_cols=192 Identities=30% Similarity=0.483 Sum_probs=167.5
Q ss_pred cccccccccCCCceEEEEE-eCCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
+++.+.||+|+||.||+|. ..+++.+|+|.+... .......+.+|+.++++++||||+++++++...+..++++||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 4667889999999999995 457889999998654 23334578899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN 271 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 271 (319)
+++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..... .....
T Consensus 83 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~-~~~~~ 152 (279)
T cd06619 83 GGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKT 152 (279)
T ss_pred CCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc-ccccC
Confidence 99886543 3788889999999999999999998 99999999999999999999999999864422 22334
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
..++..|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 57899999999999889999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.76 Aligned_cols=202 Identities=34% Similarity=0.598 Sum_probs=167.7
Q ss_pred hcccccccccCCCceEEEEEeC-CCc--EEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 187 (319)
.|.+.+.||+|+||.||+|... ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 4677889999999999999654 333 4788887643 233356788999999999 7999999999999999999999
Q ss_pred EEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceE
Q 020946 188 VFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 253 (319)
||+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEE
Confidence 9999999999986432 134889999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 254 VADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 254 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|+|||++..............+..|+|||++....++.++|||||||++|||++ |+.||.+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999864322211222233567999999988889999999999999999998 9999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=264.88 Aligned_cols=200 Identities=30% Similarity=0.533 Sum_probs=170.8
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
.+.+.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++++||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466788999999999999987777789999886432 2345788899999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc--c
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--A 270 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~ 270 (319)
++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........ .
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999986543 36899999999999999999999998 999999999999999999999999998754322111 1
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
...++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 1123457999999998899999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=286.00 Aligned_cols=197 Identities=24% Similarity=0.419 Sum_probs=160.4
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccC------CCCcceeeeEEeeC-Ce
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH------HRNLVNLVGYCAEK-GQ 182 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~-~~ 182 (319)
..+|.+.+.||+|+||+||+|.. .+++.||||++..... ....+..|+.+++.++ |++++.+++++... +.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 46788889999999999999954 4688999999864322 2334556666666664 45588888888764 46
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCC-----------
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSM----------- 250 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~----------- 250 (319)
.+++|+++ +++|.+++... ..+++..+..++.|++.||+|||++ + |+||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccccc
Confidence 78888887 67888888543 4699999999999999999999974 7 99999999999998765
Q ss_pred -----ceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 251 -----RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 251 -----~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 281 ~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred CCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999876422 22345678999999999999999999999999999999999999998754
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=270.71 Aligned_cols=199 Identities=26% Similarity=0.445 Sum_probs=174.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+|.+.+.||+|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.++|||++++++.+......++|+||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3677788999999999999954 578899999987665555677889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 99999998853 34889999999999999999999998 9999999999999999999999999876432221 12
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 23468899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=270.45 Aligned_cols=204 Identities=32% Similarity=0.572 Sum_probs=173.5
Q ss_pred HHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
...|.+.+.||+|+||.||++.. .++..+++|.+........+.+.+|+..++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 34577788999999999999963 234568999987655555677899999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC
Q 020946 185 LVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM 250 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 250 (319)
++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 9999999999999986432 234889999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 251 RARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 251 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999986433221 1223446788999999998999999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=265.02 Aligned_cols=203 Identities=31% Similarity=0.502 Sum_probs=172.4
Q ss_pred HHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
...+|.+.+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.+++.++|||++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 345688889999999999999987777789999876443 23467889999999999999999998875 4568899999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc-
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH- 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 268 (319)
+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999997655556899999999999999999999988 99999999999999999999999999864322211
Q ss_pred -ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+.
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 112345678999999988889999999999999999999 9999987654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.02 Aligned_cols=203 Identities=35% Similarity=0.604 Sum_probs=168.1
Q ss_pred HhcccccccccCCCceEEEEEeC-CCc--EEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 186 (319)
..|.+.+.||+|+||.||+|... ++. .+++|.+... .......+.+|+.++.++ +||||+++++++.+.+..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 35677899999999999999653 444 4577776543 233345788999999999 899999999999999999999
Q ss_pred EEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 187 YVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
+||+++++|.+++.... ...+++.+++.++.|++.||+|||+++ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 235789999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||+|||++..............+..|+|||.+.+..++.++||||||+++|||+| |..||.+.+.
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence 9999999863222111222234667999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=270.82 Aligned_cols=198 Identities=28% Similarity=0.424 Sum_probs=171.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.|++.+.||+|+||.||++.. .++..+|+|.+.... .....++.+|++++.+++||||+++++++.+.+..++++||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 366788999999999999954 467889999886542 233456889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||++..... ...
T Consensus 82 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~ 155 (308)
T cd06615 82 DGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMA 155 (308)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc-ccc
Confidence 999999998543 568999999999999999999997 46 99999999999999999999999999864322 223
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 34568899999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.58 Aligned_cols=210 Identities=25% Similarity=0.450 Sum_probs=172.1
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEee--CC
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KG 181 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~ 181 (319)
.+.....|.+.+.||+|+||+||++.. .++..+|+|++... .......+..|+.++..++||||++++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 344556788999999999999999954 46778999988643 22335678899999999999999999998854 45
Q ss_pred eEEEEEEEccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeEEcCCCCCCEEEcCC------
Q 020946 182 QHMLVYVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAV----PPVIHRDIKSSNILLDQS------ 249 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~dlk~~Nill~~~------ 249 (319)
..|+||||+++++|.+++... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+|||++.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 789999999999999988642 23469999999999999999999998431 249999999999999642
Q ss_pred -----------CceEEeecCCCccccccccccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 250 -----------MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 250 -----------~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..+||+|||++.............+|+.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3489999999875544444445678999999999854 458899999999999999999999997543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=273.81 Aligned_cols=198 Identities=23% Similarity=0.340 Sum_probs=165.6
Q ss_pred cccccccC--CCceEEEEE-eCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 116 FTTLIGQG--AFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 116 ~~~~lg~G--~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
+.++||+| +|++||++. ..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++++||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 788999995 4578999999986542 223456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc----
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---- 266 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~---- 266 (319)
++++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++++||+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999986544456899999999999999999999998 999999999999999999999999864322110
Q ss_pred ----ccccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 ----KHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ----~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 01122346778999999865 468999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=274.80 Aligned_cols=206 Identities=31% Similarity=0.513 Sum_probs=178.2
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 183 (319)
+....++|..+||+|+||.|.+|.. .+.+.+|||+++.+.. .+.+--..|-++|+.. +-|.++++..+++.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 3345678889999999999999954 4567899999987632 2223335677777766 467899999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|+||||+.+|+|-.++. ..+.+.+..+..+|.+|+-||-+||+++ |+.||||.+|||++.+|++||+|||+++..
T Consensus 426 yFVMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999988873 4466899999999999999999999999 999999999999999999999999999865
Q ss_pred ccc-ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccC
Q 020946 264 MVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319 (319)
Q Consensus 264 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~~ 319 (319)
... .++.+++|||.|+|||.+...+|+..+|+|||||+||||+.|++||+|.+|+|
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 544 45678999999999999999999999999999999999999999999998874
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=266.59 Aligned_cols=199 Identities=30% Similarity=0.470 Sum_probs=171.0
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999654 5778899998665555566788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 271 (319)
++|..++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9998887543 346899999999999999999999998 999999999999999999999999998643222 22234
Q ss_pred cccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 272 IRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 272 ~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..+++.|+|||++. ...++.++|+|||||++|||++|+.||...+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 56889999999973 4567889999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=265.44 Aligned_cols=205 Identities=32% Similarity=0.535 Sum_probs=177.2
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
+....|.+.+.||+|+||.||+|..+++..+|+|.+.... ...+++.+|+..++.++|+||+++++++.+....++++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4456788899999999999999988778899999987543 335678999999999999999999999998889999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++.......+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997655557899999999999999999999998 99999999999999999999999999864332111
Q ss_pred --ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 --AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 --~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 112234568999999998889999999999999999999 9999977543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=264.54 Aligned_cols=199 Identities=31% Similarity=0.505 Sum_probs=170.5
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-----cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
.|.+.+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 356778999999999999954 578999999876432 11234688899999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 83 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 83 MEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999988543 45889999999999999999999998 999999999999999999999999998643221
Q ss_pred cc----ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. .....++..|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 11 123457889999999998889999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=268.27 Aligned_cols=203 Identities=33% Similarity=0.555 Sum_probs=171.8
Q ss_pred HhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
..+.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++.++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4556788999999999999953 2356789998876555556789999999999999999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 186 VYVFMSKGSLASHLYDENY-------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
++||+++++|.+++..... ..+++..++.++.|++.|++|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 34889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 253 RVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
+|+|||++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||....+
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 9999999864322111 122334678999999998899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.41 Aligned_cols=197 Identities=33% Similarity=0.592 Sum_probs=172.1
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHH--HHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEK--EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|++.+.||+|+||+||++... +++.+|+|++......... ...+|+..+++++||||+++++++.+....+++++|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999654 5668999999776443322 3456999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc-ccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~-~~~~~~~ 269 (319)
++++|.+++. ....+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||.+.. .......
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred cccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999996 2345899999999999999999999998 99999999999999999999999999864 2233344
Q ss_pred cccccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 270 ANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
....++..|+|||++. +..++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4567899999999998 888999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=252.67 Aligned_cols=206 Identities=27% Similarity=0.421 Sum_probs=174.6
Q ss_pred HHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-----eEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 184 (319)
..+|.+.+.||+|||+-||.++ ..++..+|+|++.-.+.++.+..++|++.-++++|||++++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4578999999999999999994 6788999999998777777888999999999999999999999875433 589
Q ss_pred EEEEEccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 185 LVYVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
++++|...|+|.+.+... ....+++.+++.|+.++++||++||+.. +|+.||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999988542 2335899999999999999999999976 7899999999999999999999999998764
Q ss_pred cccccc----------ccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDKH----------AANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~~----------~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....-. -.....|..|+|||.+. +...++++|||||||+||+|+.|..||+..-+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 322111 11245789999999985 34568999999999999999999999976543
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=264.33 Aligned_cols=200 Identities=26% Similarity=0.421 Sum_probs=174.1
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
|++.+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|+.+++.++||||+++.+.+.+.+..++++||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 56788999999999999954 47889999988543 23345678889999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-ccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 270 (319)
+++|.+++.......+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++++|||++....... ...
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 999999886655566899999999999999999999998 9999999999999999999999999986443221 223
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 4568899999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=266.98 Aligned_cols=200 Identities=28% Similarity=0.498 Sum_probs=165.6
Q ss_pred HhcccccccccCCCceEEEEEeC-CCc----EEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGE----TVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
..+++.+.||+|+||+||+|.+. +++ .+++|.+.... .....++..|+..++.++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35567789999999999999653 444 47778775432 223356778888999999999999999875 456788
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999653 346899999999999999999999988 99999999999999999999999999874322
Q ss_pred cc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 266 DK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 266 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 21 1223456778999999988899999999999999999998 999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=271.06 Aligned_cols=208 Identities=32% Similarity=0.550 Sum_probs=173.1
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeC--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeE
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 176 (319)
.++....|.+.+.||+|+||.||++... +...+|+|.+.... .....++.+|+.++..+ +||||++++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3555678999999999999999999542 23469999987542 33345688899999999 79999999999
Q ss_pred EeeCCeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCC
Q 020946 177 CAEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS 242 (319)
Q Consensus 177 ~~~~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~ 242 (319)
+.+.+..++++||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 999999999999999999999996532 134889999999999999999999988 999999999
Q ss_pred CEEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 243 NILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 243 Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||++++++.+||+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|||++ |+.||.+...
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999986432211 1112234568999999988889999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=269.90 Aligned_cols=205 Identities=31% Similarity=0.552 Sum_probs=173.9
Q ss_pred HHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK 180 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 180 (319)
+....+.+.+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 4456788899999999999999953 234579999886543 23345788999999999 799999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
+..++++||+++++|.+++.......+++.++..++.|++.||+|||+++ ++|+||||+|||+++++.++++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997654445899999999999999999999988 999999999999999999999999998
Q ss_pred cccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 261 REEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 261 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 74432211 112345678999999998899999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=268.55 Aligned_cols=199 Identities=26% Similarity=0.441 Sum_probs=174.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+|.+.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5678889999999999999964 578999999987655555667889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 99999998843 34889999999999999999999988 9999999999999999999999999986432221 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23467889999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=269.32 Aligned_cols=203 Identities=29% Similarity=0.510 Sum_probs=170.1
Q ss_pred HhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
..|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45677889999999999999642 357899999875432 22456889999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC
Q 020946 185 LVYVFMSKGSLASHLYDE--------------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM 250 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 250 (319)
++++|+.+++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999988532 1234788889999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 251 RARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 251 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.+||+|||+++...... ......+++.|+|||.+....++.++||||||+++|||++ |..||.+...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999987432221 1123345778999999988889999999999999999998 8899987654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=264.90 Aligned_cols=201 Identities=30% Similarity=0.554 Sum_probs=171.1
Q ss_pred HhcccccccccCCCceEEEEEeC----CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..|.+.+.||+|+||.||+|.+. +...||+|.+.... ......+.+|+..++.++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 45678899999999999999663 23579999886543 33345788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++++|.+++.... ..+++.++..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999986533 46899999999999999999999988 999999999999999999999999998754311
Q ss_pred c---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 267 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 1 1112334678999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=262.35 Aligned_cols=196 Identities=30% Similarity=0.497 Sum_probs=165.7
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
+.||+|+||.||+|.. .+++.+|+|...... ......+.+|+++++.++||||+++++++...+..++++||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999965 478899999876442 33346789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc---ccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA---ANI 272 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~ 272 (319)
.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9998543 345899999999999999999999988 999999999999999999999999998643221111 111
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
..+..|+|||.+.+..++.++|+||||+++|||++ |..||...+.
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 23456999999988889999999999999999998 9999976553
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=264.94 Aligned_cols=199 Identities=28% Similarity=0.473 Sum_probs=171.5
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|.+.+.||+|+||.||+|.. .+++.+|+|.+..........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4567778899999999999954 578899999987654444556788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
++++|.+++... +.+++.+++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...... ...
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 999999988543 46899999999999999999999998 999999999999999999999999998643222 122
Q ss_pred cccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 270 ANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
....++..|+|||++. ...++.++|+|||||++|+|++|+.||...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 3456899999999974 456889999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=268.24 Aligned_cols=198 Identities=26% Similarity=0.464 Sum_probs=174.0
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
+|.+.+.||.|++|.||+|. ..+++.|++|.+........+.+.+|+..++.++|||++++++++...+..++++||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 46778899999999999995 46789999999876555556778899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-ccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 270 (319)
+++|..++.. ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 100 ~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 100 GGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred CCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9999998843 35899999999999999999999998 9999999999999999999999999886433222 222
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3467889999999988889999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=274.46 Aligned_cols=195 Identities=24% Similarity=0.385 Sum_probs=165.5
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
+....|.+.+.||+|+||.||+|.. .+++.||+|+.... ....|+.+++.++||||+++++++.+.+..++++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3445688899999999999999965 46778999975322 2346899999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
+++. ++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9984 6888887543 356899999999999999999999998 9999999999999999999999999987543333
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCC-CCCC
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS-PLQG 314 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~-pf~~ 314 (319)
......||+.|+|||++.+..++.++|||||||++|||+++.. +|.+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 3445678999999999999999999999999999999998544 4443
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=261.25 Aligned_cols=196 Identities=30% Similarity=0.537 Sum_probs=167.8
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCChh
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA 196 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~ 196 (319)
+.||+|+||.||+|...++..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999877889999999865532 23456889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc--ccccc
Q 020946 197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--ANIRG 274 (319)
Q Consensus 197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~ 274 (319)
+++.... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++......... ....+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9885433 45889999999999999999999988 999999999999999999999999998643222111 12234
Q ss_pred ccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
+..|+|||++.+..++.++|+||||+++|||++ |..||.+...
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 567999999988889999999999999999998 9999987643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=264.74 Aligned_cols=204 Identities=29% Similarity=0.515 Sum_probs=174.4
Q ss_pred HHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
++..++|.+.+.||+|+||.||++...++..+++|.+.... ...+.+.+|+.+++.++|+||+++.+.+.+ ...++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 34567788999999999999999987777889999886542 234678899999999999999999999887 7789999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999997655556889999999999999999999988 9999999999999999999999999886432211
Q ss_pred c--ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 268 H--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 268 ~--~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
. .....++..|+|||++....++.++|+||||+++|+|++ |+.||.+.+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 1 112235677999999988889999999999999999999 999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=266.74 Aligned_cols=201 Identities=28% Similarity=0.464 Sum_probs=172.7
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|||++++++.+...+..+++|||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778889999999999999654 58899999987665555677889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
++++|..++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 9999988775433 46899999999999999999999988 999999999999999999999999987643222 222
Q ss_pred cccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||++. ...++.++|+|||||++|||++|+.||...+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 3456788999999984 3457889999999999999999999997653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=278.95 Aligned_cols=201 Identities=27% Similarity=0.453 Sum_probs=180.3
Q ss_pred HHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..-|.+...||+|.|+.|.+|. ..++..||+|.+... +......+.+|+++|+.++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 3456778899999999999994 458999999998765 3333455889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||..+|.+.+++.... ...+..+..+..|+..|++|||+++ |+|||||.+|+|++.+.++||+|||++.......
T Consensus 135 eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999999996543 4666888899999999999999999 9999999999999999999999999998877778
Q ss_pred cccccccccCccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...+++|++.|.|||++.+..|+ +++|+||+|++||.|+.|.+||+|-+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 88899999999999999988875 89999999999999999999999754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=270.38 Aligned_cols=195 Identities=25% Similarity=0.390 Sum_probs=158.5
Q ss_pred ccccccCCCceEEEEEeC---CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEEEEEEcc
Q 020946 117 TTLIGQGAFGPVYKAQMS---TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYVFMS 191 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 191 (319)
.+.||+|+||+||+|... +++.+|+|.+.... ....+.+|+.+++.++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999653 56789999886432 23457789999999999999999998854 456889999985
Q ss_pred CCChhhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE----cCCCceEEeecCCC
Q 020946 192 KGSLASHLYDE-------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLS 260 (319)
Q Consensus 192 ~g~l~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~ 260 (319)
++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4777766421 1235889999999999999999999998 9999999999999 45678999999998
Q ss_pred cccccc----ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 REEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+..... .......+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 743221 12234568999999999876 4689999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=261.91 Aligned_cols=198 Identities=34% Similarity=0.591 Sum_probs=174.2
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
..+.+.+.||+|++|.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..++++||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4567789999999999999987 488999999876544 46678999999999999999999999998999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN 271 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 271 (319)
+++|.+++.......+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||.++...... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~~ 158 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--DS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--cc
Confidence 999999997665557999999999999999999999998 9999999999999999999999999987552222 13
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
...+..|+|||.+....++.++|+||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 345678999999988889999999999999999997 999997664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=264.37 Aligned_cols=196 Identities=36% Similarity=0.620 Sum_probs=163.5
Q ss_pred cccccCCCceEEEEEeC-CCc--EEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQMS-TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||+|... ++. .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999764 343 4688887643 233456788999999999 799999999999999999999999999
Q ss_pred CChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecC
Q 020946 193 GSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG 258 (319)
Q Consensus 193 g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 258 (319)
++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 124789999999999999999999988 9999999999999999999999999
Q ss_pred CCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 259 LSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 259 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
++..............+..|+|||++....++.++|+||||+++|||++ |+.||.+.+
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 9863322111222334667999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=262.14 Aligned_cols=201 Identities=30% Similarity=0.479 Sum_probs=175.3
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|.+.+.||+|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 4577889999999999999965 467899999987665555678899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++++|.+++... ...+++.++..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 999999988553 246899999999999999999999988 9999999999999999999999999986433221 22
Q ss_pred cccccccCccCccccCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTR---NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~---~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||.+... .++.++|+||||+++|||++|+.||.+.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 345678899999998776 88999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=261.33 Aligned_cols=200 Identities=21% Similarity=0.385 Sum_probs=174.3
Q ss_pred cccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|++.+.||+|+||.||.++ ..+++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..++++||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 6677899999999999995 457889999987643 2344567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++++|.+++.......+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999997654556899999999999999999999988 9999999999999999999999999986443322 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||.+.+..++.++|+||||+++|||++|+.||.+..
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 34568999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=264.84 Aligned_cols=198 Identities=30% Similarity=0.481 Sum_probs=173.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
+|.+.+.||.|++|.||+|.. .+++.+|+|.+.... ......+.+|+.+++.++|+|++++.+++.+....++++||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 456778899999999999965 468899999986543 334567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
++++|.+++... .+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||+++..... ...
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999999998543 6899999999999999999999988 999999999999999999999999998754432 223
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 34567889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=263.29 Aligned_cols=199 Identities=30% Similarity=0.555 Sum_probs=170.3
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcc---------cHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ---------GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999954 46889999988643221 12467889999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++++||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999543 46889999999999999999999988 99999999999999999999999999875
Q ss_pred ccccc-------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDK-------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 43211 1123457889999999988889999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=268.97 Aligned_cols=207 Identities=32% Similarity=0.570 Sum_probs=173.6
Q ss_pred HHHHHhcccccccccCCCceEEEEEe--------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 177 (319)
++....|.+.+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|+..+..+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 45577888999999999999999953 134579999886542 33356788999999999 899999999999
Q ss_pred eeCCeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 178 AEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 178 ~~~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
...+..+++|||+++++|.+++.... ...+++.++..++.|++.||.|||+++ ++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence 99999999999999999999986532 235788899999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|++++++.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+.
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999987543221 1222345678999999988889999999999999999998 8999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=276.79 Aligned_cols=207 Identities=29% Similarity=0.517 Sum_probs=172.8
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccC-CCCcceeeeEEe
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLH-HRNLVNLVGYCA 178 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 178 (319)
.++....+.+.+.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4566667788899999999999999742 346899999975432 22346889999999997 999999999999
Q ss_pred eCCeEEEEEEEccCCChhhhhhhcC-------------------------------------------------------
Q 020946 179 EKGQHMLVYVFMSKGSLASHLYDEN------------------------------------------------------- 203 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~~l~~~~------------------------------------------------------- 203 (319)
..+..++|+||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986431
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCC
Q 020946 204 -----------------------------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS 242 (319)
Q Consensus 204 -----------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~ 242 (319)
...+++..+..++.|++.||+|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 123677788999999999999999988 999999999
Q ss_pred CEEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 243 NILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 243 Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
|||+++++.+||+|||+++...... ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999987432211 1122346788999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=274.94 Aligned_cols=195 Identities=27% Similarity=0.420 Sum_probs=164.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeC------Ce
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 182 (319)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 4677889999999999999954 578899999986532 22345677899999999999999999987543 35
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++++++ +++|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 95 ~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcccee
Confidence 68888887 778887773 245999999999999999999999998 99999999999999999999999999875
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 432 2334568999999999866 57899999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.95 Aligned_cols=197 Identities=26% Similarity=0.493 Sum_probs=163.2
Q ss_pred cCHHHHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 104 ~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
++++++.. .+...+.||+|+||.||+|.. .++..||+|.+...... ..+|+..+++++||||++++++|.+.+.
T Consensus 683 ~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 683 ITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 44555543 345567899999999999965 57899999988643322 1346888999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+++|+|.+++. .++|..+.+++.|++.||+|||+...++++|||+||+||+++.++..++. ||....
T Consensus 758 ~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999999999994 38899999999999999999996644569999999999999999888775 665432
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 832 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 832 LCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 211 1223578999999999999999999999999999999999999854
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=267.40 Aligned_cols=197 Identities=29% Similarity=0.490 Sum_probs=172.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++++|
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 467788999999999999965 468999999986432 2234568899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 82 YVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999998544 46899999999999999999999988 999999999999999999999999998754333
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 334568899999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=261.46 Aligned_cols=193 Identities=30% Similarity=0.509 Sum_probs=161.7
Q ss_pred ccccCCCceEEEEEeC---CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 119 LIGQGAFGPVYKAQMS---TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. ....++++||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999653 45579999986553 233467899999999999999999999885 457899999999999
Q ss_pred hhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc----cc
Q 020946 195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----AA 270 (319)
Q Consensus 195 l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~ 270 (319)
|.+++... ...+++..+++++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99988543 346899999999999999999999998 99999999999999999999999999864322211 11
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
...++..|+|||.+....++.++||||||+++|||++ |+.||.+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 1223578999999988889999999999999999996 999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=263.59 Aligned_cols=196 Identities=29% Similarity=0.451 Sum_probs=161.7
Q ss_pred ccccCCCceEEEEEeCC---CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 119 LIGQGAFGPVYKAQMST---GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....+++|||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999996543 4578999886543 2334578889999999999999999999999999999999999999
Q ss_pred hhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc---c
Q 020946 195 LASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---H 268 (319)
Q Consensus 195 l~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 268 (319)
|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986432 224667788899999999999999988 9999999999999999999999999986432221 1
Q ss_pred ccccccccCccCccccCCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTR-------NFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~-------~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.....++..|+|||++... .++.++|+||||+++|||++ |+.||....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 1234467889999998542 35789999999999999996 9999987654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=263.40 Aligned_cols=201 Identities=31% Similarity=0.526 Sum_probs=169.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC------CeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK------GQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~~ 183 (319)
..|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++..+ +|||++++++++... ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 4566778899999999999954 468899999986543 3356788899999988 699999999998753 468
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++++||+++++|.+++.......+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999999987655567899999999999999999999988 999999999999999999999999998743
Q ss_pred ccc-ccccccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVD-KHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... .......++..|+|||++. ...++.++|+|||||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 222 2233456889999999985 3457889999999999999999999997543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=268.47 Aligned_cols=200 Identities=26% Similarity=0.426 Sum_probs=169.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 3577788999999999999955 468899999986542 22345677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
++ ++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....... .
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 97 5888887543 346889999999999999999999998 9999999999999999999999999986433221 2
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 233457889999998865 457899999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=266.14 Aligned_cols=206 Identities=28% Similarity=0.525 Sum_probs=173.3
Q ss_pred HHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG 181 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 181 (319)
+....|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 44567888899999999999999643 34689999986543 233457889999999999999999999999999
Q ss_pred eEEEEEEEccCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceE
Q 020946 182 QHMLVYVFMSKGSLASHLYDEN--------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 253 (319)
..++++||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 9999999999999999986422 234788899999999999999999988 99999999999999999999
Q ss_pred EeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 254 VADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 254 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|+|||+++...... ......++..|+|||.+....++.++||||||+++|||++ |+.||.+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 99999986432221 1223346788999999988889999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=264.78 Aligned_cols=199 Identities=26% Similarity=0.385 Sum_probs=167.6
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|++|.||+|.. .++..||+|.+.... ....+.+.+|+.++..++||||+++++++.+++..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 56778899999999999965 478899999986432 223467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 191 SKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+ ++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 7 68888875433 256899999999999999999999998 9999999999999999999999999986432221 1
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||.+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 223456889999998865 457899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=264.91 Aligned_cols=201 Identities=29% Similarity=0.525 Sum_probs=167.8
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGE----TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
...+++.+.||+|+||+||+|.+ .++. .||+|++... ......++.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 45667789999999999999964 3444 4899988654 333356788999999999999999999998754 567
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++++|+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 899999999999998653 346899999999999999999999998 9999999999999999999999999987543
Q ss_pred cccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 265 VDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 265 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 2221 112234678999999988899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=263.63 Aligned_cols=196 Identities=28% Similarity=0.441 Sum_probs=159.9
Q ss_pred ccccCCCceEEEEEeCC---CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 119 LIGQGAFGPVYKAQMST---GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++||||+++++.+.+.+..+++|||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999995433 3468888775432 2334567889999999999999999999999999999999999999
Q ss_pred hhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc---c
Q 020946 195 LASHLYDENY---GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---H 268 (319)
Q Consensus 195 l~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 268 (319)
|.+++..... ...++.....++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 23567888999999999999999998 9999999999999999999999999986432221 1
Q ss_pred ccccccccCccCccccC-------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYIS-------TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~-------~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.....++..|+|||++. ...++.++||||||+++|||++ |+.||....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 12234567899999874 2456889999999999999999 8899987653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=262.85 Aligned_cols=198 Identities=31% Similarity=0.546 Sum_probs=170.9
Q ss_pred cccccccccCCCceEEEEEeCCCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
|.+.+.||+|+||+||+|...+++.+|+|.+..... .....+.+|+..++.++|+||+++.+++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 567788999999999999877899999998864321 12345888999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc--
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-- 265 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-- 265 (319)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 82 EFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999998543 45889999999999999999999988 99999999999999999999999998764311
Q ss_pred -----cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 -----DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
........++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 111223457889999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=265.39 Aligned_cols=201 Identities=29% Similarity=0.445 Sum_probs=173.5
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|.+.+.||+|++|.||++.. .++..+|+|.+........+.+.+|+.++++++|||++++++.+.+.+..+++|||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 3577788899999999999965 468899999987665555677889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
++++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 85 ~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 85 DGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 999999988543 346899999999999999999999998 999999999999999999999999987643222 122
Q ss_pred cccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||.+. ...++.++|+||||+++|||++|+.||.+..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 3456889999999974 3457789999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=265.39 Aligned_cols=204 Identities=33% Similarity=0.543 Sum_probs=169.4
Q ss_pred HHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
...+.+.+.||+|++|.||+|... .+..|++|.+.... ......+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 355778899999999999999654 35678999876443 33345688999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC---ceEEe
Q 020946 184 MLVYVFMSKGSLASHLYDENY-----GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARVA 255 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~ 255 (319)
++++||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865421 25899999999999999999999998 99999999999998654 59999
Q ss_pred ecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 256 DFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 256 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|||+++....... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999875422111 112223567999999988899999999999999999997 9999987653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=278.41 Aligned_cols=192 Identities=24% Similarity=0.305 Sum_probs=163.9
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
...|.+.+.||+|+||.||++.. ..++.||+|... ...+.+|+.++++++|+||+++++++...+..++++++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34678889999999999999955 467899999632 23456899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-- 267 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-- 267 (319)
+. ++|.+++... ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 94 6888887543 346999999999999999999999998 9999999999999999999999999987432221
Q ss_pred -cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
......||..|+|||++.+..++.++|||||||+||||++|..|+-
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 1223568999999999999999999999999999999999876553
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=260.85 Aligned_cols=197 Identities=34% Similarity=0.576 Sum_probs=169.5
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEe-eCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA-EKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 190 (319)
..|.+.+.||+|+||.||++.. .+..+|+|...... ..+.+.+|+.+++.++|+|++++++++. +.+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4677889999999999999976 47889999886432 3467889999999999999999999754 556789999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 270 (319)
++++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++..... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~~ 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc--CC
Confidence 9999999987655556899999999999999999999998 999999999999999999999999998743322 22
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
....+..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 3345678999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=268.97 Aligned_cols=202 Identities=30% Similarity=0.418 Sum_probs=173.6
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQ---GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++.++.++||||+++++.+.+.+..+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4667789999999999999654 5899999998754322 34568899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+.+++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999987655567999999999999999999999988 9999999999999999999999999875322111
Q ss_pred -----------------------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 -----------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 -----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11123578899999999888899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=266.03 Aligned_cols=203 Identities=30% Similarity=0.440 Sum_probs=174.5
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
+....|++.+.||+|+||+||++.. .++..+|+|++.... ....+.+.+|+++++.++||||+++++++...+..+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3445677889999999999999954 468899999876543 33356788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
+||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999988754 3468999999999999999999997 45 99999999999999999999999999764322
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......++..|+|||++.+..++.++|+|||||++|+|++|+.||....+
T Consensus 157 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 157 -SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred -hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 222345689999999999888999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=261.48 Aligned_cols=196 Identities=33% Similarity=0.561 Sum_probs=167.9
Q ss_pred cccccCCCceEEEEEeCC--C--cEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQMST--G--ETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+.+|+..+++++||||+++++++.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999996532 3 3689999877654 456788999999999999999999999988 889999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc----c
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK----H 268 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 268 (319)
++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654356899999999999999999999998 9999999999999999999999999987543211 1
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 206 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG 206 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 123446788999999998899999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=260.94 Aligned_cols=192 Identities=31% Similarity=0.535 Sum_probs=162.1
Q ss_pred ccccCCCceEEEEEe---CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 119 LIGQGAFGPVYKAQM---STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
.||+|+||.||+|.+ .++..+|+|++.... ....+++.+|+.+++.++||||+++++++. .+..++++||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999954 357889999986443 223567889999999999999999999885 45678999999999
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc----c
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----A 269 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~----~ 269 (319)
+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||.||++++++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998543 46899999999999999999999998 99999999999999999999999999875432221 1
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
....++..|+|||.+....++.++|+||||+++|||++ |+.||.+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12234578999999988889999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=267.55 Aligned_cols=207 Identities=34% Similarity=0.579 Sum_probs=173.1
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 179 (319)
++....|++.+.||+|+||.||++... ....+|+|.+... ......++.+|+.++..+ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344567788899999999999999653 2367999988754 223345688999999999 79999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEE
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDE--------------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL 245 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 245 (319)
.+..+++|||+++++|..++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999998542 2346899999999999999999999988 999999999999
Q ss_pred EcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 246 LDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 246 l~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
+++++.+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999999999999987543221 1122335678999999988899999999999999999998 9999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=261.65 Aligned_cols=198 Identities=30% Similarity=0.499 Sum_probs=167.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-----cccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHM 184 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 184 (319)
.|.+.+.||+|+||.||.|.. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 356778999999999999964 468899999875321 12235678899999999999999999988763 4678
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+++++|.+++... ..+++.....++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||++....
T Consensus 83 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999999988543 35788899999999999999999998 9999999999999999999999999886432
Q ss_pred cc----ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 265 VD----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 265 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.. .......++..|+|||++.+..++.++|+||||+++|||++|+.||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 11 1223345888999999998888999999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=262.79 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=172.3
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|++|.||++.. .++..+++|.+... ......++.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 466778899999999999964 58899999987543 22334578899999999999999999999999999999999
Q ss_pred EccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 189 FMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|+++++|.+++.. .....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998853 22346899999999999999999999998 999999999999999999999999988644322
Q ss_pred c-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 K-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 2 1233468899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=267.76 Aligned_cols=205 Identities=26% Similarity=0.473 Sum_probs=170.1
Q ss_pred HHHhcccccccccCCCceEEEEEeCC---------------CcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCccee
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMST---------------GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNL 173 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~ 173 (319)
...+|.+.+.||+|+||.||++.... ...||+|.+... .......+.+|++++++++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45678889999999999999985432 235899998754 23334578899999999999999999
Q ss_pred eeEEeeCCeEEEEEEEccCCChhhhhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDEN----------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 174 ~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
++++...+..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999885432 123688899999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCccc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GRSPLQGLME 317 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~~pf~~~~~ 317 (319)
|++++++.+||+|||++........ .....++..|+|||++....++.++|+||||+++|||++ |..||...+.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999999864322211 122334678999999988889999999999999999988 7788877543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=260.06 Aligned_cols=200 Identities=29% Similarity=0.481 Sum_probs=174.3
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
+.|.+.+.||+|++|.||+|... ++..+++|.+..... .+++.+|+..++.++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 35667788999999999999765 478999999865432 678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999999988543 356899999999999999999999988 9999999999999999999999999987543322 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||....+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 334578899999999888999999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=284.12 Aligned_cols=195 Identities=31% Similarity=0.588 Sum_probs=172.4
Q ss_pred ccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCChhh
Q 020946 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS 197 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~ 197 (319)
+||+|.||+||.|+. .+...+|||.+........+-+++|+.+-+.++|.|||+++|.|.+++..-+.||.+++|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 599999999999954 4566899999877666667789999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEeecCCCcccc-ccccccccc
Q 020946 198 HLYDENYGPL--TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEM-VDKHAANIR 273 (319)
Q Consensus 198 ~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~-~~~~~~~~~ 273 (319)
.|.. ..+++ .+.++-.+.+||++||.|||++. |+|||||-+|||++ -.|.+||+|||-++... .+..+.++.
T Consensus 662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9854 56777 77788899999999999999998 99999999999997 56899999999887554 345567889
Q ss_pred cccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 274 GTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 274 ~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
||..|||||+++. ..|...+|||||||++.||.||++||..+.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 9999999999975 4689999999999999999999999976643
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=264.63 Aligned_cols=199 Identities=26% Similarity=0.386 Sum_probs=169.4
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.+++.++|||++++++++......++++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4677788999999999999664 68899999886432 22345678999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
++++.+..+... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 82 CDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred cCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 999888777643 335899999999999999999999988 9999999999999999999999999987543322 2
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.+..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 223457889999999865 567899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=262.54 Aligned_cols=200 Identities=30% Similarity=0.547 Sum_probs=164.2
Q ss_pred ccccccccCCCceEEEEEeCCC-c--EEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------CeE
Q 020946 115 NFTTLIGQGAFGPVYKAQMSTG-E--TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQH 183 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 183 (319)
.+.+.||+|+||.||+|...+. . .+|+|.+... .....+.+.+|+..++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999976433 2 5899988654 233356788999999999999999999987532 256
Q ss_pred EEEEEEccCCChhhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCC
Q 020946 184 MLVYVFMSKGSLASHLYDE----NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 259 (319)
++++||+++|+|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887432 2234889999999999999999999988 99999999999999999999999999
Q ss_pred Ccccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 260 SREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 260 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 875432211 122345678999999999999999999999999999999 8999987543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=264.54 Aligned_cols=205 Identities=28% Similarity=0.503 Sum_probs=172.3
Q ss_pred HHHHhcccccccccCCCceEEEEEeCC-----CcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEee-CC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMST-----GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KG 181 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 181 (319)
+...+|.+.+.||+|+||.||+|.... +..|++|.+... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345678889999999999999997644 678999988654 23335668899999999999999999998766 46
Q ss_pred eEEEEEEEccCCChhhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEe
Q 020946 182 QHMLVYVFMSKGSLASHLYDENY------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA 255 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 255 (319)
..+++++|+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 78999999999999999865322 45899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 256 DFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 256 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
|||+++...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||.+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 999987432221 1122345678999999988889999999999999999999 999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=271.08 Aligned_cols=209 Identities=33% Similarity=0.559 Sum_probs=173.7
Q ss_pred HHHHHHHhcccccccccCCCceEEEEEeC--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeee
Q 020946 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVG 175 (319)
Q Consensus 106 ~~~l~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~ 175 (319)
..++...+|++.+.||+|+||.||++... .+..+|+|.+.... ....+++.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34566678999999999999999999531 12368999886542 23356788999999999 7999999999
Q ss_pred EEeeCCeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCC
Q 020946 176 YCAEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS 241 (319)
Q Consensus 176 ~~~~~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 241 (319)
+|.+.+..++++||+++++|.+++.... ...+++.++..++.|++.||.|||+++ ++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence 9999999999999999999999986432 234788899999999999999999988 99999999
Q ss_pred CCEEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 242 SNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 242 ~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
+||++++++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999987433221 1122234567999999999999999999999999999998 8999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.87 Aligned_cols=207 Identities=31% Similarity=0.560 Sum_probs=171.7
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 177 (319)
++...++.+.+.||+|+||.||++... ....+|+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888999999999999999531 24578999887542 23345688999999999 699999999999
Q ss_pred eeCCeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 178 AEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 178 ~~~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
.+.+..++++||+++++|.+++.... ...+++.++..++.|++.||.|||+++ ++|+||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 99999999999999999999986532 235889999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|++++++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999874432111 112234567999999988899999999999999999999 9999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=265.53 Aligned_cols=201 Identities=30% Similarity=0.550 Sum_probs=168.0
Q ss_pred cccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 456788999999999999542 23578999886543 23345788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCE
Q 020946 187 YVFMSKGSLASHLYDE----------------------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI 244 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~----------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni 244 (319)
+||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheE
Confidence 9999999999987532 1234788999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 245 LLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 245 ll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|+++++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999987432221 1122345678999999988889999999999999999999 9999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=259.55 Aligned_cols=200 Identities=27% Similarity=0.446 Sum_probs=171.4
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEee-CCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 189 (319)
|.+.+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+.. .+..++++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 67789999999999999954 467899999986432 2334568889999999999999999988764 4568999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
+++++|.+++.......+++.++..++.|++.|+++||+.+ ++|+||+|+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999997655566899999999999999999999998 999999999999999999999999998644322 22
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 234567899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=262.02 Aligned_cols=201 Identities=31% Similarity=0.541 Sum_probs=166.6
Q ss_pred cccccccccCCCceEEEEEeC----CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe-----
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ----- 182 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 182 (319)
|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+..++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 356788999999999999653 23679999987542 2334578899999999999999999998866544
Q ss_pred -EEEEEEEccCCChhhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeec
Q 020946 183 -HMLVYVFMSKGSLASHLYDE----NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF 257 (319)
Q Consensus 183 -~~lv~e~~~~g~l~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 257 (319)
.++++||+++++|..++... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999888543 2235899999999999999999999988 999999999999999999999999
Q ss_pred CCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 258 GLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 258 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|+++....... ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99875432211 112234678999999988889999999999999999999 9999987653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=275.59 Aligned_cols=194 Identities=27% Similarity=0.509 Sum_probs=177.2
Q ss_pred ccccccCCCceEEEE-EeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 117 TTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
.+.||+|.||+||-| ...+|+.||||++.+. ....+..+++|+.+|+.+.||.||.+...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 378999999999999 5568999999999754 3344678999999999999999999999999999999999998 67
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC---CceEEeecCCCcccccccccc
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLSREEMVDKHAA 270 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~ 270 (319)
+..+.+..+..+.+++.....+..||+.||.|||.++ |+|+||||+|||+... -.+||+|||+|+.........
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 8888888888889999999999999999999999999 9999999999999644 479999999999888888888
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
...|||.|+|||++..+.|...-|+||.|||+|--++|..||..
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 99999999999999999999999999999999999999999954
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=260.73 Aligned_cols=200 Identities=26% Similarity=0.408 Sum_probs=170.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 467788999999999999964 47899999987542 22334568899999999999999999999999999999999
Q ss_pred EccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 189 FMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|+++++|.+++.. .....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988753 22345888999999999999999999988 999999999999999999999999988653322
Q ss_pred c-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 267 K-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 267 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
. ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 2 122346888999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=272.00 Aligned_cols=206 Identities=34% Similarity=0.594 Sum_probs=169.2
Q ss_pred HHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 179 (319)
++..++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 34456788999999999999999953 356789999987543 22345688899999999 68999999998865
Q ss_pred -CCeEEEEEEEccCCChhhhhhhcC-------------------------------------------------------
Q 020946 180 -KGQHMLVYVFMSKGSLASHLYDEN------------------------------------------------------- 203 (319)
Q Consensus 180 -~~~~~lv~e~~~~g~l~~~l~~~~------------------------------------------------------- 203 (319)
+...++++||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 456789999999999999885421
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc---ccc
Q 020946 204 ----------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAA 270 (319)
Q Consensus 204 ----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~ 270 (319)
...+++.++..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++....... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 123678888999999999999999998 9999999999999999999999999987532221 111
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
...++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 2335678999999988899999999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=265.33 Aligned_cols=206 Identities=26% Similarity=0.484 Sum_probs=170.2
Q ss_pred HHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG 181 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 181 (319)
+...+|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+..++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34567889999999999999999542 24579999876443 223346788999999999999999999999999
Q ss_pred eEEEEEEEccCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceE
Q 020946 182 QHMLVYVFMSKGSLASHLYDEN--------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 253 (319)
..+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999996421 123567788999999999999999988 99999999999999999999
Q ss_pred EeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 254 VADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 254 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|+|||+++....... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999874322111 112234678999999988889999999999999999998 8999987553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=275.04 Aligned_cols=206 Identities=32% Similarity=0.548 Sum_probs=177.9
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC---CC--cEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS---TG--ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG 181 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 181 (319)
++.+....+.++||.|-||.||+|... .| ..||||.-+.+ ...+.+.|..|..+|+.++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 455666677889999999999999542 22 36899998875 445577899999999999999999999999765
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..|+|||+++.|.|..+|..+ ...++......++.||+.||.|||+.+ ++||||..+|||+....-+||+|||+++
T Consensus 464 P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 689999999999999999654 456888899999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc--ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 262 EEMVDKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 262 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
....+.. .....-+..|||||.+.-..++.++|||.|||++||+++ |..||.|..+.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 7655432 233455788999999999999999999999999999988 99999998765
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.20 Aligned_cols=198 Identities=30% Similarity=0.520 Sum_probs=172.0
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCC-----cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
|...+.||+|++|.||+|... ++..+++|.+.... ....+.+.+|+.+++.++|+||+++.+++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999999999999664 78999999886432 223467889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 82 ELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999998543 45889999999999999999999998 9999999999999999999999999987544333
Q ss_pred cccccccccCccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 334556889999999987766 8999999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.42 Aligned_cols=192 Identities=23% Similarity=0.416 Sum_probs=160.9
Q ss_pred cccccCCCceEEEEEeCC-------------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 118 TLIGQGAFGPVYKAQMST-------------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
+.||+|+||.||+|...+ ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999996432 2258899876655445567888999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc-------eEEeec
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-------ARVADF 257 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-------~kl~Df 257 (319)
+++||+++++|..++... ...+++..+..++.|++.||+|||+++ ++||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999998887543 346899999999999999999999998 999999999999987654 899999
Q ss_pred CCCccccccccccccccccCccCccccC-CCCCCcchhhHHHHHHHHHHH-hCCCCCCCcc
Q 020946 258 GLSREEMVDKHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELI-AGRSPLQGLM 316 (319)
Q Consensus 258 g~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~ell-tg~~pf~~~~ 316 (319)
|++..... .....++..|+|||.+. +..++.++||||||+++|||+ +|+.||.+..
T Consensus 157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 98864322 22345788899999886 567899999999999999998 5999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.86 Aligned_cols=200 Identities=26% Similarity=0.434 Sum_probs=174.0
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|++.+.||+|++|.||++.. .+++.+|+|.+.... ......+.+|+.+++.++|||++++++.+...+..++++||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 66788999999999999954 578899999986542 233567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-CceEEeecCCCccccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~~~ 269 (319)
++++|.+++.......+++..+..++.|++.||.|||+++ ++|+||+|+||+++++ +.++|+|||++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 9999999997655556899999999999999999999998 9999999999999855 46899999998765444444
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 44568899999999988889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.56 Aligned_cols=201 Identities=30% Similarity=0.548 Sum_probs=169.7
Q ss_pred HhcccccccccCCCceEEEEEeC-C---CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-T---GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
.+|++.+.||+|+||.||+|... + +..+|+|.+.... ....+.+.+|+.+++.++||||+++.+++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56778899999999999999652 2 3379999886542 23346788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++++|.+++.... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999986543 46899999999999999999999998 999999999999999999999999998754322
Q ss_pred cc----ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 267 KH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 267 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.. .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 11 111223567999999998889999999999999999887 999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=266.97 Aligned_cols=194 Identities=25% Similarity=0.393 Sum_probs=157.7
Q ss_pred cccccCCCceEEEEEeC---CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQMS---TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 192 (319)
..||+|+||+||+|... ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. ....++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999754 45689999886432 23467889999999999999999998854 5578999999864
Q ss_pred CChhhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE----cCCCceEEeecCCCc
Q 020946 193 GSLASHLYDE-------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSR 261 (319)
Q Consensus 193 g~l~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~~ 261 (319)
+|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 776665321 2235889999999999999999999998 9999999999999 566799999999987
Q ss_pred cccccc----cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 262 EEMVDK----HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 262 ~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||+||++||....+
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~ 221 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence 432221 1234567999999999866 4589999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=262.88 Aligned_cols=196 Identities=30% Similarity=0.482 Sum_probs=165.1
Q ss_pred cccccccccCCCceEEEEEe-----CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHML 185 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 185 (319)
+.+.+.||+|+||+||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988642 367789999987543 23456788999999999999999999988653 46889
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
+|||+++++|.+++... .+++.++..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998543 4899999999999999999999998 99999999999999999999999999875432
Q ss_pred ccc----ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 266 DKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 266 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
... .....++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 211 12233566799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.89 Aligned_cols=202 Identities=30% Similarity=0.564 Sum_probs=169.6
Q ss_pred HhcccccccccCCCceEEEEEeC-CCc---EEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGE---TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..++..+.||+|+||.||+|... ++. .+|+|.+... .....+.+..|+++++.++|||++++.+++.+.+..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 45667889999999999999653 333 7999988654 233356788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++++|.+++... ...+++.++..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999998653 356899999999999999999999998 999999999999999999999999998644322
Q ss_pred ccc----cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 267 KHA----ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 267 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
... .....+..|+|||++....++.++||||||+++|||++ |+.||...+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 111 11223457999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=259.37 Aligned_cols=197 Identities=35% Similarity=0.630 Sum_probs=171.0
Q ss_pred cccccCCCceEEEEEeCC----CcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQMST----GETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||+|.... +..+++|.+...... ..+.+.+|+..+..++|+|++++++++.+....++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999996643 789999998765333 367889999999999999999999999999999999999999
Q ss_pred CChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 193 GSLASHLYDEN-------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 193 g~l~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++|.+++.... ...+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999986541 356899999999999999999999988 99999999999999999999999999875433
Q ss_pred c---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 266 D---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 266 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
. .......++..|+|||.+....++.++||||||+++|||++ |+.||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 2 12334557889999999988889999999999999999999 6999987643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.50 Aligned_cols=201 Identities=30% Similarity=0.571 Sum_probs=169.1
Q ss_pred HhcccccccccCCCceEEEEEeC-CC---cEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TG---ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..|++.+.||+|+||.||+|... ++ ..||+|.+... ......+|..|+..++.++||||+++.+++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788899999999999999653 33 36999998654 333356789999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+++++|.+++... ...+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999988653 346899999999999999999999988 999999999999999999999999988643222
Q ss_pred ccccc----c--ccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 267 KHAAN----I--RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~----~--~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
..... . ..+..|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 11111 1 12457999999998999999999999999999887 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=263.80 Aligned_cols=199 Identities=28% Similarity=0.471 Sum_probs=171.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+.|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3455667899999999999954 467899999886442 33346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+++++|.+++.. ..+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 999999998843 45899999999999999999999988 9999999999999999999999999986433222 1
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 223457889999999998899999999999999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=262.21 Aligned_cols=194 Identities=31% Similarity=0.495 Sum_probs=168.3
Q ss_pred cccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 120 IGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 120 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
||+|+||+||++.. .+|+.+|+|.+.... ......+.+|+++++.++|||++++.+.+...+..++++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999954 478899999886432 22244567899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t 275 (319)
.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.............++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99997655457899999999999999999999998 999999999999999999999999988654333333445678
Q ss_pred cCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 89999999988889999999999999999999999997754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=258.88 Aligned_cols=200 Identities=27% Similarity=0.422 Sum_probs=172.8
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|++|.||+|... +|+.||+|.+... .....+.+.+|++++++++|+|++++++++.+.+..++++|
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 5778899999999999999665 8899999988642 22335678899999999999999999999999999999999
Q ss_pred EccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 189 FMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|+++++|.+++.. .....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998854 22345899999999999999999999998 999999999999999999999999998643322
Q ss_pred c-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 267 K-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 267 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 2 223346788999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=266.63 Aligned_cols=194 Identities=28% Similarity=0.441 Sum_probs=168.9
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
...||+|+||.||++.. .+++.||+|.+........+.+.+|+..+..++|||++++++++...+..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34699999999999954 47899999998655444566788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-ccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRG 274 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 274 (319)
..++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......+
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 987743 35899999999999999999999998 9999999999999999999999999886432221 2234568
Q ss_pred ccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=266.27 Aligned_cols=194 Identities=30% Similarity=0.472 Sum_probs=168.9
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
...||+|+||.||++.. .++..||+|.+........+.+.+|+..++.++||||+++++.+...+..+++|||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35699999999999954 46889999998665545566788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-ccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRG 274 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 274 (319)
.+++.. ..+++.++..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++....... ......+
T Consensus 107 ~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 180 (292)
T cd06658 107 TDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG 180 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeec
Confidence 998743 35889999999999999999999998 9999999999999999999999999986432221 2233568
Q ss_pred ccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+..|+|||.+.+..++.++|+||||+++|||++|+.||.+..
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=265.03 Aligned_cols=204 Identities=26% Similarity=0.495 Sum_probs=169.6
Q ss_pred HHhcccccccccCCCceEEEEEeC-----------------CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcce
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-----------------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 172 (319)
..+|.+.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456788899999999999998432 2346899998754 2333567899999999999999999
Q ss_pred eeeEEeeCCeEEEEEEEccCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDEN---------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 173 ~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
+++++...+..++++||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986532 124778889999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCccc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GRSPLQGLME 317 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~~pf~~~~~ 317 (319)
||+++++.++|+|||+++...... .......+..|+|||......++.++|+||||+++|||++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999987432221 1112234678999999888889999999999999999998 7899976653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=262.98 Aligned_cols=200 Identities=26% Similarity=0.441 Sum_probs=169.0
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667789999999999999654 7899999988654 2233467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
++++|..++.... ...+++..+..++.|++.||.|||+. + ++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SL 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC-Cc
Confidence 9999988885431 23689999999999999999999974 6 99999999999999999999999999864322 22
Q ss_pred ccccccccCccCccccCCC------CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTR------NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~------~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 3344578899999998543 35889999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=264.99 Aligned_cols=203 Identities=29% Similarity=0.507 Sum_probs=171.0
Q ss_pred HHhcccccccccCCCceEEEEEeCC-----------------CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcce
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMST-----------------GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVN 172 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 172 (319)
..+|.+.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4567888999999999999985432 2468999987543 334567889999999999999999
Q ss_pred eeeEEeeCCeEEEEEEEccCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDEN---------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 173 ~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
+++++...+..++++||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986532 125899999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCcc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GRSPLQGLM 316 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--g~~pf~~~~ 316 (319)
|++++++.++|+|||+++...... ......++..|+|||.+....++.++||||||+++|||++ |..||...+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999986432221 1223345778999999988889999999999999999998 788887654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=295.93 Aligned_cols=201 Identities=26% Similarity=0.402 Sum_probs=175.5
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
....|.+.++||+|+||.|..++. .+++.+|+|++... ...+..-|.+|-.+|..-+.+=|+++...|.+.+++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 456678889999999999999954 57889999999752 23345568889999999899999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
|||||+||+|...+.. ...+|++.+..++..|+.||.-||+-| +|||||||+|||+|..|++||+|||.|.....
T Consensus 153 VMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999999999943 337999999999999999999999999 99999999999999999999999998865543
Q ss_pred cc--cccccccccCccCccccC----C-CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 266 DK--HAANIRGTFGYLDPEYIS----T-RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 266 ~~--~~~~~~~t~~y~aPE~~~----~-~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
+. .....+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||...
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 32 345678999999999983 3 67999999999999999999999999754
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=258.46 Aligned_cols=190 Identities=27% Similarity=0.500 Sum_probs=160.9
Q ss_pred cccccCCCceEEEEEeCCCc-----------EEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGE-----------TVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999664322 4778877554333 6788899999999999999999999988 778999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-------ceEEeecCC
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-------RARVADFGL 259 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-------~~kl~Dfg~ 259 (319)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999986543 26899999999999999999999988 99999999999999887 799999999
Q ss_pred CccccccccccccccccCccCccccCCC--CCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
+..... .....++..|+|||++... .++.++|+||||+++|||++ |..||...+
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 875432 2234467789999999776 78999999999999999999 688887764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=286.84 Aligned_cols=198 Identities=30% Similarity=0.547 Sum_probs=172.3
Q ss_pred ccccccCCCceEEEEEe-CCCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 117 TTLIGQGAFGPVYKAQM-STGE----TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.++||+|+||+||+|.+ +.|+ +||+|++... ..+...++.+|+-.|.+++|||+++++|+|.... ..+|.+||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 47899999999999954 3443 7899998765 4445678999999999999999999999998765 88899999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc-
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA- 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 269 (319)
+.|.|.++++.. +..+.....+.|..||++||.|||.++ ++||||..+|||+..-..+||+|||+++....+...
T Consensus 780 P~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999764 467888889999999999999999998 999999999999999999999999999865544332
Q ss_pred --cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccccC
Q 020946 270 --ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319 (319)
Q Consensus 270 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~~ 319 (319)
....-.+.|||-|.+....|+.++|||||||++||++| |..|+.++..+|
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 23345788999999999999999999999999999999 999999987654
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.69 Aligned_cols=192 Identities=24% Similarity=0.426 Sum_probs=159.2
Q ss_pred ccccCCCceEEEEEeCC-------------------------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCccee
Q 020946 119 LIGQGAFGPVYKAQMST-------------------------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 173 (319)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999995411 13588998865544445678889999999999999999
Q ss_pred eeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC---
Q 020946 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM--- 250 (319)
Q Consensus 174 ~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~--- 250 (319)
+++|.+.+..++||||+++++|..++... ...+++..+..++.|++.||+|||+++ ++||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999888543 346899999999999999999999988 99999999999997643
Q ss_pred ----ceEEeecCCCccccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHH-hCCCCCCCccc
Q 020946 251 ----RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELI-AGRSPLQGLME 317 (319)
Q Consensus 251 ----~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~ell-tg~~pf~~~~~ 317 (319)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3899999987533221 22346788999998865 56899999999999999985 69999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=260.45 Aligned_cols=198 Identities=26% Similarity=0.456 Sum_probs=171.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.|+..+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 455667899999999999965 468899999886542 334567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++++|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 99999998843 35889999999999999999999988 9999999999999999999999999986433222 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||++.+..++.++|+||||+++|||++|+.||.+.+
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 23457889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=259.22 Aligned_cols=198 Identities=29% Similarity=0.495 Sum_probs=167.1
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-----cccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHML 185 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 185 (319)
|...+.||+|+||.||+|.. .++..+++|.+.... ......+.+|+.+++.++||||+++++++.+ .+..++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 55678899999999999954 568899999875432 1223468889999999999999999998865 357889
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++||+++++|.+++... ..+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 84 FMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999999998543 35889999999999999999999988 99999999999999999999999999864322
Q ss_pred c----ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 D----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
. .......++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 1 11223457889999999998889999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=260.37 Aligned_cols=202 Identities=29% Similarity=0.549 Sum_probs=169.6
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCc----EEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGE----TVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
...|++.+.||+|+||.||+|... +|. .+|+|.+.... ......+.+|+..++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 456778899999999999999653 333 58999876553 3345678899999999999999999999887 7889
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999998654 345899999999999999999999988 9999999999999999999999999987543
Q ss_pred ccccc---cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 265 VDKHA---ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 265 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
..... ....++..|+|||.+....++.++|+||||+++|||++ |+.||.+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 22211 11223568999999988889999999999999999999 9999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=260.88 Aligned_cols=199 Identities=31% Similarity=0.502 Sum_probs=166.8
Q ss_pred hcccccccccCCCceEEEEEe-----CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHML 185 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 185 (319)
.+.+.+.||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++.+++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 567788999999999999963 3578999999876655556788999999999999999999998754 346899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 99999999999998543 345899999999999999999999998 99999999999999999999999999875432
Q ss_pred cccc----cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 266 DKHA----ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 266 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.... ....++..|+|||++.+..++.++|+||||+++|||++|..|+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 2211 1122345699999998888999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=260.14 Aligned_cols=204 Identities=28% Similarity=0.462 Sum_probs=170.0
Q ss_pred HHHHhcccccccccCCCceEEEEEeCC----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
+...++.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 345567888999999999999996532 3478999886554 3445678999999999999999999998875 457
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++++||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 8999999999999998643 235899999999999999999999988 999999999999999999999999998643
Q ss_pred ccccc--ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 264 MVDKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 264 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
..... .....++..|+|||.+....++.++||||||+++|||++ |+.||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 32211 112234568999999988889999999999999999996 9999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=262.58 Aligned_cols=200 Identities=27% Similarity=0.448 Sum_probs=173.7
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+|.+.+.||+|+||.||++.. .++..+++|.+........+.+.+|+.+++.++|||++++.+.+...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5777889999999999999954 578899999986554444567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 99999999854 34789999999999999999999998 9999999999999999999999999876432222 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+++.|+|||.+....++.++|+||||+++|+|++|+.||...++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 234578899999999888899999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.04 Aligned_cols=198 Identities=30% Similarity=0.465 Sum_probs=174.9
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
|++.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++.+++++||||+++++.+.+.+..++++||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 567889999999999999654 68899999986532 23356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 82 LLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 9999999998544 46899999999999999999999998 999999999999999999999999998755444333
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 45568889999999988889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=258.19 Aligned_cols=199 Identities=29% Similarity=0.498 Sum_probs=168.5
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHM 184 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 184 (319)
.|.+.+.||+|+||.||+|.. .++..+|+|.+... .......+.+|+.+++.++||||+++++++.+. +..+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 467788999999999999954 56899999987532 122345788999999999999999999988764 4688
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+++++|.+++... ..+++.....++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++...
T Consensus 83 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999999988543 35889999999999999999999998 9999999999999999999999999987432
Q ss_pred cc----ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VD----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 21 11223458899999999988889999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=257.25 Aligned_cols=197 Identities=35% Similarity=0.598 Sum_probs=169.2
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
..|.+.+.||+|+||.||++.. +++.+|+|.+.... ..+.+.+|+.++..++|||++++++++... ..++++||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4678889999999999999975 67889999886432 245788999999999999999999998765 4789999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN 271 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 271 (319)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--CCC
Confidence 999999997655556899999999999999999999988 999999999999999999999999998643221 122
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
...+..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+.
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 334678999999988899999999999999999998 9999987653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=261.73 Aligned_cols=200 Identities=28% Similarity=0.461 Sum_probs=168.0
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|++|.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++.+++.+.+..++|+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 35677889999999999999654 788999999865422 2234567899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++..... ..
T Consensus 85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 974 8988886543 36899999999999999999999998 999999999999999999999999998643221 11
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 223346889999999865 568899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=263.26 Aligned_cols=203 Identities=33% Similarity=0.581 Sum_probs=170.1
Q ss_pred HHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
...|.+.+.||+|+||.||+|... ++..+|+|.+.... .....++.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 345677889999999999999653 46789999986542 23346788999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 184 MLVYVFMSKGSLASHLYDEN--------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
++++||+++++|.+++.... ...+++.+++.++.|++.||+|||+++ ++||||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 124788899999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
|++++++.++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999986432221 1122234667999999988899999999999999999998 888997654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=260.45 Aligned_cols=200 Identities=25% Similarity=0.420 Sum_probs=167.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|+||.||+|.. .++..+|+|++..... .....+.+|+.+++.++|+||+++.+++.+.+..++++||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 3567788999999999999954 4788999999865432 2234677899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
+. +++.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..... ..
T Consensus 85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 85 MH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred cc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 95 67877765432 45788889999999999999999998 999999999999999999999999998643221 12
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 233457889999999865 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=257.68 Aligned_cols=202 Identities=30% Similarity=0.454 Sum_probs=173.6
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.|++.+.||.|++|+||+|.. .++..+++|++.... ....+.+.+|+..++.++|+|++++.+.+...+..++++|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 467788999999999999964 467899999986542 234567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc-
Q 020946 191 SKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH- 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 268 (319)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999865433 56899999999999999999999988 99999999999999999999999998764333221
Q ss_pred ----ccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 ----AANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ----~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....++..|+|||.+... .++.++|+||||+++|||++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 1334578899999998766 789999999999999999999999987653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=259.97 Aligned_cols=198 Identities=28% Similarity=0.414 Sum_probs=170.8
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|++|.||+|.. .+|+.|++|++.... ......+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 67788999999999999965 478999999987543 233567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--c
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--H 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 268 (319)
+++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 -~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 82 -PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred -CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 999999886543 56999999999999999999999998 9999999999999999999999999987543322 1
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||.+.+ ..++.++||||||+++|||++|++||.+.+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 334568899999999865 446899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=262.99 Aligned_cols=200 Identities=25% Similarity=0.426 Sum_probs=170.0
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||++.. .+++.|++|.+.... ......+.+|+++++.++||||+++++.+...+..+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 356778999999999999954 467899999886543 2234567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999998543 46899999999999999999999988 9999999999999999999999999876311100
Q ss_pred ---------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 ---------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......++..|+|||.+....++.++|+||||+++|||++|+.||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 01123568889999999888899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=255.08 Aligned_cols=195 Identities=25% Similarity=0.390 Sum_probs=169.7
Q ss_pred cccc-cccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEee----CCeEEEE
Q 020946 114 CNFT-TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE----KGQHMLV 186 (319)
Q Consensus 114 ~~~~-~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv 186 (319)
|.+. ++||-|-.|.|-.+ +..+++.+|+|++... ...++|+++--.. .|||||++++++.+ ...+.+|
T Consensus 63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred heehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 4443 67999999999999 5568999999998543 2335666654333 69999999998765 3578899
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc---CCCceEEeecCCCccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREE 263 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~ 263 (319)
||.|++|.|...+.++....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|.. .|..+||+|||+|+..
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccccc
Confidence 99999999999998888888999999999999999999999999 99999999999996 4567999999999987
Q ss_pred cccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+.+-||.|.|||++...+|+...|+||+||++|-|++|-+||....
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 77777888999999999999999999999999999999999999999998654
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=256.95 Aligned_cols=198 Identities=30% Similarity=0.489 Sum_probs=171.7
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|++.+.||+|++|.||+|.. .+++.+++|.+..... ...+.+.+|+.+++.++|+||+++++.+.+.+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 367788999999999999964 4788999999876543 2567889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc-
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH- 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 268 (319)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998543 35788999999999999999999998 99999999999999999999999999865432222
Q ss_pred ----ccccccccCccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 269 ----AANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 269 ----~~~~~~t~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.....++..|+|||++.... ++.++||||||+++|||++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 11345788999999997766 889999999999999999999999765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=256.90 Aligned_cols=200 Identities=25% Similarity=0.399 Sum_probs=172.6
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|.+.+.||+|+||.+|++.. .+++.+|+|.+... .....+++.+|+.++++++||||+++.+++.+.+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 367788999999999999954 57889999988643 233345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+++++|.+++.......+++.++..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999886655456899999999999999999999988 9999999999999999999999999986432221 1
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 22345788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=253.66 Aligned_cols=204 Identities=25% Similarity=0.507 Sum_probs=172.2
Q ss_pred CHHHHHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCe
Q 020946 105 SYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 105 ~~~~l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 182 (319)
+++|+-+-+ .+.||+|+|+.|--+ .+.+|.++|||++.+...-...++.+|++++...+ |+||++++.+|+++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 344544333 367999999999988 67899999999998776666778899999999985 9999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC---ceEEeecCC
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGL 259 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~ 259 (319)
.|+|||-|.+|+|..++..+ ..+++.++.++..+|+.||.|||.++ |.||||||+|||-.... -+||+||.+
T Consensus 151 FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999654 46999999999999999999999999 99999999999996543 589999988
Q ss_pred Ccccccc--------ccccccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 260 SREEMVD--------KHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 260 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....... ....+.+|+..|||||+.. ...|+.+.|.||||||||-|++|-+||.|.=
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 6432221 2233567888999999863 3468999999999999999999999998853
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=255.66 Aligned_cols=194 Identities=32% Similarity=0.506 Sum_probs=162.7
Q ss_pred cccccCCCceEEEEEeC-C---CcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQMS-T---GETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||+|... . +..+|+|.+..... ...+++.+|+.+++.++||||+++++++. .+..++++||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999542 2 26899999875533 24567889999999999999999999875 5568999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc---
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--- 269 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 269 (319)
++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999996543 6899999999999999999999988 999999999999999999999999998754322211
Q ss_pred -cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 270 -ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 270 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 11223467999999998899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=255.40 Aligned_cols=199 Identities=31% Similarity=0.569 Sum_probs=170.5
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
.+++.+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+++++.++|||++++++++......++++||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 567788999999999999987778899999886432 2346788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc--cc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--AA 270 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 270 (319)
++|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||+++....... ..
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999886432 45889999999999999999999998 99999999999999999999999999864322211 11
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
...++..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 2234578999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=278.09 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=176.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
+.|++...||.|+||.||+|.. .++-..|.|++...+....+++.-|+++|....||+||.+++.|...+.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4566777899999999999954 355567889988777777889999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~ 269 (319)
.+|..+..+..- ...+++.++..+++|++.||.|||+++ |||||||.-|||++.+|.++|+|||.+..... ....
T Consensus 112 ~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred CCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999888654 357999999999999999999999999 99999999999999999999999998754332 2345
Q ss_pred cccccccCccCcccc-----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYI-----STRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~-----~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..+.|||+|||||+. ...+|+.++||||||++|.||..+.+|-..++
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 678999999999986 34689999999999999999999999977654
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=254.22 Aligned_cols=195 Identities=32% Similarity=0.547 Sum_probs=167.2
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCChh
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA 196 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~ 196 (319)
+.||+|++|.||++...+++.|++|.+...... ....+.+|+++++.++||||+++++++.+.+..++++||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999997766999999988654332 4567899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc---cccc
Q 020946 197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA---ANIR 273 (319)
Q Consensus 197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~ 273 (319)
+++... ...+++..+..++.+++.||.|||+++ ++||||+|+||+++.++.++|+|||++......... ....
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 998653 246889999999999999999999998 999999999999999999999999998643321111 1123
Q ss_pred cccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 274 ~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.+..|+|||.+.+..++.++|+||||+++|||+| |..||.+..
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 3567999999988889999999999999999999 899997754
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=254.84 Aligned_cols=199 Identities=36% Similarity=0.623 Sum_probs=170.5
Q ss_pred ccccccccCCCceEEEEEeCC-----CcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 115 NFTTLIGQGAFGPVYKAQMST-----GETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
++.+.||+|+||.||++.... +..+|+|.+...... ..+.+..|+..+..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999996543 378999999765433 46688999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++.......+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 999999999986544333899999999999999999999998 99999999999999999999999999875433211
Q ss_pred cc--ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 269 AA--NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 269 ~~--~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.. ...+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11 2336789999999988889999999999999999998 899997654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=277.04 Aligned_cols=198 Identities=29% Similarity=0.515 Sum_probs=173.5
Q ss_pred ccccccccCCCceEEEEEeC--CCc--EEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 115 NFTTLIGQGAFGPVYKAQMS--TGE--TVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.+.++||+|.||.|++|.|. +|+ .||||++..+... ...+|.+|+.+|.+|+|+|+++++|+..+ ....+|+|+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 45578999999999999663 444 6899999877544 56789999999999999999999999887 678899999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
++.|+|.+.|+......|.......++.||+.||.||.+++ +|||||..+|+|+.....+||+|||+.+....+...
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999998866777888999999999999999999999 999999999999999999999999998855444332
Q ss_pred c----ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 270 A----NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 270 ~----~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
. ...-...|+|||.+....++.++|||+|||++|||+| |..||.|..
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 2 2335678999999999999999999999999999999 999999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=259.42 Aligned_cols=199 Identities=28% Similarity=0.435 Sum_probs=162.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHH-HhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVML-LGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.|.+.+.||+|+||.||++.. .+|..||+|.+.... .....++..|+.. ++..+||||+++++++...+..++++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 356778899999999999965 468999999986542 2223445556554 6667899999999999999999999999
Q ss_pred ccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 190 MSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
++ ++|.+++... ....+++..+..++.|++.||.|||++ + ++||||||+||++++++.+||+|||++......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 96 6787776432 234689999999999999999999986 6 999999999999999999999999998754332
Q ss_pred ccccccccccCccCccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 267 KHAANIRGTFGYLDPEYIST----RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 22233567889999998864 45689999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=261.54 Aligned_cols=198 Identities=30% Similarity=0.404 Sum_probs=168.0
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcc-----cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ-----GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
|++.+.||+|++|.||+|.. .+++.||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 56678899999999999965 46899999998654322 2345678999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD- 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 266 (319)
||+ +++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 999 899999986543 36999999999999999999999998 999999999999999999999999998754332
Q ss_pred ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+++.|+|||.+.+ ..++.++|+||||+++|||++|.+||.+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 12223346788999998854 567899999999999999999988887654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=259.37 Aligned_cols=198 Identities=27% Similarity=0.467 Sum_probs=176.3
Q ss_pred cccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 114 CNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+++..+||+|+||.||+| ...+|..+|+|.+..+ .+.+++..|+.++++.+.|++|+++|.+.....+|+|||||--
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 356688999999999999 5668999999987543 4577899999999999999999999998888899999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN 271 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~ 271 (319)
|+..+.++.+ +.++++.++..++...+.||+|||... -+|||||.-|||++.+|..||+|||.+-.... .....+
T Consensus 113 GSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 113 GSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred CcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 9999998664 468999999999999999999999987 79999999999999999999999999854322 233457
Q ss_pred cccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..|||.|||||++....|+.++||||||++..||..|++||.+..+
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 7899999999999999999999999999999999999999988653
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=260.03 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=168.9
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|+..+.||+|++|.||+|.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 45678899999999999965 478899999886542 223457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
. ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...... ...
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 5 68988887655667999999999999999999999988 999999999999999999999999998643222 122
Q ss_pred cccccccCccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||.+.+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2344688999999886544 6889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=259.64 Aligned_cols=197 Identities=29% Similarity=0.506 Sum_probs=166.5
Q ss_pred HhcccccccccCCCceEEEEEe-----CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 183 (319)
..|.+.+.||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++|||++++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4566778899999999999963 357889999986543 33346789999999999999999999998775 568
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++++||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999998543 235899999999999999999999998 999999999999999999999999998754
Q ss_pred ccccc----ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 020946 264 MVDKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312 (319)
Q Consensus 264 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf 312 (319)
..... .....++..|+|||.+.+..++.++||||||+++|||++++.|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 32211 12344677899999998888999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=258.21 Aligned_cols=203 Identities=29% Similarity=0.533 Sum_probs=171.0
Q ss_pred HhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
..+.+.+.||+|+||.||+|... +...+++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45667788999999999999653 3457999988654333 3567899999999999999999999999989999
Q ss_pred EEEEEccCCChhhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeec
Q 020946 185 LVYVFMSKGSLASHLYDENY-------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF 257 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 257 (319)
+++||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999865431 25899999999999999999999998 999999999999999999999999
Q ss_pred CCCccccccc--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 258 GLSREEMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 258 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~ 224 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch
Confidence 9976432211 1223346778999999988888999999999999999999 8899976543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=256.40 Aligned_cols=195 Identities=30% Similarity=0.533 Sum_probs=166.1
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
...||+|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++++||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 35799999999999964 46788999998766555667889999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCCCcccccc-ccccc
Q 020946 196 ASHLYDENYGPL--TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVD-KHAAN 271 (319)
Q Consensus 196 ~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~-~~~~~ 271 (319)
.+++.... ..+ ++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++...... .....
T Consensus 93 ~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 93 SALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred HHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence 99986532 234 78888999999999999999988 999999999999976 679999999998643221 22233
Q ss_pred cccccCccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 272 IRGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
..+++.|+|||++... .++.++|+||||+++|+|++|+.||...
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 4578999999998654 3789999999999999999999999754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=257.89 Aligned_cols=192 Identities=30% Similarity=0.477 Sum_probs=157.9
Q ss_pred ccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHH---hccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLL---GRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.||+|+||.||++.. .+++.+|+|.+..... .....+.+|..++ ...+|||++.+.+++...+..+++|||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 4688999998865321 1122334444333 34479999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN 271 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 271 (319)
+++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++...... ....
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 154 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence 99999888543 45999999999999999999999998 999999999999999999999999998643222 2233
Q ss_pred cccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 272 IRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 272 ~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..++..|+|||.+. +..++.++|+|||||++|||++|+.||.+..
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 46899999999986 4568999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=258.23 Aligned_cols=201 Identities=30% Similarity=0.516 Sum_probs=169.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEee------CCeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE------KGQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~ 183 (319)
..|.+.+.||+|+||.||+|.. .+++.+|+|++..... ....+..|+.++.++ +|+||+++++++.. .+..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 5667778999999999999955 5788999998855432 345678899999988 69999999998853 4578
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
+++|||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 99999999999999987655566889999999999999999999998 999999999999999999999999998643
Q ss_pred ccc-ccccccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVD-KHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... .......+++.|+|||.+. ...++.++|+||||+++|||++|+.||....
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 221 2233456889999999985 3567889999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=259.58 Aligned_cols=198 Identities=29% Similarity=0.441 Sum_probs=169.7
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|++.+.||+|++|.||+|... +++.||+|.+... .....+.+.+|+++++.++|+||+++++++.+.+..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 4778899999999999999654 6889999988653 233356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-- 267 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-- 267 (319)
++++.+...... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 82 VERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 988666554432 345899999999999999999999998 9999999999999999999999999987544332
Q ss_pred cccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 268 HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
......++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+.
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 23345678899999999877 8899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=255.22 Aligned_cols=192 Identities=27% Similarity=0.418 Sum_probs=168.5
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 120 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
||+|++|.||++... +++.+++|++.... ....+.+.+|+.+++.++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999664 58899999986532 23346789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t 275 (319)
.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.............++
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 9998543 35899999999999999999999988 999999999999999999999999998755443333345678
Q ss_pred cCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+.|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 99999999988889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=256.63 Aligned_cols=197 Identities=27% Similarity=0.527 Sum_probs=168.2
Q ss_pred cccccccccCCCceEEEEE-eCCCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
|+..+.||+|++|.||++. ..+++.+|+|++..... ...+.+.+|+..++.++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 5566889999999999995 46789999999864321 1245788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMV 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~ 265 (319)
+||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 82 VEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999988543 46889999999999999999999998 99999999999998775 699999999864432
Q ss_pred cc-----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 266 DK-----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 266 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 21 112345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.87 Aligned_cols=196 Identities=27% Similarity=0.438 Sum_probs=158.5
Q ss_pred ccccCCCceEEEEEeCCCc---EEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 119 LIGQGAFGPVYKAQMSTGE---TVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+..++.++||||+++++.|.+....+++|||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999643333 45667665432 2345678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc---ccc
Q 020946 195 LASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---KHA 269 (319)
Q Consensus 195 l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~---~~~ 269 (319)
|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++...... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999986532 234667778899999999999999988 999999999999999999999999987532211 112
Q ss_pred cccccccCccCccccCC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYIST-------RNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~-------~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
....++..|+|||++.. ..++.++||||||+++|||++ |..||...++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 23457889999998743 245789999999999999997 6778876543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=276.77 Aligned_cols=201 Identities=23% Similarity=0.362 Sum_probs=157.9
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC--CCcEEEEEEe--------------cc---CCcccHHHHHHHHHHHhccCCC
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS--TGETVAVKVL--------------AT---DSKQGEKEFQTEVMLLGRLHHR 168 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~ 168 (319)
+.....|++.+.||+|+||+||++... ++...+.|.+ .. ........+.+|+.+++.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 444578999999999999999998542 2222222211 00 1112245678999999999999
Q ss_pred CcceeeeEEeeCCeEEEEEEEccCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEE
Q 020946 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL 245 (319)
Q Consensus 169 niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 245 (319)
||+++++++.+.+..+++++++. +++.+++.... .......++..++.|++.||+|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999984 57777764422 122345667889999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCCccccccc--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 020946 246 LDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312 (319)
Q Consensus 246 l~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf 312 (319)
++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.|+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999987543222 223457899999999999999999999999999999999987643
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=261.27 Aligned_cols=200 Identities=31% Similarity=0.571 Sum_probs=165.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCc----EEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGE----TVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
..++..+.||+|+||.||+|.. .++. .+|+|.+..... ....++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4455678899999999999964 3444 478888765432 2234688999999999999999999998754 4678
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
+++|+++|+|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999988643 345889999999999999999999988 99999999999999999999999999875332
Q ss_pred ccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 266 DKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 266 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 221 122335678999999998999999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=255.48 Aligned_cols=199 Identities=27% Similarity=0.468 Sum_probs=170.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|+..+..++||||+++++++.+.+..++++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3456678899999999999954 478899999876432 23345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 84 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 999999998843 35899999999999999999999988 9999999999999999999999999886433221 1
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 223457889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=265.95 Aligned_cols=198 Identities=26% Similarity=0.364 Sum_probs=167.9
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------C
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------G 181 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 181 (319)
..+|...+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 45688889999999999999954 57899999998643 223345677899999999999999999987643 3
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..++++||+. ++|.+.+.. .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 5799999995 578877743 2888999999999999999999998 9999999999999999999999999987
Q ss_pred cccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
............++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 5443333344567899999999999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=259.62 Aligned_cols=195 Identities=26% Similarity=0.407 Sum_probs=164.1
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|+||.||+|.. .+|+.+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 66778899999999999965 478899999986532 222356778999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
. ++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..... ...
T Consensus 82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 82 D-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 6 5788777543 346899999999999999999999998 999999999999999999999999998743222 122
Q ss_pred cccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 270 ANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
....+++.|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 234578899999998664 47899999999999999999988853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=257.46 Aligned_cols=202 Identities=29% Similarity=0.429 Sum_probs=167.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEe-----eCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCA-----EKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~~ 184 (319)
.+|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++..+ +||||+++++++. .++..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 4567788999999999999954 467899999875432 2245678899999999 6999999999874 345789
Q ss_pred EEEEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 185 LVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
++|||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceee
Confidence 99999999999988753 23346889999999999999999999988 99999999999999999999999999865
Q ss_pred ccccc-cccccccccCccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDK-HAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~-~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..... ......+++.|+|||++.. ..++.++|||||||++|||++|+.||....+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 43221 2234468999999998753 4578999999999999999999999986643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=256.05 Aligned_cols=197 Identities=31% Similarity=0.492 Sum_probs=171.6
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
|.+.+.||+|++|.||++... +++.+++|.+.... .....++.+|++.++.++||||+++++.+...+..++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456678999999999999654 68899999886653 3345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 270 (319)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 157 (265)
T cd06605 83 GGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-AK 157 (265)
T ss_pred CCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-hh
Confidence 999999886543 568999999999999999999999 77 9999999999999999999999999886443222 12
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 266888999999998889999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.18 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=170.4
Q ss_pred cccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 188 (319)
|++.+.||.|+||.||++. ..++..+|+|.+... .....+.+..|+.+++.++||||+++++++.. ....++++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 5677889999999999995 457889999988643 23335578889999999999999999997754 456899999
Q ss_pred EccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 189 FMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLH-----DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 189 ~~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
|+++++|.+++... ....+++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999988542 2456899999999999999999999 666 9999999999999999999999999987
Q ss_pred ccccccc-ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EEMVDKH-AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 5443332 334568999999999988889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=255.54 Aligned_cols=197 Identities=29% Similarity=0.512 Sum_probs=167.1
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---c-------cHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---Q-------GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
|...+.||+|++|.||+|.. .+++.+|+|.+..... . ..+.+.+|+.+++.++|||++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 55678899999999999954 4788999998753211 0 12457889999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++++||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 99999999999999998554 46899999999999999999999988 99999999999999999999999999865
Q ss_pred ccccc---cccccccccCccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 263 EMVDK---HAANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 263 ~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
..... ......++..|+|||.+.... ++.++|+||||+++|||++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 33211 122345788999999987654 789999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=252.88 Aligned_cols=198 Identities=30% Similarity=0.476 Sum_probs=174.3
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
|++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|+..+.+++|+|++++++++...+..++++||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 567789999999999999654 589999999876543 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc-
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA- 269 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 269 (319)
+++|.+++... ..+++..+..++.|++.|++|||+ .+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 99999999643 568999999999999999999999 88 999999999999999999999999998754332222
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 24567889999999988899999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=257.55 Aligned_cols=192 Identities=24% Similarity=0.442 Sum_probs=160.4
Q ss_pred cccccCCCceEEEEEeC-C-------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMS-T-------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+.||+|+||.||+|... . ...+++|.+........+.+.+|..+++.++|||++++++++..++..+++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 35899999999999542 2 234888887655444456788999999999999999999999998999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc--------eEEeecCCCc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--------ARVADFGLSR 261 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--------~kl~Dfg~~~ 261 (319)
+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999986543 36899999999999999999999998 999999999999987765 6999999876
Q ss_pred cccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhC-CCCCCCcc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAG-RSPLQGLM 316 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg-~~pf~~~~ 316 (319)
.... .....++..|+|||++.+ ..++.++||||||+++|||++| ..||...+
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~ 210 (258)
T cd05078 157 TVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210 (258)
T ss_pred ccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence 4322 233457889999999976 4578999999999999999998 56776544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=259.12 Aligned_cols=197 Identities=28% Similarity=0.448 Sum_probs=162.8
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
...+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+..+.++. ||||+++++++...+..++++||+.
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 3456799999999999954 468999999886542 233557889999999996 9999999999999999999999986
Q ss_pred CCChhh---hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 192 KGSLAS---HLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 192 ~g~l~~---~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
. ++.+ .+.......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++.......
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 4 4443 33333345699999999999999999999974 6 9999999999999999999999999986543333
Q ss_pred cccccccccCccCccccCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 268 HAANIRGTFGYLDPEYISTR---NFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~---~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 33344678899999998765 6899999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=257.47 Aligned_cols=196 Identities=34% Similarity=0.567 Sum_probs=163.9
Q ss_pred cccccCCCceEEEEEeCC-------CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMST-------GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999996532 2579999876442 23456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-----ceEEeecCC
Q 020946 190 MSKGSLASHLYDEN-----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-----RARVADFGL 259 (319)
Q Consensus 190 ~~~g~l~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Dfg~ 259 (319)
+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 234788999999999999999999988 99999999999999887 899999999
Q ss_pred Cccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 260 SREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 260 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
+....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 86432221 1112335678999999998899999999999999999998 999997654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=255.20 Aligned_cols=194 Identities=28% Similarity=0.449 Sum_probs=169.1
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
.+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 46899999999999964 57889999988655444456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-ccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRG 274 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 274 (319)
.+++.. ..+++..+..++.|++.||+|||+++ ++||||+|+||++++++.++|+|||.+....... ......+
T Consensus 104 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 177 (285)
T cd06648 104 TDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG 177 (285)
T ss_pred HHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence 998854 45899999999999999999999998 9999999999999999999999999876432221 1223458
Q ss_pred ccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
++.|+|||.+.+..++.++|+||||+++|||++|+.||.+.+
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 899999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.64 Aligned_cols=194 Identities=33% Similarity=0.584 Sum_probs=158.8
Q ss_pred cccccCCCceEEEEEeC----CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEe-eCCeEEEEEEEcc
Q 020946 118 TLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA-EKGQHMLVYVFMS 191 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 191 (319)
+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++. ..+..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999642 2357999987543 2334567888999999999999999999875 4556889999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc----
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---- 267 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---- 267 (319)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999986432 34677888999999999999999988 9999999999999999999999999986432211
Q ss_pred -cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCc
Q 020946 268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~ 315 (319)
......++..|+|||.+.+..++.++||||||+++|||++ |.+||...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1112345678999999988899999999999999999999 56677654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=255.17 Aligned_cols=198 Identities=28% Similarity=0.521 Sum_probs=169.2
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccC---CCCcceeeeEEeeCCeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 188 (319)
|++.+.||+|+||.||+|.. .+++.+|+|.+... ......++.+|+.+++.++ |||++++++++.+....+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 45667899999999999964 57899999998654 3334567888999999886 9999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 83 YAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred cCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999998843 36899999999999999999999998 9999999999999999999999999886543322
Q ss_pred cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2234468889999998864 4578999999999999999999999977643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=254.22 Aligned_cols=191 Identities=30% Similarity=0.475 Sum_probs=158.0
Q ss_pred ccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHH---HHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVM---LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.||+|+||.||++.. .+++.||+|.+..... .....+..|.. .+...+||||+.+.+++.+.+..++++||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999954 4688999998865321 11122333433 3445579999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN 271 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 271 (319)
+++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~-~~~~~ 154 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 154 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc-cCCcC
Confidence 9999988854 346999999999999999999999988 99999999999999999999999999864322 22234
Q ss_pred cccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 272 IRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 272 ~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
..++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.+.
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 568999999999864 46899999999999999999999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=255.15 Aligned_cols=197 Identities=26% Similarity=0.385 Sum_probs=163.9
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccC-CCCcceeeeEEeeC--CeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEK--GQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 188 (319)
|.+.+.||+|+||.||+|.. .+++.+|+|.+.... ........+|+..+.++. |+|++++++++.+. +..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999954 478899999986542 222234457888888885 99999999999887 88999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|++ +++.+.+.... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++ +.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 58888775432 46899999999999999999999998 999999999999999 9999999999876544333
Q ss_pred ccccccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||.+. +..++.++|+|||||++|||++|+.||.+.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 34456789999999764 4567899999999999999999999998754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=256.15 Aligned_cols=201 Identities=30% Similarity=0.453 Sum_probs=167.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC-----CeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK-----GQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~ 184 (319)
..|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++... +..+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 4577788999999999999955 578899999986432 2245677899999988 799999999998753 3689
Q ss_pred EEEEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 185 LVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+++||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 99999999999998753 23346899999999999999999999988 99999999999999999999999999865
Q ss_pred ccccc-cccccccccCccCccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDK-HAANIRGTFGYLDPEYISTR-----NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~-~~~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..... ......++..|+|||.+... .++.++|+|||||++|||++|+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 33221 22334678899999998543 36899999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=259.96 Aligned_cols=200 Identities=26% Similarity=0.394 Sum_probs=166.1
Q ss_pred cccccccccCCCceEEEEEeC---CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS---TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHML 185 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 185 (319)
|++.+.||+|++|.||+|... ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 667788999999999999654 47899999987632 33345678899999999999999999999888 78999
Q ss_pred EEEEccCCChhhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC----CCceEEeecC
Q 020946 186 VYVFMSKGSLASHLYDE---NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ----SMRARVADFG 258 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg 258 (319)
|+||+++ ++.+.+... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 666655322 2236889999999999999999999998 999999999999999 8999999999
Q ss_pred CCccccccc----cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 259 LSREEMVDK----HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 259 ~~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 987432221 1223457889999998865 4578999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=257.13 Aligned_cols=200 Identities=27% Similarity=0.422 Sum_probs=166.2
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 4677889999999999999654 788999998864422 2345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCCCcccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVD-K 267 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~-~ 267 (319)
++ +++.+++.......+++..+..++.|++.||+|||+++ ++|+||+|+||++++ ++.+||+|||++...... .
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 96 57887775544445688888999999999999999988 999999999999985 567999999998643222 1
Q ss_pred cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||.+.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2233456889999998865 457899999999999999999999997654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=258.44 Aligned_cols=199 Identities=29% Similarity=0.438 Sum_probs=168.2
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|++.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 4677889999999999999664 68899999876432 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
++++++..+.... ..+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 82 VDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred CCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9998888766432 34899999999999999999999988 999999999999999999999999998643322 22
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||.+.+ ..++.++||||||+++|||++|++||.+.+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 233457889999999865 457889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=254.74 Aligned_cols=199 Identities=29% Similarity=0.430 Sum_probs=167.7
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|++.+.||+|++|.||+|.. .+|..||+|++.... ......+.+|+..++.++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 35668899999999999965 478999999986542 223456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
+ ++|.+++.......+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 5 68998886554456899999999999999999999988 9999999999999999999999999986432221 12
Q ss_pred cccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23346889999998765 457899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=254.98 Aligned_cols=200 Identities=29% Similarity=0.429 Sum_probs=167.0
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhcc---CCCCcceeeeEEeeCCe-----
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRL---HHRNLVNLVGYCAEKGQ----- 182 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 182 (319)
|++.+.||+|+||.||+|... ++..+|+|++..... .....+.+|+.++..+ +|||++++.+++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456788999999999999765 589999999864322 2234556677766555 69999999999988776
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++++||+. ++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 47888886544446899999999999999999999988 99999999999999999999999999875
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...........++..|+|||.+.+..++.++|+||||+++|||++|++||.+.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 5443333344578899999999988999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.80 Aligned_cols=204 Identities=20% Similarity=0.294 Sum_probs=153.3
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeCC----CcEEEEEEeccCCcccH-----------HHHHHHHHHHhccCCCCcc
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATDSKQGE-----------KEFQTEVMLLGRLHHRNLV 171 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv 171 (319)
.++...+|.+.+.||+|+||.||+|...+ +..+|+|+......... .....+...+..++|+|++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34555678999999999999999997543 44667776433221110 1112333456677899999
Q ss_pred eeeeEEeeCC----eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc
Q 020946 172 NLVGYCAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD 247 (319)
Q Consensus 172 ~~~~~~~~~~----~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 247 (319)
++++.+.... ..++++++.. .++.+.+.. ....++..+..++.|++.||+|||+.+ ++||||||+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~ 160 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVD 160 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence 9998765543 2355566553 355555432 234678888999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCCcccccc--------ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 248 QSMRARVADFGLSREEMVD--------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 248 ~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.++.++|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999998643211 11223468999999999999999999999999999999999999998773
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=256.27 Aligned_cols=199 Identities=27% Similarity=0.399 Sum_probs=166.7
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVY 187 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 187 (319)
.|.+.+.||+|++|.||+|... ++..+++|.+..... .....+.+|+.++.+++||||+++++++... +..++++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4667788999999999999664 688999999865432 2233567899999999999999999998877 8999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD- 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 266 (319)
||+. ++|.+.+.... ..+++..++.++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||++......
T Consensus 86 e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 86 EYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred hhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9997 48888875433 36899999999999999999999998 999999999999999999999999998754332
Q ss_pred ccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 222334578899999998654 46899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=252.57 Aligned_cols=199 Identities=25% Similarity=0.466 Sum_probs=167.2
Q ss_pred cccccccccCCCceEEEEEeCC--CcEEEEEEeccCC----------cccHHHHHHHHHHHhc-cCCCCcceeeeEEeeC
Q 020946 114 CNFTTLIGQGAFGPVYKAQMST--GETVAVKVLATDS----------KQGEKEFQTEVMLLGR-LHHRNLVNLVGYCAEK 180 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~ 180 (319)
|.+.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5567889999999999997654 6789999875321 1123456678887764 7999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeec
Q 020946 181 GQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADF 257 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Df 257 (319)
+..++++||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999988743 234568999999999999999999996 55 999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 258 GLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 258 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
|++.............++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9987544333334556889999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=256.64 Aligned_cols=193 Identities=28% Similarity=0.451 Sum_probs=168.2
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCChh
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA 196 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~ 196 (319)
..||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|+|++++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999965 578899999886554445667889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cccccccc
Q 020946 197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGT 275 (319)
Q Consensus 197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t 275 (319)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 87743 35889999999999999999999998 9999999999999999999999999876433221 22335678
Q ss_pred cCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+.|+|||.+....++.++|+||||+++|+|++|..||.+..
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=253.64 Aligned_cols=201 Identities=31% Similarity=0.543 Sum_probs=164.4
Q ss_pred cccccccccCCCceEEEEEeC----CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC------
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------ 181 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 181 (319)
|.+.+.||+|+||.||+|.+. +++.+|+|++... .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 356678999999999999642 4678999998654 2333567889999999999999999999886532
Q ss_pred eEEEEEEEccCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeec
Q 020946 182 QHMLVYVFMSKGSLASHLYDEN----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF 257 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 257 (319)
..+++++|+++|+|..++.... ...+++...+.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 3478889999999988875322 224788999999999999999999988 999999999999999999999999
Q ss_pred CCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 258 GLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 258 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|+++...... ......+++.|++||.+....++.++||||||+++|||++ |+.||.+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence 9987543221 1122345678999999988889999999999999999999 9999987653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=247.99 Aligned_cols=198 Identities=35% Similarity=0.570 Sum_probs=174.9
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
|.+.+.||+|++|.||++... ++..+++|++..........+.+|+..++.++|+|++++++++...+..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 456788999999999999664 6889999999766544567889999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 272 (319)
++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+............
T Consensus 82 ~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 82 GSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred CcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99999886542 46899999999999999999999988 999999999999999999999999998754433223455
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.++..|+|||.+....++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 6889999999998888999999999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=254.24 Aligned_cols=199 Identities=28% Similarity=0.481 Sum_probs=167.8
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
|++.+.||+|++|.||+|.. .+|..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 56778999999999999965 4688999999875532 234567789999999999999999999999999999999998
Q ss_pred CCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 192 KGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 192 ~g~l~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
+ +|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 5 8888775432 246899999999999999999999998 9999999999999999999999999986432221 12
Q ss_pred cccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23456889999998855 457899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=250.47 Aligned_cols=192 Identities=26% Similarity=0.423 Sum_probs=159.1
Q ss_pred hccccccc--ccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLI--GQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+.+.+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +|||++++++.+...+..+++||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 44555555 9999999999954 5788999999864321111 22222212 79999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 267 (319)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-- 162 (267)
T PHA03390 90 YIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-- 162 (267)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC--
Confidence 99999999998544 37999999999999999999999998 99999999999999998 999999998864422
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....++..|+|||++.+..++.++|+||||+++|||++|+.||....+
T Consensus 163 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 163 -PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred -CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 2234688999999999988999999999999999999999999986543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=272.99 Aligned_cols=191 Identities=32% Similarity=0.455 Sum_probs=166.0
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
+.||.|+||.||.|+. .+.+.||||.+.-..+ +...++..|+..|.+++|||++.+.|+|-.....|+|||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 6799999999999954 5778999999865433 345689999999999999999999999999889999999994 5
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccccc
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR 273 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 273 (319)
+-.+.+.- ...++.+..+..|+.+.+.||.|||+.+ .||||||.-|||+++.|.+||+|||.+... ....+++
T Consensus 111 SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~---~PAnsFv 183 (948)
T KOG0577|consen 111 SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM---APANSFV 183 (948)
T ss_pred cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc---Cchhccc
Confidence 66666532 3457889999999999999999999999 999999999999999999999999987533 4456789
Q ss_pred cccCccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 274 GTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 274 ~t~~y~aPE~~---~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
|||.|||||++ +.+.|+-++||||||++..||.-+++|+-+++
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN 229 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 229 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence 99999999997 56889999999999999999999999976653
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=256.13 Aligned_cols=197 Identities=32% Similarity=0.424 Sum_probs=166.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+++.+|+.+++.++||||+++.++|.+.+..++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 3467778999999999999965 4688999998864322 23356889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+. |++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9996 5777766432 346899999999999999999999988 99999999999999999999999998864322
Q ss_pred cccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||++. ...++.++||||||+++|||++|+.||.+..
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred -CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 23456788999999874 4568899999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=250.44 Aligned_cols=202 Identities=27% Similarity=0.379 Sum_probs=166.6
Q ss_pred hcccccccccCCCceEEEEEe-C--C--CcEEEEEEeccCCcc--cHHHHHHHHHHHhccCCCCcceeeeEEee-CCeEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-S--T--GETVAVKVLATDSKQ--GEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHM 184 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~--~--~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~ 184 (319)
.|+....||+|.||.||+|.. + + ...+|+|.++..... -....-+|+.+++.++|||++.+..++.+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 467778899999999999933 2 2 237899998755322 23456789999999999999999998876 77899
Q ss_pred EEEEEccCCChhhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC----CceEEeec
Q 020946 185 LVYVFMSKGSLASHLYD---ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS----MRARVADF 257 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Df 257 (319)
+++||.+. +|...++. .....++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999977 77777643 22346889999999999999999999988 9999999999999877 89999999
Q ss_pred CCCcccccc----ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 258 GLSREEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 258 g~~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
|+++..... .....++-|..|.|||++.+ ..|+++.|||++|||+.||+|-++.|.+..++
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 999853222 22345678999999999876 57899999999999999999999999987653
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=253.40 Aligned_cols=199 Identities=30% Similarity=0.465 Sum_probs=172.6
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.|.+.+.||+|++|.||+|... ++..+++|++..... ....+.+|+..++.++|+|++++++.+...+..++++||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3555678999999999999665 688999999876544 45678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-ccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 270 (319)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 99 ~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 99 GGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 999999996543 36999999999999999999999988 9999999999999999999999999875432221 122
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 3457889999999988889999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=251.57 Aligned_cols=200 Identities=28% Similarity=0.491 Sum_probs=171.3
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|+||.||++... +|..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.+.+..++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 567788999999999999654 6789999998653 2233457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCccccccc-c
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDK-H 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~-~ 268 (319)
++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999999987655556899999999999999999999988 99999999999999875 46999999886543222 1
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||++....++.++|+||||+++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 223458889999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=253.42 Aligned_cols=199 Identities=31% Similarity=0.431 Sum_probs=169.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 188 (319)
+|.+.+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++++.+ .+..+++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 356678899999999999965 4688999999875422 345678899999999999999999998865 347899999
Q ss_pred EccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 189 FMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999887643 23455889999999999999999999988 999999999999999999999999998643322
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 159 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 -LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred -ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 122345788999999999999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=254.00 Aligned_cols=196 Identities=30% Similarity=0.445 Sum_probs=166.3
Q ss_pred cccccccccCCCceEEEEEe----CCCcEEEEEEeccCC----cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 184 (319)
|++.+.||+|+||.||.+.. .+|..||+|++.... ....+.+.+|+.++..+ +|+||+++.+.+...+..+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56778899999999999964 478899999986532 22345678899999999 5999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 82 LILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999998643 45889999999999999999999988 9999999999999999999999999986532
Q ss_pred ccc--cccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 265 VDK--HAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 265 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 221 1223558899999999865 3467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=252.57 Aligned_cols=201 Identities=32% Similarity=0.510 Sum_probs=169.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCC------eE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKG------QH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~~ 183 (319)
++|.+.+.||+|++|.||+|.. .+++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.+.. ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 5678889999999999999965 4678999999865443 346789999999999 6999999999987644 48
Q ss_pred EEEEEEccCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 184 MLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
++++||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999998885432 457899999999999999999999998 9999999999999999999999999886
Q ss_pred ccccc-ccccccccccCccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EEMVD-KHAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~~~~-~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..... .......++..|+|||++.. ..++.++||||||+++|+|++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 43222 22234558889999998743 356789999999999999999999997643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=250.64 Aligned_cols=191 Identities=32% Similarity=0.460 Sum_probs=160.4
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHH-HhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVML-LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|++|.||+|.. .+++.||+|++..... .....+..|... ....+|+|++++++++.+.+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999955 4688999999864321 112233444444 4455899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 272 (319)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.... ....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence 9999988543 46899999999999999999999988 99999999999999999999999998864322 2344
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.++..|+|||.+.+..++.++||||||+++|||++|..||...+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 57889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=254.90 Aligned_cols=200 Identities=25% Similarity=0.357 Sum_probs=164.4
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCe-----E
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQ-----H 183 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~ 183 (319)
.|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 466778999999999999965 478899999876542 223456788999999995 6999999998877655 8
Q ss_pred EEEEEEccCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCC
Q 020946 184 MLVYVFMSKGSLASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGL 259 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~ 259 (319)
+++|||+++ +|.+++.... ...+++..++.++.|++.||.|||+++ ++||||+|+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999985 7888875432 245899999999999999999999998 999999999999998 88999999999
Q ss_pred Ccccccc-ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 260 SREEMVD-KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 260 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 8643222 11223356888999998754 567899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=257.49 Aligned_cols=201 Identities=33% Similarity=0.463 Sum_probs=165.7
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 186 (319)
..|++.+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.++++++|+||+++++++... +..+++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 3567788999999999999965 4689999999864422 1233566899999999999999999998754 568999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+.+ +|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 87 ~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 87 MEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999964 788777543 356899999999999999999999998 999999999999999999999999998754332
Q ss_pred -ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 -KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12223345788999999865 5678999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=251.77 Aligned_cols=192 Identities=32% Similarity=0.525 Sum_probs=166.7
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 120 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
||+|+||.||++... +++.+++|.+..... ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999765 589999999865432 3355788899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--------
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-------- 267 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-------- 267 (319)
.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9998653 36899999999999999999999988 9999999999999999999999999986433221
Q ss_pred -cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......++..|+|||......++.++|+||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=228.85 Aligned_cols=195 Identities=29% Similarity=0.426 Sum_probs=167.1
Q ss_pred ccccccCCCceEEEE-EeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 117 TTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
.++||+|.||+||+| ..++++.||+|.++.+ +........+|+.+++.++|.|||++++....+...-+|+||+. .
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 467999999999999 5668899999988654 33334567899999999999999999999999999999999994 4
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-ccccc
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANI 272 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 272 (319)
+|..+... -++.++.+.+..++.|+++||.++|+++ +.|||+||.|.||+.+|++|++|||+++...... .....
T Consensus 86 dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 86 DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 77777643 4567899999999999999999999999 9999999999999999999999999998543332 33445
Q ss_pred ccccCccCccccCC-CCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 273 RGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 273 ~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
.-|..|.+|.++.+ +-|++..|+||-|||+.|+.. |++.|+|.+
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 67999999999876 568999999999999999987 999999865
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=250.09 Aligned_cols=208 Identities=28% Similarity=0.439 Sum_probs=173.3
Q ss_pred HHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEee-C
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-K 180 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~ 180 (319)
+.+.+.++..++.+|.||.||+|.| .+.+.|.+|.++.. +.-....+..|-..+..+.|||+.++.+++.+ .
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 4456666778899999999999944 33456778877654 34445678889999999999999999998865 5
Q ss_pred CeEEEEEEEccCCChhhhhh-----h-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEE
Q 020946 181 GQHMLVYVFMSKGSLASHLY-----D-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV 254 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~-----~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 254 (319)
...+++|.++.-|+|..+|. + +..+.++..+...++.|++.|++|||+++ ++|.||..+|++|++..++||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEe
Confidence 67889999999999999996 2 23345777888999999999999999999 999999999999999999999
Q ss_pred eecCCCcccccc---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccccC
Q 020946 255 ADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319 (319)
Q Consensus 255 ~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~~ 319 (319)
+|=.+++..... ........+..||+||.+....|+..+|+|||||+||||+| |+.|+...++.|
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 999999864332 22344556889999999999999999999999999999999 999998877643
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=238.39 Aligned_cols=197 Identities=29% Similarity=0.483 Sum_probs=162.7
Q ss_pred cccccccCCCceEEEEEe-CCCcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 116 FTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 116 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+...||.|..|+||++.. .+|...|||.+... +++..+++.+.+.++..- ..|.||+.+|+|..+...++.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 346799999999999954 56889999988654 555567777888776655 489999999999999888899998853
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 272 (319)
..+.|.....+++++..+-++...+..||.||-++. +|+|||+||+|||+|+.|++|+||||.+-...........
T Consensus 176 --C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrs 251 (391)
T KOG0983|consen 176 --CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRS 251 (391)
T ss_pred --HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccccc
Confidence 233343445567999999999999999999998754 3999999999999999999999999998655444444455
Q ss_pred ccccCccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 273 RGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 273 ~~t~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.|-+.|||||-+.. ..|+.++||||||+.++||.||+.||.+-.
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 68899999999854 578999999999999999999999999844
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=253.57 Aligned_cols=200 Identities=30% Similarity=0.517 Sum_probs=169.2
Q ss_pred HhcccccccccCCCceEEEEEeC-----CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEee--CCeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-----TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 183 (319)
..+.+.+.||+|+||.||++.+. ++..+|+|.+...... ..+.+.+|+..++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35567788999999999999643 3678999998765432 45679999999999999999999999877 5578
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999996543 35899999999999999999999988 999999999999999999999999998754
Q ss_pred ccccc----ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 264 MVDKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 264 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
..... .....++..|+|||.+....++.++|+||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 32211 11223456799999998888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=260.73 Aligned_cols=197 Identities=27% Similarity=0.440 Sum_probs=163.6
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeC-----CeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 184 (319)
..|.+.+.||+|+||.||+|. ..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 467888999999999999995 4578999999986432 23345678899999999999999999987654 3579
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+.+ ++...+.. ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 85 lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 85 IVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 99999964 77776632 45899999999999999999999998 9999999999999999999999999986432
Q ss_pred ccc----cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 265 VDK----HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 265 ~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 1123467899999998754 56899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=253.28 Aligned_cols=199 Identities=28% Similarity=0.435 Sum_probs=169.0
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|++|+||+|... +++.|++|.+..... .......+|+..+.+++ |||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999764 578999998865422 22334557899999998 999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 270 (319)
+++|.+++.......+++.++..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++..........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 889998886655456899999999999999999999998 9999999999999999999999999987554433334
Q ss_pred ccccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...++..|+|||.+. ...++.++|+||||+++|||++|+.||.+.+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 456788999999874 4567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=261.30 Aligned_cols=202 Identities=23% Similarity=0.424 Sum_probs=168.1
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 185 (319)
+....|.+.++||+||.+.||++...+.+.+|+|.+... +.+...-|..|+..|.+++ |.+|+++++|-..++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345567778899999999999998877788888866443 4555678999999999995 9999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
||||= ..+|..+|.........| .++.+..|++.++.++|+++ |||.||||.|+|+-.+ .+||+|||.|.....
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQP 511 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCc
Confidence 99986 568988886554433334 77889999999999999999 9999999999999764 899999999976554
Q ss_pred ccc---ccccccccCccCccccCCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 DKH---AANIRGTFGYLDPEYISTR-----------NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~~~---~~~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+.. ....+||+.||+||.+... +.++++||||||||||+|+.|+.||....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 433 3456899999999988422 25689999999999999999999998654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=246.90 Aligned_cols=198 Identities=30% Similarity=0.492 Sum_probs=174.0
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 188 (319)
|...+.||+|++|.||+|... ++..+++|++..... ...+.+.+|+..+++++||||+++++.+.+. +..++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 456688999999999999664 788999999865532 3456789999999999999999999999988 89999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 82 YVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred ecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999986543 7999999999999999999999988 99999999999999999999999999875544332
Q ss_pred ---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 ---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 344568899999999988889999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=254.14 Aligned_cols=196 Identities=32% Similarity=0.444 Sum_probs=165.7
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|...+.||+|+||.||++.. .++..+|+|.+..... .....+.+|+..++.++|||++++++++.+.+..++++|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 355667899999999999964 4788999999864322 223568889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+. |++.+.+... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.... .
T Consensus 106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~---~ 177 (317)
T cd06635 106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS---P 177 (317)
T ss_pred CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC---C
Confidence 996 5777766433 356899999999999999999999998 9999999999999999999999999876432 2
Q ss_pred ccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||.+..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 23456888999999973 4568899999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=252.58 Aligned_cols=198 Identities=32% Similarity=0.471 Sum_probs=167.2
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 188 (319)
|++.+.||+|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|||++++++++.+. +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999654 58899999987653 33345688999999999999999999999887 89999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 8888875432 46899999999999999999999988 9999999999999999999999999987543332
Q ss_pred -cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 -HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223456788999998754 467899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=255.73 Aligned_cols=196 Identities=26% Similarity=0.328 Sum_probs=162.8
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
.+.+|.|+++.|+++.. +++.||+|++... .....+.+.+|+..++.++||||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455555555555544 7899999998754 33445678999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc--------
Q 020946 195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-------- 266 (319)
Q Consensus 195 l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-------- 266 (319)
|.+++.......+++.....++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+......
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999997655556899999999999999999999998 999999999999999999999999987533211
Q ss_pred ccccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......++..|+|||++.. ..++.++|+||||+++|||++|+.||.+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223446778999999865 458899999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=257.75 Aligned_cols=196 Identities=28% Similarity=0.397 Sum_probs=161.8
Q ss_pred cccccC--CCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQG--AFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
..||+| +||+||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999954 589999999986542 22346788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc----
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---- 268 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 268 (319)
+++.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999886654456899999999999999999999988 99999999999999999999999985432111100
Q ss_pred ----ccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 ----AANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ----~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 111234567999999866 357899999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.63 Aligned_cols=200 Identities=28% Similarity=0.483 Sum_probs=174.2
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|++|.||++... ++..+++|++..... .....+.+|++.++.++|||++++.+.+...+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 567788999999999999654 688999999875432 44567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 191 SKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 191 ~~g~l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
++++|.+++.... ...+++..+..++.+++.||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999886543 367999999999999999999999998 9999999999999999999999999986543322
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......+++.|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 2234568889999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=266.15 Aligned_cols=196 Identities=24% Similarity=0.394 Sum_probs=176.9
Q ss_pred ccccccCCCceEEEEEeCCCc-EEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 117 TTLIGQGAFGPVYKAQMSTGE-TVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
...||-|+||.|=++..+... .+|+|++++. +....+.+..|-++|...+.|.||+++-.|.+....|+.||-|-+
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 356999999999999775443 4889988654 333355677899999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 272 (319)
|.+...+.+ ++.|+......++.-+++|++|||+++ ||.|||||+|++++.+|-+||.|||+|+.......+-++
T Consensus 505 GElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 505 GELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred chhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCceeee
Confidence 999999954 457999999999999999999999999 999999999999999999999999999998888889999
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+|||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 999999999999999999999999999999999999999998753
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=254.11 Aligned_cols=199 Identities=29% Similarity=0.436 Sum_probs=163.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC--------
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-------- 181 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 181 (319)
.|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 578889999999999999965 478899999886432 222345678999999999999999999987654
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..++++||+.+ ++.+.+... ...+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 45999999964 777777433 346899999999999999999999998 9999999999999999999999999986
Q ss_pred cccccc-----cccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EEMVDK-----HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 432211 11234567889999988654 47889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=231.80 Aligned_cols=194 Identities=28% Similarity=0.446 Sum_probs=160.1
Q ss_pred cccccCCCceEEEEE-eCCCcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
..||+|++|.|-+.+ ..+|...|+|.+... +.+..+++.+|+.+..+. .+|.+|.++|.....+..++.||.|. .+
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hh
Confidence 569999999998884 468999999998754 344456677888876554 79999999999989999999999994 46
Q ss_pred hhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccccc
Q 020946 195 LASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272 (319)
Q Consensus 195 l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 272 (319)
|+.+-.. ...+.+++...-+|+..+..||.|||++-+ ++|||+||.|||++.+|++|+||||.+-.....-..+..
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d 208 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD 208 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh
Confidence 6655432 345679999999999999999999999754 999999999999999999999999998654333333335
Q ss_pred ccccCccCccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 273 RGTFGYLDPEYIST----RNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 273 ~~t~~y~aPE~~~~----~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
.|-..|||||.+.. ..|+.++||||||+.+.||.+++.||+.
T Consensus 209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 67888999998843 4789999999999999999999999875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=244.34 Aligned_cols=198 Identities=33% Similarity=0.526 Sum_probs=172.8
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|++|.||++.. .+++.+++|.+..... ...+.+.+|++++.+++|||++++.+++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 56778999999999999954 4678999999876543 34567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc-c
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-A 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 269 (319)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 82 ENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred CCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 999999988543 56899999999999999999999998 99999999999999999999999999875433222 2
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||...+..++.++|+||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 34567889999999988788999999999999999999999997654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=247.58 Aligned_cols=200 Identities=26% Similarity=0.423 Sum_probs=172.7
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|++.+.||+|++|.||++.. .+++.+++|.+.... .....++.+|+.+++.++|+||+++.+++.+....++++||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 56778899999999999954 478899999986542 233456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-M 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-C
Confidence 999999988552 2346899999999999999999999998 999999999999999999999999998754333 2
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+++.|+|||.+.+..++.++|+||||+++|||++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3335578899999999988999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=257.12 Aligned_cols=195 Identities=26% Similarity=0.352 Sum_probs=162.7
Q ss_pred cccccccCCCceEEEEEe-CCCcEEEEEEeccCCccc--------------HHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 116 FTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQG--------------EKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 116 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
+.+.||+|+||+||+|.. .+++.||+|.+....... ...+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 457799999999999964 478999999886432211 12467899999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
+..++++||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccce
Confidence 99999999996 688888854 345899999999999999999999988 999999999999999999999999988
Q ss_pred ccccc---------------cccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 261 REEMV---------------DKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 261 ~~~~~---------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..... ........+++.|+|||.+.+. .++.++|+||||+++|||++|+.||.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 64321 1111223467889999998664 46899999999999999999999998654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=257.03 Aligned_cols=199 Identities=31% Similarity=0.458 Sum_probs=164.9
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccC--CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC--CeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK--GQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~ 184 (319)
..+|.+.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456778899999999999999654 6889999987542 222345677899999999 999999999988643 4689
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||++ ++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 5888887443 6889999999999999999999988 9999999999999999999999999986433
Q ss_pred ccc------cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDK------HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 1223457889999998754 567899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=258.57 Aligned_cols=198 Identities=30% Similarity=0.447 Sum_probs=169.6
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-----eEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHM 184 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 184 (319)
+|.+.+.||+|++|.||+|... ++..+|+|.+.... ....+.+.+|+..++.++||||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3677889999999999999654 58899999886543 334567889999999999999999999987765 789
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++++|++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 4788887543 37999999999999999999999998 9999999999999999999999999987543
Q ss_pred ccc----cccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDK----HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 332 13344578899999999877 88999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=251.08 Aligned_cols=198 Identities=29% Similarity=0.487 Sum_probs=162.1
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 188 (319)
..|.+.+.||+|++|.||+|... +++.+|+|.+.... .....++..|+..+... .||||+++++++.+....++++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 34577889999999999999765 48899999986542 22334566677766666 49999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
|+. +++.+.+... ...+++..+..++.|++.||.|||+ .+ ++||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 4666665432 3478999999999999999999997 46 9999999999999999999999999986543333
Q ss_pred cccccccccCccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 268 HAANIRGTFGYLDPEYISTRN----FTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~----~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 333345788999999987554 78999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=251.10 Aligned_cols=202 Identities=31% Similarity=0.424 Sum_probs=166.6
Q ss_pred HHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC----
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG---- 181 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 181 (319)
.....|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567788899999999999999654 68899999986543 223356778999999999999999999887654
Q ss_pred ------eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEe
Q 020946 182 ------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA 255 (319)
Q Consensus 182 ------~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 255 (319)
..++++||+++ ++...+... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 676666443 346899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccccccc--cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 256 DFGLSREEMVDK--HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 256 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
|||++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987543222 1122345778999998864 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=257.18 Aligned_cols=199 Identities=26% Similarity=0.401 Sum_probs=165.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEee----CCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 184 (319)
..|.+.+.||+|++|.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++.+++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 4677788999999999999954 578999999986542 2334567789999999999999999988753 35789
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 85 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 9999995 6888887543 45899999999999999999999988 9999999999999999999999999986432
Q ss_pred cccc-----ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDKH-----AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 2211 123467889999999855 568899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=256.81 Aligned_cols=197 Identities=28% Similarity=0.441 Sum_probs=165.2
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC-----CeEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHM 184 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 184 (319)
+|.+.+.||+|+||+||+|. ..++..||+|.+... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 57778899999999999995 457899999988653 223345677899999999999999999987644 3579
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 86 IVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 9999995 688888743 346999999999999999999999998 9999999999999999999999999987543
Q ss_pred cc-ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 265 VD-KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 265 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.. .......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 32 22234567889999998754 56899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=248.24 Aligned_cols=206 Identities=28% Similarity=0.457 Sum_probs=165.4
Q ss_pred CCcCHHHHHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCc-ccHHHHHHHHHHHh-ccCCCCcceeeeEEe
Q 020946 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK-QGEKEFQTEVMLLG-RLHHRNLVNLVGYCA 178 (319)
Q Consensus 102 ~~~~~~~l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~-~l~h~niv~~~~~~~ 178 (319)
..|+-.+|.. ...||.|.||+|++- ..+.|+..|||.++.... ...+++..|.+... .-+.||||+++|.+.
T Consensus 59 ~~F~~~~Lqd-----lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQD-----LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHH-----HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 3455444443 256999999999998 456899999999986643 44567888887654 447999999999999
Q ss_pred eCCeEEEEEEEccCCChhh---hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEe
Q 020946 179 EKGQHMLVYVFMSKGSLAS---HLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA 255 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~---~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 255 (319)
..+..|+.||+|. .+++. +.+......+++...-.|..-..+||.||-.... |+|||+||+|||++..|.+|||
T Consensus 134 ~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeee
Confidence 9999999999994 35543 3344445568999888999999999999987543 9999999999999999999999
Q ss_pred ecCCCccccccccccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 256 DFGLSREEMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 256 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
|||.+-........+...|-..|||||-+.. ..|+.++||||||++|||+.||+.|+++-
T Consensus 211 DFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 211 DFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred cccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 9999865544444444568889999999853 45899999999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=249.71 Aligned_cols=198 Identities=29% Similarity=0.432 Sum_probs=168.0
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|++|.||++.. .+++.+++|.+..... .....+..|+.++++++|+||+++++++.+.+..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 34567899999999999965 4788999998865432 23467888999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
++ ++.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 75 8888775533 57899999999999999999999998 9999999999999999999999999886443322 22
Q ss_pred cccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 234578889999998766 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=255.13 Aligned_cols=196 Identities=28% Similarity=0.433 Sum_probs=163.1
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeC------Ce
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 182 (319)
.+|.+.+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++.+++||||+++.+++... +.
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 567778899999999999995 4578899999986432 22345678899999999999999999987643 34
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 97 ~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 67777776 7788877743 35899999999999999999999998 99999999999999999999999999875
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 170 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred cc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 22334567889999998865 568899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=258.64 Aligned_cols=195 Identities=27% Similarity=0.417 Sum_probs=166.3
Q ss_pred cccccCCCceEEEE-EeCCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 118 ~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
+.||-|+||+|.++ +..+...+|+|.+.+.+- ......+.|-.+|+....+=||+|+..|.+++.+|+||+|+++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 46999999999999 455667899998876432 22345678999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc---------c
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE---------M 264 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~---------~ 264 (319)
++-.+|... +.|+++.+..++.++..|+++.|.-| +|||||||+|||||.+|++||+|||||.-. .
T Consensus 715 DmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 715 DMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred cHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 999988653 46899999999999999999999988 999999999999999999999999998410 0
Q ss_pred ccc----------------------------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCC
Q 020946 265 VDK----------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS 310 (319)
Q Consensus 265 ~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~ 310 (319)
... .....+||+.|+|||++....|+..+|+||.|||||||+.|++
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 000 0011248999999999999999999999999999999999999
Q ss_pred CCCCccc
Q 020946 311 PLQGLME 317 (319)
Q Consensus 311 pf~~~~~ 317 (319)
||...+.
T Consensus 870 pf~~~tp 876 (1034)
T KOG0608|consen 870 PFLADTP 876 (1034)
T ss_pred CccCCCC
Confidence 9987654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=273.02 Aligned_cols=208 Identities=32% Similarity=0.553 Sum_probs=174.9
Q ss_pred HHHHHHHhcccccccccCCCceEEEEEeC--------CCcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeee
Q 020946 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVG 175 (319)
Q Consensus 106 ~~~l~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 175 (319)
..++......+.+.||+|.||.|++|... ....||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 44555555567779999999999999532 1457999998765 334567899999999998 5999999999
Q ss_pred EEeeCCeEEEEEEEccCCChhhhhhhcC------C--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCC
Q 020946 176 YCAEKGQHMLVYVFMSKGSLASHLYDEN------Y--------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS 241 (319)
Q Consensus 176 ~~~~~~~~~lv~e~~~~g~l~~~l~~~~------~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 241 (319)
+|...+..+++.||++.|+|.+++.... . ..++..+.+.++.||+.|++||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997644 0 13888999999999999999999988 99999999
Q ss_pred CCEEEcCCCceEEeecCCCcccccccccc--ccc--cccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 242 SNILLDQSMRARVADFGLSREEMVDKHAA--NIR--GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 242 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~--~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
+|||+.++..+||+|||+++......... ... -+..|||||.+....|+.++|||||||+|||++| |..||++..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999998544332221 111 3567999999999999999999999999999999 999999843
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=253.39 Aligned_cols=205 Identities=28% Similarity=0.431 Sum_probs=169.5
Q ss_pred HHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcc-------cHHHHHHHHHHHhccCCCCcceeeeEEe-e
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQ-------GEKEFQTEVMLLGRLHHRNLVNLVGYCA-E 179 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~-~ 179 (319)
+...+|-+..+||+|||++||+| ++...+.||+|+-.....+ ..+...+|..+-+.+.||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 44567777889999999999999 6778899999986443211 1233567899999999999999999986 4
Q ss_pred CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCceEEee
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVAD 256 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~D 256 (319)
.+.+|-|+||+++.+|+-+|... ..+++.++..|+.||+.||.||.+.. +||||-||||.|||+.+ .|.+||+|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 56788999999999999999654 45899999999999999999999875 88999999999999964 47899999
Q ss_pred cCCCcccccccc--------ccccccccCccCccccC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 257 FGLSREEMVDKH--------AANIRGTFGYLDPEYIS----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 257 fg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
||+++....++. +....||.+|++||.+- ..+.+.|.||||+|||+|+.+.|+.||....
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 999985543322 33467999999999873 3467899999999999999999999997644
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=248.88 Aligned_cols=208 Identities=26% Similarity=0.417 Sum_probs=178.6
Q ss_pred CcCHHHHHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC--CC----Ccceeee
Q 020946 103 EYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH--HR----NLVNLVG 175 (319)
Q Consensus 103 ~~~~~~l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~~~~ 175 (319)
.+...|....+|.+...+|+|.||.|-.+ +...+..||+|+++.-.+. .+...-|+++|.++. .| -++.+.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 45667888899999999999999999999 4456889999998754443 445567899999994 33 3788889
Q ss_pred EEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-------
Q 020946 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ------- 248 (319)
Q Consensus 176 ~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~------- 248 (319)
+|...++.++|+|.+ +-++.+++..++..+++..++..++.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence 999999999999998 559999999888889999999999999999999999999 999999999999931
Q ss_pred -------------CCceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 249 -------------SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 249 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
+..++++|||.|...... ....+.|.-|.|||++.+..++..+||||+||||+||+||...|+.-
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 346899999999754332 35677899999999999999999999999999999999999999875
Q ss_pred cc
Q 020946 316 ME 317 (319)
Q Consensus 316 ~~ 317 (319)
.+
T Consensus 313 en 314 (415)
T KOG0671|consen 313 EN 314 (415)
T ss_pred Cc
Confidence 53
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.16 Aligned_cols=199 Identities=30% Similarity=0.451 Sum_probs=169.1
Q ss_pred ccccccccCCCceEEEE-EeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.-...||.|.||.||-| ...+|+..|+|.+... .........+|+.++..++|||+|+++|+-.+.+..++.||||+
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence 33468999999999999 6678999999987654 23334578899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc----
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---- 267 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---- 267 (319)
+|+|.+.+.. .+..++.....+..|++.|+.|||+++ ||||||||.||+++.+|.+|++|||.|.......
T Consensus 1318 ~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1318 GGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999943 334666667778899999999999999 9999999999999999999999999987544332
Q ss_pred -cccccccccCccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 268 -HAANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
......||+.|||||++.+.+ ...++||||+||+..||+||+.||..++.+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 123456999999999997643 457899999999999999999999887653
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=254.31 Aligned_cols=197 Identities=26% Similarity=0.422 Sum_probs=165.2
Q ss_pred HHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC------
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------ 181 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 181 (319)
..+|.+.+.||+|+||.||++. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 3467788999999999999995 4578999999885432 222456789999999999999999999887543
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..+++++|+ +++|..++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 458999998 6788877743 45899999999999999999999988 9999999999999999999999999987
Q ss_pred cccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5322 2234467889999999865 458899999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=248.99 Aligned_cols=195 Identities=33% Similarity=0.448 Sum_probs=164.3
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+...+.||+|+||+||+|.. .++..+++|.+..... .....+.+|+.+++.++|||++++.+++.+.+..++++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 34456799999999999965 4788999999864322 2235678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
+. +++.+++... ...+++.++..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.... ..
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---PA 174 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC---CC
Confidence 95 5777776443 346899999999999999999999998 9999999999999999999999999876432 22
Q ss_pred cccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....++..|+|||++. ...++.++||||||+++|||++|+.||.+..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3456888999999984 4568899999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=241.74 Aligned_cols=196 Identities=25% Similarity=0.464 Sum_probs=173.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 187 (319)
.+++.++||+|+|..|..+++ .+.+.+|+|+++++ ..++.+..+.|-.+.... +||.+|-+..+|+....+++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 446678999999999999965 46788999998764 344456677787777766 7999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-c
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-D 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~ 266 (319)
||+++|+|--++.. ...++++.+..+..+|..||.|||+++ |+.||||.+|||+|..|++||+|+|+++.... .
T Consensus 331 eyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 99999999877743 456999999999999999999999999 99999999999999999999999999986544 4
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
..+.+++|||.|.|||.+++..|....|+|+|||+|+||+.|+.||+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 56678999999999999999999999999999999999999999996
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=250.19 Aligned_cols=198 Identities=30% Similarity=0.418 Sum_probs=165.7
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..+|...+.||+|++|.||+|.. .++..+|+|.+... .....+++.+|+++++.++|+|++++.+++......+++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34455667899999999999965 46789999988643 222345678899999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+. |++.+.+... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 99996 6787776543 345899999999999999999999988 99999999999999999999999998864322
Q ss_pred ccccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+++.|+|||.+. ...++.++||||||+++|+|++|+.||.+..
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 23445788999999974 3567889999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=250.18 Aligned_cols=197 Identities=28% Similarity=0.431 Sum_probs=165.0
Q ss_pred HHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEee-CCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 186 (319)
...|.+.+.||+|+||.||++. ..++..+|+|.+... .....+.+.+|+.++..++||||+++.+++.. .+..+++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 3467788999999999999995 448899999987543 22234667889999999999999999998865 5678899
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+ +++|..++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 89 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~-- 159 (328)
T cd07856 89 TELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD-- 159 (328)
T ss_pred eehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC--
Confidence 9998 5688877742 35788888999999999999999998 9999999999999999999999999986432
Q ss_pred ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22233457889999998765 678999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=253.04 Aligned_cols=195 Identities=27% Similarity=0.453 Sum_probs=161.7
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------Ce
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 182 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 3566778999999999999964 57899999988643 222245678999999999999999999988654 34
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++++|+.. ++..+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 95 ~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 6899999864 665544 235899999999999999999999998 99999999999999999999999999875
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2234467889999999865 568899999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=255.06 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=163.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC----------
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK---------- 180 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------- 180 (319)
.+|.+.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5678889999999999999954 57889999998765555567788999999999999999999766543
Q ss_pred ----CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEe
Q 020946 181 ----GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVA 255 (319)
Q Consensus 181 ----~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~ 255 (319)
...++++||++ ++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++ +++.++|+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 588877742 35899999999999999999999998 99999999999997 45678999
Q ss_pred ecCCCccccccc----cccccccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 256 DFGLSREEMVDK----HAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 256 Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
|||+++...... ......++..|+|||.+. +..++.++|+|||||++|||++|+.||.+..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986432111 112235688899999864 4568899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=246.86 Aligned_cols=196 Identities=31% Similarity=0.462 Sum_probs=165.8
Q ss_pred cccccccccCCCceEEEEEe----CCCcEEEEEEeccCC----cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 184 (319)
|.+.+.||+|++|.||++.. .++..+|+|++.... ....+.+.+|+.++.++ +||||+++.+.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678899999999999853 357889999986432 22345678899999999 5999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 82 LILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999988543 45889999999999999999999988 9999999999999999999999999986533
Q ss_pred cccc--ccccccccCccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 265 VDKH--AANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 265 ~~~~--~~~~~~t~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
.... .....++..|+|||.+.+.. .+.++|+||||+++|||++|..||..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 2221 22345789999999987654 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=241.46 Aligned_cols=192 Identities=33% Similarity=0.508 Sum_probs=167.3
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 120 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
||+|+||.||++... +++.+++|.+..... .....+..|+.+++.++||||+++++.+...+..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999654 588999999865432 2345788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRG 274 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 274 (319)
.+++... ..+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 9998544 35899999999999999999999988 999999999999999999999999998754332 22334567
Q ss_pred ccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 275 t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+..|+|||...+..++.++|+||||+++|+|++|+.||....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=250.12 Aligned_cols=200 Identities=31% Similarity=0.468 Sum_probs=162.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeC--------
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-------- 180 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 180 (319)
..|.+.+.||+|++|.||+|.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 4678889999999999999965 4688999998864422 2234567899999999999999999987543
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
...+++++|+.. ++...+... ...+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999864 676666432 346999999999999999999999998 999999999999999999999999998
Q ss_pred cccccccc------------ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 261 REEMVDKH------------AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 261 ~~~~~~~~------------~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 64322111 122346788999998754 458899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=245.73 Aligned_cols=198 Identities=31% Similarity=0.475 Sum_probs=168.1
Q ss_pred cccccccccCCCceEEEEEeC-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
|.+.+.||+|++|.||+|... +++.+|+|.+.... ....+.+..|+.+++.++|+|++++.+++.+.+..++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345678999999999999654 58999999987653 333467788999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 269 (319)
+ ++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 7 58999886542 46899999999999999999999998 9999999999999999999999999987543322 22
Q ss_pred cccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+..|+|||.+... .++.++|+||||+++|||++|+.||.+.+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 234457789999998766 88999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=247.11 Aligned_cols=199 Identities=28% Similarity=0.509 Sum_probs=171.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 187 (319)
.|.+.+.||+|++|.||++.. .++..+|+|++... .....+.+.+|..++.+++ ||||+++++++...+..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 367788999999999999965 47899999998653 1223456788999999998 999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 82 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 82 EYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999999998643 36999999999999999999999998 9999999999999999999999999876432211
Q ss_pred ---------------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 ---------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ---------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......++..|+|||......++.++|+||||+++++|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1123457889999999988889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=249.23 Aligned_cols=197 Identities=29% Similarity=0.406 Sum_probs=160.5
Q ss_pred cccccccccCCCceEEEEEeC-C--CcEEEEEEeccC--CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC----CeE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMS-T--GETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK----GQH 183 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~ 183 (319)
|.+.+.||+|+||.||++... + +..+|+|.+... .....+.+.+|+.+++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 567789999999999999653 4 778999988643 222345678899999999 599999999875432 456
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
+++++|+. ++|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.++|+|||++...
T Consensus 82 ~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 78888875 688888843 346899999999999999999999998 999999999999999999999999998643
Q ss_pred cccc-----cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVDK-----HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 2211 1223468899999998755 568999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.52 Aligned_cols=199 Identities=25% Similarity=0.421 Sum_probs=164.7
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
+|.+.+.||+|+||.||++... .+..+++|+++.. .......+..|+.+++.++||||+++++++.+.+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4678899999999999999653 3455666665432 122334567789999999999999999999998899999
Q ss_pred EEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 187 YVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+||+++++|.+++.. .....+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988754 23456899999999999999999999988 999999999999986 469999999886543
Q ss_pred ccc-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 265 VDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 265 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 222 223456788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=267.84 Aligned_cols=144 Identities=29% Similarity=0.391 Sum_probs=127.9
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|.+.+.||+|+||.||+|... +++.||+|++.... ......+..|+.++..++||||+++++++...+..++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 5678899999999999999654 78999999986542 2224578889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
|+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998543 45889999999999999999999988 9999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=235.10 Aligned_cols=180 Identities=24% Similarity=0.279 Sum_probs=152.9
Q ss_pred CCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCChhhhhhh
Q 020946 123 GAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD 201 (319)
Q Consensus 123 G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~ 201 (319)
|.+|.||++. ..+++.+|+|.+.... .+.+|...+....||||+++++++.+.+..++++||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999995 4578899999986542 223445555566799999999999999999999999999999998854
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccccccccCccCc
Q 020946 202 ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281 (319)
Q Consensus 202 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aP 281 (319)
. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+..... ......++..|+||
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~y~aP 151 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENMYCAP 151 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc--ccccCCcCccccCC
Confidence 3 35899999999999999999999988 99999999999999999999999998754322 22334467789999
Q ss_pred cccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 282 E~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
|.+.+..++.++|+||+|+++|||++|+.||..
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=250.41 Aligned_cols=196 Identities=28% Similarity=0.441 Sum_probs=164.6
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe------
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ------ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 182 (319)
..|.+.+.||+|++|.||+|... ++..||+|++... .....+.+.+|+.+++.++|||++++.+++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 35778899999999999999654 6789999988643 22234567789999999999999999987765544
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++++|+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 95 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999998 6689888853 45899999999999999999999988 99999999999999999999999999875
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322 334467889999999854 467899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=256.23 Aligned_cols=201 Identities=29% Similarity=0.502 Sum_probs=174.8
Q ss_pred HhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEee-----CCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE-----KGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~ 184 (319)
.++.|.+.+|+|.+|.||++ ...+++.+|+|++..+... .++++.|.++++.. .|||++.++|++.. ++++|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 45678899999999999999 4568899999998765443 56778899999888 69999999998854 57999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
||||||.+|+..+.........+.|+.+..|+..++.|+.+||.+. ++|||+|-.|||++.++.+||+|||++....
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 9999999999999998766778999999999999999999999988 9999999999999999999999999987654
Q ss_pred cc-ccccccccccCccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VD-KHAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~-~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. ....+..|||.|||||++.. ..|+..+|+||||++..||--|.+|+-++.
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 43 34456789999999999843 357789999999999999999999998765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=251.02 Aligned_cols=194 Identities=25% Similarity=0.419 Sum_probs=163.4
Q ss_pred HhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+...+|.|+|+.|-++ ...+++..++|++.... .+..+|+.++... +||||+++.+.+.+..+.|+|||+
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45677778999999999999 45678899999986542 2234566555554 799999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE-cCCCceEEeecCCCcccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-DQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
+.++-+.+.+.... .....+..|+.+|+.|+.|||+++ ++||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 99998888775443 222677789999999999999999 9999999999999 58899999999998755433
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..+.+-|..|.|||++....|++++|+||||++||+|++|+.||..-..
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 4456778999999999999999999999999999999999999986543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=225.07 Aligned_cols=197 Identities=35% Similarity=0.549 Sum_probs=170.9
Q ss_pred cccccccccCCCceEEEEEeCC-CcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+..++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 3466789999999999997654 889999998765444 56788999999999999999999999999899999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--cc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HA 269 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 269 (319)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+|++|.||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999865432 2789999999999999999999988 9999999999999999999999999887544332 23
Q ss_pred cccccccCccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 270 ANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
....++..|++||.+ ....++.++|+|+||++++||++|+.||.+
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678889999998 677788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=249.13 Aligned_cols=202 Identities=22% Similarity=0.330 Sum_probs=151.4
Q ss_pred HHHhcccccccccCCCceEEEEEe-----------------CCCcEEEEEEeccCCcccHHH--------------HHHH
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-----------------STGETVAVKVLATDSKQGEKE--------------FQTE 158 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 158 (319)
..+.|.+.++||+|+||.||+|.. ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 345677889999999999999953 235679999986543322222 3346
Q ss_pred HHHHhccCCCCc-----ceeeeEEee--------CCeEEEEEEEccCCChhhhhhhcC----------------------
Q 020946 159 VMLLGRLHHRNL-----VNLVGYCAE--------KGQHMLVYVFMSKGSLASHLYDEN---------------------- 203 (319)
Q Consensus 159 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~l~~~l~~~~---------------------- 203 (319)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 677787753 356899999999999999886421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccc--ccccccCccCc
Q 020946 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA--NIRGTFGYLDP 281 (319)
Q Consensus 204 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~t~~y~aP 281 (319)
...+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||++.......... ...+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 113467788899999999999999988 9999999999999999999999999986433222111 23347899999
Q ss_pred cccCCCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCC
Q 020946 282 EYISTRNF----------------------TKKSDVYSFGVLLFELIAGRS-PLQG 314 (319)
Q Consensus 282 E~~~~~~~----------------------~~~~Dv~slGvil~elltg~~-pf~~ 314 (319)
|.+..... ..+.|+||+||++|+|++|.. ||.+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 98754321 134799999999999999886 7764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=231.94 Aligned_cols=200 Identities=30% Similarity=0.459 Sum_probs=162.8
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC--------CeE
Q 020946 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--------GQH 183 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~~ 183 (319)
.-..++|+|.||+||+|+. ++|+.||+|...-+ ...-.....+|+.+|..++|+|++.++..|... ...
T Consensus 20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 3345799999999999954 56778898865432 122234557899999999999999999988542 358
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|+|+++++. +|.-.|.. ....++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+++..
T Consensus 100 ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccce
Confidence 999999976 77777733 3356899999999999999999999998 999999999999999999999999999632
Q ss_pred cc-----cccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccccC
Q 020946 264 MV-----DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319 (319)
Q Consensus 264 ~~-----~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~~~ 319 (319)
.. ........-|..|.+||.+.+ +.|+++.|+|+-||||.||.||.+.|.+-+|++
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq 236 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ 236 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH
Confidence 21 222334556999999998855 789999999999999999999999999988864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=262.82 Aligned_cols=186 Identities=30% Similarity=0.506 Sum_probs=147.5
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC--------------
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-------------- 181 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------------- 181 (319)
+.||+||||.||+++. -||+.+|||++.... ...-..+.+|+..+++++|||+|+++..+.+..
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 6799999999999953 389999999987653 333456889999999999999999986432110
Q ss_pred --------------------------------------------------------------------------------
Q 020946 182 -------------------------------------------------------------------------------- 181 (319)
Q Consensus 182 -------------------------------------------------------------------------------- 181 (319)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred -------------------------eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEE
Q 020946 182 -------------------------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236 (319)
Q Consensus 182 -------------------------~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H 236 (319)
.+|+-||||+...+.+++..+.... .....++++.+|++||.|+|+++ +||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~g---iIH 720 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQG---IIH 720 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCc---eee
Confidence 1356677777766666665443221 35667899999999999999999 999
Q ss_pred cCCCCCCEEEcCCCceEEeecCCCcccc-------------------ccccccccccccCccCccccCCC---CCCcchh
Q 020946 237 RDIKSSNILLDQSMRARVADFGLSREEM-------------------VDKHAANIRGTFGYLDPEYISTR---NFTKKSD 294 (319)
Q Consensus 237 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~D 294 (319)
|||||.||++++++.+||+|||++.... .....+...||.-|+|||++.+. .|+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999987411 11133456799999999999664 4999999
Q ss_pred hHHHHHHHHHHHh
Q 020946 295 VYSFGVLLFELIA 307 (319)
Q Consensus 295 v~slGvil~ellt 307 (319)
+|||||+|+||+.
T Consensus 801 mYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY 813 (1351)
T ss_pred hHHHHHHHHHHhc
Confidence 9999999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=222.43 Aligned_cols=186 Identities=34% Similarity=0.574 Sum_probs=165.3
Q ss_pred CCceEEEEEeC-CCcEEEEEEeccCCccc-HHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCChhhhhhh
Q 020946 124 AFGPVYKAQMS-TGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD 201 (319)
Q Consensus 124 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~ 201 (319)
+||.||+|... +++.+++|++....... .+.+.+|+..+++++|+|++++.+++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999765 58999999997665444 67899999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccccccccCccCc
Q 020946 202 ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281 (319)
Q Consensus 202 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aP 281 (319)
.. .+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+.............++..|++|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence 43 3889999999999999999999998 999999999999999999999999998765444344556688899999
Q ss_pred cccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 282 E~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
|.+....++.++|+||||+++|+|++|..||..
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999888899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=241.13 Aligned_cols=196 Identities=22% Similarity=0.354 Sum_probs=165.6
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc----cc----HHHHHHHHHHHhccC---CCCcceeeeEEeeC
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK----QG----EKEFQTEVMLLGRLH---HRNLVNLVGYCAEK 180 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~----~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 180 (319)
.|...+.+|+|+||.|+.|..+ +...|++|.+.++.. .. .-.+-.|+.+|..++ |+||++++++|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 3555678999999999999554 456899998865421 11 113557999999997 99999999999999
Q ss_pred CeEEEEEEEc-cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCC
Q 020946 181 GQHMLVYVFM-SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259 (319)
Q Consensus 181 ~~~~lv~e~~-~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 259 (319)
+.+|+++|-. ++.+|.+++..+ ..+++.++..|..|++.|+++||+++ |+|||||-+||.++.+|-+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 9999999976 456888888544 45899999999999999999999999 99999999999999999999999998
Q ss_pred CccccccccccccccccCccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCC
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~pf~~ 314 (319)
+.... ......++||..|.|||++.+.+|- ..-|||++|++||.++....||..
T Consensus 717 aa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 86543 3345678999999999999998884 568999999999999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=215.82 Aligned_cols=191 Identities=19% Similarity=0.384 Sum_probs=163.2
Q ss_pred HhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEeeC--CeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEK--GQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 187 (319)
..|++.+.+|+|.+++||.| ...+++.++||++++- ..+.+.+|+.+|..+. ||||+.++++..+. ....+++
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 46777889999999999999 5668899999999653 3467889999999996 99999999998764 4678999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-CceEEeecCCCcccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVD 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~ 266 (319)
||+.+.+....- ..++...+..++.+++.||.|+|+.| |.|||+||.|++||.. ..++|+|+|+|......
T Consensus 115 E~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 115 EYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 999987776554 34788889999999999999999999 9999999999999854 57999999999876555
Q ss_pred ccccccccccCccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 267 KHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
........+..|--||++ +...|+..-|+|||||+|..|+..+.||-
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 555556677888999998 55778999999999999999999888863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=245.96 Aligned_cols=194 Identities=26% Similarity=0.409 Sum_probs=157.7
Q ss_pred cccccCCCce-EEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 118 TLIGQGAFGP-VYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 118 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
+++|.|+.|+ ||+|.. +|++||||++-.+ ..+...+|+..|+.- +||||+++++.-.+....|+..|.| ..+|
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 5689998875 899988 6899999988432 234557899999877 6999999999988999999999999 4699
Q ss_pred hhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---C--CceEEeecCCCccccccc-
Q 020946 196 ASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---S--MRARVADFGLSREEMVDK- 267 (319)
Q Consensus 196 ~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~--~~~kl~Dfg~~~~~~~~~- 267 (319)
.+++... ..........+....|++.||++||+.+ |+||||||.||||+. + ..++|+|||+++....+.
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9988653 1111111345678899999999999988 999999999999975 2 478999999998655432
Q ss_pred ---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccccC
Q 020946 268 ---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319 (319)
Q Consensus 268 ---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~~ 319 (319)
......||.+|+|||++....-+..+||||+||++|+.++ |..||.+..++|
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~ 722 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ 722 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh
Confidence 2445679999999999998888889999999999999999 599998876653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=228.06 Aligned_cols=194 Identities=26% Similarity=0.406 Sum_probs=160.1
Q ss_pred ccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-----eEEEEEE
Q 020946 117 TTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHMLVYV 188 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e 188 (319)
.+-||-|+||.||.+. -.+|+.||.|.+..- +-...+.+-+|+++|..++|.|++..+++..... +.|++.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 4779999999999994 458999999987542 2233567889999999999999999998876543 4566777
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
+|.. +|...+- ..+.++.+.++-+.+||++||.|||+.+ |.||||||.|.|++.+..+||+|||+++....+.
T Consensus 138 LmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 138 LMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 7743 5665553 3456888899999999999999999999 9999999999999999999999999998665443
Q ss_pred -cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 -HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..+...-|..|.|||.+.+ ..|+...||||.|||+.||+.++..|..-.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 3344567899999999876 579999999999999999999999887643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=225.35 Aligned_cols=145 Identities=24% Similarity=0.368 Sum_probs=123.0
Q ss_pred CCCCCCcCHHHHHH-HhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----C---
Q 020946 98 ASGIPEYSYKDLQK-ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----H--- 167 (319)
Q Consensus 98 ~~~~~~~~~~~l~~-~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h--- 167 (319)
..++......|+.. ++|.+.++||.|.|++||++ +.++.+.||+|+.+...-. .+....||++|++++ |
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCC
Confidence 34555667778777 99999999999999999999 6678899999998765333 445578999999884 3
Q ss_pred CCcceeeeEEee----CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 168 RNLVNLVGYCAE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 168 ~niv~~~~~~~~----~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
.+||+|++.|.. +.+.++|+|++ +.+|..++.....+.++...+++|++|++.||.|||.+. +|||.||||+|
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN 218 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN 218 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence 369999999875 45889999998 778999998888889999999999999999999999875 49999999999
Q ss_pred EEE
Q 020946 244 ILL 246 (319)
Q Consensus 244 ill 246 (319)
||+
T Consensus 219 vLl 221 (590)
T KOG1290|consen 219 VLL 221 (590)
T ss_pred eee
Confidence 999
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=245.05 Aligned_cols=197 Identities=20% Similarity=0.303 Sum_probs=139.4
Q ss_pred HHhcccccccccCCCceEEEEEeC-C----CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeE------Eee
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-T----GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY------CAE 179 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~~ 179 (319)
...|.+.+.||+|+||.||+|... + +..||+|.+...... +....+ .+....+.++..+... +..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 346778899999999999999654 4 689999987543211 111111 1222222333322221 245
Q ss_pred CCeEEEEEEEccCCChhhhhhhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCC
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDENYG------------------PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS 241 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 241 (319)
....++++||+.+++|.+++...... ......+..++.|++.||+|||+++ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 66899999999999999988543210 1123345679999999999999988 99999999
Q ss_pred CCEEEcC-CCceEEeecCCCccccc--cccccccccccCccCccccCCC----------------------CCCcchhhH
Q 020946 242 SNILLDQ-SMRARVADFGLSREEMV--DKHAANIRGTFGYLDPEYISTR----------------------NFTKKSDVY 296 (319)
Q Consensus 242 ~Nill~~-~~~~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~Dv~ 296 (319)
+|||+++ ++.+||+|||+++.... ........+++.|+|||.+... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 57999999999974322 2233456789999999965322 234567999
Q ss_pred HHHHHHHHHHhCCCCCCC
Q 020946 297 SFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 297 slGvil~elltg~~pf~~ 314 (319)
||||+||||+++..|+..
T Consensus 364 SlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred HHHHHHHHHHhCcCCCch
Confidence 999999999998777653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=235.31 Aligned_cols=214 Identities=23% Similarity=0.288 Sum_probs=180.3
Q ss_pred CCCCCCcCHHHHHHHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC------CCc
Q 020946 98 ASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH------RNL 170 (319)
Q Consensus 98 ~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~ni 170 (319)
+.++..+.+.|+...+|.+....|+|-|++|.+|. ...|+.||||++..... ..+.=..|+++|++|+. -++
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 34666778899999999999999999999999994 45688999999976432 23344679999999962 379
Q ss_pred ceeeeEEeeCCeEEEEEEEccCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC
Q 020946 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 171 v~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 249 (319)
++++..|...+++|||+|-+ ..+|.+.|..- ..-.|....+..+++|+..||..|-..+ |+|.||||+|||+++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 99999999999999999987 45888888642 2345888899999999999999999988 9999999999999976
Q ss_pred -CceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 250 -MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 250 -~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..+||||||.|.....+ ..+.+..+..|.|||++.+..|+...|+||.||+||||+||+..|+|.++
T Consensus 573 k~iLKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cceeeeccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 46899999998654333 23344567789999999999999999999999999999999999999876
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=218.04 Aligned_cols=190 Identities=28% Similarity=0.403 Sum_probs=161.7
Q ss_pred cccccCCCceEEEE-EeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC------eEEEEEE
Q 020946 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------QHMLVYV 188 (319)
Q Consensus 118 ~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e 188 (319)
+.+|.|.- .|..+ +.-.+++||+|..... .....++..+|...+..++|+||++++.++.... ..|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 55788877 66666 4447899999987543 3444567789999999999999999999986543 5789999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
+| ..+|...+.. .++-..+.++..|++.|++|||+.+ |+||||||+||++..+..+||.|||+++.....-.
T Consensus 102 ~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~ 173 (369)
T KOG0665|consen 102 LM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFM 173 (369)
T ss_pred hh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcccc
Confidence 99 4588877752 3677889999999999999999999 99999999999999999999999999987666545
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.+....|..|.|||++.+..+.+.+||||+||++.||++|+..|+|.+
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 667788999999999988889999999999999999999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=211.36 Aligned_cols=195 Identities=21% Similarity=0.391 Sum_probs=157.5
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeee-EEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVG-YCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~lv~e 188 (319)
+.|++.+.||+|.||.+-++.. .++..+++|.+... .....+|.+|..---.+ .|.||+.-++ .|+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 4578889999999999999954 56778999987543 23467888888765555 5899998776 5677888999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc--CCCceEEeecCCCcccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD--QSMRARVADFGLSREEMVD 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~ 266 (319)
|++.|+|.+.+-. ..+.+....+++.|++.|+.|+|+++ ++|||||.+||||- +.-++||||||+++....
T Consensus 103 ~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred cCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 9999999998843 45888899999999999999999999 99999999999994 345899999999864322
Q ss_pred ccccccccccCccCccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 267 KHAANIRGTFGYLDPEYISTR-----NFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.......+..|.+||..... ...+.+|+|.||++++.++||+.||+..
T Consensus 176 -tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 176 -TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred -eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 22233356679999987432 3468899999999999999999999843
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=194.03 Aligned_cols=182 Identities=38% Similarity=0.664 Sum_probs=156.8
Q ss_pred cccCCCceEEEEEeC-CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCChhh
Q 020946 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS 197 (319)
Q Consensus 120 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~ 197 (319)
||+|.+|.||++... +++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999764 4899999998765432 34678999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCCCccccccc-cccccccc
Q 020946 198 HLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDK-HAANIRGT 275 (319)
Q Consensus 198 ~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~-~~~~~~~t 275 (319)
++.... ..+++..+..++.+++.++.+||+.+ ++|+||+|.||++++ ++.++|+|||.+....... ......+.
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 985432 35889999999999999999999998 999999999999999 8999999999886443221 13335578
Q ss_pred cCccCccccCCC-CCCcchhhHHHHHHHHHH
Q 020946 276 FGYLDPEYISTR-NFTKKSDVYSFGVLLFEL 305 (319)
Q Consensus 276 ~~y~aPE~~~~~-~~~~~~Dv~slGvil~el 305 (319)
..|++||.+... .++.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 899999999776 888999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=204.03 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=165.6
Q ss_pred hcccccccccCCCceEEEEEeCC--CcEEEEEEeccCCcccHHHHHHHHHHHhccCC----CCcceeeeEE-eeCCeEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMST--GETVAVKVLATDSKQGEKEFQTEVMLLGRLHH----RNLVNLVGYC-AEKGQHML 185 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 185 (319)
.|.+.+.||+|+||.||.+.... ...+|+|+...........+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 68889999999999999996544 35789998765533333367788888888863 5788888888 47778899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-----CceEEeecCCC
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-----MRARVADFGLS 260 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfg~~ 260 (319)
||+.+ +.+|.+.......+.++..+...++.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 98887 779998776555578999999999999999999999999 9999999999999854 46999999999
Q ss_pred c--cccccc--------c-ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 R--EEMVDK--------H-AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+ ...... . .....||.+|+++.+..+...+++.|+||++.++.||+.|..||.+...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 8 321111 1 2245699999999999999999999999999999999999999988763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=205.78 Aligned_cols=196 Identities=28% Similarity=0.413 Sum_probs=161.7
Q ss_pred HhcccccccccCCCceEEEEEeC----CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 186 (319)
..|...++||+|.|++||++.+. ..+.||+|.+...+ ...++.+|++.|..+ .+.||+++.+++...++..+|
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 34566789999999999999432 46789999886543 345688999999999 499999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCCCcccc-
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEM- 264 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~- 264 (319)
+||++.....++.. .++..++..++..++.||.++|.+| |+|||+||.|+|.+. .+.-.|.|||++....
T Consensus 114 lp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred ecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999998888883 3678889999999999999999999 999999999999985 4678899999975100
Q ss_pred ----------------c----------------------------cccccccccccCccCccccCC-CCCCcchhhHHHH
Q 020946 265 ----------------V----------------------------DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFG 299 (319)
Q Consensus 265 ----------------~----------------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slG 299 (319)
. ........||++|.|||++.. ...+++.||||-|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 000012348999999999854 6778999999999
Q ss_pred HHHHHHHhCCCCCCCccc
Q 020946 300 VLLFELIAGRSPLQGLME 317 (319)
Q Consensus 300 vil~elltg~~pf~~~~~ 317 (319)
||++-+++++.||-....
T Consensus 266 VI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKD 283 (418)
T ss_pred ceeehhhccccccccCcc
Confidence 999999999999976554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=221.61 Aligned_cols=199 Identities=29% Similarity=0.443 Sum_probs=172.9
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.|.+...+|.|.||.||+++ ..+++..|+|+++.....+..-++.|+-+++..+||||+.++|-+-..+..++.|||+.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 45566789999999999994 45889999999988777777778899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-cccccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-~~~~~~ 270 (319)
+|+|.+.-+ ..+++++.++.+.++..++|++|||+.+ -+|||||=.|||+++.|.+|++|||.+-... .-....
T Consensus 96 ggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 96 GGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred CCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 999998774 3467999999999999999999999998 7999999999999999999999999875432 223456
Q ss_pred ccccccCccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 271 NIRGTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 271 ~~~~t~~y~aPE~~---~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.+.||+.|||||+- ....|..++|+|++|+...|+-.-++|.-++.
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 78899999999986 56789999999999999999877777755443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=202.94 Aligned_cols=162 Identities=19% Similarity=0.169 Sum_probs=124.8
Q ss_pred HHhcccccccccCCCceEEEEEeC--CCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS--TGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
...|.+.+.||+|+||+||+|... +++.+|||++... .....+.+.+|+++|+.++|+|+++.+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 456788899999999999999653 5777899986533 12234568999999999999999863332 2467
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCC-CCCCEEEcCCCceEEeecCCCcc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI-KSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+++|||+++++|.... . .. ...++.|++.+|.|||+++ |+|||| ||+|||++.++.+||+|||+++.
T Consensus 94 ~LVmE~~~G~~L~~~~---~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 94 GLVRGWTEGVPLHLAR---P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEEccCCCCHHHhC---c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 9999999999886321 1 11 1467889999999999998 999999 99999999999999999999874
Q ss_pred ccccc---------cccccccccCccCccccCCC
Q 020946 263 EMVDK---------HAANIRGTFGYLDPEYISTR 287 (319)
Q Consensus 263 ~~~~~---------~~~~~~~t~~y~aPE~~~~~ 287 (319)
..... ...+..+++.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 32221 11345678889999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=183.23 Aligned_cols=202 Identities=25% Similarity=0.367 Sum_probs=166.2
Q ss_pred HHHHhcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC-CCcceeeeEEeeCCeEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv 186 (319)
+....|.+.+.||+|+||.+|.| ...+|+.||+|+-+.... ...+..|..+...+++ ..|..+..+..+.....+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 34567889999999999999999 677899999998754432 3456778888888864 6777788888889999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC---CceEEeecCCCccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLSREE 263 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~~~~ 263 (319)
|++. +.+|.+... -....++..+++.++-|++.-++|+|.++ ++||||||+|+|+.-+ ..+.++|||+++..
T Consensus 90 MdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 9998 667776553 23346899999999999999999999999 9999999999999644 46889999999743
Q ss_pred cccc--------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVDK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.... ......||.+|.+--...+...+.+.|+-|+|.+|..+.-|..||+|+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 2221 12245699999998888888899999999999999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=186.79 Aligned_cols=198 Identities=23% Similarity=0.356 Sum_probs=164.5
Q ss_pred hcccccccccCCCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.|.+.++||+|+||.++.| .+-++++||||.-...+ ..-+++.|....+.|. .++|...+.+-.++-+..||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 5678899999999999999 56689999999754332 2346778888888774 789998888888888889999987
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-----CCceEEeecCCCccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-----SMRARVADFGLSREEMV 265 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~~ 265 (319)
+.+|.+.. +-....|+..++..+|.|++.-++|+|++. +|.|||||+|+||.. ...+-++|||+|+....
T Consensus 107 -GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 55666554 334556999999999999999999999999 999999999999963 34689999999985433
Q ss_pred ccc--------ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..+ .....||.+||+---..+++.+.+.|+-|||=++++.|-|.+||.|+..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 222 2345699999999999999999999999999999999999999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=224.34 Aligned_cols=146 Identities=20% Similarity=0.214 Sum_probs=112.9
Q ss_pred ccCC-CCcceeeeEE-------eeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 020946 164 RLHH-RNLVNLVGYC-------AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235 (319)
Q Consensus 164 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 235 (319)
.++| +||.+++++| .+....+.++|++ .++|.+++... ...+++.+++.++.||+.||.|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 5777888877 2234567778877 66999999643 356999999999999999999999998 99
Q ss_pred EcCCCCCCEEEcCC-------------------CceEEeecCCCccccccc-----------------cccccccccCcc
Q 020946 236 HRDIKSSNILLDQS-------------------MRARVADFGLSREEMVDK-----------------HAANIRGTFGYL 279 (319)
Q Consensus 236 H~dlk~~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~-----------------~~~~~~~t~~y~ 279 (319)
||||||+|||++.. +.+|++|||+++...... ......+|+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 455666666654311000 001134788899
Q ss_pred CccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 280 aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
|||++.+..++.++|||||||+||||++|..||..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-26 Score=183.39 Aligned_cols=196 Identities=23% Similarity=0.433 Sum_probs=160.0
Q ss_pred cccccccccCCCceEEEEEeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.++..+|.+...|+.|+|+++ |..+++|++... .....++|.+|.-.|+.+.||||.+++|.|.....+.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 356678999999999999995 555666776543 33345689999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEe--ecCCCccccccccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA--DFGLSREEMVDKHA 269 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~--Dfg~~~~~~~~~~~ 269 (319)
.|+|...++.+..-..+..++.+++.++++|++|||+.. +-|.---|.+..+++|++.+.+|+ |--++- ..
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf------qe 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QE 343 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee------ec
Confidence 999999999877767788899999999999999999965 334444799999999999888774 322221 11
Q ss_pred cccccccCccCccccCCCCCC---cchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFT---KKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~---~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......|.||+||.+..++-+ ..+|+|||++++|||.|+..||.++++
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 223357899999999766543 579999999999999999999998765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=180.61 Aligned_cols=174 Identities=14% Similarity=0.177 Sum_probs=135.4
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHH---------HHHHHHHHhccCCCCcceeeeEE
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE---------FQTEVMLLGRLHHRNLVNLVGYC 177 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~ 177 (319)
+++...+|+..++||.|+||.||.... ++..+|+|++.......... +.+|+..+.+++|++|..+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 566788899999999999999999866 57789999997653332222 67899999999999999998886
Q ss_pred eeC--------CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC
Q 020946 178 AEK--------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 178 ~~~--------~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 249 (319)
... +..+++|||+++.+|.++. .++. ....+++.++..+|+.+ ++|||++|.||+++++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 533 3588999999999997763 1332 24558999999999999 9999999999999998
Q ss_pred CceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHH
Q 020946 250 MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELI 306 (319)
Q Consensus 250 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ell 306 (319)
+ ++|+|||........... ..+.....|..++|+|+||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999987543211111 01334556778999999999987653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-23 Score=183.63 Aligned_cols=198 Identities=34% Similarity=0.563 Sum_probs=167.5
Q ss_pred cccccccccCCCceEEEEEeCCCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCC-CcceeeeEEeeCCeEEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ---GEKEFQTEVMLLGRLHHR-NLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 189 (319)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|...+..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 456678999999999999775 88899998765332 366789999999999988 799999999777778999999
Q ss_pred ccCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCccccccc
Q 020946 190 MSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDK 267 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 267 (319)
+.++++.+++..... ..++......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643221 26888999999999999999999999 99999999999999988 79999999986433222
Q ss_pred -------cccccccccCccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 -------HAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 -------~~~~~~~t~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......++..|+|||.+.. ..++...|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2356779999999999977 578899999999999999999999987765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=170.13 Aligned_cols=138 Identities=24% Similarity=0.267 Sum_probs=106.8
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccCCcc--c-------H-----------------HHHHHHHHHHhccCCCCc
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ--G-------E-----------------KEFQTEVMLLGRLHHRNL 170 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni 170 (319)
...||+|++|.||+|...+|+.||+|+++..... . . .....|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999998778999999998754211 1 0 122348999999988776
Q ss_pred ceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEEcCCCCCCEEEcCC
Q 020946 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL-HDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 171 v~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlk~~Nill~~~ 249 (319)
.....+.. ...++||||++++++...... ...+++.....++.|++.+|.++ |+.+ ++||||||+|||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~- 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC-
Confidence 44333222 234899999998776654322 24688999999999999999999 6888 999999999999984
Q ss_pred CceEEeecCCCcc
Q 020946 250 MRARVADFGLSRE 262 (319)
Q Consensus 250 ~~~kl~Dfg~~~~ 262 (319)
+.++|+|||++..
T Consensus 154 ~~v~LiDFG~a~~ 166 (190)
T cd05147 154 GKLYIIDVSQSVE 166 (190)
T ss_pred CcEEEEEcccccc
Confidence 7899999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=169.12 Aligned_cols=108 Identities=30% Similarity=0.323 Sum_probs=93.5
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 272 (319)
|+|.+++... ...+++.++..++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ..
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~ 64 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----QS 64 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----cC
Confidence 6888888643 356999999999999999999999865 999999999999999 9998654322 22
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 58899999999999999999999999999999999999997643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=163.02 Aligned_cols=184 Identities=15% Similarity=0.113 Sum_probs=138.4
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccCCccc----HHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG----EKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
...|++|+||+||.+.. ++..++.+.+....... ...+.+|+++|++++ |+++++++++ +..+++|+|+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999998866 67888888776554321 125789999999995 5789999886 34689999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCC-CCCCEEEcCCCceEEeecCCCcccccccc--
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI-KSSNILLDQSMRARVADFGLSREEMVDKH-- 268 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 268 (319)
+.+|...... . ...++.|++.+|.++|+++ |+|||| ||+|||+++++.++|+|||++........
T Consensus 82 G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 8888653311 1 1357789999999999999 999999 79999999999999999999874332221
Q ss_pred ---c-c--------ccccccCccCccccCC-CCCC-cchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 ---A-A--------NIRGTFGYLDPEYIST-RNFT-KKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ---~-~--------~~~~t~~y~aPE~~~~-~~~~-~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
. . -...++.|++|+...- ...+ ...++++-|.-+|.++|++.|+.+-.|
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 0 1124667777765322 1233 667999999999999999999876654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=164.12 Aligned_cols=139 Identities=21% Similarity=0.214 Sum_probs=109.2
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccCCcc---------------------c-----HHHHHHHHHHHhccCCCCc
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ---------------------G-----EKEFQTEVMLLGRLHHRNL 170 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni 170 (319)
...||+|++|.||+|...+|+.||+|++...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999997768999999998754211 0 1123578899999999987
Q ss_pred ceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCC
Q 020946 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 171 v~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~ 249 (319)
.....+... ..++||||++++++...... ...++......++.|++.++.++|+ .+ ++||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 554443332 24899999988765443222 2357788899999999999999999 88 99999999999999 7
Q ss_pred CceEEeecCCCccc
Q 020946 250 MRARVADFGLSREE 263 (319)
Q Consensus 250 ~~~kl~Dfg~~~~~ 263 (319)
+.++|+|||++...
T Consensus 154 ~~~~liDFG~a~~~ 167 (190)
T cd05145 154 GKPYIIDVSQAVEL 167 (190)
T ss_pred CCEEEEEcccceec
Confidence 89999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-23 Score=191.63 Aligned_cols=197 Identities=24% Similarity=0.358 Sum_probs=153.9
Q ss_pred cccccccCCCceEEEEE-eCCCcEEEEEEec----cC-Cccc-HHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLA----TD-SKQG-EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 116 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~----~~-~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
....+|.|.+|.|+... ......++.|... .. .... ...+..|+.+-..++|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45779999999888773 3344444444332 11 1111 1225667778888999999888877766655555699
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc---
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV--- 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~--- 265 (319)
|++. +|...+... ..++..++..++.|++.|+.|+|+.+ +.|||+|++|++++.++.+||+|||.+.....
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999988543 35788889999999999999999999 99999999999999999999999998753211
Q ss_pred c--ccccccccccCccCccccCCCCCCc-chhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 266 D--KHAANIRGTFGYLDPEYISTRNFTK-KSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 266 ~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
. ......+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||.-...+
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 1 2345678999999999999999986 589999999999999999999876544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-23 Score=185.80 Aligned_cols=185 Identities=31% Similarity=0.461 Sum_probs=154.3
Q ss_pred cccCCCceEEEEE----eCCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 120 IGQGAFGPVYKAQ----MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 120 lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+|+|.||.|++++ ...+.-+|+|++..... ........|..++...+ ||.++++...++.+...+++.++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999873 23466788888765421 11124456777888886 99999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 272 (319)
|.+...+.. ...+++.....+...++-+++++|+.+ ++|||+|++||+++.+|++++.|||+++........
T Consensus 82 g~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 82 GDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred chhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 999888844 345777777888889999999999998 999999999999999999999999998754333222
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
+||..|||||++. .....+|.||||++++||+||..||.+
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999997 567889999999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=187.97 Aligned_cols=196 Identities=22% Similarity=0.258 Sum_probs=155.7
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCCcceeeeEEeeCCeE
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~ 183 (319)
-++....+.+.+.||+|+||+||+|...+|+.||+|+-+..+.... ---.+++.+|+ -+.|..+...+...+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3455667778899999999999999777799999999877654421 11122233333 23445555555566778
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-------CCCceEEee
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-------QSMRARVAD 256 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-------~~~~~kl~D 256 (319)
++|++|.+.|+|.+++. ..+.++|..++.++.|+++.++.||..+ |||+||||+|+||. +...++|+|
T Consensus 770 ~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 89999999999999994 5567999999999999999999999999 99999999999995 234699999
Q ss_pred cCCCcccccc---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCC
Q 020946 257 FGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS 310 (319)
Q Consensus 257 fg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~ 310 (319)
||.+.....- ......++|-.+-.+|...++.++..+|.|.|+.+++-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9988644322 23455678999999999999999999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.4e-21 Score=155.23 Aligned_cols=133 Identities=19% Similarity=0.280 Sum_probs=104.4
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-----CCCCcceeeeEEeeCC---e-EEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-----HHRNLVNLVGYCAEKG---Q-HMLVYV 188 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e 188 (319)
+.||+|++|.||. ...++.. +||++........+.+.+|+..++.+ +||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6799999999996 3334444 69988765444567899999999999 5799999999998863 3 337899
Q ss_pred E--ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEEcCCCCCCEEEcC----CCceEEee-cCCC
Q 020946 189 F--MSKGSLASHLYDENYGPLTWNLRVHIALDVARGL-EYLHDGAVPPVIHRDIKSSNILLDQ----SMRARVAD-FGLS 260 (319)
Q Consensus 189 ~--~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~D-fg~~ 260 (319)
| +.+++|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+| ||..
T Consensus 86 ~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 86 FDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred CCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 9 5579999999442 35555 35677888777 9999999 999999999999974 34799999 5543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-21 Score=160.24 Aligned_cols=197 Identities=22% Similarity=0.323 Sum_probs=125.5
Q ss_pred ccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCC----------CCcceeeeEEe--
Q 020946 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHH----------RNLVNLVGYCA-- 178 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~-- 178 (319)
...+.||.|+++.||.+.. .+|+++|+|++.... ....+.+++|.-....+.+ -.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3457899999999999955 578999999875442 2234566666655555332 12222222211
Q ss_pred -------eCC--------eEEEEEEEccCCChhhhhh---hcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcC
Q 020946 179 -------EKG--------QHMLVYVFMSKGSLASHLY---DENYG--PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238 (319)
Q Consensus 179 -------~~~--------~~~lv~e~~~~g~l~~~l~---~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 238 (319)
... ..+++|+-+ .++|.+.+. ..... .+....++.+..|+++.+++||+.+ ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 111 124555555 567776642 22211 2334445677789999999999999 99999
Q ss_pred CCCCCEEEcCCCceEEeecCCCccccccccccccccccCccCccccCC--------CCCCcchhhHHHHHHHHHHHhCCC
Q 020946 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--------RNFTKKSDVYSFGVLLFELIAGRS 310 (319)
Q Consensus 239 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Dv~slGvil~elltg~~ 310 (319)
|+|+|++++++|.+.|+||+........... ...+..|.+||.... ..++.+.|.|+||+++|.|.+|+.
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999999876533222221 334578999997633 357889999999999999999999
Q ss_pred CCCCccc
Q 020946 311 PLQGLME 317 (319)
Q Consensus 311 pf~~~~~ 317 (319)
||.....
T Consensus 249 Pf~~~~~ 255 (288)
T PF14531_consen 249 PFGLSSP 255 (288)
T ss_dssp STCCCGG
T ss_pred CCCCCCc
Confidence 9987654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=149.38 Aligned_cols=134 Identities=19% Similarity=0.329 Sum_probs=112.6
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcc--------cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ--------GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+.||+|++|.||+|.. .|..+++|........ ....+.+|+..+..+.|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 6788999986543211 123577899999999999988877777777888999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+++++|.+.+... .. ....++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 12 77889999999999999998 99999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=150.86 Aligned_cols=140 Identities=20% Similarity=0.212 Sum_probs=108.0
Q ss_pred cccccccccCCCceEEEEE--eCCCcEEEEEEeccCCcc------------------------cHHHHHHHHHHHhccCC
Q 020946 114 CNFTTLIGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQ------------------------GEKEFQTEVMLLGRLHH 167 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h 167 (319)
|.+.+.||+|++|.||+|. ..+|+.||+|++...... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6678899999999999997 568999999998653210 01235689999999975
Q ss_pred CC--cceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEE
Q 020946 168 RN--LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL 245 (319)
Q Consensus 168 ~n--iv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 245 (319)
.. +.+++++ ...++||||+++.++...... ...+...+...++.|++.++.+||+++. ++|+||||+||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIl 181 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNIL 181 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEE
Confidence 33 3344432 235899999999888765422 2345566678899999999999998762 999999999999
Q ss_pred EcCCCceEEeecCCCcc
Q 020946 246 LDQSMRARVADFGLSRE 262 (319)
Q Consensus 246 l~~~~~~kl~Dfg~~~~ 262 (319)
++ ++.++|+|||.+..
T Consensus 182 i~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 182 VH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EE-CCCEEEEEChhhhc
Confidence 99 78999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=147.85 Aligned_cols=131 Identities=22% Similarity=0.357 Sum_probs=106.5
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEeccCCcc--------cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ--------GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.||+|++|.||+|.+ ++..+++|........ ...++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 6788999986543211 1245778999999999887666555566667779999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++++|.+.+.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998774321 0 78999999999999998 99999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-19 Score=145.60 Aligned_cols=134 Identities=19% Similarity=0.183 Sum_probs=105.5
Q ss_pred cccccccccCCCceEEEEEeCCCcEEEEEEeccCCcc----------------------cHHHHHHHHHHHhccCCCC--
Q 020946 114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ----------------------GEKEFQTEVMLLGRLHHRN-- 169 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n-- 169 (319)
|.+.+.||+|+||.||++...+|+.||||++...... .......|...+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 6677899999999999998778999999987543200 0123567888888887774
Q ss_pred cceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC
Q 020946 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 170 iv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 249 (319)
+...++ .+..+++|||+++++|...... .....++.+++.++.++|+.+ ++|+||+|.||+++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 444443 2456899999999988765410 234678899999999999988 9999999999999999
Q ss_pred CceEEeecCCCcc
Q 020946 250 MRARVADFGLSRE 262 (319)
Q Consensus 250 ~~~kl~Dfg~~~~ 262 (319)
+.++|+|||++..
T Consensus 162 ~~~~liDfg~~~~ 174 (198)
T cd05144 162 EKIYIIDWPQMVS 174 (198)
T ss_pred CcEEEEECCcccc
Confidence 9999999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.1e-19 Score=165.11 Aligned_cols=134 Identities=20% Similarity=0.282 Sum_probs=108.9
Q ss_pred ccccccccCCCceEEEEEeCCCcEEEEEEe-ccC-C------cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVL-ATD-S------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
...+.||+|+||+||+|.+.+. .+++|+. ... . ....+++.+|++++..++|++++....++.+.+..+++
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 3467899999999999977444 4444432 211 1 11234678999999999999999888888777788999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|||+++++|.+++. ....++.+++.+|.+||+.+ ++|||+||+|||+ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999998884 34678999999999999998 9999999999999 5779999999999754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-20 Score=175.47 Aligned_cols=194 Identities=23% Similarity=0.306 Sum_probs=143.3
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCC-cccHHHHHHHHHH--HhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS-KQGEKEFQTEVML--LGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.+.+.+.||.+.|=+|.+|+...|. |+||++.... ....+.|.++++- ...++|||.+++.-+.....-.|+|=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999887776 8999886543 3444444444333 5566899999988776655556666666
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc-
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH- 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 268 (319)
..+ +|.+.+..+ .-+...+.+-|+.|++.||.-+|..+ |+|||||.+||||+.-.-+.|+||..-+.......
T Consensus 103 vkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 644 788777332 23666778889999999999999999 99999999999999999999999986442111111
Q ss_pred -------ccccccccCccCccccCCC-----------CCCcchhhHHHHHHHHHHHh-CCCCCC
Q 020946 269 -------AANIRGTFGYLDPEYISTR-----------NFTKKSDVYSFGVLLFELIA-GRSPLQ 313 (319)
Q Consensus 269 -------~~~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~slGvil~ellt-g~~pf~ 313 (319)
..+-..-..|.|||-+-.. ..+++-||||+||++.||++ |++||.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1112233469999976321 14688999999999999998 899995
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-19 Score=167.55 Aligned_cols=163 Identities=30% Similarity=0.542 Sum_probs=119.8
Q ss_pred ccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
+..+.+..|+||.||..+.. +.+.+|+|+-+. ..+.+- ++.....|.+| |
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq------~lilRn--ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ------NLILRN--ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhccccc------chhhhc--cccccCCccee---------------------c
Confidence 44578999999999999653 567788854211 111110 22222334333 5
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-------
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD------- 266 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~------- 266 (319)
+-...+. +.+.++... +.+++|||+-+ |+|||+||+|.+|+.-|++|++|||+++.....
T Consensus 137 Dc~tllk--~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 137 DCATLLK--NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhhhcc--cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 5555553 334455443 77899999988 999999999999999999999999987632110
Q ss_pred ---------ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccC
Q 020946 267 ---------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319 (319)
Q Consensus 267 ---------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~~ 319 (319)
-.....+||+.|.|||++..+.|....|+|++|+|+||.+-|..||.|.+.||
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 01224579999999999999999999999999999999999999999987764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=154.85 Aligned_cols=152 Identities=28% Similarity=0.478 Sum_probs=126.2
Q ss_pred HhccCCCCcceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCC
Q 020946 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS 241 (319)
Q Consensus 162 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 241 (319)
|+.+.|.|+.+++|.+.++...+.+.+|+..|+|.+.+.. ....+++.....+..+++.||+|||+.. -..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 4578899999999999999999999999999999999976 3456888889999999999999999855 238999999
Q ss_pred CCEEEcCCCceEEeecCCCccccc---cccccccccccCccCccccCCCC-------CCcchhhHHHHHHHHHHHhCCCC
Q 020946 242 SNILLDQSMRARVADFGLSREEMV---DKHAANIRGTFGYLDPEYISTRN-------FTKKSDVYSFGVLLFELIAGRSP 311 (319)
Q Consensus 242 ~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Dv~slGvil~elltg~~p 311 (319)
.|++++..+.+||+|||+...... ...........-|.|||.+.... .+.+.|+||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999998754321 11111223455699999986531 46789999999999999999999
Q ss_pred CCCcc
Q 020946 312 LQGLM 316 (319)
Q Consensus 312 f~~~~ 316 (319)
|+...
T Consensus 158 ~~~~~ 162 (484)
T KOG1023|consen 158 FDLRN 162 (484)
T ss_pred ccccc
Confidence 98743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=129.87 Aligned_cols=134 Identities=20% Similarity=0.241 Sum_probs=112.3
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC--CCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
.+.||+|.++.||++...+ ..+++|....... ...+.+|...+..++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999998744 7899998865433 4678899999999976 588999998888889999999998876
Q ss_pred hhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 195 l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+... +......++.+++.++.+||.....+++|+|++|+||++++++.++++|||.+..
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 4566778899999999999986434599999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=135.87 Aligned_cols=135 Identities=24% Similarity=0.286 Sum_probs=96.2
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccCCcc--cHHH----------------------HHHHHHHHhccCCCC--c
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ--GEKE----------------------FQTEVMLLGRLHHRN--L 170 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i 170 (319)
.+.||+|+||+||+|...+++.||+|++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998778999999998654211 1111 134555555554332 3
Q ss_pred ceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCC
Q 020946 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 171 v~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~ 249 (319)
.+.+++ ...+++|||++++.+......... .. .....++.+++.++.++|. .+ ++|+||+|+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 333332 246899999998654322211110 11 5678899999999999999 77 99999999999999 8
Q ss_pred CceEEeecCCCcc
Q 020946 250 MRARVADFGLSRE 262 (319)
Q Consensus 250 ~~~kl~Dfg~~~~ 262 (319)
+.++++|||.+..
T Consensus 151 ~~~~liDfg~a~~ 163 (187)
T cd05119 151 GKVYIIDVPQAVE 163 (187)
T ss_pred CcEEEEECccccc
Confidence 8999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=141.60 Aligned_cols=142 Identities=24% Similarity=0.371 Sum_probs=107.8
Q ss_pred CCCCcceeeeEEeeC---------------------------CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHH
Q 020946 166 HHRNLVNLVGYCAEK---------------------------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218 (319)
Q Consensus 166 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~ 218 (319)
.|||||++.++|.+. ..+|+||.-.. .+|.+++..+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 599999999877542 24677776653 48888885443 555566778899
Q ss_pred HHHHHHHHHcCCCCCeEEcCCCCCCEEEc--CCC--ceEEeecCCCcccc-------ccccccccccccCccCccccCCC
Q 020946 219 VARGLEYLHDGAVPPVIHRDIKSSNILLD--QSM--RARVADFGLSREEM-------VDKHAANIRGTFGYLDPEYISTR 287 (319)
Q Consensus 219 i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~--~~kl~Dfg~~~~~~-------~~~~~~~~~~t~~y~aPE~~~~~ 287 (319)
+++|+.|||.++ +.|||+|++|||+. +|+ .+.|+|||.|.-.. ..+......|....||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999999 99999999999994 333 57899999864211 12223334577889999987432
Q ss_pred C------CCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 288 N------FTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 288 ~------~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
+ --.|+|.|+.|.+.||+++...||.+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 1 13689999999999999999999987
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-16 Score=133.70 Aligned_cols=135 Identities=19% Similarity=0.255 Sum_probs=103.8
Q ss_pred cccc-cCCCceEEEEEeCCCcEEEEEEeccCC-------------cccHHHHHHHHHHHhccCCCCc--ceeeeEEeeC-
Q 020946 118 TLIG-QGAFGPVYKAQMSTGETVAVKVLATDS-------------KQGEKEFQTEVMLLGRLHHRNL--VNLVGYCAEK- 180 (319)
Q Consensus 118 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~- 180 (319)
..|| .|+.|+||.+.. ++..+++|.+.... ......+.+|+.++..++|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 899999999977 47788998774311 1223467889999999998875 6677764432
Q ss_pred C---eEEEEEEEccC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEee
Q 020946 181 G---QHMLVYVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD 256 (319)
Q Consensus 181 ~---~~~lv~e~~~~-g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 256 (319)
. ..++++|++++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+|+||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 688887743 235543 3568999999999999 99999999999999988999999
Q ss_pred cCCCccc
Q 020946 257 FGLSREE 263 (319)
Q Consensus 257 fg~~~~~ 263 (319)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-18 Score=153.34 Aligned_cols=120 Identities=28% Similarity=0.486 Sum_probs=104.4
Q ss_pred eEEEEEEEccCCChhhhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 182 QHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
.+|+.|+++...+|.+++.. ......++...+.++.|++.|++| ++ .+|+|+||.||++..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 57889999999999999963 334457788899999999999999 66 899999999999999999999999997
Q ss_pred ccccccc-------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 020946 261 REEMVDK-------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307 (319)
Q Consensus 261 ~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt 307 (319)
....... ......||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 6544333 3445679999999999999999999999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.3e-17 Score=153.87 Aligned_cols=201 Identities=26% Similarity=0.375 Sum_probs=157.7
Q ss_pred cccccccccCCCceEEEEEe--CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM--STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 188 (319)
|.+.+.||+|.|+.|-.... .....+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..++..+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 34556699999999998854 234456667665432 222334455777777776 9999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH-DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMV- 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~- 265 (319)
|..++++.+..........+......+..|+..++.|+| ..+ +.|+|+||+|.+++..+ .++++|||+|.....
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999988773333224566677889999999999999 777 99999999999999999 999999999864433
Q ss_pred ---ccccccccc-ccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 ---DKHAANIRG-TFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ---~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 222334567 9999999999875 446889999999999999999999976544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-15 Score=134.83 Aligned_cols=139 Identities=20% Similarity=0.245 Sum_probs=97.8
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCccc----------------------------------------HHHHHH
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG----------------------------------------EKEFQT 157 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 157 (319)
+.||.|++|+||+|++.+|+.||||+..+..... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999999999999999986542110 002344
Q ss_pred HHHHHhcc----CCCCcceeeeEE-eeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHHcCCC
Q 020946 158 EVMLLGRL----HHRNLVNLVGYC-AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR-GLEYLHDGAV 231 (319)
Q Consensus 158 e~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~~ 231 (319)
|...+.++ +|.+-+.+-.++ ......+++|||++++++.+....... .. ....++.+++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC-
Confidence 54444444 233333333333 234567999999999999887643221 12 23456666666 467889888
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 232 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++|+|++|.||++++++.++++|||++...
T Consensus 278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred --ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999998643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4e-13 Score=122.89 Aligned_cols=166 Identities=20% Similarity=0.256 Sum_probs=126.5
Q ss_pred EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHH
Q 020946 132 QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNL 211 (319)
Q Consensus 132 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~ 211 (319)
...++.+|.|...+..+........+.++.|+.++||||++++..+...+..|+|+|-+. .|..++.. +....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHH
Confidence 455788999998876655444567788999999999999999999999999999999863 45666633 33556
Q ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-cccccccccCccCccccCCCCCC
Q 020946 212 RVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRNFT 290 (319)
Q Consensus 212 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~ 290 (319)
....+.||+.||.|||+.+. ++|++|.-..|+++..|+.||++|.++....... .......--.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 67788999999999987654 9999999999999999999999998865322111 111122223466676554333
Q ss_pred cchhhHHHHHHHHHHHhC
Q 020946 291 KKSDVYSFGVLLFELIAG 308 (319)
Q Consensus 291 ~~~Dv~slGvil~elltg 308 (319)
-..|.|.||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.4e-13 Score=108.48 Aligned_cols=130 Identities=15% Similarity=0.158 Sum_probs=95.5
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcce-eeeEEeeCCeEEEEEEEccCCChh
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVN-LVGYCAEKGQHMLVYVFMSKGSLA 196 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~g~l~ 196 (319)
+.|+.|.++.||++.. .+..+++|....... ....+..|...+..+.+.++++ ++.+. ....+++|||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 4578999999999987 478899998755432 1234578888888886655543 44433 33458999999998775
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--CCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV--PPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
... . ....++.+++.+|..||+.+. ..++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 1 113456789999999998761 2359999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-13 Score=126.85 Aligned_cols=135 Identities=19% Similarity=0.187 Sum_probs=87.8
Q ss_pred cccccCCCceEEEEEeCC-CcEEEEEEeccCCcc----------------------------------cHH------HHH
Q 020946 118 TLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQ----------------------------------GEK------EFQ 156 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~------~~~ 156 (319)
+.||+|++|+||+|.+.+ |+.||||+..+.-.. -.+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999998876 999999999754110 011 133
Q ss_pred HHHHHHhcc----CCCCcceeeeEEee-CCeEEEEEEEccCCChhhhhhhcCCC----CCCHHHHHHHHHHHHHHHHHHH
Q 020946 157 TEVMLLGRL----HHRNLVNLVGYCAE-KGQHMLVYVFMSKGSLASHLYDENYG----PLTWNLRVHIALDVARGLEYLH 227 (319)
Q Consensus 157 ~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~g~l~~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~LH 227 (319)
+|...+.++ .+.+.+.+-.++.+ ....++||||+.++.+.+.-.....+ .+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 344433333 23333443333333 45678999999999997743211111 12222233333333 3
Q ss_pred cCCCCCeEEcCCCCCCEEEcCCC----ceEEeecCCCcc
Q 020946 228 DGAVPPVIHRDIKSSNILLDQSM----RARVADFGLSRE 262 (319)
Q Consensus 228 ~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~~~~ 262 (319)
..+ ++|+|++|.||+++.++ .+++.|||++..
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 456 99999999999999888 999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.4e-13 Score=121.92 Aligned_cols=203 Identities=22% Similarity=0.255 Sum_probs=156.1
Q ss_pred CHHHHHHHhccccccccc--CCCceEEEEEe---CCCcEEEEEEeccC--CcccHHHHHHHHHHHhcc-CCCCcceeeeE
Q 020946 105 SYKDLQKATCNFTTLIGQ--GAFGPVYKAQM---STGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176 (319)
Q Consensus 105 ~~~~l~~~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 176 (319)
...+.......+.+-+|. |.+|.+|.+.. .++..+|+|.-+.. .......-.+|...-+.+ .|+|.++....
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 445666677788889999 99999999954 57788999974322 222233334566666666 49999998888
Q ss_pred EeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEEcCCCCCCEEEcCC-Cc
Q 020946 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR----GLEYLHDGAVPPVIHRDIKSSNILLDQS-MR 251 (319)
Q Consensus 177 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~ 251 (319)
+...+..++-.|++. .+|..+.+... ..++....+....+... |+.++|+.. ++|.|+||.||++..+ ..
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence 999999999999884 78888886533 33777788888888888 999999988 9999999999999999 88
Q ss_pred eEEeecCCCccccccccc------cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 252 ARVADFGLSREEMVDKHA------ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 252 ~kl~Dfg~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
.+++|||+.......... ....+...|++||++. ..++..+|+|++|.++.+-.++..++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 999999987644333211 1225788899999874 456899999999999999888765543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.7e-12 Score=100.59 Aligned_cols=135 Identities=20% Similarity=0.227 Sum_probs=96.0
Q ss_pred cccccCCCceEEEEEeCC-------CcEEEEEEeccCC------------c---------cc-HHHH----HHHHHHHhc
Q 020946 118 TLIGQGAFGPVYKAQMST-------GETVAVKVLATDS------------K---------QG-EKEF----QTEVMLLGR 164 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~---------~~-~~~~----~~e~~~l~~ 164 (319)
..||.|.-+.||.|...+ +..+|||+.+... . .. ...+ ++|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 4799999874321 0 01 1122 378888888
Q ss_pred cCC--CCcceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEEcCCCC
Q 020946 165 LHH--RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL-HDGAVPPVIHRDIKS 241 (319)
Q Consensus 165 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlk~ 241 (319)
+.. -++..++++ ...++||||+.+..+....... ..++..+...+..+++.+|..| |..+ ++|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 853 455566654 4678999999765443222111 2355556677889999999999 8888 99999999
Q ss_pred CCEEEcCCCceEEeecCCCcc
Q 020946 242 SNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 242 ~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.||++++ +.+.|+|||.+-.
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred HHEEEEC-CcEEEEECCCcee
Confidence 9999974 5799999997753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.6e-13 Score=111.33 Aligned_cols=151 Identities=25% Similarity=0.358 Sum_probs=115.2
Q ss_pred HHHHhccCCCCcceeeeEEeeC-----CeEEEEEEEccCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 020946 159 VMLLGRLHHRNLVNLVGYCAEK-----GQHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAV 231 (319)
Q Consensus 159 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 231 (319)
..-|-.+.|.|||++..|+.+. ....++.|||+.|++..+|+... ...+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445556799999999888654 35788999999999999997532 345777778899999999999999975
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEeecCCCccc-cc----cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHH
Q 020946 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREE-MV----DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELI 306 (319)
Q Consensus 232 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~-~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ell 306 (319)
||++|+++..+.|++..++-+|+.--.-.... .. ........+-++|.+||.=...+-+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999999988887543211100 00 01111234678999999877777788999999999999997
Q ss_pred hCCC
Q 020946 307 AGRS 310 (319)
Q Consensus 307 tg~~ 310 (319)
-+..
T Consensus 277 ilEi 280 (458)
T KOG1266|consen 277 ILEI 280 (458)
T ss_pred Hhee
Confidence 7654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.1e-11 Score=96.58 Aligned_cols=141 Identities=23% Similarity=0.246 Sum_probs=106.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccC--------CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATD--------SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..+-||+-+.|+++.+ .|+.+.||.-... .+-...+..+|.+.|.++.--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5688999999999988 6888888854321 122245677899999988766666555667777777889999
Q ss_pred ccC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC---ceEEeecCCCcc
Q 020946 190 MSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGLSRE 262 (319)
Q Consensus 190 ~~~-g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~ 262 (319)
+++ -++.+++...............++..+-..+.-||.++ ++|+||..+||++.+++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 36777776554433333444788999999999999999 99999999999997654 457999999753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.8e-11 Score=102.01 Aligned_cols=142 Identities=18% Similarity=0.246 Sum_probs=108.1
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCC--CCcceeeeEEeeC---CeEEEEEEEcc
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEK---GQHMLVYVFMS 191 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~ 191 (319)
+.|+.|..+.+|++...+|..+++|....... .....+..|..+++.+.+ .++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999876668999998765422 234578899999999875 3456677776653 36689999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA----------------------------------------- 230 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 230 (319)
+.++...+.. ..++..+...++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888775531 34677777788888888888888531
Q ss_pred ------------CCCeEEcCCCCCCEEEcC--CCceEEeecCCCcc
Q 020946 231 ------------VPPVIHRDIKSSNILLDQ--SMRARVADFGLSRE 262 (319)
Q Consensus 231 ------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~ 262 (319)
...++|+|+.|.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-11 Score=95.65 Aligned_cols=131 Identities=24% Similarity=0.341 Sum_probs=100.7
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEeccCC--------cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDS--------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+++|+-+.+|.+.+ -|.++.+|.-.+.. +-...+..+|..++.++.--.|....-+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999977 45567777532221 111235667899998887666666666667778888999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++|+++..+. +.++|||++...
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 998888888443 2557777888889999999 99999999999998774 999999998743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-11 Score=112.09 Aligned_cols=190 Identities=21% Similarity=0.243 Sum_probs=141.2
Q ss_pred ccccccccCCCceEEEEEe--CCCcEEEEEEeccCCcccHHH--HHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEE
Q 020946 115 NFTTLIGQGAFGPVYKAQM--STGETVAVKVLATDSKQGEKE--FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.....||.|.|+.|+.... .++..+++|.+.........+ -..|+.+...+ .|.+++++...+....+.++--||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 3456799999999999843 467788999876543322222 23455555555 488999988888777788899999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-CceEEeecCCCcccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVDKH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 268 (319)
++++++..... ....+.+...+++..|++.++.++|+.. ++|+|++|+||++..+ +..++.|||........
T Consensus 348 ~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 348 CEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred hcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccccee--
Confidence 99998877662 2234777788999999999999999888 9999999999999886 78899999987542221
Q ss_pred ccccccccCcc--CccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 020946 269 AANIRGTFGYL--DPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311 (319)
Q Consensus 269 ~~~~~~t~~y~--aPE~~~~~~~~~~~Dv~slGvil~elltg~~p 311 (319)
........+++ +++......+..++|++|||.-+.|.+++...
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 11222333444 55555667888999999999999998887653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.9e-12 Score=119.78 Aligned_cols=198 Identities=24% Similarity=0.310 Sum_probs=140.3
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
.+-+.+|.++.++.+.- ..|...+.|+..... ..+.+....+-.++-...+|.+++...-+......+++++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 34577888888887732 234444444433221 11122233333333334566666655555556678999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc-ccc-------
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-EEM------- 264 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~-~~~------- 264 (319)
++|...++... ..+.+-.......+..+++|||+.. +.|+|++|.|.+...+++.+++|||... ...
T Consensus 889 ~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 889 GDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred CCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 99999886543 4555556667777888999999876 8999999999999999999999998321 000
Q ss_pred --------------------cc----ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccC
Q 020946 265 --------------------VD----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319 (319)
Q Consensus 265 --------------------~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~~ 319 (319)
.. .......+|+.|.+||.+.+......+|+|++|++++|.++|.+||...+.++
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 00 01123458999999999999999999999999999999999999999877653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.6e-10 Score=99.74 Aligned_cols=168 Identities=20% Similarity=0.241 Sum_probs=125.1
Q ss_pred CCceEEEE-EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee----CCeEEEEEEEccC-CChhh
Q 020946 124 AFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLVYVFMSK-GSLAS 197 (319)
Q Consensus 124 ~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~l~~ 197 (319)
...+.|++ ...+|..+++|++..+..........-++.++++.|+|+|++..++.. +...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678888 345899999999954433333334456788999999999999988762 4578999999986 46666
Q ss_pred hhhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 198 HLYDE-------------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 198 ~l~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
.-+.. .....++...+.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54332 1224678899999999999999999999 8889999999999999889998887654332
Q ss_pred ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCC
Q 020946 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS 310 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~ 310 (319)
.+. . |-+ +--.+-|.=.||.+++.|.||..
T Consensus 445 ~d~-----------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP-----------T--EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC-----------C--cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 222 0 111 12356799999999999999843
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-09 Score=92.76 Aligned_cols=139 Identities=16% Similarity=0.139 Sum_probs=98.8
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEeccCCcc-----------cHHHHHHHHHHHhccCCCCc--ceeeeEEee-----C
Q 020946 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-----------GEKEFQTEVMLLGRLHHRNL--VNLVGYCAE-----K 180 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----~ 180 (319)
.+-.-....|++..+ +|+.+.||........ ....+.+|...+..+..-+| ..++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445777766 6788999976433211 11246788888887753333 344555543 2
Q ss_pred CeEEEEEEEccCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-------CCce
Q 020946 181 GQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-------SMRA 252 (319)
Q Consensus 181 ~~~~lv~e~~~~g-~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-------~~~~ 252 (319)
...++|+|++++. +|.+++......+.+......++.+++..+.-||+.+ ++|+|+++.|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999876 7888874322234566777889999999999999999 999999999999985 4689
Q ss_pred EEeecCCCc
Q 020946 253 RVADFGLSR 261 (319)
Q Consensus 253 kl~Dfg~~~ 261 (319)
.++||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.7e-10 Score=88.39 Aligned_cols=124 Identities=25% Similarity=0.359 Sum_probs=80.7
Q ss_pred eEEEEEeCCCcEEEEEEeccCC--------------c-------c-----cHHHHHHHHHHHhccCCC--CcceeeeEEe
Q 020946 127 PVYKAQMSTGETVAVKVLATDS--------------K-------Q-----GEKEFQTEVMLLGRLHHR--NLVNLVGYCA 178 (319)
Q Consensus 127 ~V~~~~~~~~~~vavK~~~~~~--------------~-------~-----~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 178 (319)
.||.|...+|..+|+|+.+... . . ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899988889999999874321 0 0 123467899999999765 455565442
Q ss_pred eCCeEEEEEEEcc--CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEEcCCCCCCEEEcCCCceEEe
Q 020946 179 EKGQHMLVYVFMS--KGSLASHLYDENYGPLTWNLRVHIALDVARGLEY-LHDGAVPPVIHRDIKSSNILLDQSMRARVA 255 (319)
Q Consensus 179 ~~~~~~lv~e~~~--~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 255 (319)
..++||||++ +..+.. +.... ++......++.+++..+.. +|..+ ++|+||.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhh-HHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4579999998 444443 32221 2234456677888886665 57888 9999999999999988 99999
Q ss_pred ecCCCcc
Q 020946 256 DFGLSRE 262 (319)
Q Consensus 256 Dfg~~~~ 262 (319)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.4e-09 Score=92.68 Aligned_cols=193 Identities=18% Similarity=0.266 Sum_probs=124.0
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEE------eeCCe-EEEEE
Q 020946 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC------AEKGQ-HMLVY 187 (319)
Q Consensus 116 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~------~~~~~-~~lv~ 187 (319)
..+.||+|+-+.+|-.-. -...+.|+..........+ .+..|... .||-+..=+.+= .+.+. .-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 356799999999996521 1223446665433322222 22233333 455332211110 11111 33445
Q ss_pred EEccCCChhhhhh-----hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 188 VFMSKGSLASHLY-----DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 188 e~~~~g~l~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
..+++..--..++ .+......|...++.+..++.+.+.||+.| .+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 5554432222221 123345789999999999999999999999 88999999999999999999987443222
Q ss_pred ccccccccccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAG-RSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg-~~pf~~~~ 316 (319)
...+.......|.+.|.+||.-. +..-+...|-|.||+++++|+.| +.||.|..
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 23334445567889999999754 34456889999999999999885 99999864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.1e-09 Score=85.48 Aligned_cols=147 Identities=20% Similarity=0.176 Sum_probs=100.1
Q ss_pred CCCcCHHHHHHHh--cccccccccCCCceEEEEEeCCCcEEEEEEeccCC--------------------c--ccHHHHH
Q 020946 101 IPEYSYKDLQKAT--CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--------------------K--QGEKEFQ 156 (319)
Q Consensus 101 ~~~~~~~~l~~~~--~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------------~--~~~~~~~ 156 (319)
+..+.+..+.+.. +.+++.||-|.-+.||.|..+.|.++|+|.=+... . ......+
T Consensus 78 yD~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~ 157 (304)
T COG0478 78 YDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAE 157 (304)
T ss_pred hhHHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHH
Confidence 3334444444322 34678899999999999999899999999642210 0 0122456
Q ss_pred HHHHHHhccCCC--CcceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 020946 157 TEVMLLGRLHHR--NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234 (319)
Q Consensus 157 ~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 234 (319)
+|.+.|..+... .+...+++ +...++|||+++-.|...-. +......++..|+.-+..+-..| +
T Consensus 158 rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---i 223 (304)
T COG0478 158 REFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---I 223 (304)
T ss_pred HHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---c
Confidence 788899888644 55555553 46789999998855544321 22233445555555555555667 9
Q ss_pred EEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 235 IHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 235 ~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
+|+|+.+-||++++||.+.++||--+.
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCcccc
Confidence 999999999999999999999997553
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.7e-08 Score=79.26 Aligned_cols=138 Identities=19% Similarity=0.187 Sum_probs=102.0
Q ss_pred cccCCCceEEEEEeCCCcEEEEEEeccC---C---cccHHHHHHHHHHHhccCCC--CcceeeeEEe-e----CCeEEEE
Q 020946 120 IGQGAFGPVYKAQMSTGETVAVKVLATD---S---KQGEKEFQTEVMLLGRLHHR--NLVNLVGYCA-E----KGQHMLV 186 (319)
Q Consensus 120 lg~G~~g~V~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~-~----~~~~~lv 186 (319)
-|+||.+-|++-... |..+-+|..... + +.....|.+|...|..+..- .+.+.. ++. . .-.-++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367999999998774 457888876421 1 23456789999998888532 244444 332 1 1246788
Q ss_pred EEEccC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc--eEEeecCCCcc
Q 020946 187 YVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--ARVADFGLSRE 262 (319)
Q Consensus 187 ~e~~~~-g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~ 262 (319)
+|-+.+ .+|.+++......+.+..+...+..+++..+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 887654 57777875544445677888899999999999999999 999999999999986666 99999987653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-08 Score=93.09 Aligned_cols=136 Identities=20% Similarity=0.270 Sum_probs=90.4
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcc----------------------------------------cHHHHHH
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ----------------------------------------GEKEFQT 157 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~ 157 (319)
+-|+.++-|+||+|.+.+|+.||||+.+++-.. .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 568899999999999999999999998654210 0112334
Q ss_pred HHHHHhccC-----CCCcceeeeEE-eeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHH-HHHHHcCC
Q 020946 158 EVMLLGRLH-----HRNLVNLVGYC-AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARG-LEYLHDGA 230 (319)
Q Consensus 158 e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~-l~~LH~~~ 230 (319)
|...+.++. .+++ .+-.++ .-.+...++|||++|..+.+...... ..++.. .++..++.+ +.-+=..+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 444444431 3333 233333 34567899999999998888753333 345533 333333332 22222245
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 231 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
++|.|..|-||+++.++.+.+.|||+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCccee
Confidence 9999999999999999999999999865
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-07 Score=78.37 Aligned_cols=106 Identities=25% Similarity=0.241 Sum_probs=81.6
Q ss_pred HHHHHHHHHHHhccCC--CCcceeeeEEeeC----CeEEEEEEEccCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 020946 152 EKEFQTEVMLLGRLHH--RNLVNLVGYCAEK----GQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLE 224 (319)
Q Consensus 152 ~~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~ 224 (319)
.....+|...+..+.. -.....+++.... ...++++|++++. +|.+++..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3456778887777743 3345566665542 2458999999874 78888854222 556677889999999999
Q ss_pred HHHcCCCCCeEEcCCCCCCEEEcCCC---ceEEeecCCCcc
Q 020946 225 YLHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGLSRE 262 (319)
Q Consensus 225 ~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~ 262 (319)
-||+.+ ++|+|+++.|||++.+. .+.++||+-++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 99999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.9e-07 Score=74.96 Aligned_cols=139 Identities=13% Similarity=0.171 Sum_probs=84.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCC--cceeeeEEeeCCeEEEEEEEccCCC-
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVGYCAEKGQHMLVYVFMSKGS- 194 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~- 194 (319)
..||+|..+.||+. .+..+++|...... ......+|.+.+..+..-. +.+.+++..+.+...++|+++++..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 35567788875432 3445788999998886433 4567777777777889999998863
Q ss_pred hhhhh---------------------hhcCCCCCCHHHHHH-HHH----------HHHH-HHHHHHcC-CCCCeEEcCCC
Q 020946 195 LASHL---------------------YDENYGPLTWNLRVH-IAL----------DVAR-GLEYLHDG-AVPPVIHRDIK 240 (319)
Q Consensus 195 l~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~LH~~-~~~~i~H~dlk 240 (319)
+...+ +.-.....+...... +-. .+.. ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 11111 110001111111000 000 0111 12222211 12347899999
Q ss_pred CCCEEEcCCCceEEeecCCCcc
Q 020946 241 SSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 241 ~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.8e-07 Score=73.29 Aligned_cols=140 Identities=12% Similarity=0.158 Sum_probs=92.1
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHH---------HHHHHHHhccC---CCCcceee
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEF---------QTEVMLLGRLH---HRNLVNLV 174 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~~~ 174 (319)
+++....|...+.+-......|.+-.. +|..+.+|.........++.| .+++..+.+++ -.....++
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 345556666667777776666776666 678899998876543322222 23444444443 22333333
Q ss_pred eEEe-----eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC
Q 020946 175 GYCA-----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 175 ~~~~-----~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 249 (319)
.+.. -....+++|||++|..|.+... ++. .++..+..++.-||+.| +.|+|..|.|++++++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 2222 2345678999999988776541 332 24456777899999999 9999999999999966
Q ss_pred CceEEeecCCCc
Q 020946 250 MRARVADFGLSR 261 (319)
Q Consensus 250 ~~~kl~Dfg~~~ 261 (319)
.++++||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.1e-09 Score=95.12 Aligned_cols=95 Identities=28% Similarity=0.529 Sum_probs=73.5
Q ss_pred HHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc----------ccccccccCccCccccCCC
Q 020946 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----------AANIRGTFGYLDPEYISTR 287 (319)
Q Consensus 218 ~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~ 287 (319)
+++.|+.|+|... .+||++|.|++|.++.++..||+.|+++-....... ..-..-...|.|||++...
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4449999999754 499999999999999999999999998643222100 0011245679999999988
Q ss_pred CCCcchhhHHHHHHHHHHH-hCCCCCCC
Q 020946 288 NFTKKSDVYSFGVLLFELI-AGRSPLQG 314 (319)
Q Consensus 288 ~~~~~~Dv~slGvil~ell-tg~~pf~~ 314 (319)
..+.++|+||+|+++|.+. .|+.-|.+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhc
Confidence 8899999999999999998 46655543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.2e-06 Score=72.55 Aligned_cols=139 Identities=17% Similarity=0.162 Sum_probs=83.4
Q ss_pred cccCCC-ceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEccCCChhh
Q 020946 120 IGQGAF-GPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS 197 (319)
Q Consensus 120 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~ 197 (319)
|..|.. ..||+.... +..+.+|...... ...+.+|+.+++.+. +--+.+++++....+..+++|+++++.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 344444 789999764 4788888875433 335677888887774 4445567777776667899999999877654
Q ss_pred hh-------------------hhcC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHHc----CC
Q 020946 198 HL-------------------YDEN--YGPLTWN--LRVHIAL--------------------DVARGLEYLHD----GA 230 (319)
Q Consensus 198 ~l-------------------~~~~--~~~l~~~--~~~~i~~--------------------~i~~~l~~LH~----~~ 230 (319)
.. +... ..++... ....... .+......|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 1100 0011100 0000000 01111222211 11
Q ss_pred CCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 231 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+.++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 24489999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.7e-06 Score=71.35 Aligned_cols=134 Identities=23% Similarity=0.270 Sum_probs=91.3
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcc-------------------cH-----HHHHHHHHHHhccC--CCCcc
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-------------------GE-----KEFQTEVMLLGRLH--HRNLV 171 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------~~-----~~~~~e~~~l~~l~--h~niv 171 (319)
..|+.|.-+.||+|...++..+|+|++...... .. ....+|..-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 357788888999998778999999998543110 11 12345666666653 33444
Q ss_pred eeeeEEeeCCeEEEEEEEccCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCC
Q 020946 172 NLVGYCAEKGQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 172 ~~~~~~~~~~~~~lv~e~~~~g-~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~ 249 (319)
+.+++. ...++|||+... .-.-.|.+ .++...+...+..++++.+.-|-. .+ ++|+||+.-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-C
Confidence 455543 457899998653 22223321 123333567788888888888876 56 99999999999999 7
Q ss_pred CceEEeecCCCcc
Q 020946 250 MRARVADFGLSRE 262 (319)
Q Consensus 250 ~~~kl~Dfg~~~~ 262 (319)
+.+.|+|||-+-.
T Consensus 203 ~~p~iID~~QaV~ 215 (268)
T COG1718 203 GEPYIIDVSQAVT 215 (268)
T ss_pred CeEEEEECccccc
Confidence 7999999997653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2e-08 Score=92.11 Aligned_cols=181 Identities=19% Similarity=0.172 Sum_probs=127.4
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCC-cceeeeEEeeCCeEEEEEEEccCC-Ch
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN-LVNLVGYCAEKGQHMLVYVFMSKG-SL 195 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-~l 195 (319)
+-+++|+++.+++.+-...+....+.+... ....-++++|.+++||| .+..++-+......++.++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 447899999999885433333335544321 44566889999999999 666666666667788889998776 22
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t 275 (319)
..-. ......+...+...+...-.++++++|+.. -+|+| ||+..+ +..+..||+............+..++
T Consensus 323 ~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~ 393 (829)
T KOG0576|consen 323 ALEM-TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGT 393 (829)
T ss_pred cccC-ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCCCC
Confidence 1111 011112334445566667778999999864 48888 777766 57899999988765554456677899
Q ss_pred cCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 020946 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312 (319)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf 312 (319)
+.|+|||+.....+..+.|.|++|+--.+|--|-+|-
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 9999999999999999999999998666655565553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.8e-06 Score=71.12 Aligned_cols=141 Identities=18% Similarity=0.262 Sum_probs=81.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC--CcceeeeEEee---CCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR--NLVNLVGYCAE---KGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~~ 192 (319)
+.++.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.++.. ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468899999999998866 69999987543 3456778888888877533 34566664432 3457899999988
Q ss_pred CChhh----------------hh---hhc--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHc-
Q 020946 193 GSLAS----------------HL---YDE--NYGPLTWNL---------RVHI------------ALDVAR-GLEYLHD- 228 (319)
Q Consensus 193 g~l~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~- 228 (319)
..+.. .+ +.. ....+.... .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 77766 11 111 111111110 0000 111222 2333332
Q ss_pred ---CCCCCeEEcCCCCCCEEEc-CCCceEEeecCCCc
Q 020946 229 ---GAVPPVIHRDIKSSNILLD-QSMRARVADFGLSR 261 (319)
Q Consensus 229 ---~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~ 261 (319)
.....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1223499999999999999 56666899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.7e-06 Score=69.91 Aligned_cols=102 Identities=24% Similarity=0.328 Sum_probs=80.0
Q ss_pred HHHHHHHhccCC-CCcceeeeEEeeCCeEEEEEEEccCCChhhhh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 020946 156 QTEVMLLGRLHH-RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233 (319)
Q Consensus 156 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 233 (319)
..|.-++..+++ +++.+++|+|. .+++.||...+++...- ........+|..+.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888876 68999999994 36788999876654210 0011224689999999999999999999865555
Q ss_pred eEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 234 VIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 234 i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
+.-.|++++|+-+++++++|++|...+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcc
Confidence 8889999999999999999999998653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.6e-06 Score=78.69 Aligned_cols=140 Identities=18% Similarity=0.162 Sum_probs=87.8
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcc-------------------------------------cHHHHHHHHH
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-------------------------------------GEKEFQTEVM 160 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~e~~ 160 (319)
+.||..+.|+||+|++.+|+.||||+-++.-+. .+-+|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 569999999999999999999999997654211 0112333433
Q ss_pred HHhc----cCCCCc---ceeeeEEe-eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 020946 161 LLGR----LHHRNL---VNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232 (319)
Q Consensus 161 ~l~~----l~h~ni---v~~~~~~~-~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 232 (319)
-..+ +.|-+. |.+-.++. -.....|+|||++|..+.+...-.. ..++...+..-+.+...-+-+- .|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qIf~--~G-- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQIFK--TG-- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHHHh--cC--
Confidence 3322 234441 11223333 2457899999999987776543332 2355444333333322222222 24
Q ss_pred CeEEcCCCCCCEEEcC----CCceEEeecCCCccc
Q 020946 233 PVIHRDIKSSNILLDQ----SMRARVADFGLSREE 263 (319)
Q Consensus 233 ~i~H~dlk~~Nill~~----~~~~kl~Dfg~~~~~ 263 (319)
++|+|-.|-||++++ ++.+.+-|||+....
T Consensus 322 -ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 322 -FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred -CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 899999999999984 678999999987643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.7e-05 Score=78.71 Aligned_cols=77 Identities=14% Similarity=0.349 Sum_probs=55.5
Q ss_pred cccccCCCceEEEEEeCCC---cEEEEEEeccCC-cccHHHHHHHHHHHhccC-CCCc--ceeeeEEeeC---CeEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTG---ETVAVKVLATDS-KQGEKEFQTEVMLLGRLH-HRNL--VNLVGYCAEK---GQHMLVY 187 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv~ 187 (319)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|..+++.+. |+++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688999999999876543 356777654332 223457889999999985 6654 7778887664 4678999
Q ss_pred EEccCCC
Q 020946 188 VFMSKGS 194 (319)
Q Consensus 188 e~~~~g~ 194 (319)
||+++..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1e-05 Score=63.39 Aligned_cols=128 Identities=18% Similarity=0.213 Sum_probs=87.3
Q ss_pred cccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 116 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
..+.|++|.+|.||++.+ .|..+|+|+-..++. ...+..|.++|..++-.++.+=+-.+.. .++.|||..+-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcch
Confidence 346799999999999998 566999998765543 5678899999999987776654333322 2344999988777
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCC-CCCEEEcCCCceEEeecCCCc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK-SSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk-~~Nill~~~~~~kl~Dfg~~~ 261 (319)
.+..... +-.+. ..+++.---|...+ |-|+.|. |...++.+++.+.|+||..|.
T Consensus 100 ~~~~~~~-----~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 100 GKLEIGG-----DRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhcc-----cHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 7655211 22222 33444434444446 8888875 555555555599999999876
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.4e-05 Score=60.40 Aligned_cols=130 Identities=22% Similarity=0.318 Sum_probs=89.1
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCC----------------cccHHHHHHHHHHHhccC------CCCcceeee
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDS----------------KQGEKEFQTEVMLLGRLH------HRNLVNLVG 175 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~~ 175 (319)
..||+|+.-.||.- ++.....||+..... ....++..+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 56999999999864 345567888876654 122455666666555554 788999999
Q ss_pred EEeeCCeEEEEEEEccC------CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC
Q 020946 176 YCAEKGQHMLVYVFMSK------GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 176 ~~~~~~~~~lv~e~~~~------g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 249 (319)
+..++.-.-+|+|.+.+ -+|.+++.. ..++. . +...+-+-..||-+++ |+.+|++|.||++...
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEEec
Confidence 99998888888988653 256666632 23554 2 3333444556777777 9999999999999643
Q ss_pred C----ceEEee-cCC
Q 020946 250 M----RARVAD-FGL 259 (319)
Q Consensus 250 ~----~~kl~D-fg~ 259 (319)
. .+.|+| ||.
T Consensus 155 ~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCceEEEEEeCCCC
Confidence 2 567776 554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=7.9e-05 Score=64.94 Aligned_cols=76 Identities=14% Similarity=0.134 Sum_probs=55.2
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC---CCcceeeeEEee---CCeEEEEEEEc
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH---RNLVNLVGYCAE---KGQHMLVYVFM 190 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~ 190 (319)
.+.||.|..+.||+....++ .+.+|..+. ......+..|...|+.+.- -.+.+++++|.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 35699999999999976555 466677432 1124578889998888853 367788887754 36689999999
Q ss_pred cCCCh
Q 020946 191 SKGSL 195 (319)
Q Consensus 191 ~~g~l 195 (319)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 87654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.1e-05 Score=64.38 Aligned_cols=73 Identities=14% Similarity=0.209 Sum_probs=43.9
Q ss_pred cccccCCCc-eEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC---CcceeeeEEeeC---CeEEEEEEEc
Q 020946 118 TLIGQGAFG-PVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLVGYCAEK---GQHMLVYVFM 190 (319)
Q Consensus 118 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~ 190 (319)
+.++.|+.. .||+. +..+++|..... .....+.+|...+..+... .+.+.++..... +..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 346766666 58875 235677765432 2245788899988877532 233444433322 2347899999
Q ss_pred cCCChh
Q 020946 191 SKGSLA 196 (319)
Q Consensus 191 ~~g~l~ 196 (319)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 886653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.7e-05 Score=61.01 Aligned_cols=125 Identities=26% Similarity=0.448 Sum_probs=87.6
Q ss_pred HhcccccccccCCC-ceEEEEEeCCCcEEEEEEecc---CC--------c----------ccHHHHHHHHHHHhccC---
Q 020946 112 ATCNFTTLIGQGAF-GPVYKAQMSTGETVAVKVLAT---DS--------K----------QGEKEFQTEVMLLGRLH--- 166 (319)
Q Consensus 112 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~--- 166 (319)
+.+++.+.||.|.- |.||++++ +|+.+|+|++.. .. . .....|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 66778899999999 99999999 688999999321 00 0 11235778888777764
Q ss_pred CCCc--ceeeeEEeeC------------------CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 020946 167 HRNL--VNLVGYCAEK------------------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226 (319)
Q Consensus 167 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L 226 (319)
+.++ |+.+||..-. ....+|.||.+... .++ ..-+.++.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 5566 8888876322 12345666554422 122 33455777888999
Q ss_pred HcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 227 H~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9998 999999999986 3489999854
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.3e-05 Score=65.18 Aligned_cols=137 Identities=15% Similarity=0.171 Sum_probs=77.4
Q ss_pred cccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcc-eeeeEEeeCCeEEEEEEEccCCChhhh
Q 020946 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV-NLVGYCAEKGQHMLVYVFMSKGSLASH 198 (319)
Q Consensus 120 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~l~~~ 198 (319)
+..|-...+|+... ++..+++|..........-...+|..+++.+....++ +++.... .+++++|+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677789998874 5678888876543222112346788888888644343 3444332 3689999987655321
Q ss_pred -----------------hhhcC--CCCCCHHH-HHHHHHH---------HHHHHHHHHcCC-----CCCeEEcCCCCCCE
Q 020946 199 -----------------LYDEN--YGPLTWNL-RVHIALD---------VARGLEYLHDGA-----VPPVIHRDIKSSNI 244 (319)
Q Consensus 199 -----------------l~~~~--~~~l~~~~-~~~i~~~---------i~~~l~~LH~~~-----~~~i~H~dlk~~Ni 244 (319)
++... ..+++... ...+..+ +...+..+-... .+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 11122111 1111111 111222222211 12489999999999
Q ss_pred EEcCCCceEEeecCCCcc
Q 020946 245 LLDQSMRARVADFGLSRE 262 (319)
Q Consensus 245 ll~~~~~~kl~Dfg~~~~ 262 (319)
++++++ +.++||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00013 Score=61.29 Aligned_cols=73 Identities=18% Similarity=0.233 Sum_probs=46.3
Q ss_pred cccccCCCceEEEEEeCC--CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcc-eeeeEEeeCCeEEEEEEEccCCC
Q 020946 118 TLIGQGAFGPVYKAQMST--GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV-NLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
+.|..|-...+|+....+ +..+++|+....... .....+|..++..+...+++ ++++.+. . .+++||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 346778888999997654 678889977543221 12334688888877543443 4444332 2 37999998866
Q ss_pred h
Q 020946 195 L 195 (319)
Q Consensus 195 l 195 (319)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00051 Score=61.94 Aligned_cols=74 Identities=18% Similarity=0.157 Sum_probs=51.1
Q ss_pred cccccCCCceEEEEEeCCC-cEEEEEEeccC-----C--cccHHHHHHHHHHHhccC---CCCcceeeeEEeeCCeEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTG-ETVAVKVLATD-----S--KQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 186 (319)
+.||.|.+..||++...+| +.+.||.-.+. . ....+++..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999988776 48999975321 1 123456677878777763 2345556655 34567899
Q ss_pred EEEccCC
Q 020946 187 YVFMSKG 193 (319)
Q Consensus 187 ~e~~~~g 193 (319)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00023 Score=62.03 Aligned_cols=141 Identities=18% Similarity=0.174 Sum_probs=82.5
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC--CcceeeeE------EeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR--NLVNLVGY------CAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~ 189 (319)
+.+..|....+|+.... +..+++|+... .....+..|+.++..+.+. .+.+++.. ....+..++++++
T Consensus 20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 20 EGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 45777877899998764 45788888754 2344566777777776432 23444331 2234567899999
Q ss_pred ccCCChhh----hh----------hhc--C-C------CCCCHHHHH----------HHHHHHHHHHHHHHcC----CCC
Q 020946 190 MSKGSLAS----HL----------YDE--N-Y------GPLTWNLRV----------HIALDVARGLEYLHDG----AVP 232 (319)
Q Consensus 190 ~~~g~l~~----~l----------~~~--~-~------~~l~~~~~~----------~i~~~i~~~l~~LH~~----~~~ 232 (319)
+++..+.. .. +.. . . ....|.... .....+..++.++.+. ...
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98866432 11 110 0 0 011221110 0111233444555431 113
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 233 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++|+|+.|.|+++++++.+.|.||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 489999999999999987778999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.76 E-value=9.6e-05 Score=73.00 Aligned_cols=153 Identities=21% Similarity=0.210 Sum_probs=110.0
Q ss_pred HHHHHHHHHhccCCCCcceeeeEEeeCCe----EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 020946 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKGQ----HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229 (319)
Q Consensus 154 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 229 (319)
....|++.+..+.|+|++.++.|-.+... ..+..+++..-++...+ +....++.+..+.+..++..|+.|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34567778888999999999888655322 22334556666666666 3345688889999999999999999997
Q ss_pred CCCCeEEcCCCCC---CEEEcCCCceEEe--ecCCCccccccccccccccccCccCccccCCCCCCc--chhhHHHHHHH
Q 020946 230 AVPPVIHRDIKSS---NILLDQSMRARVA--DFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK--KSDVYSFGVLL 302 (319)
Q Consensus 230 ~~~~i~H~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~Dv~slGvil 302 (319)
. ..|.-+..+ +...+.++.+.++ ||+................+..|.+||......++. ..|+|++|..+
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 6 556555555 5555666777777 888876655554444555677788999886665554 47999999999
Q ss_pred HHHHhCCCC
Q 020946 303 FELIAGRSP 311 (319)
Q Consensus 303 ~elltg~~p 311 (319)
..+..|..+
T Consensus 383 ~~~~~~~~i 391 (1351)
T KOG1035|consen 383 LQLSQGEDI 391 (1351)
T ss_pred hhhhhcCcc
Confidence 998887543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0006 Score=59.60 Aligned_cols=73 Identities=23% Similarity=0.331 Sum_probs=45.2
Q ss_pred ccccCCCceEEEEEeCC-------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcc-eeeeEEeeCCeEEEEEEEc
Q 020946 119 LIGQGAFGPVYKAQMST-------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV-NLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~ 190 (319)
.+..|-...+|+....+ ++.+++|+...... ......+|..++..+....+. ++++++. + ..+++|+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 35556667889887654 57899998755432 223456777777777533333 4555543 2 3578998
Q ss_pred cCCChh
Q 020946 191 SKGSLA 196 (319)
Q Consensus 191 ~~g~l~ 196 (319)
++..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 876553
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0011 Score=58.24 Aligned_cols=141 Identities=20% Similarity=0.268 Sum_probs=78.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC--CcceeeeE------EeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR--NLVNLVGY------CAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~ 189 (319)
+.++.|....+|+....++ .+++|+..... ..+.+..|..++..+... .+.+++.. ....+..+++++|
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4467777789999876545 56778764421 133455566666665321 23344332 1224567899999
Q ss_pred ccCCChhh----h----------hhhcCCC----------CCCHHHHH------------HHHHHHHHHHHHHHc----C
Q 020946 190 MSKGSLAS----H----------LYDENYG----------PLTWNLRV------------HIALDVARGLEYLHD----G 229 (319)
Q Consensus 190 ~~~g~l~~----~----------l~~~~~~----------~l~~~~~~------------~i~~~i~~~l~~LH~----~ 229 (319)
+++..+.. . ++..... .-.|.... .....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 98754321 0 1110000 00111100 001123334555532 1
Q ss_pred CCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 230 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
....++|+|+.+.|+++++++...|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 12459999999999999998777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0037 Score=55.09 Aligned_cols=141 Identities=16% Similarity=0.191 Sum_probs=74.6
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC--CCcceeee------EEeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--RNLVNLVG------YCAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e~ 189 (319)
+.++.|....+|+....+| .+++|+... ...+.+..|...+..+.. -.+.+.+. +....+..+++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 3466777789999876555 678888752 122333444454444421 11233332 12235667899999
Q ss_pred ccCCChhh-----------hh---hhcC---------CCCCCH-HHHHH------------HH-HHHHHHHHHHHcC---
Q 020946 190 MSKGSLAS-----------HL---YDEN---------YGPLTW-NLRVH------------IA-LDVARGLEYLHDG--- 229 (319)
Q Consensus 190 ~~~g~l~~-----------~l---~~~~---------~~~l~~-~~~~~------------i~-~~i~~~l~~LH~~--- 229 (319)
+++..+.. .+ +... ...+.| ..... .. ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 98864311 11 1100 001112 11110 11 1111122333211
Q ss_pred -CCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 230 -AVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 230 -~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
-..+++|+|+.|.||+++++...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123599999999999999776568999998753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0013 Score=56.79 Aligned_cols=72 Identities=19% Similarity=0.336 Sum_probs=46.3
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCCcceeeeEEeeCCeEEEEEEEccCC
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
+.++.|....+|+.. .+++.+.||+-. ......|..|..-|+.+. --.+.+.+++....+..++++||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 558889999999988 478889999865 223456778888777773 445677888877777779999998866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00017 Score=62.16 Aligned_cols=132 Identities=17% Similarity=0.168 Sum_probs=90.7
Q ss_pred cccccccccCCCceEEEEEeCCCcEEEEEEeccC--------------------Cccc--HHHHHHHHHHHhccC-CC-C
Q 020946 114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--------------------SKQG--EKEFQTEVMLLGRLH-HR-N 169 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--------------------~~~~--~~~~~~e~~~l~~l~-h~-n 169 (319)
+.+.+.||-|.-+-+|.+...+|++.++|.-... +... .-...+|...|+.+. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567899999999999998888999998853211 0000 112356777777774 32 2
Q ss_pred cceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC
Q 020946 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 170 iv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 249 (319)
+...++ .+..++||+++.+..|...-+-.. .-.+...+..-+.-|-.+| +||+|..--||+++++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d--------~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRHVED--------PPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeeecCC--------hHHHHHHHHHHHHHHHHcC---ceecccchheeEEecC
Confidence 333443 346788999998877665442211 2234445555667777778 9999999999999999
Q ss_pred CceEEeecCCC
Q 020946 250 MRARVADFGLS 260 (319)
Q Consensus 250 ~~~kl~Dfg~~ 260 (319)
+.++++||--+
T Consensus 239 ~~i~vIDFPQm 249 (465)
T KOG2268|consen 239 DKIVVIDFPQM 249 (465)
T ss_pred CCEEEeechHh
Confidence 99999999743
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.003 Score=55.12 Aligned_cols=141 Identities=18% Similarity=0.258 Sum_probs=78.1
Q ss_pred CCCceEEEEEeCCCcEEEEEEec-cCCcccHHHHHHHHHHHhccCC--CCcceeeeEEeeCC--eEEEEEEEccCCChhh
Q 020946 123 GAFGPVYKAQMSTGETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEKG--QHMLVYVFMSKGSLAS 197 (319)
Q Consensus 123 G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~g~l~~ 197 (319)
|..-.+|+... +++.+++.... ...........+|..+++.+.- .-....++.|.++. ..+.+|+|.++....+
T Consensus 36 G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 33334444443 37777777321 1223334556778888887743 23344566776655 7799999998742222
Q ss_pred hhhhcC-----------------------------------CCCC-CHHHHHHHH--------HHHHHHHHHHHcCCC--
Q 020946 198 HLYDEN-----------------------------------YGPL-TWNLRVHIA--------LDVARGLEYLHDGAV-- 231 (319)
Q Consensus 198 ~l~~~~-----------------------------------~~~l-~~~~~~~i~--------~~i~~~l~~LH~~~~-- 231 (319)
.+.... ..++ .|....+.+ -....-..+|+.+..
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 111000 0000 011111000 012223445544322
Q ss_pred ---CCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 232 ---PPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 232 ---~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+.++|+|+.+.|+++++++.+-+.||+++....
T Consensus 195 ~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 469999999999999999889999999886543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0041 Score=55.42 Aligned_cols=139 Identities=15% Similarity=0.229 Sum_probs=78.2
Q ss_pred ccccCCCceEEEEEeCC-----CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcc-eeeeEEeeCCeEEEEEEEccC
Q 020946 119 LIGQGAFGPVYKAQMST-----GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV-NLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~ 192 (319)
.+-.|-.-.+|+....+ ++.+++|+.........+ ..+|..+++.+..-++. ++++.+.. + .+++|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 34457777899886532 367899987654332222 36788888877654444 45555533 2 47889876
Q ss_pred CChhhh-----------------hhhcC----CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hc-C
Q 020946 193 GSLASH-----------------LYDEN----YGPLTWNLRVHIALDV-----------------ARGLEYL----HD-G 229 (319)
Q Consensus 193 g~l~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------~~~l~~L----H~-~ 229 (319)
.++... +|... .....+.++.++..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 555321 11111 0011233333332111 1111122 21 1
Q ss_pred CCCCeEEcCCCCCCEEEcC-CCceEEeecCCCcc
Q 020946 230 AVPPVIHRDIKSSNILLDQ-SMRARVADFGLSRE 262 (319)
Q Consensus 230 ~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~ 262 (319)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1124899999999999986 46899999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=2.2e-05 Score=79.27 Aligned_cols=158 Identities=12% Similarity=-0.014 Sum_probs=112.7
Q ss_pred HHHHHHHhccCCCCcceeeeEEee--CCeEEEEEEEccCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcC--
Q 020946 156 QTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDG-- 229 (319)
Q Consensus 156 ~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~-- 229 (319)
..|...++...|+++.....-..+ ..+.+..++|+..|.+.+.+.... ...+...-+.....+......-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 345555666789988776554432 345678889999999999886532 22233333333333335555554443
Q ss_pred CCCCeEEcCCCCCCEEEcCCCceEEeecCCCc-cccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhC
Q 020946 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR-EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG 308 (319)
Q Consensus 230 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~-~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg 308 (319)
+....+|+++|+-|.+|..+-.+++.++|+.+ ............+++.|++|+....-+++.++|+|..|+-+|++.-|
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 22347899999999999999999999999998 43333444456688899999998888899999999999999998888
Q ss_pred CCCCC
Q 020946 309 RSPLQ 313 (319)
Q Consensus 309 ~~pf~ 313 (319)
..+|.
T Consensus 1437 n~~fi 1441 (2724)
T KOG1826|consen 1437 NAYFI 1441 (2724)
T ss_pred cHHHH
Confidence 88774
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0034 Score=54.08 Aligned_cols=32 Identities=22% Similarity=0.481 Sum_probs=26.0
Q ss_pred CCeEEcCCCCCCEEEcCCCc-eEEeecCCCccc
Q 020946 232 PPVIHRDIKSSNILLDQSMR-ARVADFGLSREE 263 (319)
Q Consensus 232 ~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~~ 263 (319)
+.++|+|+.|.||++++++. .-|.||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 34899999999999997555 469999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0059 Score=53.81 Aligned_cols=137 Identities=21% Similarity=0.267 Sum_probs=90.9
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccC-------C--------------ccc-----HHHHHHHHHHHhccCCCCc
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATD-------S--------------KQG-----EKEFQTEVMLLGRLHHRNL 170 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-------~--------------~~~-----~~~~~~e~~~l~~l~h~ni 170 (319)
...|..|.-+.||.|.-.+|..+|||+++.. . +.. ......|+.-|++++.-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3468889999999998889999999987432 0 000 1134567777777765443
Q ss_pred ceeeeEEeeCCeEEEEEEEccCCCh-hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC
Q 020946 171 VNLVGYCAEKGQHMLVYVFMSKGSL-ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 171 v~~~~~~~~~~~~~lv~e~~~~g~l-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 249 (319)
.-.--+.. ....|||+|+..... .-.| ....++...+..+-.|++.-|.-|-+... +||.||.--|+|+.++
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~LyhdG 301 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHDG 301 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEECC
Confidence 32111111 245789999853222 2223 22346666777777888888887765442 9999999999999754
Q ss_pred CceEEeecCCCc
Q 020946 250 MRARVADFGLSR 261 (319)
Q Consensus 250 ~~~kl~Dfg~~~ 261 (319)
.+.|+|.+-+-
T Consensus 302 -~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 -KLYIIDVSQSV 312 (520)
T ss_pred -EEEEEEccccc
Confidence 89999998653
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00031 Score=51.62 Aligned_cols=34 Identities=29% Similarity=0.274 Sum_probs=23.0
Q ss_pred CCCCcceEEehhHHHHHHHHHHHHHHHHhhhhcc
Q 020946 2 KGESSGLIIGISIGVVIGVLLAISALFCFRYHRK 35 (319)
Q Consensus 2 ~~~~~~~i~~i~~~~~~~~~l~~~~~~~~~~~~~ 35 (319)
++-+.+.|++|++|+++++++++++++++.+|++
T Consensus 59 h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~ 92 (122)
T PF01102_consen 59 HRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLR 92 (122)
T ss_dssp SSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred cCccccceeehhHHHHHHHHHHHHHHHHHHHHHh
Confidence 3556788999999999988776655544444333
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00038 Score=49.27 Aligned_cols=34 Identities=35% Similarity=0.332 Sum_probs=22.9
Q ss_pred CCCCcceEEehhHHHHHHHHHHHHHHHHhhhhcc
Q 020946 2 KGESSGLIIGISIGVVIGVLLAISALFCFRYHRK 35 (319)
Q Consensus 2 ~~~~~~~i~~i~~~~~~~~~l~~~~~~~~~~~~~ 35 (319)
++.+++.|+||+||+++++.+++.++++|+..|+
T Consensus 61 ~~ls~gaiagi~vg~~~~v~~lv~~l~w~f~~r~ 94 (96)
T PTZ00382 61 SGLSTGAIAGISVAVVAVVGGLVGFLCWWFVCRG 94 (96)
T ss_pred CCcccccEEEEEeehhhHHHHHHHHHhheeEEee
Confidence 4678899999999988777555544444444333
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.015 Score=51.66 Aligned_cols=73 Identities=18% Similarity=0.090 Sum_probs=45.6
Q ss_pred ccccCCCceEEEEEeCCC-cEEEEEEecc-------CCcccHHHHHHHHHHHhccC--CCCcceeeeEEeeCCeEEEEEE
Q 020946 119 LIGQGAFGPVYKAQMSTG-ETVAVKVLAT-------DSKQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+|-|...-||++..++| +.++||.-.+ .-+-..++..-|...|.... -|..++-+-+ .+.+...++||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-EccccceehHh
Confidence 478999999999987654 5899995421 11223445556777776653 3544443322 34556678899
Q ss_pred EccC
Q 020946 189 FMSK 192 (319)
Q Consensus 189 ~~~~ 192 (319)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.033 Score=50.34 Aligned_cols=72 Identities=10% Similarity=0.111 Sum_probs=47.0
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCC----c---ccHHHHHHHHHHHhccC---CCCcceeeeEEeeCCeEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDS----K---QGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 187 (319)
+.||.|..-.||+... ++..++||.-.... . -...+-..|...|+.+. ..++.+++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 5689999999999876 45678899754211 1 12333344566665553 246777888776 4467789
Q ss_pred EEccC
Q 020946 188 VFMSK 192 (319)
Q Consensus 188 e~~~~ 192 (319)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99966
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.025 Score=50.18 Aligned_cols=138 Identities=16% Similarity=0.241 Sum_probs=74.8
Q ss_pred cccCCCceEEEEEeCC----CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcc-eeeeEEeeCCeEEEEEEEccCCC
Q 020946 120 IGQGAFGPVYKAQMST----GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV-NLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 120 lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
|..|=.-.+|+....+ +..+++|+....... .-.-.+|..+++.+..-++. ++++++. .+ ++.+|+++..
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~ 96 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART 96 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence 4446666788875432 237889987654332 22235778888887655554 4555553 32 4788887654
Q ss_pred hhhh-------h----------hhcC---CC-CCCHHHHHHHHHHH----------------------HHHHH----HHH
Q 020946 195 LASH-------L----------YDEN---YG-PLTWNLRVHIALDV----------------------ARGLE----YLH 227 (319)
Q Consensus 195 l~~~-------l----------~~~~---~~-~l~~~~~~~i~~~i----------------------~~~l~----~LH 227 (319)
+... + |... .. .-.+..+.++..++ ..-+. .+.
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 4210 1 1111 00 11233322222111 11111 121
Q ss_pred cCCC-CCeEEcCCCCCCEEEcC-CCceEEeecCCCcc
Q 020946 228 DGAV-PPVIHRDIKSSNILLDQ-SMRARVADFGLSRE 262 (319)
Q Consensus 228 ~~~~-~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~ 262 (319)
..+. .-.+|+|+.+.|||+++ ++.++++||..|-.
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1121 13789999999999975 57899999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.05 Score=47.64 Aligned_cols=29 Identities=31% Similarity=0.386 Sum_probs=25.1
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 232 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..++|+|+.+.||++++ +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999998 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.006 Score=50.28 Aligned_cols=29 Identities=24% Similarity=0.486 Sum_probs=20.7
Q ss_pred eEEcCCCCCCEEE-cCCCceEEeecCCCcc
Q 020946 234 VIHRDIKSSNILL-DQSMRARVADFGLSRE 262 (319)
Q Consensus 234 i~H~dlk~~Nill-~~~~~~kl~Dfg~~~~ 262 (319)
++|+|+.|.|||+ +.++.++++||..|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 7899999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.051 Score=47.95 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=81.6
Q ss_pred cccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCCcce---eeeE--EeeCC--eEEEEEEE
Q 020946 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVN---LVGY--CAEKG--QHMLVYVF 189 (319)
Q Consensus 120 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~---~~~~--~~~~~--~~~lv~e~ 189 (319)
|.+ .--.+|+....+|+. ++|+.... ....++..|+..+..+. .+--++ +-|- ..-.+ ..+.+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789988767776 88887665 34566677777777663 222222 2221 11123 77889999
Q ss_pred ccCCChhh-h----h----------hh--cC--------CCCCCHHH-------------HHHHHHHHHHHHHHHHcCCC
Q 020946 190 MSKGSLAS-H----L----------YD--EN--------YGPLTWNL-------------RVHIALDVARGLEYLHDGAV 231 (319)
Q Consensus 190 ~~~g~l~~-~----l----------~~--~~--------~~~l~~~~-------------~~~i~~~i~~~l~~LH~~~~ 231 (319)
++|..+.. . + +. .. .....|.. ......++...+..+.+.-.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99877762 1 1 10 00 01123330 01123344445555543211
Q ss_pred -----CC--eEEcCCCCCCEEEcCCCc-eEEeecCCCcc
Q 020946 232 -----PP--VIHRDIKSSNILLDQSMR-ARVADFGLSRE 262 (319)
Q Consensus 232 -----~~--i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~ 262 (319)
.+ +||+|+.|.||+++.+.. ..+.||+-+..
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 12 899999999999999875 88999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.038 Score=48.46 Aligned_cols=30 Identities=17% Similarity=0.272 Sum_probs=27.2
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 233 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+++|+|+.+.|+|+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999998999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.081 Score=54.03 Aligned_cols=154 Identities=19% Similarity=0.279 Sum_probs=83.8
Q ss_pred CHHHHHHHhcccc---cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-------CCCCcceee
Q 020946 105 SYKDLQKATCNFT---TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-------HHRNLVNLV 174 (319)
Q Consensus 105 ~~~~l~~~~~~~~---~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~ 174 (319)
...++....|.+. +.|+ |..-.+|+....+|..+++|+...... ......|...+..+ .-|.+++-.
T Consensus 15 ~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~ 91 (1013)
T PRK06148 15 DAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSL 91 (1013)
T ss_pred HHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecC
Confidence 3445556666653 4464 456788999877888999999876432 23334444444433 233333322
Q ss_pred e-----EEee-CC--eEEEEEEEccCCChhhh-------h----------hh--c------CCCCCCHHH----------
Q 020946 175 G-----YCAE-KG--QHMLVYVFMSKGSLASH-------L----------YD--E------NYGPLTWNL---------- 211 (319)
Q Consensus 175 ~-----~~~~-~~--~~~lv~e~~~~g~l~~~-------l----------~~--~------~~~~l~~~~---------- 211 (319)
+ .... .+ ..+.+++|+++..+.+. + +. + ....+.|..
T Consensus 92 ~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l 171 (1013)
T PRK06148 92 SGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRL 171 (1013)
T ss_pred CCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhh
Confidence 1 1111 22 46778999998766541 0 00 0 011223321
Q ss_pred -------HHHHHHHHHHHHH-----HHHcCCCCCeEEcCCCCCCEEEcCCC--ceE-EeecCCCcc
Q 020946 212 -------RVHIALDVARGLE-----YLHDGAVPPVIHRDIKSSNILLDQSM--RAR-VADFGLSRE 262 (319)
Q Consensus 212 -------~~~i~~~i~~~l~-----~LH~~~~~~i~H~dlk~~Nill~~~~--~~k-l~Dfg~~~~ 262 (319)
...++.+++.... .+.+.. ..+||+|+.+.|||++.+. .+. |+|||-+..
T Consensus 172 ~~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp-~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 172 HFIDDPEDRALVERFLARFERNVAPRLAALP-AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhcCCHHHHHHHHHHHHHHHHHHHHHHhcCC-cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1122223332222 122211 2499999999999999875 455 999997653
|
|
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.0069 Score=34.05 Aligned_cols=23 Identities=30% Similarity=0.632 Sum_probs=15.5
Q ss_pred eEEehhHHHHHHHHHHHHHHHHh
Q 020946 8 LIIGISIGVVIGVLLAISALFCF 30 (319)
Q Consensus 8 ~i~~i~~~~~~~~~l~~~~~~~~ 30 (319)
..++|++|++++++++++.++++
T Consensus 4 s~IaIIv~V~vg~~iiii~~~~Y 26 (38)
T PF02439_consen 4 STIAIIVAVVVGMAIIIICMFYY 26 (38)
T ss_pred chhhHHHHHHHHHHHHHHHHHHH
Confidence 45778888888776666555553
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.0012 Score=41.97 Aligned_cols=33 Identities=24% Similarity=0.508 Sum_probs=0.4
Q ss_pred cceEEehhHHHHHHHHHHHHHHHHhhhhccccC
Q 020946 6 SGLIIGISIGVVIGVLLAISALFCFRYHRKRSQ 38 (319)
Q Consensus 6 ~~~i~~i~~~~~~~~~l~~~~~~~~~~~~~~~~ 38 (319)
+.+++|+++|++++++++++++.++.+|.|+++
T Consensus 8 ~~vlaavIaG~Vvgll~ailLIlf~iyR~rkkd 40 (64)
T PF01034_consen 8 SEVLAAVIAGGVVGLLFAILLILFLIYRMRKKD 40 (64)
T ss_dssp -----------------------------S---
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 455667777777666655555544444444443
|
Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q. |
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.002 Score=48.74 Aligned_cols=37 Identities=30% Similarity=0.606 Sum_probs=22.5
Q ss_pred CCCcceEEehhHHHHHHHHHHH-HHHHHhhhhccccCC
Q 020946 3 GESSGLIIGISIGVVIGVLLAI-SALFCFRYHRKRSQI 39 (319)
Q Consensus 3 ~~~~~~i~~i~~~~~~~~~l~~-~~~~~~~~~~~~~~~ 39 (319)
.+.+.++||++||+-+.+++++ +++|+|++|++|.+.
T Consensus 45 ~knknIVIGvVVGVGg~ill~il~lvf~~c~r~kktdf 82 (154)
T PF04478_consen 45 SKNKNIVIGVVVGVGGPILLGILALVFIFCIRRKKTDF 82 (154)
T ss_pred cCCccEEEEEEecccHHHHHHHHHhheeEEEecccCcc
Confidence 3445689999998776665543 344445555555543
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.33 Score=42.96 Aligned_cols=70 Identities=14% Similarity=0.149 Sum_probs=43.0
Q ss_pred CCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC--CCcceee---e--EEeeCCeEEEEEEEccCCC
Q 020946 124 AFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--RNLVNLV---G--YCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 124 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~---~--~~~~~~~~~lv~e~~~~g~ 194 (319)
.-..||+....++..+++|+..... .....+..|+..+..+.. -.++... | ....++..+.+++++++..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3467899887778889999875432 235566677777665531 1122212 2 2233467788999987654
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.0029 Score=36.26 Aligned_cols=24 Identities=21% Similarity=0.439 Sum_probs=11.2
Q ss_pred CCcceEEehhHHHHHHHHHHHHHH
Q 020946 4 ESSGLIIGISIGVVIGVLLAISAL 27 (319)
Q Consensus 4 ~~~~~i~~i~~~~~~~~~l~~~~~ 27 (319)
.+.+.-+++.+++-++++++++++
T Consensus 7 ~~~~vaIa~~VvVPV~vI~~vl~~ 30 (40)
T PF08693_consen 7 NSNTVAIAVGVVVPVGVIIIVLGA 30 (40)
T ss_pred CCceEEEEEEEEechHHHHHHHHH
Confidence 345555555554444444433333
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.074 Score=43.99 Aligned_cols=75 Identities=16% Similarity=0.239 Sum_probs=50.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc---CCCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL---HHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
+.+.-|..-+.|.... +..++.||+-. ......|..|+.-|..+ +--++.+.+.+-.+.++.|+|++|++.+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3345555555555544 55688899742 23345677777666655 44567778888888899999999999866
Q ss_pred hh
Q 020946 195 LA 196 (319)
Q Consensus 195 l~ 196 (319)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 319 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-45 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-30 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-27 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-26 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-25 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-24 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-24 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-24 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-23 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-23 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-23 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-23 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-23 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-23 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-23 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-23 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-23 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-23 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-23 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-23 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-23 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-23 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-23 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-22 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-22 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-22 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-22 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-22 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-22 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-22 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-22 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-22 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-22 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-22 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-22 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-22 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-22 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-22 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-22 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-22 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-21 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-21 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-20 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-19 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-19 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-15 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-12 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-12 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-12 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-111
Identities = 92/216 (42%), Positives = 134/216 (62%), Gaps = 10/216 (4%)
Query: 104 YSYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVML 161
DL++AT NF LIG G FG VYK + G VA+K +S QG +EF+TE+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDV 219
L H +LV+L+G+C E+ + +L+Y +M G+L HLY + ++W R+ I +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAA-NIRGTF 276
ARGL YLH +IHRD+KS NILLD++ ++ DFG+S++ E+ H + ++GT
Sbjct: 149 ARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
GY+DPEY T+KSDVYSFGV+LFE++ RS +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-105
Identities = 95/216 (43%), Positives = 136/216 (62%), Gaps = 7/216 (3%)
Query: 104 YSYKDLQKATCNFTT--LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-EKEFQTEVM 160
+S ++LQ A+ NF+ ++G+G FG VYK +++ G VAVK L + QG E +FQTEV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG--PLTWNLRVHIALD 218
++ HRNL+ L G+C + +LVY +M+ GS+AS L + PL W R IAL
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAAN-IRGTF 276
ARGL YLHD P +IHRD+K++NILLD+ A V DFGL++ H +RGT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
G++ PEY+ST ++K+DV+ +GV+L ELI G+
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-104
Identities = 85/233 (36%), Positives = 129/233 (55%), Gaps = 21/233 (9%)
Query: 96 VSASGIPEYSYKDLQKATCNF--------TTLIGQGAFGPVYKAQMSTGETVAVKVLAT- 146
VS + +S+ +L+ T NF +G+G FG VYK ++ TVAVK LA
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAM 65
Query: 147 ---DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-E 202
+++ +++F E+ ++ + H NLV L+G+ ++ LVYV+M GSL L +
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 203 NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
PL+W++R IA A G+ +LH+ IHRDIKS+NILLD++ A+++DFGL+R
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 263 EMVDKHAAN---IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
I GT Y+ PE + T KSD+YSFGV+L E+I G +
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-76
Identities = 74/242 (30%), Positives = 115/242 (47%), Gaps = 26/242 (10%)
Query: 97 SASGIPEYSYKDLQKATCNFT--TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE 154
S + ++L + + +G FG V+KAQ+ E VAVK+ KQ +
Sbjct: 7 HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-Q 64
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWN 210
+ EV L + H N++ +G L+ F KGSL+ L ++WN
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWN 121
Query: 211 LRVHIALDVARGLEYLH-------DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
HIA +ARGL YLH DG P + HRDIKS N+LL ++ A +ADFGL+ +
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 264 MVDKHAANIR---GTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
K A + GT Y+ PE + R+ + D+Y+ G++L+EL + + G
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 316 ME 317
++
Sbjct: 242 VD 243
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-71
Identities = 73/204 (35%), Positives = 113/204 (55%), Gaps = 6/204 (2%)
Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
IG G+FG V++A+ G VAVK+L + EF EV ++ RL H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAVP 232
+G + +V ++S+GSL L+ L R+ +A DVA+G+ YLH+ P
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-P 158
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTK 291
P++HR++KS N+L+D+ +V DFGLSR + ++ + GT ++ PE + +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 292 KSDVYSFGVLLFELIAGRSPLQGL 315
KSDVYSFGV+L+EL + P L
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNL 242
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-69
Identities = 71/239 (29%), Positives = 122/239 (51%), Gaps = 26/239 (10%)
Query: 96 VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-- 152
S +P + +++ + IG+G FG V+K + + VA+K L +GE
Sbjct: 8 FPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 153 -----KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
+EFQ EV ++ L+H N+V L G +V F+ G L L D+ P+
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKA-HPI 119
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-----MRARVADFGLSRE 262
W++++ + LD+A G+EY+ + PP++HRD++S NI L + A+VADFGLS++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 263 EMVDKHAANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ + G F ++ PE I +T+K+D YSF ++L+ ++ G P +
Sbjct: 179 S--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-69
Identities = 65/212 (30%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL 165
YK+++ ++G+GAFG V KA+ + VA+K + ++S+ K F E+ L R+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRV 58
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLE 224
+H N+V L G C LV + GSL + L+ E T + L ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMR-ARVADFGLSREEMVDKHAANIRGTFGYLDPEY 283
YLH +IHRD+K N+LL ++ DFG + + + H N +G+ ++ PE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPEV 174
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
N+++K DV+S+G++L+E+I R P +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 9e-68
Identities = 76/208 (36%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG G FG VY+A G+ VAVK D Q + + E L L H N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
C ++ LV F G L L + + ++ V+ A+ +ARG+ YLHD A+ P+I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 236 HRDIKSSNILLDQSMRAR--------VADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
HRD+KSSNIL+ Q + + DFGL+RE + G + ++ PE I
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-GAYAWMAPEVIRAS 189
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGL 315
F+K SDV+S+GVLL+EL+ G P +G+
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-66
Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLG 163
+K L F T + + G ++K + G + VKVL S + ++F E L
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
H N++ ++G C + +M GSL + L++ + + V ALD+AR
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
G+ +LH P + + S ++++D+ M AR++ + ++ P
Sbjct: 123 GMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----GRMYAPAWVAP 177
Query: 282 EYISTR---NFTKKSDVYSFGVLLFELIAGRSPLQGL 315
E + + + +D++SF VLL+EL+ P L
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 7e-65
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G+G FG K TGE + +K L ++ ++ F EV ++ L H N++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ + + ++ G+L + + W+ RV A D+A G+ YLH +IHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAAN---------------IRGTFGYLDPEY 283
+ S N L+ ++ VADFGL+R + +K + G ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
I+ R++ +K DV+SFG++L E+I + + +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-64
Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 31/262 (11%)
Query: 77 GRNGNGKSMWLEGFKRSNVVSASGIPEY--SYKDLQKATCNFTTLIGQGAFGPVYKAQMS 134
G N + F R ++ + E+ ++ L+ LIG+G FG VY +
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLE-----IGELIGKGRFGQVYHGRWH 55
Query: 135 TGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192
GE VA++++ D++ K F+ EVM + H N+V +G C ++
Sbjct: 56 -GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113
Query: 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252
+L S + D L N IA ++ +G+ YLH ++H+D+KS N+ D +
Sbjct: 114 RTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKV 168
Query: 253 RVADFGLSREEMVDKHAANI------RGTFGYLDPEYISTRN---------FTKKSDVYS 297
+ DFGL V + G +L PE I + F+K SDV++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 298 FGVLLFELIAGRSPLQGLMEQQ 319
G + +EL A P + +
Sbjct: 229 LGTIWYELHAREWPFKTQPAEA 250
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-62
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
IG G+FG VYK + VAVK+L + Q + F+ EV +L + H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
Q +V + SL HL+ + IA ARG++YLH +IHR
Sbjct: 90 -TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 238 DIKSSNILLDQSMRARVADFGLSREE---MVDKHAANIRGTFGYLDPEYISTRN---FTK 291
D+KS+NI L + ++ DFGL+ E+ + G+ ++ PE I ++ ++
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 292 KSDVYSFGVLLFELIAGRSPLQGL 315
+SDVY+FG++L+EL+ G+ P +
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNI 228
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-62
Identities = 59/241 (24%), Positives = 96/241 (39%), Gaps = 38/241 (15%)
Query: 103 EYSYKDLQKATCNFT--TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTE-- 158
E + + N LIG+G +G VYK + VAVKV S + F E
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF---SFANRQNFINEKN 57
Query: 159 VMLLGRLHHRNLVNLVGYCAE-----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
+ + + H N+ + + +++LV + GSL +L W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSC 114
Query: 214 HIALDVARGLEYLH------DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
+A V RGL YLH D P + HRD+ S N+L+ ++DFGLS ++
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 268 HAANIR---------GTFGYLDPEYI-------STRNFTKKSDVYSFGVLLFELIAGRSP 311
GT Y+ PE + + K+ D+Y+ G++ +E+ +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 312 L 312
L
Sbjct: 235 L 235
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-60
Identities = 65/247 (26%), Positives = 106/247 (42%), Gaps = 34/247 (13%)
Query: 97 SASGIPEYSY----KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE 152
S SG+P K +Q IG+G +G V+ + GE VAVKV T +
Sbjct: 23 SGSGLPLLVQRTIAKQIQ-----MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA-S 75
Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYC----AEKGQHMLVYVFMSKGSLASHLYDENYGPLT 208
+TE+ + H N++ + Q L+ + GSL +L L
Sbjct: 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLD 132
Query: 209 WNLRVHIALDVARGLEYLHDGAV-----PPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
+ +A GL +LH P + HRD+KS NIL+ ++ +AD GL+ +
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 264 MVDKHAANI-----RGTFGYLDPE----YISTRNF--TKKSDVYSFGVLLFELIAGRSPL 312
+ D + +I GT Y+ PE ++ +F +D+YSFG++L+E+
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 313 QGLMEQQ 319
+ E Q
Sbjct: 253 GIVEEYQ 259
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-59
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQ--TEVMLLGRLHHRNLVNL 173
+G+G +G V++ GE VAVK+ S + EK + TE+ L H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 174 VGYC----AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
+ Q L+ + GSL +L L + I L +A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIE 124
Query: 230 AV-----PPVIHRDIKSSNILLDQSMRARVADFGLSREE-----MVDKHAANIRGTFGYL 279
P + HRD+KS NIL+ ++ + +AD GL+ +D GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 280 DPE------YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
PE + + K+ D+++FG++L+E+ + + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-57
Identities = 64/249 (25%), Positives = 106/249 (42%), Gaps = 38/249 (15%)
Query: 97 SASGIPEYSY----KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE 152
S SG+P + + IG+G FG V++ + GE VAVK+ S + E
Sbjct: 28 SGSGLPLLVQRTIARTIV-----LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREE 78
Query: 153 KEFQTE--VMLLGRLHHRNLVNLVGYCAEKG----QHMLVYVFMSKGSLASHLYDENYGP 206
+ + E + L H N++ + + Q LV + GSL +L
Sbjct: 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---T 135
Query: 207 LTWNLRVHIALDVARGLEYLHDGAV-----PPVIHRDIKSSNILLDQSMRARVADFGLSR 261
+T + +AL A GL +LH V P + HRD+KS NIL+ ++ +AD GL+
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195
Query: 262 EE-----MVDKHAANIRGTFGYLDPE------YISTRNFTKKSDVYSFGVLLFELIAGRS 310
+D + GT Y+ PE + K++D+Y+ G++ +E+ S
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255
Query: 311 PLQGLMEQQ 319
+ Q
Sbjct: 256 IGGIHEDYQ 264
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-48
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
IG+G FG V+ ++ T VAVK + +F E +L + H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+K +V + G + L L + + D A G+EYL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-------IRGTFGYLDPEYISTRNFT 290
D+ + N L+ + +++DFG+SREE +AA+ ++ T PE ++ ++
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGRYS 293
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+SDV+SFG+LL+E + G SP L QQ
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-46
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 14/204 (6%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC-A 178
IG+G FG V G VAVK + D+ + F E ++ +L H NLV L+G
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
EKG +V +M+KGSL +L L + + +LDV +EYL +HRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRD 142
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVY 296
+ + N+L+ + A+V+DFGL++E + ++ T PE + + F+ KSDV+
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 198
Query: 297 SFGVLLFELIA-GRSPLQGLMEQQ 319
SFG+LL+E+ + GR P + +
Sbjct: 199 SFGILLWEIYSFGRVPYPRIPLKD 222
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-46
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 14/204 (6%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC-A 178
IG+G FG V G VAVK + D+ + F E ++ +L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
EKG +V +M+KGSL +L L + + +LDV +EYL +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRD 314
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVY 296
+ + N+L+ + A+V+DFGL++E + ++ T PE + + F+ KSDV+
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 370
Query: 297 SFGVLLFELIA-GRSPLQGLMEQQ 319
SFG+LL+E+ + GR P + +
Sbjct: 371 SFGILLWEIYSFGRVPYPRIPLKD 394
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 8/204 (3%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G G +G VY+ VAVK L D+ + +EF E ++ + H NLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ ++ FM+ G+L +L + N ++ + +++A ++ +EYL IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRN 343
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVY 296
+ + N L+ ++ +VADFGLSR D + A+ F PE ++ F+ KSDV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 297 SFGVLLFELIA-GRSPLQGLMEQQ 319
+FGVLL+E+ G SP G+ Q
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQ 427
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-45
Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 8/204 (3%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G G +G VY+ VAVK L D+ + +EF E ++ + H NLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ ++ FM+ G+L +L + N ++ + +++A ++ +EYL IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVY 296
+ + N L+ ++ +VADFGLSR D + A+ F PE ++ F+ KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 297 SFGVLLFELIA-GRSPLQGLMEQQ 319
+FGVLL+E+ G SP G+ Q
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLSQ 220
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-45
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG+G+F VYK T VA L +K + F+ E +L L H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 176 YC--AEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
KG+ +V V M+ G+L ++L + + + + + +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRT- 149
Query: 232 PPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
PP+IHRD+K NI + + ++ D GL+ A + GT ++ PE +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMY-EEKYD 207
Query: 291 KKSDVYSFGVLLFELIAGRSP 311
+ DVY+FG+ + E+ P
Sbjct: 208 ESVDVYAFGMCMLEMATSEYP 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-45
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 8/203 (3%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
IG G FG V+ + VA+K + + E++F E ++ +L H LV L G C E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ LV FM G L+ +L G + + LDV G+ YL + VIHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVYS 297
+ N L+ ++ +V+DFG++R + D++ ++ F PE S ++ KSDV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 298 FGVLLFELIA-GRSPLQGLMEQQ 319
FGVL++E+ + G+ P + +
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSE 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 8/207 (3%)
Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
+GQG FG V+ + VA+K L + E F E ++ +L H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 246
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
+E+ +V +MSKGSL L E L V +A +A G+ Y+ +
Sbjct: 247 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKS 293
HRD++++NIL+ +++ +VADFGL+R +++ A F PE FT KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 294 DVYSFGVLLFELIA-GRSPLQGLMEQQ 319
DV+SFG+LL EL GR P G++ ++
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNRE 389
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-44
Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 28/302 (9%)
Query: 32 YHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFK 91
+H +S +P + G+D + + + S ++++ +G
Sbjct: 9 HHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGS------ENLYFQGAN 62
Query: 92 RSNVVSASGIPEYS------YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAV 141
++ ++ PE +F +IG+G FG VY + + AV
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 142 KVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYCAEK-GQHMLVYVFMSKGSLASHL 199
K L + GE +F TE +++ H N+++L+G C G ++V +M G L + +
Sbjct: 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
Query: 200 YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259
+E T + L VA+G+++L +HRD+ + N +LD+ +VADFGL
Sbjct: 183 RNET-HNPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGL 238
Query: 260 SREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQ 313
+R+ + + T L E + T+ FT KSDV+SFGVLL+EL+ G P
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298
Query: 314 GL 315
+
Sbjct: 299 DV 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-44
Identities = 72/251 (28%), Positives = 110/251 (43%), Gaps = 35/251 (13%)
Query: 94 NVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE------TVAVKVLATD 147
S + + +D+ +G+GAFG V+ A+ VAVK L
Sbjct: 28 QYFSDACVHHIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA 82
Query: 148 SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------- 199
S+ ++FQ E LL L H+++V G C E ++V+ +M G L L
Sbjct: 83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAK 142
Query: 200 -----YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV 254
D GPL + +A VA G+ YL +HRD+ + N L+ Q + ++
Sbjct: 143 LLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKI 199
Query: 255 ADFGLSREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-G 308
DFG+SR+ + G L PE I R FT +SDV+SFGV+L+E+ G
Sbjct: 200 GDFGMSRD--IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 309 RSPLQGLMEQQ 319
+ P L +
Sbjct: 258 KQPWYQLSNTE 268
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-44
Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 8/203 (3%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+GQG FG V+ + VA+K L + E F E ++ +L H LV L +E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ +V +MSKGSL L E L V +A +A G+ Y+ +HRD+
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 389
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVYS 297
+++NIL+ +++ +VADFGL+R +++ A F PE FT KSDV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 298 FGVLLFELIA-GRSPLQGLMEQQ 319
FG+LL EL GR P G++ ++
Sbjct: 450 FGILLTELTTKGRVPYPGMVNRE 472
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-44
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+G G FG V + VA+K++ S E EF E ++ L H LV L G C +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ ++ +M+ G L ++L E + + DV +EYL +HRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDL 146
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAAN------IRGTFGYLDPEYISTRNFTKKS 293
+ N L++ +V+DFGLSR + D++ ++ +R + PE + F+ KS
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKFSSKS 202
Query: 294 DVYSFGVLLFELIA-GRSPLQGLMEQQ 319
D+++FGVL++E+ + G+ P + +
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 120 IGQGAFGPVYKAQMSTGE-----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G GAFG VYK VA+K L S + KE E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+G C L+ M G L ++ E+ + ++ + +A+G+ YL D +
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL-- 138
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDPEYISTRNFT 290
+HRD+ + N+L+ ++ DFGL++ ++ + G ++ E I R +T
Sbjct: 139 -VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGL 315
+SDV+S+GV ++EL+ G P G+
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-43
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 8/203 (3%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+G G FG V+ + VAVK L S F E L+ +L H+ LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ ++ +M GSL L + LT N + +A +A G+ ++ + IHRD+
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 135
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVYS 297
+++NIL+ ++ ++ADFGL+R +++ A F PE I+ FT KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 298 FGVLLFELIA-GRSPLQGLMEQQ 319
FG+LL E++ GR P G+ +
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPE 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 70/240 (29%), Positives = 116/240 (48%), Gaps = 22/240 (9%)
Query: 94 NVVSASGIPEYS------YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKV 143
++ ++ PE +F +IG+G FG VY + + AVK
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 144 LATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLVYVFMSKGSLASHLYD 201
L + GE +F TE +++ H N+++L+G C +G ++V +M G L + + +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 202 ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
E T + L VA+G++YL +HRD+ + N +LD+ +VADFGL+R
Sbjct: 121 ET-HNPTVKDLIGFGLQVAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 262 EEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
+ ++ + T L E + T+ FT KSDV+SFGVLL+EL+ G P +
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-43
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+G G FG V + VAVK++ S E EF E + +L H LV G C++
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ +V ++S G L ++L L + + + DV G+ +L IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDL 130
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAAN------IRGTFGYLDPEYISTRNFTKKS 293
+ N L+D+ + +V+DFG++R + D++ ++ ++ + PE ++ KS
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFKYSSKS 186
Query: 294 DVYSFGVLLFELIA-GRSPLQGLMEQQ 319
DV++FG+L++E+ + G+ P +
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-43
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 16/212 (7%)
Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLV 174
IG+G FG VY + A+K L+ ++ + F E +L+ L+H N++ L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 175 GYC-AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
G +G ++ +M G L + P +L + L VARG+EYL A
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYL---AEQK 144
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYISTRN 288
+HRD+ + N +LD+S +VADFGL+R+ + ++ + + L E + T
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
FT KSDV+SFGVLL+EL+ G P + +
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-43
Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 120 IGQGAFGPVYKAQMSTGE------TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
+GQG+FG VY+ VA+K + + E+ EF E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--------YDENYGPLTWNLRVHIALDVARGLE 224
L+G ++ +++ M++G L S+L + P + + + +A ++A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--RGTFGYL--- 279
YL+ +HRD+ + N ++ + ++ DFG++R D + + +G G L
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 205
Query: 280 --DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
PE + FT SDV+SFGV+L+E+ P QGL +Q
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-43
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G FG V +AQ+ + VAVK+L D + +EF E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 174 VGYCAEKG---QHMLVYV---FMSKGSLASHL----YDENYGPLTWNLRVHIALDVARGL 223
VG + + V FM G L + L EN L V +D+A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--RGTFGYL-- 279
EYL + IHRD+ + N +L + M VADFGLSR ++ + +G L
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASKLPV 203
Query: 280 ---DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
E ++ +T SDV++FGV ++E++ G++P G+
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLV 174
IG G G V ++ VA+K L + ++ +F +E ++G+ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G M+V +M GSL + L + G T V + V G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLG---Y 172
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--------IRGTFGYLDPEYIST 286
+HRD+ + N+L+D ++ +V+DFGLSR D AA IR T PE I+
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAF 228
Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
R F+ SDV+SFGV+++E++A G P + +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 71/249 (28%), Positives = 109/249 (43%), Gaps = 36/249 (14%)
Query: 97 SASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQ 150
S + +D+ +G+GAFG V+ A+ VAVK L +
Sbjct: 5 SGIHVQHIKRRDIV-----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA 59
Query: 151 GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL----------- 199
K+FQ E LL L H ++V G C + ++V+ +M G L L
Sbjct: 60 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 200 ---YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD 256
+ G L + +HIA +A G+ YL A +HRD+ + N L+ ++ ++ D
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGD 176
Query: 257 FGLSREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRS 310
FG+SR+ V G L PE I R FT +SDV+SFGV+L+E+ G+
Sbjct: 177 FGMSRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 311 PLQGLMEQQ 319
P L +
Sbjct: 235 PWFQLSNTE 243
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 33/225 (14%)
Query: 116 FTTLIGQGAFGPVYKAQMSTGE---TVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNL 170
F +IG+G FG V KA++ A+K + + + + +F E+ +L +L HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL--------------YDENYGPLTWNLRVHIA 216
+NL+G C +G L + G+L L + L+ +H A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
DVARG++YL + IHRD+ + NIL+ ++ A++ADFGLSR + V + T
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-----KKTM 200
Query: 277 GYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
G L E ++ +T SDV+S+GVLL+E+++ G +P G+
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-42
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G+G FG V Q +TGE VAVK L +++ ++F+ E+ +L L H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 175 GYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
G C G+ L+ ++ GSL +L + + + + +G+EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKR-- 134
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYISTRN 288
IHRD+ + NIL++ R ++ DFGL++ DK ++ + PE ++
Sbjct: 135 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 289 FTKKSDVYSFGVLLFELI 306
F+ SDV+SFGV+L+EL
Sbjct: 194 FSVASDVWSFGVVLYELF 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-42
Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 30/219 (13%)
Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G FG V + + + VAVK + D S++ +EF +E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 174 VGYCAEKGQH-----MLVYVFMSKGSLASHL----YDENYGPLTWNLRVHIALDVARGLE 224
+G C E M++ FM G L ++L + + + +D+A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--RGTFGYL--- 279
YL + +HRD+ + N +L M VADFGLS+ ++ + +G +
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMPVK 214
Query: 280 --DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
E ++ R +T KSDV++FGV ++E+ G +P G+
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G+G FG V +TG VAVK L +++FQ E+ +L LH +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 175 GYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
G G+ LV ++ G L L + L + + + + +G+EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR-- 147
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYISTRN 288
+HRD+ + NIL++ ++ADFGL++ +DK +R + PE +S
Sbjct: 148 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLME 317
F+++SDV+SFGV+L+EL E
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-42
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
+G G FG V+ A + VAVK + S + F E ++ L H LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
+ ++ FM+KGSL L + + + +A G+ ++ IHRD+
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 310
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVYS 297
+++NIL+ S+ ++ADFGL+R +++ A F PE I+ +FT KSDV+S
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 370
Query: 298 FGVLLFELIA-GRSPLQGLMEQQ 319
FG+LL E++ GR P G+ +
Sbjct: 371 FGILLMEIVTYGRIPYPGMSNPE 393
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-42
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLV 174
+G G FG V ++ +VA+K L + ++ +F E ++G+ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G + M+V +M GSL S L ++ T V + +A G++YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG---Y 168
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--------IRGTFGYLDPEYIST 286
+HRD+ + NIL++ ++ +V+DFGL R D AA IR T PE I+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAY 224
Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
R FT SDV+S+G++L+E+++ G P + Q
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-42
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G+G FG V Q +TGE VAVK L +++ ++F+ E+ +L L H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 175 GYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
G C G+ L+ ++ GSL +L + + + + +G+EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKR-- 165
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYISTR 287
IHRD+ + NIL++ R ++ DFGL++ DK ++ G PE ++
Sbjct: 166 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP-GESPIFWYAPESLTES 223
Query: 288 NFTKKSDVYSFGVLLFELI 306
F+ SDV+SFGV+L+EL
Sbjct: 224 KFSVASDVWSFGVVLYELF 242
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-42
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 120 IGQGAFGPVYKAQMSTGE-----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G GAFG VYK VA+K L S + KE E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+G C L+ M G L ++ E+ + ++ + +A+G+ YL D +
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL-- 138
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDPEYISTRNFT 290
+HRD+ + N+L+ ++ DFGL++ ++ + G ++ E I R +T
Sbjct: 139 -VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGL 315
+SDV+S+GV ++EL+ G P G+
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 120 IGQGAFGPVYKAQM-----STGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G FG V + +TGE VAVK L + + E+ +L L+H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G C E G + L+ F+ GSL +L N + ++ A+ + +G++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQY 147
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYIST 286
+HRD+ + N+L++ + ++ DFGL++ DK ++ PE +
Sbjct: 148 ---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD-RDSPVFWYAPECLMQ 203
Query: 287 RNFTKKSDVYSFGVLLFELI 306
F SDV+SFGV L EL+
Sbjct: 204 SKFYIASDVWSFGVTLHELL 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 120 IGQGAFGPVYKAQMSTGE---TVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G G FG V K + TVAVK+L + + E E ++ +L + +V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G C E MLV G L +L + + + + V+ G++YL +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF--- 138
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--------IRGTFGYLDPEYIST 286
+HRD+ + N+LL A+++DFGLS+ D++ ++ PE I+
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINY 194
Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
F+ KSDV+SFGVL++E + G+ P +G+ +
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 120 IGQGAFGPVYKAQMSTGE-----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G G FG V+K V +KV+ +Q + ++ +G L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+G C LV ++ GSL H+ ++ G L L ++ + +A+G+ YL + +
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEHGM-- 136
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDPEYISTRNFT 290
+HR++ + N+LL + +VADFG++ D ++ E I +T
Sbjct: 137 -VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+SDV+S+GV ++EL+ G P GL +
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 120 IGQGAFGPVYKAQMSTGE------TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
+G GAFG VY+ Q+S VAVK L + ++ +F E +++ + +H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLH 227
+G + ++ M+ G L S L L +H+A D+A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARV---ADFGLSREEMVDKHAANIRGTFGYL----- 279
+ IHRDI + N LL RV DFG++R+ + + + +G L
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYYRKGGCAMLPVKWM 212
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
PE FT K+D +SFGVLL+E+ + G P Q+
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 120 IGQGAFGPVYKAQ--MSTGET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVG 175
+G G FG V + M + VA+KVL +++ + E E ++ +L + +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
C + MLV G L L + + + V+ G++YL + +
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF---V 132
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--ANIRGTF--GYLDPEYISTRNFTK 291
HRD+ + N+LL A+++DFGLS+ D A G + + PE I+ R F+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+SDV+S+GV ++E ++ G+ P + + +
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 69/215 (32%), Positives = 111/215 (51%), Gaps = 23/215 (10%)
Query: 120 IGQGAFGPVYKA--QMSTGE---TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
IG G FG VYK + S+G+ VA+K L A +++ +F E ++G+ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
G ++ M++ +M G+L L E G + V + +A G++YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMN--- 167
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--------IRGTFGYLDPEYIS 285
+HRD+ + NIL++ ++ +V+DFGLSR D A IR T PE IS
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAIS 223
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
R FT SDV+SFG++++E++ G P L +
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-41
Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 37/246 (15%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE------TVAVKVL-ATDSKQGEK 153
+ E S ++ F +G+ FG VYK + VA+K L +
Sbjct: 3 LKEISLSAVR-----FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE 57
Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------------- 199
EF+ E ML RL H N+V L+G + +++ + S G L L
Sbjct: 58 EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 200 YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259
L VH+ +A G+EYL V+H+D+ + N+L+ + +++D GL
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 260 SREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQ 313
RE V L PE I F+ SD++S+GV+L+E+ + G P
Sbjct: 175 FRE--VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 314 GLMEQQ 319
G Q
Sbjct: 233 GYSNQD 238
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 76/225 (33%), Positives = 116/225 (51%), Gaps = 34/225 (15%)
Query: 120 IGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLV 171
+G+GAFG V +A +T TVAVK+L + E +E+ +L + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHL--------------YDENYGPLTWNLRVHIA 216
NL+G C + G ++V V F G+L+++L D LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
VA+G+E+L A IHRD+ + NILL + ++ DFGL+R+ + K +R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPDYVRKGD 209
Query: 277 GYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
L PE I R +T +SDV+SFGVLL+E+ + G SP G+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-41
Identities = 69/261 (26%), Positives = 109/261 (41%), Gaps = 40/261 (15%)
Query: 92 RSNVVSASGIPEYSYKDLQKATC----------NFTTLIGQGAFGPVYKAQ------MST 135
R++ + P Y + + +G GAFG VY+ Q +
Sbjct: 41 RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 100
Query: 136 GETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
VAVK L + ++ +F E +++ + +H+N+V +G + ++ M+ G
Sbjct: 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 195 LASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
L S L L +H+A D+A G +YL + IHRDI + N LL
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 217
Query: 250 MRARV---ADFGLSREEMVDKHAANI--RGTFGYL-----DPEYISTRNFTKKSDVYSFG 299
RV DFG++R D + A +G L PE FT K+D +SFG
Sbjct: 218 GPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273
Query: 300 VLLFELIA-GRSPLQGLMEQQ 319
VLL+E+ + G P Q+
Sbjct: 274 VLLWEIFSLGYMPYPSKSNQE 294
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-41
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G+G F V + + G A+K + +Q +E Q E + +H N++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 178 A-EKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
E+G ++ + +G+L + + + LT + + + L + RGLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIRGTFGYLDP 281
HRD+K +NILL + + D G + + + A R T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 282 EYISTR---NFTKKSDVYSFGVLLFELIAGRSP 311
E S + +++DV+S G +L+ ++ G P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-41
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
LIG G FG V+KA+ G+T +K + EK + EV L +L H N+V+ G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAER-EVKALAKLDHVNIVHYNGCW 73
Query: 178 AEKGQHML-------------VYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
+++ M KG+L + L L + + + +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
G++Y+H +I+RD+K SNI L + + ++ DFGL D +GT Y+ P
Sbjct: 134 GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
E IS++++ K+ D+Y+ G++L EL+
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G FG V TGE VAVK L D Q ++ E+ +L L+H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 174 VGYCAEKGQ--HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G C + G LV ++ GSL +L + + + A + G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYIST 286
IHRD+ + N+LLD ++ DFGL++ +R G PE +
Sbjct: 156 ---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED-GDSPVFWYAPECLKE 211
Query: 287 RNFTKKSDVYSFGVLLFELI 306
F SDV+SFGV L+EL+
Sbjct: 212 YKFYYASDVWSFGVTLYELL 231
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 120 IGQGAFGPVYKA--QMSTGET--VAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
+G G+FG V + +G+T VAVK L + +F EV + L HRNL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L G +V GSL L ++ G A+ VA G+ YL
Sbjct: 86 LYGVVLTP-PMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESKRF- 142
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGY--LDPEYISTRN 288
IHRD+ + N+LL ++ DFGL R + D + + PE + TR
Sbjct: 143 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
F+ SD + FGV L+E+ G+ P GL Q
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-40
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 31/223 (13%)
Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLV 171
+G GAFG V +A VAVK+L + + EK +E+ ++ L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHL------------YDENYGPLTWNLRVHIALDV 219
NL+G C G +++ + G L + L + + +H + V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL 279
A+G+ +L A IHRD+ + N+LL A++ DFGL+R+ + + I L
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD--IMNDSNYIVKGNARL 228
Query: 280 -----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316
PE I +T +SDV+S+G+LL+E+ + G +P G++
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 69/228 (30%), Positives = 116/228 (50%), Gaps = 39/228 (17%)
Query: 120 IGQGAFGPVYKA--------QMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRN 169
+G+GAFG V A + TVAVK+L D+ + + + +E+ ++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHL--------------YDENYGPLTWNLRVHI 215
++NL+G C + G ++ + SKG+L +L +T+ V
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--R 273
+ARG+EYL A IHRD+ + N+L+ ++ ++ADFGL+R D + + +
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKK 215
Query: 274 GTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
T G L PE + R +T +SDV+SFGVL++E+ G SP G+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 66/241 (27%), Positives = 113/241 (46%), Gaps = 44/241 (18%)
Query: 116 FTTLIGQGAFGPVYKAQ------MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHR 168
+ IG+GAFG V++A+ VAVK+L + S + +FQ E L+ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHL----------------------YDENYGP 206
N+V L+G CA L++ +M+ G L L P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
L+ ++ IA VA G+ YL + +HRD+ + N L+ ++M ++ADFGLSR +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR----N 223
Query: 267 KHAANI--RGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318
++A+ + PE I +T +SDV+++GV+L+E+ + G P G+ +
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 319 Q 319
+
Sbjct: 284 E 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG+G+FG + G +K ++ S + +E + EV +L + H N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 176 YCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
E G +Y+ M G L + + + + + + L+++HD
Sbjct: 91 SFEENGS---LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---R 144
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFTK 291
++HRDIKS NI L + ++ DFG++R A GT YL PE + +
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
KSD+++ G +L+EL + +
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEA 227
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-40
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 120 IGQGAFGPVYKA-------QMSTGET-VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV 171
+GQG F ++K ET V +KVL + + F ++ +L H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
G C +++LV F+ GSL ++L +N + ++ +A +A + +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLEENT- 133
Query: 232 PPVIHRDIKSSNILLDQSMRAR--------VADFGLSRE-EMVDKHAANIRGTFGYLDPE 282
+IH ++ + NILL + + ++D G+S D I PE
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV----PPE 187
Query: 283 YIS-TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
I +N +D +SFG L+E+ + G PL L Q+
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-40
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLV 174
IG+G FG V++ + E VA+K + + +F E + + + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G E ++ + G L S L L + A ++ L YL
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKRF--- 137
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKK 292
+HRDI + N+L+ + ++ DFGLSR + +G ++ PE I+ R FT
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 293 SDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
SDV+ FGV ++E++ G P QG+
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNND 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-40
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G+G FG VY+ + + VAVK + +++F +E +++ L H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G E+ ++ G L +L N L V +L + + + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC--- 134
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDPEYISTRNFTK 291
+HRDI NIL+ ++ DFGLSR + D+ T ++ PE I+ R FT
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
SDV+ F V ++E+++ G+ P L +
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-40
Identities = 62/231 (26%), Positives = 115/231 (49%), Gaps = 40/231 (17%)
Query: 120 IGQGAFGPVYKAQMSTGE------TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
+G+G FG V KA + TVAVK+L ++ E + +E +L +++H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL----------------------YDENYGPLTWN 210
L G C++ G +L+ + GSL L + LT
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
+ A +++G++YL A ++HRD+ + NIL+ + + +++DFGLSR+ V + +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD--VYEEDS 205
Query: 271 NIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
++ + G + E + +T +SDV+SFGVLL+E++ G +P G+
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-40
Identities = 83/321 (25%), Positives = 145/321 (45%), Gaps = 52/321 (16%)
Query: 31 RYHRKRSQIGNSSSRRAATLPI-RANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEG 89
+H SQ + + +P+ R V + S S ++ P + + + + L G
Sbjct: 5 HHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAG 64
Query: 90 FKRSNVVSASGIP-----EYSYKDLQKATCNFTTLIGQGAFGPVYKA--------QMSTG 136
VS +P E+ L +G+G FG V A +
Sbjct: 65 ------VSEYELPEDPKWEFPRDKLT-----LGKPLGEGCFGQVVMAEAVGIDKDKPKEA 113
Query: 137 ETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
TVAVK+L D+ + + + +E+ ++ + H+N++NL+G C + G ++ + SKG+
Sbjct: 114 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 195 LASHL--------------YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
L +L +T+ V +ARG+EYL A IHRD+
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLA 230
Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDV 295
+ N+L+ ++ ++ADFGL+R+ ++ + T G L PE + R +T +SDV
Sbjct: 231 ARNVLVTENNVMKIADFGLARD--INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 296 YSFGVLLFELIA-GRSPLQGL 315
+SFGVL++E+ G SP G+
Sbjct: 289 WSFGVLMWEIFTLGGSPYPGI 309
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-39
Identities = 70/326 (21%), Positives = 125/326 (38%), Gaps = 26/326 (7%)
Query: 3 GESSGLIIGISIGVVIGVLLAIS-ALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCS 61
G L + + +A + A Y R + S R P + S
Sbjct: 292 GAPEPLTV-----TAPSLTIAENMADLIDGYCRLVNGATQSFIIR----PQKEGERALPS 342
Query: 62 ILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIG 121
I + + + + + E + + +Y ++Q+ IG
Sbjct: 343 IPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDY---EIQRERIELGRCIG 399
Query: 122 QGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGY 176
+G FG V++ + E VA+K + + +F E + + + H ++V L+G
Sbjct: 400 EGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
E ++ + G L S L L + A ++ L YL +H
Sbjct: 460 ITEN-PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKRF---VH 514
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSD 294
RDI + N+L+ + ++ DFGLSR + +G ++ PE I+ R FT SD
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574
Query: 295 VYSFGVLLFELIA-GRSPLQGLMEQQ 319
V+ FGV ++E++ G P QG+
Sbjct: 575 VWMFGVCMWEILMHGVKPFQGVKNND 600
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-39
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 120 IGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLV 171
+G GAFG V +A TVAVK+L + E+ +E+ +L L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHL----------------YDENYGPLTWNLRVHI 215
NL+G C G +++ + G L + L +++ L +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275
+ VA+G+ +L A IHRD+ + NILL ++ DFGL+R+ + + +
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKNDSNYVVKG 205
Query: 276 FGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
L PE I +T +SDV+S+G+ L+EL + G SP G+
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 120 IGQGAFGPVYKAQ--MSTGET-VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
+G G FG V + M + VA+KVL K +E E ++ +L + +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
C + MLV G L L + + + V+ G++YL + +
Sbjct: 404 VCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKNF---V 458
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--ANIRGTFGY--LDPEYISTRNFTK 291
HR++ + N+LL A+++DFGLS+ D A G + PE I+ R F+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+SDV+S+GV ++E ++ G+ P + + +
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-39
Identities = 70/226 (30%), Positives = 115/226 (50%), Gaps = 35/226 (15%)
Query: 120 IGQGAFGPVYKA--------QMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRN 169
+G+GAFG V A + + VAVK+L +D+ + + + +E+ ++ + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHL--------------YDENYGPLTWNLRVHI 215
++NL+G C + G ++ + SKG+L +L L+ V
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275
A VARG+EYL A IHRD+ + N+L+ + ++ADFGL+R+ + + T
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD--IHHIDYYKKTT 251
Query: 276 FGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
G L PE + R +T +SDV+SFGVLL+E+ G SP G+
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-39
Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 51/274 (18%)
Query: 88 EGFKRSNVVSASGIPEYSYKDLQKATCN-----------FTTLIGQGAFGPVYKAQ---- 132
E + V+ S EY Y D ++ + F ++G GAFG V A
Sbjct: 10 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 69
Query: 133 --MSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV 188
VAVK+L + E+ +E+ ++ +L H N+VNL+G C G L++
Sbjct: 70 SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129
Query: 189 FMSKGSLASHL---------------------YDENYGPLTWNLRVHIALDVARGLEYLH 227
+ G L ++L +E+ LT+ + A VA+G+E+L
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL- 188
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPE 282
+HRD+ + N+L+ ++ DFGL+R+ + + + L PE
Sbjct: 189 --EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IMSDSNYVVRGNARLPVKWMAPE 244
Query: 283 YISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
+ +T KSDV+S+G+LL+E+ + G +P G+
Sbjct: 245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-39
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG G++G K + S G+ + K L ++ ++ +EV LL L H N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 176 YCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
++ L Y+ M G LAS + + L + + + L+ H +
Sbjct: 73 RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 231 VPP--VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTR 287
V+HRD+K +N+ LD ++ DFGL+R D A GT Y+ PE ++
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
++ +KSD++S G LL+EL A P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTA 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 64/237 (27%), Positives = 109/237 (45%), Gaps = 22/237 (9%)
Query: 93 SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQG 151
+ S +Y Y + ++G+G +G VY +S +A+K + +
Sbjct: 8 GDCESDLLEYDYEYDENGDRV-----VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLT 208
+ E+ L L H+N+V +G +E G + +FM GSL++ L +GPL
Sbjct: 63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGF---IKIFMEQVPGGSLSA-LLRSKWGPLK 118
Query: 209 WNLRV--HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSRE-EM 264
N + + GL+YLHD ++HRDIK N+L++ +++DFG S+
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 265 VDKHAANIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
++ GT Y+ PE I R + K +D++S G + E+ G+ P L E Q
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ 232
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G FG VY A+ + +A+KVL + E + + EV + L H N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILRL 74
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
GY + + L+ + G++ L + ++A L Y H V
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRV-- 130
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYISTRN 288
IHRDIK N+LL + ++ADFG S HA + R GT YL PE I R
Sbjct: 131 -IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
+K D++S GVL +E + G+ P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRL--HHRNLVNLV 174
IG G V++ + A+K L Q ++ E+ L +L H ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 175 GYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
Y +Y+ M L S L + + R ++ + +H G
Sbjct: 76 DYEITDQY---IYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 128
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRN 288
++H D+K +N L+ M ++ DFG++ + + GT Y+ PE I +
Sbjct: 129 --IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 289 -----------FTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318
+ KSDV+S G +L+ + G++P Q ++ Q
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 31/221 (14%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNL--VNLV 174
IG G V++ + A+K L Q ++ E+ L +L + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 175 GYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
Y +Y+ M L S L + + R ++ + +H G
Sbjct: 95 DYEITDQY---IYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRN 288
++H D+K +N L+ M ++ DFG++ + + GT Y+ PE I +
Sbjct: 148 --IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 289 -----------FTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318
+ KSDV+S G +L+ + G++P Q ++ Q
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 24/204 (11%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G+G+FG V++ + TG AVK + + + E++ L +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG-A 118
Query: 178 AEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+G V +FM GSL + + G L + ++ GLEYLH +
Sbjct: 119 VREGPW--VNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRI--- 171
Query: 235 IHRDIKSSNILLDQS-MRARVADFGLSR------EEMVDKHAANIRGTFGYLDPEYISTR 287
+H D+K+ N+LL RA + DFG + I GT ++ PE + +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
K D++S ++ ++ G P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-37
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLV----- 171
+G+G FG V++A+ A+K + +++ +E EV L +L H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 172 ----NLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLT-WNLRVHIALDVARGL 223
N + +Y+ M K +L + ++ +HI L +A +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---------- 273
E+LH + +HRD+K SNI +V DFGL D+ +
Sbjct: 132 EFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 274 ---GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
GT Y+ PE I +++ K D++S G++LFEL+ P ME+
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERV 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-37
Identities = 54/267 (20%), Positives = 89/267 (33%), Gaps = 26/267 (9%)
Query: 51 PIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQ 110
+ V S R +++ G+ S S + S++ L
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRV-SFRGEASETLQSPGYDPSRPESFF---QQSFQRLS 63
Query: 111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRL-H 166
+ +G G++G V+K + G AVK + EV ++
Sbjct: 64 R--------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
H V L E G +Y+ SL H L D L
Sbjct: 116 HPCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALA 171
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
+LH + +H D+K +NI L R ++ DFGL E G Y+ PE +
Sbjct: 172 HLHSQGL---VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-L 227
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSP 311
++ +DV+S G+ + E+
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-37
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQG-EKEFQTEVMLLGRLHHRNLVNLV 174
+G+G FG VY A+ +A+KVL K+G E + + E+ + L H N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
Y ++ + L+ F +G L L + +G ++A L Y H+ V
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCHERKV--- 135
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYISTRNF 289
IHRDIK N+L+ ++ADFG S HA ++R GT YL PE I +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRRTMCGTLDYLPPEMIEGKTH 189
Query: 290 TKKSDVYSFGVLLFELIAGRSP 311
+K D++ GVL +E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 57/205 (27%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
+G G VY A+ VA+K + ++ E K F+ EV +L H+N+V+++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 175 GYCAEKGQHMLV--YVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
E + LV Y+ +G +L+ ++ E++GPL+ + ++ + G+++ HD +
Sbjct: 78 DVDEEDDCYYLVMEYI---EGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNF 289
+HRDIK NIL+D + ++ DFG+++ E ++ GT Y PE
Sbjct: 133 ---VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
+ +D+YS G++L+E++ G P G
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLV 174
IG+G F VY+A + G VA+K + K E+ LL +L+H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 175 GYCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDG 229
E + + + + G L+ + + + + + + LE++H
Sbjct: 99 ASFIEDNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN 288
V +HRDIK +N+ + + ++ D GL R AA+ + GT Y+ PE I
Sbjct: 156 RV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
+ KSD++S G LL+E+ A +SP G
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYG 238
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-37
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
L+G+G G VY+A+ VA+K+++ Q E GRL ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 175 GYCAEKGQHMLV--YVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
+ GQ + + G LA+ L + GPL V I + L+ H
Sbjct: 101 DFGEIDGQLYVDMRLI---NGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK----HAANIRGTFGYLDPEYISTR 287
HRD+K NIL+ A + DFG++ N GT Y+ PE S
Sbjct: 156 ---THRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ T ++D+Y+ +L+E + G P QG
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQG 237
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 30/234 (12%)
Query: 96 VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE 154
+ + + + + ++GQGA V++ + TG+ A+KV S +
Sbjct: 1 MGSQSTSNHLWL--------LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52
Query: 155 -FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYD-ENYGPLTW 209
E +L +L+H+N+V L E+ + M GSL + L + N L
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSREEMV 265
+ + + DV G+ +L + + +HR+IK NI+ D ++ DFG +RE
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 266 DKHAANIRGTFGYLDPEYIS--------TRNFTKKSDVYSFGVLLFELIAGRSP 311
D+ ++ GT YL P+ + + D++S GV + G P
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
++ +G F VY+AQ + +G A+K L ++ ++ + EV + +L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 177 CAEKGQHM-----LVYVFM--SKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHD 228
+ + + KG L L E+ GPL+ + + I R ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-------------EEMVDKHAANIRGT 275
PP+IHRD+K N+LL ++ DFG + + + T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 276 FGYLDPEYIST-RNF--TKKSDVYSFGVLLFELIAGRSP 311
Y PE I NF +K D+++ G +L+ L + P
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 31/221 (14%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNL--VNLV 174
IG G V++ + A+K L Q ++ E+ L +L + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 175 GYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
Y +Y+ M L S L + + R ++ + +H G
Sbjct: 123 DYEITDQY---IYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRN 288
++H D+K +N L+ M ++ DFG++ + + G Y+ PE I +
Sbjct: 176 --IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 289 -----------FTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318
+ KSDV+S G +L+ + G++P Q ++ Q
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-35
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 96 VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE 154
+ + + + + ++GQGA V++ + TG+ A+KV S +
Sbjct: 1 MGSQSTSNHLWL--------LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52
Query: 155 -FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYD-ENYGPLTWN 210
E +L +L+H+N+V L E V + F GSL + L + N L +
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSREEMVD 266
+ + DV G+ +L + + +HR+IK NI+ D ++ DFG +RE D
Sbjct: 113 EFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 267 KHAANIRGTFGYLDPEYIST--------RNFTKKSDVYSFGVLLFELIAGRSP 311
+ ++ GT YL P+ + + D++S GV + G P
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 3e-35
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLV--- 174
+G G FG V + TGE VA+K + +E + E+ ++ +L+H N+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 175 ---GYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGA 230
A +L + G L +L EN L + D++ L YLH+
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 231 VPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
+ IHRD+K NI+L Q + ++ D G ++E + GT YL PE + +
Sbjct: 142 I---IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 198
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
+T D +SFG L FE I G P
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
P ++ + + +G GAFG VYKA+ TG A KV+ T S++ +++ E+
Sbjct: 17 PNEVWEIVGE--------LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 68
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL--- 217
+L H +V L+G G+ ++ F G++ + + E LT I +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLT---EPQIQVVCR 124
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKH 268
+ L +LH + IHRD+K+ N+L+ R+ADFG+S R+ +
Sbjct: 125 QMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--- 178
Query: 269 AANIRGTFGYLDPEYISTRNFTK-----KSDVYSFGVLLFELIAGRSPL 312
GT ++ PE + K+D++S G+ L E+ P
Sbjct: 179 -----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVM 160
P+ Y +K IGQGA G VY A ++TG+ VA++ + + ++ E++
Sbjct: 18 PKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL--- 217
++ + N+VN + + +V +++ GSL + E + IA
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTE--TCMD---EGQIAAVCR 123
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKH 268
+ + LE+LH V IHRDIKS NILL ++ DFG R MV
Sbjct: 124 ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--- 177
Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
GT ++ PE ++ + + K D++S G++ E+I G P
Sbjct: 178 -----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 33/219 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL-----------------ATDSKQGEKEFQTEVMLL 162
+ QG F + + + A+K K +F+ E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR- 221
+ + + G + ++Y +M S+ E + L N I + V +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD--EYFFVLDKNYTCFIPIQVIKC 155
Query: 222 -------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG 274
Y+H + HRD+K SNIL+D++ R +++DFG S E MVDK RG
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRG 212
Query: 275 TFGYLDPEYISTRNFT--KKSDVYSFGVLLFELIAGRSP 311
T+ ++ PE+ S + K D++S G+ L+ + P
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
P K IG+G+ G V A+ +G VAVK++ +Q + EV+
Sbjct: 43 PRLLLDSYVK--------IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
++ H N+V + + ++ F+ G+L + + L + V
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQ--VRLNEEQIATVCEAVL 151
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKHAAN 271
+ L YLH VIHRDIKS +ILL R +++DFG R+ +V
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------ 202
Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
GT ++ PE IS + + D++S G+++ E++ G P
Sbjct: 203 --GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 41/237 (17%)
Query: 91 KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK 149
+ + PE + L+K IG+G+FG V+K T + VA+K++ +
Sbjct: 9 GLPGMQNLKADPEELFTKLEK--------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 150 QGEKE-FQTEVMLLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPL 207
+ E E Q E+ +L + + G K + ++ ++ GS L + GPL
Sbjct: 61 EDEIEDIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSA-LDLLEP--GPL 116
Query: 208 TWNLRVHIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---- 260
IA ++ +GL+YLH IHRDIK++N+LL + ++ADFG++
Sbjct: 117 D---ETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 261 -----REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
R V GT ++ PE I + K+D++S G+ EL G P
Sbjct: 171 DTQIKRNTFV--------GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
++G G V+ A+ + VAVKVL A D + F+ E L+H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 174 --VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
G AE L Y+ M +L ++ E GP+T + + D + L + H
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ 134
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPEYI 284
+ IHRD+K +NI++ + +V DFG++R A + GT YL PE
Sbjct: 135 NGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ +SDVYS G +L+E++ G P G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G F ++ T E A K++ Q EK E+ + L H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106
Query: 174 VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
G+ + V+V + + SL + LT + + G +YLH
Sbjct: 107 HGFFEDNDF---VFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
V IHRD+K N+ L++ + ++ DFGL+ + D R GT Y+ PE +S
Sbjct: 162 V---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKVLCGTPNYIAPEVLS 214
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
+ + + DV+S G +++ L+ G+ P
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
PE + L+K +G+G++G VYKA TG+ VA+K + + +E E+
Sbjct: 27 PEEVFDVLEK--------LGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEIS 76
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL--- 217
++ + ++V G + +V + GS++ + LT IA
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLT---EDEIATILQ 132
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKH 268
+GLEYLH IHRDIK+ NILL+ A++ADFG++ R ++
Sbjct: 133 STLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--- 186
Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
GT ++ PE I + +D++S G+ E+ G+ P
Sbjct: 187 -----GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G F ++ T E A K++ Q EK E+ + L H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 174 VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
G+ + V+V + + SL + LT + + G +YLH
Sbjct: 81 HGFFEDNDF---VFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
V IHRD+K N+ L++ + ++ DFGL+ + D R GT Y+ PE +S
Sbjct: 136 V---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKVLCGTPNYIAPEVLS 188
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
+ + + DV+S G +++ L+ G+ P
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 37/224 (16%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
++GQGAFG V KA+ A+K + ++ +EVMLL L+H+ +V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 178 AEKGQHML----------VYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
E+ + +++ M G+L ++ EN + + + L
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALS 130
Query: 225 YLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---------- 273
Y+H G +IHRD+K NI +D+S ++ DFGL++ +
Sbjct: 131 YIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 274 -----GTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSP 311
GT Y+ E + T ++ +K D+YS G++ FE+I S
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 38/239 (15%), Positives = 75/239 (31%), Gaps = 53/239 (22%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRL--------- 165
++GQ +A TGE+ V V + K+ + EV+ L L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 166 -------------HHRNLVNLVGYCAEKGQHMLVYVF-------MSKGSLASHLYD--EN 203
++ ++ ++ F + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 204 YGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
+ L + R+ + L V R L LH G ++H ++ +I+LDQ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 263 EMVDKHAANIRGTFGYLDPEYIS----------TRNFTKKSDVYSFGVLLFELIAGRSP 311
+ +A G+ PE + T D ++ G+ ++ + P
Sbjct: 261 DG---ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177
++G GA G + M VAVK + + EV LL H N++ +C
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRY--FC 85
Query: 178 AEKGQHMLVYVFMS--KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPV 234
EK + Y+ + +L ++ + + GL +LH +
Sbjct: 86 TEKDRQF-QYIAIELCAATLQ-EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN----I 139
Query: 235 IHRDIKSSNILL-----DQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEYIS 285
+HRD+K NIL+ ++A ++DFGL ++ V +H+ + R GT G++ PE +S
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 286 ---TRNFTKKSDVYSFGVLLFELIAGRSP 311
N T D++S G + + +I+ S
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 28/231 (12%), Positives = 54/231 (23%), Gaps = 45/231 (19%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLV 174
+ G V+ + E A+KV ++ E RL +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 175 GYC--------------------------AEKGQHMLVYVFMSKGSLAS-----HLYDEN 203
++L+ S L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 204 YGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
G + + R L G ++H N+ + R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 263 EMVDKHAANIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSP 311
Y E++ ST FT + + G+ ++ + P
Sbjct: 244 V--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 43/219 (19%), Positives = 76/219 (34%), Gaps = 32/219 (14%)
Query: 119 LIGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL---HHRN 169
L+G+GAF VY+A + +KV EF L+ RL
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIGTQLMERLKPSMQHM 128
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHL---YDENYGPLTWNLRVHIALDVARGLEYL 226
+ + +LV S G+L + + + + L + A+ + +E +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 227 HDGAVPPVIHRDIKSSNILL-----------DQSMRARVADFGLSRE---EMVDKHAANI 272
HD + IH DIK N +L D S + D G S +
Sbjct: 189 HDCEI---IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
T G+ E +S + + + D + ++ ++ G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQG-EKEFQTEVMLLGRLHHRNLVNLV 174
L+G+G+F VY+A+ + TG VA+K++ + K G + Q EV + +L H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 175 GYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
Y + VY+ + G + +L P + N H + G+ YLH +
Sbjct: 78 NYFEDSNY---VYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEYISTR 287
+HRD+ SN+LL ++M ++ADFGL+ + + GT Y+ PE +
Sbjct: 134 ---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMP---HEKHYTLCGTPNYISPEIATRS 187
Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
+SDV+S G + + L+ GR P
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 28/228 (12%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE-FQTE 158
I Y+ + IG GA V A E VA+K + + Q + E
Sbjct: 12 INRDDYELQEV--------IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV----H 214
+ + + HH N+V+ K + LV +S GS+ + V
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDEST 122
Query: 215 IAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHA 269
IA +V GLEYLH IHRD+K+ NILL + ++ADFG+S D
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 270 ANIRGTF-G---YLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPL 312
+R TF G ++ PE + R + K+D++SFG+ EL G +P
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 75/283 (26%), Positives = 115/283 (40%), Gaps = 31/283 (10%)
Query: 52 IRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKD--- 108
+ G D + V + + R S P Y D
Sbjct: 110 LSHTGPDLIPEVPRQLV---TNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIY 166
Query: 109 -----------LQKATCN---FTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQ 150
Q T N ++G+G FG V Q+ +TG+ A K L ++
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 151 GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTW 209
GE E +L +++ R +V+L Y E + LV M+ G L H+Y
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE 285
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269
V A ++ GLE LH + ++RD+K NILLD R++D GL+ + +
Sbjct: 286 ARAVFYAAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQT 341
Query: 270 ANIR-GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
R GT GY+ PE + +T D ++ G LL+E+IAG+SP
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-33
Identities = 35/240 (14%), Positives = 72/240 (30%), Gaps = 54/240 (22%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE----------------------- 154
++GQ +A TGE+ V V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 155 -----FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM----SKGSLASHLYD--EN 203
F L+ + ++ + + +++ + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 204 YGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
+ L + R+ + L V R L LH G ++H ++ +I+LDQ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 263 EMVDKHAANIRGTFGYLDPEYISTRN-----------FTKKSDVYSFGVLLFELIAGRSP 311
D + G+ PE + R T D ++ G++++ + P
Sbjct: 256 ---DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQT 157
PE + DL++ IG G+FG VY A+ + E VA+K ++ KQ ++
Sbjct: 52 PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 103
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
EV L +L H N + G + LV + GS + L + + PL V IA
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQ---EVEIAA 158
Query: 218 ---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS-----REEMVDKHA 269
+GL YLH + IHRD+K+ NILL + ++ DFG + V
Sbjct: 159 VTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---- 211
Query: 270 ANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
GT ++ PE I + + K DV+S G+ EL + PL
Sbjct: 212 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 52/195 (26%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
+G G G V+K +G +A K++ + K + E+ +L + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
G+ + M GSL + + G + + +++ V +GL YL + ++HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQ-VLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHR 156
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
D+K SNIL++ ++ DFG+S +++D A + GT Y+ PE + +++ +SD++S
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 215
Query: 298 FGVLLFELIAGRSPL 312
G+ L E+ GR P+
Sbjct: 216 MGLSLVEMAVGRYPI 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 75/292 (25%), Positives = 126/292 (43%), Gaps = 31/292 (10%)
Query: 45 RRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIP-- 102
R +RA ++ + L S + E+ V R G G + R+ + P
Sbjct: 103 RPQKAQALRAAYLEPQAQLFCSFLDAET-VARARAGAGDG-LFQPLLRAVLAHLGQAPFQ 160
Query: 103 ------------EYSYKDLQKATCN-FTTL--IGQGAFGPVYKAQM-STGETVAVKVLAT 146
++ + + Q + F +G+G FG V+ QM +TG+ A K L
Sbjct: 161 EFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK 220
Query: 147 D---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLY-- 200
++G + E +L ++H R +V+L Y E + LV M+ G + H+Y
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 201 DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260
DE+ + + GLE+LH + I+RD+K N+LLD R++D GL+
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 261 REEMVDKHAANIR-GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
E + GT G++ PE + + D ++ GV L+E+IA R P
Sbjct: 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 51/239 (21%), Positives = 91/239 (38%), Gaps = 26/239 (10%)
Query: 92 RSNVVSASGIPEYSYKDLQKATCNFTTLIGQGA--FGPVYKAQ-MSTGETVAVKV--LAT 146
+S+ Y+ L IG+G V A+ TGE V V+ L
Sbjct: 13 YFQGMSSFLPEGGCYELLTV--------IGKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64
Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP 206
S + Q E+ + +H N+V + +V FM+ GS +
Sbjct: 65 CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG 124
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS------ 260
+ +I V + L+Y+H +HR +K+S+IL+ + ++ +
Sbjct: 125 MNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISH 181
Query: 261 --REEMVDKHAANIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
R+ +V +L PE + + + + KSD+YS G+ EL G P + +
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 43/204 (21%), Positives = 75/204 (36%), Gaps = 20/204 (9%)
Query: 119 LIGQGAFGPVYKA--QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL-- 173
I G G +Y A + G V +K L + E L + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 174 VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
++ + Y+ M SL L + L++ L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHS-- 200
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
+++ D+K NI+L + + ++ D G ++ + GT G+ PE + T T
Sbjct: 201 -IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--IN-SFGYLYGTPGFQAPEIVRTG-PT 254
Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
+D+Y+ G L L G
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNG 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 43/222 (19%), Positives = 71/222 (31%), Gaps = 38/222 (17%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRL-HHRNLVNLV 174
IG G FG V+K G A+K E+ EV L H ++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 175 GYCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDG 229
AE + + + GSLA + + L V RGL Y+H
Sbjct: 78 SAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 230 AVPPVIHRDIKSSNILLDQS-------------------MRARVADFGLSREEMVDKHAA 270
++ +H DIK SNI + ++ + ++ D G
Sbjct: 135 SL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSPQ 188
Query: 271 NIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSP 311
G +L E + K+D+++ + +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 38/234 (16%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
P ++ ++ +G G +G VYK + + TG+ A+KV+ E+E + E+
Sbjct: 22 PAGIFELVEL--------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEIN 72
Query: 161 LLGRL-HHRNLVNLVG------YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
+L + HHRN+ G Q LV F GS+ + + L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EE 129
Query: 214 HIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
IA ++ RGL +LH V IHRDIK N+LL ++ ++ DFG+S +
Sbjct: 130 WIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTV 183
Query: 271 NIRGTF-G---YLDPEYISTRNFTK-----KSDVYSFGVLLFELIAGRSPLQGL 315
R TF G ++ PE I+ KSD++S G+ E+ G PL +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G GAFG V++ + +TG K + T + + E+ ++ +LHH L+NL
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+K + +L+ F+S G L + E+Y ++ ++ GL+++H+ + ++H D
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174
Query: 239 IKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
IK NI+ ++ ++ DFGL+ + D+ T + PE + +D++
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 297 SFGVLLFELIAGRSPLQG 314
+ GVL + L++G SP G
Sbjct: 235 AIGVLGYVLLSGLSPFAG 252
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
+G+G+FG V + TG+ AVKV++ K ++ EV LL +L H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 176 YCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
+ +KG LV + G L + + E I V G+ Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-------ARIIRQVLSGITYMHKNK 146
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
+ +HRD+K N+LL + R+ DFGLS K + GT Y+ PE +
Sbjct: 147 I---VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ +K DV+S GV+L+ L++G P G E
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G GAFG V++ + +TG A K + T + ++ + E+ + L H LVNL
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ + +++Y FMS G L + DE+ ++ + V V +GL ++H+ +H D
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNY---VHLD 280
Query: 239 IKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
+K NI+ +S ++ DFGL+ + GT + PE + +D++
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340
Query: 297 SFGVLLFELIAGRSPLQG 314
S GVL + L++G SP G
Sbjct: 341 SVGVLSYILLSGLSPFGG 358
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
+G GA+G V + T A+K++ S + EV +L L H N++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
+K + LV G L ++E I V G+ YLH +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-------AVIIKQVLSGVTYLHKHNI 157
Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
+HRD+K N+LL ++ ++ DFGLS K GT Y+ PE + +
Sbjct: 158 ---VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KK 213
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ +K DV+S GV+LF L+AG P G +Q+
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEV-MLLGRLHHRNLVNLVGY 176
+G+GA+G V K + + +G+ +AVK + E K ++ + + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENY---GPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+G + M SL Y + + ++ IA+ + + LE+LH
Sbjct: 75 LFREGDVWICMELMD-TSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTR----N 288
VIHRD+K SN+L++ + ++ DFG+S +VD A +I G Y+ PE I+
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
++ KSD++S G+ + EL R P
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPY 213
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
++G GAF V+ Q TG+ A+K + + + E+ +L ++ H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 178 AEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
+ LV +S G L +Y E + V ++YLH+ G
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDA-------SLVIQQVLSAVKYLHENG-- 126
Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
++HRD+K N+L +++ + + DFGLS+ E + + GT GY+ PE ++ +
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKP 183
Query: 289 FTKKSDVYSFGVLLFELIAGRSP-----LQGLMEQ 318
++K D +S GV+ + L+ G P L E+
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK 218
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLH-HRNLVNLVGY 176
+G G G V+K + TG +AVK + + E K ++ ++ + H +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+ M + L GP+ + + + + + L YL + VIH
Sbjct: 93 FITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIH 148
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTRNFTK---- 291
RD+K SNILLD+ + ++ DFG+S +VD A + G Y+ PE I + TK
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISG-RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 292 -KSDVYSFGVLLFELIAGRSPLQGL---MEQ 318
++DV+S G+ L EL G+ P + E
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEV 238
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 44/227 (19%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177
++G G+ G V G VAVK + E+ LL H N++ YC
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIRY--YC 76
Query: 178 AEKGQHMLVYVFMS--KGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-G 229
+E L Y+ + +L + ++ DEN + + +A G+ +LH
Sbjct: 77 SETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 230 AVPPVIHRDIKSSNILLD-------------QSMRARVADFGLSREEMVDKHAANIR--- 273
+IHRD+K NIL+ +++R ++DFGL ++ + +
Sbjct: 136 ----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 274 --GTFGYLDPEYIS-------TRNFTKKSDVYSFGVLLFELIAGRSP 311
GT G+ PE + R T+ D++S G + + +++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
F ++G+G+F V A+ +T A+K+L E + E ++ RL H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 171 VNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR------- 221
V L Y + L + + G L ++ R
Sbjct: 93 VKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIV 140
Query: 222 -GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFG 277
LEYLH + IHRD+K NILL++ M ++ DFG ++ + A GT
Sbjct: 141 SALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
Y+ PE ++ ++ K SD+++ G ++++L+AG P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLA-------------TDSKQGEKEFQTEVMLLGRL 165
+G GA+G V + + A+KV+ + ++ +E E+ LL L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVA 220
H N++ L +K LV F G L H +DE +I +
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-------ANIMKQIL 156
Query: 221 RGLEYLHD-GAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTF 276
G+ YLH ++HRDIK NILL + + ++ DFGLS D + GT
Sbjct: 157 SGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
Y+ PE + + + +K DV+S GV+++ L+ G P G +Q
Sbjct: 213 YYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEV-MLLGRLHHRNLVNLVGY 176
IG+GA+G V K +G+ +AVK + + + E K+ ++ +++ +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 177 CAEKGQHMLVYVFMSKGSLAS---HLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+G + MS S ++Y + + I L + L +L +
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLDPEYI----STRN 288
+IHRDIK SNILLD+S ++ DFG+S ++VD A G Y+ PE I S +
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISG-QLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
+ +SDV+S G+ L+EL GR P
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPY 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G G FG V+K + +TG +A K++ T + ++E + E+ ++ +L H NL+ L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
K +LV ++ G L + DE+Y LT + + G+ ++H ++H D
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQMY---ILHLD 212
Query: 239 IKSSNILLDQSMRARV--ADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
+K NIL ++ DFGL+R + GT +L PE ++ + +D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 297 SFGVLLFELIAGRSPLQG 314
S GV+ + L++G SP G
Sbjct: 273 SVGVIAYMLLSGLSPFLG 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 41/198 (20%), Positives = 87/198 (43%), Gaps = 8/198 (4%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
+G+G FG V++ + S+ +T K + + + E+ +L HRN+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
+ ++++ F+S + + + L V V L++LH + H D
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNI---GHFD 127
Query: 239 IKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
I+ NI+ +S ++ +FG +R+ + + Y PE + +D++
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMW 187
Query: 297 SFGVLLFELIAGRSPLQG 314
S G L++ L++G +P
Sbjct: 188 SLGTLVYVLLSGINPFLA 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLVNLVGY 176
+G+G+FG V K + T + AVKV+ S + + EV LL +L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
+ +V + G L + E+ I V G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHKHN- 141
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
++HRD+K NILL ++ ++ DFGLS + + GT Y+ PE +
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ +K DV+S GV+L+ L++G P G
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYG 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE--FQTEVMLLGRLHHRNLVNLVGY 176
+G+G+FG V K T + AVKV+ S + + EV LL +L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
+ +V + G L + E+ I V G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHKHN- 141
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
++HRD+K NILL ++ ++ DFGLS + + GT Y+ PE +
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRG 197
Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
+ +K DV+S GV+L+ L++G P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 12/203 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVG 175
+G+G F V + STG+ A K L + E E+ +L ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPV 234
+ +L+ + + G + S E ++ N + + + G+ YLH +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN----I 152
Query: 235 IHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
+H D+K NILL ++ DFG+SR+ I GT YL PE ++ T
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
+D+++ G++ + L+ SP G
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVG 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLH---H 167
+ +IG+G FG VY + TG+ A+K L KQGE E ++L +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 168 RNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
+V + Y + + M+ G L HL G + A ++ GLE++
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHM 308
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIS 285
H+ V ++RD+K +NILLD+ R++D GL+ + K + GT GY+ PE +
Sbjct: 309 HNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQ 363
Query: 286 TRN-FTKKSDVYSFGVLLFELIAGRSP 311
+ +D +S G +LF+L+ G SP
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 63/255 (24%), Positives = 105/255 (41%), Gaps = 38/255 (14%)
Query: 69 GPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPV 128
GP +G G+ + Y K+ +G+GAF V
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSD-----NYDVKEE----------LGKGAFSVV 45
Query: 129 YKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185
+ +TG A K++ T S + ++ + E + +L H N+V L E+ H L
Sbjct: 46 RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105
Query: 186 VYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDI 239
V+ ++ G L A Y E H + + Y H G ++HR++
Sbjct: 106 VFDLVTGGELFEDIVAREFYSEADA-------SHCIQQILESIAYCHSNG----IVHRNL 154
Query: 240 KSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
K N+LL + ++ADFGL+ E + GT GYL PE + ++K D++
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 214
Query: 297 SFGVLLFELIAGRSP 311
+ GV+L+ L+ G P
Sbjct: 215 ACGVILYILLVGYPP 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 49/202 (24%), Positives = 80/202 (39%), Gaps = 22/202 (10%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
IG+G++G V A Q T A K + + F+ E+ ++ L H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 179 EKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVP 232
+ LV + G L ++ E+ I DV + Y H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDA-------ARIMKDVLSAVAYCHKLN--- 126
Query: 233 PVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
V HRD+K N L ++ DFGL+ K GT Y+ P+ + +
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLY 184
Query: 290 TKKSDVYSFGVLLFELIAGRSP 311
+ D +S GV+++ L+ G P
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 39/226 (17%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL------------------------ATDSKQGEK 153
IG+G++G V A + A+KVL +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 154 EFQT--EVMLLGRLHHRNLVNL--VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTW 209
Q E+ +L +L H N+V L V + +V+ +++G + + PL+
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKH 268
+ D+ +G+EYLH + IHRDIK SN+L+ + ++ADFG+S E + D
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 269 AANIRGTFGYLDPEYISTRNFT---KKSDVYSFGVLLFELIAGRSP 311
+N GT ++ PE +S K DV++ GV L+ + G+ P
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
+G+GAF V + +TG A K++ T S + ++ + E + +L H N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
E+ H LV+ ++ G L A Y E H + + Y H +
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADA-------SHCIQQILESIAYCHSNGI 126
Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
+HR++K N+LL + ++ADFGL+ E + GT GYL PE +
Sbjct: 127 ---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
++K D+++ GV+L+ L+ G P
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 30/213 (14%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
IG+G+FG V Q T + A+K + E + E+ ++ L H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR-------- 221
VNL Y + + M +V + G L HL VH + +
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQN----------VHFKEETVKLFICELVM 126
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
L+YL + + IHRD+K NILLD+ + DF ++ + + GT Y+ P
Sbjct: 127 ALDYLQNQRI---IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
Query: 282 EYISTRNF---TKKSDVYSFGVLLFELIAGRSP 311
E S+R + D +S GV +EL+ GR P
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEF---QTEVMLLGRLHHRNL 170
++ L+G+G FG V + +TG A+K+L + + E TE +L H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHI-ALDVARGLEYLHD 228
L Y + + V + + G L HL E R ++ LEYLH
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSALEYLHS 123
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTR 287
V ++RDIK N++LD+ ++ DFGL +E + D GT YL PE +
Sbjct: 124 RDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
++ + D + GV+++E++ GR P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 34/215 (15%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL---------ATDSKQGEKEFQTEVMLLGRL-HHR 168
+G+G V + T + AVK++ A + ++ + EV +L ++ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGL 223
N++ L LV+ M KG L E I + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET-------RKIMRALLEVI 137
Query: 224 EYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
LH ++HRD+K NILLD M ++ DFG S + + + GT YL PE
Sbjct: 138 CALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 283 ------YISTRNFTKKSDVYSFGVLLFELIAGRSP 311
+ + K+ D++S GV+++ L+AG P
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEF---QTEVMLLGRLHHRNL 170
+ L+G+G FG V + +TG A+K+L + + E TE +L H L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHI-ALDVARGLEYLHD 228
L Y + + V + + G L HL E R ++ L+YLH
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVSALDYLHS 266
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTR 287
V++RD+K N++LD+ ++ DFGL +E + D GT YL PE +
Sbjct: 267 EK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
++ + D + GV+++E++ GR P
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGYC 177
+G GAFG V+ + S+G +K + D Q E + E+ +L L H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 178 AEKGQHMLVYVFMSKGSLASHLYD------ENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
+ +V G L + L+ + + L Y H
Sbjct: 90 EDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH- 144
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
V+H+D+K NIL ++ DFGL+ D+H+ N GT Y+ PE R
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-R 200
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ T K D++S GV+++ L+ G P G
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTG 227
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEK------EFQTEVMLLGRLHHRNLVN 172
+G G F V K + STG A K + + + E + EV +L ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L + +L+ +S G L L + L+ + G+ YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKI- 136
Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
H D+K NI+L ++ DFGL+ E NI GT ++ PE ++
Sbjct: 137 --AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
++D++S GV+ + L++G SP G
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 115 NFTTLIGQGAFGPVY----KAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHR 168
++GQG+FG V+ + + A+KVL + + + E +L ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 169 NLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR------ 221
+V L Y + + L+ F+ G L + L E V + +
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE----------VMFTEEDVKFYLAEL 135
Query: 222 --GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGY 278
L++LH + I+RD+K NILLD+ ++ DFGLS+E + + A GT Y
Sbjct: 136 ALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ PE ++ R T+ +D +SFGVL+FE++ G P QG
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEK------EFQTEVMLLGRLHHRNLVN 172
+G G F V K + STG A K + + + E + EV +L ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L + +L+ +S G L L + L+ + G+ YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKI- 136
Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
H D+K NI+L ++ DFGL+ E NI GT ++ PE ++
Sbjct: 137 --AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
++D++S GV+ + L++G SP G
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
+G+GAF V + ++ G+ A ++ T S + ++ + E + L H N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
+E+G H L++ ++ G L A Y E H + + + H G
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA-------SHCIQQILEAVLHCHQMG- 130
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLDPEYIST 286
V+HR++K N+LL + ++ADFGL+ E ++ A GT GYL PE +
Sbjct: 131 ---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSP-----LQGLMEQ 318
+ K D+++ GV+L+ L+ G P L +Q
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 58/246 (23%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKV-----LATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
IGQG++G V A + T A+K+ + + + + +TEV L+ +LHH N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV-------------------- 213
++ LV G L L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 214 ------------------HIALDVARGLEYLHD-GAVPPVIHRDIKSSNILL--DQSMRA 252
+I + L YLH+ G + HRDIK N L ++S
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEI 209
Query: 253 RVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS--TRNFTKKSDVYSFGVLLFEL 305
++ DFGLS+E + GT ++ PE ++ ++ K D +S GVLL L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 306 IAGRSP 311
+ G P
Sbjct: 270 LMGAVP 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 62/304 (20%), Positives = 120/304 (39%), Gaps = 34/304 (11%)
Query: 30 FRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEG 89
+++++R + R L S+ D + ++ + + + E
Sbjct: 13 NKFNKERRR-ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTEN 71
Query: 90 FKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLA--- 145
++ +P+++ + +IG+G V + +TG AVK++
Sbjct: 72 LYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 146 -----TDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSKGSL---- 195
++ + + E +L ++ H +++ L+ LV+ M KG L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191
Query: 196 -ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRAR 253
E I + + +LH ++HRD+K NILLD +M+ R
Sbjct: 192 TEKVALSEKET-------RSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIR 240
Query: 254 VADFGLSREEMVDKHAANIRGTFGYLDPE------YISTRNFTKKSDVYSFGVLLFELIA 307
++DFG S + + GT GYL PE + + K+ D+++ GV+LF L+A
Sbjct: 241 LSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 308 GRSP 311
G P
Sbjct: 301 GSPP 304
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEK------EFQTEVMLLGRLHHRNLVN 172
+G G F V K Q TG+ A K + + E + EV +L + H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L K +L+ +S G L L ++ LT + + G+ YLH +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRI- 129
Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
H D+K NI+L + R ++ DFG++ + NI GT ++ PE ++
Sbjct: 130 --AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP 187
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
++D++S GV+ + L++G SP G
Sbjct: 188 LGLEADMWSIGVITYILLSGASPFLG 213
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G+GA VY+ Q T + A+KVL +K +TE+ +L RL H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 178 AEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
+ LV ++ G L Y E + + YLH+ G
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDA-------ADAVKQILEAVAYLHENG-- 168
Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
++HRD+K N+L ++ADFGLS+ + GT GY PE +
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
+ + D++S G++ + L+ G P
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEP 249
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 35/223 (15%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKV-----LATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
IG+G F V + TG+ AVK+ + ++ + E + L H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 174 VGYCAEKGQHMLVYVFMSKGSL---------ASHLYDENYGPLTWNLRVHIALDVARGLE 224
+ + G +V+ FM L A +Y E H + L
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-------SHYMRQILEALR 144
Query: 225 YLHD-GAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR-GTFGYL 279
Y HD +IHRD+K +LL + S ++ FG++ + A R GT ++
Sbjct: 145 YCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL----QGLMEQ 318
PE + + K DV+ GV+LF L++G P + L E
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG 243
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
+G+GA+G V A T E VAVK++ E + E+ + L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLEYLHD 228
E L + S G L + E + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--EPDIGMP--------EPDAQRFFHQLMAGVVYLHG 123
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLS---REEMVDKHAANIRGTFGYLDPEYIS 285
+ HRDIK N+LLD+ +++DFGL+ R ++ + GT Y+ PE +
Sbjct: 124 IGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 TRNFT-KKSDVYSFGVLLFELIAGRSP 311
R F + DV+S G++L ++AG P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--------SKQGEKEFQTEVMLLGRLHHRNL 170
+G GA G V A + T + VA+++++ +TE+ +L +L+H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEY 225
+ + + + + +V M G L + E + ++Y
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-------KLYFYQMLLAVQY 254
Query: 226 LHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
LH+ + IHRD+K N+LL ++ ++ DFG S+ + GT YL PE
Sbjct: 255 LHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 283 YIS---TRNFTKKSDVYSFGVLLFELIAGRSP 311
+ T + + D +S GV+LF ++G P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
++G+GA V + T + AVK++ EV +L + HRN++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 177 CAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
E+ + LV+ M GS+ SH+ ++E + DVA L++LH+ G
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA-------SVVVQDVASALDFLHNKG- 131
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR--------GTFGYL 279
+ HRD+K NIL +Q ++ DF L ++ + I G+ Y+
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 280 DPE-----YISTRNFTKKSDVYSFGVLLFELIAGRSP 311
PE + K+ D++S GV+L+ L++G P
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 18/210 (8%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--------ATDSKQGEKEFQTEVMLLGRLHHRNL 170
+G GAFG V+ A + V VK + + E+ +L R+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHD 228
+ ++ +G LV G L+ + + L L +I + + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
+ IHRDIK NI++ + ++ DFG + K GT Y PE +
Sbjct: 149 KDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205
Query: 289 FT-KKSDVYSFGVLLFELIAGRSPLQGLME 317
+ + +++S GV L+ L+ +P L E
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCELEE 235
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEK------EFQTEVMLLGRLHHRNLVN 172
+G G F V K + STG A K + + + + + EV +L + H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L K +L+ ++ G L L ++ LT + G+ YLH +
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQI- 135
Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
H D+K NI+L R ++ DFGL+ + NI GT ++ PE ++
Sbjct: 136 --AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
++D++S GV+ + L++G SP G
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLG 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
+G+GA+G V A T E VAVK++ E + E+ + L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLEYLHD 228
E L + S G L + E + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--EPDIGMP--------EPDAQRFFHQLMAGVVYLHG 123
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYIS 285
+ HRDIK N+LLD+ +++DFGL+ + + GT Y+ PE +
Sbjct: 124 IGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 TRNFT-KKSDVYSFGVLLFELIAGRSP 311
R F + DV+S G++L ++AG P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 37/220 (16%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNL 170
+IG+GAF V +M TG+ A+K++ K+GE F+ E +L R +
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 171 VNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR------- 221
L + A + ++ L V + G L + L +G I ++AR
Sbjct: 124 TQL--HFAFQDENYLYLVMEYYVGGDLLTLLS--KFGE-------RIPAEMARFYLAEIV 172
Query: 222 -GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGY 278
++ +H +HRDIK NILLD+ R+ADFG + D + GT Y
Sbjct: 173 MAIDSVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 279 LDPEYISTRNFTKKSDVY-------SFGVLLFELIAGRSP 311
L PE + + Y + GV +E+ G++P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 34/217 (15%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
L+G+G++G V + T AVK+L GE + E+ LL RL H+N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 174 --VGYCAEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVAR--------G 222
V Y EK + +V + G + D + A G
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFP--------VCQAHGYFCQLIDG 121
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---REEMVDKHAANIRGTFGYL 279
LEYLH + +H+DIK N+LL +++ G++ D +G+ +
Sbjct: 122 LEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 280 DPEYIS-TRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
PE + F+ K D++S GV L+ + G P +G
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEF-QT---EVMLLGRLHHRNLVNLV 174
+G G + VYK +TG VA+K + DS++G T E+ L+ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVRLY 69
Query: 175 GYCAEKGQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
+ + LV+ FM K + S L NL + + +GL + H+ +
Sbjct: 70 DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI 129
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR 261
+HRD+K N+L+++ + ++ DFGL+R
Sbjct: 130 ---LHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
NF ++G+G+FG V ++ T E AVK+L + EK +L
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-----VLALP 398
Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
L L C + + V +++ G L H+ G V A ++A GL
Sbjct: 399 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGL 455
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPE 282
+L + I+RD+K N++LD ++ADFG+ +E + D GT Y+ PE
Sbjct: 456 FFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
I+ + + K D ++FGVLL+E++AG++P +G
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNLV 174
+G+G +G VYKA+ S G VA+K + D+ E E E+ LL LHH N+V+L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ LV+ FM K L L DEN L + + RG+ + H +
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCHQHRI--- 140
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR 261
+HRD+K N+L++ ++ADFGL+R
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
++G+G+FG V+ A+ T + A+K L + EK +L
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR-----VLSLA 74
Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
H L ++ + +++ V +++ G L H+ + A ++ GL
Sbjct: 75 WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 131
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YL 279
++LH + ++RD+K NILLD+ ++ADFG+ +E M+ N TF G Y+
Sbjct: 132 QFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---TFCGTPDYI 185
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
PE + + + D +SFGVLL+E++ G+SP G E++
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 115 NFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS---KQGEKEF-QTEVMLLGRLH 166
++G+G +G V++ + +TG+ A+KVL + + E +L +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 167 HRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR---- 221
H +V+L+ Y + G + L+ ++S G L L E D A
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE----------GIFMEDTACFYLA 128
Query: 222 ----GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTF 276
L +LH + I+RD+K NI+L+ ++ DFGL +E + D + GT
Sbjct: 129 EISMALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
Y+ PE + + D +S G L+++++ G P G
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
F ++G+G+FG V A++ TG+ AVKVL + EK +L
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR-----ILSLA 80
Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
+H L L C + + V F++ G L H+ A ++ L
Sbjct: 81 RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISAL 137
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YL 279
+LHD + I+RD+K N+LLD ++ADFG+ +E + + TF G Y+
Sbjct: 138 MFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---TFCGTPDYI 191
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
PE + + D ++ GVLL+E++ G +P + E
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 33/213 (15%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--------DSKQGEKEFQTEVMLLGRLHHRNL 170
+G GA G V A + T + VA+K+++ +TE+ +L +L+H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEY 225
+ + + + + +V M G L + E + ++Y
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-------KLYFYQMLLAVQY 129
Query: 226 LHD-GAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
LH+ G +IHRD+K N+LL ++ ++ DFG S+ + GT YL P
Sbjct: 130 LHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 282 EYIS---TRNFTKKSDVYSFGVLLFELIAGRSP 311
E + T + + D +S GV+LF ++G P
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNL 173
IG+G +G VYKA+ TGE VA+K + D+ E E E+ LL L+H N+V L
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ + + LV+ F+ + L + + L + +GL + H V
Sbjct: 68 LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV-- 124
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR 261
+HRD+K N+L++ ++ADFGL+R
Sbjct: 125 -LHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
NF ++G+G+FG V ++ T E AVK+L + EK +L
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-----VLALP 77
Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
L L C + + V +++ G L H+ G V A ++A GL
Sbjct: 78 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGL 134
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YL 279
+L + I+RD+K N++LD ++ADFG+ +E + D TF G Y+
Sbjct: 135 FFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYI 188
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
PE I+ + + K D ++FGVLL+E++AG++P +G E +
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177
+G+G+F K + + AVK++ SK+ E Q E+ L H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 178 AEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
++ LV ++ G L + E +I + + ++HD G
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEA-------SYIMRKLVSAVSHMHDVG-- 126
Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTR 287
V+HRD+K N+L + ++ ++ DFG +R + D T Y PE ++
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
+ + D++S GV+L+ +++G+ P
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVP 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-25
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG+G F V A+ + TG VA+K++ + ++ EV ++ L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+ L+ + S G + +L +G + + ++Y H + +H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRI---VH 137
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSDV 295
RD+K+ N+LLD M ++ADFG S E V G Y PE + + + DV
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197
Query: 296 YSFGVLLFELIAGRSPLQG 314
+S GV+L+ L++G P G
Sbjct: 198 WSLGVILYTLVSGSLPFDG 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 2e-24
Identities = 50/147 (34%), Positives = 75/147 (51%), Gaps = 13/147 (8%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNLV 174
IG+G +G VYKAQ + GET A+K + + E E T E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
K + +LV+ + + L L D G L L + G+ Y HD V
Sbjct: 67 DVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRRV--- 121
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR 261
+HRD+K N+L+++ ++ADFGL+R
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 2e-24
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNL 173
IG+G +G V+KA+ T E VA+K + D + E E+ LL L H+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRL 66
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ LV+ F + L + D G L + + +GL + H V
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV-- 122
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE----------EMVDKHAANIRGTFGYLDPEY 283
+HRD+K N+L++++ ++A+FGL+R E+V T Y P+
Sbjct: 123 -LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---------TLWYRPPDV 172
Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
+ + ++ D++S G + EL PL
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 24/201 (11%), Positives = 54/201 (26%), Gaps = 39/201 (19%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
G ++A + VA+ + + +E + + L R+ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPP 233
+ ++V ++ GSL + + +A + H G
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQSLAAAADAAHRAG---- 149
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
V S + + +A + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA-------NPQD 183
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
D+ G L+ L+ R PL
Sbjct: 184 DIRGIGASLYALLVNRWPLPE 204
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
+IG+GAFG V ++ + + A+K+L K+ E F+ E +L + + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 175 GYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLE 224
+ A + + L V + G L + L + ++AR ++
Sbjct: 140 -HYAFQDDNNLYLVMDYYVGGDLLTLLS---------KFEDRLPEEMARFYLAEMVIAID 189
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGYLDPE 282
+H +HRDIK NIL+D + R+ADFG + M D ++ GT Y+ PE
Sbjct: 190 SVHQLHY---VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 283 YISTRNFTKKS-----DVYSFGVLLFELIAGRSP 311
+ K D +S GV ++E++ G +P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-24
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVM-----LLGRLHHR 168
+F +IG+G+FG V A+ + AVKVL + +KE + +M LL + H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHP 99
Query: 169 NLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
LV L + + + V +++ G L HL E R + A ++A L YLH
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAA-EIASALGYLH 156
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YLDPEY 283
+ ++RD+K NILLD + DFGL +E + + TF G YL PE
Sbjct: 157 SLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS---TFCGTPEYLAPEV 210
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ + + + D + G +L+E++ G P
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-24
Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEF---QTEVMLLGR-LHHRN 169
+ +IG+G++ V ++ T A+KV+ + +++ QTE + + +H
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 170 LVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
LV L C + + V +++ G L H+ + P R + A +++ L YLH+
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSA-EISLALNYLHE 128
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YLDPEYI 284
+ I+RD+K N+LLD ++ D+G+ +E + + TF G Y+ PE +
Sbjct: 129 RGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPEIL 182
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSP 311
++ D ++ GVL+FE++AGRSP
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 7e-24
Identities = 71/275 (25%), Positives = 106/275 (38%), Gaps = 84/275 (30%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTE-------------V 159
+G+GAFG V +A + +T TVAVK+L + E + +E V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 160 MLLG--------------------------------------RLHHRNLVNLVGYCAEKG 181
LLG R + VG
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 182 QHMLVYVFMSKGSLASHLYDENY---------------GPLTWNLRVHIALDVARGLEYL 226
+ L + S+ S +S +E LT + + VA+G+E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLD-----P 281
A IHRD+ + NILL + ++ DFGL+R+ D +R L P
Sbjct: 210 ---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAP 264
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
E I R +T +SDV+SFGVLL+E+ + G SP G+
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 26/204 (12%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
IG G++ + +T AVK++ + +E + +LL H N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYD 86
Query: 179 EKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVP 232
+ +V M G L + E + + + +EYLH G
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKFFSEREA-------SAVLFTITKTVEYLHAQG--- 136
Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTR 287
V+HRD+K SNIL R+ DFG +++ + T ++ PE + +
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
+ D++S GVLL+ ++ G +P
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTP 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
+ +G G+FG V + +G A+K+L K+ + E +L ++ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------G 222
V L + +V +++ G + SHL + AR
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----------RFSEPHARFYAAQIVLT 153
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
EYLH + I+RD+K N+L+DQ +V DFG ++ V + GT L PE
Sbjct: 154 FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPE 208
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSP 311
I ++ + K D ++ GVL++E+ AG P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 9e-24
Identities = 48/225 (21%), Positives = 77/225 (34%), Gaps = 33/225 (14%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
P K Q E + + R+ + N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 175 GYCAEKGQHMLVYVFM---SKGSLASHLYDENYGP-----LTWNLRVHIALDVARGLEYL 226
G + +Y+ M K +L + + ++ + IA +E+L
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE----AVEFL 180
Query: 227 HD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR------------ 273
H G ++HRD+K SNI +V DFGL D+ +
Sbjct: 181 HSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236
Query: 274 -GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
GT Y+ PE I N++ K D++S G++LFEL+ ME
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQME 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
+G+G FG V++A+ A+K + +++ +E EV L +L H +V
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 177 CAEKGQHMLVYVFMS 191
E
Sbjct: 73 WLETPPEKWQEEMDE 87
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 9e-24
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEF------QTEVMLLGRLHHR--N 169
L+G G FG VY +S VA+K + D E EV+LL ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
++ L+ + +L+ + + L+D G L L V + + H
Sbjct: 110 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 228 DGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
+ V +HRDIK NIL+D ++ DFG + D + GT Y PE+I
Sbjct: 167 NCGV---LHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRY 222
Query: 287 RNFT-KKSDVYSFGVLLFELIAGRSP 311
+ + + V+S G+LL++++ G P
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL------ATDSKQGEKEFQTEVMLLGRLH----H 167
L+G+G FG V+ ++ VA+KV+ EV LL ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEY 225
++ L+ + + + + + A L+D GPL V +++
Sbjct: 98 PGVIRLLDWFETQEG---FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
H V +HRDIK NIL+D A++ DFG + D+ + GT Y PE+I
Sbjct: 155 CHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGA-LLHDEPYTDFDGTRVYSPPEWI 210
Query: 285 STRNFT-KKSDVYSFGVLLFELIAGRSP 311
S + + V+S G+LL++++ G P
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
+ +IG+G++ V ++ T A++V+ D Q EK +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH-----VFEQA 109
Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
+H LV L C + + V +++ G L H+ + P R + A +++ L
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSA-EISLAL 166
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YL 279
YLH+ + I+RD+K N+LLD ++ D+G+ +E + + TF G Y+
Sbjct: 167 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYI 220
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
PE + ++ D ++ GVL+FE++AGRSP
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
IG G FG + T E VAVK + + E Q E++ L H N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLEYLHDG 229
++ + S G L + N G + D AR G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERI--CNAGRFS--------EDEARFFFQQLLSGVSYCHSM 135
Query: 230 AVPPVIHRDIKSSNILLDQS--MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
+ HRD+K N LLD S R ++ DFG S+ ++ + GT Y+ PE + +
Sbjct: 136 QI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 288 NFT-KKSDVYSFGVLLFELIAGRSP 311
+ K +DV+S GV L+ ++ G P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 65/282 (23%)
Query: 64 SDSTVGPESPVK--SGRNGNGKSMWLEGFKRSNVVSASG-----IPEYSYKDLQKATCNF 116
+ S PV+ S S +G K + VV+ G E SY D +
Sbjct: 7 TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV----- 61
Query: 117 TTLIGQGAFGPVYKAQMS-TGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
IG G+FG VY+A++ +GE VA+K VL Q ++ E+ ++ +L H N+V L
Sbjct: 62 ---IGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 175 GYCAEKGQHM------LVYVFMSKGSLASHL--YDENYGPLTWNLRVHIAL---DVARGL 223
+ G+ LV ++ + ++ Y L +++ L + R L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP---VIYVKLYMYQLFRSL 169
Query: 224 EYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
Y+H + HRDIK N+LLD + ++ DFG +++ + + N+
Sbjct: 170 AYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNV---------S 215
Query: 283 YISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
YI +R ++T DV+S G +L EL+ G+ P+
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-F-QT---EVMLLGRLHHRNLVNL 173
IGQG FG V+KA+ TG+ VA+K + ++ EKE F T E+ +L L H N+VNL
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVNL 81
Query: 174 VGYCAEKGQHM--------LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
+ C K LV+ F LA L T + + + GL Y
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-----YLD 280
+H + +HRD+K++N+L+ + ++ADFGL+R + K++ R T Y
Sbjct: 140 IHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196
Query: 281 PEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
PE + R++ D++ G ++ E+ +QG
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-23
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G G FG V + TG VAVK+L S + + E+ L H +++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ +V ++S G L ++ +G + + + ++Y H V
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEARRLFQQILSAVDYCHRHMV--- 132
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKS 293
+HRD+K N+LLD M A++ADFGLS + G+ Y PE IS R + +
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 192
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
D++S GV+L+ L+ G P
Sbjct: 193 DIWSCGVILYALLCGTLPFDD 213
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 3e-23
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---T 157
P+YS +D +G G+FG V+ + G A+KVL + K+ +
Sbjct: 1 PKYSLQDF-----QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 55
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
E ++L + H ++ + G + Q ++ ++ G L S L
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----------RFPN 105
Query: 218 DVAR--------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269
VA+ LEYLH + I+RD+K NILLD++ ++ DFG ++ V
Sbjct: 106 PVAKFYAAEVCLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAKY--VPDVT 160
Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
+ GT Y+ PE +ST+ + K D +SFG+L++E++AG +P
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 20/203 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVG- 175
++G G G V + TG+ A+K+L + + EV + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 176 YCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
Y + + M G L S + + T I D+ +++LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-- 148
Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
+ HRD+K N+L ++ ++ DFG ++E T Y+ PE +
Sbjct: 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTPCYTPYYVAPEVLGPEK 205
Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
+ K D++S GV+++ L+ G P
Sbjct: 206 YDKSCDMWSLGVIMYILLCGFPP 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNL 173
+G+G +G VYKA T ETVA+K + + E+E EV LL L HRN++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ L++ + L ++ + ++ + + G+ + H
Sbjct: 99 KSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHSRRC-- 153
Query: 234 VIHRDIKSSNILLDQSMRAR-----VADFGLSR 261
+HRD+K N+LL S + + DFGL+R
Sbjct: 154 -LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNL 173
+G+G F VYKA+ +T + VA+K + + K+ E+ LL L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+ K LV+ FM L + +N LT + L +GLEYLH +
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI-- 133
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR 261
+HRD+K +N+LLD++ ++ADFGL++
Sbjct: 134 -LHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
+IG+GAFG V + ST + A+K+L+ K+ + F E ++ + +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134
Query: 175 GYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLE 224
+ A + L V +M G L + + + AR L+
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALD 182
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--AANIRGTFGYLDPE 282
+H IHRD+K N+LLD+S ++ADFG + + GT Y+ PE
Sbjct: 183 AIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 283 YISTR----NFTKKSDVYSFGVLLFELIAGRSP 311
+ ++ + ++ D +S GV L+E++ G +P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-23
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 19/202 (9%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177
+G G G V + T E A+K+L + + EV L R ++V +V
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKML---QDC--PKARREVELHWRASQCPHIVRIVDVY 124
Query: 178 ----AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVP 232
A + ++V + G L S + D T I + ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 181
Query: 233 PVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
+ HRD+K N+L + ++ DFG ++E T Y+ PE + +
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 290 TKKSDVYSFGVLLFELIAGRSP 311
K D++S GV+++ L+ G P
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPP 262
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-23
Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 39/218 (17%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVK--VLATDSKQGEKEFQT---------EVMLLGRLHHR 168
I G++G V S G VA+K + E+ LL HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 169 NLVNL--VGYCAEKGQHMLVYVFMSKGSLASHLYD--------ENYGPLTWNLRVHIAL- 217
N++ L + E+ +Y+ L + ++ HI
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVT-------ELMRTDLAQVIHDQRIVIS---PQHIQYF 139
Query: 218 --DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275
+ GL LH+ V +HRD+ NILL + + DF L+RE+ D + +
Sbjct: 140 MYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 276 FGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
Y PE + + FTK D++S G ++ E+ + L
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-AL 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLV 174
+G+G++G V K + TG VA+K L +D + K+ E+ LL +L H NLVNL+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK--IAMREIKLLKQLRHENLVNLL 90
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
C +K + LV+ F+ ++ L + L + + + G+ + H +
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNI--- 145
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSRE 262
IHRDIK NIL+ QS ++ DFG +R
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFART 173
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
+G+G + VYK T VA+K + + ++G T EV LL L H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLHD 67
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
+ LV+ ++ K L +L D+ + + + RGL Y H V+
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVL 122
Query: 236 HRDIKSSNILLDQSMRARVADFGLSRE----------EMVDKHAANIRGTFGYLDPEYI- 284
HRD+K N+L+++ ++ADFGL+R E+V T Y P+ +
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---------TLWYRPPDILL 173
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ +++ + D++ G + +E+ GR G
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLV 174
IG+G++G V+K + TG+ VA+K L ++ K + E+ +L +L H NLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIALREIRMLKQLKHPNLVNLL 68
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
K + LV+ + ++ L D + +L I + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNC--- 123
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSRE 262
IHRD+K NIL+ + ++ DFG +R
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARL 151
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 52/234 (22%), Positives = 94/234 (40%), Gaps = 52/234 (22%)
Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLG 163
++ + GQG FG V + TG +VA+K + D + +E Q + L
Sbjct: 24 RFQVERM--------AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLA 74
Query: 164 RLHHRNLVNL--VGYCAEKGQHMLVYV-----FMSKGSLASHL--YDENYGPLTWNLRVH 214
LHH N+V L Y + +Y+ ++ +L Y +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP---PIL 130
Query: 215 IAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAA 270
I + + R + LH +V V HRDIK N+L++++ ++ DFG ++ +
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEP 187
Query: 271 NIRGTFGYLDPEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
N+ YI +R ++T D++S G + E++ G P+
Sbjct: 188 NV---------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-22
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
+G+G+FG V A T + VA+K ++ S + + E+ L L H +++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKL 74
Query: 174 VGYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
+ + + + G L ++ +T + + +EY H +
Sbjct: 75 YDVITTPTD---IVMVIEYAGGELFDYIV--EKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT- 290
+HRD+K N+LLD ++ ++ADFGLS G+ Y PE I+ + +
Sbjct: 130 ---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
+ DV+S G++L+ ++ GR P
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G G FG V + TG VAVK+L S + + E+ L H +++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLEYL 226
+ +V ++S G L ++ G L +R G++Y
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI--CKNGRLD--------EKESRRLFQQILSGVDYC 132
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
H V +HRD+K N+LLD M A++ADFGLS + G+ Y PE IS
Sbjct: 133 HRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 189
Query: 287 RNFT-KKSDVYSFGVLLFELIAGRSP 311
R + + D++S GV+L+ L+ G P
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 46/232 (19%)
Query: 115 NFTTLIGQGAFGPVYKAQMS----TGETVAVKVL----------ATDSKQGEKEFQTEVM 160
++G GA+G V+ + TG+ A+KVL T+ + E++ +
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ-----V 111
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
L LV L Y + + L+ +++ G L +HL
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQR----------ERFTEHE 160
Query: 220 AR--------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHA 269
+ LE+LH + I+RDIK NILLD + + DFGLS+E + D + A
Sbjct: 161 VQIYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 270 ANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ GT Y+ P+ + + K D +S GVL++EL+ G SP E+
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-21
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKEF-QT---EVMLLGRLH---HRNL 170
IG GA+G VYKA+ +G VA+K + + G + EV LL RL H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 171 VNLV-----GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
V L+ + + LV+ + + L ++L L + RGL++
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
LH + +HRD+K NIL+ ++ADFGL+R
Sbjct: 136 LHANCI---VHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 63/275 (22%), Positives = 114/275 (41%), Gaps = 64/275 (23%)
Query: 65 DSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIP-EYSYKDLQKATCNFTTLIGQG 123
+ P + VK + + K +G E +Y + + IG G
Sbjct: 4 TMSNAPLNGVKLNPLDDPN----KVIKVLASDGKTGEQREIAYTNCKV--------IGNG 51
Query: 124 AFGPVYKAQMSTGETVAVK-VLATDSKQGEKEFQT-EVMLLGRLHHRNLVNLVGYCAEKG 181
+FG V++A++ + VA+K VL +K F+ E+ ++ + H N+V+L + G
Sbjct: 52 SFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNG 105
Query: 182 QHM------LVYVFMSKGSLASHL--YDENYGPLTWNLRVHIAL---DVARGLEYLHDGA 230
LV ++ + ++ Y + + + I L + R L Y+H
Sbjct: 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP---MLLIKLYMYQLLRSLAYIHSIG 161
Query: 231 VPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-- 287
+ HRDIK N+LLD S ++ DFG ++ ++ N+ YI +R
Sbjct: 162 I---CHRDIKPQNLLLDPPSGVLKLIDFGSAK--ILIAGEPNV---------SYICSRYY 207
Query: 288 ----------NFTKKSDVYSFGVLLFELIAGRSPL 312
N+T D++S G ++ EL+ G+ PL
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PL 241
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-21
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 38/212 (17%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
IG GA G V A VA+K L+ + FQ E++L+ ++H+N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 170 LVNLV-----GYCAEKGQHM-LVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVA 220
++ L+ E+ Q + +V M + L E L + +
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM--------L 137
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLD 280
G+++LH + IHRD+K SNI++ ++ DFGL+R T Y
Sbjct: 138 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
PE I + + D++S G ++ E+I G L
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGG-VL 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 8e-21
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
IG GA G V A VA+K L+ + FQ E++L+ ++H+N
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 170 LVNLVG-YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
+++L+ + +K V++ + ++L L ++ + G+++LH
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
+ IHRD+K SNI++ ++ DFGL+R T Y PE I
Sbjct: 183 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
+ + D++S G ++ E++ + L
Sbjct: 240 YKENVDIWSVGCIMGEMVRHK-IL 262
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 43/261 (16%), Positives = 82/261 (31%), Gaps = 80/261 (30%)
Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLG 163
Y + +G G+FG V + +G+ A+K + D + +E ++
Sbjct: 8 KYSLGKT--------LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMK 55
Query: 164 RLHHRNLVNL--VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV-- 219
L H N++ L Y + L N + + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 220 -----------------------------------ARGLEYLHDGAVPPVIHRDIKSSNI 244
R + ++H + HRDIK N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI---CHRDIKPQNL 172
Query: 245 LLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR------------NFTK 291
L++ + ++ DFG ++ + ++ YI +R +T
Sbjct: 173 LVNSKDNTLKLCDFGSAK--KLIPSEPSV---------AYICSRFYRAPELMLGATEYTP 221
Query: 292 KSDVYSFGVLLFELIAGRSPL 312
D++S G + ELI G+ PL
Sbjct: 222 SIDLWSIGCVFGELILGK-PL 241
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 25/215 (11%)
Query: 120 IGQGAFGPVYKAQ---MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
+G+G +G VYKA+ + A+K + E+ LL L H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 177 CAEKGQH--MLVYVFMS---KGSLASHLYDENYG---PLTWNLRVHIALDVARGLEYLHD 228
L++ + + H + L + + + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 229 GAVPPVIHRDIKSSNILLDQSMRAR----VADFGLSRE--EMVDK--HAANIRGTFGYLD 280
V +HRD+K +NIL+ R +AD G +R + + TF Y
Sbjct: 147 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 281 PEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
PE + R++TK D+++ G + EL+
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 53/234 (22%), Positives = 96/234 (41%), Gaps = 49/234 (20%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGR 164
Y DL+ +G G G V+ A + VA+K + Q K E+ ++ R
Sbjct: 13 YMDLKP--------LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR 64
Query: 165 LHHRNLVNLVG-YCAEKGQHMLVYVFMSKGS---LASHLYDEN------YGPLTWNLRVH 214
L H N+V + Q +++ + + + + GPL H
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL---EEH 121
Query: 215 IAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAA 270
L + RGL+Y+H V +HRD+K +N+ ++ + + ++ DFGL+R
Sbjct: 122 ARLFMYQLLRGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLAR------IMD 172
Query: 271 NIRGTFGYLDPEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
G+L E + T+ N+TK D+++ G + E++ G+ L
Sbjct: 173 PHYSHKGHL-SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TL 224
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-20
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 22/157 (14%)
Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLH---HRN 169
IG+GA+G V+KA+ + G VA+K + + +E T EV +L L H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 170 LVNL-----VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
+V L V + + LV+ + + L ++L + + + RGL+
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
+LH V +HRD+K NIL+ S + ++ADFGL+R
Sbjct: 135 FLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-20
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGR 164
Y+ ++K +G+G + V++A ++ E V VK+L K K+ + E+ +L
Sbjct: 38 YQLVRK--------LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILEN 86
Query: 165 L-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
L N++ L + VF + Y LT ++ + L
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKAL 143
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSREEMVDKHAANIR-GTFGYLDP 281
+Y H + +HRD+K N+++D R R+ D+GL+ N+R + + P
Sbjct: 144 DYCHSMGI---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGP 199
Query: 282 EYI-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
E + + + D++S G +L +I + P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 47/222 (21%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL-----ATDSKQGEKEFQT--EVMLLGRLHHRNLV 171
+G+GA+G V A TGE VA+K + + + T E+ +L H N++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR------TLREIKILKHFKHENII 72
Query: 172 NLVG-YCAEKGQHM----LVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
+ + ++ ++ M + L D++ + L R
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT-----L---RA 124
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
++ LH V IHRD+K SN+L++ + +V DFGL+R + E
Sbjct: 125 VKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 283 YISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
+++TR +++ DV+S G +L EL R P+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PI 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 63/224 (28%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
+G GA+G V A +GE VA+K L+ + FQ+ E++LL + H N
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 170 LVNL--VGYCAEKGQHM----LVYVFMSK---GSLASHLYDENYGPLTWNLRVHIALDVA 220
++ L V A ++ LV FM + +E L + +
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM--------L 136
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLD 280
+GL+Y+H V +HRD+K N+ +++ ++ DFGL+R +
Sbjct: 137 KGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHADAEM------------- 180
Query: 281 PEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
Y+ TR ++ + D++S G ++ E++ G+ L
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TL 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH----------- 166
+G G F V+ A+ M VA+K++ K + + E+ LL R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 167 HRNLVNLVG---YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
+++ L+ + G H+ +V+ + + +L + + + + I+ + G
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRA------RVADFGLSREEMVDKHAANIRGTF 276
L+Y+H +IH DIK N+L++ ++AD G + D+H N T
Sbjct: 144 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC--WYDEHYTNSIQTR 199
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
Y PE + + +D++S L+FELI G
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 54/222 (24%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL-----ATDSKQGEKEFQT--EVMLLGRLHHRNLV 171
IG+GA+G V A VA+K + T ++ T E+ +L R H N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR------TLREIKILLRFRHENII 88
Query: 172 NLVG-YCAEKGQHM----LVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
+ A + M +V M K HL +++ + + RG
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--------LRG 140
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
L+Y+H V +HRD+K SN+LL+ + ++ DFGL+R A G+L E
Sbjct: 141 LKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLAR------VADPDHDHTGFL-TE 190
Query: 283 YISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
Y++TR +TK D++S G +L E+++ R P+
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI 231
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 57/232 (24%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA------TDSKQGEKEFQT--EVMLLGRLH-HRN 169
+G+GA+G V+K+ TGE VAVK + TD+++ T E+M+L L H N
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR------TFREIMILTELSGHEN 70
Query: 170 LVNLVG-YCAEKGQHM-LVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
+VNL+ A+ + + LV+ +M A+ L + + + L + + +
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL-----I---KVI 122
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP-- 281
+YLH G + +HRD+K SNILL+ +VADFGLSR + + N +
Sbjct: 123 KYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 282 ---------EYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
+Y++TR +TK D++S G +L E++ G+ P+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 63/252 (25%), Positives = 100/252 (39%), Gaps = 64/252 (25%)
Query: 89 GFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD 147
GF R V + Y+DLQ +G GA+G V A TG VA+K L
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQP--------VGSGAYGAVCSAVDGRTGAKVAIKKLY-- 59
Query: 148 SKQGEKEFQT---------EVMLLGRLHHRNLVNL--VGYCAEKGQHM----LVYVFMSK 192
+ FQ+ E+ LL + H N++ L V E LV FM
Sbjct: 60 -----RPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114
Query: 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252
L + E L + + + +GL Y+H + IHRD+K N+ +++
Sbjct: 115 -DLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCEL 167
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR------------NFTKKSDVYSFGV 300
++ DFGL+R+ + Y+ TR +T+ D++S G
Sbjct: 168 KILDFGLARQADSEM-------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214
Query: 301 LLFELIAGRSPL 312
++ E+I G+ L
Sbjct: 215 IMAEMITGK-TL 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 53/239 (22%), Positives = 91/239 (38%), Gaps = 68/239 (28%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA------TDSKQGEKEFQT--EVMLLGRLHHRNL 170
IG+G++G VY A +T + VA+K + D K+ E+ +L RL +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR------ILREITILNRLKSDYI 87
Query: 171 VNLVG-YCAEKGQHM----LVYVFM---------SKGSLASHLYDENYGPLTWNLRVHIA 216
+ L + +V + L +E+ + +NL
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP----IFLTEEHIKTILYNL----- 138
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
L G ++H+ + IHRD+K +N LL+Q +V DFGL+R +K +
Sbjct: 139 L---LGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 277 GYLDP------------EYISTR------------NFTKKSDVYSFGVLLFELIAGRSP 311
+P ++ TR N+TK D++S G + EL+
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHR------ 168
+IG+G+FG V KA + VA+K++ +Q E+ +L L +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
N+++++ + + + +S +L + + + L A + + L+ LH
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 229 GAVPPVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
+IH D+K NILL Q R+ +V DFG S E + I+ F Y PE I
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTYIQSRF-YRAPEVILG 273
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ D++S G +L EL+ G L G
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPG 301
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 46/231 (19%), Positives = 87/231 (37%), Gaps = 57/231 (24%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
IG G++G V +A VA+K + + F+ E+ +L RL+H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDH 113
Query: 170 LVNLVG-YCAEKGQHM----LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
+V ++ + + +V LT + ++ G++
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPV--YLTELHIKTLLYNLLVGVK 170
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP--- 281
Y+H + +HRD+K +N L++Q +V DFGL+R ++ + D
Sbjct: 171 YVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 282 --------------EYISTR------------NFTKKSDVYSFGVLLFELI 306
++ TR N+T+ DV+S G + EL+
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 48/217 (22%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
+G GA+G V A TG VAVK L+ + FQ+ E+ LL + H N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 170 LVNL--VGYCAEKGQHM----LVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDV 219
++ L V A + LV M + L D++ L + +
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-------- 141
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTF 276
RGL+Y+H + IHRD+K SN+ +++ ++ DFGL+R +EM A T
Sbjct: 142 LRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-----TR 193
Query: 277 GYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
Y PE + + ++ + D++S G ++ EL+ GR L
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TL 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 44/202 (21%), Positives = 75/202 (37%), Gaps = 40/202 (19%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVG-Y 176
+G G G V + T E A+K+L + + EV L R ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKML---QDC--PKARREVELHWRASQCPHIVRIVDVY 80
Query: 177 CAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVP 232
+ + M G L S + D T I + ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 137
Query: 233 PVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
+ HRD+K N+L + ++ DFG ++E + +
Sbjct: 138 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---------------------TTGEKY 175
Query: 290 TKKSDVYSFGVLLFELIAGRSP 311
K D++S GV+++ L+ G P
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPP 197
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHR------ 168
LIG+G+FG V KA E VA+K++ Q Q EV LL ++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKY 116
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
+V+L + + LV+ +S +L L + N+ ++ NL A + L +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 229 GAVPPVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
+ +IH D+K NILL R+ ++ DFG S + + I+ F Y PE +
Sbjct: 176 PELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-QRIYQYIQSRF-YRSPEVLLG 232
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ D++S G +L E+ G G
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSG 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 52/257 (20%), Positives = 84/257 (32%), Gaps = 68/257 (26%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLL-----------GRLHH 167
+G G F V+ + + + VA+KV+ + E E+ LL R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 168 RNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
L++ G H+ +V+ + L + NY L I V +GL+YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 227 HDGAVPPVIHRDIKSSNILL---------------------------------------- 246
H +IH DIK NILL
Sbjct: 163 HTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 247 ---------DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
+ ++ ++AD G + V KH T Y E + + +D++S
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278
Query: 298 FGVLLFELIAGRSPLQG 314
+ FEL G +
Sbjct: 279 TACMAFELATGDYLFEP 295
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 2e-13
Identities = 36/266 (13%), Positives = 73/266 (27%), Gaps = 73/266 (27%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK--------QGE 152
+P + +K IG+G FG V++ + VA+K++A + +
Sbjct: 17 LPTEKLQRCEK--------IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 153 KEFQTEVMLLGRLH---------HRNLVNLVGYCAEKG---------------------- 181
+E E+++ L + L +G
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 182 --------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
Q +V F G L + I + L
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLR 182
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
HRD+ N+LL ++ ++ + + + G +S ++T
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI--------PSCGL----QVSIIDYTLSR 230
Query: 294 DVYSFGVLLFELIAGRSPLQGLMEQQ 319
V+ ++ G + Q
Sbjct: 231 LERDGIVVFCDVSMDEDLFTGDGDYQ 256
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 50/232 (21%), Positives = 85/232 (36%), Gaps = 44/232 (18%)
Query: 119 LIGQGAFGPVYKAQMSTGE------TVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
IGQG FG +Y A M++ E VKV +D+ E + + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 173 LVG----------YCAEKGQHMLVYVFM---SKG-SLASHLYDENYGPLTWNLRVHIALD 218
++ Y FM G L +Y+ N + + ++L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL-QKIYEANAKRFSRKTVLQLSLR 160
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV--ADFGLS---REEMVDKH----- 268
+ LEY+H+ +H DIK+SN+LL+ +V D+GL+ E V K
Sbjct: 161 ILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217
Query: 269 AANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
GT E+ S +++ D+ G + + + G P +
Sbjct: 218 KRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 50/230 (21%), Positives = 78/230 (33%), Gaps = 49/230 (21%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRL-----HHRN 169
+G G FG V Q + + AVKV+ K + E +L ++ ++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLEY 225
+V G HM + L LY+ NY +++ + L Y
Sbjct: 98 IVKYHGKFMYYD-HM----CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT------FG-- 277
L + H D+K NILLD + + + T FG
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 278 -YLD---PEYISTR-----------NFTKKSDVYSFGVLLFELIAGRSPL 312
+ I+TR + SD++SFG +L EL G L
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS-LL 258
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 34/217 (15%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG G FG + + + T E VA+K+ S+ Q E++ L + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYYF 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+ +V + SL L+D + + IA+ + +EY+H + I+
Sbjct: 74 GPCGKYNAMVLELLGP-SL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL---IY 128
Query: 237 RDIKSSNILLDQSMRAR-----VADFGLS---REEMVDKH-----AANIRGTFGYLDPEY 283
RD+K N L+ + + DF L+ + KH ++ GT Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----ARY 183
Query: 284 ISTRN-----FTKKSDVYSFGVLLFELIAGRSPLQGL 315
+S +++ D+ + G + + G P QGL
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-12
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG G+FG +Y ++ GE VA+K+ +K Q E + M+ G + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG---IPTIRWC 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
AE +++V + SL L++ + + +A + +EY+H IH
Sbjct: 74 GAEGDYNVMVMELLGP-SL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF---IH 128
Query: 237 RDIKSSNILLDQSMRA---RVADFGLS---REEMVDKH-----AANIRGTFGYLDPEYIS 285
RD+K N L+ + + DFGL+ R+ +H N+ GT Y S
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT-----ARYAS 183
Query: 286 TRNF-----TKKSDVYSFGVLLFELIAGRSPLQGL 315
+++ D+ S G +L G P QGL
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-12
Identities = 49/234 (20%), Positives = 84/234 (35%), Gaps = 43/234 (18%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVA---VKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
IG G FG +Y A + E A VKV ++ E + + + + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 175 -------------GYCAEKGQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVA 220
G KG+ V G L + +N G + + + + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-QKISGQN-GTFKKSTVLQLGIRML 161
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV--ADFGLS---REEMVDKH-----AA 270
LEY+H+ +H DIK++N+LL +V AD+GLS K
Sbjct: 162 DVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218
Query: 271 NIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
GT E+ S +++SDV G + + G+ P + ++
Sbjct: 219 GHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG G+FG +Y + T E VA+K+ +K Q E + +L G + N+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG---IPNVRWF 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
E ++LV + SL L++ L+ + +A + +E++H + +H
Sbjct: 72 GVEGDYNVLVMDLLGP-SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF---LH 126
Query: 237 RDIKSSNILLDQSMRAR---VADFGLS---REEMVDKH-----AANIRGTFGYLDPEYIS 285
RDIK N L+ RA + DFGL+ R+ +H N+ GT Y S
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT-----ARYAS 181
Query: 286 TRN-----FTKKSDVYSFGVLLFELIAGRSPLQGL 315
+++ D+ S G +L + G P QGL
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 48/226 (21%), Positives = 88/226 (38%), Gaps = 40/226 (17%)
Query: 119 LIGQGAFGPVYKA--QMSTGETVAVKVL-ATDS--KQGEKEFQTEVMLLGRLHHR----- 168
+G+G FG V + VA+K++ + + E+ +L ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 169 -NLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
V + + G HM + + + K + L + N+ P H+A + L +L
Sbjct: 82 FLCVLMSDWFNFHG-HMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLD-- 280
H+ + H D+K NIL S + + S EE K+ + IR G+ +
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS-IRVADFGSATFDHEH 195
Query: 281 -PEYISTR-----------NFTKKSDVYSFGVLLFELIAGRSPLQG 314
++TR + + DV+S G +LFE G + Q
Sbjct: 196 HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 38/231 (16%), Positives = 82/231 (35%), Gaps = 44/231 (19%)
Query: 120 IGQGAFGPVYKAQ---------MSTGETVAVKVLATDSK----------QGEKEFQTEVM 160
+ G +Y+A + ++K+ A D + + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 161 LLGRLHHRNLVNLVGYCAEKGQH-MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
L + +G+ + ++ LV + + SL S L L+ + +A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV--ADFGLSRE--------EMVDKHA 269
LE+LH+ +H ++ + NI +D +++V A +G + V+
Sbjct: 169 LDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225
Query: 270 ANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
+ G E+IS +++SD+ S G + + + G P
Sbjct: 226 SPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG+G+FG +++ + + VA+K S Q E++T +L G + N+ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVYYF 74
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
E ++LV + SL L D + A + ++ +H+ ++ ++
Sbjct: 75 GQEGLHNVLVIDLLGP-SL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL---VY 129
Query: 237 RDIKSSNILLDQSMRAR-----VADFGLS---REEMVDKH-----AANIRGTFGYLDPEY 283
RDIK N L+ + V DFG+ R+ + +H N+ GT Y
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----ARY 184
Query: 284 ISTRN-----FTKKSDVYSFGVLLFELIAGRSPLQGL 315
+S +++ D+ + G + + G P QGL
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 54/233 (23%)
Query: 119 LIGQGAFGPVYKAQ--MSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHR---NL 170
+G+GAFG V + + G VAVK++ + ++E+ +L L+ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 171 VNLVGYCAEKGQHMLVYVFMSKG-------SLASHLYD----ENYGPLTWNLRVHIALDV 219
V ML + F G L YD + P + +A +
Sbjct: 77 FRCV--------QMLEW-FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GT 275
+ + +LH + H D+K NIL QS + + R+E + I+ G+
Sbjct: 128 CKSVNFLHSNKL---THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD-IKVVDFGS 183
Query: 276 FGYLD---PEYISTR-----------NFTKKSDVYSFGVLLFELIAGRSPLQG 314
Y D +STR +++ DV+S G +L E G +
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 319 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.17 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.8 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.51 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.15 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.52 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.32 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 97.18 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.07 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.06 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.11 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 95.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.64 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.05 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 94.38 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.46 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 91.69 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 91.47 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 91.34 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.04 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.52 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.74 | |
| 2llm_A | 43 | Amyloid beta A4 protein; alzheimer'S disease, prot | 84.92 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=384.70 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=176.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.++++++|||||++++++.+.+..|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 588899999999999999954 57999999999754 333456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+++|+|.+++.......+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999999997766667899999999999999999999999 9999999999999999999999999998654332 2
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+.
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 230 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 3456799999999999999999999999999999999999999988654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=382.95 Aligned_cols=209 Identities=30% Similarity=0.524 Sum_probs=180.7
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEee
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 179 (319)
.++..+++++.+.||+|+||+||+|.+ .+++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 344456778899999999999999976 24678999999754 33446789999999999999999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEE
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL 245 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 245 (319)
.+..++||||+++|+|.+++.... ...++|.++..++.||+.||+|||+++ |+||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceE
Confidence 999999999999999999996432 245899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 246 LDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 246 l~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
+++++.+||+|||+++...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.+
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998543322 2345679999999999999999999999999999999999 89999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=381.63 Aligned_cols=205 Identities=32% Similarity=0.554 Sum_probs=179.1
Q ss_pred HHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
+..+.+.+.||+|+||+||+|.+. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 345678899999999999999753 47789999998766666788999999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceE
Q 020946 185 LVYVFMSKGSLASHLYDE-----------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 253 (319)
+||||+++|+|.+++... ....++|.++..++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999653 2346999999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 254 VADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 254 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
|+|||+|+...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999997543322 2233568999999999999999999999999999999999 99999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=382.68 Aligned_cols=203 Identities=33% Similarity=0.561 Sum_probs=174.0
Q ss_pred HhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
..+.+.+.||+|+||+||+|.+. ++..||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45577889999999999999753 478899999987766667889999999999999999999999999999999
Q ss_pred EEEEccCCChhhhhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 186 VYVFMSKGSLASHLYDEN-------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
||||+++|+|.+++.... ..+++|.+++.++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996532 246999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 253 RVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||+|||+++...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 999999998543322 2234679999999999999999999999999999999999 9999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=380.44 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=180.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 3577888999999999999965 579999999997665555677899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 99999998854 35999999999999999999999999 999999999999999999999999999864333 344
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 275 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 567899999999999999999999999999999999999999988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=376.42 Aligned_cols=200 Identities=26% Similarity=0.474 Sum_probs=179.8
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|+||+||+|. ..+|+.||+|++... .....+.+.+|+++++.++|||||++++++.+.+..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999995 468999999998643 23345678999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc--
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-- 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-- 266 (319)
|+++|+|.+++... +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 113 y~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 113 YAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999654 46999999999999999999999999 999999999999999999999999999754322
Q ss_pred -ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 234567899999999999999999999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-54 Score=372.13 Aligned_cols=200 Identities=32% Similarity=0.550 Sum_probs=169.4
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
...+.+.+.||+|+||+||+|.+. ..||||+++.. .....+.|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 345578899999999999999874 36999998754 33445689999999999999999999998865 56899999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc--
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-- 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-- 266 (319)
|+++|+|.+++... ...+++.++..|+.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999999654 356999999999999999999999988 999999999999999999999999999754322
Q ss_pred -ccccccccccCccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 -KHAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 23345689999999999853 4689999999999999999999999988654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=382.01 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=181.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|+||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 3477889999999999999954 579999999997766666677899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 231 ~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 231 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred CCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 99999998854 35999999999999999999999999 999999999999999999999999999754333 344
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 567899999999999999999999999999999999999999988654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=363.55 Aligned_cols=198 Identities=28% Similarity=0.467 Sum_probs=171.3
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEee----CCeEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLV 186 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 186 (319)
+++.+.||+|+||+||+|.. .++..||+|++... .....+.|.+|+.++++++|||||+++++|.+ .+..++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35677899999999999954 57899999998653 33345679999999999999999999999865 3468999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEeecCCCccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMV 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~ 265 (319)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 9999999999999654 46999999999999999999999976 5699999999999998 47899999999997532
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+..
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 334456789999999999865 69999999999999999999999998654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=363.15 Aligned_cols=200 Identities=25% Similarity=0.436 Sum_probs=164.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
++|++.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4688999999999999999964 57999999998654 2233567899999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+ +|+|.+++... +.+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 68999988653 46999999999999999999999999 9999999999999999999999999998665555
Q ss_pred cccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...+.+||+.|+|||++.+..| +.++|||||||++|||+||+.||.+.+.
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~ 217 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 217 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 5567889999999999998876 5799999999999999999999987653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=371.42 Aligned_cols=201 Identities=31% Similarity=0.490 Sum_probs=172.3
Q ss_pred HhcccccccccCCCceEEEEEe----CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
..|++.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3588999999999999999954 257899999986542 2334568899999999999999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
||||+++|+|.+++... +.+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999654 46999999999999999999999999 99999999999999999999999999975433
Q ss_pred -cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 -DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 231 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence 3344567899999999999999999999999999999999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=369.12 Aligned_cols=196 Identities=25% Similarity=0.337 Sum_probs=171.3
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.|.+.+.||+|+||+||+|.. .+|+.||||+++.... ..+|+.+++.++|||||++++++.+.+..|+||||++
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 466778899999999999964 5799999999965422 2469999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCccccccc---
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDK--- 267 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~--- 267 (319)
+|+|.+++... +.+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+|+......
T Consensus 134 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 134 GGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999654 46999999999999999999999998 99999999999999887 69999999997543321
Q ss_pred ---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 268 ---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 268 ---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 123457999999999999999999999999999999999999999886653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=356.26 Aligned_cols=198 Identities=28% Similarity=0.406 Sum_probs=162.2
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC----eEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 188 (319)
++.+.+.||+|+||+||+|.+ +|+.||||++...... ...++.|+..+.+++|||||+++++|.+.+ ..++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 567789999999999999988 6899999998653221 223345677778899999999999998754 5799999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA-----VPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|+++|+|.+++... .++|+.+.+++.|++.||+|||++. .++|+||||||+|||++.++++||+|||+++..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999653 5899999999999999999999871 234999999999999999999999999999754
Q ss_pred cccc-----cccccccccCccCccccCCC------CCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 264 MVDK-----HAANIRGTFGYLDPEYISTR------NFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 264 ~~~~-----~~~~~~~t~~y~aPE~~~~~------~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.... ......||+.|||||++.+. .++.++|||||||+||||+||+.||...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 3322 12245799999999999754 3678999999999999999998776543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=365.24 Aligned_cols=208 Identities=34% Similarity=0.563 Sum_probs=178.4
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCC-CCcceeeeEEe
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHH-RNLVNLVGYCA 178 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~ 178 (319)
+|+....|.+.+.||+|+||+||+|.+. .++.||||.+.... ....+.|.+|+.+|.+++| ||||+++|+|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 4556678899999999999999999653 23589999997653 3345679999999999965 89999999997
Q ss_pred eC-CeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 179 EK-GQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 179 ~~-~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
+. +..++||||+++|+|.++++... ...+++.++..++.||+.||+|||+++ |+||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccc
Confidence 64 56899999999999999996532 245899999999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||+++++.+||+|||+|+...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+...
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998543322 2335678999999999999999999999999999999998 9999998653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=347.15 Aligned_cols=197 Identities=27% Similarity=0.438 Sum_probs=160.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC---------
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--------- 181 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------- 181 (319)
.|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 478889999999999999964 579999999986543 334567899999999999999999999987654
Q ss_pred ---eEEEEEEEccCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeec
Q 020946 182 ---QHMLVYVFMSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF 257 (319)
Q Consensus 182 ---~~~lv~e~~~~g~l~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 257 (319)
..|++|||+++|+|.+++..... ...++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999965322 23456778899999999999999999 999999999999999999999999
Q ss_pred CCCccccccc-------------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 258 GLSREEMVDK-------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 258 g~~~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
|+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.+.
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 9997543221 1234579999999999999999999999999999999996 88754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=353.06 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=172.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEee------CCe
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE------KGQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 182 (319)
.+|.+.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 3688899999999999999954 589999999996542 3335678899999999999999999998764 367
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.|+||||++ |+|.+++.. .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 789988854 457999999999999999999999999 99999999999999999999999999975
Q ss_pred ccc-----cccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMV-----DKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~-----~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... .....+.+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.++
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 322 2234467899999999998765 569999999999999999999999998654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=364.48 Aligned_cols=202 Identities=27% Similarity=0.441 Sum_probs=183.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..+++|||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 4688999999999999999954 589999999997766666678899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC--CceEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS--MRARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~~~ 268 (319)
++|+|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 237 ~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 237 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred CCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 999999998543 356999999999999999999999999 9999999999999854 8999999999987665555
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 6677899999999999999999999999999999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=361.97 Aligned_cols=200 Identities=29% Similarity=0.448 Sum_probs=171.9
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHH---HHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQ---TEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
..|.+.+.||+|+||+||+|.. .+|+.||+|++.... ......+. .++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 3477789999999999999954 579999999986431 12222333 3466777889999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+||||+++|+|..++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++.+|++||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999654 46999999999999999999999999 9999999999999999999999999997543
Q ss_pred ccccccccccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 VDKHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
. ....+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+.+.
T Consensus 344 ~-~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 344 K-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp S-CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred C-CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 3 3345678999999999996 46799999999999999999999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=340.05 Aligned_cols=195 Identities=25% Similarity=0.399 Sum_probs=167.4
Q ss_pred HhcccccccccCCCceEEEEEe----CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 186 (319)
..|++.+.||+|+||+||+|.. .+++.||+|.+.... ...++.+|+++|..+ +||||+++++++.+.+..|+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 5689999999999999999953 256789999886542 345688999999988 699999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-CceEEeecCCCccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMV 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~ 265 (319)
|||+++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 99 mE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 99 MPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999882 4899999999999999999999999 9999999999999876 7999999999964221
Q ss_pred c-----------------------------ccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 266 D-----------------------------KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 266 ~-----------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
. ....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1 112345799999999999765 5899999999999999999999999654
Q ss_pred c
Q 020946 316 M 316 (319)
Q Consensus 316 ~ 316 (319)
+
T Consensus 251 ~ 251 (361)
T 4f9c_A 251 S 251 (361)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=316.81 Aligned_cols=201 Identities=28% Similarity=0.454 Sum_probs=178.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|++.+.||+|+||+||+|.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 4678889999999999999965 47899999998653 2234567889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-cc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VD 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-~~ 266 (319)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++... ..
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999988654 45899999999999999999999998 9999999999999999999999999997532 23
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 344567899999999999999999999999999999999999999987643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=317.96 Aligned_cols=200 Identities=28% Similarity=0.469 Sum_probs=178.9
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.|.+.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 578889999999999999965 68999999998654 333456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.........
T Consensus 96 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 96 ASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp CTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 9999999999654 45999999999999999999999998 999999999999999999999999999765555555
Q ss_pred cccccccCccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....||+.|+|||++.+..++ .++|||||||++|||++|+.||.+.+.
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 667899999999999887775 799999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=317.69 Aligned_cols=201 Identities=26% Similarity=0.409 Sum_probs=179.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 4688899999999999999965 4789999999875422 13567899999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC----ceEEeecCCC
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFGLS 260 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~~ 260 (319)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++ .+||+|||++
T Consensus 92 lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999954 356999999999999999999999998 99999999999998776 7999999999
Q ss_pred ccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~ 223 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 765544445567799999999999999999999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=310.03 Aligned_cols=199 Identities=26% Similarity=0.444 Sum_probs=178.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+|.+.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 4688889999999999999964 678999999987665556778899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
++++|.+++... .+++.++..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ...
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 999999999653 4899999999999999999999998 999999999999999999999999998754332 233
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....||+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 45679999999999999999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.06 Aligned_cols=205 Identities=29% Similarity=0.474 Sum_probs=173.4
Q ss_pred HHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCe
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 182 (319)
.+.-..|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 34456788899999999999999965 47899999998653 223345678899999988 79999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+++|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999999654 45999999999999999999999998 99999999999999999999999999975
Q ss_pred cc-ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EM-VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 33 23344567899999999999988999999999999999999999999988654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=320.31 Aligned_cols=199 Identities=25% Similarity=0.462 Sum_probs=174.9
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 186 (319)
..|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 4678889999999999999965 467899999987542 22345678899999877 899999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc-cc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE-MV 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~-~~ 265 (319)
|||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.. ..
T Consensus 132 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999998654 45999999999999999999999999 999999999999999999999999999753 23
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 34455678999999999999999999999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=307.13 Aligned_cols=202 Identities=29% Similarity=0.506 Sum_probs=178.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|.+.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4678889999999999999965 578999999987666666788999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc-
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA- 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 269 (319)
++++|.+++... ...+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999653 356999999999999999999999999 999999999999999999999999998643222111
Q ss_pred --------------cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 --------------ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 --------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....||+.|+|||++.+..++.++||||||+++|||++|..||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 145689999999999999999999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=317.48 Aligned_cols=200 Identities=26% Similarity=0.404 Sum_probs=177.5
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5688899999999999999954 46889999998643 2233567889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+.+|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 95 e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999854 356999999999999999999999999 9999999999999999999999999998655555
Q ss_pred cccccccccCccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+..
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 5567789999999999863 458999999999999999999999997543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=308.51 Aligned_cols=208 Identities=26% Similarity=0.406 Sum_probs=182.2
Q ss_pred CcCHHHHHHHh------------cccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCC
Q 020946 103 EYSYKDLQKAT------------CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN 169 (319)
Q Consensus 103 ~~~~~~l~~~~------------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n 169 (319)
.++++++..+. +...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 35666665544 455678999999999999765 79999999998766666778999999999999999
Q ss_pred cceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC
Q 020946 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 170 iv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 249 (319)
|+++++++...+..+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 99999999999999999999999999998843 45999999999999999999999998 9999999999999999
Q ss_pred CceEEeecCCCcccccc-ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 250 MRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 250 ~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+.+||+|||++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999998754332 22345679999999999999999999999999999999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=309.50 Aligned_cols=203 Identities=26% Similarity=0.411 Sum_probs=180.0
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
....|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 346789999999999999999965 4789999999865422 235779999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC----ceEEeecC
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFG 258 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 258 (319)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++ .+||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999954 356999999999999999999999998 99999999999999887 89999999
Q ss_pred CCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 259 LSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 259 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
++.............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 99765444445566799999999999999999999999999999999999999987653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=309.43 Aligned_cols=203 Identities=42% Similarity=0.786 Sum_probs=179.1
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
..|++.+.||+|+||.||+|...+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 35677889999999999999988899999999877666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc---
Q 020946 192 KGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--- 266 (319)
Q Consensus 192 ~g~l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~--- 266 (319)
+++|.+++.... ...+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999986543 235899999999999999999999998 999999999999999999999999998743221
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 122345689999999999888999999999999999999999999986543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=314.36 Aligned_cols=204 Identities=25% Similarity=0.436 Sum_probs=179.7
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
.....|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3467899999999999999999965 478999999987542 3334678899999999999999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC---CceEEeecCCCcc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLSRE 262 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~~~ 262 (319)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 106 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999988543 46899999999999999999999998 9999999999999865 4599999999976
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 5544444567799999999999999999999999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=310.08 Aligned_cols=199 Identities=28% Similarity=0.465 Sum_probs=176.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 4578889999999999999965 478999999986531 233567789999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++... .
T Consensus 86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~--~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP--D 158 (318)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS--S
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC--C
Confidence 999999999999653 46899999999999999999999998 9999999999999999999999999997532 2
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 208 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 33456799999999999999999999999999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=325.15 Aligned_cols=202 Identities=24% Similarity=0.361 Sum_probs=175.1
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|..++..++||||++++++|.+.+..++||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 56788899999999999999664 57899999986421 122334889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 154 Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred ecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999652 356999999999999999999999998 9999999999999999999999999997543322
Q ss_pred --cccccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 --HAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 --~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 223467999999999986 56789999999999999999999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=313.26 Aligned_cols=202 Identities=29% Similarity=0.512 Sum_probs=177.3
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 185 (319)
...|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 35678889999999999999965 478899999986532 23345677888888876 89999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 96 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999653 35999999999999999999999998 99999999999999999999999999975332
Q ss_pred -cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 -DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 2334567899999999999999999999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=323.07 Aligned_cols=200 Identities=25% Similarity=0.391 Sum_probs=174.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||+||+|.. .+++.||+|++... .....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 4677889999999999999965 46889999998642 1222345789999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 149 E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999999988543 5899999999999999999999998 9999999999999999999999999997543322
Q ss_pred --cccccccccCccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 --HAANIRGTFGYLDPEYISTRN----FTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 --~~~~~~~t~~y~aPE~~~~~~----~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 234678999999999997655 78999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=309.98 Aligned_cols=201 Identities=20% Similarity=0.324 Sum_probs=178.3
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+|.+.+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 4678899999999999999965 468899999986543 33567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC--CCceEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--SMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~ 268 (319)
++++|.+++... ...+++.++..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||++........
T Consensus 84 ~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 84 SGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 999999998543 346999999999999999999999998 999999999999987 78999999999976554444
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 5566799999999999988899999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=315.57 Aligned_cols=208 Identities=31% Similarity=0.566 Sum_probs=178.2
Q ss_pred HHHHHhcccccccccCCCceEEEEEe--------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 177 (319)
++....|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++.+ +||||++++++|
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34456788999999999999999964 235579999997653 33456789999999999 899999999999
Q ss_pred eeCCeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCC
Q 020946 178 AEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243 (319)
Q Consensus 178 ~~~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 243 (319)
.+.+..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999997543 235899999999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 244 ILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 244 ill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+...+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999987433221 2233457889999999999999999999999999999999 99999886543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=310.43 Aligned_cols=198 Identities=26% Similarity=0.470 Sum_probs=175.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 186 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|..++..+ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4578889999999999999965 468899999987542 23345678899999887 899999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-c
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-V 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-~ 265 (319)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++... .
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999998654 35999999999999999999999998 9999999999999999999999999997532 2
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 3344567899999999999999999999999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=310.57 Aligned_cols=200 Identities=25% Similarity=0.427 Sum_probs=176.7
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3678889999999999999964 68899999998643 1223457889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+ +|+|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 78999888654 45999999999999999999999998 9999999999999999999999999998655555
Q ss_pred cccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+||+.|+|||++.+..+ ++++||||||+++|+|++|+.||.+...
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 5566789999999999988776 6899999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=305.74 Aligned_cols=202 Identities=26% Similarity=0.480 Sum_probs=173.2
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..+|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45788999999999999999964 578999999985442 23346788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999654 46999999999999999999999998 999999999999999999999999998754322
Q ss_pred c--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 K--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2 22345689999999999999999999999999999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=313.50 Aligned_cols=202 Identities=30% Similarity=0.482 Sum_probs=177.7
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 185 (319)
...|++.+.||+|+||.||+|... +++.||+|++... .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 356788899999999999999664 5789999998653 223356678899999988 79999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM- 264 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~- 264 (319)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999654 35999999999999999999999998 9999999999999999999999999997532
Q ss_pred ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 22344567899999999999999999999999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=327.64 Aligned_cols=202 Identities=32% Similarity=0.490 Sum_probs=180.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4577788999999999999965 47999999998643 2233556889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++.......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999997655556999999999999999999999998 9999999999999999999999999997654444
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 4456689999999999999899999999999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=314.48 Aligned_cols=201 Identities=25% Similarity=0.408 Sum_probs=179.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 4688999999999999999955 478999999997665555668899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC--CCceEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--SMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~ 268 (319)
++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 131 ~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 131 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999999988543 346899999999999999999999998 999999999999974 46899999999976544444
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 455679999999999999999999999999999999999999998765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.12 Aligned_cols=202 Identities=27% Similarity=0.435 Sum_probs=173.1
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.+|.+.+.||+|+||+||+|...+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 4688899999999999999988889999999986542 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
++ ++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 101 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 101 ME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp CS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 97 4788877543 356999999999999999999999998 999999999999999999999999999754322 23
Q ss_pred ccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
.....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+++
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 344568999999999876 56899999999999999999999999887654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=307.27 Aligned_cols=206 Identities=36% Similarity=0.584 Sum_probs=170.6
Q ss_pred HHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
....|++.+.||+|+||+||+|.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 345788899999999999999977 68899999987553 333467889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 188 VFMSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
||+++++|.+++..... ..+++..+..++.|++.||+|||+++ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999964321 23899999999999999999999876 45999999999999999999999999998743332
Q ss_pred -ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 223456789999999999999999999999999999999999999988654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=310.33 Aligned_cols=199 Identities=26% Similarity=0.389 Sum_probs=177.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4678889999999999999965 478999999986432 233567889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC--
Confidence 999999999999654 35999999999999999999999999 99999999999999999999999999975432
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 23456799999999999999999999999999999999999999987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=313.88 Aligned_cols=201 Identities=29% Similarity=0.448 Sum_probs=168.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHH-HhccCCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVML-LGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 4678899999999999999965 468899999986542 2223455666666 5778999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc-c
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-V 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~-~ 265 (319)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++... .
T Consensus 118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999998654 45899999999999999999999999 9999999999999999999999999997532 2
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 3345567899999999999999999999999999999999999999987653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=319.24 Aligned_cols=203 Identities=25% Similarity=0.369 Sum_probs=175.8
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
...|++.+.||+|+||+||++.. .+|+.||+|++.... ....+.+.+|..++..++||||+++++++.+.+..++|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 35677889999999999999965 479999999986431 22234578899999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 140 mE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999996532 36999999999999999999999998 999999999999999999999999999754333
Q ss_pred cc--ccccccccCccCccccC-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KH--AANIRGTFGYLDPEYIS-------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~--~~~~~~t~~y~aPE~~~-------~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.. ....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 22 23467999999999986 45789999999999999999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=307.70 Aligned_cols=202 Identities=25% Similarity=0.483 Sum_probs=168.9
Q ss_pred HHhcccccccccCCCceEEEEEe----CCCcEEEEEEeccCC----cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
...|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999965 578999999987542 2234567889999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999998654 35899999999999999999999998 99999999999999999999999999875
Q ss_pred cccc-ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 3322 233456799999999999999999999999999999999999999987653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=307.48 Aligned_cols=205 Identities=25% Similarity=0.419 Sum_probs=177.5
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
+....|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467899999999999999999954 57899999998532 12246778999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc---eEEeec
Q 020946 183 HMLVYVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADF 257 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Df 257 (319)
.++||||+++++|.+.+... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998877543 2345899999999999999999999998 999999999999986654 999999
Q ss_pred CCCccccccc-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 258 GLSREEMVDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 258 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 9987543322 2345679999999999999999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=312.95 Aligned_cols=197 Identities=28% Similarity=0.454 Sum_probs=171.0
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999964 57899999999876656677899999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE--cCCCceEEeecCCCccccccccccccc
Q 020946 196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL--DQSMRARVADFGLSREEMVDKHAANIR 273 (319)
Q Consensus 196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 273 (319)
.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++............
T Consensus 174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 249 (373)
T 2x4f_A 174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249 (373)
T ss_dssp HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence 9988653 245899999999999999999999998 9999999999999 567899999999998655444445567
Q ss_pred cccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 274 ~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999988999999999999999999999999987653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=312.97 Aligned_cols=201 Identities=21% Similarity=0.266 Sum_probs=172.7
Q ss_pred HHHHhcccccccccCCCceEEEE------EeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCCcceeeeEEee
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAE 179 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~------~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 179 (319)
+...+|.+.+.||+|+||+||+| ...+++.||+|++... ...++..|..++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 34567888899999999999999 3457889999998654 3456777777777776 9999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC--------
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDE---NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-------- 248 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-------- 248 (319)
.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999642 3456999999999999999999999998 999999999999998
Q ss_pred ---CCceEEeecCCCcccc---ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 249 ---SMRARVADFGLSREEM---VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 249 ---~~~~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
++.+||+|||+++... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999996432 223344567999999999999999999999999999999999999999654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=318.02 Aligned_cols=203 Identities=25% Similarity=0.418 Sum_probs=176.7
Q ss_pred HHHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
....|.+.+.||+|+||.||+|. ..+|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45689999999999999999995 4588999999987543 23356789999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc---CCCceEEeecCCCccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREE 263 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~ 263 (319)
|||+++|+|.+.+... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ +++.+||+|||++...
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999998654 45999999999999999999999998 99999999999998 4678999999999754
Q ss_pred cccc-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 3322 23456799999999999999999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=303.65 Aligned_cols=207 Identities=28% Similarity=0.412 Sum_probs=174.1
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-----cccHHHHHHHHHHHhcc---CCCCcceeeeEE
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-----KQGEKEFQTEVMLLGRL---HHRNLVNLVGYC 177 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~~~~~~ 177 (319)
.++...+|.+.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 345567899999999999999999964 578999999986422 12234566777777666 499999999999
Q ss_pred eeCC-----eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 178 AEKG-----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 178 ~~~~-----~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
.... ..++++||+. ++|.+++.......+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 8765 5799999996 69999997766556999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
||+|||+++............+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999765555555667899999999999889999999999999999999999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=311.17 Aligned_cols=204 Identities=22% Similarity=0.333 Sum_probs=178.2
Q ss_pred HhcccccccccC--CCceEEEEEeC-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQG--AFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
.+|.+.+.||+| +||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 478899999999 99999999654 79999999987542 33346788899999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++++|.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999997765567999999999999999999999999 999999999999999999999999987532111
Q ss_pred --------ccccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 267 --------KHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 267 --------~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 11223468999999999977 67999999999999999999999999886543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.41 Aligned_cols=202 Identities=27% Similarity=0.426 Sum_probs=175.2
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC--eEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--QHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 187 (319)
.+|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888999999999999999654 68999999987543 334567889999999999999999999988755 789999
Q ss_pred EEccCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE----cCCCceEEeecCCCcc
Q 020946 188 VFMSKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSRE 262 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~~~ 262 (319)
||+++++|.+++.... ...+++.+++.++.|++.||.|||+++ ++||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999996543 234999999999999999999999998 9999999999999 7788899999999976
Q ss_pred ccccccccccccccCccCccccC--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIS--------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...........+|+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 55555555667999999999985 5788999999999999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=306.70 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=172.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|++.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 3578889999999999999965 4789999999865432 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc---
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--- 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~--- 266 (319)
+++++|.+++.. ...+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999843 346999999999999999999999998 999999999999999999999999998643221
Q ss_pred ccccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.+..+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 22335679999999999977665 7899999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=321.36 Aligned_cols=202 Identities=29% Similarity=0.474 Sum_probs=177.3
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4566778899999999999966 479999999986432 233467889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 188 VFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986543 346999999999999999999999998 99999999999999999999999999975433
Q ss_pred ccc-ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 DKH-AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 322 334589999999999999999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=304.84 Aligned_cols=199 Identities=21% Similarity=0.322 Sum_probs=174.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.+++.+ +||||+++++++.+.+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 4678889999999999999964 6889999999865432 34678999999999 999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc-----eEEeecCCCcccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-----ARVADFGLSREEM 264 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~~~~~~ 264 (319)
+ +++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9 99999998654 357999999999999999999999998 999999999999998887 9999999997533
Q ss_pred cccc--------ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 VDKH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 2221 2456799999999999999999999999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=299.05 Aligned_cols=204 Identities=23% Similarity=0.294 Sum_probs=170.1
Q ss_pred CHHHHHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC
Q 020946 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK 180 (319)
Q Consensus 105 ~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 180 (319)
...++....|++.+.||+|+||+||+|... +++.||||++..... .....+..|+..+..+ +||||++++++|.+.
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 345677789999999999999999999664 799999999865422 2233445555555555 899999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred CEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceee
Confidence 9999999999 678988886543 46999999999999999999999998 999999999999999999999999998
Q ss_pred ccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
.............||+.|+|||++.+ .++.++||||||+++|||++|..||.+
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 205 VELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp EECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred eecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 76544444455679999999999876 789999999999999999999777654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=308.16 Aligned_cols=205 Identities=30% Similarity=0.530 Sum_probs=175.3
Q ss_pred HHHHhcccccccccCCCceEEEEEeC----CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
+...+|.+.+.||+|+||.||+|... .+..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44567889999999999999999763 3456999999765 334456789999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++||||+++++|.+++... ...+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 126 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999543 356999999999999999999999998 999999999999999999999999998754
Q ss_pred cccc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 264 MVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 264 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 3221 1223345778999999988899999999999999999999 9999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=302.55 Aligned_cols=202 Identities=26% Similarity=0.444 Sum_probs=162.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 3567788999999999999965 478999999987543 33346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 190 MSKGSLASHLYDEN----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 190 ~~~g~l~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++ ++|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 59988886432 245899999999999999999999998 99999999999999999999999999875432
Q ss_pred c-ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 D-KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
. .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2 22344578999999999876 4689999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=294.57 Aligned_cols=201 Identities=23% Similarity=0.356 Sum_probs=179.3
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
...|.+.+.||+|+||.||+|.. .++..+|+|.+........+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 46789999999999999999965 46779999998766556678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE---cCCCceEEeecCCCcccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999988654 45899999999999999999999999 9999999999999 78899999999998765544
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......+|+.|+|||++.+. ++.++||||||+++|||++|+.||.+..+
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 212 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH
Confidence 455566799999999998654 89999999999999999999999987653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.91 Aligned_cols=200 Identities=27% Similarity=0.432 Sum_probs=164.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+|.+.+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 4688899999999999999965 4789999999875433 2466889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc--eEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--ARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~~~~~~~ 268 (319)
++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.......
T Consensus 99 ~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 99 SGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 999999998654 35999999999999999999999999 999999999999987765 99999999975444444
Q ss_pred ccccccccCccCccccCCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKK-SDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~-~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..+
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 556679999999999988877655 8999999999999999999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=315.47 Aligned_cols=200 Identities=32% Similarity=0.547 Sum_probs=174.5
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-eEEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-QHMLVYVF 189 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 189 (319)
...|.+.+.||+|+||.||+|.. .++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 35567788999999999999988 47899999997643 4578999999999999999999999987765 78999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
+++|+|.+++.......+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.... ..
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc--cc
Confidence 99999999998765556899999999999999999999998 99999999999999999999999999874322 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 23467889999999999999999999999999999998 99999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=320.89 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=167.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 5688889999999999999954 57899999998653 2333456788999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV- 265 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~- 265 (319)
||+++++|.+++... ..+++..+..++.|++.||+|||+ ++ |+||||||+|||++.++.+||+|||+++....
T Consensus 228 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999998654 469999999999999999999998 88 99999999999999999999999999975322
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 2334567899999999999999999999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=301.34 Aligned_cols=203 Identities=26% Similarity=0.409 Sum_probs=180.0
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
....|.+.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 356799999999999999999965 4789999999865422 135679999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC----ceEEeecC
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFG 258 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 258 (319)
.+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999954 346899999999999999999999998 99999999999999887 79999999
Q ss_pred CCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 259 LSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 259 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
++.............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 99765444444556799999999999999999999999999999999999999987653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=307.70 Aligned_cols=200 Identities=26% Similarity=0.418 Sum_probs=161.0
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
...|.+.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 456888999999999999999664 67899999987542 345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCceEEeecCCCcccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSREEMVD 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~ 266 (319)
+++++|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 130 VTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999998543 45899999999999999999999998 999999999999975 889999999998765444
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 444566799999999999999999999999999999999999999976543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=310.51 Aligned_cols=196 Identities=24% Similarity=0.375 Sum_probs=161.2
Q ss_pred hcccc-cccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHh-ccCCCCcceeeeEEee----CCeEEE
Q 020946 113 TCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLG-RLHHRNLVNLVGYCAE----KGQHML 185 (319)
Q Consensus 113 ~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~~~l 185 (319)
.|.+. +.||+|+||+||+|.. .+++.||+|++.. ...+.+|+.++. ..+||||+++++++.. .+..++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 34454 6899999999999955 5789999999853 245677888764 4589999999998875 567899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCceEEeecCCCcc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSRE 262 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~ 262 (319)
||||+++|+|.+++.......+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999997655556999999999999999999999998 999999999999997 78999999999986
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 544444556788999999999999999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=294.94 Aligned_cols=201 Identities=31% Similarity=0.556 Sum_probs=177.4
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
..|.+.+.||+|+||.||+|...+++.||+|++..... ..+++.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 56788899999999999999887889999999975433 35678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--cc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HA 269 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 269 (319)
+++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 89 ~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999653 356899999999999999999999999 9999999999999999999999999987543221 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 33456788999999998899999999999999999999 9999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.87 Aligned_cols=198 Identities=34% Similarity=0.544 Sum_probs=168.9
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC----eEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 187 (319)
.+|++.+.||+|+||+||+|... ++.||+|++..... ....+..|+.++++++||||+++++++.+.. ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 46788899999999999999874 89999999865432 2345567899999999999999999998754 479999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCCeEEcCCCCCCEEEcCCCceEEeec
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG----------AVPPVIHRDIKSSNILLDQSMRARVADF 257 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~i~H~dlk~~Nill~~~~~~kl~Df 257 (319)
||+++|+|.+++... .+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+||
T Consensus 102 e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCC
T ss_pred ecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999653 499999999999999999999998 7 999999999999999999999999
Q ss_pred CCCccccccc---cccccccccCccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 258 GLSREEMVDK---HAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 258 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+..+
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 9996433222 2234578999999999976 3456788999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=298.87 Aligned_cols=200 Identities=28% Similarity=0.446 Sum_probs=170.2
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
+|.+.+.||+|+||+||+|...+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 577889999999999999987889999999986543 223467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
++ +|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ...
T Consensus 83 ~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 83 DQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp SE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred CC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 75 888888543 356999999999999999999999998 999999999999999999999999998643222 223
Q ss_pred cccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.++
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 34568999999999865 4589999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=304.22 Aligned_cols=203 Identities=25% Similarity=0.375 Sum_probs=177.7
Q ss_pred HHHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCc--------ccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
...+|.+.+.||+|+||.||+|. ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45789999999999999999995 45788999999875421 1234577899999999999999999999999
Q ss_pred CeEEEEEEEccCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCC
Q 020946 181 GQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259 (319)
Q Consensus 181 ~~~~lv~e~~~~g-~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 259 (319)
+..+++|||+..| +|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 99988854 346999999999999999999999998 99999999999999999999999999
Q ss_pred CccccccccccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+.............||+.|+|||++.+..+ +.++||||||+++|||++|+.||.+..+
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 235 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH
Confidence 976555445556779999999999988776 7899999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=316.57 Aligned_cols=200 Identities=29% Similarity=0.450 Sum_probs=177.5
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678889999999999999965 479999999986432 223467899999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999853 356999999999999999999999998 9999999999999999999999999997655444
Q ss_pred cccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+..
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 4556789999999999988766 689999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=310.42 Aligned_cols=210 Identities=33% Similarity=0.546 Sum_probs=180.5
Q ss_pred CHHHHHHHhcccccccccCCCceEEEEEe--------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceee
Q 020946 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLV 174 (319)
Q Consensus 105 ~~~~l~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~ 174 (319)
...++...+|.+.+.||+|+||.||+|.. ..+..||+|++.... ......+.+|+.+++.+ +||||++++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 33456667899999999999999999964 233579999997653 33456789999999999 899999999
Q ss_pred eEEeeCCeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCC
Q 020946 175 GYCAEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240 (319)
Q Consensus 175 ~~~~~~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 240 (319)
+++.+.+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+++ ++|||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 218 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 218 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 99999999999999999999999997643 245999999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCCcccccc---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 241 SSNILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 241 ~~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
|+|||+++++.+||+|||+++..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998754322 22334557889999999999999999999999999999999 999998765
Q ss_pred c
Q 020946 317 E 317 (319)
Q Consensus 317 ~ 317 (319)
.
T Consensus 299 ~ 299 (382)
T 3tt0_A 299 V 299 (382)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=296.62 Aligned_cols=199 Identities=29% Similarity=0.448 Sum_probs=167.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc--------------------------ccHHHHHHHHHHHhc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--------------------------QGEKEFQTEVMLLGR 164 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~ 164 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4678889999999999999964 5788999999865421 113568899999999
Q ss_pred cCCCCcceeeeEEee--CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCC
Q 020946 165 LHHRNLVNLVGYCAE--KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS 242 (319)
Q Consensus 165 l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~ 242 (319)
++||||+++++++.+ .+..+++|||+++++|.+++. ...+++.++..++.|++.||+|||+++ ++||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 999999999999986 568999999999999988662 346999999999999999999999998 999999999
Q ss_pred CEEEcCCCceEEeecCCCcccccc-ccccccccccCccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 243 NILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 243 Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
|||++.++.+||+|||+++..... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.+..
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999998754322 2234567999999999997655 3788999999999999999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=297.12 Aligned_cols=203 Identities=26% Similarity=0.434 Sum_probs=172.5
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
...|.+.+.||+|+||.||++.. .++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46789999999999999999965 578899999986543 3446788999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE---cCCCceEEeecCCCccc
Q 020946 189 FMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREE 263 (319)
Q Consensus 189 ~~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~ 263 (319)
|+++++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988542 2356999999999999999999999998 9999999999999 45678999999999765
Q ss_pred cccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..........+|+.|+|||++. ..++.++||||||+++|||++|+.||.+...
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~ 230 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence 4444455667999999999986 5689999999999999999999999987653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.47 Aligned_cols=211 Identities=43% Similarity=0.761 Sum_probs=178.5
Q ss_pred CcCHHHHH--HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCCcceeeeEEee
Q 020946 103 EYSYKDLQ--KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179 (319)
Q Consensus 103 ~~~~~~l~--~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 179 (319)
.+++.++. ...|.+.+.||+|+||.||+|...+++.||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 45555554 456777899999999999999887899999999876532 233478999999999999999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeec
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF 257 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 257 (319)
.+..+++|||+++++|.+++.... ...+++..+..++.|++.||.|||++..++++||||||+|||+++++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999997543 234999999999999999999999982122999999999999999999999999
Q ss_pred CCCcccccc--ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 258 GLSREEMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 258 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
|++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 998754322 22334558999999999988889999999999999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=305.64 Aligned_cols=201 Identities=27% Similarity=0.447 Sum_probs=168.3
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCC----eE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 183 (319)
.+|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5688899999999999999964 6789999999976532 22457889999999999999999999987654 34
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++||||+++++|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 92 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999999999654 46999999999999999999999998 999999999999999999999999998743
Q ss_pred ccc----ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVD----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 322 122335689999999999999999999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.02 Aligned_cols=209 Identities=31% Similarity=0.507 Sum_probs=182.6
Q ss_pred CHHHHHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 105 ~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
...++....|.+.+.||+|+||.||+|.+. ++..||||++.... ...++|.+|+.++++++||||++++++|.+.+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 334556677888999999999999999765 48899999997643 3467899999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++||||+++|+|.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999997766667999999999999999999999998 999999999999999999999999998754
Q ss_pred cccc--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 264 MVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 264 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.... ......++..|+|||++....++.++||||||+++|||++ |+.||.+.+.
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 3221 1223446788999999988889999999999999999999 9999988654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=320.18 Aligned_cols=206 Identities=30% Similarity=0.511 Sum_probs=179.6
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
.++....|.+.+.||+|+||.||+|...++..||||++.... ...+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 345567788899999999999999998888999999997654 34678999999999999999999999986 5678999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++|+|.+++.......+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999997544446899999999999999999999998 999999999999999999999999999754322
Q ss_pred c--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 267 K--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 267 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
. ......+|+.|+|||++....++.++||||||+++|||++ |+.||.+.+.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 1 1223446788999999988899999999999999999999 9999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=312.99 Aligned_cols=205 Identities=29% Similarity=0.487 Sum_probs=176.6
Q ss_pred HHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
+....|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 44567788899999999999999765 78999999987542 23345688999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999999653 245899999999999999999999998 999999999999999999999999998753322
Q ss_pred cc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 267 KH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 267 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.. .....+++.|+|||++....++.++||||||+++|||++ |+.||.+.+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 11 112235778999999988889999999999999999998 9999988654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.41 Aligned_cols=197 Identities=24% Similarity=0.345 Sum_probs=166.1
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------Ce
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 182 (319)
.+|.+.+.||+|+||+||+|. ..+++.||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 467888999999999999995 457899999998654 333456788999999999999999999998654 46
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 142 ~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 7999999975 4666552 24899999999999999999999998 99999999999999999999999999986
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 655445566789999999999999999999999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=295.70 Aligned_cols=204 Identities=27% Similarity=0.487 Sum_probs=178.3
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
+...+|.+.+.||+|+||.||+|...++..||+|++..... ..+++.+|+.++..++||||+++++++.+.+..+++||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 34567889999999999999999888888999999975433 35678999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred ccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999996542 35899999999999999999999998 9999999999999999999999999987443322
Q ss_pred -cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 1223446778999999988889999999999999999999 9999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.70 Aligned_cols=211 Identities=24% Similarity=0.368 Sum_probs=179.7
Q ss_pred cCHHHHHHHhcccc-cccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 020946 104 YSYKDLQKATCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCA 178 (319)
Q Consensus 104 ~~~~~l~~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 178 (319)
|...+.....|.+. +.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++..+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44556667788887 8999999999999965 47899999998754 233467889999999999 4699999999999
Q ss_pred eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCceEEe
Q 020946 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVA 255 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~ 255 (319)
+.+..++||||+++++|.+++.......+++.++..++.|++.||+|||+++ ++||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999999986655567999999999999999999999998 999999999999987 7899999
Q ss_pred ecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 256 DFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 256 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|||+++............+|+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999765444444556799999999999999999999999999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=307.96 Aligned_cols=203 Identities=30% Similarity=0.467 Sum_probs=163.8
Q ss_pred HHHHHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCC--
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKG-- 181 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-- 181 (319)
+....+|.+.+.||+|+||.||+|. ..+|+.||+|++... .......+.+|+.++..+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3445678999999999999999995 457899999998643 3344567789999999997 999999999997544
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..++||||++ ++|..++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 7899999997 689888854 35899999999999999999999999 9999999999999999999999999986
Q ss_pred cccc----------------------cccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 262 EEMV----------------------DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 262 ~~~~----------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4321 112234579999999999976 6789999999999999999999999988653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=327.13 Aligned_cols=203 Identities=30% Similarity=0.482 Sum_probs=177.8
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 184 (319)
....|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 335677889999999999999965 47889999998643 223345678899999987 7999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999654 35999999999999999999999998 9999999999999999999999999997532
Q ss_pred -ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 -VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.........||+.|+|||++.+..|+.++||||||+++|||++|+.||.+.++
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 23345567899999999999999999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.79 Aligned_cols=205 Identities=29% Similarity=0.531 Sum_probs=166.8
Q ss_pred HHHHhcccccccccCCCceEEEEEeC----CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
+....|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34457888899999999999999654 5678999999765 333456799999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++||||+++++|.+++... ...+++.++..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 122 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999999643 346999999999999999999999998 999999999999999999999999998754
Q ss_pred cccc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 264 MVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 264 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 3221 1122335778999999998999999999999999999998 9999987653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=305.68 Aligned_cols=203 Identities=26% Similarity=0.343 Sum_probs=178.0
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----CCCcceeeeEEeeC
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----HRNLVNLVGYCAEK 180 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~ 180 (319)
.++...+|.+.+.||+|+||+||+|.. .+++.||+|++... ....+.+..|+.+++.++ ||||+++++++...
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 344567889999999999999999965 57899999998643 233456778999999886 99999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC------------
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ------------ 248 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~------------ 248 (319)
+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhc
Confidence 9999999999 999999998766667999999999999999999999998 999999999999975
Q ss_pred -------------CCceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 249 -------------SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 249 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
++.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 7899999999987432 2234567899999999999999999999999999999999999999875
Q ss_pred c
Q 020946 316 M 316 (319)
Q Consensus 316 ~ 316 (319)
.
T Consensus 263 ~ 263 (360)
T 3llt_A 263 E 263 (360)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=297.67 Aligned_cols=210 Identities=31% Similarity=0.521 Sum_probs=183.7
Q ss_pred cCHHHHHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 104 ~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
+.-.++....|.+.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4445566778899999999999999999654 58899999987543 335678999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++|||+++++|.+++.......+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999998766677999999999999999999999998 99999999999999999999999999875
Q ss_pred ccccc--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 263 EMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 43222 2233456888999999988899999999999999999999 9999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.99 Aligned_cols=197 Identities=23% Similarity=0.413 Sum_probs=153.3
Q ss_pred Hhcccc---cccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFT---TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~---~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 186 (319)
..|++. +.||+|+||.||+|.. .+++.||+|++.. .....+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 456654 7899999999999965 4789999999853 23467789999999997 99999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC---ceEEeecCCCccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGLSREE 263 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~~ 263 (319)
|||+++++|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+|||++.++ .+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 85 MELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp ECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999654 46999999999999999999999998 99999999999998765 8999999999744
Q ss_pred ccc-ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 322 23345678999999999999999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=297.76 Aligned_cols=200 Identities=26% Similarity=0.406 Sum_probs=168.9
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC-------
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------- 181 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 181 (319)
...|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357888999999999999999664 89999999987543 334577899999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEEccCCChhhhhhhcCC-CCCCHH
Q 020946 182 --------------------------------------------------QHMLVYVFMSKGSLASHLYDENY-GPLTWN 210 (319)
Q Consensus 182 --------------------------------------------------~~~lv~e~~~~g~l~~~l~~~~~-~~l~~~ 210 (319)
..+++|||+++++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999965332 235667
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-------------cccccccccC
Q 020946 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-------------HAANIRGTFG 277 (319)
Q Consensus 211 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~t~~ 277 (319)
.++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++...... ......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999998 9999999999999999999999999987543321 2234569999
Q ss_pred ccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 278 y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999988764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=303.86 Aligned_cols=205 Identities=32% Similarity=0.568 Sum_probs=176.1
Q ss_pred HHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
....|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3467888899999999999999653 34789999997653 3335678999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCC
Q 020946 183 HMLVYVFMSKGSLASHLYDEN----------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 240 (319)
.+++|||+++++|.+++.... ...+++.+++.++.|++.||.|||+++ ++|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 999999999999999996532 156899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCCcccccc---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 241 SSNILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 241 ~~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
|+|||++.++.+||+|||+++..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 99999999999999999998643222 12234567899999999988899999999999999999999 999998765
Q ss_pred c
Q 020946 317 E 317 (319)
Q Consensus 317 ~ 317 (319)
.
T Consensus 282 ~ 282 (343)
T 1luf_A 282 H 282 (343)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=291.01 Aligned_cols=203 Identities=26% Similarity=0.440 Sum_probs=175.5
Q ss_pred HHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
....|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4567899999999999999999664 789999999865421 235789999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC----ceEEeecC
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFG 258 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 258 (319)
.+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .+||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999999653 45899999999999999999999998 99999999999998877 89999999
Q ss_pred CCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 259 LSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 259 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
++.............+++.|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 98755444444456789999999999999999999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=307.49 Aligned_cols=207 Identities=31% Similarity=0.515 Sum_probs=176.4
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
++....|.+.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 344567889999999999999999742 4668999998654 334456788999999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC---ce
Q 020946 181 GQHMLVYVFMSKGSLASHLYDEN-----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RA 252 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~ 252 (319)
+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999997643 245899999999999999999999999 99999999999999554 59
Q ss_pred EEeecCCCcccccc---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 253 RVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 253 kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999998643221 22334567899999999988999999999999999999998 9999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.75 Aligned_cols=203 Identities=29% Similarity=0.478 Sum_probs=176.5
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
-...+|.+.+.||+|+||+||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3457899999999999999999965 47899999998643 23346778999999999999999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc---CCCceEEeecCCCcc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSRE 262 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~ 262 (319)
|+||+++++|.+.+... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 99 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999988654 35999999999999999999999998 99999999999995 456799999999976
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.++
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 555445556679999999999875 599999999999999999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=299.63 Aligned_cols=203 Identities=29% Similarity=0.504 Sum_probs=173.5
Q ss_pred HHHHhcccccccccCCCceEEEEEe-----CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee--CC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KG 181 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~ 181 (319)
+...+|++.+.||+|+||+||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3456788999999999999999973 3688999999987666666789999999999999999999999865 35
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 6899999999999999996543 35899999999999999999999998 9999999999999999999999999987
Q ss_pred cccccc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 262 EEMVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 262 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 543221 122345677899999999899999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=292.46 Aligned_cols=201 Identities=26% Similarity=0.459 Sum_probs=177.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4678889999999999999965 46899999998654 23334678899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc---eEEeecCCCccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMV 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~ 265 (319)
|+++++|.+.+... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++. +||+|||++.....
T Consensus 86 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 86 LVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999888654 45899999999999999999999998 999999999999986655 99999999976554
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
........+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 4444556799999999999999999999999999999999999999977653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=308.40 Aligned_cols=204 Identities=24% Similarity=0.399 Sum_probs=165.3
Q ss_pred HHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--------cccHHHHHHHHHHHhccCCCCcceeeeEEe
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 178 (319)
+.....|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45567899999999999999999954 578999999986431 111235789999999999999999999975
Q ss_pred eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC---CceEEe
Q 020946 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVA 255 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~ 255 (319)
.+..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -cCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 4568999999999999998853 356999999999999999999999998 9999999999999754 459999
Q ss_pred ecCCCccccccccccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 256 DFGLSREEMVDKHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 256 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|||+++............||+.|+|||++. ...++.++||||||+++|+|++|+.||.+...
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 999998655544455678999999999985 36788999999999999999999999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=291.99 Aligned_cols=195 Identities=27% Similarity=0.423 Sum_probs=167.6
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|++.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 578889999999999999965 478999999987543 23346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
+++ ++.+.+.. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++...... ..
T Consensus 83 ~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 83 CDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 975 66665543 2356999999999999999999999998 999999999999999999999999999754322 23
Q ss_pred ccccccccCccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCC
Q 020946 269 AANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPL 312 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltg~~pf 312 (319)
.....+|+.|+|||++.+.. ++.++||||||+++|||++|+.||
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 34557899999999997655 899999999999999999988774
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.31 Aligned_cols=204 Identities=27% Similarity=0.493 Sum_probs=175.7
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
+...+|.+.+.||+|+||.||++...++..||+|++..... ..+++.+|+.++..++||||+++++++.+.+..+++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 33457888999999999999999988888999999975533 35678999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++++|.+++... ...+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 100 YMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred ccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999653 345999999999999999999999998 9999999999999999999999999987543221
Q ss_pred -cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 2223456788999999988899999999999999999998 9999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=299.59 Aligned_cols=208 Identities=29% Similarity=0.538 Sum_probs=178.4
Q ss_pred HHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
++....|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34456788899999999999999964 34578999999754 333456789999999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENY----------------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 238 (319)
+..+++|||+++++|.+++..... ..+++.++..++.|++.||.|||+++ ++|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999975432 34889999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 020946 239 IKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG 314 (319)
Q Consensus 239 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~ 314 (319)
|||+||++++++.+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987443221 2233456788999999988889999999999999999999 9999988
Q ss_pred cccc
Q 020946 315 LMEQ 318 (319)
Q Consensus 315 ~~~~ 318 (319)
...+
T Consensus 256 ~~~~ 259 (314)
T 2ivs_A 256 IPPE 259 (314)
T ss_dssp CCGG
T ss_pred CCHH
Confidence 6643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=298.52 Aligned_cols=208 Identities=31% Similarity=0.534 Sum_probs=179.3
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDSK-QGEKEFQTEVMLLGRL-HHRNLVNLVGYCA 178 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 178 (319)
.++...+|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 345557888999999999999999964 3567899999975532 3456789999999999 8999999999999
Q ss_pred eCCeEEEEEEEccCCChhhhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCC
Q 020946 179 EKGQHMLVYVFMSKGSLASHLYDENY----------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS 242 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~ 242 (319)
+.+..+++|||+++|+|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999975432 24899999999999999999999998 999999999
Q ss_pred CEEEcCCCceEEeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 243 NILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 243 Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||+++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999999875433221 223457889999999988899999999999999999999 9999987653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.76 Aligned_cols=208 Identities=34% Similarity=0.582 Sum_probs=175.9
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCA 178 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 178 (319)
.++...+|.+.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.++..+ +||||+++++++.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 345567889999999999999999963 356789999997643 33356789999999999 7999999999998
Q ss_pred eCC-eEEEEEEEccCCChhhhhhhcCC-----------------------------------------------------
Q 020946 179 EKG-QHMLVYVFMSKGSLASHLYDENY----------------------------------------------------- 204 (319)
Q Consensus 179 ~~~-~~~lv~e~~~~g~l~~~l~~~~~----------------------------------------------------- 204 (319)
+.+ ..+++|||+++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 48999999999999999965432
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc---ccc
Q 020946 205 -----------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAA 270 (319)
Q Consensus 205 -----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~ 270 (319)
..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 12889999999999999999999998 9999999999999999999999999987442221 233
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 4568899999999999999999999999999999998 9999987653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.65 Aligned_cols=204 Identities=29% Similarity=0.415 Sum_probs=170.1
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
..+|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 56799999999999999999955 57889999998543 2344568899999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhc--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020946 185 LVYVFMSKGSLASHLYDE--------------------------------------NYGPLTWNLRVHIALDVARGLEYL 226 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~i~~~l~~L 226 (319)
+||||+++|+|.+++... ....+++..+..++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988420 011235677889999999999999
Q ss_pred HcCCCCCeEEcCCCCCCEEEcCCC--ceEEeecCCCccccccc-----cccccccccCccCccccCC--CCCCcchhhHH
Q 020946 227 HDGAVPPVIHRDIKSSNILLDQSM--RARVADFGLSREEMVDK-----HAANIRGTFGYLDPEYIST--RNFTKKSDVYS 297 (319)
Q Consensus 227 H~~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~s 297 (319)
|+++ ++||||||+|||++.++ .+||+|||++....... ......||+.|+|||++.+ ..++.++||||
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9998 99999999999998776 89999999987432211 2345668999999999865 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCccc
Q 020946 298 FGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 298 lGvil~elltg~~pf~~~~~ 317 (319)
||+++|||++|+.||.+...
T Consensus 262 lG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHHHCCCCCCCCCh
Confidence 99999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=302.81 Aligned_cols=207 Identities=31% Similarity=0.574 Sum_probs=175.3
Q ss_pred HHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 179 (319)
++....|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++.++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34456788999999999999999964 24568999998754 333456789999999999 89999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcC
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDENY---------------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 238 (319)
.+..+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+++ ++|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 9999999999999999999965432 23799999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 020946 239 IKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG 314 (319)
Q Consensus 239 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~ 314 (319)
|||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||.+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999875433221 233457889999999988899999999999999999998 9999988
Q ss_pred ccc
Q 020946 315 LME 317 (319)
Q Consensus 315 ~~~ 317 (319)
...
T Consensus 278 ~~~ 280 (344)
T 1rjb_A 278 IPV 280 (344)
T ss_dssp CCC
T ss_pred CCc
Confidence 653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=316.38 Aligned_cols=205 Identities=32% Similarity=0.513 Sum_probs=174.6
Q ss_pred HHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
++....|.+.+.||+|+||.||+|...++..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 44556788899999999999999998878889999997653 335789999999999999999999999876 6789999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++.......+++.++..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999997544456899999999999999999999998 9999999999999999999999999997543221
Q ss_pred --cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 268 --HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 268 --~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
......++..|+|||++....++.++||||||+++|||++ |+.||.+...
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 1223456788999999988899999999999999999999 9999988654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=312.06 Aligned_cols=202 Identities=29% Similarity=0.453 Sum_probs=173.8
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
....|.+.+.||+|+||+||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356799999999999999999965 478899999987542 33456789999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCceEEeecCCCccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSREE 263 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~ 263 (319)
|||+++|+|.+.+... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++...
T Consensus 115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999988654 45899999999999999999999998 999999999999976 455999999999765
Q ss_pred cccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..........||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 190 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 190 ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp BTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5555555677999999999986 4689999999999999999999999988654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=301.64 Aligned_cols=202 Identities=20% Similarity=0.290 Sum_probs=167.0
Q ss_pred HHHhcccccccccCCCceEEEEEeCC------CcEEEEEEeccCCccc-----------HHHHHHHHHHHhccCCCCcce
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMST------GETVAVKVLATDSKQG-----------EKEFQTEVMLLGRLHHRNLVN 172 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 172 (319)
....|.+.+.||+|+||.||+|.... ++.||+|++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578889999999999999997644 4789999986553211 112344566777889999999
Q ss_pred eeeEEeeC----CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-
Q 020946 173 LVGYCAEK----GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD- 247 (319)
Q Consensus 173 ~~~~~~~~----~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~- 247 (319)
+++++... ...++||||+ +++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99998764 4589999999 99999998653 356999999999999999999999998 99999999999999
Q ss_pred -CCCceEEeecCCCcccccccc--------ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 248 -QSMRARVADFGLSREEMVDKH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 248 -~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 889999999999964332211 123459999999999999999999999999999999999999998643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.48 Aligned_cols=201 Identities=38% Similarity=0.637 Sum_probs=165.2
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCc----ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK----QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 4678889999999999999987 488999999865422 23467889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC--------CCceEEeecCC
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--------SMRARVADFGL 259 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--------~~~~kl~Dfg~ 259 (319)
||+++++|.+++. ...+++..+..++.|++.||.|||+++..+++||||||+||+++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999884 346999999999999999999999988666899999999999986 67899999999
Q ss_pred CccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+...... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 163 AREWHRT-TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred ccccccc-cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8754332 22345789999999999888999999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=291.21 Aligned_cols=212 Identities=40% Similarity=0.697 Sum_probs=182.2
Q ss_pred CCCcCHHHHHHHhcccc--------cccccCCCceEEEEEeCCCcEEEEEEeccC----CcccHHHHHHHHHHHhccCCC
Q 020946 101 IPEYSYKDLQKATCNFT--------TLIGQGAFGPVYKAQMSTGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHR 168 (319)
Q Consensus 101 ~~~~~~~~l~~~~~~~~--------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~ 168 (319)
...|++.++...+.++. +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 45688889988887765 5699999999999987 6889999998643 223356789999999999999
Q ss_pred CcceeeeEEeeCCeEEEEEEEccCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc
Q 020946 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD 247 (319)
Q Consensus 169 niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 247 (319)
||+++++++.+.+..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 9999999999999999999999999999998643 2346999999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 248 QSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 248 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+++.+||+|||++....... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.+..+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 99999999999986433221 1234568999999999865 478999999999999999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=288.87 Aligned_cols=201 Identities=28% Similarity=0.513 Sum_probs=155.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 3578889999999999999965 578999999986432 223467899999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD- 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 266 (319)
||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999998643 356999999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 22334568999999999998899999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.64 Aligned_cols=203 Identities=31% Similarity=0.512 Sum_probs=179.4
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
....+|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4567899999999999999999965 478999999986542 344678899999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE---cCCCceEEeecCCCc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSR 261 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~ 261 (319)
+|+||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 103 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999988543 46999999999999999999999998 9999999999999 567899999999987
Q ss_pred cccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.++
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 5544444556679999999999865 689999999999999999999999988654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=298.23 Aligned_cols=198 Identities=30% Similarity=0.421 Sum_probs=172.5
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
...|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688889999999999999964 6889999999865432 2235788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+. |++.+.+... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99997 6888877543 356999999999999999999999998 99999999999999999999999999875432
Q ss_pred ccccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....||+.|+|||++. ...++.++||||||+++|||++|+.||.+..
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23457899999999983 5678999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=292.60 Aligned_cols=202 Identities=27% Similarity=0.500 Sum_probs=175.6
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
...+|.+.+.||+|+||.||++.. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 356889999999999999999965 4789999999976554455678999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE---cCCCceEEeecCCCccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMV 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~ 265 (319)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||++ ++++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999988654 35899999999999999999999998 9999999999999 7888999999999865332
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......+|+.|+|||++.+..++.++||||||+++|||++|+.||.+.++
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 212 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred -CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 223445689999999999999999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=294.91 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=169.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+|.+.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 3578889999999999999965 4689999998865432 234568899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-c
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-K 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~ 267 (319)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .
T Consensus 83 ~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999999888743 346999999999999999999999998 999999999999999999999999998754322 2
Q ss_pred cccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 2345578999999999865 6789999999999999999999999988654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.25 Aligned_cols=208 Identities=32% Similarity=0.560 Sum_probs=176.7
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe--------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeE
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 176 (319)
.++....|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 345567889999999999999999965 356789999997653 33456788999999999 89999999999
Q ss_pred EeeCCeEEEEEEEccCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCC
Q 020946 177 CAEKGQHMLVYVFMSKGSLASHLYDENY--------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS 242 (319)
Q Consensus 177 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~ 242 (319)
+.+.+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 9999999999999999999999965431 24899999999999999999999998 999999999
Q ss_pred CEEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 243 NILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 243 Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||+++.++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 9999999999999999987443221 2233456788999999988889999999999999999999 9999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.46 Aligned_cols=204 Identities=27% Similarity=0.521 Sum_probs=167.3
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcE----EEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGET----VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
....|++.+.||+|+||+||+|.. .+++. ||+|.+... .....+.+.+|+.++++++||||++++++|.+.+ .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 345688889999999999999964 34443 588887543 3344678999999999999999999999998765 7
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
+++++|+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 7899999999999999764 356999999999999999999999998 999999999999999999999999998743
Q ss_pred cccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 264 MVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 264 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 226 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence 3222 2223456889999999999999999999999999999999 99999886543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=294.71 Aligned_cols=196 Identities=29% Similarity=0.474 Sum_probs=163.8
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhc--cCCCCcceeeeEEee----CCeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR--LHHRNLVNLVGYCAE----KGQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~ 184 (319)
...|.+.+.||+|+||+||+|.. +++.||+|++... ....+..|.+++.. ++||||+++++++.+ ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788899999999999999987 7899999998543 33455556666555 799999999998754 34689
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEEcCCCCCCEEEcCCCceEEee
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH--------DGAVPPVIHRDIKSSNILLDQSMRARVAD 256 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlk~~Nill~~~~~~kl~D 256 (319)
++|||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+ ++||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999943 46999999999999999999999 777 99999999999999999999999
Q ss_pred cCCCcccccccc-----ccccccccCccCccccCCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCCc
Q 020946 257 FGLSREEMVDKH-----AANIRGTFGYLDPEYISTR------NFTKKSDVYSFGVLLFELIAG----------RSPLQGL 315 (319)
Q Consensus 257 fg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~------~~~~~~Dv~slGvil~elltg----------~~pf~~~ 315 (319)
||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999864322211 2234789999999999776 455799999999999999999 8898765
Q ss_pred c
Q 020946 316 M 316 (319)
Q Consensus 316 ~ 316 (319)
.
T Consensus 237 ~ 237 (301)
T 3q4u_A 237 V 237 (301)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=289.85 Aligned_cols=202 Identities=28% Similarity=0.467 Sum_probs=177.7
Q ss_pred HHHHHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee-----
Q 020946 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----- 179 (319)
Q Consensus 106 ~~~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 179 (319)
........|.+.+.||+|+||.||+|... +++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 34566788999999999999999999764 78999999986543 356789999999999999999998854
Q ss_pred -----------CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC
Q 020946 180 -----------KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ 248 (319)
Q Consensus 180 -----------~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~ 248 (319)
....+++|||+++++|.+++.......+++..+..++.|++.||.|||+++ ++|+||||+||++++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVD 157 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcC
Confidence 445899999999999999997665567999999999999999999999998 999999999999999
Q ss_pred CCceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 249 SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 249 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
++.+||+|||++.............+|+.|+|||++.+..++.++||||||+++|||++|..||..
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 999999999998765444444556799999999999988999999999999999999999998753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=291.41 Aligned_cols=201 Identities=34% Similarity=0.683 Sum_probs=170.8
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCccc-------HHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQG-------EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
..+|.+.+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35688899999999999999965 578999999986543221 167889999999999999999999987665
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc-----eEEeec
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-----ARVADF 257 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Df 257 (319)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++++||||||+|||++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6899999999999988654 356999999999999999999999876 45999999999999988776 999999
Q ss_pred CCCccccccccccccccccCccCcccc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 258 GLSREEMVDKHAANIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 258 g~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|+++.... ......+|+.|+|||++ ....++.++||||||+++|||++|+.||.+...
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 99874322 33456789999999998 455678999999999999999999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=294.90 Aligned_cols=200 Identities=27% Similarity=0.463 Sum_probs=169.1
Q ss_pred Hhcccc-cccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 188 (319)
..|.+. +.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 356664 7899999999999964 57899999999766555677889999999885 79999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc---eEEeecCCCccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMV 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~ 265 (319)
|+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++. +||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999654 35899999999999999999999998 999999999999998765 99999999864322
Q ss_pred c--------ccccccccccCccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 D--------KHAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~--------~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
. .......||+.|+|||++.. ..++.++||||||+++|||++|+.||.+..
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 1 11223458999999999864 568899999999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=310.56 Aligned_cols=199 Identities=26% Similarity=0.372 Sum_probs=156.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC-----CeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 183 (319)
.+|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 4688999999999999999954 57899999998653 333456788999999999999999999998443 578
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999997 5788888854 356999999999999999999999998 999999999999999999999999999754
Q ss_pred ccc----------------------------ccccccccccCccCcccc-CCCCCCcchhhHHHHHHHHHHHh-------
Q 020946 264 MVD----------------------------KHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIA------- 307 (319)
Q Consensus 264 ~~~----------------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dv~slGvil~ellt------- 307 (319)
... .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 321 122345689999999986 56779999999999999999999
Q ss_pred ----CCCCCCCcc
Q 020946 308 ----GRSPLQGLM 316 (319)
Q Consensus 308 ----g~~pf~~~~ 316 (319)
|++||++..
T Consensus 287 ~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 287 YHADRGPLFPGSS 299 (458)
T ss_dssp SGGGCCCSCC---
T ss_pred ccccccccCCCCc
Confidence 788887754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=291.99 Aligned_cols=201 Identities=23% Similarity=0.437 Sum_probs=176.4
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..+|.+.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888899999999999999654 6889999998654 223456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999988543 46899999999999999999999998 999999999999999999999999998754322
Q ss_pred -ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 23344568999999999999899999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=298.83 Aligned_cols=201 Identities=23% Similarity=0.436 Sum_probs=176.7
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..+|.+.+.||+|+||.||++.. .+++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45788899999999999999965 46789999998654 223456788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988553 46899999999999999999999998 999999999999999999999999998754322
Q ss_pred -ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+|+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 23344678999999999988889999999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=308.28 Aligned_cols=202 Identities=27% Similarity=0.426 Sum_probs=174.3
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC--eEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--QHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 187 (319)
.+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888999999999999999654 68999999987543 334567889999999999999999999998755 789999
Q ss_pred EEccCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE----cCCCceEEeecCCCcc
Q 020946 188 VFMSKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSRE 262 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~~~ 262 (319)
||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999996533 234999999999999999999999998 9999999999999 7778899999999976
Q ss_pred ccccccccccccccCccCccccCC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST--------RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 555555556679999999999864 567889999999999999999999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=289.96 Aligned_cols=200 Identities=25% Similarity=0.421 Sum_probs=173.1
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeC--CeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 187 (319)
.+|.+.+.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. +..+++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4678889999999999999988 48899999987653 33456789999999999999999999999876 7889999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++.......+++.++..++.|++.||.|||+++ ++++||||||+||+++.++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~---- 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF---- 163 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT----
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee----
Confidence 9999999999997665556999999999999999999999876 55999999999999999999999999886532
Q ss_pred cccccccccCccCccccCCCCCCc---chhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTK---KSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~---~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......+|+.|+|||.+.+..++. ++||||||+++|||++|+.||.+...
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 223456899999999997655444 89999999999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=285.50 Aligned_cols=202 Identities=27% Similarity=0.426 Sum_probs=175.8
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
...|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46788999999999999999965 478999999986542 3345678999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc--
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-- 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-- 266 (319)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999998843 346999999999999999999999998 999999999999999999999999998643221
Q ss_pred -ccccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 -KHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.+...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 22334568999999999987665 7899999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=292.41 Aligned_cols=203 Identities=28% Similarity=0.449 Sum_probs=164.4
Q ss_pred HHHhcccccccccCCCceEEEEEeC----CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
...+|.+.+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4567889999999999999999653 2457999998754 3334567899999999999999999999984 45788
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++|||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999999654 346899999999999999999999998 9999999999999999999999999987543
Q ss_pred ccc--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 265 VDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 265 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
... ......+|+.|+|||++....++.++||||||+++|||++ |+.||.+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 322 1223456788999999988899999999999999999997 9999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=299.07 Aligned_cols=204 Identities=27% Similarity=0.459 Sum_probs=177.5
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc--------ccHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--------QGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 177 (319)
......|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++..+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334567889999999999999999764 799999999865431 1134678899999999 799999999999
Q ss_pred eeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeec
Q 020946 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF 257 (319)
Q Consensus 178 ~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 257 (319)
...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence 9999999999999999999999654 45999999999999999999999998 999999999999999999999999
Q ss_pred CCCccccccccccccccccCccCccccCC------CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 258 GLSREEMVDKHAANIRGTFGYLDPEYIST------RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 258 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
|++.............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 245 G~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 245 GFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 99876554444556789999999999853 358899999999999999999999997754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=302.56 Aligned_cols=199 Identities=22% Similarity=0.382 Sum_probs=168.3
Q ss_pred HHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC---------
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--------- 180 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 180 (319)
..+|.+.+.||+|+||.||+|. ..+|+.||+|++..+... ..+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 3578889999999999999995 468999999998654322 24799999999999999999998543
Q ss_pred -----------------------------CeEEEEEEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 020946 181 -----------------------------GQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDG 229 (319)
Q Consensus 181 -----------------------------~~~~lv~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 229 (319)
...++||||++ ++|.+.+.. .....+++..+..++.|++.||.|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34889999997 587777653 3446799999999999999999999999
Q ss_pred CCCCeEEcCCCCCCEEEc-CCCceEEeecCCCccccccccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHh
Q 020946 230 AVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIA 307 (319)
Q Consensus 230 ~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~ellt 307 (319)
+ |+||||||+|||++ +++.+||+|||+++............+|+.|+|||++.+. .++.++|||||||++|||++
T Consensus 161 g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 G---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp T---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred c---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 8 99999999999998 6889999999999865555555567789999999998764 58999999999999999999
Q ss_pred CCCCCCCccc
Q 020946 308 GRSPLQGLME 317 (319)
Q Consensus 308 g~~pf~~~~~ 317 (319)
|+.||.+.+.
T Consensus 238 g~~pf~~~~~ 247 (383)
T 3eb0_A 238 GKPLFSGETS 247 (383)
T ss_dssp SSCSSCCSSH
T ss_pred CCCCCCCCCh
Confidence 9999988653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=296.79 Aligned_cols=205 Identities=30% Similarity=0.525 Sum_probs=161.7
Q ss_pred HHHhcccccccccCCCceEEEEEeCC-Cc---EEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMST-GE---TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
...+|.+.+.||+|+||.||+|.... +. .||+|++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34578889999999999999996543 32 7999998754 334457889999999999999999999999877655
Q ss_pred ------EEEEEEccCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceE
Q 020946 184 ------MLVYVFMSKGSLASHLYDEN----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253 (319)
Q Consensus 184 ------~lv~e~~~~g~l~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 253 (319)
++++||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999986432 225899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 254 VADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 254 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 99999987543222 1223446788999999999999999999999999999999 9999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.68 Aligned_cols=199 Identities=21% Similarity=0.290 Sum_probs=173.4
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 188 (319)
..+|.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+..+..+ +|+|++++++++.+....++++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45688899999999999999964 688999999986432 234578899999999 79999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc-----eEEeecCCCccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-----ARVADFGLSREE 263 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~~~~~ 263 (319)
|+ +++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 99999999654 346999999999999999999999998 999999999999987766 999999998754
Q ss_pred cccc--------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVDK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 3321 1234569999999999999999999999999999999999999998854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=310.43 Aligned_cols=201 Identities=28% Similarity=0.454 Sum_probs=174.4
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc-------------ccHHHHHHHHHHHhccCCCCcceeeeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK-------------QGEKEFQTEVMLLGRLHHRNLVNLVGY 176 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 176 (319)
...|.+.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 35788899999999999999965 4688999999865321 235678899999999999999999999
Q ss_pred EeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC---ceE
Q 020946 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RAR 253 (319)
Q Consensus 177 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~k 253 (319)
+.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999988654 45999999999999999999999998 99999999999998775 699
Q ss_pred EeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 254 VADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 254 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997655554555677999999999987 4689999999999999999999999988654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=288.47 Aligned_cols=200 Identities=30% Similarity=0.490 Sum_probs=172.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .++..||+|++... .......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 4678889999999999999954 46779999998543 2233567889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..... .
T Consensus 89 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-~ 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-S 162 (279)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc-c
Confidence 999999999998654 45899999999999999999999998 99999999999999999999999998854322 2
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence 23456789999999999999999999999999999999999999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=300.61 Aligned_cols=198 Identities=25% Similarity=0.348 Sum_probs=162.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC------e
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------Q 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 182 (319)
.+|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 4678889999999999999954 57889999998653 2333567889999999999999999999997654 7
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+. ++|.+.+. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 899999997 47877773 24899999999999999999999998 99999999999999999999999999976
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...........+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5444344556799999999999999999999999999999999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.89 Aligned_cols=200 Identities=27% Similarity=0.429 Sum_probs=165.1
Q ss_pred hcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
+|.+.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 5778899999999999999654 7899999998654322 1224557999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
+ ++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ...
T Consensus 83 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 83 D-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp S-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred c-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 7 5888888654 346899999999999999999999998 999999999999999999999999998644322 223
Q ss_pred cccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 34568999999999876 6789999999999999999999999988653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=298.36 Aligned_cols=198 Identities=22% Similarity=0.376 Sum_probs=167.2
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCC--CCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||++...+++.||+|++.... ....+.+.+|+.++..++| |||+++++++.+.+..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4678899999999999999988889999999986542 3334678999999999976 99999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
| +.+++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+++......
T Consensus 89 e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp C-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred e-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9 5688999999653 46899999999999999999999998 99999999999997 5689999999997543322
Q ss_pred ---cccccccccCccCccccCC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 ---HAANIRGTFGYLDPEYIST-----------RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ---~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 2234579999999999854 678999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=300.83 Aligned_cols=198 Identities=21% Similarity=0.371 Sum_probs=168.2
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccC--CCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.++..++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458888999999999999998878999999998654 2334567899999999996 599999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
| +.+++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 5688999998654 36899999999999999999999998 99999999999996 5799999999997543322
Q ss_pred ---cccccccccCccCccccCC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 ---HAANIRGTFGYLDPEYIST-----------RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ---~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 2235679999999999854 468999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=294.51 Aligned_cols=201 Identities=29% Similarity=0.456 Sum_probs=169.9
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 4688889999999999999965 468999999986543 2234567899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~ 267 (319)
|+++++|..+... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..... ..
T Consensus 105 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 105 FVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999888887643 346999999999999999999999998 99999999999999999999999999875332 22
Q ss_pred cccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......+|+.|+|||++.+. .++.++||||||+++|||++|+.||.+.++
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 33456789999999999765 789999999999999999999999987653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=305.69 Aligned_cols=200 Identities=27% Similarity=0.385 Sum_probs=174.0
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc------CCCCcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL------HHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 183 (319)
..+|.+.+.||+|+||+||+|.. .+++.||+|++... ....+.+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45688899999999999999954 56899999999653 22345667788877776 578999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc--eEEeecCCCc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--ARVADFGLSR 261 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~ 261 (319)
+++|||+. ++|.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 69999997766667999999999999999999999998 999999999999999887 9999999986
Q ss_pred cccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 251 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 432 233456789999999999999999999999999999999999999988764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=320.22 Aligned_cols=205 Identities=32% Similarity=0.513 Sum_probs=178.5
Q ss_pred HHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
++....|.+.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+++.++||||+++++++.+ +..++||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 45566788889999999999999998878889999997654 335789999999999999999999999876 6789999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++.......+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999999999997544456899999999999999999999998 9999999999999999999999999997543221
Q ss_pred --cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 268 --HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 268 --~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
......++..|+|||++....++.++||||||++||||++ |+.||.+...
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 1223446788999999988899999999999999999999 9999988654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=290.13 Aligned_cols=200 Identities=28% Similarity=0.482 Sum_probs=175.8
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
...|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 356888999999999999999654 67899999985431 22346789999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999999998654 35899999999999999999999998 99999999999999999999999999864332
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 22345678999999999999999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=296.99 Aligned_cols=197 Identities=23% Similarity=0.401 Sum_probs=169.8
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 187 (319)
....|.+.+.||+|+||.||+|.. .+++.||+|++...... ..+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 356789999999999999999965 47889999999654322 34677788777 7999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC----CceEEeecCCCccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS----MRARVADFGLSREE 263 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~~ 263 (319)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+.++ +.+||+|||++...
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999998543 46999999999999999999999998 9999999999998543 35999999999754
Q ss_pred ccc-ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 264 MVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 264 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 332 2344567899999999998888999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=302.12 Aligned_cols=202 Identities=26% Similarity=0.441 Sum_probs=176.1
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
+....|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 3446788889999999999999965 47899999998765 333456789999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 110 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999654 3589999999999999999999985 7 99999999999999999999999999864322
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 185 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp -HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred -ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 23345678999999999999999999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=293.90 Aligned_cols=205 Identities=32% Similarity=0.562 Sum_probs=165.0
Q ss_pred HHHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 106 ~~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
..|+...+|.+.+.||+|+||+||+|... ..+|+|++.... ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 34556678899999999999999999863 469999987543 33456789999999999999999999965 45568
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence 9999999999999998543 356999999999999999999999998 999999999999999999999999998643
Q ss_pred cc---cccccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MV---DKHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~---~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.. ........||+.|+|||++. ...++.++||||||+++|||++|+.||.+..+
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 22 12233456899999999986 66788999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=299.25 Aligned_cols=200 Identities=30% Similarity=0.443 Sum_probs=171.3
Q ss_pred HhcccccccccCCCceEEEEEe----CCCcEEEEEEeccCC----cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCe
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 182 (319)
..|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999976 478999999986432 22345677899999999 69999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999654 35899999999999999999999998 99999999999999999999999999874
Q ss_pred cccc--ccccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVD--KHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 3222 22334679999999999975 457899999999999999999999997543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=296.47 Aligned_cols=207 Identities=25% Similarity=0.501 Sum_probs=177.1
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
++...+|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344567899999999999999999543 46789999987543 33345788999999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 181 GQHMLVYVFMSKGSLASHLYDEN--------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
+..+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999986421 245789999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 253 RVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 999999987543222 1223456889999999988899999999999999999999 8999987653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=299.33 Aligned_cols=196 Identities=28% Similarity=0.438 Sum_probs=164.9
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC------e
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------Q 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 182 (319)
.+|.+.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 4578889999999999999965 57999999998543 2333567889999999999999999999997653 4
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 69999999 8899998854 35899999999999999999999999 99999999999999999999999999975
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 3345678999999999876 789999999999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=291.94 Aligned_cols=204 Identities=31% Similarity=0.519 Sum_probs=176.0
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
+...+|.+.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+ +..++++|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3446788999999999999999988888899999986543 346788999999999999999999999864 56899999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999996543336899999999999999999999998 9999999999999999999999999987543222
Q ss_pred -cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 2223456788999999988889999999999999999999 9999987653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.18 Aligned_cols=201 Identities=30% Similarity=0.457 Sum_probs=170.5
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEee--------C
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--------K 180 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 180 (319)
.+|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4788899999999999999965 578999999986543 2234577899999999999999999999877 4
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
+..++||||+++ +|.+.+... ...+++.++..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 568999999975 777777543 346999999999999999999999998 999999999999999999999999998
Q ss_pred ccccc-----cccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 REEMV-----DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~~~~~-----~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+.... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.++
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 64321 122334568999999999875 5689999999999999999999999988654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=297.66 Aligned_cols=201 Identities=29% Similarity=0.541 Sum_probs=168.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcE----EEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGET----VAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
..|.+.+.||+|+||.||+|.. .+++. ||+|.+.... ......+.+|+.+++.++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4677889999999999999965 34543 7888775432 333456778999999999999999999886 456889
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999653 346899999999999999999999998 99999999999999999999999999975432
Q ss_pred cc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 266 DK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 266 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.. ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 22 2234567889999999998899999999999999999999 9999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=287.99 Aligned_cols=199 Identities=27% Similarity=0.468 Sum_probs=176.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577889999999999999954 578999999987553 34457889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 999999999843 46999999999999999999999998 9999999999999999999999999986543322 2
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+|+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 345578999999999999999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=296.64 Aligned_cols=200 Identities=24% Similarity=0.394 Sum_probs=163.9
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+|.+.+.||+|+||+||+|. ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 478889999999999999995 45789999999865432 224567899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-----CCCceEEeecCCCccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-----QSMRARVADFGLSREE 263 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-----~~~~~kl~Dfg~~~~~ 263 (319)
|++ ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ +++.+||+|||++...
T Consensus 114 ~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 114 YAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp CCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred cCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 997 5999988654 35999999999999999999999998 99999999999994 4556999999998643
Q ss_pred ccc-ccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVD-KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+..+
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 322 223445689999999999764 589999999999999999999999987653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=303.82 Aligned_cols=197 Identities=27% Similarity=0.398 Sum_probs=164.5
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------CeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 184 (319)
..|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3578889999999999999976 4689999999865422 234799999999999999999988542 2367
Q ss_pred EEEEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-CceEEeecCCCc
Q 020946 185 LVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSR 261 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~ 261 (319)
+||||+++ ++...+.. .....+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 56555432 33457999999999999999999999998 9999999999999955 678999999998
Q ss_pred cccccccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
............+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 65444445566789999999998664 79999999999999999999999998865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=303.84 Aligned_cols=195 Identities=28% Similarity=0.373 Sum_probs=164.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC-----CeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 183 (319)
.+|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++... +..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 4688899999999999999954 57889999999653 333456789999999999999999999998776 578
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 99999986 699998854 356999999999999999999999999 999999999999999999999999999754
Q ss_pred cccc-----------------------cccccccccCccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 020946 264 MVDK-----------------------HAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPL 312 (319)
Q Consensus 264 ~~~~-----------------------~~~~~~~t~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltg~~pf 312 (319)
.... ......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 3221 12456789999999986 5677999999999999999999854444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=286.03 Aligned_cols=200 Identities=32% Similarity=0.543 Sum_probs=176.5
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
..|.+.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46788899999999999999888888999999976543 35678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc--ccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHA 269 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 269 (319)
+++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...... ...
T Consensus 87 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 99999999654 356899999999999999999999998 999999999999999999999999998754322 122
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 33456788999999988899999999999999999999 999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=291.52 Aligned_cols=204 Identities=25% Similarity=0.407 Sum_probs=171.0
Q ss_pred HHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--------cccHHHHHHHHHHHhccCCCCcceeeeEEe
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 178 (319)
......|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 34567899999999999999999965 468899999986432 112345789999999999999999999987
Q ss_pred eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc---eEEe
Q 020946 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVA 255 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~ 255 (319)
..+ .+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +||+
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred CCc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 654 8999999999999998853 356999999999999999999999998 999999999999987654 9999
Q ss_pred ecCCCccccccccccccccccCccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 256 DFGLSREEMVDKHAANIRGTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 256 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|||++.............||+.|+|||++ ....++.++||||||+++|+|++|+.||.+...
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 99998755443333456789999999997 356789999999999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=292.63 Aligned_cols=200 Identities=26% Similarity=0.468 Sum_probs=172.2
Q ss_pred HHHHhcccccccccCCCceEEEEEeC-CC-------cEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS-TG-------ETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
+...+|.+.+.||+|+||.||+|... ++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 34567888999999999999999543 33 47999999766666677899999999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc--------e
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--------A 252 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--------~ 252 (319)
+..+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++. +
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999996542 34899999999999999999999999 999999999999998887 9
Q ss_pred EEeecCCCccccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhC-CCCCCCc
Q 020946 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAG-RSPLQGL 315 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg-~~pf~~~ 315 (319)
||+|||++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++| .+||...
T Consensus 161 kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 161 KLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222 (289)
T ss_dssp EECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred eeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence 9999999864322 233457899999999976 7789999999999999999995 5555543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=295.37 Aligned_cols=202 Identities=35% Similarity=0.612 Sum_probs=171.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcE--EEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGET--VAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 186 (319)
..|.+.+.||+|+||.||+|.. .++.. +|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..+++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 4678899999999999999954 35654 499988653 334456789999999999 899999999999999999999
Q ss_pred EEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 187 YVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
|||+++++|.+++.... ...+++.+++.++.|++.||.|||+++ ++||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 246899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
||+|||+++............+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999875443333444567889999999988889999999999999999998 999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=291.40 Aligned_cols=203 Identities=28% Similarity=0.485 Sum_probs=172.6
Q ss_pred HHHHHhcccccccccCCCceEEEEEe-----CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC-
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK- 180 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~- 180 (319)
.+....|++.+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 34456688899999999999999973 46889999998754 334457889999999999999999999999876
Q ss_pred -CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCC
Q 020946 181 -GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259 (319)
Q Consensus 181 -~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 259 (319)
+..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccc
Confidence 66899999999999999995543 46999999999999999999999998 99999999999999999999999999
Q ss_pred Cccccccc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 260 SREEMVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 260 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
+....... ......+|..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 87543322 22345678889999999888899999999999999999999998643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=290.65 Aligned_cols=200 Identities=28% Similarity=0.446 Sum_probs=166.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 5688899999999999999965 4788999999875422 22467889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 114 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp ECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999999999654 46999999999999999999999998 9999999999999999999999999986543321
Q ss_pred --cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 --HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 --~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......+++.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 2234568999999999999999999999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=303.61 Aligned_cols=208 Identities=24% Similarity=0.317 Sum_probs=176.4
Q ss_pred CcCHHHHHHHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC--------CCCccee
Q 020946 103 EYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH--------HRNLVNL 173 (319)
Q Consensus 103 ~~~~~~l~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~ 173 (319)
.+...++...+|.+.+.||+|+||+||+|. ..+++.||+|++... ....+.+.+|+.+++.++ |+||+++
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 344555566789999999999999999995 457889999998643 233567889999999885 7889999
Q ss_pred eeEEe----eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcC
Q 020946 174 VGYCA----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQ 248 (319)
Q Consensus 174 ~~~~~----~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~ 248 (319)
++++. +....++||||+ ++++.+.+.......+++..++.++.|++.||.|||++ + |+||||||+|||++.
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~ 182 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECC
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEec
Confidence 99987 456889999999 67777777666556799999999999999999999998 8 999999999999987
Q ss_pred CC-------------------------------------------------ceEEeecCCCccccccccccccccccCcc
Q 020946 249 SM-------------------------------------------------RARVADFGLSREEMVDKHAANIRGTFGYL 279 (319)
Q Consensus 249 ~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~ 279 (319)
++ .+||+|||++..... ......||+.|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~ 260 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYR 260 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGC
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCccc
Confidence 75 799999999875432 234457899999
Q ss_pred CccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 280 aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 99999998999999999999999999999999987553
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.65 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=173.0
Q ss_pred HhcccccccccCCCceEEEEEe--CCCcEEEEEEeccCC--cccHHHHHHHHHHHhcc---CCCCcceeeeEEe-----e
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM--STGETVAVKVLATDS--KQGEKEFQTEVMLLGRL---HHRNLVNLVGYCA-----E 179 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~ 179 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4688899999999999999976 468899999986432 22233566777776665 8999999999987 4
Q ss_pred CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCC
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 259 (319)
....++++||+. ++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 567899999997 69999997766566999999999999999999999998 99999999999999999999999999
Q ss_pred CccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+.............+|+.|+|||++.+..++.++||||||+++|||++|+.||.+..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9765444444556789999999999999999999999999999999999999987653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.57 Aligned_cols=199 Identities=25% Similarity=0.394 Sum_probs=166.3
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe------EEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ------HML 185 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~l 185 (319)
.+|.+.+.||+|+||.||+|....+..+|+|.+...... ..+|+.+++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468888999999999999998877777999987543222 2368999999999999999999865443 789
Q ss_pred EEEEccCCChhhhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEeecCCCccc
Q 020946 186 VYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREE 263 (319)
Q Consensus 186 v~e~~~~g~l~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~ 263 (319)
||||++++.+..... ......+++..+..++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999997654433322 223457999999999999999999999998 99999999999999 7899999999999765
Q ss_pred cccccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..........+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 555555567789999999998654 689999999999999999999999988653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=305.74 Aligned_cols=199 Identities=20% Similarity=0.243 Sum_probs=160.9
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHH---HHHhccCCCCcceee-------eEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEV---MLLGRLHHRNLVNLV-------GYC 177 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~ 177 (319)
..|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+ ..++.++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 3567789999999999999975 57999999998743 333456788999 555666899999998 666
Q ss_pred eeCC-----------------eEEEEEEEccCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 020946 178 AEKG-----------------QHMLVYVFMSKGSLASHLYDENY-----GPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235 (319)
Q Consensus 178 ~~~~-----------------~~~lv~e~~~~g~l~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 235 (319)
.+.+ ..+++|||+ +|+|.+++..... ..+++..+..++.|++.||+|||+++ |+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 5543 278999999 6899999965321 12345888899999999999999998 99
Q ss_pred EcCCCCCCEEEcCCCceEEeecCCCccccccccccccccccCccCccccCCC-----------CCCcchhhHHHHHHHHH
Q 020946 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-----------NFTKKSDVYSFGVLLFE 304 (319)
Q Consensus 236 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~slGvil~e 304 (319)
||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 99999999999999999999999997532 23344567 999999999877 89999999999999999
Q ss_pred HHhCCCCCCCccc
Q 020946 305 LIAGRSPLQGLME 317 (319)
Q Consensus 305 lltg~~pf~~~~~ 317 (319)
|++|+.||.+...
T Consensus 306 lltg~~Pf~~~~~ 318 (377)
T 3byv_A 306 IWCADLPITKDAA 318 (377)
T ss_dssp HHHSSCCC-----
T ss_pred HHHCCCCCccccc
Confidence 9999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=298.33 Aligned_cols=201 Identities=20% Similarity=0.294 Sum_probs=165.2
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC----CCcEEEEEEeccCCcc-----------cHHHHHHHHHHHhccCCCCcce
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDSKQ-----------GEKEFQTEVMLLGRLHHRNLVN 172 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~ 172 (319)
++....|.+.+.||+|+||.||+|... ++..+|+|+....... ....+.+|+..+..++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 344567889999999999999999764 5778999998654321 1234667888899999999999
Q ss_pred eeeEEee----CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC
Q 020946 173 LVGYCAE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ 248 (319)
Q Consensus 173 ~~~~~~~----~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~ 248 (319)
+++++.+ ....+++|||+ +++|.+++.... .+++.+++.++.|++.||+|||+++ ++||||||+|||++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence 9999988 67899999999 999999986543 6999999999999999999999998 999999999999998
Q ss_pred CC--ceEEeecCCCccccccc--------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 249 SM--RARVADFGLSREEMVDK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 249 ~~--~~kl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
++ .+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 87 99999999996432221 11345789999999999998999999999999999999999999965
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.08 Aligned_cols=197 Identities=28% Similarity=0.438 Sum_probs=154.7
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------Ce
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 182 (319)
.+|.+.+.||+|+||.||+|. ..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 467888999999999999995 457899999998653 233456788999999999999999999998654 56
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 79999998 6899888843 46999999999999999999999998 99999999999999999999999999875
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 332 2345678999999999876 6789999999999999999999999988653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.27 Aligned_cols=201 Identities=26% Similarity=0.386 Sum_probs=164.6
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcc-----------cHHHHHHHHHHHhccCCCCcceeeeEEee
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-----------GEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 179 (319)
...|.+.+.||+|+||.||+|...++..||+|++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 3678888999999999999998878999999988543211 13678999999999999999999999854
Q ss_pred -----CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEE
Q 020946 180 -----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV 254 (319)
Q Consensus 180 -----~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 254 (319)
....++||||+. |+|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEE
Confidence 336899999997 6888888643 356999999999999999999999998 999999999999999999999
Q ss_pred eecCCCccccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 255 ADFGLSREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 255 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+|||++.............+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999975544445556678999999999876 778999999999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=285.05 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=167.3
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
.+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+..++.++||||+++++++.+.+..++++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 46788899999999999999764 78999999986432 233567889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999654 35899999999999999999999998 9999999999999999999999999987654444
Q ss_pred cccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 4445678999999999987765 689999999999999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.78 Aligned_cols=201 Identities=21% Similarity=0.398 Sum_probs=176.1
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCccc-----------------HHHHHHHHHHHhccCCCCcceee
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----------------EKEFQTEVMLLGRLHHRNLVNLV 174 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~~ 174 (319)
..|.+.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|+.+++.++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4688889999999999999988 89999999986432111 17899999999999999999999
Q ss_pred eEEeeCCeEEEEEEEccCCChhhh------hhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEc
Q 020946 175 GYCAEKGQHMLVYVFMSKGSLASH------LYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLD 247 (319)
Q Consensus 175 ~~~~~~~~~~lv~e~~~~g~l~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~ 247 (319)
+++.+.+..++||||+++++|.++ +.......+++..+..++.|++.||.|||+ ++ ++|+||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEc
Confidence 999999999999999999999998 644435779999999999999999999998 88 99999999999999
Q ss_pred CCCceEEeecCCCccccccccccccccccCccCccccCCC-CCCc-chhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 248 QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-NFTK-KSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 248 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.++.+||+|||++...... ......+++.|+|||++.+. .++. ++||||||+++|||++|+.||.+...
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999998754332 33456789999999999877 6666 99999999999999999999987654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=298.78 Aligned_cols=202 Identities=32% Similarity=0.565 Sum_probs=162.5
Q ss_pred hcccccccccCCCceEEEEEeC--CC--cEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEee-CCeEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS--TG--ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 186 (319)
.|.+.+.||+|+||.||+|... ++ ..||+|.+... .....+.+.+|+.++++++||||+++++++.+ .+..+++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4567789999999999999653 22 36899998654 33445778999999999999999999998754 5678999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999543 356899999999999999999999998 999999999999999999999999998743222
Q ss_pred c-----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 267 K-----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 267 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
. ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||.+....
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 1 1223456788999999999999999999999999999999 78889876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=289.19 Aligned_cols=201 Identities=25% Similarity=0.381 Sum_probs=158.4
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc-cc-HHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK-QG-EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
...|++.+.||+|+||.||+|.. .+++.||+|++..... .. .+.+.++...++.++||||+++++++.+.+..+++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45788899999999999999965 5789999999875422 22 233455556688889999999999999999999999
Q ss_pred EEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 188 VFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 188 e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
||++ ++|.+++.. .....+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588777643 2445799999999999999999999997 8 9999999999999999999999999987654
Q ss_pred ccccccccccccCccCcccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 265 VDKHAANIRGTFGYLDPEYI----STRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.........+|+.|+|||++ .+..++.++||||||+++|||++|+.||.+.
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 44444455799999999996 5667899999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=296.15 Aligned_cols=206 Identities=31% Similarity=0.572 Sum_probs=175.3
Q ss_pred HHHHhcccccccccCCCceEEEEEeC-CC-----cEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS-TG-----ETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK 180 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 180 (319)
+....|.+.+.||+|+||.||+|... ++ ..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 33456788899999999999999653 22 479999987653 33456789999999999 899999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDEN------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ 248 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~ 248 (319)
+..+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 99999999999999999986432 345899999999999999999999998 999999999999999
Q ss_pred CCceEEeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 249 SMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 249 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 99999999999875433221 223457889999999988899999999999999999999 9999987643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.37 Aligned_cols=199 Identities=28% Similarity=0.462 Sum_probs=170.0
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEee----CCeEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHML 185 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 185 (319)
.|.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 467788999999999999954 57889999998654 33445678999999999999999999998875 356899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEeecCCCcccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEM 264 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~ 264 (319)
||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++++|+||||+|||++ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999653 45899999999999999999999876 4599999999999998 78999999999986432
Q ss_pred ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
. .......+|+.|+|||++.+ .++.++||||||+++|+|++|+.||.+..
T Consensus 184 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 184 A-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred c-cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 2 23345678999999998864 58999999999999999999999998743
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=292.25 Aligned_cols=206 Identities=25% Similarity=0.439 Sum_probs=157.7
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEe--------e
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCA--------E 179 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~ 179 (319)
...+|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 345788899999999999999965 578999999987666666678899999999996 999999999984 3
Q ss_pred CCeEEEEEEEccCCChhhhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecC
Q 020946 180 KGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG 258 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 258 (319)
....++++||+. |+|.+++.. .....+++..++.++.|++.||.|||+++ ++++||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345889999995 789888854 23456999999999999999999999875 459999999999999999999999999
Q ss_pred CCcccccccc-------------ccccccccCccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 259 LSREEMVDKH-------------AANIRGTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 259 ~~~~~~~~~~-------------~~~~~~t~~y~aPE~~---~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
++........ .....+|+.|+|||++ .+..++.++||||||+++|||++|+.||.+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9875432211 1144589999999998 567789999999999999999999999986543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=288.09 Aligned_cols=198 Identities=31% Similarity=0.536 Sum_probs=163.2
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
..|.+.+.||+|+||.||+|.. .++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 4678889999999999999987 4789999998643 335678999999999999999999998874 4789999999
Q ss_pred CCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc-eEEeecCCCccccccccc
Q 020946 192 KGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-ARVADFGLSREEMVDKHA 269 (319)
Q Consensus 192 ~g~l~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~~~~ 269 (319)
+++|.+++..... ..+++..++.++.|++.||.|||+.+..+++||||||+|||++.++. +||+|||++..... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~--~~ 160 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HM 160 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc--cc
Confidence 9999999965432 24788999999999999999999932123999999999999998876 79999999864322 22
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 34568999999999999999999999999999999999999998653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.70 Aligned_cols=202 Identities=28% Similarity=0.466 Sum_probs=175.9
Q ss_pred HHhcccccccccCCCceEEEEEe-----CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEe--eCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA--EKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 183 (319)
..+|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35788899999999999999973 468899999998776666678999999999999999999999886 45678
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999996532 35899999999999999999999998 999999999999999999999999998754
Q ss_pred cccc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 3222 2233457888999999988889999999999999999999999997543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=288.35 Aligned_cols=201 Identities=27% Similarity=0.440 Sum_probs=170.5
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee----CCeEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHML 185 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 185 (319)
..+|.+.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788899999999999999965 6889999999876666667789999999999999999999999863 347899
Q ss_pred EEEEccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 186 VYVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++||+++++|.+++... ....+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988652 3456999999999999999999999998 999999999999999999999999987643
Q ss_pred ccccc----------ccccccccCccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 264 MVDKH----------AANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 264 ~~~~~----------~~~~~~t~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
..... .....||+.|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 22111 12335799999999987554 68999999999999999999999965
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.21 Aligned_cols=204 Identities=30% Similarity=0.529 Sum_probs=169.2
Q ss_pred HHHhcccccccccCCCceEEEEEeCC-----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMST-----GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
...+|.+.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34567778999999999999996532 2369999987543 33455788999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++||||+++++|.+++... ...+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999998653 356999999999999999999999998 999999999999999999999999998754
Q ss_pred cccc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 264 MVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 264 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 3221 1122345788999999998899999999999999999999 9999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=287.95 Aligned_cols=192 Identities=21% Similarity=0.381 Sum_probs=170.2
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEee--CCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAE--KGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|. ..+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.+ ....+++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 578889999999999999995 468899999998643 3567899999999997 9999999999987 66789999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCcccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVD 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~ 266 (319)
||+++++|.+++. .+++..+..++.|++.||+|||+++ ++||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999998883 3889999999999999999999999 99999999999999776 8999999999765444
Q ss_pred ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 267 KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
.......+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 45556678999999999876 6789999999999999999999999954
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.16 Aligned_cols=202 Identities=29% Similarity=0.398 Sum_probs=168.0
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcc-----cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ-----GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
..+|.+.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 35688899999999999999965 46899999998653221 1346789999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++|||+++ +|..++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 99999975 888877543 346889999999999999999999999 9999999999999999999999999987543
Q ss_pred cc-ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 VD-KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.. .......+|+.|+|||++.+ ..++.++||||||+++|||++|.+||.+..+
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 22 23345678999999999865 4589999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=285.38 Aligned_cols=201 Identities=27% Similarity=0.480 Sum_probs=171.2
Q ss_pred Hhccccc-ccccCCCceEEEEEe---CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTT-LIGQGAFGPVYKAQM---STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
..|.+.+ .||+|+||.||+|.. .++..||+|++... .....+.+.+|+.+++.++||||+++++++ +.+..+++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 899999999999964 36778999999765 334456789999999999999999999999 55678999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999998543 356999999999999999999999998 999999999999999999999999998754322
Q ss_pred c----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 267 K----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 267 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 1 1223446889999999988889999999999999999998 9999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.27 Aligned_cols=203 Identities=27% Similarity=0.434 Sum_probs=171.7
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
+.....|.+.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 344567888999999999999999654 68999999986543 346788999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred eecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999998643 356999999999999999999999998 999999999999999999999999998654322
Q ss_pred -ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+..
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 22334568999999999999999999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=314.69 Aligned_cols=194 Identities=28% Similarity=0.498 Sum_probs=165.4
Q ss_pred ccccCCCceEEEEEeC---CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 119 LIGQGAFGPVYKAQMS---TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|+.+++.++||||++++++|.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999653 45679999997653 3456789999999999999999999999976 56899999999999
Q ss_pred hhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc----cc
Q 020946 195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----AA 270 (319)
Q Consensus 195 l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~ 270 (319)
|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999643 456999999999999999999999998 99999999999999999999999999975432221 12
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 2345689999999998999999999999999999998 9999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=285.11 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=174.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---------cccHHHHHHHHHHHhccC-CCCcceeeeEEeeC
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---------KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEK 180 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 180 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 4678889999999999999965 478899999986542 112356789999999995 99999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
+..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999654 46899999999999999999999998 999999999999999999999999998
Q ss_pred ccccccccccccccccCccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYIS------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.............+++.|+|||++. ...++.++||||||+++|||++|+.||.+..
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 7654444455567899999999884 4568899999999999999999999997754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=285.26 Aligned_cols=201 Identities=27% Similarity=0.417 Sum_probs=164.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688899999999999999964 57899999998753 2334567889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 188 VFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 188 e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
||+++++|.+++.. .....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998854 23456899999999999999999999998 99999999999999999999999999875432
Q ss_pred cc-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 266 DK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 266 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 22 223456899999999999999999999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=287.80 Aligned_cols=202 Identities=27% Similarity=0.463 Sum_probs=171.1
Q ss_pred HHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
...|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 356888999999999999999664 6889999999776666678899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 268 (319)
+++++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999988653 346999999999999999999999998 999999999999999999999999987532211 22
Q ss_pred ccccccccCccCcccc-----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYI-----STRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~-----~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....+|+.|+|||++ ....++.++||||||+++|+|++|+.||.+..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 3345689999999998 46778999999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=284.11 Aligned_cols=197 Identities=27% Similarity=0.463 Sum_probs=167.9
Q ss_pred ccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
...||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 34799999999999964 57889999999776555567899999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCCCcccccc-cccccc
Q 020946 196 ASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVD-KHAANI 272 (319)
Q Consensus 196 ~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~-~~~~~~ 272 (319)
.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++. ++.+||+|||++...... ......
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 183 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCccccc
Confidence 99996542 234678889999999999999999998 999999999999987 899999999998754322 223455
Q ss_pred ccccCccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 273 RGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.+++.|+|||++.+. .++.++||||||+++|||++|+.||.+..
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 789999999998654 38899999999999999999999997643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=287.84 Aligned_cols=205 Identities=29% Similarity=0.530 Sum_probs=165.1
Q ss_pred HHHhcccccccccCCCceEEEEEeC----CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC--
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-- 181 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 181 (319)
....|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3567888999999999999999543 34589999987542 333467899999999999999999999998755
Q ss_pred ---eEEEEEEEccCCChhhhhhh----cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEE
Q 020946 182 ---QHMLVYVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV 254 (319)
Q Consensus 182 ---~~~lv~e~~~~g~l~~~l~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 254 (319)
..++++||+++++|.+++.. .....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 35999999999999999853 23356999999999999999999999998 999999999999999999999
Q ss_pred eecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 255 ADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 255 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 9999987543221 2233457889999999999999999999999999999999 9999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.77 Aligned_cols=199 Identities=33% Similarity=0.560 Sum_probs=166.8
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC-CeEEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-GQHMLVYVF 189 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~ 189 (319)
...|++.+.||+|+||.||++.. +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35788899999999999999987 58899999986543 456789999999999999999999987554 478999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 269 (319)
+++++|.+++.......+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--Q 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--c
Confidence 99999999996654334889999999999999999999998 999999999999999999999999998743322 2
Q ss_pred cccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 33457889999999988899999999999999999998 9999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=292.93 Aligned_cols=199 Identities=27% Similarity=0.404 Sum_probs=170.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeC-----CeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 184 (319)
.+|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 3688899999999999999954 478899999987543 33346788999999999999999999998765 3689
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+. ++|.+++... .+++.++..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 107 iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 9999997 5898888543 5999999999999999999999998 9999999999999999999999999987543
Q ss_pred cccc----ccccccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 VDKH----AANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 ~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.... .....||+.|+|||++. ...++.++||||||+++|||++|+.||.+...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 3221 23457899999999864 45689999999999999999999999987654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=292.65 Aligned_cols=203 Identities=24% Similarity=0.408 Sum_probs=175.7
Q ss_pred HHHHHhcccccccccCCCceEEEEEe--CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC------CcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM--STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR------NLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~ 179 (319)
++...+|.+.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.+++.++|+ +++++++++.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 34456889999999999999999965 46889999998643 23356788899999888765 49999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-----------
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ----------- 248 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~----------- 248 (319)
.+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999 889999997766567999999999999999999999998 999999999999987
Q ss_pred --------CCceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 249 --------SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 249 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
++.+||+|||++.... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 6689999999987532 223456789999999999999999999999999999999999999987653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.81 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=166.6
Q ss_pred CHHHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhc--cCCCCcceeeeEEeeC--
Q 020946 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR--LHHRNLVNLVGYCAEK-- 180 (319)
Q Consensus 105 ~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~-- 180 (319)
...+.....|.+.+.||+|+||.||+|.. .++.||+|++... ....+..|.+++.. ++||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34555678999999999999999999987 4899999998543 23344455555554 4899999999999887
Q ss_pred --CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCCeEEcCCCCCCEEEcCCC
Q 020946 181 --GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG--------AVPPVIHRDIKSSNILLDQSM 250 (319)
Q Consensus 181 --~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~~i~H~dlk~~Nill~~~~ 250 (319)
...+++|||+++|+|.+++... .+++..+..++.|++.||+|||++ + ++||||||+|||++.++
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 7899999999999999999543 589999999999999999999988 6 99999999999999999
Q ss_pred ceEEeecCCCcccccccc-----ccccccccCccCccccCCCCCCcc------hhhHHHHHHHHHHHhC----------C
Q 020946 251 RARVADFGLSREEMVDKH-----AANIRGTFGYLDPEYISTRNFTKK------SDVYSFGVLLFELIAG----------R 309 (319)
Q Consensus 251 ~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~------~Dv~slGvil~elltg----------~ 309 (319)
.+||+|||++........ .....||+.|+|||++.+..++.+ +|||||||++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 999999999864322221 124578999999999987766655 9999999999999999 7
Q ss_pred CCCCCc
Q 020946 310 SPLQGL 315 (319)
Q Consensus 310 ~pf~~~ 315 (319)
.||...
T Consensus 260 ~p~~~~ 265 (337)
T 3mdy_A 260 LPYHDL 265 (337)
T ss_dssp CTTTTT
T ss_pred ccHhhh
Confidence 777654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=288.37 Aligned_cols=201 Identities=31% Similarity=0.521 Sum_probs=168.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEee------CCeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE------KGQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~ 183 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++.. .+..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 4678889999999999999965 578999999986543 2356788999999999 79999999999977 4688
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
+++|||+++++|.+++.......+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 99999999999999997655567999999999999999999999998 999999999999999999999999998754
Q ss_pred ccc-ccccccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVD-KHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... .......+|+.|+|||++. +..++.++||||||+++|+|++|+.||.+..
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 322 2233456899999999986 5678999999999999999999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=282.50 Aligned_cols=205 Identities=28% Similarity=0.476 Sum_probs=178.4
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
.+....+|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4556789999999999999999999654 7899999998654 234467889999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC---CceEEeecCCC
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLS 260 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~ 260 (319)
++++||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.+ +.+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999988654 35899999999999999999999998 9999999999999754 47999999998
Q ss_pred ccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.............+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+...
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 75544444445568999999999875 489999999999999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=283.18 Aligned_cols=202 Identities=28% Similarity=0.487 Sum_probs=169.8
Q ss_pred HHhcccccccccCCCceEEEEEeCC----CcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
...|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 3578889999999999999996432 336999998765 334456789999999999999999999998654 5689
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999654 346899999999999999999999998 99999999999999999999999999875433
Q ss_pred cc--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 266 DK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 266 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.. ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 22 2233456889999999988899999999999999999998 9999976543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=296.73 Aligned_cols=200 Identities=25% Similarity=0.388 Sum_probs=155.3
Q ss_pred Hhccc-ccccccCCCceEEEEEeC---CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEE
Q 020946 112 ATCNF-TTLIGQGAFGPVYKAQMS---TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHML 185 (319)
Q Consensus 112 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 185 (319)
..|.+ .++||+|+||+||+|... +++.||+|++.... ....+.+|+.+++.++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 468999999999999754 57899999986442 23567899999999999999999999954 678999
Q ss_pred EEEEccCCChhhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE----cCCCceEE
Q 020946 186 VYVFMSKGSLASHLYDE-------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARV 254 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl 254 (319)
||||+. ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 5787776421 2234899999999999999999999999 9999999999999 67789999
Q ss_pred eecCCCcccccc----ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 255 ADFGLSREEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 255 ~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999999754322 22344678999999999977 4589999999999999999999999987654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.52 Aligned_cols=197 Identities=18% Similarity=0.273 Sum_probs=169.2
Q ss_pred HHhcccccccccCCCceEEEEEeC---------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcce---------
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS---------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVN--------- 172 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 172 (319)
...|.+.+.||+|+||.||+|... +++.||+|++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 357888999999999999999664 3789999998643 46789999999999999987
Q ss_pred ------eeeEEee-CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEE
Q 020946 173 ------LVGYCAE-KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL 245 (319)
Q Consensus 173 ------~~~~~~~-~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 245 (319)
+++++.. .+..++||||+ +++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6677766 77899999999 999999997654467999999999999999999999998 999999999999
Q ss_pred EcCCC--ceEEeecCCCccccccc--------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 246 LDQSM--RARVADFGLSREEMVDK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 246 l~~~~--~~kl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 99999999996543221 113347899999999999999999999999999999999999999876
Q ss_pred c
Q 020946 316 M 316 (319)
Q Consensus 316 ~ 316 (319)
.
T Consensus 272 ~ 272 (352)
T 2jii_A 272 L 272 (352)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.46 Aligned_cols=203 Identities=28% Similarity=0.521 Sum_probs=167.3
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcE----EEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGET----VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
...|.+.+.||+|+||.||+|.. .+++. ||+|.+... .....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 35678889999999999999964 34543 577777543 3445678999999999999999999999998765 78
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++++|+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 899999999999999654 356999999999999999999999998 9999999999999999999999999987543
Q ss_pred ccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 265 VDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 265 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 222 2223446788999999999999999999999999999999 99999886653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=288.06 Aligned_cols=196 Identities=30% Similarity=0.462 Sum_probs=169.4
Q ss_pred cccccccccCCCceEEEEEe-----CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHML 185 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 185 (319)
|++.+.||+|+||+||++.+ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999998854 367899999997653 3345678999999999999999999999987 467899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
+|||+++++|.+++... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999543 4899999999999999999999999 99999999999999999999999999875433
Q ss_pred cc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 266 DK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 266 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.. ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 22 223445788899999998888999999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=281.48 Aligned_cols=200 Identities=24% Similarity=0.376 Sum_probs=168.1
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEE-eeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC-AEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e 188 (319)
..+|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+.+++.++|++++..+..+ .+.+..+++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46788999999999999999964 6889999998754432 23578899999999998888777665 56778899999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE---cCCCceEEeecCCCccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMV 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~ 265 (319)
|+ +++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||+ ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99 99999998643 346999999999999999999999999 9999999999999 7889999999999875433
Q ss_pred cc--------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.+...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 21 12345789999999999999999999999999999999999999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.09 Aligned_cols=205 Identities=35% Similarity=0.597 Sum_probs=174.5
Q ss_pred HHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeC
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK 180 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 180 (319)
+....|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++..+ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3456888999999999999999963 356799999997653 23346789999999999 799999999998775
Q ss_pred C-eEEEEEEEccCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEE
Q 020946 181 G-QHMLVYVFMSKGSLASHLYDENY--------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL 245 (319)
Q Consensus 181 ~-~~~lv~e~~~~g~l~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 245 (319)
+ ..++++||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 4 58999999999999999965432 12889999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 246 LDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 246 l~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999987543222 2234567889999999988999999999999999999998 999998765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.36 Aligned_cols=199 Identities=22% Similarity=0.322 Sum_probs=170.3
Q ss_pred HHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccC--CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 185 (319)
....|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567899999999999999999654 7999999998754 233456788899999998 89999999999999999999
Q ss_pred EEEEccCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC--------------
Q 020946 186 VYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-------------- 249 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-------------- 249 (319)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999996532 256899999999999999999999998 9999999999999844
Q ss_pred -----CceEEeecCCCccccccccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 250 -----MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 250 -----~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
..+||+|||++..... .....+|+.|+|||++.+. .++.++||||||+++|||++|.+||..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccCCceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 4799999999875432 2234589999999999765 667899999999999999999987754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=284.43 Aligned_cols=201 Identities=31% Similarity=0.559 Sum_probs=168.0
Q ss_pred hcccccccccCCCceEEEEEeCC----CcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEe-eCCeEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA-EKGQHMLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv 186 (319)
+|.+.+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++. ..+..+++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 57788999999999999996532 236899988754 3334567899999999999999999999865 45678999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 106 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 106 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccccc
Confidence 999999999999964 3456899999999999999999999998 999999999999999999999999998744322
Q ss_pred c-----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 267 K-----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 267 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.+...
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 1 2233457789999999998999999999999999999999 6777776554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=286.89 Aligned_cols=199 Identities=27% Similarity=0.434 Sum_probs=164.7
Q ss_pred HhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEe------------
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA------------ 178 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------------ 178 (319)
.+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 46788899999999999999664 58999999987766666678899999999999999999999873
Q ss_pred --eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEe
Q 020946 179 --EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVA 255 (319)
Q Consensus 179 --~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~ 255 (319)
+.+..+++|||++ |+|.+++.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++ +++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 3468899999997 699998843 46899999999999999999999998 99999999999997 56799999
Q ss_pred ecCCCcccccc----ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 256 DFGLSREEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 256 Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|||+++..... .......+|+.|+|||.+.. ..++.++||||||+++|||++|+.||.+..+
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 99998754221 12234557899999998754 7789999999999999999999999987653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=280.82 Aligned_cols=198 Identities=24% Similarity=0.380 Sum_probs=169.9
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEE-eeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC-AEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.+++.++|++++..+.++ .+.+..+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4678889999999999999964 6889999999865432 34688999999999998877766655 567788999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE---cCCCceEEeecCCCcccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+ +++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||+ ++++.+||+|||++......
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 87 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred c-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9 89999998643 346999999999999999999999998 9999999999999 48889999999998754332
Q ss_pred cc--------ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.+..
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 21 235578999999999999999999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.82 Aligned_cols=207 Identities=30% Similarity=0.515 Sum_probs=172.2
Q ss_pred HHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
++....|.+.+.||+|+||.||+|.. .++..||+|++... ......++.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34456788999999999999999963 35678999998654 334456788999999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCce
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENY-----GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRA 252 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~ 252 (319)
+..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999976432 35899999999999999999999998 999999999999984 4569
Q ss_pred EEeecCCCcccccc---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 253 RVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 253 kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
||+|||++...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 99999998643221 12234457889999999988899999999999999999998 9999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=296.42 Aligned_cols=196 Identities=12% Similarity=0.109 Sum_probs=151.6
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHH---HHHhccCCCCcceee-------eEEe
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEV---MLLGRLHHRNLVNLV-------GYCA 178 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~ 178 (319)
.|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+ ..|+. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 367789999999999999965 4789999999976532 2345677785 45555 799987754 4444
Q ss_pred eC-----------------CeEEEEEEEccCCChhhhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCeE
Q 020946 179 EK-----------------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLR------VHIALDVARGLEYLHDGAVPPVI 235 (319)
Q Consensus 179 ~~-----------------~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~i~ 235 (319)
.. ...++||||++ ++|.+++.... ..+++..+ ..++.|++.||+|||+++ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 33 33799999998 89999997542 23455555 778899999999999999 99
Q ss_pred EcCCCCCCEEEcCCCceEEeecCCCccccccccccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 236 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999875432 2224556799999999987 789999999999999999999999998
Q ss_pred Ccc
Q 020946 314 GLM 316 (319)
Q Consensus 314 ~~~ 316 (319)
+..
T Consensus 295 ~~~ 297 (371)
T 3q60_A 295 LVT 297 (371)
T ss_dssp BCC
T ss_pred CcC
Confidence 874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.62 Aligned_cols=206 Identities=28% Similarity=0.419 Sum_probs=171.7
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 186 (319)
..|++.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ .+..+++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 4678889999999999999965 478999999987542 3345678999999999999999999998754 6789999
Q ss_pred EEEccCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 187 YVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGA--VPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
|||+++++|.+++... ....+++..+..++.|++.||+|||+++ ..+++|+||||+||+++.++.+||+|||++..
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999999998653 2345999999999999999999999865 23499999999999999999999999999864
Q ss_pred ccccc-cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp C---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH
Confidence 33221 12345689999999999888999999999999999999999999987653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=284.96 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=169.2
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC----cccHHHHHHHHHHHhccCCCCcceeeeEEe--eCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCA--EKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~ 184 (319)
.+|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. +.+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 4688899999999999999965 478899999986532 234567899999999999999999999984 456889
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++|||++++ +.+++.......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999876 777776655667999999999999999999999998 9999999999999999999999999986432
Q ss_pred c---cccccccccccCccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 V---DKHAANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~---~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
. ........+|+.|+|||++.+.. ++.++||||||+++|||++|+.||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 2 12223456899999999997644 3789999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.37 Aligned_cols=203 Identities=29% Similarity=0.448 Sum_probs=173.0
Q ss_pred cCHHHHHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhc--cCCCCcceeeeEEeeCC
Q 020946 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR--LHHRNLVNLVGYCAEKG 181 (319)
Q Consensus 104 ~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~ 181 (319)
+...+....+|.+.+.||+|+||.||+|.. +++.||+|++... ....+.+|.+++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 445667788999999999999999999987 5899999998542 34567788888876 78999999999998775
Q ss_pred ----eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEEcCCCCCCEEEcCC
Q 020946 182 ----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH--------DGAVPPVIHRDIKSSNILLDQS 249 (319)
Q Consensus 182 ----~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlk~~Nill~~~ 249 (319)
..++++||+++|+|.+++... .+++.++..++.|++.||.||| +.+ ++||||||+|||++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN 183 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence 789999999999999999543 5899999999999999999999 777 9999999999999999
Q ss_pred CceEEeecCCCccccccc-----cccccccccCccCccccCCCC------CCcchhhHHHHHHHHHHHhC----------
Q 020946 250 MRARVADFGLSREEMVDK-----HAANIRGTFGYLDPEYISTRN------FTKKSDVYSFGVLLFELIAG---------- 308 (319)
Q Consensus 250 ~~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~------~~~~~Dv~slGvil~elltg---------- 308 (319)
+.+||+|||++....... ......+|+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 999999999986543322 223457899999999997652 34789999999999999999
Q ss_pred CCCCCCcc
Q 020946 309 RSPLQGLM 316 (319)
Q Consensus 309 ~~pf~~~~ 316 (319)
+.||.+..
T Consensus 264 ~~p~~~~~ 271 (342)
T 1b6c_B 264 QLPYYDLV 271 (342)
T ss_dssp CCTTTTTS
T ss_pred ccCccccC
Confidence 78997753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=285.18 Aligned_cols=200 Identities=30% Similarity=0.513 Sum_probs=168.6
Q ss_pred Hhccccc-ccccCCCceEEEEEe---CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 112 ATCNFTT-LIGQGAFGPVYKAQM---STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 112 ~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
.+|.+.+ .||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4677777 999999999999943 346789999987543 22356789999999999999999999999 6677899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
++||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 95 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999999653 45999999999999999999999998 99999999999999999999999999875432
Q ss_pred ccc----ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 266 DKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 266 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 221 122346788999999988889999999999999999999 9999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=288.68 Aligned_cols=204 Identities=30% Similarity=0.450 Sum_probs=157.1
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
...|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+++.+|+.+++.++||||+++++++...+..+++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 45678889999999999999964 478899999986542 3335678899999999999999999999999999999999
Q ss_pred EccCCChhhhhhh------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 189 FMSKGSLASHLYD------ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 189 ~~~~g~l~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
|+++++|.+++.. .....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999998863 12456899999999999999999999998 99999999999999999999999998764
Q ss_pred cccc------ccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVD------KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 3221 11234568999999999865 5789999999999999999999999987543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=281.27 Aligned_cols=200 Identities=32% Similarity=0.505 Sum_probs=167.2
Q ss_pred hcccccccccCCCceEEEEEe-CCC---cEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE-EEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STG---ETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH-MLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv 186 (319)
.|.+.+.||+|+||+||+|.. .++ ..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 345568999999999999964 233 379999987543 33456789999999999999999999999876654 999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+||+.+++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999965 3456899999999999999999999998 999999999999999999999999998743221
Q ss_pred -----ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCcc
Q 020946 267 -----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLM 316 (319)
Q Consensus 267 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg-~~pf~~~~ 316 (319)
.......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||.+..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 122345678999999999999999999999999999999994 55555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=290.37 Aligned_cols=203 Identities=30% Similarity=0.511 Sum_probs=174.4
Q ss_pred HHHHhcccccccccCCCceEEEEEe-----CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC--
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-- 181 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 181 (319)
+....|.+.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3456788899999999999999973 468899999998766556678999999999999999999999987644
Q ss_pred eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 182 ~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
..++++||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 689999999999999999654 346899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccccc----ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 262 EEMVDKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 262 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 5433221 22345677899999998888999999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.77 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=159.6
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe-----
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ----- 182 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 182 (319)
..-.+|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+++..+..++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 4456788999999999999999965 5789999998865432 23456678888899999999999999876443
Q ss_pred --EEEEEEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEEcCCCCCCEEEcC-CCceEEe
Q 020946 183 --HMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH--DGAVPPVIHRDIKSSNILLDQ-SMRARVA 255 (319)
Q Consensus 183 --~~lv~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlk~~Nill~~-~~~~kl~ 255 (319)
.+++|||+++ +|...+.. .....+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999976 55444432 34456899999999999999999999 777 999999999999997 8999999
Q ss_pred ecCCCccccccccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 256 DFGLSREEMVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 256 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|||+++............+|+.|+|||++.+. .++.++||||||+++|||++|+.||.+...
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 99999865555555566789999999998654 489999999999999999999999987653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=292.76 Aligned_cols=195 Identities=27% Similarity=0.437 Sum_probs=165.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE-----
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH----- 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----- 183 (319)
.+|.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 4677889999999999999954 578999999987542 23356788999999999999999999999876654
Q ss_pred -EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 184 -MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 184 -~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+++|||+. ++|.+.+. ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 122 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 67877762 34999999999999999999999998 99999999999999999999999999874
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 194 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 194 AD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 33 23345678999999999876 789999999999999999999999998765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=313.85 Aligned_cols=194 Identities=30% Similarity=0.521 Sum_probs=164.4
Q ss_pred cccccCCCceEEEEEe---CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQM---STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||.||+|.+ ..++.||||+++... ....+++.+|+.+++.++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 246789999997542 3345789999999999999999999999864 568899999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc----c
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK----H 268 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 268 (319)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999643 46999999999999999999999998 9999999999999999999999999987443221 1
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 223456788999999999999999999999999999998 9999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.14 Aligned_cols=204 Identities=25% Similarity=0.418 Sum_probs=174.4
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeC-CC-cEEEEEEeccCCcccHHHHHHHHHHHhccCCCC------cceeeeEEe
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMS-TG-ETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN------LVNLVGYCA 178 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~ 178 (319)
.+....+|.+.+.||+|+||.||+|... ++ ..||+|++... ....+.+.+|+.+++.++|++ ++.+.+++.
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3444568899999999999999999653 44 68999998643 233567788999999887665 899999999
Q ss_pred eCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE------------
Q 020946 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL------------ 246 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill------------ 246 (319)
..+..+++|||+ ++++.+++.......+++.++..++.|++.||.|||+++ |+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccc
Confidence 999999999999 678888887666567999999999999999999999998 9999999999999
Q ss_pred -------cCCCceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 247 -------DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 247 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+.++.+||+|||++.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 667899999999987532 223456789999999999999999999999999999999999999987653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=290.82 Aligned_cols=202 Identities=28% Similarity=0.368 Sum_probs=171.1
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CC-----CcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HR-----NLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~ 183 (319)
..+|.+.+.||+|+||+||+|.. .+++.||+|++... ......+..|+.+++.++ |+ +|+++.+++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 45788899999999999999964 47889999998643 223456778888888775 54 499999999999999
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc--CCCceEEeecCCCc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD--QSMRARVADFGLSR 261 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~ 261 (319)
++||||+. ++|.+++.......+++..+..++.|++.||.|||++. .+|+||||||+|||++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 59999997766567999999999999999999999531 2399999999999995 47789999999997
Q ss_pred cccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 262 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 210 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 210 QLG--QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ETT--CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecc--cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 542 233456789999999999999999999999999999999999999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=294.66 Aligned_cols=199 Identities=24% Similarity=0.360 Sum_probs=169.5
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC-CcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR-NLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 189 (319)
..|.+.+.||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++|+ ++..+..++.+.+..+++|||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4678899999999999999964 6789999998765432 23578899999999874 555566667778899999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEE---cCCCceEEeecCCCcccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~ 266 (319)
+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 85 ~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred C-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9 99999998643 346999999999999999999999998 9999999999999 68899999999999754332
Q ss_pred cc--------ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.. .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 21 2256799999999999999999999999999999999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=288.70 Aligned_cols=198 Identities=26% Similarity=0.381 Sum_probs=168.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeC-----CeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 184 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 4678889999999999999965 478999999986542 33355788999999999999999999988754 6789
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+++||+. ++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 91 lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 9999996 689888854 35999999999999999999999998 9999999999999999999999999987432
Q ss_pred ccc-----------cccccccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDK-----------HAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~-----------~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......||+.|+|||++. +..++.++||||||+++|||++|+.||.+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 122346899999999875 4778999999999999999999999998765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=284.06 Aligned_cols=201 Identities=28% Similarity=0.412 Sum_probs=149.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHH-HHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... .....++..|+. +++.++||||+++++++.+.+..+++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 4567788999999999999965 478999999987643 233345555555 7778899999999999999999999999
Q ss_pred EccCCChhhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 189 FMSKGSLASHLYD---ENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 189 ~~~~g~l~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
|+++ +|.+++.. .....+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9975 77776642 2345799999999999999999999998 8 9999999999999999999999999997654
Q ss_pred ccccccccccccCccCcccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDKHAANIRGTFGYLDPEYI----STRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.........||+.|+|||++ .+..++.++||||||+++|||++|+.||.+..
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 44444445799999999998 46678999999999999999999999998743
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=289.19 Aligned_cols=192 Identities=29% Similarity=0.497 Sum_probs=156.2
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHH--HHHHhccCCCCcceeeeEEee-----CCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTE--VMLLGRLHHRNLVNLVGYCAE-----KGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~~~~~~~~-----~~~~~ 184 (319)
..|.+.+.||+|+||.||+|.. +++.||+|++.... ...+..| +..+..++||||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 4678889999999999999977 78999999986432 2334444 444556899999999986543 23678
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCCeEEcCCCCCCEEEcCCCceEEe
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG---------AVPPVIHRDIKSSNILLDQSMRARVA 255 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~i~H~dlk~~Nill~~~~~~kl~ 255 (319)
+||||+++|+|.+++... ..++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 999999999999999554 358999999999999999999998 7 9999999999999999999999
Q ss_pred ecCCCcccccc---------ccccccccccCccCccccCC-------CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 256 DFGLSREEMVD---------KHAANIRGTFGYLDPEYIST-------RNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 256 Dfg~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99998643221 12224568999999999976 456788999999999999999976653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=286.18 Aligned_cols=195 Identities=27% Similarity=0.439 Sum_probs=165.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe------
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ------ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 182 (319)
.+|.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 3577889999999999999965 578999999986542 2334678899999999999999999999987653
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++|||+. ++|.+++. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 58877763 24899999999999999999999998 99999999999999999999999999875
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus 176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 332 2334578999999999876 778999999999999999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=284.84 Aligned_cols=198 Identities=22% Similarity=0.362 Sum_probs=145.5
Q ss_pred Hhcccc-cccccCCCceEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee----CCeEEE
Q 020946 112 ATCNFT-TLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHML 185 (319)
Q Consensus 112 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 185 (319)
..|.+. +.||+|+||.||+|... +++.||+|++... .....+....+..++||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 456774 56999999999999654 7899999998543 1222233344667799999999999876 456899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCceEEeecCCCcc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSRE 262 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~ 262 (319)
||||+++|+|.+++.......+++.++..++.|++.||.|||+++ ++||||||+|||++. ++.+||+|||++..
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999999997765567999999999999999999999998 999999999999976 45599999999875
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus 181 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 181 TTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp C-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 432 233456789999999999888899999999999999999999999976543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.65 Aligned_cols=202 Identities=31% Similarity=0.519 Sum_probs=162.7
Q ss_pred HHhcccccccccCCCceEEEEEeC--CCc--EEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS--TGE--TVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
...|.+.+.||+|+||+||+|.+. +++ .||+|++... .....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999642 333 6899988654 2234567899999999999999999999998765 8
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
++++||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999986542 45899999999999999999999998 999999999999999999999999998754
Q ss_pred cccc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 264 MVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 264 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 3222 1223457788999999988889999999999999999999 9999987653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=291.16 Aligned_cols=201 Identities=24% Similarity=0.365 Sum_probs=169.7
Q ss_pred HHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----------CCCcceeeeE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----------HRNLVNLVGY 176 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~ 176 (319)
+...+|.+.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++++++ ||||++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 3456789999999999999999964 57899999998643 233566788999888876 8999999999
Q ss_pred EeeCC----eEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEc----
Q 020946 177 CAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLD---- 247 (319)
Q Consensus 177 ~~~~~----~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~---- 247 (319)
+...+ ..+++|||+ +++|.+++.......+++..+..++.|++.||+|||++ + |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 87654 789999999 88999999776666799999999999999999999998 8 99999999999995
Q ss_pred --CCCceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 248 --QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 248 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..+.+||+|||++..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 344899999999875432 2344578999999999999999999999999999999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=280.48 Aligned_cols=199 Identities=26% Similarity=0.441 Sum_probs=150.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc-cc-HHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK-QG-EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
..|.+.+.||+|+||.||+|.. .+|+.||+|++..... .. .+.+.++..+++.++||||+++++++.+.+..+++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 4677889999999999999966 4789999999875432 22 2334455567888899999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
|+ ++.+ ..+.......+++..+..++.|++.||.|||++ + ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~-~~~~-~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 105 LM-GTCA-EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CC-SEEH-HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cc-CCcH-HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 99 4444 444333345799999999999999999999985 8 9999999999999999999999999987554444
Q ss_pred cccccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 268 HAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
......+|+.|+|||++. ...++.++||||||+++|||++|+.||.+.
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 444567899999999984 567889999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.73 Aligned_cols=201 Identities=21% Similarity=0.373 Sum_probs=168.1
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccC--CCCcceeeeEEeeCCeEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~ 184 (319)
+....|.+.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++.+++ ||||+++++++.+.+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345678889999999999999998888999999998654 2334567899999999997 599999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
++|| +.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||+++ +.+||+|||++....
T Consensus 105 lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 9999 5688999999654 46899999999999999999999998 999999999999975 799999999987543
Q ss_pred ccc---cccccccccCccCccccCC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 265 VDK---HAANIRGTFGYLDPEYIST-----------RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 265 ~~~---~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 322 1234568999999999865 478899999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=285.26 Aligned_cols=202 Identities=25% Similarity=0.428 Sum_probs=171.6
Q ss_pred HHHHHhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCcc------cHHHHHHHHHHHhccC--CCCcceeeeEEe
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQ------GEKEFQTEVMLLGRLH--HRNLVNLVGYCA 178 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~ 178 (319)
+....+|.+.+.||+|+||.||+|. ..+++.||+|++...... ..+.+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3445678899999999999999995 457899999998654221 2245678999999996 599999999999
Q ss_pred eCCeEEEEEEEccC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEee
Q 020946 179 EKGQHMLVYVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVAD 256 (319)
Q Consensus 179 ~~~~~~lv~e~~~~-g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~D 256 (319)
+.+..++++|++.. ++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999976 8999998653 46899999999999999999999998 99999999999999 788999999
Q ss_pred cCCCccccccccccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 257 FGLSREEMVDKHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 257 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
||++..... .......+|+.|+|||++.+..+ +.++||||||+++|||++|+.||.+.
T Consensus 194 fg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 194 FGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred Ccccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 999875432 23344668999999999877665 68899999999999999999999764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=302.06 Aligned_cols=200 Identities=28% Similarity=0.455 Sum_probs=173.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEee------CCeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE------KGQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~ 183 (319)
.+|.+.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5788999999999999999955 57899999998754 33445678999999999999999999998765 6678
Q ss_pred EEEEEEccCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCc---eEEeecCC
Q 020946 184 MLVYVFMSKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADFGL 259 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~ 259 (319)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999996533 235899999999999999999999998 999999999999997664 99999999
Q ss_pred CccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
+.............+|+.|+|||++.+..++.++||||||+++|||++|+.||.+
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9865555555567899999999999999999999999999999999999999965
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.19 Aligned_cols=205 Identities=27% Similarity=0.453 Sum_probs=171.7
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC----CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
++...+|.+.+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.+++.++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 344577889999999999999999653 2457999998654 3333567899999999999999999999985 456
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred eEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 89999999999999999654 346899999999999999999999998 99999999999999999999999999975
Q ss_pred ccccc--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 263 EMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 43322 1223456789999999988899999999999999999997 9999987653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=272.82 Aligned_cols=192 Identities=27% Similarity=0.450 Sum_probs=160.1
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee----------
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE---------- 179 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 179 (319)
...|.+.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788999999999999999965 57899999998543 2335678899999999999999999998865
Q ss_pred ---CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEee
Q 020946 180 ---KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD 256 (319)
Q Consensus 180 ---~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 256 (319)
.+..+++|||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 45789999999999999999653 345788999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccccc---------------ccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHh
Q 020946 257 FGLSREEMVD---------------KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIA 307 (319)
Q Consensus 257 fg~~~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~ellt 307 (319)
||++...... .......+|+.|+|||++.+. .++.++||||||+++|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9998743211 122345689999999999764 78999999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=281.50 Aligned_cols=200 Identities=29% Similarity=0.465 Sum_probs=166.7
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
...|.+.+.||+|+||.||+|...+ .+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3467888999999999999998743 49999986542 2334567889999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc---
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV--- 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~--- 265 (319)
|+++++|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+||+++ ++.+||+|||++.....
T Consensus 110 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999543 346899999999999999999999998 99999999999998 67999999999764321
Q ss_pred ---cccccccccccCccCccccCC---------CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 ---DKHAANIRGTFGYLDPEYIST---------RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ---~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
........|++.|+|||++.. ..++.++||||||+++|||++|+.||.+...
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 122234458999999999864 4578999999999999999999999987653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=308.33 Aligned_cols=201 Identities=21% Similarity=0.319 Sum_probs=169.9
Q ss_pred cCHHHHHHHhcccccccccCCCceEEEEEeC--CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMS--TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 104 ~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
+...++...+|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.+.
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 3444555678999999999999999999764 6899999998654 333456788999999999999999999999876
Q ss_pred Ce-----EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEe
Q 020946 181 GQ-----HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA 255 (319)
Q Consensus 181 ~~-----~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 255 (319)
+. .|+||||+++++|.+++.. .+++.+++.++.|++.||.|||+++ |+||||||+|||++++ .+||+
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 65 7999999999999987732 5999999999999999999999998 9999999999999986 89999
Q ss_pred ecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 256 DFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 256 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+..
T Consensus 224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~ 280 (681)
T 2pzi_A 224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRY 280 (681)
T ss_dssp CCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred ecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccc
Confidence 99998754322 455699999999998654 4899999999999999999999987643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=280.49 Aligned_cols=203 Identities=27% Similarity=0.438 Sum_probs=163.8
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcc------cHHHHHHHHHHHhcc----CCCCcceeee
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ------GEKEFQTEVMLLGRL----HHRNLVNLVG 175 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~ 175 (319)
.+.....|.+.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 455567899999999999999999965 57889999998654321 223456788888888 8999999999
Q ss_pred EEeeCCeEEEEEEE-ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceE
Q 020946 176 YCAEKGQHMLVYVF-MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRAR 253 (319)
Q Consensus 176 ~~~~~~~~~lv~e~-~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~k 253 (319)
++.+.+..++++|+ +.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 7899999999654 35999999999999999999999998 99999999999999 889999
Q ss_pred EeecCCCccccccccccccccccCccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 254 VADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 254 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
|+|||++..... .......+++.|+|||++.+..+. .++||||||+++|||++|+.||.+.
T Consensus 181 l~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 181 LIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp ECCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEEcchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 999999875433 233456689999999998776664 5899999999999999999999764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=289.78 Aligned_cols=196 Identities=24% Similarity=0.361 Sum_probs=155.7
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..+++|||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556889999999998876668999999998543 245678899999876 89999999999999999999999995
Q ss_pred CCChhhhhhhcCCCC-----CCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC-------------CceE
Q 020946 192 KGSLASHLYDENYGP-----LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-------------MRAR 253 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~-----l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-------------~~~k 253 (319)
|+|.+++....... .++..+..++.|++.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999986543211 123345789999999999999998 9999999999999754 4899
Q ss_pred EeecCCCccccccc-----cccccccccCccCccccCC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCc
Q 020946 254 VADFGLSREEMVDK-----HAANIRGTFGYLDPEYIST-------RNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315 (319)
Q Consensus 254 l~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~-------~~~~~~~Dv~slGvil~ellt-g~~pf~~~ 315 (319)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999987543321 1234579999999999865 678999999999999999999 99999764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=288.22 Aligned_cols=197 Identities=24% Similarity=0.373 Sum_probs=158.6
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+|.+.+.||+|+||+||.....+++.||||++...... .+.+|+.+++.+ +||||+++++++.+.+..+++|||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 356777899999999977665568999999998654322 346799999998 7999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-----CCceEEeecCCCccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-----SMRARVADFGLSREEMV 265 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~~ 265 (319)
. |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ...+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6 69999986543 34555567889999999999999998 999999999999953 23688999999875432
Q ss_pred c----ccccccccccCccCccccC---CCCCCcchhhHHHHHHHHHHHh-CCCCCCCcc
Q 020946 266 D----KHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM 316 (319)
Q Consensus 266 ~----~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~ 316 (319)
. .......||+.|+|||++. ...++.++|||||||++|||++ |+.||....
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 2 2233467999999999997 4677889999999999999999 999996543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=284.22 Aligned_cols=194 Identities=19% Similarity=0.228 Sum_probs=161.8
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--------cccHHHHHHHHHHHhccC---------CCCcc
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--------KQGEKEFQTEVMLLGRLH---------HRNLV 171 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv 171 (319)
+...+|.+.+.||+|+||+||+|.. +|+.||+|++.... ....+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3356788999999999999999987 78999999987542 222367888999888885 77777
Q ss_pred eeeeEEe-----------------e-------------CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHH
Q 020946 172 NLVGYCA-----------------E-------------KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221 (319)
Q Consensus 172 ~~~~~~~-----------------~-------------~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~ 221 (319)
++.+.+. + .+..++||||+++|++.+.+.. ..+++.+++.++.|++.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 7766542 2 6789999999999987777733 45899999999999999
Q ss_pred HHHHHH-cCCCCCeEEcCCCCCCEEEcCCC--------------------ceEEeecCCCccccccccccccccccCccC
Q 020946 222 GLEYLH-DGAVPPVIHRDIKSSNILLDQSM--------------------RARVADFGLSREEMVDKHAANIRGTFGYLD 280 (319)
Q Consensus 222 ~l~~LH-~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~a 280 (319)
||+||| +++ |+||||||+|||++.++ .+||+|||+++.... ....||+.|+|
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~a 245 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTC
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccC
Confidence 999999 888 99999999999999887 899999999975432 24479999999
Q ss_pred ccccCCCCCCcchhhHHHHHH-HHHHHhCCCCCCC
Q 020946 281 PEYISTRNFTKKSDVYSFGVL-LFELIAGRSPLQG 314 (319)
Q Consensus 281 PE~~~~~~~~~~~Dv~slGvi-l~elltg~~pf~~ 314 (319)
||++.+.. +.++|||||+++ .+++++|..||.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99998766 899999998777 7778889999965
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=265.78 Aligned_cols=176 Identities=13% Similarity=0.121 Sum_probs=153.1
Q ss_pred HHHHhcccccccccCCCceEEEEEeC-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
+...+|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+..+..++||||+++++++.+.+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44567899999999999999999654 589999999976533 22467899999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+||||+++++|.+++.. + ....++..++.|++.||+|||+++ |+||||||+|||+++++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 99999999999999832 2 355678899999999999999999 9999999999999999999998544
Q ss_pred ccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
|++| ++.++||||||+++|||++|+.||.+.+.
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3333 68999999999999999999999998654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.48 Aligned_cols=197 Identities=21% Similarity=0.233 Sum_probs=153.0
Q ss_pred cccccccccCCCceEEEEE-eCCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCC-CCcc---------eeeeE---
Q 020946 114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHH-RNLV---------NLVGY--- 176 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv---------~~~~~--- 176 (319)
+...+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|+.+++.++| +|.. .....
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 4566889999999999996 56799999999874322 235778999999999987 2211 11111
Q ss_pred ---------Eee-----CCeEEEEEEEccCCChhhhhh-----hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEc
Q 020946 177 ---------CAE-----KGQHMLVYVFMSKGSLASHLY-----DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237 (319)
Q Consensus 177 ---------~~~-----~~~~~lv~e~~~~g~l~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 237 (319)
+.. ....+++|+++ .++|.+++. ......+++..++.++.|++.||+|||+++ |+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 111 12345555554 689988874 223345788899999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCceEEeecCCCccccccccccccccccCccCcccc----------CCCCCCcchhhHHHHHHHHHHHh
Q 020946 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI----------STRNFTKKSDVYSFGVLLFELIA 307 (319)
Q Consensus 238 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~Dv~slGvil~ellt 307 (319)
||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999998754332 344567 999999999 66678899999999999999999
Q ss_pred CCCCCCCccc
Q 020946 308 GRSPLQGLME 317 (319)
Q Consensus 308 g~~pf~~~~~ 317 (319)
|+.||.+...
T Consensus 313 g~~Pf~~~~~ 322 (413)
T 3dzo_A 313 ADLPNTDDAA 322 (413)
T ss_dssp SSCCCCTTGG
T ss_pred CCCCCCCcch
Confidence 9999988654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=259.90 Aligned_cols=175 Identities=25% Similarity=0.407 Sum_probs=150.4
Q ss_pred hcccc-cccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHH-hccCCCCcceeeeEEee----CCeEEE
Q 020946 113 TCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLL-GRLHHRNLVNLVGYCAE----KGQHML 185 (319)
Q Consensus 113 ~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~l 185 (319)
.|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 35555 7899999999999955 5789999999853 34567788887 56689999999999877 678899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCceEEeecCCCcc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSRE 262 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~ 262 (319)
+|||+++++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999998766567999999999999999999999999 999999999999998 78999999998853
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. +..++.++||||||+++|||++|+.||.+..
T Consensus 170 ~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 170 TT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp CT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred cc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 21 2456789999999999999999999997654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.23 Aligned_cols=184 Identities=20% Similarity=0.154 Sum_probs=130.2
Q ss_pred cccccCCCceEEEE-EeCCCcEEEEEEeccCC----------cccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEE
Q 020946 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDS----------KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 118 ~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 185 (319)
...+.|+.|....+ +.-.|+.+++|++.... ....++|.+|+++|+++ +|+||+++++++++.+..|+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34667777766665 33468899999986531 12345799999999999 79999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
||||++|++|.+.+... ++++.. +|+.||+.||+|+|+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999999543 456654 58899999999999999 99999999999999999999999999975433
Q ss_pred c-ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCC
Q 020946 266 D-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS 310 (319)
Q Consensus 266 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~ 310 (319)
. ....+.+||+.|+|||++.+ .+..++|+||+|+++++|.++..
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 2 33456789999999999975 45778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=243.30 Aligned_cols=181 Identities=17% Similarity=0.223 Sum_probs=146.1
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccCCc--------ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK--------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+.||+|+||+||+|.. .++.+++|....... ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46799999999999955 678889998644221 113457899999999999999977777777788899999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++++|.+++.. +..++.|++.||+|||+++ |+||||||+|||+++ .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999853 4689999999999999999 999999999999999 999999999986543221
Q ss_pred --------ccccccccCccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 269 --------AANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 269 --------~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
.....||+.|+|||++.. ..|+...|+|+..+-.++-+.++-+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 235679999999999976 668888999999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=198.83 Aligned_cols=155 Identities=14% Similarity=0.146 Sum_probs=122.4
Q ss_pred cccccccccCCCceEEEEEeCCCcEEEEEEeccCCc------------------ccHHHHHHHHHHHhccCCCCcceeee
Q 020946 114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK------------------QGEKEFQTEVMLLGRLHHRNLVNLVG 175 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~ 175 (319)
|.+.+.||+|+||.||+|...+|+.||+|++..... .....+.+|+.+++.++ | +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 345589999999999999777899999999864321 12456889999999998 5 66666
Q ss_pred EEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEe
Q 020946 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA 255 (319)
Q Consensus 176 ~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 255 (319)
++.. +..++||||+++++|.+ +. . .....++.|++.||.|||+++ ++||||||+|||++ ++.+||+
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence 5544 45699999999999988 41 1 124579999999999999999 99999999999999 9999999
Q ss_pred ecCCCccccccccccccccccCccCccccCC----------CCCCcchhhHH
Q 020946 256 DFGLSREEMVDKHAANIRGTFGYLDPEYIST----------RNFTKKSDVYS 297 (319)
Q Consensus 256 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~----------~~~~~~~Dv~s 297 (319)
|||+++ .+..++|||++.. ..|...+|+|.
T Consensus 235 DFG~a~------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 235 DFPQSV------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCTTCE------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred ECCCCe------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999985 2345788888743 34556667765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.3e-22 Score=167.25 Aligned_cols=135 Identities=19% Similarity=0.210 Sum_probs=103.9
Q ss_pred cccccccccCCCceEEEEEe-CCCcE--EEEEEeccCCcc------------------------cHHHHHHHHHHHhccC
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGET--VAVKVLATDSKQ------------------------GEKEFQTEVMLLGRLH 166 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 166 (319)
|.+.+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|+..+..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999976 68888 999987543111 0136788999999998
Q ss_pred CCCc--ceeeeEEeeCCeEEEEEEEccC-C----ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEEcC
Q 020946 167 HRNL--VNLVGYCAEKGQHMLVYVFMSK-G----SLASHLYDENYGPLTWNLRVHIALDVARGLEYLH-DGAVPPVIHRD 238 (319)
Q Consensus 167 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~d 238 (319)
|+++ ..++++ +..++||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.+ ++|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8764 333332 356899999942 4 55554421 234567889999999999999 888 99999
Q ss_pred CCCCCEEEcCCCceEEeecCCCcc
Q 020946 239 IKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 239 lk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
|||+|||+++ .++|+|||+|..
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEE
T ss_pred CCHHHEEEcC--cEEEEECccccc
Confidence 9999999998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-19 Score=158.41 Aligned_cols=135 Identities=13% Similarity=0.126 Sum_probs=96.5
Q ss_pred cccccccccCCCceEEEEEeCCCcEEEEEEeccCCc--------------ccHH--------HHHHHHHHHhccCCCCcc
Q 020946 114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK--------------QGEK--------EFQTEVMLLGRLHHRNLV 171 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~niv 171 (319)
|.+.+.||+|++|.||+|...+|+.||||+++.... .... ...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 677889999999999999888999999998754210 0011 123455666666444332
Q ss_pred eeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-
Q 020946 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM- 250 (319)
Q Consensus 172 ~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~- 250 (319)
-..-+... ..++||||+++++|..... .+ ....++.|++.+|.+||+++ +|||||||.|||+++++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCeeeecc--CceEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 21111112 2379999999888765431 11 23568899999999999998 99999999999998876
Q ss_pred ---------ceEEeecCCCc
Q 020946 251 ---------RARVADFGLSR 261 (319)
Q Consensus 251 ---------~~kl~Dfg~~~ 261 (319)
.+.|+||+-+-
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCE
T ss_pred cccccccccceEEEEeCCcc
Confidence 38999999653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-13 Score=116.99 Aligned_cols=142 Identities=15% Similarity=0.069 Sum_probs=110.5
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.|.+...++.|+.+.||++.. +++.+++|+...........+.+|...++.+. +..+.++++++.+.+..+++|||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 466677888888999999976 46899999986532223346888999998884 6778889999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA----------------------------------------- 230 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 230 (319)
+.++.+.+. +......++.+++.+|..||+..
T Consensus 94 G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 94 GVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 998877641 11223468889999999999811
Q ss_pred ---------------CCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 231 ---------------VPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 231 ---------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 02389999999999998766667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=5.5e-12 Score=106.40 Aligned_cols=131 Identities=18% Similarity=0.113 Sum_probs=97.3
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCC--cceeeeEEeeCCeEEEEEEEccCCChh
Q 020946 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVGYCAEKGQHMLVYVFMSKGSLA 196 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~l~ 196 (319)
..+.|..+.||++...+|..+++|+.... ....+.+|...++.+.+.+ +.+++++....+..+++|||+++.++.
T Consensus 27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 33456669999998777888999997543 2345778888888885444 456888888778899999999998874
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------------
Q 020946 197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA---------------------------------------------- 230 (319)
Q Consensus 197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------- 230 (319)
.. . .+ ...++.+++..|..||+..
T Consensus 104 --~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 --SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp --TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred --cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 21 1 11 2356777888888888643
Q ss_pred ---------CCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 231 ---------VPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 231 ---------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=3.9e-11 Score=106.26 Aligned_cols=140 Identities=16% Similarity=0.282 Sum_probs=104.6
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEec--cCC-cccHHHHHHHHHHHhccC--CCCcceeeeEEeeC---CeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLA--TDS-KQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEK---GQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~ 189 (319)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.+++.++.+. +..+++|||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56899999999999875 4678888775 322 122456788999998886 45578888888776 458999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA--------------------------------------- 230 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 230 (319)
+++..+.+.. ...++..+...++.+++..|..||+..
T Consensus 123 v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 123 VSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred cCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9988775422 123678888899999999999999731
Q ss_pred ----------------CCCeEEcCCCCCCEEEcCCCc--eEEeecCCCcc
Q 020946 231 ----------------VPPVIHRDIKSSNILLDQSMR--ARVADFGLSRE 262 (319)
Q Consensus 231 ----------------~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~ 262 (319)
.+.++|+|+++.||++++++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.17 E-value=2.5e-11 Score=105.03 Aligned_cols=186 Identities=21% Similarity=0.252 Sum_probs=119.9
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCC--cceeeeEEeeCC---eEEEEEEEcc
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRN--LVNLVGYCAEKG---QHMLVYVFMS 191 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~ 191 (319)
+.++.|....||+.. ..+++|+.... .....+.+|...++.+. +.. +.+.+......+ ..|+||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999863 56888886432 33567889999998873 333 334444433332 4588999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA----------------------------------------- 230 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 230 (319)
+.++..... ..++..++..++.+++..+..||+..
T Consensus 100 G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 100 GVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 988875432 23677777888888888888888621
Q ss_pred --------------CCCeEEcCCCCCCEEEcC--CCceEEeecCCCccccccccccccccccCccCccccCC-----CC-
Q 020946 231 --------------VPPVIHRDIKSSNILLDQ--SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-----RN- 288 (319)
Q Consensus 231 --------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~- 288 (319)
.+.++|+|++|.||++++ +..+.|+||+.+.................-..|+.... ..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 134799999999999998 55678999998754322111100000000012221100 00
Q ss_pred --------CCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 289 --------FTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 289 --------~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
.....+.|+++.++|++.+|..+|-
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1123689999999999999998763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.8e-07 Score=79.11 Aligned_cols=134 Identities=17% Similarity=0.133 Sum_probs=93.9
Q ss_pred cccCCCc-eEEEEEeC-CCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEccCCChh
Q 020946 120 IGQGAFG-PVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSKGSLA 196 (319)
Q Consensus 120 lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~l~ 196 (319)
+..|..+ .||+.... ++..+++|+.... ....+.+|...|+.+. +-.+.++++++.+.+..+++|+++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445555 68987654 4567888986432 3456788988888774 334677889999999999999999988776
Q ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---------------------------------------------
Q 020946 197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV--------------------------------------------- 231 (319)
Q Consensus 197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--------------------------------------------- 231 (319)
+..... ......++.+++..|.-||+...
T Consensus 109 ~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 109 QVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 654321 11223455566666666664210
Q ss_pred ----------CCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 232 ----------PPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 232 ----------~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999999887777999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=3e-07 Score=79.38 Aligned_cols=136 Identities=21% Similarity=0.226 Sum_probs=92.0
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC---CcceeeeEEe-eCCeEEEEEEEccCC
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLVGYCA-EKGQHMLVYVFMSKG 193 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g 193 (319)
+.++.|....||+. +..+++|+.. .......+.+|..+|..+.+. .+.+.+.++. ..+..+++|+++++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899987 5677888753 223346788999999998642 3455666664 345678999999988
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------
Q 020946 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA------------------------------------------- 230 (319)
Q Consensus 194 ~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 230 (319)
.+...... .++..+...++.+++..|..||+..
T Consensus 99 ~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 99 ILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp ECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred ECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 77653211 1344444555555555555555421
Q ss_pred --------------CCCeEEcCCCCCCEEEcC---CCc-eEEeecCCCccc
Q 020946 231 --------------VPPVIHRDIKSSNILLDQ---SMR-ARVADFGLSREE 263 (319)
Q Consensus 231 --------------~~~i~H~dlk~~Nill~~---~~~-~kl~Dfg~~~~~ 263 (319)
.+.++|+|++|.||++++ ++. ..|+||+.+...
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 124799999999999997 455 489999987543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=2e-07 Score=82.13 Aligned_cols=79 Identities=4% Similarity=-0.008 Sum_probs=53.8
Q ss_pred ccc-ccCCCceEEEEEeC-------CCcEEEEEEeccCC---cccHHHHHHHHHHHhccC-C--CCcceeeeEEeeC---
Q 020946 118 TLI-GQGAFGPVYKAQMS-------TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLH-H--RNLVNLVGYCAEK--- 180 (319)
Q Consensus 118 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--- 180 (319)
+.| +.|....+|+.... ++..+++|+..... ......+.+|...++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999998653 26678888865432 111245678888887774 2 3466778777655
Q ss_pred CeEEEEEEEccCCChh
Q 020946 181 GQHMLVYVFMSKGSLA 196 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~ 196 (319)
+..+++||++++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3578999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.4e-06 Score=74.67 Aligned_cols=74 Identities=18% Similarity=0.108 Sum_probs=47.9
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEeccCCc-------ccHHHHHHHHHHHhccCC--CCcc-eeeeEEeeCCeEEEE
Q 020946 118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-------QGEKEFQTEVMLLGRLHH--RNLV-NLVGYCAEKGQHMLV 186 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~niv-~~~~~~~~~~~~~lv 186 (319)
+.+|.|..+.||++... +++.+++|....... ...+.+..|.+.++.+.. +..+ +++.+ +.+..+++
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999653 568899997643211 123456778888887732 4444 44443 34456899
Q ss_pred EEEccCC
Q 020946 187 YVFMSKG 193 (319)
Q Consensus 187 ~e~~~~g 193 (319)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.20 E-value=8.3e-06 Score=69.52 Aligned_cols=75 Identities=17% Similarity=0.276 Sum_probs=54.4
Q ss_pred ccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC---CcceeeeEEeeCCeEEEEEEEccCC
Q 020946 117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLVGYCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~~~~g 193 (319)
.+.+|.|..+.||+....+|+.+.+|+...........|..|...|+.+.-. .+.+.+++. ..+++|||++.+
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 3568999999999999999999999987655444455688899988877422 234444432 247889998765
Q ss_pred Ch
Q 020946 194 SL 195 (319)
Q Consensus 194 ~l 195 (319)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=2.2e-05 Score=68.34 Aligned_cols=138 Identities=19% Similarity=0.254 Sum_probs=76.8
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----CCCcceee-e--EEeeCCeEEEEEEEc
Q 020946 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----HRNLVNLV-G--YCAEKGQHMLVYVFM 190 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~~ 190 (319)
.|+.|..+.||+....+| .+++|+.... ...+..|..++..+. .|.++... | +....+..+++++|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 466677899999977544 5889988642 233344444444442 24433311 1 223467789999999
Q ss_pred cCCChh--------------hhhhhc--CC--C--------CCCHHHH-------------------------------H
Q 020946 191 SKGSLA--------------SHLYDE--NY--G--------PLTWNLR-------------------------------V 213 (319)
Q Consensus 191 ~~g~l~--------------~~l~~~--~~--~--------~l~~~~~-------------------------------~ 213 (319)
++..+. ..++.. .. . .-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 886542 111111 00 0 0122210 0
Q ss_pred HHHHHHHHHHHHHHc--------C--CCCCeEEcCCCCCCEEEcCCCceEEeecCCCc
Q 020946 214 HIALDVARGLEYLHD--------G--AVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261 (319)
Q Consensus 214 ~i~~~i~~~l~~LH~--------~--~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 261 (319)
.+..++..++.+|+. . ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666653 0 12349999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.4e-05 Score=67.47 Aligned_cols=136 Identities=16% Similarity=0.170 Sum_probs=89.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCCcceeeeEEeeCCeEEEEEEEccCCC
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLVYVFMSKGS 194 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~ 194 (319)
+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.++...+..+++|||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4588999999999976 5678888986532 3556888988888773 3567788888888889999999999875
Q ss_pred hhh-----------hhhhcCC-C-------------------CCCHHHHH---HHH----------------HHHHHH-H
Q 020946 195 LAS-----------HLYDENY-G-------------------PLTWNLRV---HIA----------------LDVARG-L 223 (319)
Q Consensus 195 l~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~i~~~-l 223 (319)
+.. .++.... . .-+|.... ++. ..++.- .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 421 1222111 0 01343221 111 111111 2
Q ss_pred HHHHc-CCCCCeEEcCCCCCCEEEcCCCceEEeecC
Q 020946 224 EYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFG 258 (319)
Q Consensus 224 ~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 258 (319)
..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23422 2235699999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.15 E-value=8.3e-06 Score=73.50 Aligned_cols=76 Identities=13% Similarity=0.113 Sum_probs=48.1
Q ss_pred CCeEEcCCCCCCEEEcCCCceEEeecCCCccccccccccccc--cccCccCccccCCCC---CCcchhhHHHHHHHHHHH
Q 020946 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR--GTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELI 306 (319)
Q Consensus 232 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~---~~~~~Dv~slGvil~ell 306 (319)
+.++|+|++|.|||+++++ ++++||+.+............. -...|++|+...... -....++......+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3499999999999999876 9999999886543222211111 123466666553211 122355667888888877
Q ss_pred hC
Q 020946 307 AG 308 (319)
Q Consensus 307 tg 308 (319)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00077 Score=58.42 Aligned_cols=32 Identities=28% Similarity=0.374 Sum_probs=27.0
Q ss_pred CCeEEcCCCCCCEEEcCC----CceEEeecCCCccc
Q 020946 232 PPVIHRDIKSSNILLDQS----MRARVADFGLSREE 263 (319)
Q Consensus 232 ~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~~ 263 (319)
+.++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 349999999999999875 68999999987643
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.51 E-value=3.2e-05 Score=43.37 Aligned_cols=31 Identities=23% Similarity=0.473 Sum_probs=22.7
Q ss_pred CCCCcceEEehhHHHHHHHHHHHHHHHHhhh
Q 020946 2 KGESSGLIIGISIGVVIGVLLAISALFCFRY 32 (319)
Q Consensus 2 ~~~~~~~i~~i~~~~~~~~~l~~~~~~~~~~ 32 (319)
++.+.+.|+||++|+++++++++.+++++++
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHee
Confidence 3567888999999999888776665554443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00051 Score=59.19 Aligned_cols=142 Identities=13% Similarity=0.183 Sum_probs=76.7
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCC--cceeee------EEeeCCeEEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVG------YCAEKGQHMLVYVF 189 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~------~~~~~~~~~lv~e~ 189 (319)
+.|+.|....+|+....+| .+++|+.... .....+..|..++..+.... +.+++. +....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3467788889999977555 6788887652 12234556666666553111 223332 11234677899999
Q ss_pred ccCCChhh--------------hhhhc--CCC-C----C---CHHHHHH------------HHHHHHHHHHHHHcC----
Q 020946 190 MSKGSLAS--------------HLYDE--NYG-P----L---TWNLRVH------------IALDVARGLEYLHDG---- 229 (319)
Q Consensus 190 ~~~g~l~~--------------~l~~~--~~~-~----l---~~~~~~~------------i~~~i~~~l~~LH~~---- 229 (319)
+++..+.. .++.. ... + . .|..... +...+...++.++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98754321 11111 000 0 1 1221100 001234445555431
Q ss_pred CCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 230 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 113489999999999999876668999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00072 Score=59.79 Aligned_cols=139 Identities=16% Similarity=0.193 Sum_probs=80.2
Q ss_pred cccccCCCceEEEEEeC--------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCC-cceeeeEEeeCCeEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMS--------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN-LVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 188 (319)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+...+ ..++++++.++ +++|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 34666778889998764 2478999986432 223455678888888774222 35566665432 8999
Q ss_pred EccCCChhhh-----------------hhhcC---CCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 020946 189 FMSKGSLASH-----------------LYDEN---YGPLT--WNLRVHIALDVAR-------------------GLEY-- 225 (319)
Q Consensus 189 ~~~~g~l~~~-----------------l~~~~---~~~l~--~~~~~~i~~~i~~-------------------~l~~-- 225 (319)
|+++..+... ++... ..... +.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987544311 11111 11122 3455555543321 2233
Q ss_pred --HHcCC-CCCeEEcCCCCCCEEEcCC----CceEEeecCCCc
Q 020946 226 --LHDGA-VPPVIHRDIKSSNILLDQS----MRARVADFGLSR 261 (319)
Q Consensus 226 --LH~~~-~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~ 261 (319)
|.... ...++|+|+.+.||+++++ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 32222 1248999999999999876 789999999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00015 Score=62.05 Aligned_cols=70 Identities=7% Similarity=0.102 Sum_probs=41.6
Q ss_pred cccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCc-ceeeeEEeeCCeEEEEEEEc-cCCCh
Q 020946 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYVFM-SKGSL 195 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~l 195 (319)
+.|+.|....+|+. ..+++|+....... .....+|...++.+...++ .++++++ .+.-+++++|+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 56888999999998 56788887543221 1123457776666642223 3555543 33357889999 55444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00051 Score=61.89 Aligned_cols=71 Identities=17% Similarity=0.250 Sum_probs=46.9
Q ss_pred cccccCCCceEEEEEeCC--------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCc-ceeeeEEeeCCeEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMST--------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 188 (319)
+.|+.|-...+|+....+ +..+++|+.... .....+..|..++..+...++ .++++.+.+ .++++
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457788889999997643 578999987432 112455678888887753333 456665532 27899
Q ss_pred EccCCC
Q 020946 189 FMSKGS 194 (319)
Q Consensus 189 ~~~~g~ 194 (319)
|+++.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 987533
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0037 Score=53.85 Aligned_cols=74 Identities=14% Similarity=0.119 Sum_probs=47.6
Q ss_pred ccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC--CcceeeeE-----EeeCCeEEEEEEEcc
Q 020946 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR--NLVNLVGY-----CAEKGQHMLVYVFMS 191 (319)
Q Consensus 119 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~~ 191 (319)
.++ |....||+....+|+.+++|...... .....+..|...+..+... .+.+++.. ....+..++++++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 356 77889999877677789999986432 2345666777777666321 23334332 223556788999998
Q ss_pred CCC
Q 020946 192 KGS 194 (319)
Q Consensus 192 ~g~ 194 (319)
+..
T Consensus 111 G~~ 113 (328)
T 1zyl_A 111 GRQ 113 (328)
T ss_dssp CEE
T ss_pred CCC
Confidence 754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0017 Score=58.94 Aligned_cols=73 Identities=12% Similarity=0.142 Sum_probs=45.5
Q ss_pred cccccCCCceEEEEEeCC-CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCc-ceeeeEEeeCCeEEEEEEEccCCCh
Q 020946 118 TLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYVFMSKGSL 195 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~l 195 (319)
+.|+.|-...+|+....+ +..+++|+....... .-...+|..++..+...++ .++++++. + .++++|+++..+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 357778888999997754 478889987543211 1112578888888865555 45666653 2 249999986443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0002 Score=41.15 Aligned_cols=29 Identities=17% Similarity=0.260 Sum_probs=14.9
Q ss_pred CCcceEEehhHHHHHHHHHHHHHHHHhhh
Q 020946 4 ESSGLIIGISIGVVIGVLLAISALFCFRY 32 (319)
Q Consensus 4 ~~~~~i~~i~~~~~~~~~l~~~~~~~~~~ 32 (319)
.....++++++|+++++++.+++++++|+
T Consensus 9 ~~~~~Ia~~vVGvll~vi~~l~~~~~~RR 37 (44)
T 2jwa_A 9 SPLTSIISAVVGILLVVVLGVVFGILIKR 37 (44)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcccchHHHHHHHHHHHHHHHHHHhheeh
Confidence 34455788888854333333333333333
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0073 Score=52.47 Aligned_cols=30 Identities=20% Similarity=0.315 Sum_probs=26.7
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 233 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++|+|+.+.||++++++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 489999999999999888899999987653
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00051 Score=39.71 Aligned_cols=28 Identities=14% Similarity=0.175 Sum_probs=11.5
Q ss_pred cceEEehhHH-HHHHHHHHHHHHHHhhhh
Q 020946 6 SGLIIGISIG-VVIGVLLAISALFCFRYH 33 (319)
Q Consensus 6 ~~~i~~i~~~-~~~~~~l~~~~~~~~~~~ 33 (319)
.+.|++-++| ++++++++++.++++|++
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 3444444444 444333333333333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00055 Score=39.44 Aligned_cols=17 Identities=24% Similarity=0.184 Sum_probs=7.7
Q ss_pred CCcceEEehhHHHHHHH
Q 020946 4 ESSGLIIGISIGVVIGV 20 (319)
Q Consensus 4 ~~~~~i~~i~~~~~~~~ 20 (319)
...+.|++-++|.++++
T Consensus 7 s~~~aIA~gVVgGv~~v 23 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFIL 23 (44)
T ss_dssp CSSHHHHHHHHHHHHHH
T ss_pred CCcceEEEeehHHHHHH
Confidence 33444555555433333
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0026 Score=55.99 Aligned_cols=72 Identities=7% Similarity=0.075 Sum_probs=41.7
Q ss_pred cccccCCCceEEEEEeCC---------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCC-cceeeeEEeeCCeEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMST---------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN-LVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 187 (319)
+.++.|..-.+|+....+ +..+++|+....... ......|...++.+...+ ..++++.. . -++++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999997643 268888987543221 112356777777664333 33565543 2 26899
Q ss_pred EEccCCC
Q 020946 188 VFMSKGS 194 (319)
Q Consensus 188 e~~~~g~ 194 (319)
+|+++..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.11 E-value=0.027 Score=45.26 Aligned_cols=99 Identities=13% Similarity=0.090 Sum_probs=64.7
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 272 (319)
-+|.+.|... ..++++++++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3678888543 46899999999999999998776221111 1334457999999999988764 2111
Q ss_pred ccccCccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 020946 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307 (319)
Q Consensus 273 ~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt 307 (319)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888763 455788899999999999775
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=95.74 E-value=0.004 Score=33.50 Aligned_cols=30 Identities=23% Similarity=0.409 Sum_probs=24.0
Q ss_pred CCCcceEEehhHHHHHHHHHHHHHHHHhhh
Q 020946 3 GESSGLIIGISIGVVIGVLLAISALFCFRY 32 (319)
Q Consensus 3 ~~~~~~i~~i~~~~~~~~~l~~~~~~~~~~ 32 (319)
+.+.+.++||++|.+++.+++++++++|.|
T Consensus 3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 3 TVSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 457788999999999988887777777643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.087 Score=47.13 Aligned_cols=73 Identities=11% Similarity=0.132 Sum_probs=45.5
Q ss_pred cccccCCCceEEEEEeCC--------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCC-cceeeeEEeeCCeEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMST--------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN-LVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 188 (319)
+.+..|-...+|+....+ +..+++|+....... .-...+|..+++.+...+ ..++++.+ . -+++++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 456677788899997643 578999987543221 122356777777774323 34455533 2 268899
Q ss_pred EccCCCh
Q 020946 189 FMSKGSL 195 (319)
Q Consensus 189 ~~~~g~l 195 (319)
|+++..+
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9987553
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.05 E-value=0.078 Score=42.41 Aligned_cols=117 Identities=9% Similarity=0.125 Sum_probs=76.6
Q ss_pred CCCCcceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEE
Q 020946 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL 245 (319)
Q Consensus 166 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 245 (319)
.||++++. .+-.+.+...+.|+.-+.+.-...+ ..++...+++++.+|+....++++ -+|--+.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 68888866 4555556555555544322222222 237788999999999988866654 379999999999
Q ss_pred EcCCCceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 020946 246 LDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314 (319)
Q Consensus 246 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~ 314 (319)
++.++.+++.-.|+-.. ++|. ..+...=.-.+=+++..+++++..|..
T Consensus 112 f~~~~~p~i~~RGik~~----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNV----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp ECTTSCEEESCCEETTT----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EcCCCCEEEEEccCccC----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999988875321 1221 112222233566777778888777754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=94.38 E-value=0.21 Score=40.10 Aligned_cols=82 Identities=9% Similarity=0.033 Sum_probs=59.9
Q ss_pred CCCCcceeeeEEeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeEEcCCCCCCE
Q 020946 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE-YLHDGAVPPVIHRDIKSSNI 244 (319)
Q Consensus 166 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dlk~~Ni 244 (319)
.||.+ -..+-.+.+...+.|+.-+++.-...+ ..++...+++++.+++.... ++++ -+|--+.|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 57887 333445666776766665444333333 23778899999999888777 5553 47899999999
Q ss_pred EEcCCCceEEeecCC
Q 020946 245 LLDQSMRARVADFGL 259 (319)
Q Consensus 245 ll~~~~~~kl~Dfg~ 259 (319)
+++.++.+++.-.|+
T Consensus 116 ~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 116 MFNRALEPFFLHVGV 130 (219)
T ss_dssp EECTTCCEEESCCEE
T ss_pred EEeCCCcEEEEEcCC
Confidence 999999999988875
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.46 E-value=0.16 Score=29.25 Aligned_cols=33 Identities=30% Similarity=0.309 Sum_probs=22.2
Q ss_pred ceEEehhHHHHHHHHHH-HHHHHHhhhhccccCC
Q 020946 7 GLIIGISIGVVIGVLLA-ISALFCFRYHRKRSQI 39 (319)
Q Consensus 7 ~~i~~i~~~~~~~~~l~-~~~~~~~~~~~~~~~~ 39 (319)
+-..+|+.|++.+++++ ++++.+|.+.|+|++.
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 44567888888867554 5555667777877653
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.69 E-value=0.045 Score=31.17 Aligned_cols=13 Identities=38% Similarity=0.746 Sum_probs=5.8
Q ss_pred EehhHHHHHHHHH
Q 020946 10 IGISIGVVIGVLL 22 (319)
Q Consensus 10 ~~i~~~~~~~~~l 22 (319)
.+|+++++.++++
T Consensus 13 ~~I~~~vv~Gv~l 25 (41)
T 2k9y_A 13 LAVIGGVAVGVVL 25 (41)
T ss_dssp THHHHHHHHHHHH
T ss_pred EEEEeehhHHHHH
Confidence 3444444444433
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.47 E-value=0.11 Score=29.45 Aligned_cols=22 Identities=36% Similarity=0.629 Sum_probs=10.3
Q ss_pred ceEEehhHHHHHHHHHHHHHHH
Q 020946 7 GLIIGISIGVVIGVLLAISALF 28 (319)
Q Consensus 7 ~~i~~i~~~~~~~~~l~~~~~~ 28 (319)
.++++++.|++++++++++.++
T Consensus 14 ~I~~~vv~Gv~ll~~iv~~~~~ 35 (41)
T 2k9y_A 14 AVIGGVAVGVVLLLVLAGVGFF 35 (41)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHS
T ss_pred EEEeehhHHHHHHHHHHHHhee
Confidence 3445555555554434443333
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=91.34 E-value=0.0084 Score=32.48 Aligned_cols=7 Identities=43% Similarity=0.790 Sum_probs=3.4
Q ss_pred EEehhHH
Q 020946 9 IIGISIG 15 (319)
Q Consensus 9 i~~i~~~ 15 (319)
|++.++|
T Consensus 10 IaagVvg 16 (35)
T 1iij_A 10 IIATVVG 16 (35)
T ss_dssp HHHHHHH
T ss_pred eHHHHHH
Confidence 4444555
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.04 E-value=0.52 Score=27.01 Aligned_cols=18 Identities=22% Similarity=0.277 Sum_probs=11.6
Q ss_pred EehhHHHHHHHHHHHHHH
Q 020946 10 IGISIGVVIGVLLAISAL 27 (319)
Q Consensus 10 ~~i~~~~~~~~~l~~~~~ 27 (319)
.+|+.|++.+++++++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~ 27 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVG 27 (44)
T ss_dssp HHHHHHHHHHHHHHHHHH
T ss_pred ceEEEeehHHHHHHHHHH
Confidence 356666666777776544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.52 E-value=0.065 Score=48.57 Aligned_cols=59 Identities=8% Similarity=0.073 Sum_probs=16.9
Q ss_pred ccccccCCCceEEEEEeCC-CcEEEE------EEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEe
Q 020946 117 TTLIGQGAFGPVYKAQMST-GETVAV------KVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178 (319)
Q Consensus 117 ~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 178 (319)
.+.|| ||.||+|.+.. ..+||+ |..... ..+....+.+|..++..++|||+++..++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 45666 99999997753 357888 665432 2223346778888888899999999888754
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.78 E-value=0.66 Score=26.54 Aligned_cols=28 Identities=21% Similarity=0.122 Sum_probs=16.2
Q ss_pred hhHHHHHHHHHHHHHHHHhhhhccccCC
Q 020946 12 ISIGVVIGVLLAISALFCFRYHRKRSQI 39 (319)
Q Consensus 12 i~~~~~~~~~l~~~~~~~~~~~~~~~~~ 39 (319)
|+.+++.+++++++++.++.+.|||+..
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 4444444334455566667788887653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.74 E-value=0.37 Score=42.64 Aligned_cols=29 Identities=31% Similarity=0.450 Sum_probs=24.6
Q ss_pred eEEcCCCCCCEEE------cCCCceEEeecCCCcc
Q 020946 234 VIHRDIKSSNILL------DQSMRARVADFGLSRE 262 (319)
Q Consensus 234 i~H~dlk~~Nill------~~~~~~kl~Dfg~~~~ 262 (319)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998753
|
| >2llm_A Amyloid beta A4 protein; alzheimer'S disease, protein fibril; NMR {Homo sapiens} PDB: 2loh_A | Back alignment and structure |
|---|
Probab=84.92 E-value=0.19 Score=28.34 Aligned_cols=28 Identities=25% Similarity=0.484 Sum_probs=15.3
Q ss_pred CCcceEEehhHHHHHHHHHHHHHHHHhh
Q 020946 4 ESSGLIIGISIGVVIGVLLAISALFCFR 31 (319)
Q Consensus 4 ~~~~~i~~i~~~~~~~~~l~~~~~~~~~ 31 (319)
.+.++++|+.++.+.+..++++.++.+|
T Consensus 14 ~srga~iGL~v~gVai~~vIVvsl~mlR 41 (43)
T 2llm_A 14 SNKGAIIGLMVGGVVIATVIVITLVMLK 41 (43)
Confidence 3566777777655554444444444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 319 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-66 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-41 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-66
Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 109 LQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGR 164
++ +F + +G G G V+K +G +A K++ + K + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 165 LHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
+ +V G G+ + M GSL L G + + +++ V +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
YL + ++HRD+K SNIL++ ++ DFG+S + ++D A + GT Y+ PE +
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERL 175
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+++ +SD++S G+ L E+ GR P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-64
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG G+FG VYK + VAVK+L + Q + F+ EV +L + H N++ +GY
Sbjct: 15 RIGSGSFGTVYKGK--WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
Q +V + SL HL+ + IA A+G++YLH +IH
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 237 RDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRN---FT 290
RD+KS+NI L + + ++ DFGL+ + G+ ++ PE I ++ ++
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+SDVY+FG++L+EL+ G+ P + +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRD 216
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-62
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVM 160
+P + K +++ +G G FG V+ + VAVK L S F E
Sbjct: 10 VPRETLKLVER--------LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEAN 60
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
L+ +L H+ LV L + ++ +M GSL L + LT N + +A +A
Sbjct: 61 LMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGY 278
G+ ++ + IHRD++++NIL+ ++ ++ADFGL+R E+ + +
Sbjct: 120 EGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
PE I+ FT KSDV+SFG+LL E++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-60
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
+G+G FG VY A+ + +A+KVL + E + + EV + L H N++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
GY + + L+ + G++ L + ++A L Y H V
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS---KRV 127
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
IHRDIK N+LL + ++ADFG S + GT YL PE I R +K D
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 186
Query: 295 VYSFGVLLFELIAGRSPLQGLMEQQ 319
++S GVL +E + G+ P + Q+
Sbjct: 187 LWSLGVLCYEFLVGKPPFEANTYQE 211
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 6e-60
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 7/207 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
F IG G FG V+ + VA+K + + E++F E ++ +L H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G C E+ LV+ FM G L+ + G + + LDV G+ YL + V
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACV 122
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
IHRD+ + N L+ ++ +V+DFG++R + + + + PE S ++ K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEQQ 319
SDV+SFGVL++E+ +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNS 209
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 6e-60
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
PE ++ + + +G GAFG VYKAQ T A KV+ T S++ +++ E+
Sbjct: 10 PEDFWEIIGE--------LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 61
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
+L H N+V L+ + ++ F + G++ + + + PLT + +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTL 120
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYL 279
L YLHD +IHRD+K+ NIL ++ADFG+S + + + GT ++
Sbjct: 121 DALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177
Query: 280 DPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
PE + R + K+DV+S G+ L E+ P L +
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 9e-60
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQT 157
PE + DL++ IG G+FG VY A+ + E VA+K ++ KQ ++
Sbjct: 13 PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
EV L +L H N + G + LV + + L + + PL +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTH 122
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
+GL YLH +IHRD+K+ NILL + ++ DFG + + A + GT
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANSFVGTPY 176
Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
++ PE I + + K DV+S G+ EL + PL +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-59
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 8/208 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
F +G G FG V + VA+K++ + E EF E ++ L H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G C ++ ++ +M+ G L ++L + + + DV +EYL
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
+HRD+ + N L++ +V+DFGLSR + + + + PE + F+ K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 293 SDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
SD+++FGVL++E+ + G+ P + +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSE 209
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-59
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 15/219 (6%)
Query: 103 EYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLL 162
+ K+L+ IG+G FG V G VAVK + + + F E ++
Sbjct: 3 ALNMKELK-----LLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVM 54
Query: 163 GRLHHRNLVNLVGYCAE-KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
+L H NLV L+G E KG +V +M+KGSL +L L + + +LDV
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
+EYL +HRD+ + N+L+ + A+V+DFGL++E + + P
Sbjct: 115 AMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAP 169
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
E + + F+ KSDV+SFG+LL+E+ + GR P + +
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (483), Expect = 2e-59
Identities = 64/239 (26%), Positives = 115/239 (48%), Gaps = 27/239 (11%)
Query: 104 YSYKDLQKATCNFTT-----------LIGQGAFGPVYKAQM----STGETVAVKVLATD- 147
++++D +A F +IG G FG V + VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 148 SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
+++ ++F +E ++G+ H N+++L G + M++ FM GSL +N G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR------ 261
T V + +A G++YL D +HRD+ + NIL++ ++ +V+DFGLSR
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+ A + + PE I R FT SDV+S+G++++E+++ G P + Q
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 189 bits (480), Expect = 3e-58
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 7/204 (3%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G GAFG V++ +TG A K + T + ++ + E+ + L H LVNL
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+ + +++Y FMS G L + DE+ ++ + V V +GL ++H+ +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHL 148
Query: 238 DIKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
D+K NI+ +S ++ DFGL+ + GT + PE + +D+
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 208
Query: 296 YSFGVLLFELIAGRSPLQGLMEQQ 319
+S GVL + L++G SP G + +
Sbjct: 209 WSVGVLSYILLSGLSPFGGENDDE 232
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-58
Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 17/231 (7%)
Query: 91 KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK 149
K ++VS G P+ Y +K IGQGA G VY A ++TG+ VA++ + +
Sbjct: 8 KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTW 209
++ E++++ + N+VN + + +V +++ GSL + + +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDE 115
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKH 268
+ + + LE+LH VIHRDIKS NILL ++ DFG +
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ + GT ++ PE ++ + + K D++S G++ E+I G P +
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-57
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 10/211 (4%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG G++G K + S G+ + K L + ++ ++ +EV LL L H N+V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 176 YCAEKGQHML--VYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHD--G 229
++ L V + G LAS + + L + + + L+ H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN 288
V+HRD+K +N+ LD ++ DFGL+R D A GT Y+ PE ++ +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 190
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ +KSD++S G LL+EL A P +++
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-57
Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVM 160
IP S + K +GQG FG V+ + VA+K L + F E
Sbjct: 14 IPRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQ 64
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
++ +L H LV L + +V +MSKGSL L E L V +A +A
Sbjct: 65 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGY 278
G+ Y+ +HRD++++NIL+ +++ +VADFGL+R E+ + +
Sbjct: 124 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
PE FT KSDV+SFG+LL EL GR P G++ ++
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (461), Expect = 3e-56
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 103 EYSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVML 161
E D+ +G G +G VY+ TVAVK L D+ + E EF E +
Sbjct: 13 EMERTDIT-----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
+ + H NLV L+G C + ++ FM+ G+L +L + N ++ + +++A ++
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYL 279
+EYL IHRD+ + N L+ ++ +VADFGLSR D + A+ + +
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
PE ++ F+ KSDV++FGVLL+E+ ++
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-55
Identities = 69/229 (30%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGET---VAVKVLATD-SKQGEKEFQT 157
P + D++ F +IG+G FG V KA++ A+K + SK ++F
Sbjct: 5 PVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 59
Query: 158 EVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY------------ 204
E+ +L +L HH N++NL+G C +G L + G+L L
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119
Query: 205 --GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
L+ +H A DVARG++YL IHRD+ + NIL+ ++ A++ADFGLSR
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 176
Query: 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
+ V R ++ E ++ +T SDV+S+GVLL+E+++
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-55
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 120 IGQGAFGPVYKAQM---STGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLVNLV 174
+G G FG V K +TVAVK+L ++ E E ++ +L + +V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
G C E MLV G L +L + + + V+ G++YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPEYISTRNFT 290
+HRD+ + N+LL A+++DFGLS+ +E K + + + PE I+ F+
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
KSDV+SFGVL++E + G+ P +G+ +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-55
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 120 IGQGAFGPVYKAQM---STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVG 175
+G G FG V + VA+KVL +++ + +E E ++ +L + +V L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
C + MLV G L L + + + + V+ G++YL + +
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFV 131
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEYISTRNFTK 291
HRD+ + N+LL A+++DFGLS+ D R + PE I+ R F+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+SDV+S+GV ++E ++ G+ P + + +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPE 220
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 6e-55
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
F IG+G+F VYK T VA L +K + F+ E +L L H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 173 LVGYCAE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
K +LV M+ G+L ++L + + + + + +GL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 229 GAVPPVIHRDIKSSNILL-DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
PP+IHRD+K NI + + ++ D GL+ A + GT ++ PE +
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMYEEK 188
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ + DVY+FG+ + E+ P
Sbjct: 189 -YDESVDVYAFGMCMLEMATSEYPYSECQNAA 219
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-55
Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 47/268 (17%)
Query: 96 VSASGIPEYSYKDLQKATCN-----------FTTLIGQGAFGPVYKA------QMSTGET 138
V+ S EY Y D ++ + F ++G GAFG V A +
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69
Query: 139 VAVKVLATDSKQGEKE-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA 196
VAVK+L + E+E +E+ ++ +L H N+VNL+G C G L++ + G L
Sbjct: 70 VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129
Query: 197 SHLY---------------------DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
++L +E+ LT+ + A VA+G+E+L +
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 186
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA---NIRGTFGYLDPEYISTRNFTKK 292
HRD+ + N+L+ ++ DFGL+R+ M D + N R ++ PE + +T K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 293 SDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
SDV+S+G+LL+E+ + G +P G+
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDA 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (457), Expect = 9e-55
Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 7/204 (3%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G GAFG V++ +TG K + T + + E+ ++ +LHH L+NL
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+K + +L+ F+S G L + E+Y ++ ++ GL+++H+ ++H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 238 DIKSSNILLDQSMRARV--ADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
DIK NI+ + + V DFGL+ + D+ T + PE + +D+
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDM 211
Query: 296 YSFGVLLFELIAGRSPLQGLMEQQ 319
++ GVL + L++G SP G + +
Sbjct: 212 WAIGVLGYVLLSGLSPFAGEDDLE 235
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-54
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
IG+G FG V++ + GE VAVK+ ++ ++ + E+ L H N++ + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 180 KGQH----MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV---- 231
LV + GSL +L N +T + +AL A GL +LH V
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 232 -PPVIHRDIKSSNILLDQSMRARVADFGL-----SREEMVDKHAANIRGTFGYLDPEYIS 285
P + HRD+KS NIL+ ++ +AD GL S + +D + GT Y+ PE +
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 286 TRN------FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
K++D+Y+ G++ +E+ S + Q
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-54
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
+G+GA+G V A T E VAVK++ + + + E+ + L+H N+V G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
E L + S G L + E + + G+ YLH + H
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNF-TKK 292
RDIK N+LLD+ +++DFGL+ ++ + GT Y+ PE + R F +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEQQ 319
DV+S G++L ++AG P +
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSC 213
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-54
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 15/208 (7%)
Query: 115 NFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
+F +IG+G FG VY + AVK L + GE +F TE +++ H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 170 LVNLVGYCAE-KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
+++L+G C +G ++V +M G L + + +E T + L VA+G+++L
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEY 283
+HRD+ + N +LD+ +VADFGL+R E + + ++ E
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSP 311
+ T+ FT KSDV+SFGVLL+EL+ +P
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP 233
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 5e-54
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
++G+G+F V A+ ++T A+K+L + E ++ RL H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ + + G L ++ G ++ LEYLH +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGI 129
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTK 291
IHRD+K NILL++ M ++ DFG ++ + A + GT Y+ PE ++ ++ K
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
SD+++ G ++++L+AG P + E
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYL 217
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 4e-53
Identities = 69/250 (27%), Positives = 115/250 (46%), Gaps = 38/250 (15%)
Query: 105 SYKDLQKATCNFTTL--IGQGAFGPVYKAQ------MSTGETVAVKVLATD-SKQGEKEF 155
L+ N + IG+GAFG V++A+ VAVK+L + S + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 156 QTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY----------- 204
Q E L+ + N+V L+G CA L++ +M+ G L L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 205 -----------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253
PL+ ++ IA VA G+ YL + +HRD+ + N L+ ++M +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 254 VADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GR 309
+ADFGLSR K N ++ PE I +T +SDV+++GV+L+E+ + G
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 310 SPLQGLMEQQ 319
P G+ ++
Sbjct: 241 QPYYGMAHEE 250
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-51
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 119 LIGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-HHRNL 170
+G GAFG V +A TVAVK+L + E+E +E+ +L L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLY----------------DENYGPLTWNLRVH 214
VNL+G C G +++ + G L + L +++ L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AAN 271
+ VA+G+ +L IHRD+ + NILL ++ DFGL+R+ D + N
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
R ++ PE I +T +SDV+S+G+ L+EL + S
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 4e-51
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 4/207 (1%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVN 172
+F ++G GAF V A+ T + VA+K +A + +G E + E+ +L ++ H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L G L+ +S G L + ++ G T + V ++YLHD +
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
+ LD+ + ++DFGLS+ E + GT GY+ PE ++ + ++K
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEQQ 319
D +S GV+ + L+ G P + +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAK 216
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-51
Identities = 42/204 (20%), Positives = 87/204 (42%), Gaps = 8/204 (3%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G+G FG V++ S+ +T K + + + E+ +L HRN+++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+ ++++ F+S + + + + L V V L++LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 238 DIKSSNILLDQSMRARV--ADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
DI+ NI+ + + +FG +R+ + + Y PE + +D+
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDM 186
Query: 296 YSFGVLLFELIAGRSPLQGLMEQQ 319
+S G L++ L++G +P QQ
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQ 210
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-50
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
++G GAFG VYK + GE V + V S + KE E ++ + + ++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L+G C L+ M G L + E+ + ++ + +A+G+ YL D
Sbjct: 76 LLGIC-LTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLED---R 130
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNF 289
++HRD+ + N+L+ ++ DFGL++ E + HA + ++ E I R +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 290 TKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
T +SDV+S+GV ++EL+ G P G+ +
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-50
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 119 LIGQGAFGPVYKAQMSTGE-----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
+IG G FG VYK + T VA+K L + ++ +F E ++G+ H N++
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L G ++ M++ +M G+ E G + V + +A G++YL +
Sbjct: 74 LEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---M 129
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN----IRGTFGYLDPEYISTRN 288
+HRD+ + NIL++ ++ +V+DFGLSR D A + + PE IS R
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
FT SDV+SFG++++E++ +
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-50
Identities = 67/231 (29%), Positives = 96/231 (41%), Gaps = 25/231 (10%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATD---SKQGEK 153
I E + L+K +G G+FG V + + +VAVK L D +
Sbjct: 5 IGEKDLRLLEK--------LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 56
Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
+F EV + L HRNL+ L G +V GSL L G
Sbjct: 57 DFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLS 114
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----A 269
A+ VA G+ YL IHRD+ + N+LL ++ DFGL R +
Sbjct: 115 RYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171
Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
+ + F + PE + TR F+ SD + FGV L+E+ G+ P GL Q
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-49
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 11/207 (5%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT----EVMLLGRLHHRNLVNL 173
++G+G+FG V+ A+ T + A+K L D + + + + +L H L ++
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
K V +++ G L H+ ++ + A ++ GL++LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS---KG 123
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFTKK 292
+++RD+K NILLD+ ++ADFG+ +E M+ N GT Y+ PE + + +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183
Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEQQ 319
D +SFGVLL+E++ G+SP G E++
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEE 210
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-49
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 119 LIGQGAFGPVYKAQM----STGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL 173
IG+G FG V++ + VA+K + +E F E + + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
+G + ++ + G L S L + A ++ L YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
+HRDI + N+L+ + ++ DFGLSR E+ A+ + ++ PE I+ R FT
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
SDV+ FGV ++E++ G P QG+
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 5e-49
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 16/220 (7%)
Query: 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEV 159
YS +D Q +G G+FG V+ + G A+KVL + + + E
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 160 MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
++L + H ++ + G + Q ++ ++ G L S L P + A +V
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEV 113
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL 279
LEYLH +I+RD+K NILLD++ ++ DFG ++ V + GT Y+
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYI 168
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
PE +ST+ + K D +SFG+L++E++AG +P +
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (415), Expect = 2e-48
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVM---LLGRLHHRNLV 171
+IG+G FG VY + TG+ A+K L KQGE E + L+ +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
+ + + M+ G L HL +G + A ++ GLE++H+
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHN--- 125
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-RNFT 290
V++RD+K +NILLD+ R++D GL+ + K GT GY+ PE + +
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
+D +S G +LF+L+ G SP +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQ 208
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (405), Expect = 5e-48
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
++G G V+ A+ + VAVKVL D + F+ E L+H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 175 GYCAEK----GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
+ +V ++ +L ++ GP+T + + D + L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQ-- 129
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD----KHAANIRGTFGYLDPEYIST 286
+IHRD+K +NI++ + +V DFG++R A + GT YL PE
Sbjct: 130 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ +SDVYS G +L+E++ G P G
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (399), Expect = 4e-47
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---------ATDSKQGEKEFQTEVMLLGRLH-H 167
++G+G V + T + AVK++ A + ++ + EV +L ++ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
N++ L LV+ M KG L +L L+ I + + LH
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALH 127
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST- 286
++HRD+K NILLD M ++ DFG S + + + GT YL PE I
Sbjct: 128 K---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 287 -----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ K+ D++S GV+++ L+AG P +
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-47
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 30/244 (12%)
Query: 91 KRSNVVSASGIP-----EYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVL 144
K + VV+ G E SY D + +IG G+FG VY+A+ +GE VA+K +
Sbjct: 2 KVTTVVATPGQGPDRPQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKV 53
Query: 145 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM------LVYVFMSKGSLASH 198
Q ++ E+ ++ +L H N+V L + G+ LV ++ +
Sbjct: 54 ----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 199 L-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVAD 256
Y L + R L Y+H + HRDIK N+LLD + ++ D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 257 FGLSREEMVDKHAANIRGTFGYLDP-EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
FG +++ + + + + Y P ++T DV+S G +L EL+ G+ G
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 316 MEQQ 319
Sbjct: 227 SGVD 230
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 8e-47
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-----FQTEVMLLGRLHHRNLVN 172
+G+G F VYKA+ +T + VA+K + + K+ E+ LL L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
L+ K LV+ FM + +N LT + L +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---H 119
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIST-RNFT 290
++HRD+K +N+LLD++ ++ADFGL++ A + T Y PE + R +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
D+++ G +L EL+ L G
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPG 203
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-46
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRL---HHRNLVN 172
IG+GA+G V+KA+ + G VA+K + T + EV +L L H N+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 173 LVGYCAEKGQHMLVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
L C + + L ++L + + + RGL++LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
V+HRD+K NIL+ S + ++ADFGL+R ++ T Y PE + +
Sbjct: 135 ---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ D++S G + E+ + +G +
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-46
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 17/210 (8%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
++G G G V + T E A+K+L Q + + EV L R ++V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 177 C----AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
A + ++V + G L S + D T I + ++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI- 132
Query: 233 PVIHRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
HRD+K N+L + ++ DFG ++E T Y+ PE + +
Sbjct: 133 --AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
K D++S GV+++ L+ G P
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-45
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 16/212 (7%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE------KEFQTEVMLLGRLHHRNLV 171
+G G F V K + STG A K + + ++ + EV +L + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
L K +L+ ++ G L L LT + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 232 PPVIHRDIKSSNILLDQ----SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
+ H D+K NI+L R ++ DFGL+ + NI GT ++ PE ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
++D++S GV+ + L++G SP G +Q+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-45
Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 119 LIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGR-LHHRNL 170
+G+GAFG V +A + +T TVAVK+L + E + +E+ +L HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 171 VNLVGYCAEKGQH-MLVYVFMSKGSLASHLYDENY--------------GPLTWNLRVHI 215
VNL+G C + G M++ F G+L+++L + LT +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANI 272
+ VA+G+E+L IHRD+ + NILL + ++ DFGL+R+ D +
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
R ++ PE I R +T +SDV+SFGVLL+E+ + +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-45
Identities = 69/229 (30%), Positives = 115/229 (50%), Gaps = 31/229 (13%)
Query: 119 LIGQGAFGPVYKAQM--------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHR 168
+G+GAFG V A+ + VAVK+L +D +++ + +E+ ++ + H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--------------ENYGPLTWNLRVH 214
N++NL+G C + G ++ + SKG+L +L L+ V
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAAN 271
A VARG+EYL IHRD+ + N+L+ + ++ADFGL+R K N
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQQ 319
R ++ PE + R +T +SDV+SFGVLL+E+ G SP G+ ++
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-45
Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
+GQG+FG VY+ + VA+K + S + EF E ++ + ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLY--------DENYGPLTWNLRVHIALDVARGLE 224
L+G ++ +++ M++G L S+L + P + + + +A ++A G+
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDP 281
YL+ +HRD+ + N ++ + ++ DFG++R E + ++ P
Sbjct: 148 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLMEQQ 319
E + FT SDV+SFGV+L+E+ P QGL +Q
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-44
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGY 176
IG+GA+G V A VA+K ++ Q + E+ +L R H N++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
+ V++ + + LY L+ + + + RGL+Y+H V+
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF----GYLDPEYIST-RNFT 290
HRD+K SN+LL+ + ++ DFGL+R D + Y PE + + +T
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
K D++S G +L E+++ R G
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 1e-44
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 11/204 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLVG 175
+G G+FG V + +G A+K+L K+ E +L ++ LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
+ +V +++ G + SHL G + A + EYLH +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
+RD+K N+L+DQ +V DFG ++ + GT L PE I ++ + K D
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPLQGLMEQQ 319
++ GVL++E+ AG P Q
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 2e-44
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
IG+G +G VYKAQ + GET A+K + + + E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
K + +LV+ + + L D G L L + G+ Y HD V+HR
Sbjct: 70 HTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHR 124
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDV 295
D+K N+L+++ ++ADFGL+R + K+ I + + ++ ++ D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 296 YSFGVLLFELIAGRSPLQGLMEQQ 319
+S G + E++ G G+ E
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 115 NFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRN 169
NF + IG+G +G VYKA+ TGE VA+K + T+++ E+ LL L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
+V L+ + + LV+ F+ + + + L + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTR 287
V+HRD+K N+L++ ++ADFGL+R V + + T Y PE + +
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
++ D++S G + E++ R+ G
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPG 205
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-44
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 16/210 (7%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE------FQTEVMLLGRLH--HRN 169
L+G G FG VY +S VA+K + D E EV+LL ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
++ L+ + +L+ E G L L V + + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN- 128
Query: 230 AVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-R 287
V+HRDIK NIL+D + ++ DFG + D + GT Y PE+I R
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
+ + V+S G+LL++++ G P + E
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-44
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLV 174
L+G+G FG V + +TG A+K+L + +K TE +L H L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ V + + G L HL T ++ LEYLH V
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHS---RDV 126
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKS 293
++RDIK N++LD+ ++ DFGL +E + D GT YL PE + ++ +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 294 DVYSFGVLLFELIAGRSPLQGLMEQQ 319
D + GV+++E++ GR P ++
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (373), Expect = 4e-43
Identities = 41/215 (19%), Positives = 84/215 (39%), Gaps = 20/215 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
IG+G+FG +++ + + VA+K + + + E L + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
++G H ++ + + G L D + A + ++ +H+ +++R
Sbjct: 70 GQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 238 DIKSSNILLDQSMR-----ARVADFGLSR--------EEMVDKHAANIRGTFGYLDPEYI 284
DIK N L+ + V DFG+ + + + + N+ GT Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
R +++ D+ + G + + G P QGL
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 7e-43
Identities = 46/213 (21%), Positives = 87/213 (40%), Gaps = 18/213 (8%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
IG G+FG +Y ++ GE VA+K+ +K + E + + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
+G + ++ + + SL L++ + + +A + +EY+H IHR
Sbjct: 72 GAEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHR 127
Query: 238 DIKSSNIL---LDQSMRARVADFGLSR--------EEMVDKHAANIRGTFGYLDPEYIST 286
D+K N L + + DFGL++ + + + N+ GT Y
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+++ D+ S G +L G P QGL
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-41
Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 19/238 (7%)
Query: 88 EGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVL-- 144
GF R V + Y+DLQ +G GA+G V A TG VA+K L
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQP--------VGSGAYGAVCSAVDGRTGAKVAIKKLYR 53
Query: 145 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE-- 202
S+ K E+ LL + H N++ L+ F +
Sbjct: 54 PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM 113
Query: 203 NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
+ L + + + +GL Y+H +IHRD+K N+ +++ ++ DFGL+R+
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
D T Y PE I + +T+ D++S G ++ E+I G++ +G
Sbjct: 171 --ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-41
Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 10/198 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IG+G +G V+KA+ T E VA+K + D + E+ LL L H+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
+ LV+ F + +D G L + + +GL + H V+H
Sbjct: 70 LHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSD 294
RD+K N+L++++ ++A+FGL+R + + + + + ++ D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 295 VYSFGVLLFELIAGRSPL 312
++S G + EL PL
Sbjct: 185 MWSAGCIFAELANAGRPL 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 6e-41
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
IGQG FG V+KA+ TG+ VA+K + + + E+ +L L H N+VNL+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 177 CAE--------KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
C KG LV+ F L T + + + GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEY 283
++HRD+K++N+L+ + ++ADFGL+R + N T Y PE
Sbjct: 136 ---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
+ R++ D++ G ++ E+ +QG EQ
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-37
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 19/226 (8%)
Query: 102 PEYSYKDLQKATCNFT------TLIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGE 152
P + ++L K + +G GA+G V A TG VAVK L S
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ----HMLVYVFMSKGSLASHLYDENYGPLT 208
K E+ LL + H N++ L+ + + V G+ +++ LT
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLT 119
Query: 209 WNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
+ + + RGL+Y+H +IHRD+K SN+ +++ ++ DFGL+R D+
Sbjct: 120 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEM 175
Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
+ + ++ ++ + D++S G ++ EL+ GR+ G
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (338), Expect = 1e-37
Identities = 41/200 (20%), Positives = 85/200 (42%), Gaps = 17/200 (8%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
+G+G + V++A ++ E V VK+L +K+ + E+ +L L N++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 177 CAEKGQHMLVYVF--MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ VF ++ Y LT ++ + L+Y H +
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHS---MGI 150
Query: 235 IHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKK 292
+HRD+K N+++D + + R+ D+GL+ + + + PE + + +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 210
Query: 293 SDVYSFGVLLFELIAGRSPL 312
D++S G +L +I + P
Sbjct: 211 LDMWSLGCMLASMIFRKEPF 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-37
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 119 LIGQGAFGPVYKAQ----MSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRL-HHRN 169
++G GA+G V+ + TG+ A+KVL + + +TE +L +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
LV L + + L+ +++ G L +HL T + ++ LE+LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK- 147
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYIST- 286
+I+RDIK NILLD + + DFGLS+E + A + GT Y+ P+ +
Sbjct: 148 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 287 -RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQQ 319
K D +S GVL++EL+ G SP E+
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-36
Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 7/205 (3%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
IG GA G V A VA+K L ++ K E++L+ ++H+N+++L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 176 YCAEKGQHMLV-YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
+ V++ + ++L L ++ + G+++LH +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 140
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
IHRD+K SNI++ ++ DFGL+R T Y PE I + + D
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200
Query: 295 VYSFGVLLFELIAGRSPLQGLMEQQ 319
++S G ++ E++ + G
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYID 225
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (300), Expect = 7e-32
Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 22/215 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
+G G F V+ A+ M VA+K++ D K + + E+ LL R++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 178 A--------------EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
A G H+++ + +L + + + + I+ + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQS----MRARVADFGLSREEMVDKHAANIRGTFGYL 279
+Y+H +IH DIK N+L++ ++ L D+H N T Y
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
PE + + +D++S L+FELI G +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 3e-23
Identities = 31/196 (15%), Positives = 58/196 (29%), Gaps = 35/196 (17%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDS----------KQGEKEFQTEVMLLGRLHHR 168
L+G+G V+ VK G+ F + R R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
L L G VY + L + + + + + + +
Sbjct: 67 ALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-------EMVDKHAANIRGTFGYLDP 281
++H D+ N+L+ + + DF S E E++++ NI F
Sbjct: 122 ---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS---- 173
Query: 282 EYISTRNFTKKSDVYS 297
R + + D+ S
Sbjct: 174 -----RTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 319 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.81 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.89 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.98 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=357.65 Aligned_cols=199 Identities=26% Similarity=0.443 Sum_probs=179.5
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
+|.+.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 588889999999999999964 5799999999876655556789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 270 (319)
+|+|.+++.. ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 101 gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp TCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 9999988754 35999999999999999999999999 999999999999999999999999999754332 3345
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 56799999999999999999999999999999999999999987653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=352.35 Aligned_cols=199 Identities=30% Similarity=0.490 Sum_probs=178.4
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|+||+||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 578899999999999999965 57899999998643 23345678999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.... ..
T Consensus 87 y~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-~~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SR 160 (263)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-CC
T ss_pred ecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-Cc
Confidence 99999999999654 45999999999999999999999999 99999999999999999999999999975433 33
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence 4456799999999999999999999999999999999999999988764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=355.11 Aligned_cols=200 Identities=28% Similarity=0.433 Sum_probs=173.8
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.|++.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 578889999999999999965 579999999986543 233456899999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc---c
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---K 267 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~---~ 267 (319)
++|+|.+++. ....+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+..... .
T Consensus 86 ~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 86 SGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp TTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999984 3457999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred cccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+..+
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 2345679999999999987776 5789999999999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=355.81 Aligned_cols=202 Identities=29% Similarity=0.453 Sum_probs=179.3
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
.|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 578889999999999999965 5789999999987666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 270 (319)
+|+|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 93 ~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp TEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99999987553 356999999999999999999999999 999999999999999999999999998754322 2334
Q ss_pred ccccccCccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 271 NIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
...||+.|+|||++. ...|+.++|||||||++|||+||+.||.+.+..
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 577999999999983 556899999999999999999999999987653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=364.59 Aligned_cols=202 Identities=25% Similarity=0.434 Sum_probs=177.9
Q ss_pred HHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 110 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..+.|++.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|+.+|+.++|||||+++++|.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345788899999999999999964 57899999998755 3334567899999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ + |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp ECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 999999999999654 3599999999999999999999974 7 99999999999999999999999999975432
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+..||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 334467899999999999999999999999999999999999999987543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-51 Score=356.36 Aligned_cols=202 Identities=28% Similarity=0.494 Sum_probs=162.9
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.+.|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35689999999999999999965 578999999987543 2334568899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc---CCCceEEeecCCCccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMV 265 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~ 265 (319)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999954 356999999999999999999999998 99999999999995 578999999999986655
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 5555667899999999999999999999999999999999999999987653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=352.57 Aligned_cols=200 Identities=32% Similarity=0.544 Sum_probs=169.0
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
...|.+.+.||+|+||+||+|++. ..||||+++.. .....+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 345778899999999999999864 46999998654 34445789999999999999999999998755 56899999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc--
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-- 266 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-- 266 (319)
|+++|+|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999654 346999999999999999999999998 999999999999999999999999999754322
Q ss_pred -ccccccccccCccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 -KHAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 -~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.+.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 23345679999999999864 3589999999999999999999999988654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=351.00 Aligned_cols=206 Identities=28% Similarity=0.421 Sum_probs=166.3
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEee--CCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 186 (319)
..|++.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 3578889999999999999954 578999999987543 3335678899999999999999999999865 4568999
Q ss_pred EEEccCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--CCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 187 YVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAV--PPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
|||+++|+|.+++.. .....+++..++.++.|++.||.|||+++. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999998854 234579999999999999999999998541 3499999999999999999999999999975
Q ss_pred cccc-ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence 4332 233457899999999999999999999999999999999999999988654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-51 Score=353.25 Aligned_cols=208 Identities=30% Similarity=0.499 Sum_probs=181.2
Q ss_pred cCHHHHHHHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCe
Q 020946 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 104 ~~~~~l~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 182 (319)
+..+|+....|++.+.||+|+||+||+|.+ .+++.||||++..+. ...++|.+|+.++++++|||||+++++|.+.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 344455667788999999999999999965 468899999987543 346789999999999999999999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.+++|||+++|+|.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999998776778999999999999999999999998 99999999999999999999999999985
Q ss_pred ccccc--cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC-CCc
Q 020946 263 EMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL-QGL 315 (319)
Q Consensus 263 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf-~~~ 315 (319)
..... ......|++.|+|||++.+..|+.++|||||||++|||++|+.|| .+.
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence 43322 223345889999999999999999999999999999999966654 443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=353.28 Aligned_cols=201 Identities=26% Similarity=0.464 Sum_probs=176.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 3588999999999999999965 57899999998643 2233567899999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD- 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 266 (319)
||+++|+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999988654 46999999999999999999999999 999999999999999999999999999754322
Q ss_pred --ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 --KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 --~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 223456799999999999999999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=343.92 Aligned_cols=198 Identities=28% Similarity=0.467 Sum_probs=170.3
Q ss_pred cccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEee----CCeEEEE
Q 020946 114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLV 186 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 186 (319)
|++.+.||+|+||+||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36777899999999999965 57889999998654 33345678999999999999999999999865 3467999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc-CCCceEEeecCCCccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMV 265 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~ 265 (319)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc-
Confidence 9999999999999654 46999999999999999999999876 5699999999999996 57899999999997532
Q ss_pred cccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
........||+.|+|||++.+ .++.++|||||||++|||++|+.||.+..
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 233456789999999999865 59999999999999999999999998654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6e-51 Score=358.69 Aligned_cols=202 Identities=27% Similarity=0.444 Sum_probs=182.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
.+|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3688999999999999999964 579999999997766666678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC--CCceEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--SMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~ 268 (319)
++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 106 ~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 106 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 999999988543 346999999999999999999999999 999999999999964 57899999999986655555
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 230 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 5667899999999999999999999999999999999999999988654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=345.53 Aligned_cols=200 Identities=32% Similarity=0.558 Sum_probs=168.1
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
.|++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|+.++++++||||++++|+|.+.+..++||||+++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 467789999999999999998888999999987543 3467899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--ccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAA 270 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 270 (319)
|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 85 g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 85 GCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999998653 356899999999999999999999998 9999999999999999999999999997543322 223
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
...||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+.
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~ 208 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH
Confidence 4568999999999999999999999999999999999 5777766543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-50 Score=356.61 Aligned_cols=202 Identities=24% Similarity=0.408 Sum_probs=182.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
+.|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3588999999999999999964 579999999997765555677889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc--CCCceEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD--QSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|........
T Consensus 109 ~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 109 SGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99999987744 3346999999999999999999999999 99999999999998 678999999999987655555
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 233 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 6667899999999999999999999999999999999999999988654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=352.29 Aligned_cols=200 Identities=28% Similarity=0.460 Sum_probs=179.9
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 478889999999999999964 68999999998643 23345678899999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-cc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~ 267 (319)
|+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.... ..
T Consensus 86 y~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 86 YANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred ccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999998654 46899999999999999999999999 99999999999999999999999999986433 33
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 45567899999999999999999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=349.03 Aligned_cols=203 Identities=31% Similarity=0.507 Sum_probs=175.4
Q ss_pred HHHHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 109 l~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
+....|++.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3445788899999999999999998888899999997543 346789999999999999999999998865 56789999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK- 267 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 267 (319)
|+++|+|.+++.......+++.+++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999999886655556999999999999999999999998 9999999999999999999999999997543322
Q ss_pred -cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCcc
Q 020946 268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLM 316 (319)
Q Consensus 268 -~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg-~~pf~~~~ 316 (319)
......+|+.|+|||++.+..++.++|||||||++|||+|| ++||...+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~ 215 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence 23345689999999999988999999999999999999995 55555543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=349.68 Aligned_cols=203 Identities=32% Similarity=0.565 Sum_probs=165.6
Q ss_pred HhcccccccccCCCceEEEEEeC-CCc---EEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGE---TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
+.|++.+.||+|+||+||+|... +++ .||||.+... .....++|.+|+.+|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45667789999999999999653 332 6899988654 344456799999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++|+|.+++... ...+++.++..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999988643 356999999999999999999999998 999999999999999999999999999754332
Q ss_pred cc------ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 267 KH------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 267 ~~------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
.. .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+.+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 21 122457899999999999999999999999999999998 89999887643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-50 Score=348.42 Aligned_cols=199 Identities=28% Similarity=0.395 Sum_probs=174.0
Q ss_pred HHhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
...|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 35688889999999999999964 5788999999875532 2245688999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++|++..++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999988766643 356999999999999999999999999 99999999999999999999999999975432
Q ss_pred ccccccccccCccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 KHAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 345679999999999854 4689999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=344.02 Aligned_cols=202 Identities=27% Similarity=0.423 Sum_probs=180.7
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC------cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5789999999999999999965 579999999986431 223578999999999999999999999999999999
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC----ceEEeecCCC
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFGLS 260 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~~ 260 (319)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+|++|||++
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999998654 36999999999999999999999999 99999999999998776 5999999999
Q ss_pred ccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
.............+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+++
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 222 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH
Confidence 8665555556678999999999999999999999999999999999999999987643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-50 Score=348.95 Aligned_cols=198 Identities=28% Similarity=0.471 Sum_probs=177.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 188 (319)
.|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 478889999999999999965 57999999998643 23345678999999999999999999999999999999999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 268 (319)
|+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+... ..
T Consensus 85 ~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~--~~ 157 (316)
T d1fota_ 85 YIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP--DV 157 (316)
T ss_dssp CCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS--SC
T ss_pred ecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec--cc
Confidence 99999999888544 45889999999999999999999998 9999999999999999999999999997543 23
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH
Confidence 3457899999999999999999999999999999999999999988654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=337.99 Aligned_cols=201 Identities=28% Similarity=0.499 Sum_probs=178.4
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
.+.+.+.||+|+||+||+|+.++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+.+..++||||+++
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 3567889999999999999988888999999976543 467899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc--ccc
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAA 270 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 270 (319)
|+|..++.... ..+++..+.+++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 84 g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 84 GCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp EEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999876543 46899999999999999999999998 9999999999999999999999999997543322 223
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+.+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 4568999999999999999999999999999999998 89999987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=343.92 Aligned_cols=200 Identities=28% Similarity=0.490 Sum_probs=171.2
Q ss_pred hcccccc-cccCCCceEEEEEeC---CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 113 TCNFTTL-IGQGAFGPVYKAQMS---TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 113 ~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
.+.+.+. ||+|+||+||+|.+. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+ +..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 4455664 999999999999543 4557999999765 34446789999999999999999999999865 5689999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+++|+|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 88 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp ECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999987543 356999999999999999999999998 9999999999999999999999999997543221
Q ss_pred ----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 268 ----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 268 ----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
......||+.|+|||++....++.++|||||||++|||+| |+.||.+.+.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 2234568999999999998899999999999999999998 9999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=349.65 Aligned_cols=207 Identities=31% Similarity=0.573 Sum_probs=174.7
Q ss_pred HHHHHhcccccccccCCCceEEEEEeCC-C-----cEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMST-G-----ETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 179 (319)
|+....|.+.+.||+|+||+||+|.... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3445678899999999999999996532 2 36999988654 334456789999999998 89999999999999
Q ss_pred CCeEEEEEEEccCCChhhhhhhcC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcC
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDEN---------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 238 (319)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 999999999999999999996542 135899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeecCCCcccccccc---ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 020946 239 IKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG 314 (319)
Q Consensus 239 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~ 314 (319)
|||+|||++.++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999975443322 234568999999999999999999999999999999998 8999998
Q ss_pred ccc
Q 020946 315 LME 317 (319)
Q Consensus 315 ~~~ 317 (319)
.+.
T Consensus 270 ~~~ 272 (325)
T d1rjba_ 270 IPV 272 (325)
T ss_dssp CCC
T ss_pred CCH
Confidence 754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-49 Score=347.63 Aligned_cols=199 Identities=26% Similarity=0.393 Sum_probs=178.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
..|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+.+..++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688899999999999999965 57999999998643 2233567889999999999999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 267 (319)
||+.+|+|..++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+... .
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~--~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--G 193 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS--S
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc--c
Confidence 999999999998654 36999999999999999999999999 9999999999999999999999999997543 2
Q ss_pred cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 268 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 33457899999999999999999999999999999999999999988654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=340.43 Aligned_cols=194 Identities=30% Similarity=0.520 Sum_probs=165.0
Q ss_pred cccccCCCceEEEEEeC---CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 118 TLIGQGAFGPVYKAQMS---TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+.||+|+||+||+|.+. .++.||||++... +....++|.+|+.++++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999653 3468999998654 23335679999999999999999999999865 467899999999
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc----c
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK----H 268 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~----~ 268 (319)
|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999998653 46999999999999999999999998 9999999999999999999999999997533221 2
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 234568999999999999999999999999999999998 9999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=339.89 Aligned_cols=201 Identities=32% Similarity=0.498 Sum_probs=170.4
Q ss_pred HHhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
...|++.+.||+|+||+||+|...+++.||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35688999999999999999998888899999986543 346789999999999999999999999855 5678999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc--cc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 268 (319)
++|+|..++.......++|.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999999987765567999999999999999999999998 999999999999999999999999999754322 22
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg-~~pf~~~~ 316 (319)
.....+|+.|+|||++....++.++|||||||++|||++| ++||.+..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~ 219 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC
Confidence 3345689999999999999999999999999999999995 55555443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=339.45 Aligned_cols=201 Identities=28% Similarity=0.517 Sum_probs=174.9
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC---CcccHHHHHHHHHHHh-ccCCCCcceeeeEEeeCCeEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLG-RLHHRNLVNLVGYCAEKGQHMLVY 187 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~ 187 (319)
.|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+..|..++. .++||||+++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 578889999999999999954 57999999998643 1233445666666654 689999999999999999999999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD- 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 266 (319)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 83 Ey~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred eecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999654 45899999999999999999999999 999999999999999999999999999754332
Q ss_pred ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~ 209 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 3344567999999999999999999999999999999999999999987653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=337.14 Aligned_cols=199 Identities=31% Similarity=0.529 Sum_probs=164.4
Q ss_pred hcccccccccCCCceEEEEEeCCC-----cEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTG-----ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
.|++.++||+|+||+||+|.+.+. ..||||++... ......+|.+|+.++++++|||||+++|++.+.+..+++
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 467788999999999999965432 37999998654 333455789999999999999999999999999999999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+.++++.+.+... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 88 TEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999887543 356999999999999999999999998 999999999999999999999999999754322
Q ss_pred c----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCC-CCCCc
Q 020946 267 K----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS-PLQGL 315 (319)
Q Consensus 267 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~-pf~~~ 315 (319)
. ......||+.|+|||++.+..++.++|||||||++|||++|.. ||.+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 1 2233468999999999999999999999999999999999554 45443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=339.49 Aligned_cols=201 Identities=20% Similarity=0.320 Sum_probs=178.8
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
++|.+.+.||+|+||+||+|.. .+++.||+|++..... +...+.+|+.+|+.++||||+++++++.+.+..|+||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 4688999999999999999965 5788999999976533 3456889999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCC--CceEEeecCCCcccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS--MRARVADFGLSREEMVDKH 268 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~~~ 268 (319)
++|+|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.......
T Consensus 84 ~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 84 SGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 999999998543 346999999999999999999999999 9999999999999854 5899999999986655555
Q ss_pred ccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.....+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 5667799999999999999999999999999999999999999988764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-48 Score=334.46 Aligned_cols=201 Identities=27% Similarity=0.455 Sum_probs=168.7
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCCcceeeeEEeeCC----eE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 183 (319)
++|++.+.||+|+||+||+|. ..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 468899999999999999995 46899999999975432 33457899999999999999999999987654 47
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|+||||+++++|.+++... +.+++.+++.++.|++.||+|||+++ |+||||||+|||++.++..+++|||.+...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 8999999999999988554 46999999999999999999999999 999999999999999999999999987643
Q ss_pred ccc----ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVD----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
... .......||+.|+|||++.+..+++++|||||||++|||+||+.||.+.++
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 222 233456799999999999999999999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-48 Score=342.78 Aligned_cols=199 Identities=29% Similarity=0.453 Sum_probs=170.9
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC---cccHHHHHH---HHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQT---EVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
.|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+ ++.+++.++||||+++++++.+.+..|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 478889999999999999965 579999999985421 122233333 4677788899999999999999999999
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 vmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999654 45899999999999999999999999 99999999999999999999999999975433
Q ss_pred cccccccccccCccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 266 DKHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 266 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.......||+.|+|||++. +..|+.++|||||||++|||+||+.||.+...
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 2344567999999999986 45789999999999999999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-48 Score=329.88 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=177.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc---------ccHHHHHHHHHHHhccC-CCCcceeeeEEeeC
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---------QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEK 180 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 180 (319)
..|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 4678899999999999999964 5789999999865421 11245789999999997 99999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
+..|+||||+++|+|.+++..+ ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999654 46999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccCccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYIS------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+............||+.|+|||.+. ...++.++||||+||++|||++|+.||.+.++
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence 8655554556678999999999884 34578899999999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=340.91 Aligned_cols=197 Identities=24% Similarity=0.381 Sum_probs=172.1
Q ss_pred hcccc-cccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhc-cCCCCcceeeeEEee----CCeEEE
Q 020946 113 TCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGR-LHHRNLVNLVGYCAE----KGQHML 185 (319)
Q Consensus 113 ~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~l 185 (319)
.|.+. +.||+|+||+||+|.. .+++.||||++.. ...+.+|+.++.+ .+||||+++++++.+ ....|+
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 56665 5699999999999954 6799999999853 3456789988665 489999999999875 457899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC---CCceEEeecCCCcc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSRE 262 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~ 262 (319)
||||+++|+|.+++.......+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeee
Confidence 999999999999997655567999999999999999999999999 999999999999985 56799999999986
Q ss_pred ccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...........||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 6555566677899999999999999999999999999999999999999987643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=330.91 Aligned_cols=199 Identities=33% Similarity=0.566 Sum_probs=167.3
Q ss_pred HhcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEee-CCeEEEEEEEc
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLVYVFM 190 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 190 (319)
..+++.+.||+|+||.||+|.+ .|..||||+++.+ ...+.+.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3467889999999999999988 5789999999654 335679999999999999999999999865 45689999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccccccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 270 (319)
++|+|.+++.......+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.... ...
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--~~~ 158 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQD 158 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC--CCc
Confidence 9999999997655456899999999999999999999988 99999999999999999999999999975432 334
Q ss_pred ccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
...+|+.|+|||++.+..+++++||||||+++|||+| |++||.+.+.+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 4568999999999998999999999999999999998 79999887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=330.09 Aligned_cols=203 Identities=27% Similarity=0.444 Sum_probs=165.2
Q ss_pred HHhcccccccccCCCceEEEEEeCC----CcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 185 (319)
...|++.+.||+|+||+||+|.... +..||||.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4578899999999999999996532 346899988654 3333567999999999999999999999986 467899
Q ss_pred EEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc
Q 020946 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265 (319)
Q Consensus 186 v~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 265 (319)
||||+++|++.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999987543 457999999999999999999999999 99999999999999999999999999975432
Q ss_pred c--ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 266 D--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 266 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
. .......||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 2 22334568999999999999999999999999999999998 89999987654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=333.70 Aligned_cols=201 Identities=28% Similarity=0.522 Sum_probs=167.9
Q ss_pred hcccccccccCCCceEEEEEeC-CCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMS-TGE----TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 186 (319)
.|++.+.||+|+||+||+|... +|+ .||+|.+... .....++|.+|+.++++++|||||+++|+|.+. ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 4788899999999999999653 444 5889988654 344567899999999999999999999999875 56788
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
++|+.+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 8999999999988654 457999999999999999999999998 999999999999999999999999998754332
Q ss_pred c---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 267 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 2 2233468999999999999999999999999999999998 89999987654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=328.18 Aligned_cols=200 Identities=28% Similarity=0.441 Sum_probs=171.6
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.|.+.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 577889999999999999964 679999999986542 23356889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccc-ccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKH 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-~~~ 268 (319)
+.+ ++..++.......+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.... ...
T Consensus 83 ~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 83 LHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred cCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 964 5555665555667999999999999999999999999 99999999999999999999999999875433 234
Q ss_pred ccccccccCccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 269 AANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.....||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 44567999999999876655 5789999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=331.66 Aligned_cols=205 Identities=32% Similarity=0.555 Sum_probs=174.8
Q ss_pred HHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeE
Q 020946 111 KATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183 (319)
Q Consensus 111 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 183 (319)
+..|++.+.||+|+||+||+|+.. ++..||||++.... ....++|.+|+.++++++||||++++++|.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 346788899999999999999753 45789999987653 33356799999999999999999999999999999
Q ss_pred EEEEEEccCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCC
Q 020946 184 MLVYVFMSKGSLASHLYDEN----------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS 241 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 241 (319)
++++||+++|+|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999986421 234889999999999999999999998 99999999
Q ss_pred CCEEEcCCCceEEeecCCCcccccc---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCC-CCCCCccc
Q 020946 242 SNILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR-SPLQGLME 317 (319)
Q Consensus 242 ~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~-~pf~~~~~ 317 (319)
+|||++.++.+||+|||+++..... .......+|+.|+|||.+.+..|+.++|||||||++|||++|. +||.+.++
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999998743222 2233466889999999999999999999999999999999985 68887765
Q ss_pred c
Q 020946 318 Q 318 (319)
Q Consensus 318 ~ 318 (319)
+
T Consensus 249 ~ 249 (301)
T d1lufa_ 249 E 249 (301)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=330.48 Aligned_cols=195 Identities=30% Similarity=0.401 Sum_probs=165.4
Q ss_pred cccccCCCceEEEEEe-CCCcEEEEEEeccCCcc-----cHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEcc
Q 020946 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ-----GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS 191 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 191 (319)
++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6799999999999965 57899999998654221 13468899999999999999999999999999999999998
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-cccc
Q 020946 192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA 270 (319)
Q Consensus 192 ~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 270 (319)
++++.... .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 84 ~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 84 TDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp EEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred chHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 87766555 33456899999999999999999999999 999999999999999999999999999754333 2334
Q ss_pred ccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 271 NIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 271 ~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
...||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+.++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 5679999999999864 5689999999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=325.42 Aligned_cols=202 Identities=31% Similarity=0.515 Sum_probs=163.1
Q ss_pred HhcccccccccCCCceEEEEEeC--CC--cEEEEEEeccC---CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS--TG--ETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 184 (319)
..|++.+.||+|+||+||+|... ++ ..||||++... .....++|.+|+.++++++||||++++|+|.+. ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 35788899999999999999642 33 37899988654 233356799999999999999999999999764 678
Q ss_pred EEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccc
Q 020946 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264 (319)
Q Consensus 185 lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 264 (319)
+||||+++|++.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998886543 46999999999999999999999998 9999999999999999999999999998543
Q ss_pred ccc----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccc
Q 020946 265 VDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEQ 318 (319)
Q Consensus 265 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~~ 318 (319)
... ......++..|+|||++.+..++.++||||||+++|||+| |+.||.+.+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 322 2233457889999999999999999999999999999998 89999887653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=327.37 Aligned_cols=208 Identities=33% Similarity=0.543 Sum_probs=173.7
Q ss_pred HHHHHHhcccccccccCCCceEEEEEeC--------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCCcceeeeE
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATDSK-QGEKEFQTEVMLLGRL-HHRNLVNLVGY 176 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~ 176 (319)
+++....|.+.+.||+|+||.||+|+.. ++..||||++..+.. ....++.+|...+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4455668889999999999999999642 224799999976533 3356788898888888 79999999999
Q ss_pred EeeCCeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCC
Q 020946 177 CAEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS 242 (319)
Q Consensus 177 ~~~~~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~ 242 (319)
|.+.+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+++ ++||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 999999999999999999999996543 245899999999999999999999999 999999999
Q ss_pred CEEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 243 NILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 243 Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|||++.++.+||+|||+++...... ......+|+.|+|||.+.+..|+.++||||||+++|||++ |++||.+.+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999999999999999987543332 2334678999999999999999999999999999999998 7999987664
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=324.86 Aligned_cols=199 Identities=28% Similarity=0.394 Sum_probs=162.0
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC----eEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLVYV 188 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 188 (319)
+|.+.+.||+|+||.||+|++ +|+.||||++...... ....+.|+..+..++||||++++++|.+.+ ..++|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 567788999999999999987 6899999998643221 222344566667889999999999998654 6899999
Q ss_pred EccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA-----VPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 189 ~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|+++|+|.+++... .++|.++..++.|++.||.|||+.. .++|+||||||+|||++.++.+||+|||+++..
T Consensus 82 y~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999999653 5999999999999999999999741 134999999999999999999999999998754
Q ss_pred cccc-----cccccccccCccCccccCCCC------CCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVDK-----HAANIRGTFGYLDPEYISTRN------FTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~~-----~~~~~~~t~~y~aPE~~~~~~------~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 3322 233467999999999986543 5778999999999999999998885543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=327.57 Aligned_cols=203 Identities=34% Similarity=0.587 Sum_probs=171.0
Q ss_pred HhcccccccccCCCceEEEEEeC-CCc--EEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEeeCCeEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQMS-TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 186 (319)
..+++.+.||+|+||+||+|.+. +|. .||||.+... .....+.+.+|+++|.++ +||||++++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 35577899999999999999654 444 5788887543 344566899999999998 799999999999999999999
Q ss_pred EEEccCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 187 YVFMSKGSLASHLYDE--------------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
|||+++|+|.+++... ....+++.++.+++.||+.||.|||+++ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 2356999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCccc
Q 020946 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLME 317 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg-~~pf~~~~~ 317 (319)
||+|||+++............+|..|+|||.+.+..++.++|||||||++|||++| .+||.+.+.
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 99999999765554455566789999999999999999999999999999999996 467887654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=327.64 Aligned_cols=207 Identities=34% Similarity=0.565 Sum_probs=165.3
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCCcceeeeEEee
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE 179 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 179 (319)
|+....|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|...+.++ +|+||+.+++++.+
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 344567899999999999999999642 3468999998754 333455677888888776 68999999998876
Q ss_pred C-CeEEEEEEEccCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCE
Q 020946 180 K-GQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI 244 (319)
Q Consensus 180 ~-~~~~lv~e~~~~g~l~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni 244 (319)
. +..+++|||+++|+|.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccce
Confidence 4 46899999999999999996532 235899999999999999999999998 99999999999
Q ss_pred EEcCCCceEEeecCCCcccccc---ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCccc
Q 020946 245 LLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLME 317 (319)
Q Consensus 245 ll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg-~~pf~~~~~ 317 (319)
|+++++.+||+|||+|+..... .......||+.|+|||++.+..++.++|||||||++|||+|| ..||.+...
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999753322 223356799999999999999999999999999999999986 568887653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=324.63 Aligned_cols=202 Identities=26% Similarity=0.404 Sum_probs=170.2
Q ss_pred HhcccccccccCCCceEEEEEe-CC-CcEEEEEEeccC--CcccHHHHHHHHHHHhcc---CCCCcceeeeEEee-----
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-ST-GETVAVKVLATD--SKQGEKEFQTEVMLLGRL---HHRNLVNLVGYCAE----- 179 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----- 179 (319)
.+|++.+.||+|+||+||+|.. .+ ++.||||++... .......+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5788999999999999999965 34 667999998643 222233456777766655 89999999999853
Q ss_pred CCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCC
Q 020946 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259 (319)
Q Consensus 180 ~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 259 (319)
....++++||+.++.+.... ......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence 34689999999876665443 344567999999999999999999999999 99999999999999999999999999
Q ss_pred CccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 260 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
++............||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.++
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 9866666666778899999999999999999999999999999999999999988654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=322.71 Aligned_cols=199 Identities=26% Similarity=0.434 Sum_probs=168.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCc------ccHHHHHHHHHHHhccC--CCCcceeeeEEeeCCe
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK------QGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 182 (319)
.+|++.+.||+|+||+||+|.. .+|+.||||++..... ....++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688999999999999999954 5789999999864321 11234678999999986 8999999999999999
Q ss_pred EEEEEEEccC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-CCceEEeecCCC
Q 020946 183 HMLVYVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLS 260 (319)
Q Consensus 183 ~~lv~e~~~~-g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~ 260 (319)
.++||||+.+ +++.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 5677776543 46999999999999999999999999 999999999999985 479999999999
Q ss_pred ccccccccccccccccCccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 261 REEMVDKHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 261 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
+... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+..
T Consensus 159 ~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 159 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp EECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred eecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 7543 233456779999999999977665 577999999999999999999998743
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=323.47 Aligned_cols=208 Identities=25% Similarity=0.492 Sum_probs=177.7
Q ss_pred HHHHHhcccccccccCCCceEEEEEeC------CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEeeC
Q 020946 108 DLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180 (319)
Q Consensus 108 ~l~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 180 (319)
++....+++.+.||+|+||+||+|.+. ++..||||++... .......|.+|+.++++++||||++++++|...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 444567788999999999999999652 3578999999754 333345689999999999999999999999999
Q ss_pred CeEEEEEEEccCCChhhhhhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCce
Q 020946 181 GQHMLVYVFMSKGSLASHLYDE--------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 252 (319)
+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 9999999999999999988542 2235789999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCcccc
Q 020946 253 RVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLMEQ 318 (319)
Q Consensus 253 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg-~~pf~~~~~~ 318 (319)
||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||+|| +.||.+.+.+
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999997543322 23344689999999999999999999999999999999997 5889877653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=321.65 Aligned_cols=199 Identities=31% Similarity=0.541 Sum_probs=168.3
Q ss_pred hcccccccccCCCceEEEEEeCCC----cEEEEEEeccC-CcccHHHHHHHHHHHhccCCCCcceeeeEEee-CCeEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTG----ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 186 (319)
++++.++||+|+||+||+|.+.++ ..||||++... .....++|.+|++++++++||||++++|++.+ .+..++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 345578899999999999976432 26899998643 44445789999999999999999999999876 4689999
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999999988643 456788899999999999999999998 999999999999999999999999999754322
Q ss_pred c-----cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 267 K-----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 267 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
. ......||+.|+|||.+....++.++||||||+++|||+||+.||...
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 1 222356899999999999999999999999999999999987777653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-46 Score=321.10 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=170.4
Q ss_pred hcccccccccCCCceEEEEEeCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEEc
Q 020946 113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 190 (319)
+|++.+.||+|+||+||+|...+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+++++|+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 577889999999999999988899999999986542 333578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc-ccc
Q 020946 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA 269 (319)
Q Consensus 191 ~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 269 (319)
.++.+..+. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.+...... ...
T Consensus 83 ~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 83 DQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp SEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 876666655 33467999999999999999999999998 999999999999999999999999998654322 223
Q ss_pred cccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 270 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.++
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 44568999999999865 4568999999999999999999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=324.32 Aligned_cols=208 Identities=31% Similarity=0.525 Sum_probs=178.3
Q ss_pred HHHHHHhcccccccccCCCceEEEEEe------CCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCCcceeeeEEe
Q 020946 107 KDLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCA 178 (319)
Q Consensus 107 ~~l~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 178 (319)
+++....|.+.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.+++.+ +|||||+++++|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 455567888999999999999999964 345689999997653 33455789999999999 6999999999999
Q ss_pred eCCeEEEEEEEccCCChhhhhhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCC
Q 020946 179 EKGQHMLVYVFMSKGSLASHLYDEN----------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS 242 (319)
Q Consensus 179 ~~~~~~lv~e~~~~g~l~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~ 242 (319)
+.+..+++|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ ++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999986532 235899999999999999999999999 999999999
Q ss_pred CEEEcCCCceEEeecCCCccccccc---cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCccc
Q 020946 243 NILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317 (319)
Q Consensus 243 Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-g~~pf~~~~~ 317 (319)
|||++.++.+|++|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+| |++||.+...
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999997543322 2234578999999999999999999999999999999999 6777766544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=317.71 Aligned_cols=199 Identities=26% Similarity=0.410 Sum_probs=166.5
Q ss_pred hcccccccccCCCceEEEEE-eCCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCCcceeeeEEeeCC----eEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLV 186 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 186 (319)
+|++.+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 58888999999999999995 4689999999986543 334567889999999999999999999987643 34555
Q ss_pred EEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcccccc
Q 020946 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266 (319)
Q Consensus 187 ~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 266 (319)
++|+.+|+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 89 ~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 6777899999999543 5999999999999999999999999 999999999999999999999999998743322
Q ss_pred c----cccccccccCccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 K----HAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~----~~~~~~~t~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
. ......||+.|+|||++ ....++.++||||+||++|||++|+.||.+.++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 2 23456789999999998 455678999999999999999999999987653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=320.41 Aligned_cols=198 Identities=27% Similarity=0.390 Sum_probs=166.1
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCcceeeeEEeeC------CeEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQHML 185 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 185 (319)
+|+..++||+|+||+||+|.. .+|+.||||++..+... ..+|+.+|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 567788999999999999965 57999999998654322 24799999999999999999998543 34789
Q ss_pred EEEEccCCChhhhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCccc
Q 020946 186 VYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREE 263 (319)
Q Consensus 186 v~e~~~~g~l~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 263 (319)
||||++++.+..... ......+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999997654433332 234557999999999999999999999998 99999999999999765 8999999999866
Q ss_pred cccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
..........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.++
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 55555666789999999998764 5789999999999999999999999987653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=315.06 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=167.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEee--------C
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--------K 180 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 180 (319)
.+|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788999999999999999965 58999999998644 33345678899999999999999999998855 3
Q ss_pred CeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCC
Q 020946 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260 (319)
Q Consensus 181 ~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 260 (319)
+..+++|||+.++.+.... .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 4679999999877666544 34456899999999999999999999998 999999999999999999999999998
Q ss_pred cccccc-----ccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 261 REEMVD-----KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 261 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.++
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 643221 222345689999999998654 689999999999999999999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-44 Score=311.46 Aligned_cols=199 Identities=21% Similarity=0.298 Sum_probs=170.6
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC-CCcceeeeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 189 (319)
.+|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+|++.++.++| +|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 4688999999999999999964 578999999885542 23456788899998865 8999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcC-----CCceEEeecCCCcccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-----SMRARVADFGLSREEM 264 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~ 264 (319)
+ +++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 8 68998887543 356999999999999999999999999 999999999999974 5789999999997432
Q ss_pred cc--------ccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 265 VD--------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 265 ~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
.. .......||+.|+|||++.+..++.++||||||+++|||+||+.||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 21 123346799999999999999999999999999999999999999987654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=315.69 Aligned_cols=196 Identities=28% Similarity=0.439 Sum_probs=163.0
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEeeCC------e
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------Q 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 182 (319)
.+|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+|+.++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 4688889999999999999964 57999999999754 2333567889999999999999999999997654 5
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++||||+ +.+|...... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 98 ~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence 79999999 5567666633 35999999999999999999999999 99999999999999999999999999975
Q ss_pred ccccccccccccccCccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 263 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.. .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 43 33445679999999999865 567899999999999999999999998765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=311.85 Aligned_cols=202 Identities=30% Similarity=0.440 Sum_probs=172.3
Q ss_pred HhcccccccccCCCceEEEEEe----CCCcEEEEEEeccC----CcccHHHHHHHHHHHhccCC-CCcceeeeEEeeCCe
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAEKGQ 182 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 182 (319)
..|++.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4588999999999999999954 25789999998643 22334568899999999966 899999999999999
Q ss_pred EEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 183 ~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
.++++||+.+|+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999986543 5788999999999999999999999 99999999999999999999999999874
Q ss_pred ccc--cccccccccccCccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 020946 263 EMV--DKHAANIRGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGLMEQ 318 (319)
Q Consensus 263 ~~~--~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltg~~pf~~~~~~ 318 (319)
... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||.+....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 322 2233456799999999998654 4688999999999999999999999887543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-43 Score=308.94 Aligned_cols=194 Identities=21% Similarity=0.355 Sum_probs=169.1
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEee--CCeEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAE--KGQHMLVY 187 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 187 (319)
..|++.+.||+|+||+||+|.. .+|+.||+|+++.. ..+++.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4788999999999999999965 67999999998643 3567889999999995 9999999999874 45689999
Q ss_pred EEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCC-ceEEeecCCCcccccc
Q 020946 188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVD 266 (319)
Q Consensus 188 e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~ 266 (319)
||+.+++|.... +.+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999987654 35999999999999999999999999 99999999999998654 6999999999866555
Q ss_pred ccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 267 KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 267 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
.......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 556667899999999998664 57999999999999999999999997643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-43 Score=303.63 Aligned_cols=199 Identities=23% Similarity=0.337 Sum_probs=164.4
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCccee-eeEEeeCCeEEEEEEE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL-VGYCAEKGQHMLVYVF 189 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e~ 189 (319)
.+|++.+.||+|+||.||+|.. .+|+.||||++..... ..++..|+++++.++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 3688999999999999999964 5789999999865432 3457889999999987776555 4555777888999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEc---CCCceEEeecCCCcccccc
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMVD 266 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~ 266 (319)
+ ++++...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 8 5566665543 3456999999999999999999999999 99999999999986 4557999999999754322
Q ss_pred c--------cccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 267 K--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 267 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 1 22345799999999999999999999999999999999999999987654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=311.59 Aligned_cols=196 Identities=24% Similarity=0.335 Sum_probs=159.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCCcceeeeEEee------CCeE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE------KGQH 183 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~ 183 (319)
+|++.+.||+|+||+||+|.. .+|+.||||++... ......++.+|+.++++++||||+++++++.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 578889999999999999965 57999999999754 23344578899999999999999999999863 3688
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
|+||||+.++ +.+.+. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++..
T Consensus 98 ~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 98 YLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 9999999654 444442 35899999999999999999999999 999999999999999999999999998866
Q ss_pred cccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 020946 264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM 316 (319)
Q Consensus 264 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~~ 316 (319)
..........+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.+
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 66556667789999999999999999999999999999999999999998765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=300.54 Aligned_cols=196 Identities=26% Similarity=0.385 Sum_probs=170.2
Q ss_pred hcccccccccCCCceEEEEEe-CCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeCCeEEEEEEE
Q 020946 113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189 (319)
Q Consensus 113 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 189 (319)
+|++.+.||+|+||+||+|+. .+++.||||+++... ......+.+|+.+++.++||||+++++++.+.+..++++++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 578889999999999999964 688999999986543 33457889999999999999999999999999999999999
Q ss_pred ccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccccccc-c
Q 020946 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H 268 (319)
Q Consensus 190 ~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 268 (319)
+.++++..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...... .
T Consensus 83 ~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 83 CDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred ccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99888877764 3457899999999999999999999998 9999999999999999999999999997544332 3
Q ss_pred ccccccccCccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCC
Q 020946 269 AANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQ 313 (319)
Q Consensus 269 ~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltg~~pf~ 313 (319)
.....+++.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 33455788899999986654 6899999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=309.25 Aligned_cols=198 Identities=26% Similarity=0.413 Sum_probs=166.2
Q ss_pred HhcccccccccCCCceEEEEE-eCCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCCcceeeeEEeeC-----CeE
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQH 183 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 183 (319)
.+|++.+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 368888999999999999996 4689999999997542 33345788999999999999999999998643 345
Q ss_pred EEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEeecCCCccc
Q 020946 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263 (319)
Q Consensus 184 ~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 263 (319)
+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++...
T Consensus 98 ~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 677788889999998843 45999999999999999999999999 999999999999999999999999998643
Q ss_pred cccccccccccccCccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 020946 264 MVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317 (319)
Q Consensus 264 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltg~~pf~~~~~ 317 (319)
. .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.++
T Consensus 172 ~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 172 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp T--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred C--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 2 334456789999999987664 568999999999999999999999987653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-37 Score=274.67 Aligned_cols=198 Identities=25% Similarity=0.341 Sum_probs=159.9
Q ss_pred HhcccccccccCCCceEEEEEe-CCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----------CCCcceeeeEEee
Q 020946 112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----------HRNLVNLVGYCAE 179 (319)
Q Consensus 112 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 179 (319)
.+|.+.+.||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4689999999999999999965 6899999999975432 2456778888887775 5789999988764
Q ss_pred --CCeEEEEEEEccCCC-hhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEcCCCCCCEEEcCCC-----
Q 020946 180 --KGQHMLVYVFMSKGS-LASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSM----- 250 (319)
Q Consensus 180 --~~~~~lv~e~~~~g~-l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~----- 250 (319)
....+++++++..+. ............+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 356667777765543 3334444555678999999999999999999997 66 99999999999998665
Q ss_pred -ceEEeecCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 020946 251 -RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315 (319)
Q Consensus 251 -~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGvil~elltg~~pf~~~ 315 (319)
.++++|||.+.... .......||+.|+|||++....++.++|+||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 39999999986432 2334567999999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=8.7e-27 Score=187.09 Aligned_cols=167 Identities=13% Similarity=0.159 Sum_probs=117.8
Q ss_pred ccccccccCCCceEEEEEeCCCcEEEEEEeccCCc------------------ccHHHHHHHHHHHhccCCCCcceeeeE
Q 020946 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK------------------QGEKEFQTEVMLLGRLHHRNLVNLVGY 176 (319)
Q Consensus 115 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 176 (319)
.+.+.||+|+||+||+|...+|+.||||+++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46788999999999999888899999998753210 011234568888999999999888765
Q ss_pred EeeCCeEEEEEEEccCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEcCCCCCCEEEcCCCceEEee
Q 020946 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD 256 (319)
Q Consensus 177 ~~~~~~~~lv~e~~~~g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 256 (319)
. ..+++|||+++..+.. ++......++.|++.+++|||+++ |+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 3 2378999998755432 334456789999999999999999 9999999999999976 589999
Q ss_pred cCCCccccccccccccccccCccCccccCCCCCCcchhhHHHHH
Q 020946 257 FGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300 (319)
Q Consensus 257 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~slGv 300 (319)
||.|..............+...+ .+. ..+.|+.++|+||..-
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~~~-~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVRNI-ITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHHHH-HHH-HHHHHCCCCCHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHHHH-HHH-HcCCCCCcccHHHHHH
Confidence 99986432221110000000000 011 1366788999999653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.81 E-value=1.6e-08 Score=83.16 Aligned_cols=141 Identities=16% Similarity=0.111 Sum_probs=93.9
Q ss_pred cccccccccCCCceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCCcceeeeEEeeCCeEEEEEEEccC
Q 020946 114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSK 192 (319)
Q Consensus 114 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 192 (319)
+++.+..+.++.+.||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+..+.+..+++|+++++
T Consensus 16 ~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G 94 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred eEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccc
Confidence 34444434344578999875 56667788876544334445677888877664 43456788888888999999999998
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----------------------------------------
Q 020946 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV----------------------------------------- 231 (319)
Q Consensus 193 g~l~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----------------------------------------- 231 (319)
..+.+..... .....++.+++..+..||+...
T Consensus 95 ~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 95 VLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred cccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 7776544211 1122344555555555654211
Q ss_pred ---------------CCeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 232 ---------------PPVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 232 ---------------~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
+.++|+|+.|.|||+++++..-|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999999876667999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.36 E-value=1.4e-06 Score=70.72 Aligned_cols=74 Identities=18% Similarity=0.157 Sum_probs=51.8
Q ss_pred cccCCC-ceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccC--CCCcceeeeEEeeCCeEEEEEEEccCCChh
Q 020946 120 IGQGAF-GPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQHMLVYVFMSKGSLA 196 (319)
Q Consensus 120 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~l~ 196 (319)
+..|.. +.||+....++..+.+|....... ..+..|...++.+. .-.+.+++.+..+.+..+++|+++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 679999887788889998654432 34566777776653 233566788888888899999999876553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.89 E-value=4.5e-05 Score=65.87 Aligned_cols=75 Identities=15% Similarity=0.044 Sum_probs=46.4
Q ss_pred cccccCCCceEEEEEeC-CCcEEEEEEeccC-------CcccHHHHHHHHHHHhccC-C-C-CcceeeeEEeeCCeEEEE
Q 020946 118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATD-------SKQGEKEFQTEVMLLGRLH-H-R-NLVNLVGYCAEKGQHMLV 186 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h-~-niv~~~~~~~~~~~~~lv 186 (319)
+.||.|..-.||+.... +++.+++|..... -....++...|...|+.+. + | .+.+++.+ +.+..+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999764 4678899964321 1112344566777777662 2 3 34445543 44566889
Q ss_pred EEEccCCC
Q 020946 187 YVFMSKGS 194 (319)
Q Consensus 187 ~e~~~~g~ 194 (319)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99987643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.43 E-value=0.00058 Score=57.06 Aligned_cols=67 Identities=15% Similarity=0.137 Sum_probs=44.8
Q ss_pred ceEEEEEeCCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCc--ceeee-----EEeeCCeEEEEEEEccCC
Q 020946 126 GPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL--VNLVG-----YCAEKGQHMLVYVFMSKG 193 (319)
Q Consensus 126 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~g 193 (319)
-.||++...+|..+++|+..... ...+++..|+..+..+....+ +..+. .....+..+.+++++++.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47999998899999999986542 235667788887777642211 11111 234466788899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.72 E-value=0.0047 Score=52.73 Aligned_cols=72 Identities=18% Similarity=0.265 Sum_probs=46.1
Q ss_pred cccccCCCceEEEEEeCC--------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCCc-ceeeeEEeeCCeEEEEEE
Q 020946 118 TLIGQGAFGPVYKAQMST--------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYV 188 (319)
Q Consensus 118 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 188 (319)
+.|+.|-.=.+|+....+ ...|.+++... ........+|..+++.+.-.++ .++++++.+ .+|++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 457777778899987543 34677777652 2223455678888887753344 456776642 57889
Q ss_pred EccCCCh
Q 020946 189 FMSKGSL 195 (319)
Q Consensus 189 ~~~~g~l 195 (319)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9876443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.98 E-value=0.063 Score=43.72 Aligned_cols=30 Identities=23% Similarity=0.322 Sum_probs=26.7
Q ss_pred CeEEcCCCCCCEEEcCCCceEEeecCCCcc
Q 020946 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE 262 (319)
Q Consensus 233 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 262 (319)
++||+|+.++||+++.+...-|.||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 499999999999999887778999998753
|